id	sid	tid	token	lemma	pos
admet-3007	1	1	nano	nano	NOUN
admet-3007	1	2	-	-	PUNCT
admet-3007	1	3	biomaterials	biomaterial	NOUN
admet-3007	1	4	in	in	ADP
admet-3007	1	5	cancer	cancer	NOUN
admet-3007	1	6	therapy	therapy	NOUN
admet-3007	1	7	:	:	PUNCT
admet-3007	1	8	advances	advance	NOUN
admet-3007	1	9	in	in	ADP
admet-3007	1	10	targeting	target	VERB
admet-3007	1	11	and	and	CCONJ
admet-3007	1	12	overcoming	overcome	VERB
admet-3007	1	13	cancer	cancer	NOUN
admet-3007	1	14	stem	stem	NOUN
admet-3007	1	15	cell	cell	NOUN
admet-3007	1	16	resistance	resistance	NOUN
admet-3007	1	17	doi	doi	PROPN
admet-3007	1	18	:	:	PUNCT
admet-3007	1	19	http://dx.doi.org/10.5599/admet.3007	http://dx.doi.org/10.5599/admet.3007	PRON
admet-3007	1	20	1	1	NUM
admet-3007	1	21	admet	admet	X
admet-3007	1	22	&	&	CCONJ
admet-3007	1	23	dmpk	dmpk	PROPN
admet-3007	1	24	13(5	13(5	NUM
admet-3007	1	25	)	)	PUNCT
admet-3007	1	26	(	(	PUNCT
admet-3007	1	27	2025	2025	NUM
admet-3007	1	28	)	)	PUNCT
admet-3007	1	29	3007	3007	NUM
admet-3007	1	30	;	;	PUNCT
admet-3007	1	31	doi	doi	NOUN
admet-3007	1	32	:	:	PUNCT
admet-3007	1	33	https://doi.org/10.5599/admet.3007	https://doi.org/10.5599/admet.3007	NOUN
admet-3007	1	34	open	open	ADJ
admet-3007	1	35	access	access	NOUN
admet-3007	1	36	:	:	PUNCT
admet-3007	1	37	issn	issn	PROPN
admet-3007	1	38	:	:	PUNCT
admet-3007	1	39	1848	1848	NUM
admet-3007	1	40	-	-	SYM
admet-3007	1	41	7718	7718	NUM
admet-3007	1	42	http://www.pub.iapchem.org/ojs/index.ph-p/admet/index	http://www.pub.iapchem.org/ojs/index.ph-p/admet/index	PROPN
admet-3007	1	43	review	review	NOUN
admet-3007	1	44	paper	paper	NOUN
admet-3007	1	45	nano	nano	NOUN
admet-3007	1	46	-	-	PUNCT
admet-3007	1	47	biomaterials	biomaterial	NOUN
admet-3007	1	48	in	in	ADP
admet-3007	1	49	cancer	cancer	NOUN
admet-3007	1	50	therapy	therapy	NOUN
admet-3007	1	51	:	:	PUNCT
admet-3007	1	52	advances	advance	NOUN
admet-3007	1	53	in	in	ADP
admet-3007	1	54	targeting	target	VERB
admet-3007	1	55	and	and	CCONJ
admet-3007	1	56	overcoming	overcome	VERB
admet-3007	1	57	cancer	cancer	NOUN
admet-3007	1	58	stem	stem	NOUN
admet-3007	1	59	cell	cell	NOUN
admet-3007	1	60	resistance	resistance	NOUN
admet-3007	1	61	marzieh	marzieh	PROPN
admet-3007	1	62	dehghani1	dehghani1	PROPN
admet-3007	1	63	,	,	PUNCT
admet-3007	1	64	behnam	behnam	NOUN
admet-3007	1	65	hajipour	hajipour	NOUN
admet-3007	1	66	-	-	PUNCT
admet-3007	1	67	verdom2	verdom2	NOUN
admet-3007	1	68	,	,	PUNCT
admet-3007	1	69	fatemeh	fatemeh	VERB
admet-3007	1	70	rahimzadeh3	rahimzadeh3	NOUN
admet-3007	1	71	and	and	CCONJ
admet-3007	1	72	parviz	parviz	ADJ
admet-3007	1	73	abdolmaleki1	abdolmaleki1	NOUN
admet-3007	1	74	,	,	PUNCT
admet-3007	1	75	*	*	PROPN
admet-3007	1	76	1department	1department	NUM
admet-3007	1	77	of	of	ADP
admet-3007	1	78	biophysics	biophysic	NOUN
admet-3007	1	79	,	,	PUNCT
admet-3007	1	80	faculty	faculty	NOUN
admet-3007	1	81	of	of	ADP
admet-3007	1	82	biological	biological	ADJ
admet-3007	1	83	sciences	science	NOUN
admet-3007	1	84	,	,	PUNCT
admet-3007	1	85	tarbiat	tarbiat	PROPN
admet-3007	1	86	modares	modares	PROPN
admet-3007	1	87	university	university	PROPN
admet-3007	1	88	,	,	PUNCT
admet-3007	1	89	tehran	tehran	PROPN
admet-3007	1	90	,	,	PUNCT
admet-3007	1	91	14115	14115	NUM
admet-3007	1	92	-	-	SYM
admet-3007	1	93	154	154	NUM
admet-3007	1	94	,	,	PUNCT
admet-3007	1	95	iran	iran	PROPN
admet-3007	1	96	2integrative	2integrative	NUM
admet-3007	1	97	oncology	oncology	NOUN
admet-3007	1	98	department	department	NOUN
admet-3007	1	99	,	,	PUNCT
admet-3007	1	100	breast	breast	NOUN
admet-3007	1	101	cancer	cancer	NOUN
admet-3007	1	102	research	research	NOUN
admet-3007	1	103	center	center	NOUN
admet-3007	1	104	,	,	PUNCT
admet-3007	1	105	motamed	motamed	PROPN
admet-3007	1	106	cancer	cancer	PROPN
admet-3007	1	107	institute	institute	PROPN
admet-3007	1	108	,	,	PUNCT
admet-3007	1	109	academic	academic	ADJ
admet-3007	1	110	center	center	NOUN
admet-3007	1	111	for	for	ADP
admet-3007	1	112	education	education	NOUN
admet-3007	1	113	,	,	PUNCT
admet-3007	1	114	culture	culture	NOUN
admet-3007	1	115	and	and	CCONJ
admet-3007	1	116	research	research	NOUN
admet-3007	1	117	(	(	PUNCT
admet-3007	1	118	acecr	acecr	NOUN
admet-3007	1	119	)	)	PUNCT
admet-3007	1	120	,	,	PUNCT
admet-3007	1	121	tehran	tehran	NOUN
admet-3007	1	122	,	,	PUNCT
admet-3007	1	123	1517964311	1517964311	NUM
admet-3007	1	124	,	,	PUNCT
admet-3007	1	125	iran	iran	PROPN
admet-3007	1	126	3faculty	3faculty	NUM
admet-3007	1	127	of	of	ADP
admet-3007	1	128	medicine	medicine	NOUN
admet-3007	1	129	and	and	CCONJ
admet-3007	1	130	health	health	NOUN
admet-3007	1	131	,	,	PUNCT
admet-3007	1	132	university	university	PROPN
admet-3007	1	133	of	of	ADP
admet-3007	1	134	sydney	sydney	PROPN
admet-3007	1	135	,	,	PUNCT
admet-3007	1	136	sydney	sydney	PROPN
admet-3007	1	137	,	,	PUNCT
admet-3007	1	138	nsw	nsw	PROPN
admet-3007	1	139	2015	2015	NUM
admet-3007	1	140	,	,	PUNCT
admet-3007	1	141	australia	australia	PROPN
admet-3007	1	142	*	*	PUNCT
admet-3007	1	143	corresponding	correspond	VERB
admet-3007	1	144	author	author	NOUN
admet-3007	1	145	:	:	PUNCT
admet-3007	1	146	e	e	NOUN
admet-3007	1	147	-	-	NOUN
admet-3007	1	148	mail	mail	NOUN
admet-3007	1	149	:	:	PUNCT
admet-3007	2	1	parviz@modares.ac.ir	parviz@modares.ac.ir	NOUN
admet-3007	2	2	;	;	PUNCT
admet-3007	2	3	tel	tel	PROPN
admet-3007	2	4	.	.	PUNCT
admet-3007	2	5	:	:	PUNCT
admet-3007	3	1	+98	+98	NUM
admet-3007	3	2	-	-	PUNCT
admet-3007	3	3	21	21	NUM
admet-3007	3	4	-	-	PUNCT
admet-3007	3	5	8288	8288	NUM
admet-3007	3	6	-	-	PUNCT
admet-3007	3	7	3404	3404	NUM
admet-3007	3	8	;	;	PUNCT
admet-3007	3	9	fax	fax	NOUN
admet-3007	3	10	:	:	PUNCT
admet-3007	3	11	+98	+98	ADJ
admet-3007	3	12	-	-	PUNCT
admet-3007	3	13	21	21	NUM
admet-3007	3	14	-	-	PUNCT
admet-3007	3	15	8288	8288	NUM
admet-3007	3	16	-	-	SYM
admet-3007	3	17	4717	4717	NUM
admet-3007	3	18	received	receive	VERB
admet-3007	3	19	:	:	PUNCT
admet-3007	3	20	august	august	PROPN
admet-3007	3	21	18	18	NUM
admet-3007	3	22	,	,	PUNCT
admet-3007	3	23	2025	2025	NUM
admet-3007	3	24	;	;	PUNCT
admet-3007	3	25	revised	revise	VERB
admet-3007	3	26	:	:	PUNCT
admet-3007	3	27	october	october	PROPN
admet-3007	3	28	19	19	NUM
admet-3007	3	29	,	,	PUNCT
admet-3007	3	30	2025	2025	NUM
admet-3007	3	31	;	;	PUNCT
admet-3007	3	32	october	october	PROPN
admet-3007	3	33	24	24	NUM
admet-3007	3	34	,	,	PUNCT
admet-3007	3	35	2025	2025	NUM
admet-3007	3	36	abstract	abstract	ADJ
admet-3007	3	37	background	background	NOUN
admet-3007	3	38	and	and	CCONJ
admet-3007	3	39	purpose	purpose	NOUN
admet-3007	3	40	:	:	PUNCT
admet-3007	3	41	cancer	cancer	NOUN
admet-3007	3	42	remains	remain	VERB
admet-3007	3	43	a	a	DET
admet-3007	3	44	leading	lead	VERB
admet-3007	3	45	cause	cause	NOUN
admet-3007	3	46	of	of	ADP
admet-3007	3	47	death	death	NOUN
admet-3007	3	48	globally	globally	ADV
admet-3007	3	49	,	,	PUNCT
admet-3007	3	50	with	with	ADP
admet-3007	3	51	long	long	ADJ
admet-3007	3	52	-	-	PUNCT
admet-3007	3	53	term	term	NOUN
admet-3007	3	54	treatment	treatment	NOUN
admet-3007	3	55	success	success	NOUN
admet-3007	3	56	hindered	hinder	VERB
admet-3007	3	57	by	by	ADP
admet-3007	3	58	metastasis	metastasis	NOUN
admet-3007	3	59	,	,	PUNCT
admet-3007	3	60	recurrence	recurrence	NOUN
admet-3007	3	61	,	,	PUNCT
admet-3007	3	62	and	and	CCONJ
admet-3007	3	63	therapy	therapy	NOUN
admet-3007	3	64	resistance	resistance	NOUN
admet-3007	3	65	.	.	PUNCT
admet-3007	4	1	a	a	DET
admet-3007	4	2	central	central	ADJ
admet-3007	4	3	driver	driver	NOUN
admet-3007	4	4	of	of	ADP
admet-3007	4	5	these	these	DET
admet-3007	4	6	limitations	limitation	NOUN
admet-3007	4	7	is	be	AUX
admet-3007	4	8	cancer	cancer	NOUN
admet-3007	4	9	stem	stem	NOUN
admet-3007	4	10	cells	cell	NOUN
admet-3007	4	11	(	(	PUNCT
admet-3007	4	12	cscs	cscs	PROPN
admet-3007	4	13	)	)	PUNCT
admet-3007	4	14	a	a	DET
admet-3007	4	15	rare	rare	ADJ
admet-3007	4	16	subpopulation	subpopulation	NOUN
admet-3007	4	17	of	of	ADP
admet-3007	4	18	tumour	tumour	NOUN
admet-3007	4	19	cells	cell	NOUN
admet-3007	4	20	endowed	endow	VERB
admet-3007	4	21	with	with	ADP
admet-3007	4	22	self	self	NOUN
admet-3007	4	23	-	-	PUNCT
admet-3007	4	24	renewal	renewal	NOUN
admet-3007	4	25	and	and	CCONJ
admet-3007	4	26	differentiation	differentiation	NOUN
admet-3007	4	27	potential	potential	NOUN
admet-3007	4	28	.	.	PUNCT
admet-3007	5	1	cscs	cscs	PROPN
admet-3007	5	2	contribute	contribute	VERB
admet-3007	5	3	critically	critically	ADV
admet-3007	5	4	to	to	ADP
admet-3007	5	5	tumour	tumour	NOUN
admet-3007	5	6	progression	progression	NOUN
admet-3007	5	7	,	,	PUNCT
admet-3007	5	8	metastatic	metastatic	ADJ
admet-3007	5	9	spread	spread	NOUN
admet-3007	5	10	,	,	PUNCT
admet-3007	5	11	and	and	CCONJ
admet-3007	5	12	resistance	resistance	NOUN
admet-3007	5	13	to	to	ADP
admet-3007	5	14	conventional	conventional	ADJ
admet-3007	5	15	therapies	therapy	NOUN
admet-3007	5	16	,	,	PUNCT
admet-3007	5	17	yet	yet	CCONJ
admet-3007	5	18	no	no	DET
admet-3007	5	19	clinically	clinically	ADV
admet-3007	5	20	validated	validate	VERB
admet-3007	5	21	strategies	strategy	NOUN
admet-3007	5	22	currently	currently	ADV
admet-3007	5	23	exist	exist	VERB
admet-3007	5	24	to	to	PART
admet-3007	5	25	accurately	accurately	ADV
admet-3007	5	26	detect	detect	VERB
admet-3007	5	27	or	or	CCONJ
admet-3007	5	28	selectively	selectively	ADV
admet-3007	5	29	eliminate	eliminate	VERB
admet-3007	5	30	them	they	PRON
admet-3007	5	31	.	.	PUNCT
admet-3007	6	1	review	review	NOUN
admet-3007	6	2	approach	approach	NOUN
admet-3007	6	3	:	:	PUNCT
admet-3007	6	4	the	the	DET
admet-3007	6	5	paper	paper	NOUN
admet-3007	6	6	systematically	systematically	ADV
admet-3007	6	7	examined	examine	VERB
admet-3007	6	8	the	the	DET
admet-3007	6	9	literature	literature	NOUN
admet-3007	6	10	on	on	ADP
admet-3007	6	11	csc	csc	PROPN
admet-3007	6	12	origin	origin	NOUN
admet-3007	6	13	,	,	PUNCT
admet-3007	6	14	phenotypic	phenotypic	ADJ
admet-3007	6	15	characterization	characterization	NOUN
admet-3007	6	16	,	,	PUNCT
admet-3007	6	17	isolation	isolation	NOUN
admet-3007	6	18	techniques	technique	NOUN
admet-3007	6	19	,	,	PUNCT
admet-3007	6	20	and	and	CCONJ
admet-3007	6	21	mechanisms	mechanism	VERB
admet-3007	6	22	underlying	underlying	ADJ
admet-3007	6	23	resistance	resistance	NOUN
admet-3007	6	24	,	,	PUNCT
admet-3007	6	25	including	include	VERB
admet-3007	6	26	dormancy	dormancy	NOUN
admet-3007	6	27	,	,	PUNCT
admet-3007	6	28	enhanced	enhance	VERB
admet-3007	6	29	dna	dna	PROPN
admet-3007	6	30	repair	repair	NOUN
admet-3007	6	31	,	,	PUNCT
admet-3007	6	32	apoptosis	apoptosis	NOUN
admet-3007	6	33	evasion	evasion	NOUN
admet-3007	6	34	,	,	PUNCT
admet-3007	6	35	and	and	CCONJ
admet-3007	6	36	microenvironmental	microenvironmental	ADJ
admet-3007	6	37	protection	protection	NOUN
admet-3007	6	38	.	.	PUNCT
admet-3007	7	1	particular	particular	ADJ
admet-3007	7	2	attention	attention	NOUN
admet-3007	7	3	was	be	AUX
admet-3007	7	4	given	give	VERB
admet-3007	7	5	to	to	ADP
admet-3007	7	6	recent	recent	ADJ
admet-3007	7	7	advances	advance	NOUN
admet-3007	7	8	in	in	ADP
admet-3007	7	9	nanomaterial	nanomaterial	NOUN
admet-3007	7	10	-	-	PUNCT
admet-3007	7	11	based	base	VERB
admet-3007	7	12	strategies	strategy	NOUN
admet-3007	7	13	metallic	metallic	ADJ
admet-3007	7	14	,	,	PUNCT
admet-3007	7	15	carbon	carbon	NOUN
admet-3007	7	16	,	,	PUNCT
admet-3007	7	17	and	and	CCONJ
admet-3007	7	18	organic	organic	ADJ
admet-3007	7	19	nanocarriers	nanocarrier	NOUN
admet-3007	7	20	,	,	PUNCT
admet-3007	7	21	designed	design	VERB
admet-3007	7	22	to	to	PART
admet-3007	7	23	improve	improve	VERB
admet-3007	7	24	csc	csc	ADJ
admet-3007	7	25	-	-	PUNCT
admet-3007	7	26	specific	specific	ADJ
admet-3007	7	27	drug	drug	NOUN
admet-3007	7	28	delivery	delivery	NOUN
admet-3007	7	29	,	,	PUNCT
admet-3007	7	30	reactive	reactive	ADJ
admet-3007	7	31	oxygen	oxygen	NOUN
admet-3007	7	32	species	specie	NOUN
admet-3007	7	33	generation	generation	NOUN
admet-3007	7	34	,	,	PUNCT
admet-3007	7	35	pathway	pathway	NOUN
admet-3007	7	36	inhibition	inhibition	NOUN
admet-3007	7	37	,	,	PUNCT
admet-3007	7	38	and	and	CCONJ
admet-3007	7	39	modulation	modulation	NOUN
admet-3007	7	40	of	of	ADP
admet-3007	7	41	the	the	DET
admet-3007	7	42	csc	csc	PROPN
admet-3007	7	43	niche	niche	NOUN
admet-3007	7	44	.	.	PUNCT
admet-3007	8	1	key	key	ADJ
admet-3007	8	2	results	result	NOUN
admet-3007	8	3	:	:	PUNCT
admet-3007	8	4	current	current	ADJ
admet-3007	8	5	csc	csc	PROPN
admet-3007	8	6	markers	marker	NOUN
admet-3007	8	7	and	and	CCONJ
admet-3007	8	8	in	in	ADP
admet-3007	8	9	vivo	vivo	NOUN
admet-3007	8	10	models	model	NOUN
admet-3007	8	11	remain	remain	VERB
admet-3007	8	12	ambiguous	ambiguous	ADJ
admet-3007	8	13	and	and	CCONJ
admet-3007	8	14	poorly	poorly	ADV
admet-3007	8	15	standardized	standardize	VERB
admet-3007	8	16	,	,	PUNCT
admet-3007	8	17	limiting	limit	VERB
admet-3007	8	18	translational	translational	ADJ
admet-3007	8	19	progress	progress	NOUN
admet-3007	8	20	.	.	PUNCT
admet-3007	9	1	nanotechnology	nanotechnology	NOUN
admet-3007	9	2	provides	provide	VERB
admet-3007	9	3	promising	promising	ADJ
admet-3007	9	4	solutions	solution	NOUN
admet-3007	9	5	by	by	ADP
admet-3007	9	6	enabling	enable	VERB
admet-3007	9	7	targeted	target	VERB
admet-3007	9	8	delivery	delivery	NOUN
admet-3007	9	9	and	and	CCONJ
admet-3007	9	10	multi	multi	ADJ
admet-3007	9	11	-	-	ADJ
admet-3007	9	12	functional	functional	ADJ
admet-3007	9	13	therapy	therapy	NOUN
admet-3007	9	14	integration	integration	NOUN
admet-3007	9	15	,	,	PUNCT
admet-3007	9	16	yet	yet	CCONJ
admet-3007	9	17	most	most	ADJ
admet-3007	9	18	systems	system	NOUN
admet-3007	9	19	are	be	AUX
admet-3007	9	20	still	still	ADV
admet-3007	9	21	at	at	ADP
admet-3007	9	22	the	the	DET
admet-3007	9	23	preclinical	preclinical	ADJ
admet-3007	9	24	stage	stage	NOUN
admet-3007	9	25	,	,	PUNCT
admet-3007	9	26	constrained	constrain	VERB
admet-3007	9	27	by	by	ADP
admet-3007	9	28	issues	issue	NOUN
admet-3007	9	29	of	of	ADP
admet-3007	9	30	biocompatibility	biocompatibility	NOUN
admet-3007	9	31	,	,	PUNCT
admet-3007	9	32	targeting	target	VERB
admet-3007	9	33	precision	precision	NOUN
admet-3007	9	34	,	,	PUNCT
admet-3007	9	35	and	and	CCONJ
admet-3007	9	36	manufacturing	manufacturing	NOUN
admet-3007	9	37	scalability	scalability	NOUN
admet-3007	9	38	.	.	PUNCT
admet-3007	10	1	conclusion	conclusion	NOUN
admet-3007	10	2	:	:	PUNCT
admet-3007	10	3	multifunctional	multifunctional	ADJ
admet-3007	10	4	nanoplatforms	nanoplatform	NOUN
admet-3007	10	5	hold	hold	VERB
admet-3007	10	6	substantial	substantial	ADJ
admet-3007	10	7	potential	potential	NOUN
admet-3007	10	8	to	to	PART
admet-3007	10	9	overcome	overcome	VERB
admet-3007	10	10	csc	csc	ADJ
admet-3007	10	11	-	-	PUNCT
admet-3007	10	12	driven	drive	VERB
admet-3007	10	13	resistance	resistance	NOUN
admet-3007	10	14	,	,	PUNCT
admet-3007	10	15	improve	improve	VERB
admet-3007	10	16	therapeutic	therapeutic	ADJ
admet-3007	10	17	selectivity	selectivity	NOUN
admet-3007	10	18	,	,	PUNCT
admet-3007	10	19	and	and	CCONJ
admet-3007	10	20	reduce	reduce	VERB
admet-3007	10	21	recurrence	recurrence	NOUN
admet-3007	10	22	.	.	PUNCT
admet-3007	11	1	however	however	ADV
admet-3007	11	2	,	,	PUNCT
admet-3007	11	3	rigorous	rigorous	ADJ
admet-3007	11	4	optimization	optimization	NOUN
admet-3007	11	5	and	and	CCONJ
admet-3007	11	6	clinical	clinical	ADJ
admet-3007	11	7	validation	validation	NOUN
admet-3007	11	8	are	be	AUX
admet-3007	11	9	essential	essential	ADJ
admet-3007	11	10	before	before	SCONJ
admet-3007	11	11	these	these	DET
admet-3007	11	12	technologies	technology	NOUN
admet-3007	11	13	can	can	AUX
admet-3007	11	14	be	be	AUX
admet-3007	11	15	integrated	integrate	VERB
admet-3007	11	16	into	into	ADP
admet-3007	11	17	routine	routine	ADJ
admet-3007	11	18	oncology	oncology	NOUN
admet-3007	11	19	.	.	PUNCT
admet-3007	12	1	this	this	DET
admet-3007	12	2	review	review	NOUN
admet-3007	12	3	advances	advance	VERB
admet-3007	12	4	understanding	understanding	NOUN
admet-3007	12	5	by	by	ADP
admet-3007	12	6	outlining	outline	VERB
admet-3007	12	7	the	the	DET
admet-3007	12	8	intersection	intersection	NOUN
admet-3007	12	9	of	of	ADP
admet-3007	12	10	csc	csc	PROPN
admet-3007	12	11	biology	biology	NOUN
admet-3007	12	12	and	and	CCONJ
admet-3007	12	13	nanomedicine	nanomedicine	NOUN
admet-3007	12	14	,	,	PUNCT
admet-3007	12	15	emphasizing	emphasize	VERB
admet-3007	12	16	translational	translational	ADJ
admet-3007	12	17	pathways	pathway	NOUN
admet-3007	12	18	for	for	ADP
admet-3007	12	19	csc	csc	ADJ
admet-3007	12	20	-	-	PUNCT
admet-3007	12	21	targeted	target	VERB
admet-3007	12	22	cancer	cancer	NOUN
admet-3007	12	23	therapy	therapy	NOUN
admet-3007	12	24	.	.	PUNCT
admet-3007	13	1	©	©	PROPN
admet-3007	13	2	2025	2025	NUM
admet-3007	13	3	by	by	ADP
admet-3007	13	4	the	the	DET
admet-3007	13	5	authors	author	NOUN
admet-3007	13	6	.	.	PUNCT
admet-3007	14	1	this	this	DET
admet-3007	14	2	article	article	NOUN
admet-3007	14	3	is	be	AUX
admet-3007	14	4	an	an	DET
admet-3007	14	5	open	open	ADJ
admet-3007	14	6	-	-	PUNCT
admet-3007	14	7	access	access	NOUN
admet-3007	14	8	article	article	NOUN
admet-3007	14	9	distributed	distribute	VERB
admet-3007	14	10	under	under	ADP
admet-3007	14	11	the	the	DET
admet-3007	14	12	terms	term	NOUN
admet-3007	14	13	and	and	CCONJ
admet-3007	14	14	conditions	condition	NOUN
admet-3007	14	15	of	of	ADP
admet-3007	14	16	the	the	DET
admet-3007	14	17	creative	creative	ADJ
admet-3007	14	18	commons	common	NOUN
admet-3007	14	19	attribution	attribution	NOUN
admet-3007	14	20	license	license	NOUN
admet-3007	14	21	(	(	PUNCT
admet-3007	14	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
admet-3007	14	23	)	)	PUNCT
admet-3007	14	24	.	.	PUNCT
admet-3007	15	1	keywords	keyword	NOUN
admet-3007	15	2	nanocarriers	nanocarrier	NOUN
admet-3007	15	3	;	;	PUNCT
admet-3007	15	4	therapeutic	therapeutic	ADJ
admet-3007	15	5	resistance	resistance	NOUN
admet-3007	15	6	;	;	PUNCT
admet-3007	15	7	drug	drug	NOUN
admet-3007	15	8	delivery	delivery	NOUN
admet-3007	15	9	systems	system	NOUN
admet-3007	15	10	;	;	PUNCT
admet-3007	15	11	nanomedicine	nanomedicine	ADJ
admet-3007	15	12	applications	application	NOUN
admet-3007	15	13	;	;	PUNCT
admet-3007	15	14	tumour	tumour	ADJ
admet-3007	15	15	microenvironment	microenvironment	ADJ
admet-3007	15	16	introduction	introduction	NOUN
admet-3007	15	17	cancer	cancer	NOUN
admet-3007	15	18	is	be	AUX
admet-3007	15	19	a	a	DET
admet-3007	15	20	major	major	ADJ
admet-3007	15	21	threat	threat	NOUN
admet-3007	15	22	to	to	ADP
admet-3007	15	23	human	human	ADJ
admet-3007	15	24	health	health	NOUN
admet-3007	15	25	,	,	PUNCT
admet-3007	15	26	responsible	responsible	ADJ
admet-3007	15	27	for	for	ADP
admet-3007	15	28	about	about	ADV
admet-3007	15	29	1	1	NUM
admet-3007	15	30	in	in	ADP
admet-3007	15	31	every	every	DET
admet-3007	15	32	6	6	NUM
admet-3007	15	33	deaths	death	NOUN
admet-3007	15	34	globally	globally	ADV
admet-3007	15	35	[	[	X
admet-3007	15	36	1	1	NUM
admet-3007	15	37	]	]	PUNCT
admet-3007	15	38	.	.	PUNCT
admet-3007	16	1	in	in	ADP
admet-3007	16	2	2024	2024	NUM
admet-3007	16	3	,	,	PUNCT
admet-3007	16	4	it	it	PRON
admet-3007	16	5	is	be	AUX
admet-3007	16	6	estimated	estimate	VERB
admet-3007	16	7	that	that	SCONJ
admet-3007	16	8	there	there	PRON
admet-3007	16	9	will	will	AUX
admet-3007	16	10	be	be	AUX
admet-3007	16	11	2	2	NUM
admet-3007	16	12	001	001	NUM
admet-3007	16	13	140	140	NUM
admet-3007	16	14	new	new	ADJ
admet-3007	16	15	cancer	cancer	NOUN
admet-3007	16	16	cases	case	NOUN
admet-3007	16	17	and	and	CCONJ
admet-3007	16	18	611	611	NUM
admet-3007	16	19	720	720	NUM
admet-3007	16	20	cancer	cancer	NOUN
admet-3007	16	21	-	-	PUNCT
admet-3007	16	22	related	relate	VERB
admet-3007	16	23	deaths	death	NOUN
admet-3007	16	24	in	in	ADP
admet-3007	16	25	the	the	DET
admet-3007	16	26	united	united	PROPN
admet-3007	16	27	states	states	PROPN
admet-3007	16	28	alone	alone	ADV
admet-3007	17	1	[	[	X
admet-3007	17	2	2	2	NUM
admet-3007	17	3	]	]	PUNCT
admet-3007	17	4	.	.	PUNCT
admet-3007	18	1	despite	despite	SCONJ
admet-3007	18	2	advances	advance	NOUN
admet-3007	18	3	in	in	ADP
admet-3007	18	4	conventional	conventional	ADJ
admet-3007	18	5	cancer	cancer	NOUN
admet-3007	18	6	therapies	therapy	NOUN
admet-3007	18	7	such	such	ADJ
admet-3007	18	8	as	as	ADP
admet-3007	18	9	surgery	surgery	NOUN
admet-3007	18	10	,	,	PUNCT
admet-3007	18	11	radiation	radiation	NOUN
admet-3007	18	12	,	,	PUNCT
admet-3007	18	13	and	and	CCONJ
admet-3007	18	14	chemotherapy	chemotherapy	NOUN
admet-3007	18	15	,	,	PUNCT
admet-3007	18	16	these	these	DET
admet-3007	18	17	treatments	treatment	NOUN
admet-3007	18	18	often	often	ADV
admet-3007	18	19	fail	fail	VERB
admet-3007	18	20	to	to	PART
admet-3007	18	21	eradicate	eradicate	VERB
admet-3007	18	22	tumours	tumour	NOUN
admet-3007	18	23	,	,	PUNCT
admet-3007	18	24	especially	especially	ADV
admet-3007	18	25	in	in	ADP
admet-3007	18	26	aggressive	aggressive	ADJ
admet-3007	18	27	and	and	CCONJ
admet-3007	18	28	metastatic	metastatic	ADJ
admet-3007	18	29	forms	form	NOUN
admet-3007	18	30	[	[	X
admet-3007	18	31	3	3	NUM
admet-3007	18	32	]	]	PUNCT
admet-3007	18	33	.	.	PUNCT
admet-3007	19	1	the	the	DET
admet-3007	19	2	primary	primary	ADJ
admet-3007	19	3	reasons	reason	NOUN
admet-3007	19	4	http://dx.doi.org/10.5599/admet.3007	http://dx.doi.org/10.5599/admet.3007	PRON
admet-3007	19	5	https://doi.org/10.5599/admet.3007	https://doi.org/10.5599/admet.3007	ADJ
admet-3007	19	6	http://www.pub.iapchem.org/ojs/index.php/admet/index	http://www.pub.iapchem.org/ojs/index.php/admet/index	NOUN
admet-3007	19	7	mailto:parviz@modares.ac.ir	mailto:parviz@modares.ac.ir	VERB
admet-3007	19	8	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
admet-3007	19	9	m.	m.	NOUN
admet-3007	19	10	dehghani	dehghani	PROPN
admet-3007	19	11	et	et	PROPN
admet-3007	19	12	al	al	PROPN
admet-3007	19	13	.	.	PROPN
admet-3007	19	14	admet	admet	PROPN
admet-3007	19	15	&	&	CCONJ
admet-3007	19	16	dmpk	dmpk	PROPN
admet-3007	19	17	13(5	13(5	NUM
admet-3007	19	18	)	)	PUNCT
admet-3007	19	19	(	(	PUNCT
admet-3007	19	20	2025	2025	NUM
admet-3007	19	21	)	)	PUNCT
admet-3007	19	22	3007	3007	NUM
admet-3007	19	23	2	2	NUM
admet-3007	19	24	for	for	ADP
admet-3007	19	25	treatment	treatment	NOUN
admet-3007	19	26	failure	failure	NOUN
admet-3007	19	27	include	include	VERB
admet-3007	19	28	metastasis	metastasis	NOUN
admet-3007	19	29	,	,	PUNCT
admet-3007	19	30	recurrence	recurrence	NOUN
admet-3007	19	31	,	,	PUNCT
admet-3007	19	32	tumour	tumour	NOUN
admet-3007	19	33	heterogeneity	heterogeneity	NOUN
admet-3007	19	34	,	,	PUNCT
admet-3007	19	35	and	and	CCONJ
admet-3007	19	36	resistance	resistance	NOUN
admet-3007	19	37	to	to	ADP
admet-3007	19	38	chemotherapy	chemotherapy	NOUN
admet-3007	19	39	and	and	CCONJ
admet-3007	19	40	radiation	radiation	NOUN
admet-3007	19	41	.	.	PUNCT
admet-3007	20	1	all	all	PRON
admet-3007	20	2	of	of	ADP
admet-3007	20	3	these	these	PRON
admet-3007	20	4	are	be	AUX
admet-3007	20	5	linked	link	VERB
admet-3007	20	6	to	to	ADP
admet-3007	20	7	the	the	DET
admet-3007	20	8	presence	presence	NOUN
admet-3007	20	9	of	of	ADP
admet-3007	20	10	cancer	cancer	NOUN
admet-3007	20	11	stem	stem	NOUN
admet-3007	20	12	cells	cell	NOUN
admet-3007	20	13	(	(	PUNCT
admet-3007	20	14	cscs	cscs	PROPN
admet-3007	20	15	)	)	PUNCT
admet-3007	20	16	,	,	PUNCT
admet-3007	20	17	also	also	ADV
admet-3007	20	18	known	know	VERB
admet-3007	20	19	as	as	ADP
admet-3007	20	20	cancer	cancer	NOUN
admet-3007	20	21	-	-	PUNCT
admet-3007	20	22	initiating	initiate	VERB
admet-3007	20	23	or	or	CCONJ
admet-3007	20	24	tumour	tumour	NOUN
admet-3007	20	25	-	-	PUNCT
admet-3007	20	26	initiating	initiate	VERB
admet-3007	20	27	cells	cell	NOUN
admet-3007	20	28	,	,	PUNCT
admet-3007	20	29	within	within	ADP
admet-3007	20	30	the	the	DET
admet-3007	20	31	tumour	tumour	NOUN
admet-3007	20	32	microenvironment	microenvironment	NOUN
admet-3007	20	33	(	(	PUNCT
admet-3007	20	34	tme	tme	NOUN
admet-3007	20	35	)	)	PUNCT
admet-3007	21	1	[	[	X
admet-3007	21	2	4	4	NUM
admet-3007	21	3	]	]	PUNCT
admet-3007	21	4	.	.	PUNCT
admet-3007	22	1	cscs	cscs	PROPN
admet-3007	22	2	were	be	AUX
admet-3007	22	3	first	first	ADV
admet-3007	22	4	identified	identify	VERB
admet-3007	22	5	in	in	ADP
admet-3007	22	6	the	the	DET
admet-3007	22	7	late	late	ADJ
admet-3007	22	8	1990s	1990	NOUN
admet-3007	22	9	by	by	ADP
admet-3007	22	10	john	john	PROPN
admet-3007	22	11	dick	dick	PROPN
admet-3007	22	12	in	in	ADP
admet-3007	22	13	cases	case	NOUN
admet-3007	22	14	of	of	ADP
admet-3007	22	15	acute	acute	ADJ
admet-3007	22	16	myeloid	myeloid	ADJ
admet-3007	22	17	leukaemia	leukaemia	NOUN
admet-3007	23	1	[	[	X
admet-3007	23	2	5	5	NUM
admet-3007	23	3	]	]	PUNCT
admet-3007	23	4	.	.	PUNCT
admet-3007	24	1	like	like	ADP
admet-3007	24	2	normal	normal	ADJ
admet-3007	24	3	stem	stem	NOUN
admet-3007	24	4	cells	cell	NOUN
admet-3007	24	5	,	,	PUNCT
admet-3007	24	6	cscs	cscs	PROPN
admet-3007	24	7	exhibit	exhibit	VERB
admet-3007	24	8	self	self	NOUN
admet-3007	24	9	-	-	PUNCT
admet-3007	24	10	renewal	renewal	NOUN
admet-3007	24	11	and	and	CCONJ
admet-3007	24	12	differentiation	differentiation	NOUN
admet-3007	24	13	capabilities	capability	NOUN
admet-3007	24	14	,	,	PUNCT
admet-3007	24	15	enabling	enable	VERB
admet-3007	24	16	them	they	PRON
admet-3007	24	17	to	to	PART
admet-3007	24	18	generate	generate	VERB
admet-3007	24	19	diverse	diverse	ADJ
admet-3007	24	20	tumour	tumour	NOUN
admet-3007	24	21	cell	cell	NOUN
admet-3007	24	22	populations	population	NOUN
admet-3007	24	23	.	.	PUNCT
admet-3007	25	1	these	these	DET
admet-3007	25	2	properties	property	NOUN
admet-3007	25	3	render	render	VERB
admet-3007	25	4	cscs	cscs	NOUN
admet-3007	25	5	highly	highly	ADV
admet-3007	25	6	tumorigenic	tumorigenic	ADJ
admet-3007	25	7	and	and	CCONJ
admet-3007	25	8	inherently	inherently	ADV
admet-3007	25	9	resistant	resistant	ADJ
admet-3007	25	10	to	to	ADP
admet-3007	25	11	conventional	conventional	ADJ
admet-3007	25	12	therapies	therapy	NOUN
admet-3007	25	13	[	[	X
admet-3007	25	14	6	6	NUM
admet-3007	25	15	]	]	PUNCT
admet-3007	25	16	.	.	PUNCT
admet-3007	26	1	they	they	PRON
admet-3007	26	2	persist	persist	VERB
admet-3007	26	3	as	as	ADP
admet-3007	26	4	a	a	DET
admet-3007	26	5	distinct	distinct	ADJ
admet-3007	26	6	population	population	NOUN
admet-3007	26	7	within	within	ADP
admet-3007	26	8	tumours	tumours	PROPN
admet-3007	26	9	,	,	PUNCT
admet-3007	26	10	contributing	contribute	VERB
admet-3007	26	11	to	to	ADP
admet-3007	26	12	recurrence	recurrence	NOUN
admet-3007	26	13	and	and	CCONJ
admet-3007	26	14	metastasis	metastasis	NOUN
admet-3007	26	15	by	by	ADP
admet-3007	26	16	forming	form	VERB
admet-3007	26	17	new	new	ADJ
admet-3007	26	18	tumours	tumour	NOUN
admet-3007	27	1	[	[	X
admet-3007	27	2	7	7	NUM
admet-3007	27	3	]	]	PUNCT
admet-3007	27	4	.	.	PUNCT
admet-3007	28	1	also	also	ADV
admet-3007	28	2	,	,	PUNCT
admet-3007	28	3	a	a	DET
admet-3007	28	4	major	major	ADJ
admet-3007	28	5	challenge	challenge	NOUN
admet-3007	28	6	in	in	ADP
admet-3007	28	7	targeting	target	VERB
admet-3007	28	8	cscs	cscs	PROPN
admet-3007	28	9	is	be	AUX
admet-3007	28	10	the	the	DET
admet-3007	28	11	lack	lack	NOUN
admet-3007	28	12	of	of	ADP
admet-3007	28	13	universally	universally	ADV
admet-3007	28	14	specific	specific	ADJ
admet-3007	28	15	and	and	CCONJ
admet-3007	28	16	exclusive	exclusive	ADJ
admet-3007	28	17	biomarkers	biomarker	NOUN
admet-3007	28	18	that	that	PRON
admet-3007	28	19	can	can	AUX
admet-3007	28	20	reliably	reliably	ADV
admet-3007	28	21	distinguish	distinguish	VERB
admet-3007	28	22	cscs	cscs	NOUN
admet-3007	28	23	from	from	ADP
admet-3007	28	24	normal	normal	ADJ
admet-3007	28	25	stem	stem	NOUN
admet-3007	28	26	cells	cell	NOUN
admet-3007	28	27	and	and	CCONJ
admet-3007	28	28	other	other	ADJ
admet-3007	28	29	tumour	tumour	ADJ
admet-3007	28	30	cells	cell	NOUN
admet-3007	28	31	.	.	PUNCT
admet-3007	29	1	while	while	SCONJ
admet-3007	29	2	surface	surface	NOUN
admet-3007	29	3	markers	marker	NOUN
admet-3007	29	4	such	such	ADJ
admet-3007	29	5	as	as	ADP
admet-3007	29	6	cd44	cd44	PROPN
admet-3007	29	7	,	,	PUNCT
admet-3007	29	8	cd133	cd133	PROPN
admet-3007	29	9	,	,	PUNCT
admet-3007	29	10	aldehyde	aldehyde	NOUN
admet-3007	29	11	dehydrogenase	dehydrogenase	NOUN
admet-3007	29	12	1	1	NUM
admet-3007	29	13	(	(	PUNCT
admet-3007	29	14	aldh1	aldh1	NOUN
admet-3007	29	15	)	)	PUNCT
admet-3007	29	16	,	,	PUNCT
admet-3007	29	17	and	and	CCONJ
admet-3007	29	18	epithelial	epithelial	ADJ
admet-3007	29	19	cell	cell	NOUN
admet-3007	29	20	adhesion	adhesion	NOUN
admet-3007	29	21	molecule	molecule	NOUN
admet-3007	29	22	(	(	PUNCT
admet-3007	29	23	epcam	epcam	NOUN
admet-3007	29	24	)	)	PUNCT
admet-3007	29	25	have	have	AUX
admet-3007	29	26	been	be	AUX
admet-3007	29	27	widely	widely	ADV
admet-3007	29	28	used	use	VERB
admet-3007	29	29	to	to	PART
admet-3007	29	30	identify	identify	VERB
admet-3007	29	31	cscs	cscs	PROPN
admet-3007	29	32	across	across	ADP
admet-3007	29	33	various	various	ADJ
admet-3007	29	34	tumour	tumour	ADJ
admet-3007	29	35	types	type	NOUN
admet-3007	29	36	,	,	PUNCT
admet-3007	29	37	they	they	PRON
admet-3007	29	38	are	be	AUX
admet-3007	29	39	not	not	PART
admet-3007	29	40	unique	unique	ADJ
admet-3007	29	41	to	to	ADP
admet-3007	29	42	cscs	cscs	PROPN
admet-3007	29	43	and	and	CCONJ
admet-3007	29	44	are	be	AUX
admet-3007	29	45	often	often	ADV
admet-3007	29	46	expressed	express	VERB
admet-3007	29	47	in	in	ADP
admet-3007	29	48	normal	normal	ADJ
admet-3007	29	49	progenitor	progenitor	NOUN
admet-3007	29	50	or	or	CCONJ
admet-3007	29	51	differentiated	differentiated	ADJ
admet-3007	29	52	cells	cell	NOUN
admet-3007	29	53	as	as	ADV
admet-3007	29	54	well	well	ADV
admet-3007	29	55	[	[	X
admet-3007	29	56	8	8	NUM
admet-3007	29	57	]	]	PUNCT
admet-3007	29	58	.	.	PUNCT
admet-3007	30	1	this	this	DET
admet-3007	30	2	overlap	overlap	NOUN
admet-3007	30	3	hampers	hamper	VERB
admet-3007	30	4	the	the	DET
admet-3007	30	5	development	development	NOUN
admet-3007	30	6	of	of	ADP
admet-3007	30	7	precise	precise	ADJ
admet-3007	30	8	diagnostic	diagnostic	ADJ
admet-3007	30	9	tools	tool	NOUN
admet-3007	30	10	and	and	CCONJ
admet-3007	30	11	therapeutic	therapeutic	ADJ
admet-3007	30	12	strategies	strategy	NOUN
admet-3007	30	13	[	[	X
admet-3007	30	14	9	9	NUM
admet-3007	30	15	]	]	PUNCT
admet-3007	30	16	.	.	PUNCT
admet-3007	31	1	as	as	ADP
admet-3007	31	2	a	a	DET
admet-3007	31	3	result	result	NOUN
admet-3007	31	4	,	,	PUNCT
admet-3007	31	5	there	there	PRON
admet-3007	31	6	is	be	VERB
admet-3007	31	7	a	a	DET
admet-3007	31	8	pressing	press	VERB
admet-3007	31	9	need	need	NOUN
admet-3007	31	10	to	to	PART
admet-3007	31	11	discover	discover	VERB
admet-3007	31	12	and	and	CCONJ
admet-3007	31	13	validate	validate	VERB
admet-3007	31	14	novel	novel	ADJ
admet-3007	31	15	csc	csc	ADJ
admet-3007	31	16	-	-	PUNCT
admet-3007	31	17	specific	specific	ADJ
admet-3007	31	18	markers	marker	NOUN
admet-3007	31	19	or	or	CCONJ
admet-3007	31	20	marker	marker	NOUN
admet-3007	31	21	combinations	combination	NOUN
admet-3007	31	22	that	that	PRON
admet-3007	31	23	can	can	AUX
admet-3007	31	24	improve	improve	VERB
admet-3007	31	25	the	the	DET
admet-3007	31	26	specificity	specificity	NOUN
admet-3007	31	27	and	and	CCONJ
admet-3007	31	28	sensitivity	sensitivity	NOUN
admet-3007	31	29	of	of	ADP
admet-3007	31	30	csc	csc	PROPN
admet-3007	31	31	detection	detection	NOUN
admet-3007	31	32	.	.	PUNCT
admet-3007	32	1	therefore	therefore	ADV
admet-3007	32	2	,	,	PUNCT
admet-3007	32	3	developing	develop	VERB
admet-3007	32	4	treatments	treatment	NOUN
admet-3007	32	5	that	that	PRON
admet-3007	32	6	specifically	specifically	ADV
admet-3007	32	7	target	target	VERB
admet-3007	32	8	cscs	cscs	NOUN
admet-3007	32	9	offers	offer	VERB
admet-3007	32	10	promising	promise	VERB
admet-3007	32	11	potential	potential	NOUN
admet-3007	32	12	to	to	PART
admet-3007	32	13	improve	improve	VERB
admet-3007	32	14	both	both	DET
admet-3007	32	15	survival	survival	NOUN
admet-3007	32	16	and	and	CCONJ
admet-3007	32	17	quality	quality	NOUN
admet-3007	32	18	of	of	ADP
admet-3007	32	19	life	life	NOUN
admet-3007	32	20	for	for	ADP
admet-3007	32	21	cancer	cancer	NOUN
admet-3007	32	22	patients	patient	NOUN
admet-3007	32	23	,	,	PUNCT
admet-3007	32	24	especially	especially	ADV
admet-3007	32	25	those	those	PRON
admet-3007	32	26	with	with	ADP
admet-3007	32	27	metastatic	metastatic	ADJ
admet-3007	32	28	disease	disease	NOUN
admet-3007	32	29	.	.	PUNCT
admet-3007	33	1	the	the	DET
admet-3007	33	2	field	field	NOUN
admet-3007	33	3	of	of	ADP
admet-3007	33	4	nanotechnology	nanotechnology	NOUN
admet-3007	33	5	has	have	AUX
admet-3007	33	6	opened	open	VERB
admet-3007	33	7	new	new	ADJ
admet-3007	33	8	avenues	avenue	NOUN
admet-3007	33	9	in	in	ADP
admet-3007	33	10	cancer	cancer	NOUN
admet-3007	33	11	treatment	treatment	NOUN
admet-3007	33	12	,	,	PUNCT
admet-3007	33	13	particularly	particularly	ADV
admet-3007	33	14	in	in	ADP
admet-3007	33	15	cancer	cancer	NOUN
admet-3007	33	16	nanomedicine	nanomedicine	NOUN
admet-3007	33	17	.	.	PUNCT
admet-3007	34	1	over	over	ADP
admet-3007	34	2	the	the	DET
admet-3007	34	3	past	past	ADJ
admet-3007	34	4	decade	decade	NOUN
admet-3007	34	5	,	,	PUNCT
admet-3007	34	6	various	various	ADJ
admet-3007	34	7	organic	organic	ADJ
admet-3007	34	8	and	and	CCONJ
admet-3007	34	9	inorganic	inorganic	ADJ
admet-3007	34	10	nano	nano	NOUN
admet-3007	34	11	-	-	PUNCT
admet-3007	34	12	biomaterials	biomaterial	NOUN
admet-3007	34	13	have	have	AUX
admet-3007	34	14	been	be	AUX
admet-3007	34	15	developed	develop	VERB
admet-3007	34	16	for	for	ADP
admet-3007	34	17	the	the	DET
admet-3007	34	18	diagnosis	diagnosis	NOUN
admet-3007	34	19	and	and	CCONJ
admet-3007	34	20	treatment	treatment	NOUN
admet-3007	34	21	of	of	ADP
admet-3007	34	22	cancer	cancer	NOUN
admet-3007	34	23	[	[	X
admet-3007	34	24	10	10	NUM
admet-3007	34	25	]	]	PUNCT
admet-3007	34	26	.	.	PUNCT
admet-3007	35	1	their	their	PRON
admet-3007	35	2	nanoscale	nanoscale	NOUN
admet-3007	35	3	size	size	NOUN
admet-3007	35	4	,	,	PUNCT
admet-3007	35	5	high	high	ADJ
admet-3007	35	6	surface	surface	NOUN
admet-3007	35	7	-	-	PUNCT
admet-3007	35	8	to	to	ADP
admet-3007	35	9	-	-	PUNCT
admet-3007	35	10	volume	volume	NOUN
admet-3007	35	11	ratio	ratio	NOUN
admet-3007	35	12	,	,	PUNCT
admet-3007	35	13	and	and	CCONJ
admet-3007	35	14	tuneable	tuneable	ADJ
admet-3007	35	15	physicochemical	physicochemical	ADJ
admet-3007	35	16	properties	property	NOUN
admet-3007	35	17	make	make	VERB
admet-3007	35	18	nano	nano	NOUN
admet-3007	35	19	-	-	PUNCT
admet-3007	35	20	biomaterials	biomaterial	NOUN
admet-3007	35	21	uniquely	uniquely	ADV
admet-3007	35	22	suited	suit	VERB
admet-3007	35	23	for	for	ADP
admet-3007	35	24	biomedical	biomedical	ADJ
admet-3007	35	25	applications	application	NOUN
admet-3007	35	26	.	.	PUNCT
admet-3007	36	1	these	these	DET
admet-3007	36	2	platforms	platform	NOUN
admet-3007	36	3	have	have	AUX
admet-3007	36	4	enabled	enable	VERB
admet-3007	36	5	more	more	ADV
admet-3007	36	6	precise	precise	ADJ
admet-3007	36	7	drug	drug	NOUN
admet-3007	36	8	delivery	delivery	NOUN
admet-3007	36	9	,	,	PUNCT
admet-3007	36	10	enhanced	enhanced	ADJ
admet-3007	36	11	imaging	imaging	NOUN
admet-3007	36	12	,	,	PUNCT
admet-3007	36	13	and	and	CCONJ
admet-3007	36	14	selective	selective	ADJ
admet-3007	36	15	targeting	targeting	NOUN
admet-3007	36	16	of	of	ADP
admet-3007	36	17	cscs	cscs	PROPN
admet-3007	36	18	[	[	X
admet-3007	36	19	11	11	NUM
admet-3007	36	20	]	]	SYM
admet-3007	36	21	.	.	PUNCT
admet-3007	37	1	natural	natural	ADJ
admet-3007	37	2	-	-	PUNCT
admet-3007	37	3	based	base	VERB
admet-3007	37	4	biomaterials	biomaterial	NOUN
admet-3007	37	5	play	play	VERB
admet-3007	37	6	a	a	DET
admet-3007	37	7	significant	significant	ADJ
admet-3007	37	8	role	role	NOUN
admet-3007	37	9	in	in	ADP
admet-3007	37	10	cellular	cellular	ADJ
admet-3007	37	11	and	and	CCONJ
admet-3007	37	12	molecular	molecular	ADJ
admet-3007	37	13	biology	biology	NOUN
admet-3007	37	14	,	,	PUNCT
admet-3007	37	15	tissue	tissue	NOUN
admet-3007	37	16	engineering	engineering	NOUN
admet-3007	37	17	,	,	PUNCT
admet-3007	37	18	regenerative	regenerative	ADJ
admet-3007	37	19	medicine	medicine	NOUN
admet-3007	37	20	,	,	PUNCT
admet-3007	37	21	and	and	CCONJ
admet-3007	37	22	material	material	NOUN
admet-3007	37	23	science	science	NOUN
admet-3007	37	24	.	.	PUNCT
admet-3007	38	1	micelles	micelle	NOUN
admet-3007	38	2	,	,	PUNCT
admet-3007	38	3	dendrimers	dendrimer	NOUN
admet-3007	38	4	,	,	PUNCT
admet-3007	38	5	hydrogels	hydrogel	NOUN
admet-3007	38	6	,	,	PUNCT
admet-3007	38	7	liposomes	liposome	NOUN
admet-3007	38	8	,	,	PUNCT
admet-3007	38	9	and	and	CCONJ
admet-3007	38	10	self	self	NOUN
admet-3007	38	11	-	-	PUNCT
admet-3007	38	12	assembled	assemble	VERB
admet-3007	38	13	polymeric	polymeric	ADJ
admet-3007	38	14	materials	material	NOUN
admet-3007	38	15	are	be	AUX
admet-3007	38	16	commonly	commonly	ADV
admet-3007	38	17	used	use	VERB
admet-3007	38	18	as	as	ADP
admet-3007	38	19	nanocarriers	nanocarrier	NOUN
admet-3007	38	20	to	to	PART
admet-3007	38	21	deliver	deliver	VERB
admet-3007	38	22	anti	anti	ADJ
admet-3007	38	23	-	-	ADJ
admet-3007	38	24	cancer	cancer	ADJ
admet-3007	38	25	drugs	drug	NOUN
admet-3007	38	26	.	.	PUNCT
admet-3007	39	1	both	both	DET
admet-3007	39	2	synthetic	synthetic	ADJ
admet-3007	39	3	polymers	polymer	NOUN
admet-3007	39	4	,	,	PUNCT
admet-3007	39	5	such	such	ADJ
admet-3007	39	6	as	as	ADP
admet-3007	39	7	polyethylene	polyethylene	NOUN
admet-3007	39	8	glycol	glycol	NOUN
admet-3007	39	9	(	(	PUNCT
admet-3007	39	10	peg	peg	NOUN
admet-3007	39	11	)	)	PUNCT
admet-3007	39	12	and	and	CCONJ
admet-3007	39	13	polyvinyl	polyvinyl	NOUN
admet-3007	39	14	alcohol	alcohol	NOUN
admet-3007	39	15	,	,	PUNCT
admet-3007	39	16	and	and	CCONJ
admet-3007	39	17	natural	natural	ADJ
admet-3007	39	18	polymers	polymer	NOUN
admet-3007	39	19	,	,	PUNCT
admet-3007	39	20	like	like	ADP
admet-3007	39	21	gelatine	gelatine	NOUN
admet-3007	39	22	,	,	PUNCT
admet-3007	39	23	silk	silk	NOUN
admet-3007	39	24	fibroin	fibroin	NOUN
admet-3007	39	25	,	,	PUNCT
admet-3007	39	26	and	and	CCONJ
admet-3007	39	27	collagen	collagen	NOUN
admet-3007	39	28	,	,	PUNCT
admet-3007	39	29	are	be	AUX
admet-3007	39	30	employed	employ	VERB
admet-3007	39	31	in	in	ADP
admet-3007	39	32	the	the	DET
admet-3007	39	33	synthesis	synthesis	NOUN
admet-3007	39	34	of	of	ADP
admet-3007	39	35	nano	nano	NOUN
admet-3007	39	36	-	-	PUNCT
admet-3007	39	37	biomaterials	biomaterial	NOUN
admet-3007	39	38	[	[	X
admet-3007	39	39	12	12	NUM
admet-3007	39	40	]	]	PUNCT
admet-3007	39	41	.	.	PUNCT
admet-3007	40	1	additionally	additionally	ADV
admet-3007	40	2	,	,	PUNCT
admet-3007	40	3	bioactive	bioactive	ADJ
admet-3007	40	4	compounds	compound	NOUN
admet-3007	40	5	such	such	ADJ
admet-3007	40	6	as	as	ADP
admet-3007	40	7	curcumin	curcumin	NOUN
admet-3007	40	8	,	,	PUNCT
admet-3007	40	9	gallic	gallic	NOUN
admet-3007	40	10	acid	acid	NOUN
admet-3007	40	11	,	,	PUNCT
admet-3007	40	12	and	and	CCONJ
admet-3007	40	13	epicatechin	epicatechin	NOUN
admet-3007	40	14	have	have	AUX
admet-3007	40	15	been	be	AUX
admet-3007	40	16	integrated	integrate	VERB
admet-3007	40	17	into	into	ADP
admet-3007	40	18	these	these	DET
admet-3007	40	19	systems	system	NOUN
admet-3007	40	20	.	.	PUNCT
admet-3007	41	1	due	due	ADP
admet-3007	41	2	to	to	ADP
admet-3007	41	3	their	their	PRON
admet-3007	41	4	excellent	excellent	ADJ
admet-3007	41	5	biocompatibility	biocompatibility	NOUN
admet-3007	41	6	and	and	CCONJ
admet-3007	41	7	multifunctionality	multifunctionality	NOUN
admet-3007	41	8	,	,	PUNCT
admet-3007	41	9	such	such	ADJ
admet-3007	41	10	biomaterials	biomaterial	NOUN
admet-3007	41	11	are	be	AUX
admet-3007	41	12	promising	promise	VERB
admet-3007	41	13	candidates	candidate	NOUN
admet-3007	41	14	for	for	ADP
admet-3007	41	15	csc	csc	ADJ
admet-3007	41	16	-	-	PUNCT
admet-3007	41	17	targeted	target	VERB
admet-3007	41	18	therapies	therapy	NOUN
admet-3007	41	19	[	[	X
admet-3007	41	20	13	13	NUM
admet-3007	41	21	]	]	PUNCT
admet-3007	41	22	.	.	PUNCT
admet-3007	42	1	this	this	DET
admet-3007	42	2	review	review	NOUN
admet-3007	42	3	aims	aim	VERB
admet-3007	42	4	to	to	PART
admet-3007	42	5	explore	explore	VERB
admet-3007	42	6	the	the	DET
admet-3007	42	7	biology	biology	NOUN
admet-3007	42	8	and	and	CCONJ
admet-3007	42	9	therapeutic	therapeutic	ADJ
admet-3007	42	10	resistance	resistance	NOUN
admet-3007	42	11	mechanisms	mechanism	NOUN
admet-3007	42	12	of	of	ADP
admet-3007	42	13	cscs	cscs	PROPN
admet-3007	42	14	and	and	CCONJ
admet-3007	42	15	to	to	PART
admet-3007	42	16	highlight	highlight	VERB
admet-3007	42	17	the	the	DET
admet-3007	42	18	current	current	ADJ
admet-3007	42	19	limitations	limitation	NOUN
admet-3007	42	20	in	in	ADP
admet-3007	42	21	their	their	PRON
admet-3007	42	22	detection	detection	NOUN
admet-3007	42	23	and	and	CCONJ
admet-3007	42	24	elimination	elimination	NOUN
admet-3007	42	25	.	.	PUNCT
admet-3007	43	1	it	it	PRON
admet-3007	43	2	also	also	ADV
admet-3007	43	3	evaluates	evaluate	VERB
admet-3007	43	4	emerging	emerge	VERB
admet-3007	43	5	nano	nano	NOUN
admet-3007	43	6	-	-	PUNCT
admet-3007	43	7	biomaterial	biomaterial	ADJ
admet-3007	43	8	-	-	PUNCT
admet-3007	43	9	based	base	VERB
admet-3007	43	10	strategies	strategy	NOUN
admet-3007	43	11	explicitly	explicitly	ADV
admet-3007	43	12	designed	design	VERB
admet-3007	43	13	for	for	ADP
admet-3007	43	14	csc	csc	PROPN
admet-3007	43	15	targeting	targeting	NOUN
admet-3007	43	16	.	.	PUNCT
admet-3007	44	1	the	the	DET
admet-3007	44	2	goal	goal	NOUN
admet-3007	44	3	is	be	AUX
admet-3007	44	4	to	to	PART
admet-3007	44	5	provide	provide	VERB
admet-3007	44	6	comprehensive	comprehensive	ADJ
admet-3007	44	7	insights	insight	NOUN
admet-3007	44	8	into	into	ADP
admet-3007	44	9	how	how	SCONJ
admet-3007	44	10	nanotechnology	nanotechnology	NOUN
admet-3007	44	11	-	-	PUNCT
admet-3007	44	12	based	base	VERB
admet-3007	44	13	platforms	platform	NOUN
admet-3007	44	14	may	may	AUX
admet-3007	44	15	overcome	overcome	VERB
admet-3007	44	16	csc	csc	PROPN
admet-3007	44	17	-	-	PUNCT
admet-3007	44	18	associated	associate	VERB
admet-3007	44	19	therapeutic	therapeutic	ADJ
admet-3007	44	20	resistance	resistance	NOUN
admet-3007	44	21	and	and	CCONJ
admet-3007	44	22	enhance	enhance	VERB
admet-3007	44	23	the	the	DET
admet-3007	44	24	effectiveness	effectiveness	NOUN
admet-3007	44	25	of	of	ADP
admet-3007	44	26	cancer	cancer	NOUN
admet-3007	44	27	treatment	treatment	NOUN
admet-3007	44	28	.	.	PUNCT
admet-3007	45	1	origin	origin	NOUN
admet-3007	45	2	of	of	ADP
admet-3007	45	3	cancer	cancer	NOUN
admet-3007	45	4	stem	stem	NOUN
admet-3007	45	5	cells	cell	NOUN
admet-3007	45	6	traditionally	traditionally	ADV
admet-3007	45	7	,	,	PUNCT
admet-3007	45	8	cancerous	cancerous	ADJ
admet-3007	45	9	tumours	tumour	NOUN
admet-3007	45	10	were	be	AUX
admet-3007	45	11	considered	consider	VERB
admet-3007	45	12	homogeneous	homogeneous	ADJ
admet-3007	45	13	masses	masse	NOUN
admet-3007	45	14	composed	compose	VERB
admet-3007	45	15	of	of	ADP
admet-3007	45	16	rapidly	rapidly	ADV
admet-3007	45	17	dividing	divide	VERB
admet-3007	45	18	cells	cell	NOUN
admet-3007	45	19	.	.	PUNCT
admet-3007	46	1	however	however	ADV
admet-3007	46	2	,	,	PUNCT
admet-3007	46	3	it	it	PRON
admet-3007	46	4	is	be	AUX
admet-3007	46	5	now	now	ADV
admet-3007	46	6	well	well	ADV
admet-3007	46	7	-	-	PUNCT
admet-3007	46	8	established	establish	VERB
admet-3007	46	9	that	that	SCONJ
admet-3007	46	10	tumours	tumour	NOUN
admet-3007	46	11	are	be	AUX
admet-3007	46	12	highly	highly	ADV
admet-3007	46	13	heterogeneous	heterogeneous	ADJ
admet-3007	46	14	and	and	CCONJ
admet-3007	46	15	consist	consist	VERB
admet-3007	46	16	of	of	ADP
admet-3007	46	17	diverse	diverse	ADJ
admet-3007	46	18	cellular	cellular	ADJ
admet-3007	46	19	populations	population	NOUN
admet-3007	46	20	.	.	PUNCT
admet-3007	47	1	among	among	ADP
admet-3007	47	2	these	these	PRON
admet-3007	47	3	,	,	PUNCT
admet-3007	47	4	cscs	cscs	PROPN
admet-3007	47	5	play	play	VERB
admet-3007	47	6	a	a	DET
admet-3007	47	7	central	central	ADJ
admet-3007	47	8	role	role	NOUN
admet-3007	47	9	in	in	ADP
admet-3007	47	10	tumour	tumour	NOUN
admet-3007	47	11	initiation	initiation	NOUN
admet-3007	47	12	,	,	PUNCT
admet-3007	47	13	progression	progression	NOUN
admet-3007	47	14	,	,	PUNCT
admet-3007	47	15	and	and	CCONJ
admet-3007	47	16	resistance	resistance	NOUN
admet-3007	47	17	to	to	ADP
admet-3007	47	18	therapy	therapy	NOUN
admet-3007	47	19	[	[	X
admet-3007	47	20	14	14	NUM
admet-3007	47	21	]	]	SYM
admet-3007	47	22	:	:	PUNCT
admet-3007	47	23	1	1	X
admet-3007	47	24	.	.	X
admet-3007	47	25	from	from	ADP
admet-3007	47	26	normal	normal	ADJ
admet-3007	47	27	stem	stem	NOUN
admet-3007	47	28	cells	cell	NOUN
admet-3007	47	29	:	:	PUNCT
admet-3007	47	30	this	this	DET
admet-3007	47	31	hypothesis	hypothesis	NOUN
admet-3007	47	32	proposes	propose	VERB
admet-3007	47	33	that	that	SCONJ
admet-3007	47	34	cscs	cscs	PROPN
admet-3007	47	35	originate	originate	VERB
admet-3007	47	36	from	from	ADP
admet-3007	47	37	tissue	tissue	NOUN
admet-3007	47	38	-	-	PUNCT
admet-3007	47	39	resident	resident	NOUN
admet-3007	47	40	normal	normal	ADJ
admet-3007	47	41	stem	stem	NOUN
admet-3007	47	42	cells	cell	NOUN
admet-3007	47	43	.	.	PUNCT
admet-3007	48	1	these	these	DET
admet-3007	48	2	cells	cell	NOUN
admet-3007	48	3	may	may	AUX
admet-3007	48	4	undergo	undergo	VERB
admet-3007	48	5	oncogenic	oncogenic	ADJ
admet-3007	48	6	transformation	transformation	NOUN
admet-3007	48	7	while	while	SCONJ
admet-3007	48	8	retaining	retain	VERB
admet-3007	48	9	their	their	PRON
admet-3007	48	10	self	self	NOUN
admet-3007	48	11	-	-	PUNCT
admet-3007	48	12	renewal	renewal	NOUN
admet-3007	48	13	and	and	CCONJ
admet-3007	48	14	differentiation	differentiation	NOUN
admet-3007	48	15	capabilities	capability	NOUN
admet-3007	48	16	.	.	PUNCT
admet-3007	49	1	in	in	ADP
admet-3007	49	2	this	this	DET
admet-3007	49	3	scenario	scenario	NOUN
admet-3007	49	4	,	,	PUNCT
admet-3007	49	5	cscs	cscs	PROPN
admet-3007	49	6	exploit	exploit	VERB
admet-3007	49	7	the	the	DET
admet-3007	49	8	same	same	ADJ
admet-3007	49	9	signalling	signal	VERB
admet-3007	49	10	pathways	pathway	NOUN
admet-3007	49	11	used	use	VERB
admet-3007	49	12	by	by	ADP
admet-3007	49	13	normal	normal	ADJ
admet-3007	49	14	stem	stem	NOUN
admet-3007	49	15	cells	cell	NOUN
admet-3007	49	16	to	to	PART
admet-3007	49	17	sustain	sustain	VERB
admet-3007	49	18	uncontrolled	uncontrolled	ADJ
admet-3007	49	19	proliferation	proliferation	NOUN
admet-3007	49	20	[	[	X
admet-3007	49	21	15	15	NUM
admet-3007	49	22	]	]	PUNCT
admet-3007	49	23	.	.	PUNCT
admet-3007	50	1	admet	admet	PROPN
admet-3007	50	2	&	&	CCONJ
admet-3007	50	3	dmpk	dmpk	PROPN
admet-3007	50	4	13(5	13(5	NUM
admet-3007	50	5	)	)	PUNCT
admet-3007	50	6	(	(	PUNCT
admet-3007	50	7	2025	2025	NUM
admet-3007	50	8	)	)	PUNCT
admet-3007	50	9	3007	3007	NUM
admet-3007	50	10	nano	nano	NOUN
admet-3007	50	11	-	-	PUNCT
admet-3007	50	12	biomaterials	biomaterial	NOUN
admet-3007	50	13	in	in	ADP
admet-3007	50	14	cancer	cancer	NOUN
admet-3007	50	15	therapy	therapy	NOUN
admet-3007	50	16	doi	doi	PROPN
admet-3007	50	17	:	:	PUNCT
admet-3007	50	18	https://doi.org/10.5599/admet.3007	https://doi.org/10.5599/admet.3007	NOUN
admet-3007	50	19	3	3	NUM
admet-3007	50	20	2	2	NUM
admet-3007	50	21	.	.	PUNCT
admet-3007	50	22	from	from	ADP
admet-3007	50	23	progenitor	progenitor	NOUN
admet-3007	50	24	cells	cell	NOUN
admet-3007	50	25	:	:	PUNCT
admet-3007	50	26	another	another	DET
admet-3007	50	27	theory	theory	NOUN
admet-3007	50	28	proposes	propose	VERB
admet-3007	50	29	that	that	SCONJ
admet-3007	50	30	cscs	cscs	PROPN
admet-3007	50	31	arise	arise	VERB
admet-3007	50	32	from	from	ADP
admet-3007	50	33	progenitor	progenitor	NOUN
admet-3007	50	34	cells	cell	NOUN
admet-3007	50	35	.	.	PUNCT
admet-3007	51	1	these	these	DET
admet-3007	51	2	cells	cell	NOUN
admet-3007	51	3	,	,	PUNCT
admet-3007	51	4	which	which	PRON
admet-3007	51	5	are	be	AUX
admet-3007	51	6	more	more	ADV
admet-3007	51	7	abundant	abundant	ADJ
admet-3007	51	8	in	in	ADP
admet-3007	51	9	adult	adult	NOUN
admet-3007	51	10	tissues	tissue	NOUN
admet-3007	51	11	than	than	ADP
admet-3007	51	12	stem	stem	NOUN
admet-3007	51	13	cells	cell	NOUN
admet-3007	51	14	,	,	PUNCT
admet-3007	51	15	possess	possess	VERB
admet-3007	51	16	limited	limited	ADJ
admet-3007	51	17	self	self	NOUN
admet-3007	51	18	-	-	PUNCT
admet-3007	51	19	renewal	renewal	NOUN
admet-3007	51	20	potential	potential	NOUN
admet-3007	51	21	.	.	PUNCT
admet-3007	52	1	oncogenic	oncogenic	ADJ
admet-3007	52	2	mutations	mutation	NOUN
admet-3007	52	3	in	in	ADP
admet-3007	52	4	these	these	DET
admet-3007	52	5	cells	cell	NOUN
admet-3007	52	6	could	could	AUX
admet-3007	52	7	disrupt	disrupt	VERB
admet-3007	52	8	regulatory	regulatory	ADJ
admet-3007	52	9	mechanisms	mechanism	NOUN
admet-3007	52	10	,	,	PUNCT
admet-3007	52	11	giving	give	VERB
admet-3007	52	12	rise	rise	NOUN
admet-3007	52	13	to	to	ADP
admet-3007	52	14	cscs	cscs	PROPN
admet-3007	52	15	[	[	X
admet-3007	52	16	16	16	NUM
admet-3007	52	17	]	]	PUNCT
admet-3007	52	18	.	.	PUNCT
admet-3007	53	1	3	3	X
admet-3007	53	2	.	.	X
admet-3007	53	3	from	from	ADP
admet-3007	53	4	differentiated	differentiated	ADJ
admet-3007	53	5	cells	cell	NOUN
admet-3007	53	6	:	:	PUNCT
admet-3007	53	7	the	the	DET
admet-3007	53	8	third	third	ADJ
admet-3007	53	9	hypothesis	hypothesis	NOUN
admet-3007	53	10	suggests	suggest	VERB
admet-3007	53	11	that	that	SCONJ
admet-3007	53	12	cscs	cscs	PROPN
admet-3007	53	13	can	can	AUX
admet-3007	53	14	develop	develop	VERB
admet-3007	53	15	from	from	ADP
admet-3007	53	16	mature	mature	ADJ
admet-3007	53	17	,	,	PUNCT
admet-3007	53	18	differentiated	differentiated	ADJ
admet-3007	53	19	cells	cell	NOUN
admet-3007	53	20	through	through	ADP
admet-3007	53	21	a	a	DET
admet-3007	53	22	process	process	NOUN
admet-3007	53	23	known	know	VERB
admet-3007	53	24	as	as	ADP
admet-3007	53	25	dedifferentiation	dedifferentiation	NOUN
admet-3007	53	26	.	.	PUNCT
admet-3007	54	1	according	accord	VERB
admet-3007	54	2	to	to	ADP
admet-3007	54	3	this	this	DET
admet-3007	54	4	theory	theory	NOUN
admet-3007	54	5	,	,	PUNCT
admet-3007	54	6	cancer	cancer	NOUN
admet-3007	54	7	-	-	PUNCT
admet-3007	54	8	causing	cause	VERB
admet-3007	54	9	genetic	genetic	ADJ
admet-3007	54	10	mutations	mutation	NOUN
admet-3007	54	11	(	(	PUNCT
admet-3007	54	12	oncogenes	oncogene	NOUN
admet-3007	54	13	)	)	PUNCT
admet-3007	54	14	trigger	trigger	NOUN
admet-3007	54	15	the	the	DET
admet-3007	54	16	dedifferentiation	dedifferentiation	NOUN
admet-3007	54	17	of	of	ADP
admet-3007	54	18	mature	mature	ADJ
admet-3007	54	19	cells	cell	NOUN
admet-3007	54	20	,	,	PUNCT
admet-3007	54	21	allowing	allow	VERB
admet-3007	54	22	them	they	PRON
admet-3007	54	23	to	to	PART
admet-3007	54	24	regain	regain	VERB
admet-3007	54	25	stem	stem	NOUN
admet-3007	54	26	cell	cell	NOUN
admet-3007	54	27	-	-	PUNCT
admet-3007	54	28	like	like	ADJ
admet-3007	54	29	properties	property	NOUN
admet-3007	54	30	.	.	PUNCT
admet-3007	55	1	this	this	DET
admet-3007	55	2	process	process	NOUN
admet-3007	55	3	often	often	ADV
admet-3007	55	4	involves	involve	VERB
admet-3007	55	5	epithelial	epithelial	ADJ
admet-3007	55	6	-	-	PUNCT
admet-3007	55	7	to	to	ADP
admet-3007	55	8	-	-	PUNCT
admet-3007	55	9	mesenchymal	mesenchymal	NOUN
admet-3007	55	10	transition	transition	NOUN
admet-3007	55	11	(	(	PUNCT
admet-3007	55	12	emt	emt	PROPN
admet-3007	55	13	)	)	PUNCT
admet-3007	55	14	,	,	PUNCT
admet-3007	55	15	allowing	allow	VERB
admet-3007	55	16	differentiated	differentiated	ADJ
admet-3007	55	17	epithelial	epithelial	ADJ
admet-3007	55	18	cells	cell	NOUN
admet-3007	55	19	to	to	PART
admet-3007	55	20	acquire	acquire	VERB
admet-3007	55	21	mesenchymal	mesenchymal	NOUN
admet-3007	55	22	and	and	CCONJ
admet-3007	55	23	stemness	stemness	ADJ
admet-3007	55	24	features	feature	NOUN
admet-3007	55	25	,	,	PUNCT
admet-3007	55	26	ultimately	ultimately	ADV
admet-3007	55	27	leading	lead	VERB
admet-3007	55	28	to	to	ADP
admet-3007	55	29	csc	csc	PROPN
admet-3007	55	30	formation	formation	NOUN
admet-3007	55	31	[	[	X
admet-3007	55	32	17	17	NUM
admet-3007	55	33	]	]	PUNCT
admet-3007	55	34	.	.	PUNCT
admet-3007	56	1	there	there	PRON
admet-3007	56	2	are	be	VERB
admet-3007	56	3	three	three	NUM
admet-3007	56	4	main	main	ADJ
admet-3007	56	5	hypotheses	hypothesis	NOUN
admet-3007	56	6	regarding	regard	VERB
admet-3007	56	7	the	the	DET
admet-3007	56	8	origin	origin	NOUN
admet-3007	56	9	of	of	ADP
admet-3007	56	10	cscs	cscs	PROPN
admet-3007	56	11	,	,	PUNCT
admet-3007	56	12	as	as	SCONJ
admet-3007	56	13	illustrated	illustrate	VERB
admet-3007	56	14	in	in	ADP
admet-3007	56	15	figure	figure	NOUN
admet-3007	56	16	1	1	NUM
admet-3007	56	17	.	.	PUNCT
admet-3007	56	18	figure	figure	NOUN
admet-3007	56	19	1	1	NUM
admet-3007	56	20	.	.	PUNCT
admet-3007	57	1	the	the	DET
admet-3007	57	2	origins	origin	NOUN
admet-3007	57	3	of	of	ADP
admet-3007	57	4	cancer	cancer	NOUN
admet-3007	57	5	stem	stem	NOUN
admet-3007	57	6	cells	cell	NOUN
admet-3007	57	7	(	(	PUNCT
admet-3007	57	8	cscs	cscs	PROPN
admet-3007	57	9	)	)	PUNCT
admet-3007	57	10	are	be	AUX
admet-3007	57	11	explained	explain	VERB
admet-3007	57	12	through	through	ADP
admet-3007	57	13	three	three	NUM
admet-3007	57	14	primary	primary	ADJ
admet-3007	57	15	hypotheses	hypothesis	NOUN
admet-3007	57	16	:	:	PUNCT
admet-3007	57	17	they	they	PRON
admet-3007	57	18	may	may	AUX
admet-3007	57	19	arise	arise	VERB
admet-3007	57	20	from	from	ADP
admet-3007	57	21	normal	normal	ADJ
admet-3007	57	22	stem	stem	NOUN
admet-3007	57	23	cells	cell	NOUN
admet-3007	57	24	,	,	PUNCT
admet-3007	57	25	progenitor	progenitor	NOUN
admet-3007	57	26	cells	cell	NOUN
admet-3007	57	27	,	,	PUNCT
admet-3007	57	28	or	or	CCONJ
admet-3007	57	29	differentiated	differentiated	ADJ
admet-3007	57	30	cells	cell	NOUN
admet-3007	57	31	that	that	PRON
admet-3007	57	32	have	have	AUX
admet-3007	57	33	undergone	undergo	VERB
admet-3007	57	34	genetic	genetic	ADJ
admet-3007	57	35	or	or	CCONJ
admet-3007	57	36	epigenetic	epigenetic	ADJ
admet-3007	57	37	changes	change	NOUN
admet-3007	57	38	.	.	PUNCT
admet-3007	58	1	each	each	PRON
admet-3007	58	2	of	of	ADP
admet-3007	58	3	these	these	DET
admet-3007	58	4	pathways	pathway	NOUN
admet-3007	58	5	suggests	suggest	VERB
admet-3007	58	6	distinct	distinct	ADJ
admet-3007	58	7	mechanisms	mechanism	NOUN
admet-3007	58	8	by	by	ADP
admet-3007	58	9	which	which	PRON
admet-3007	58	10	cscs	cscs	PROPN
admet-3007	58	11	contribute	contribute	VERB
admet-3007	58	12	to	to	ADP
admet-3007	58	13	tumour	tumour	NOUN
admet-3007	58	14	initiation	initiation	NOUN
admet-3007	58	15	,	,	PUNCT
admet-3007	58	16	progression	progression	NOUN
admet-3007	58	17	,	,	PUNCT
admet-3007	58	18	and	and	CCONJ
admet-3007	58	19	therapy	therapy	NOUN
admet-3007	58	20	resistance	resistance	NOUN
admet-3007	58	21	.	.	PUNCT
admet-3007	59	1	additionally	additionally	ADV
admet-3007	59	2	,	,	PUNCT
admet-3007	59	3	the	the	DET
admet-3007	59	4	role	role	NOUN
admet-3007	59	5	of	of	ADP
admet-3007	59	6	environmental	environmental	ADJ
admet-3007	59	7	factors	factor	NOUN
admet-3007	59	8	(	(	PUNCT
admet-3007	59	9	ef	ef	PROPN
admet-3007	59	10	)	)	PUNCT
admet-3007	59	11	,	,	PUNCT
admet-3007	59	12	such	such	ADJ
admet-3007	59	13	as	as	ADP
admet-3007	59	14	hypoxia	hypoxia	NOUN
admet-3007	59	15	,	,	PUNCT
admet-3007	59	16	inflammation	inflammation	NOUN
admet-3007	59	17	,	,	PUNCT
admet-3007	59	18	and	and	CCONJ
admet-3007	59	19	exposure	exposure	NOUN
admet-3007	59	20	to	to	ADP
admet-3007	59	21	carcinogens	carcinogen	NOUN
admet-3007	59	22	,	,	PUNCT
admet-3007	59	23	is	be	AUX
admet-3007	59	24	crucial	crucial	ADJ
admet-3007	59	25	in	in	ADP
admet-3007	59	26	shaping	shape	VERB
admet-3007	59	27	the	the	DET
admet-3007	59	28	transformation	transformation	NOUN
admet-3007	59	29	of	of	ADP
admet-3007	59	30	these	these	DET
admet-3007	59	31	cells	cell	NOUN
admet-3007	59	32	into	into	ADP
admet-3007	59	33	cscs	cscs	NOUN
admet-3007	59	34	isolation	isolation	NOUN
admet-3007	59	35	and	and	CCONJ
admet-3007	59	36	identification	identification	NOUN
admet-3007	59	37	of	of	ADP
admet-3007	59	38	cancer	cancer	NOUN
admet-3007	59	39	stem	stem	NOUN
admet-3007	59	40	cells	cell	NOUN
admet-3007	59	41	cscs	cscs	PROPN
admet-3007	59	42	represent	represent	VERB
admet-3007	59	43	a	a	DET
admet-3007	59	44	small	small	ADJ
admet-3007	59	45	fraction	fraction	NOUN
admet-3007	59	46	of	of	ADP
admet-3007	59	47	the	the	DET
admet-3007	59	48	tumour	tumour	NOUN
admet-3007	59	49	cell	cell	NOUN
admet-3007	59	50	population	population	NOUN
admet-3007	59	51	,	,	PUNCT
admet-3007	59	52	typically	typically	ADV
admet-3007	59	53	comprising	comprise	VERB
admet-3007	59	54	only	only	ADV
admet-3007	59	55	0.01	0.01	NUM
admet-3007	59	56	to	to	PART
admet-3007	59	57	2.00	2.00	NUM
admet-3007	59	58	%	%	NOUN
admet-3007	59	59	of	of	ADP
admet-3007	59	60	the	the	DET
admet-3007	59	61	total	total	ADJ
admet-3007	59	62	tumour	tumour	NOUN
admet-3007	59	63	mass	mass	NOUN
admet-3007	59	64	.	.	PUNCT
admet-3007	60	1	this	this	DET
admet-3007	60	2	rarity	rarity	NOUN
admet-3007	60	3	poses	pose	VERB
admet-3007	60	4	significant	significant	ADJ
admet-3007	60	5	challenges	challenge	NOUN
admet-3007	60	6	for	for	ADP
admet-3007	60	7	their	their	PRON
admet-3007	60	8	isolation	isolation	NOUN
admet-3007	60	9	and	and	CCONJ
admet-3007	60	10	characterization	characterization	NOUN
admet-3007	60	11	.	.	PUNCT
admet-3007	61	1	cscs	cscs	PROPN
admet-3007	61	2	are	be	AUX
admet-3007	61	3	identified	identify	VERB
admet-3007	61	4	using	use	VERB
admet-3007	61	5	distinct	distinct	ADJ
admet-3007	61	6	biomarkers	biomarker	NOUN
admet-3007	61	7	that	that	PRON
admet-3007	61	8	vary	vary	VERB
admet-3007	61	9	among	among	ADP
admet-3007	61	10	tumour	tumour	ADJ
admet-3007	61	11	types	type	NOUN
admet-3007	61	12	,	,	PUNCT
admet-3007	61	13	including	include	VERB
admet-3007	61	14	both	both	CCONJ
admet-3007	61	15	solid	solid	ADJ
admet-3007	61	16	tumours	tumour	NOUN
admet-3007	61	17	(	(	PUNCT
admet-3007	61	18	e.g.	e.g.	ADV
admet-3007	61	19	prostate	prostate	NOUN
admet-3007	61	20	,	,	PUNCT
admet-3007	61	21	lung	lung	NOUN
admet-3007	61	22	,	,	PUNCT
admet-3007	61	23	ovarian	ovarian	ADJ
admet-3007	61	24	,	,	PUNCT
admet-3007	61	25	liver	liver	NOUN
admet-3007	61	26	,	,	PUNCT
admet-3007	61	27	brain	brain	NOUN
admet-3007	61	28	)	)	PUNCT
admet-3007	61	29	and	and	CCONJ
admet-3007	61	30	haematological	haematological	ADJ
admet-3007	61	31	malignancies	malignancy	NOUN
admet-3007	61	32	(	(	PUNCT
admet-3007	61	33	e.g.	e.g.	ADV
admet-3007	61	34	chronic	chronic	ADJ
admet-3007	61	35	myeloid	myeloid	NOUN
admet-3007	61	36	leukaemia	leukaemia	NOUN
admet-3007	61	37	)	)	PUNCT
admet-3007	61	38	.	.	PUNCT
admet-3007	62	1	a	a	DET
admet-3007	62	2	wide	wide	ADJ
admet-3007	62	3	range	range	NOUN
admet-3007	62	4	of	of	ADP
admet-3007	62	5	cell	cell	NOUN
admet-3007	62	6	surface	surface	NOUN
admet-3007	62	7	markers	marker	NOUN
admet-3007	62	8	has	have	AUX
admet-3007	62	9	been	be	AUX
admet-3007	62	10	employed	employ	VERB
admet-3007	62	11	for	for	ADP
admet-3007	62	12	csc	csc	PROPN
admet-3007	62	13	isolation	isolation	NOUN
admet-3007	62	14	,	,	PUNCT
admet-3007	62	15	including	include	VERB
admet-3007	62	16	cd44	cd44	PROPN
admet-3007	62	17	,	,	PUNCT
admet-3007	62	18	cd24	cd24	PROPN
admet-3007	62	19	,	,	PUNCT
admet-3007	62	20	cd29	cd29	PROPN
admet-3007	62	21	,	,	PUNCT
admet-3007	62	22	cd90	cd90	PROPN
admet-3007	62	23	,	,	PUNCT
admet-3007	62	24	cd133	cd133	PROPN
admet-3007	62	25	,	,	PUNCT
admet-3007	62	26	cd13	cd13	PROPN
admet-3007	62	27	,	,	PUNCT
admet-3007	62	28	cd271	cd271	PROPN
admet-3007	62	29	,	,	PUNCT
admet-3007	62	30	sox9	sox9	PROPN
admet-3007	62	31	,	,	PUNCT
admet-3007	62	32	atp	atp	NOUN
admet-3007	62	33	-	-	PUNCT
admet-3007	62	34	binding	bind	VERB
admet-3007	62	35	cassette	cassette	NOUN
admet-3007	62	36	(	(	PUNCT
admet-3007	62	37	abc	abc	PROPN
admet-3007	62	38	)	)	PUNCT
admet-3007	62	39	transporters	transporter	NOUN
admet-3007	62	40	(	(	PUNCT
admet-3007	62	41	abcb1	abcb1	NOUN
admet-3007	62	42	,	,	PUNCT
admet-3007	62	43	abcb5	abcb5	PROPN
admet-3007	62	44	,	,	PUNCT
admet-3007	62	45	abcg2	abcg2	NOUN
admet-3007	62	46	)	)	PUNCT
admet-3007	62	47	,	,	PUNCT
admet-3007	62	48	epcam	epcam	NOUN
admet-3007	62	49	,	,	PUNCT
admet-3007	62	50	and	and	CCONJ
admet-3007	62	51	aldh1	aldh1	NOUN
admet-3007	62	52	.	.	PUNCT
admet-3007	63	1	the	the	DET
admet-3007	63	2	biomarkers	biomarker	NOUN
admet-3007	63	3	of	of	ADP
admet-3007	63	4	cscs	cscs	PROPN
admet-3007	63	5	in	in	ADP
admet-3007	63	6	different	different	ADJ
admet-3007	63	7	cancers	cancer	NOUN
admet-3007	63	8	are	be	AUX
admet-3007	63	9	summarized	summarize	VERB
admet-3007	63	10	in	in	ADP
admet-3007	63	11	table	table	NOUN
admet-3007	63	12	1	1	NUM
admet-3007	63	13	[	[	X
admet-3007	63	14	18	18	NUM
admet-3007	63	15	]	]	PUNCT
admet-3007	63	16	.	.	PUNCT
admet-3007	64	1	among	among	ADP
admet-3007	64	2	these	these	PRON
admet-3007	64	3	,	,	PUNCT
admet-3007	64	4	cd44	cd44	PROPN
admet-3007	64	5	is	be	AUX
admet-3007	64	6	widely	widely	ADV
admet-3007	64	7	recognized	recognize	VERB
admet-3007	64	8	for	for	ADP
admet-3007	64	9	its	its	PRON
admet-3007	64	10	high	high	ADJ
admet-3007	64	11	expression	expression	NOUN
admet-3007	64	12	in	in	ADP
admet-3007	64	13	cscs	cscs	PROPN
admet-3007	64	14	from	from	ADP
admet-3007	64	15	multiple	multiple	ADJ
admet-3007	64	16	tumour	tumour	ADJ
admet-3007	64	17	types	type	NOUN
admet-3007	64	18	.	.	PUNCT
admet-3007	65	1	cd44	cd44	NOUN
admet-3007	65	2	is	be	AUX
admet-3007	65	3	a	a	DET
admet-3007	65	4	cell	cell	NOUN
admet-3007	65	5	surface	surface	NOUN
admet-3007	65	6	glycoprotein	glycoprotein	NOUN
admet-3007	65	7	encoded	encode	VERB
admet-3007	65	8	by	by	ADP
admet-3007	65	9	the	the	DET
admet-3007	65	10	cd44	cd44	PROPN
admet-3007	65	11	gene	gene	NOUN
admet-3007	65	12	,	,	PUNCT
admet-3007	65	13	involved	involve	VERB
admet-3007	65	14	in	in	ADP
admet-3007	65	15	cell	cell	NOUN
admet-3007	65	16	adhesion	adhesion	NOUN
admet-3007	65	17	,	,	PUNCT
admet-3007	65	18	migration	migration	NOUN
admet-3007	65	19	,	,	PUNCT
admet-3007	65	20	and	and	CCONJ
admet-3007	65	21	signalling	signal	VERB
admet-3007	65	22	.	.	PUNCT
admet-3007	66	1	in	in	ADP
admet-3007	66	2	haematological	haematological	ADJ
admet-3007	66	3	cancers	cancer	NOUN
admet-3007	66	4	,	,	PUNCT
admet-3007	66	5	elevated	elevate	VERB
admet-3007	66	6	cd44	cd44	PROPN
admet-3007	66	7	levels	level	NOUN
admet-3007	66	8	correlate	correlate	VERB
admet-3007	66	9	with	with	ADP
admet-3007	66	10	chemoresistance	chemoresistance	NOUN
admet-3007	66	11	and	and	CCONJ
admet-3007	66	12	poor	poor	ADJ
admet-3007	66	13	prognosis.[19	prognosis.[19	NOUN
admet-3007	66	14	]	]	PUNCT
admet-3007	66	15	.	.	PUNCT
admet-3007	67	1	cd133	cd133	PROPN
admet-3007	67	2	,	,	PUNCT
admet-3007	67	3	also	also	ADV
admet-3007	67	4	known	know	VERB
admet-3007	67	5	as	as	ADP
admet-3007	67	6	prominin-1	prominin-1	PROPN
admet-3007	67	7	,	,	PUNCT
admet-3007	67	8	is	be	AUX
admet-3007	67	9	another	another	DET
admet-3007	67	10	well	well	ADV
admet-3007	67	11	-	-	PUNCT
admet-3007	67	12	established	establish	VERB
admet-3007	67	13	csc	csc	PROPN
admet-3007	67	14	marker	marker	NOUN
admet-3007	67	15	found	find	VERB
admet-3007	67	16	in	in	ADP
admet-3007	67	17	tumours	tumour	NOUN
admet-3007	67	18	of	of	ADP
admet-3007	67	19	the	the	DET
admet-3007	67	20	breast	breast	NOUN
admet-3007	67	21	,	,	PUNCT
admet-3007	67	22	ovary	ovary	ADJ
admet-3007	67	23	,	,	PUNCT
admet-3007	67	24	pancreas	pancrea	NOUN
admet-3007	67	25	,	,	PUNCT
admet-3007	67	26	liver	liver	NOUN
admet-3007	67	27	,	,	PUNCT
admet-3007	67	28	lung	lung	NOUN
admet-3007	67	29	,	,	PUNCT
admet-3007	67	30	stomach	stomach	NOUN
admet-3007	67	31	,	,	PUNCT
admet-3007	67	32	and	and	CCONJ
admet-3007	67	33	colon	colon	NOUN
admet-3007	67	34	[	[	NOUN
admet-3007	67	35	20	20	NUM
admet-3007	67	36	]	]	PUNCT
admet-3007	67	37	.	.	PUNCT
admet-3007	68	1	high	high	ADJ
admet-3007	68	2	cd133	cd133	X
admet-3007	68	3	expression	expression	NOUN
admet-3007	68	4	is	be	AUX
admet-3007	68	5	associated	associate	VERB
admet-3007	68	6	with	with	ADP
admet-3007	68	7	enhanced	enhanced	ADJ
admet-3007	68	8	tumorigenic	tumorigenic	ADJ
admet-3007	68	9	capacity	capacity	NOUN
admet-3007	68	10	,	,	PUNCT
admet-3007	68	11	particularly	particularly	ADV
admet-3007	68	12	in	in	ADP
admet-3007	68	13	lung	lung	NOUN
admet-3007	68	14	cscs	csc	NOUN
admet-3007	68	15	,	,	PUNCT
admet-3007	68	16	where	where	SCONJ
admet-3007	68	17	it	it	PRON
admet-3007	68	18	contributes	contribute	VERB
admet-3007	68	19	to	to	ADP
admet-3007	68	20	self	self	NOUN
admet-3007	68	21	-	-	PUNCT
admet-3007	68	22	renewal	renewal	NOUN
admet-3007	68	23	,	,	PUNCT
admet-3007	68	24	metastasis	metastasis	NOUN
admet-3007	68	25	via	via	ADP
admet-3007	68	26	emt	emt	PROPN
admet-3007	68	27	,	,	PUNCT
admet-3007	68	28	and	and	CCONJ
admet-3007	68	29	tumour	tumour	NOUN
admet-3007	68	30	progression	progression	NOUN
admet-3007	68	31	[	[	X
admet-3007	68	32	21	21	NUM
admet-3007	68	33	]	]	PUNCT
admet-3007	68	34	.	.	PUNCT
admet-3007	69	1	https://doi.org/10.5599/admet.3007	https://doi.org/10.5599/admet.3007	PROPN
admet-3007	69	2	m.	m.	PROPN
admet-3007	69	3	dehghani	dehghani	PROPN
admet-3007	69	4	et	et	PROPN
admet-3007	69	5	al	al	PROPN
admet-3007	69	6	.	.	PROPN
admet-3007	69	7	admet	admet	PROPN
admet-3007	69	8	&	&	CCONJ
admet-3007	69	9	dmpk	dmpk	PROPN
admet-3007	69	10	13(5	13(5	NUM
admet-3007	69	11	)	)	PUNCT
admet-3007	69	12	(	(	PUNCT
admet-3007	69	13	2025	2025	NUM
admet-3007	69	14	)	)	PUNCT
admet-3007	69	15	3007	3007	NUM
admet-3007	69	16	4	4	NUM
admet-3007	69	17	table	table	NOUN
admet-3007	69	18	1	1	NUM
admet-3007	69	19	.	.	PUNCT
admet-3007	70	1	biomarkers	biomarker	NOUN
admet-3007	70	2	of	of	ADP
admet-3007	70	3	cancer	cancer	NOUN
admet-3007	70	4	stem	stem	NOUN
admet-3007	70	5	cells	cell	NOUN
admet-3007	70	6	in	in	ADP
admet-3007	70	7	different	different	ADJ
admet-3007	70	8	cancers	cancer	NOUN
admet-3007	70	9	types	type	NOUN
admet-3007	70	10	of	of	ADP
admet-3007	70	11	cscs	cscs	PROPN
admet-3007	70	12	origin	origin	NOUN
admet-3007	70	13	specific	specific	ADJ
admet-3007	70	14	marker	marker	NOUN
admet-3007	70	15	ref	ref	NOUN
admet-3007	70	16	.	.	PUNCT
admet-3007	71	1	breast	breast	NOUN
admet-3007	71	2	cancer	cancer	NOUN
admet-3007	71	3	cd24	cd24	PROPN
admet-3007	71	4	,	,	PUNCT
admet-3007	71	5	cd44	cd44	PROPN
admet-3007	71	6	,	,	PUNCT
admet-3007	71	7	cd133	cd133	PROPN
admet-3007	71	8	,	,	PUNCT
admet-3007	71	9	cd13	cd13	PROPN
admet-3007	71	10	,	,	PUNCT
admet-3007	71	11	cd14	cd14	PROPN
admet-3007	71	12	,	,	PUNCT
admet-3007	71	13	cd15	cd15	PROPN
admet-3007	71	14	,	,	PUNCT
admet-3007	71	15	cxcr4	cxcr4	NOUN
admet-3007	71	16	,	,	PUNCT
admet-3007	71	17	epcam	epcam	NOUN
admet-3007	71	18	,	,	PUNCT
admet-3007	71	19	lgr5	lgr5	NOUN
admet-3007	71	20	,	,	PUNCT
admet-3007	71	21	cd49f	cd49f	PROPN
admet-3007	71	22	,	,	PUNCT
admet-3007	71	23	cd90	cd90	PROPN
admet-3007	71	24	,	,	PUNCT
admet-3007	71	25	cd117	cd117	PROPN
admet-3007	71	26	,	,	PUNCT
admet-3007	71	27	cd61	cd61	PROPN
admet-3007	71	28	,	,	PUNCT
admet-3007	71	29	pcor	pcor	NOUN
admet-3007	71	30	,	,	PUNCT
admet-3007	71	31	abcg2	abcg2	PUNCT
admet-3007	72	1	[	[	X
admet-3007	72	2	22	22	NUM
admet-3007	72	3	]	]	PUNCT
admet-3007	72	4	ovarian	ovarian	ADJ
admet-3007	72	5	cancer	cancer	NOUN
admet-3007	72	6	cd133	cd133	PROPN
admet-3007	72	7	,	,	PUNCT
admet-3007	72	8	cd44	cd44	PROPN
admet-3007	72	9	,	,	PUNCT
admet-3007	72	10	cd24	cd24	PROPN
admet-3007	72	11	,	,	PUNCT
admet-3007	72	12	cd117	cd117	PROPN
admet-3007	72	13	,	,	PUNCT
admet-3007	72	14	aldh1	aldh1	NOUN
admet-3007	72	15	,	,	PUNCT
admet-3007	72	16	cd105	cd105	PROPN
admet-3007	72	17	,	,	PUNCT
admet-3007	72	18	cd106	cd106	PROPN
admet-3007	72	19	,	,	PUNCT
admet-3007	72	20	sox2	sox2	NOUN
admet-3007	72	21	,	,	PUNCT
admet-3007	72	22	epcam	epcam	NOUN
admet-3007	72	23	,	,	PUNCT
admet-3007	72	24	abcb1	abcb1	NOUN
admet-3007	73	1	[	[	X
admet-3007	73	2	23	23	NUM
admet-3007	73	3	]	]	PUNCT
admet-3007	73	4	lung	lung	NOUN
admet-3007	73	5	cancer	cancer	NOUN
admet-3007	73	6	cd133	cd133	PROPN
admet-3007	73	7	,	,	PUNCT
admet-3007	73	8	cd44	cd44	PROPN
admet-3007	73	9	,	,	PUNCT
admet-3007	73	10	abcg2	abcg2	NOUN
admet-3007	73	11	,	,	PUNCT
admet-3007	73	12	aldh1a1	aldh1a1	ADV
admet-3007	73	13	,	,	PUNCT
admet-3007	73	14	epcam	epcam	NOUN
admet-3007	73	15	,	,	PUNCT
admet-3007	73	16	y	y	PROPN
admet-3007	73	17	-	-	PUNCT
admet-3007	73	18	box	box	PROPN
admet-3007	73	19	2	2	NUM
admet-3007	73	20	,	,	PUNCT
admet-3007	73	21	oct4	oct4	NOUN
admet-3007	73	22	[	[	X
admet-3007	73	23	24	24	NUM
admet-3007	73	24	]	]	SYM
admet-3007	73	25	pancreatic	pancreatic	ADJ
admet-3007	73	26	cancer	cancer	NOUN
admet-3007	73	27	cd133	cd133	PROPN
admet-3007	73	28	,	,	PUNCT
admet-3007	73	29	cd24	cd24	PROPN
admet-3007	73	30	,	,	PUNCT
admet-3007	73	31	cd44	cd44	PROPN
admet-3007	73	32	,	,	PUNCT
admet-3007	73	33	esa	esa	PROPN
admet-3007	73	34	,	,	PUNCT
admet-3007	73	35	oct4	oct4	PROPN
admet-3007	73	36	cxcr4	cxcr4	NOUN
admet-3007	73	37	,	,	PUNCT
admet-3007	73	38	dclk1	dclk1	NOUN
admet-3007	73	39	,	,	PUNCT
admet-3007	73	40	c	c	X
admet-3007	73	41	-	-	PUNCT
admet-3007	73	42	met	meet	VERB
admet-3007	73	43	,	,	PUNCT
admet-3007	73	44	abcg2	abcg2	NOUN
admet-3007	73	45	,	,	PUNCT
admet-3007	73	46	lgr5	lgr5	NOUN
admet-3007	73	47	,	,	PUNCT
admet-3007	73	48	abcb1	abcb1	NOUN
admet-3007	74	1	[	[	X
admet-3007	74	2	25	25	NUM
admet-3007	74	3	]	]	X
admet-3007	74	4	colorectal	colorectal	ADJ
admet-3007	74	5	cancer	cancer	NOUN
admet-3007	74	6	cd44	cd44	PROPN
admet-3007	74	7	+	+	PROPN
admet-3007	74	8	,	,	PUNCT
admet-3007	74	9	cd144	cd144	ADJ
admet-3007	74	10	,	,	PUNCT
admet-3007	74	11	cd133	cd133	PROPN
admet-3007	74	12	+	+	NOUN
admet-3007	74	13	,	,	PUNCT
admet-3007	74	14	cd26	cd26	PROPN
admet-3007	74	15	+	+	PROPN
admet-3007	74	16	,	,	PUNCT
admet-3007	74	17	cd24	cd24	PROPN
admet-3007	74	18	,	,	PUNCT
admet-3007	74	19	cd29	cd29	PROPN
admet-3007	74	20	,	,	PUNCT
admet-3007	74	21	aldh1	aldh1	NOUN
admet-3007	74	22	+	+	ADJ
admet-3007	74	23	,	,	PUNCT
admet-3007	74	24	cd166	cd166	PROPN
admet-3007	74	25	+	+	PROPN
admet-3007	74	26	,	,	PUNCT
admet-3007	74	27	lgr5	lgr5	NOUN
admet-3007	74	28	,	,	PUNCT
admet-3007	74	29	(	(	PUNCT
admet-3007	74	30	epcam)high	epcam)high	PROPN
admet-3007	74	31	,	,	PUNCT
admet-3007	74	32	cxcr4	cxcr4	NOUN
admet-3007	75	1	[	[	X
admet-3007	75	2	26	26	NUM
admet-3007	75	3	]	]	PUNCT
admet-3007	75	4	prostate	prostate	NOUN
admet-3007	75	5	cancer	cancer	NOUN
admet-3007	75	6	sca-1	sca-1	NOUN
admet-3007	75	7	,	,	PUNCT
admet-3007	75	8	aldh	aldh	ADJ
admet-3007	75	9	,	,	PUNCT
admet-3007	75	10	cd133	cd133	PROPN
admet-3007	75	11	,	,	PUNCT
admet-3007	75	12	trop-2	trop-2	NUM
admet-3007	75	13	,	,	PUNCT
admet-3007	75	14	cd44	cd44	PROPN
admet-3007	75	15	,	,	PUNCT
admet-3007	75	16	integrin	integrin	NOUN
admet-3007	75	17	α2β1	α2β1	PROPN
admet-3007	75	18	,	,	PUNCT
admet-3007	75	19	oct4	oct4	PROPN
admet-3007	75	20	,	,	PUNCT
admet-3007	75	21	nanog	nanog	PROPN
admet-3007	75	22	,	,	PUNCT
admet-3007	75	23	sox2	sox2	VERB
admet-3007	75	24	[	[	X
admet-3007	75	25	27	27	NUM
admet-3007	75	26	]	]	PUNCT
admet-3007	75	27	brain	brain	NOUN
admet-3007	75	28	cancer	cancer	NOUN
admet-3007	75	29	cd133	cd133	PROPN
admet-3007	75	30	,	,	PUNCT
admet-3007	75	31	cd44	cd44	PROPN
admet-3007	75	32	,	,	PUNCT
admet-3007	75	33	cd15	cd15	PROPN
admet-3007	75	34	,	,	PUNCT
admet-3007	75	35	cd105	cd105	PROPN
admet-3007	75	36	,	,	PUNCT
admet-3007	75	37	cd70	cd70	PROPN
admet-3007	75	38	,	,	PUNCT
admet-3007	75	39	cd24	cd24	PROPN
admet-3007	75	40	,	,	PUNCT
admet-3007	75	41	integrin	integrin	NOUN
admet-3007	75	42	α6	α6	PROPN
admet-3007	75	43	,	,	PUNCT
admet-3007	75	44	s100a4	s100a4	PROPN
admet-3007	75	45	,	,	PUNCT
admet-3007	75	46	aldh1a3	aldh1a3	X
admet-3007	75	47	,	,	PUNCT
admet-3007	75	48	nanog	nanog	PROPN
admet-3007	75	49	,	,	PUNCT
admet-3007	75	50	oct-4	oct-4	ADV
admet-3007	75	51	,	,	PUNCT
admet-3007	75	52	sox-2	sox-2	NOUN
admet-3007	75	53	,	,	PUNCT
admet-3007	75	54	nestin	nestin	NOUN
admet-3007	75	55	[	[	X
admet-3007	75	56	28	28	NUM
admet-3007	75	57	]	]	PUNCT
admet-3007	75	58	chronic	chronic	ADJ
admet-3007	75	59	myeloid	myeloid	NOUN
admet-3007	75	60	leukaemia	leukaemia	PROPN
admet-3007	75	61	il1rap	il1rap	PROPN
admet-3007	75	62	,	,	PUNCT
admet-3007	75	63	cd93	cd93	PROPN
admet-3007	75	64	,	,	PUNCT
admet-3007	75	65	cd26	cd26	PROPN
admet-3007	75	66	,	,	PUNCT
admet-3007	75	67	cd25	cd25	PROPN
admet-3007	75	68	[	[	X
admet-3007	75	69	29	29	NUM
admet-3007	75	70	]	]	X
admet-3007	75	71	melanoma	melanoma	NOUN
admet-3007	75	72	cd20	cd20	PROPN
admet-3007	75	73	+	+	PROPN
admet-3007	75	74	,	,	PUNCT
admet-3007	75	75	cd133	cd133	PROPN
admet-3007	75	76	+	+	PROPN
admet-3007	75	77	,	,	PUNCT
admet-3007	75	78	abcb5	abcb5	PROPN
admet-3007	75	79	,	,	PUNCT
admet-3007	75	80	abcb1	abcb1	NOUN
admet-3007	75	81	,	,	PUNCT
admet-3007	75	82	abcg2	abcg2	NOUN
admet-3007	75	83	,	,	PUNCT
admet-3007	75	84	cd271	cd271	PROPN
admet-3007	75	85	+	+	PROPN
admet-3007	75	86	,	,	PUNCT
admet-3007	75	87	cd34	cd34	PROPN
admet-3007	75	88	,	,	PUNCT
admet-3007	75	89	cd44	cd44	PROPN
admet-3007	75	90	[	[	NOUN
admet-3007	75	91	30	30	NUM
admet-3007	75	92	]	]	X
admet-3007	75	93	hepatocellular	hepatocellular	ADJ
admet-3007	75	94	carcinoma	carcinoma	NOUN
admet-3007	75	95	cd90	cd90	PROPN
admet-3007	75	96	,	,	PUNCT
admet-3007	75	97	epcam	epcam	NOUN
admet-3007	75	98	,	,	PUNCT
admet-3007	75	99	cd133	cd133	PROPN
admet-3007	75	100	,	,	PUNCT
admet-3007	75	101	cd24	cd24	PROPN
admet-3007	75	102	,	,	PUNCT
admet-3007	75	103	sox9	sox9	PROPN
admet-3007	75	104	,	,	PUNCT
admet-3007	75	105	ck19	ck19	PROPN
admet-3007	75	106	,	,	PUNCT
admet-3007	75	107	sox12	sox12	NOUN
admet-3007	75	108	,	,	PUNCT
admet-3007	75	109	cd44	cd44	PROPN
admet-3007	75	110	,	,	PUNCT
admet-3007	75	111	cd13	cd13	PROPN
admet-3007	75	112	,	,	PUNCT
admet-3007	75	113	cd47	cd47	PROPN
admet-3007	75	114	,	,	PUNCT
admet-3007	75	115	lgr5	lgr5	NOUN
admet-3007	75	116	,	,	PUNCT
admet-3007	75	117	dlk1	dlk1	NOUN
admet-3007	75	118	,	,	PUNCT
admet-3007	75	119	α2δ1	α2δ1	NOUN
admet-3007	75	120	,	,	PUNCT
admet-3007	75	121	icam-1	icam-1	NUM
admet-3007	75	122	,	,	PUNCT
admet-3007	75	123	ov6	ov6	X
admet-3007	75	124	[	[	X
admet-3007	75	125	31	31	NUM
admet-3007	75	126	]	]	X
admet-3007	75	127	cd24	cd24	PROPN
admet-3007	75	128	is	be	AUX
admet-3007	75	129	another	another	DET
admet-3007	75	130	marker	marker	NOUN
admet-3007	75	131	frequently	frequently	ADV
admet-3007	75	132	expressed	express	VERB
admet-3007	75	133	in	in	ADP
admet-3007	75	134	cancers	cancer	NOUN
admet-3007	75	135	such	such	ADJ
admet-3007	75	136	as	as	ADP
admet-3007	75	137	breast	breast	NOUN
admet-3007	75	138	,	,	PUNCT
admet-3007	75	139	liver	liver	NOUN
admet-3007	75	140	,	,	PUNCT
admet-3007	75	141	bladder	bladder	NOUN
admet-3007	75	142	,	,	PUNCT
admet-3007	75	143	lung	lung	NOUN
admet-3007	75	144	,	,	PUNCT
admet-3007	75	145	and	and	CCONJ
admet-3007	75	146	ovarian	ovarian	ADJ
admet-3007	75	147	cancer	cancer	NOUN
admet-3007	75	148	.	.	PUNCT
admet-3007	76	1	this	this	DET
admet-3007	76	2	marker	marker	NOUN
admet-3007	76	3	is	be	AUX
admet-3007	76	4	critical	critical	ADJ
admet-3007	76	5	in	in	ADP
admet-3007	76	6	promoting	promote	VERB
admet-3007	76	7	tumour	tumour	NOUN
admet-3007	76	8	development	development	NOUN
admet-3007	76	9	,	,	PUNCT
admet-3007	76	10	invasion	invasion	NOUN
admet-3007	76	11	,	,	PUNCT
admet-3007	76	12	metastasis	metastasis	NOUN
admet-3007	76	13	,	,	PUNCT
admet-3007	76	14	and	and	CCONJ
admet-3007	76	15	apoptosis	apoptosis	NOUN
admet-3007	76	16	inhibition	inhibition	NOUN
admet-3007	76	17	,	,	PUNCT
admet-3007	76	18	particularly	particularly	ADV
admet-3007	76	19	in	in	ADP
admet-3007	76	20	ovarian	ovarian	ADJ
admet-3007	76	21	cancer	cancer	NOUN
admet-3007	76	22	[	[	X
admet-3007	76	23	32	32	NUM
admet-3007	76	24	]	]	PUNCT
admet-3007	76	25	.	.	PUNCT
admet-3007	77	1	epcam	epcam	PROPN
admet-3007	77	2	is	be	AUX
admet-3007	77	3	abundantly	abundantly	ADV
admet-3007	77	4	expressed	express	VERB
admet-3007	77	5	in	in	ADP
admet-3007	77	6	colorectal	colorectal	ADJ
admet-3007	77	7	and	and	CCONJ
admet-3007	77	8	hepatocellular	hepatocellular	ADJ
admet-3007	77	9	cscs	csc	NOUN
admet-3007	77	10	,	,	PUNCT
admet-3007	77	11	where	where	SCONJ
admet-3007	77	12	it	it	PRON
admet-3007	77	13	facilitates	facilitate	VERB
admet-3007	77	14	tumour	tumour	NOUN
admet-3007	77	15	proliferation	proliferation	NOUN
admet-3007	77	16	,	,	PUNCT
admet-3007	77	17	invasion	invasion	NOUN
admet-3007	77	18	,	,	PUNCT
admet-3007	77	19	and	and	CCONJ
admet-3007	77	20	metastatic	metastatic	ADJ
admet-3007	77	21	spread	spread	NOUN
admet-3007	78	1	[	[	X
admet-3007	78	2	33	33	NUM
admet-3007	78	3	]	]	PUNCT
admet-3007	78	4	.	.	PUNCT
admet-3007	79	1	in	in	ADP
admet-3007	79	2	addition	addition	NOUN
admet-3007	79	3	to	to	ADP
admet-3007	79	4	surface	surface	NOUN
admet-3007	79	5	markers	marker	NOUN
admet-3007	79	6	,	,	PUNCT
admet-3007	79	7	intracellular	intracellular	ADJ
admet-3007	79	8	enzymes	enzyme	NOUN
admet-3007	79	9	and	and	CCONJ
admet-3007	79	10	membrane	membrane	NOUN
admet-3007	79	11	transporters	transporter	NOUN
admet-3007	79	12	also	also	ADV
admet-3007	79	13	serve	serve	VERB
admet-3007	79	14	as	as	ADP
admet-3007	79	15	critical	critical	ADJ
admet-3007	79	16	indicators	indicator	NOUN
admet-3007	79	17	of	of	ADP
admet-3007	79	18	csc	csc	PROPN
admet-3007	79	19	identity	identity	NOUN
admet-3007	79	20	and	and	CCONJ
admet-3007	79	21	function	function	NOUN
admet-3007	79	22	.	.	PUNCT
admet-3007	80	1	one	one	NUM
admet-3007	80	2	such	such	ADJ
admet-3007	80	3	marker	marker	NOUN
admet-3007	80	4	is	be	AUX
admet-3007	80	5	aldehyde	aldehyde	NOUN
admet-3007	80	6	dehydrogenase	dehydrogenase	NOUN
admet-3007	80	7	(	(	PUNCT
admet-3007	80	8	aldh	aldh	NOUN
admet-3007	80	9	)	)	PUNCT
admet-3007	80	10	,	,	PUNCT
admet-3007	80	11	a	a	DET
admet-3007	80	12	detoxifying	detoxify	VERB
admet-3007	80	13	enzyme	enzyme	NOUN
admet-3007	80	14	that	that	PRON
admet-3007	80	15	contributes	contribute	VERB
admet-3007	80	16	to	to	ADP
admet-3007	80	17	cellular	cellular	ADJ
admet-3007	80	18	redox	redox	ADJ
admet-3007	80	19	balance	balance	NOUN
admet-3007	80	20	,	,	PUNCT
admet-3007	80	21	signalling	signal	VERB
admet-3007	80	22	pathways	pathway	NOUN
admet-3007	80	23	,	,	PUNCT
admet-3007	80	24	and	and	CCONJ
admet-3007	80	25	therapy	therapy	NOUN
admet-3007	80	26	resistance	resistance	NOUN
admet-3007	80	27	.	.	PUNCT
admet-3007	81	1	in	in	ADP
admet-3007	81	2	particular	particular	ADJ
admet-3007	81	3	,	,	PUNCT
admet-3007	81	4	aldh	aldh	ADJ
admet-3007	81	5	activity	activity	NOUN
admet-3007	81	6	is	be	AUX
admet-3007	81	7	elevated	elevate	VERB
admet-3007	81	8	in	in	ADP
admet-3007	81	9	prostate	prostate	NOUN
admet-3007	81	10	cscs	csc	NOUN
admet-3007	81	11	,	,	PUNCT
admet-3007	81	12	where	where	SCONJ
admet-3007	81	13	it	it	PRON
admet-3007	81	14	facilitates	facilitate	VERB
admet-3007	81	15	survival	survival	NOUN
admet-3007	81	16	under	under	ADP
admet-3007	81	17	oxidative	oxidative	ADJ
admet-3007	81	18	stress	stress	NOUN
admet-3007	81	19	and	and	CCONJ
admet-3007	81	20	drug	drug	NOUN
admet-3007	81	21	pressure	pressure	NOUN
admet-3007	81	22	[	[	X
admet-3007	81	23	34	34	NUM
admet-3007	81	24	]	]	PUNCT
admet-3007	81	25	.	.	PUNCT
admet-3007	82	1	in	in	ADP
admet-3007	82	2	breast	breast	NOUN
admet-3007	82	3	cscs	cscs	NOUN
admet-3007	82	4	,	,	PUNCT
admet-3007	82	5	overexpression	overexpression	NOUN
admet-3007	82	6	of	of	ADP
admet-3007	82	7	aldh1a3	aldh1a3	NOUN
admet-3007	82	8	is	be	AUX
admet-3007	82	9	strongly	strongly	ADV
admet-3007	82	10	correlated	correlate	VERB
admet-3007	82	11	with	with	ADP
admet-3007	82	12	higher	high	ADJ
admet-3007	82	13	tumour	tumour	NOUN
admet-3007	82	14	grade	grade	NOUN
admet-3007	82	15	,	,	PUNCT
admet-3007	82	16	advanced	advanced	ADJ
admet-3007	82	17	cancer	cancer	NOUN
admet-3007	82	18	stage	stage	NOUN
admet-3007	82	19	,	,	PUNCT
admet-3007	82	20	and	and	CCONJ
admet-3007	82	21	increased	increase	VERB
admet-3007	82	22	metastatic	metastatic	ADJ
admet-3007	82	23	potential	potential	NOUN
admet-3007	82	24	[	[	X
admet-3007	82	25	35	35	NUM
admet-3007	82	26	]	]	PUNCT
admet-3007	82	27	.	.	PUNCT
admet-3007	83	1	another	another	DET
admet-3007	83	2	major	major	ADJ
admet-3007	83	3	class	class	NOUN
admet-3007	83	4	of	of	ADP
admet-3007	83	5	markers	marker	NOUN
admet-3007	83	6	includes	include	VERB
admet-3007	83	7	abc	abc	PROPN
admet-3007	83	8	transporters	transporter	NOUN
admet-3007	83	9	,	,	PUNCT
admet-3007	83	10	which	which	PRON
admet-3007	83	11	are	be	AUX
admet-3007	83	12	closely	closely	ADV
admet-3007	83	13	linked	link	VERB
admet-3007	83	14	to	to	PART
admet-3007	83	15	multidrug	multidrug	VERB
admet-3007	83	16	resistance	resistance	NOUN
admet-3007	83	17	(	(	PUNCT
admet-3007	83	18	mdr	mdr	PROPN
admet-3007	83	19	)	)	PUNCT
admet-3007	83	20	.	.	PUNCT
admet-3007	84	1	members	member	NOUN
admet-3007	84	2	such	such	ADJ
admet-3007	84	3	as	as	ADP
admet-3007	84	4	abcb1	abcb1	NOUN
admet-3007	84	5	(	(	PUNCT
admet-3007	84	6	mdr1	mdr1	PROPN
admet-3007	84	7	)	)	PUNCT
admet-3007	84	8	,	,	PUNCT
admet-3007	84	9	abcc1	abcc1	PROPN
admet-3007	84	10	(	(	PUNCT
admet-3007	84	11	mrp1	mrp1	PROPN
admet-3007	84	12	)	)	PUNCT
admet-3007	84	13	,	,	PUNCT
admet-3007	84	14	and	and	CCONJ
admet-3007	84	15	abcg2	abcg2	NOUN
admet-3007	84	16	(	(	PUNCT
admet-3007	84	17	bcrp	bcrp	PROPN
admet-3007	84	18	)	)	PUNCT
admet-3007	84	19	are	be	AUX
admet-3007	84	20	frequently	frequently	ADV
admet-3007	84	21	overexpressed	overexpresse	VERB
admet-3007	84	22	in	in	ADP
admet-3007	84	23	drug	drug	NOUN
admet-3007	84	24	-	-	PUNCT
admet-3007	84	25	resistant	resistant	ADJ
admet-3007	84	26	tumours	tumour	NOUN
admet-3007	84	27	and	and	CCONJ
admet-3007	84	28	csc	csc	PROPN
admet-3007	84	29	subpopulations	subpopulation	NOUN
admet-3007	84	30	.	.	PUNCT
admet-3007	85	1	abcc1	abcc1	PROPN
admet-3007	85	2	plays	play	VERB
admet-3007	85	3	a	a	DET
admet-3007	85	4	key	key	ADJ
admet-3007	85	5	role	role	NOUN
admet-3007	85	6	in	in	ADP
admet-3007	85	7	transporting	transport	VERB
admet-3007	85	8	chemotherapeutic	chemotherapeutic	ADJ
admet-3007	85	9	agents	agent	NOUN
admet-3007	85	10	like	like	ADP
admet-3007	85	11	anthracyclines	anthracycline	NOUN
admet-3007	85	12	and	and	CCONJ
admet-3007	85	13	mitoxantrone	mitoxantrone	NOUN
admet-3007	85	14	,	,	PUNCT
admet-3007	85	15	and	and	CCONJ
admet-3007	85	16	is	be	AUX
admet-3007	85	17	found	find	VERB
admet-3007	85	18	in	in	ADP
admet-3007	85	19	cscs	cscs	PROPN
admet-3007	85	20	of	of	ADP
admet-3007	85	21	lung	lung	NOUN
admet-3007	85	22	,	,	PUNCT
admet-3007	85	23	stomach	stomach	NOUN
admet-3007	85	24	,	,	PUNCT
admet-3007	85	25	colon	colon	NOUN
admet-3007	85	26	,	,	PUNCT
admet-3007	85	27	breast	breast	NOUN
admet-3007	85	28	,	,	PUNCT
admet-3007	85	29	prostate	prostate	NOUN
admet-3007	85	30	,	,	PUNCT
admet-3007	85	31	neuroblastoma	neuroblastoma	ADJ
admet-3007	85	32	,	,	PUNCT
admet-3007	85	33	glioma	glioma	NOUN
admet-3007	85	34	,	,	PUNCT
admet-3007	85	35	and	and	CCONJ
admet-3007	85	36	leukaemia	leukaemia	VERB
admet-3007	86	1	[	[	X
admet-3007	86	2	36	36	NUM
admet-3007	86	3	]	]	PUNCT
admet-3007	86	4	.	.	PUNCT
admet-3007	87	1	among	among	ADP
admet-3007	87	2	these	these	PRON
admet-3007	87	3	,	,	PUNCT
admet-3007	87	4	abcg2	abcg2	PROPN
admet-3007	87	5	stands	stand	VERB
admet-3007	87	6	out	out	ADP
admet-3007	87	7	as	as	ADP
admet-3007	87	8	a	a	DET
admet-3007	87	9	pivotal	pivotal	ADJ
admet-3007	87	10	multidrug	multidrug	NOUN
admet-3007	87	11	-	-	PUNCT
admet-3007	87	12	resistant	resistant	ADJ
admet-3007	87	13	transporter	transporter	NOUN
admet-3007	87	14	,	,	PUNCT
admet-3007	87	15	contributing	contribute	VERB
admet-3007	87	16	not	not	PART
admet-3007	87	17	only	only	ADV
admet-3007	87	18	to	to	PART
admet-3007	87	19	chemoresistance	chemoresistance	VERB
admet-3007	87	20	but	but	CCONJ
admet-3007	87	21	also	also	ADV
admet-3007	87	22	to	to	ADP
admet-3007	87	23	tumour	tumour	NOUN
admet-3007	87	24	progression	progression	NOUN
admet-3007	87	25	[	[	X
admet-3007	87	26	37	37	NUM
admet-3007	87	27	]	]	PUNCT
admet-3007	87	28	.	.	PUNCT
admet-3007	88	1	its	its	PRON
admet-3007	88	2	high	high	ADJ
admet-3007	88	3	expression	expression	NOUN
admet-3007	88	4	has	have	AUX
admet-3007	88	5	been	be	AUX
admet-3007	88	6	reported	report	VERB
admet-3007	88	7	in	in	ADP
admet-3007	88	8	a	a	DET
admet-3007	88	9	wide	wide	ADJ
admet-3007	88	10	range	range	NOUN
admet-3007	88	11	of	of	ADP
admet-3007	88	12	cancers	cancer	NOUN
admet-3007	88	13	,	,	PUNCT
admet-3007	88	14	including	include	VERB
admet-3007	88	15	lung	lung	NOUN
admet-3007	88	16	,	,	PUNCT
admet-3007	88	17	liver	liver	NOUN
admet-3007	88	18	,	,	PUNCT
admet-3007	88	19	melanoma	melanoma	NOUN
admet-3007	88	20	,	,	PUNCT
admet-3007	88	21	and	and	CCONJ
admet-3007	88	22	retinoblastoma	retinoblastoma	VERB
admet-3007	88	23	[	[	X
admet-3007	88	24	38	38	NUM
admet-3007	88	25	]	]	PUNCT
admet-3007	88	26	.	.	PUNCT
admet-3007	89	1	despite	despite	SCONJ
admet-3007	89	2	the	the	DET
admet-3007	89	3	usefulness	usefulness	NOUN
admet-3007	89	4	of	of	ADP
admet-3007	89	5	surface	surface	NOUN
admet-3007	89	6	and	and	CCONJ
admet-3007	89	7	intracellular	intracellular	ADJ
admet-3007	89	8	markers	marker	NOUN
admet-3007	89	9	in	in	ADP
admet-3007	89	10	identifying	identify	VERB
admet-3007	89	11	cscs	csc	NOUN
admet-3007	89	12	,	,	PUNCT
admet-3007	89	13	several	several	ADJ
admet-3007	89	14	limitations	limitation	NOUN
admet-3007	89	15	and	and	CCONJ
admet-3007	89	16	challenges	challenge	NOUN
admet-3007	89	17	persist	persist	VERB
admet-3007	89	18	.	.	PUNCT
admet-3007	90	1	many	many	ADJ
admet-3007	90	2	of	of	ADP
admet-3007	90	3	these	these	DET
admet-3007	90	4	markers	marker	NOUN
admet-3007	90	5	,	,	PUNCT
admet-3007	90	6	such	such	ADJ
admet-3007	90	7	as	as	ADP
admet-3007	90	8	cd44	cd44	PROPN
admet-3007	90	9	,	,	PUNCT
admet-3007	90	10	cd133	cd133	PROPN
admet-3007	90	11	,	,	PUNCT
admet-3007	90	12	and	and	CCONJ
admet-3007	90	13	aldh	aldh	NOUN
admet-3007	90	14	,	,	PUNCT
admet-3007	90	15	are	be	AUX
admet-3007	90	16	not	not	PART
admet-3007	90	17	exclusively	exclusively	ADV
admet-3007	90	18	expressed	express	VERB
admet-3007	90	19	by	by	ADP
admet-3007	90	20	cscs	cscs	PROPN
admet-3007	90	21	but	but	CCONJ
admet-3007	90	22	are	be	AUX
admet-3007	90	23	also	also	ADV
admet-3007	90	24	found	find	VERB
admet-3007	90	25	in	in	ADP
admet-3007	90	26	normal	normal	ADJ
admet-3007	90	27	stem	stem	NOUN
admet-3007	90	28	or	or	CCONJ
admet-3007	90	29	progenitor	progenitor	NOUN
admet-3007	90	30	cells	cell	NOUN
admet-3007	90	31	,	,	PUNCT
admet-3007	90	32	leading	lead	VERB
admet-3007	90	33	to	to	ADP
admet-3007	90	34	potential	potential	ADJ
admet-3007	90	35	off	off	ADP
admet-3007	90	36	-	-	PUNCT
admet-3007	90	37	target	target	NOUN
admet-3007	90	38	effects	effect	NOUN
admet-3007	90	39	and	and	CCONJ
admet-3007	90	40	reduced	reduce	VERB
admet-3007	90	41	specificity	specificity	NOUN
admet-3007	90	42	in	in	ADP
admet-3007	90	43	therapeutic	therapeutic	ADJ
admet-3007	90	44	targeting	targeting	NOUN
admet-3007	91	1	[	[	X
admet-3007	91	2	9	9	NUM
admet-3007	91	3	]	]	PUNCT
admet-3007	91	4	.	.	PUNCT
admet-3007	92	1	moreover	moreover	ADV
admet-3007	92	2	,	,	PUNCT
admet-3007	92	3	the	the	DET
admet-3007	92	4	expression	expression	NOUN
admet-3007	92	5	of	of	ADP
admet-3007	92	6	csc	csc	PROPN
admet-3007	92	7	markers	marker	NOUN
admet-3007	92	8	can	can	AUX
admet-3007	92	9	be	be	AUX
admet-3007	92	10	highly	highly	ADV
admet-3007	92	11	heterogeneous	heterogeneous	ADJ
admet-3007	92	12	and	and	CCONJ
admet-3007	92	13	dynamic	dynamic	ADJ
admet-3007	92	14	,	,	PUNCT
admet-3007	92	15	varying	vary	VERB
admet-3007	92	16	not	not	PART
admet-3007	92	17	only	only	ADV
admet-3007	92	18	among	among	ADP
admet-3007	92	19	different	different	ADJ
admet-3007	92	20	tumour	tumour	NOUN
admet-3007	92	21	types	type	NOUN
admet-3007	92	22	but	but	CCONJ
admet-3007	92	23	also	also	ADV
admet-3007	92	24	within	within	ADP
admet-3007	92	25	a	a	DET
admet-3007	92	26	single	single	ADJ
admet-3007	92	27	tumour	tumour	NOUN
admet-3007	92	28	due	due	ADP
admet-3007	92	29	to	to	ADP
admet-3007	92	30	microenvironmental	microenvironmental	ADJ
admet-3007	92	31	influences	influence	NOUN
admet-3007	92	32	and	and	CCONJ
admet-3007	92	33	clonal	clonal	ADJ
admet-3007	92	34	evolution	evolution	NOUN
admet-3007	92	35	.	.	PUNCT
admet-3007	93	1	this	this	DET
admet-3007	93	2	heterogeneity	heterogeneity	NOUN
admet-3007	93	3	complicates	complicate	VERB
admet-3007	93	4	the	the	DET
admet-3007	93	5	development	development	NOUN
admet-3007	93	6	of	of	ADP
admet-3007	93	7	universal	universal	ADJ
admet-3007	93	8	csc	csc	VERB
admet-3007	93	9	-	-	PUNCT
admet-3007	93	10	targeted	target	VERB
admet-3007	93	11	therapies	therapy	NOUN
admet-3007	93	12	and	and	CCONJ
admet-3007	93	13	necessitates	necessitate	VERB
admet-3007	93	14	the	the	DET
admet-3007	93	15	use	use	NOUN
admet-3007	93	16	of	of	ADP
admet-3007	93	17	multiple	multiple	ADJ
admet-3007	93	18	markers	marker	NOUN
admet-3007	93	19	or	or	CCONJ
admet-3007	93	20	functional	functional	ADJ
admet-3007	93	21	assays	assay	NOUN
admet-3007	93	22	for	for	ADP
admet-3007	93	23	accurate	accurate	ADJ
admet-3007	93	24	csc	csc	PROPN
admet-3007	93	25	isolation	isolation	NOUN
admet-3007	93	26	and	and	CCONJ
admet-3007	93	27	characterization	characterization	NOUN
admet-3007	93	28	[	[	X
admet-3007	93	29	39	39	NUM
admet-3007	93	30	]	]	PUNCT
admet-3007	93	31	.	.	PUNCT
admet-3007	94	1	furthermore	furthermore	ADV
admet-3007	94	2	,	,	PUNCT
admet-3007	94	3	some	some	DET
admet-3007	94	4	csc	csc	PROPN
admet-3007	94	5	subpopulations	subpopulation	NOUN
admet-3007	94	6	may	may	AUX
admet-3007	94	7	evade	evade	VERB
admet-3007	94	8	detection	detection	NOUN
admet-3007	94	9	altogether	altogether	ADV
admet-3007	94	10	due	due	ADJ
admet-3007	94	11	to	to	ADP
admet-3007	94	12	low	low	ADJ
admet-3007	94	13	or	or	CCONJ
admet-3007	94	14	transient	transient	ADJ
admet-3007	94	15	marker	marker	NOUN
admet-3007	94	16	expression	expression	NOUN
admet-3007	94	17	,	,	PUNCT
admet-3007	94	18	posing	pose	VERB
admet-3007	94	19	a	a	DET
admet-3007	94	20	significant	significant	ADJ
admet-3007	94	21	obstacle	obstacle	NOUN
admet-3007	94	22	in	in	ADP
admet-3007	94	23	both	both	DET
admet-3007	94	24	research	research	NOUN
admet-3007	94	25	and	and	CCONJ
admet-3007	94	26	clinical	clinical	ADJ
admet-3007	94	27	applications	application	NOUN
admet-3007	94	28	[	[	X
admet-3007	94	29	40	40	NUM
admet-3007	94	30	]	]	PUNCT
admet-3007	94	31	.	.	PUNCT
admet-3007	95	1	however	however	ADV
admet-3007	95	2	,	,	PUNCT
admet-3007	95	3	nanostructures	nanostructure	NOUN
admet-3007	95	4	offer	offer	VERB
admet-3007	95	5	promising	promise	VERB
admet-3007	95	6	solutions	solution	NOUN
admet-3007	95	7	to	to	PART
admet-3007	95	8	overcome	overcome	VERB
admet-3007	95	9	these	these	DET
admet-3007	95	10	limitations	limitation	NOUN
admet-3007	95	11	in	in	ADP
admet-3007	95	12	conventional	conventional	ADJ
admet-3007	95	13	cscs	cscs	NOUN
admet-3007	95	14	marker	marker	NOUN
admet-3007	95	15	detection	detection	NOUN
admet-3007	95	16	.	.	PUNCT
admet-3007	96	1	admet	admet	PROPN
admet-3007	96	2	&	&	CCONJ
admet-3007	96	3	dmpk	dmpk	PROPN
admet-3007	96	4	13(5	13(5	NUM
admet-3007	96	5	)	)	PUNCT
admet-3007	96	6	(	(	PUNCT
admet-3007	96	7	2025	2025	NUM
admet-3007	96	8	)	)	PUNCT
admet-3007	96	9	3007	3007	NUM
admet-3007	96	10	nano	nano	NOUN
admet-3007	96	11	-	-	PUNCT
admet-3007	96	12	biomaterials	biomaterial	NOUN
admet-3007	96	13	in	in	ADP
admet-3007	96	14	cancer	cancer	NOUN
admet-3007	96	15	therapy	therapy	NOUN
admet-3007	96	16	doi	doi	PROPN
admet-3007	96	17	:	:	PUNCT
admet-3007	96	18	https://doi.org/10.5599/admet.3007	https://doi.org/10.5599/admet.3007	NOUN
admet-3007	96	19	5	5	NUM
admet-3007	96	20	mechanism	mechanism	NOUN
admet-3007	96	21	of	of	ADP
admet-3007	96	22	resistance	resistance	NOUN
admet-3007	96	23	to	to	ADP
admet-3007	96	24	therapeutics	therapeutic	NOUN
admet-3007	96	25	in	in	ADP
admet-3007	96	26	cancer	cancer	NOUN
admet-3007	96	27	stem	stem	NOUN
admet-3007	96	28	cells	cell	NOUN
admet-3007	96	29	one	one	NUM
admet-3007	96	30	of	of	ADP
admet-3007	96	31	the	the	DET
admet-3007	96	32	major	major	ADJ
admet-3007	96	33	obstacles	obstacle	NOUN
admet-3007	96	34	in	in	ADP
admet-3007	96	35	effective	effective	ADJ
admet-3007	96	36	cancer	cancer	NOUN
admet-3007	96	37	treatment	treatment	NOUN
admet-3007	96	38	is	be	AUX
admet-3007	96	39	the	the	DET
admet-3007	96	40	inherent	inherent	ADJ
admet-3007	96	41	resistance	resistance	NOUN
admet-3007	96	42	of	of	ADP
admet-3007	96	43	cscs	cscs	PROPN
admet-3007	96	44	to	to	ADP
admet-3007	96	45	conventional	conventional	ADJ
admet-3007	96	46	therapies	therapy	NOUN
admet-3007	96	47	,	,	PUNCT
admet-3007	96	48	which	which	PRON
admet-3007	96	49	often	often	ADV
admet-3007	96	50	leads	lead	VERB
admet-3007	96	51	to	to	ADP
admet-3007	96	52	disease	disease	NOUN
admet-3007	96	53	recurrence	recurrence	NOUN
admet-3007	96	54	.	.	PUNCT
admet-3007	97	1	standard	standard	ADJ
admet-3007	97	2	treatments	treatment	NOUN
admet-3007	97	3	,	,	PUNCT
admet-3007	97	4	such	such	ADJ
admet-3007	97	5	as	as	ADP
admet-3007	97	6	chemotherapy	chemotherapy	NOUN
admet-3007	97	7	and	and	CCONJ
admet-3007	97	8	radiation	radiation	NOUN
admet-3007	97	9	,	,	PUNCT
admet-3007	97	10	typically	typically	ADV
admet-3007	97	11	fail	fail	VERB
admet-3007	97	12	to	to	PART
admet-3007	97	13	eradicate	eradicate	VERB
admet-3007	97	14	cscs	cscs	NOUN
admet-3007	97	15	[	[	X
admet-3007	97	16	41	41	NUM
admet-3007	97	17	]	]	PUNCT
admet-3007	97	18	.	.	PUNCT
admet-3007	98	1	several	several	ADJ
admet-3007	98	2	factors	factor	NOUN
admet-3007	98	3	contribute	contribute	VERB
admet-3007	98	4	to	to	ADP
admet-3007	98	5	cscs	cscs	PROPN
admet-3007	98	6	'	'	PART
admet-3007	98	7	resistance	resistance	NOUN
admet-3007	98	8	,	,	PUNCT
admet-3007	98	9	as	as	SCONJ
admet-3007	98	10	illustrated	illustrate	VERB
admet-3007	98	11	in	in	ADP
admet-3007	98	12	figure	figure	NOUN
admet-3007	98	13	2	2	NUM
admet-3007	98	14	.	.	PUNCT
admet-3007	98	15	figure	figure	NOUN
admet-3007	98	16	2	2	NUM
admet-3007	98	17	.	.	PUNCT
admet-3007	98	18	cancer	cancer	NOUN
admet-3007	98	19	stem	stem	NOUN
admet-3007	98	20	cells	cell	NOUN
admet-3007	98	21	employ	employ	VERB
admet-3007	98	22	diverse	diverse	ADJ
admet-3007	98	23	mechanisms	mechanism	NOUN
admet-3007	98	24	to	to	PART
admet-3007	98	25	evade	evade	VERB
admet-3007	98	26	therapeutic	therapeutic	ADJ
admet-3007	98	27	interventions	intervention	NOUN
admet-3007	98	28	,	,	PUNCT
admet-3007	98	29	contributing	contribute	VERB
admet-3007	98	30	to	to	ADP
admet-3007	98	31	treatment	treatment	NOUN
admet-3007	98	32	resistance	resistance	NOUN
admet-3007	98	33	and	and	CCONJ
admet-3007	98	34	disease	disease	NOUN
admet-3007	98	35	recurrence	recurrence	NOUN
admet-3007	98	36	.	.	PUNCT
admet-3007	99	1	slow	slow	ADJ
admet-3007	99	2	proliferation	proliferation	NOUN
admet-3007	99	3	rate	rate	NOUN
admet-3007	99	4	research	research	NOUN
admet-3007	99	5	indicates	indicate	VERB
admet-3007	99	6	that	that	SCONJ
admet-3007	99	7	cells	cell	NOUN
admet-3007	99	8	with	with	ADP
admet-3007	99	9	slow	slow	ADJ
admet-3007	99	10	cell	cell	NOUN
admet-3007	99	11	cycle	cycle	NOUN
admet-3007	99	12	progression	progression	NOUN
admet-3007	99	13	are	be	AUX
admet-3007	99	14	less	less	ADV
admet-3007	99	15	susceptible	susceptible	ADJ
admet-3007	99	16	to	to	ADP
admet-3007	99	17	chemotherapy	chemotherapy	NOUN
admet-3007	99	18	[	[	X
admet-3007	99	19	42	42	NUM
admet-3007	99	20	]	]	PUNCT
admet-3007	99	21	.	.	PUNCT
admet-3007	100	1	most	most	ADJ
admet-3007	100	2	cscs	cscs	PROPN
admet-3007	100	3	reside	reside	VERB
admet-3007	100	4	in	in	ADP
admet-3007	100	5	the	the	DET
admet-3007	100	6	g0	g0	ADJ
admet-3007	100	7	phase	phase	NOUN
admet-3007	100	8	,	,	PUNCT
admet-3007	100	9	a	a	DET
admet-3007	100	10	quiescent	quiescent	ADJ
admet-3007	100	11	state	state	NOUN
admet-3007	100	12	that	that	PRON
admet-3007	100	13	allows	allow	VERB
admet-3007	100	14	them	they	PRON
admet-3007	100	15	to	to	PART
admet-3007	100	16	evade	evade	VERB
admet-3007	100	17	therapies	therapy	NOUN
admet-3007	100	18	targeting	target	VERB
admet-3007	100	19	actively	actively	ADV
admet-3007	100	20	dividing	divide	VERB
admet-3007	100	21	cells	cell	NOUN
admet-3007	100	22	.	.	PUNCT
admet-3007	101	1	after	after	ADP
admet-3007	101	2	chemotherapy	chemotherapy	NOUN
admet-3007	101	3	or	or	CCONJ
admet-3007	101	4	radiation	radiation	NOUN
admet-3007	101	5	,	,	PUNCT
admet-3007	101	6	these	these	DET
admet-3007	101	7	cells	cell	NOUN
admet-3007	101	8	can	can	AUX
admet-3007	101	9	exit	exit	VERB
admet-3007	101	10	the	the	DET
admet-3007	101	11	g0	g0	ADJ
admet-3007	101	12	phase	phase	NOUN
admet-3007	101	13	,	,	PUNCT
admet-3007	101	14	contributing	contribute	VERB
admet-3007	101	15	to	to	ADP
admet-3007	101	16	cancer	cancer	NOUN
admet-3007	101	17	recurrence	recurrence	NOUN
admet-3007	101	18	.	.	PUNCT
admet-3007	102	1	conventional	conventional	ADJ
admet-3007	102	2	therapies	therapy	NOUN
admet-3007	102	3	mainly	mainly	ADV
admet-3007	102	4	target	target	VERB
admet-3007	102	5	proliferating	proliferate	VERB
admet-3007	102	6	cells	cell	NOUN
admet-3007	102	7	by	by	ADP
admet-3007	102	8	causing	cause	VERB
admet-3007	102	9	dna	dna	NOUN
admet-3007	102	10	damage	damage	NOUN
admet-3007	102	11	and	and	CCONJ
admet-3007	102	12	inhibiting	inhibit	VERB
admet-3007	102	13	mitosis	mitosis	NOUN
admet-3007	102	14	.	.	PUNCT
admet-3007	103	1	however	however	ADV
admet-3007	103	2	,	,	PUNCT
admet-3007	103	3	these	these	DET
admet-3007	103	4	treatments	treatment	NOUN
admet-3007	103	5	are	be	AUX
admet-3007	103	6	less	less	ADV
admet-3007	103	7	effective	effective	ADJ
admet-3007	103	8	against	against	ADP
admet-3007	103	9	slow	slow	ADJ
admet-3007	103	10	-	-	PUNCT
admet-3007	103	11	cycling	cycling	NOUN
admet-3007	103	12	cells	cell	NOUN
admet-3007	103	13	like	like	ADP
admet-3007	103	14	cscs	cscs	PROPN
admet-3007	103	15	.	.	PUNCT
admet-3007	104	1	consequently	consequently	ADV
admet-3007	104	2	,	,	PUNCT
admet-3007	104	3	while	while	SCONJ
admet-3007	104	4	chemotherapy	chemotherapy	NOUN
admet-3007	104	5	may	may	AUX
admet-3007	104	6	eliminate	eliminate	VERB
admet-3007	104	7	the	the	DET
admet-3007	104	8	bulk	bulk	NOUN
admet-3007	104	9	of	of	ADP
admet-3007	104	10	the	the	DET
admet-3007	104	11	tumour	tumour	NOUN
admet-3007	104	12	,	,	PUNCT
admet-3007	104	13	cscs	cscs	PROPN
admet-3007	104	14	survive	survive	VERB
admet-3007	104	15	and	and	CCONJ
admet-3007	104	16	can	can	AUX
admet-3007	104	17	re	re	VERB
admet-3007	104	18	-	-	VERB
admet-3007	104	19	initiate	initiate	VERB
admet-3007	104	20	metastasis	metastasis	NOUN
admet-3007	104	21	,	,	PUNCT
admet-3007	104	22	leading	lead	VERB
admet-3007	104	23	to	to	PART
admet-3007	104	24	relapse	relapse	VERB
admet-3007	104	25	[	[	X
admet-3007	104	26	43	43	NUM
admet-3007	104	27	]	]	PUNCT
admet-3007	104	28	.	.	PUNCT
admet-3007	105	1	overexpression	overexpression	NOUN
admet-3007	105	2	of	of	ADP
admet-3007	105	3	transporters	transporter	NOUN
admet-3007	105	4	abc	abc	PROPN
admet-3007	105	5	transporters	transporter	NOUN
admet-3007	105	6	are	be	AUX
admet-3007	105	7	a	a	DET
admet-3007	105	8	superfamily	superfamily	NOUN
admet-3007	105	9	of	of	ADP
admet-3007	105	10	membrane	membrane	ADJ
admet-3007	105	11	proteins	protein	NOUN
admet-3007	105	12	that	that	PRON
admet-3007	105	13	utilize	utilize	VERB
admet-3007	105	14	energy	energy	NOUN
admet-3007	105	15	derived	derive	VERB
admet-3007	105	16	from	from	ADP
admet-3007	105	17	atp	atp	NOUN
admet-3007	105	18	hydrolysis	hydrolysis	NOUN
admet-3007	105	19	to	to	PART
admet-3007	105	20	transport	transport	VERB
admet-3007	105	21	a	a	DET
admet-3007	105	22	wide	wide	ADJ
admet-3007	105	23	variety	variety	NOUN
admet-3007	105	24	of	of	ADP
admet-3007	105	25	substrates	substrate	NOUN
admet-3007	105	26	across	across	ADP
admet-3007	105	27	cellular	cellular	ADJ
admet-3007	105	28	membranes	membrane	NOUN
admet-3007	105	29	.	.	PUNCT
admet-3007	106	1	these	these	DET
admet-3007	106	2	substrates	substrate	NOUN
admet-3007	106	3	include	include	VERB
admet-3007	106	4	vitamins	vitamin	NOUN
admet-3007	106	5	,	,	PUNCT
admet-3007	106	6	proteins	protein	NOUN
admet-3007	106	7	,	,	PUNCT
admet-3007	106	8	peptides	peptide	NOUN
admet-3007	106	9	,	,	PUNCT
admet-3007	106	10	amino	amino	NOUN
admet-3007	106	11	acids	acid	NOUN
admet-3007	106	12	,	,	PUNCT
admet-3007	106	13	polysaccharides	polysaccharide	NOUN
admet-3007	106	14	,	,	PUNCT
admet-3007	106	15	drugs	drug	NOUN
admet-3007	106	16	,	,	PUNCT
admet-3007	106	17	and	and	CCONJ
admet-3007	106	18	metal	metal	NOUN
admet-3007	106	19	ions	ion	NOUN
admet-3007	106	20	[	[	X
admet-3007	106	21	44	44	NUM
admet-3007	106	22	]	]	PUNCT
admet-3007	106	23	.	.	PUNCT
admet-3007	107	1	overexpression	overexpression	NOUN
admet-3007	107	2	of	of	ADP
admet-3007	107	3	these	these	DET
admet-3007	107	4	transporters	transporter	NOUN
admet-3007	107	5	has	have	AUX
admet-3007	107	6	been	be	AUX
admet-3007	107	7	reported	report	VERB
admet-3007	107	8	in	in	ADP
admet-3007	107	9	many	many	ADJ
admet-3007	107	10	cancers	cancer	NOUN
admet-3007	107	11	,	,	PUNCT
admet-3007	107	12	particularly	particularly	ADV
admet-3007	107	13	in	in	ADP
admet-3007	107	14	cscs	cscs	PROPN
admet-3007	107	15	[	[	X
admet-3007	107	16	45	45	NUM
admet-3007	107	17	]	]	PUNCT
admet-3007	107	18	.	.	PUNCT
admet-3007	108	1	by	by	ADP
admet-3007	108	2	overexpressing	overexpresse	VERB
admet-3007	108	3	abc	abc	PROPN
admet-3007	108	4	transporters	transporter	NOUN
admet-3007	108	5	,	,	PUNCT
admet-3007	108	6	cscs	cscs	PROPN
admet-3007	108	7	increase	increase	VERB
admet-3007	108	8	the	the	DET
admet-3007	108	9	efflux	efflux	NOUN
admet-3007	108	10	of	of	ADP
admet-3007	108	11	chemotherapy	chemotherapy	NOUN
admet-3007	108	12	drugs	drug	NOUN
admet-3007	108	13	,	,	PUNCT
admet-3007	108	14	leading	lead	VERB
admet-3007	108	15	to	to	ADP
admet-3007	108	16	drug	drug	NOUN
admet-3007	108	17	resistance	resistance	NOUN
admet-3007	108	18	[	[	X
admet-3007	108	19	46	46	NUM
admet-3007	108	20	]	]	PUNCT
admet-3007	108	21	.	.	PUNCT
admet-3007	109	1	certain	certain	ADJ
admet-3007	109	2	abc	abc	PROPN
admet-3007	109	3	transporters	transporter	NOUN
admet-3007	109	4	are	be	AUX
admet-3007	109	5	more	more	ADV
admet-3007	109	6	highly	highly	ADV
admet-3007	109	7	expressed	express	VERB
admet-3007	109	8	in	in	ADP
admet-3007	109	9	cscs	cscs	PROPN
admet-3007	109	10	compared	compare	VERB
admet-3007	109	11	to	to	ADP
admet-3007	109	12	regular	regular	ADJ
admet-3007	109	13	cancer	cancer	NOUN
admet-3007	109	14	cells	cell	NOUN
admet-3007	109	15	or	or	CCONJ
admet-3007	109	16	normal	normal	ADJ
admet-3007	109	17	cells	cell	NOUN
admet-3007	109	18	.	.	PUNCT
admet-3007	110	1	for	for	ADP
admet-3007	110	2	example	example	NOUN
admet-3007	110	3	,	,	PUNCT
admet-3007	110	4	abcb1	abcb1	NOUN
admet-3007	110	5	is	be	AUX
admet-3007	110	6	overexpressed	overexpresse	VERB
admet-3007	110	7	in	in	ADP
admet-3007	110	8	pancreatic	pancreatic	ADJ
admet-3007	110	9	cscs	csc	NOUN
admet-3007	110	10	,	,	PUNCT
admet-3007	110	11	abcg2	abcg2	NOUN
admet-3007	110	12	in	in	ADP
admet-3007	110	13	breast	breast	NOUN
admet-3007	110	14	cscs	cscs	NOUN
admet-3007	110	15	,	,	PUNCT
admet-3007	110	16	abcb1	abcb1	NOUN
admet-3007	110	17	and	and	CCONJ
admet-3007	110	18	abcb5	abcb5	NOUN
admet-3007	110	19	in	in	ADP
admet-3007	110	20	melanoma	melanoma	NOUN
admet-3007	110	21	,	,	PUNCT
admet-3007	110	22	and	and	CCONJ
admet-3007	110	23	abcb1	abcb1	NOUN
admet-3007	110	24	in	in	ADP
admet-3007	110	25	ovarian	ovarian	ADJ
admet-3007	110	26	cscs	cscs	NOUN
admet-3007	111	1	[	[	X
admet-3007	111	2	47	47	NUM
admet-3007	111	3	]	]	PUNCT
admet-3007	111	4	.	.	PUNCT
admet-3007	112	1	some	some	DET
admet-3007	112	2	transporters	transporter	NOUN
admet-3007	112	3	can	can	AUX
admet-3007	112	4	transport	transport	VERB
admet-3007	112	5	a	a	DET
admet-3007	112	6	wide	wide	ADJ
admet-3007	112	7	variety	variety	NOUN
admet-3007	112	8	of	of	ADP
admet-3007	112	9	drugs	drug	NOUN
admet-3007	112	10	,	,	PUNCT
admet-3007	112	11	while	while	SCONJ
admet-3007	112	12	others	other	NOUN
admet-3007	112	13	are	be	AUX
admet-3007	112	14	more	more	ADV
admet-3007	112	15	selective	selective	ADJ
admet-3007	112	16	.	.	PUNCT
admet-3007	113	1	for	for	ADP
admet-3007	113	2	example	example	NOUN
admet-3007	113	3	,	,	PUNCT
admet-3007	113	4	the	the	DET
admet-3007	113	5	abcc1	abcc1	PROPN
admet-3007	113	6	transporter	transporter	NOUN
admet-3007	113	7	,	,	PUNCT
admet-3007	113	8	overexpressed	overexpresse	VERB
admet-3007	113	9	in	in	ADP
admet-3007	113	10	glioblastoma	glioblastoma	NOUN
admet-3007	113	11	cscs	cscs	NOUN
admet-3007	113	12	,	,	PUNCT
admet-3007	113	13	is	be	AUX
admet-3007	113	14	https://doi.org/10.5599/admet.3007	https://doi.org/10.5599/admet.3007	ADJ
admet-3007	113	15	m.	m.	NOUN
admet-3007	113	16	dehghani	dehghani	PROPN
admet-3007	113	17	et	et	PROPN
admet-3007	113	18	al	al	PROPN
admet-3007	113	19	.	.	PROPN
admet-3007	113	20	admet	admet	PROPN
admet-3007	113	21	&	&	CCONJ
admet-3007	113	22	dmpk	dmpk	PROPN
admet-3007	113	23	13(5	13(5	NUM
admet-3007	113	24	)	)	PUNCT
admet-3007	113	25	(	(	PUNCT
admet-3007	113	26	2025	2025	NUM
admet-3007	113	27	)	)	PUNCT
admet-3007	113	28	3007	3007	NUM
admet-3007	113	29	6	6	NUM
admet-3007	113	30	involved	involve	VERB
admet-3007	113	31	in	in	ADP
admet-3007	113	32	the	the	DET
admet-3007	113	33	efflux	efflux	NOUN
admet-3007	113	34	of	of	ADP
admet-3007	113	35	multiple	multiple	ADJ
admet-3007	113	36	drugs	drug	NOUN
admet-3007	113	37	,	,	PUNCT
admet-3007	113	38	including	include	VERB
admet-3007	113	39	doxorubicin	doxorubicin	PROPN
admet-3007	113	40	(	(	PUNCT
admet-3007	113	41	dox	dox	NOUN
admet-3007	113	42	)	)	PUNCT
admet-3007	113	43	,	,	PUNCT
admet-3007	113	44	methotrexate	methotrexate	NOUN
admet-3007	113	45	,	,	PUNCT
admet-3007	113	46	paclitaxel	paclitaxel	PROPN
admet-3007	113	47	(	(	PUNCT
admet-3007	113	48	ptx	ptx	NOUN
admet-3007	113	49	)	)	PUNCT
admet-3007	113	50	,	,	PUNCT
admet-3007	113	51	and	and	CCONJ
admet-3007	113	52	others	other	NOUN
admet-3007	113	53	.	.	PUNCT
admet-3007	114	1	in	in	ADP
admet-3007	114	2	contrast	contrast	NOUN
admet-3007	114	3	,	,	PUNCT
admet-3007	114	4	abca1	abca1	PROPN
admet-3007	114	5	,	,	PUNCT
admet-3007	114	6	expressed	express	VERB
admet-3007	114	7	in	in	ADP
admet-3007	114	8	ovarian	ovarian	ADJ
admet-3007	114	9	cscs	csc	NOUN
admet-3007	114	10	,	,	PUNCT
admet-3007	114	11	has	have	VERB
admet-3007	114	12	a	a	DET
admet-3007	114	13	more	more	ADV
admet-3007	114	14	limited	limited	ADJ
admet-3007	114	15	drug	drug	NOUN
admet-3007	114	16	transport	transport	NOUN
admet-3007	114	17	capacity	capacity	NOUN
admet-3007	114	18	,	,	PUNCT
admet-3007	114	19	primarily	primarily	ADV
admet-3007	114	20	transporting	transport	VERB
admet-3007	114	21	cisplatin	cisplatin	NOUN
admet-3007	114	22	[	[	X
admet-3007	114	23	48	48	NUM
admet-3007	114	24	]	]	PUNCT
admet-3007	114	25	.	.	PUNCT
admet-3007	115	1	antioxidant	antioxidant	ADJ
admet-3007	115	2	activities	activity	NOUN
admet-3007	115	3	the	the	DET
admet-3007	115	4	aldh	aldh	NOUN
admet-3007	115	5	superfamily	superfamily	ADV
admet-3007	115	6	plays	play	VERB
admet-3007	115	7	a	a	DET
admet-3007	115	8	pivotal	pivotal	ADJ
admet-3007	115	9	role	role	NOUN
admet-3007	115	10	in	in	ADP
admet-3007	115	11	detoxifying	detoxify	VERB
admet-3007	115	12	endogenous	endogenous	ADJ
admet-3007	115	13	and	and	CCONJ
admet-3007	115	14	exogenous	exogenous	ADJ
admet-3007	115	15	aldehydes	aldehyde	NOUN
admet-3007	115	16	by	by	ADP
admet-3007	115	17	catalysing	catalyse	VERB
admet-3007	115	18	their	their	PRON
admet-3007	115	19	oxidation	oxidation	NOUN
admet-3007	115	20	into	into	ADP
admet-3007	115	21	carboxylic	carboxylic	ADJ
admet-3007	115	22	acids	acid	NOUN
admet-3007	115	23	.	.	PUNCT
admet-3007	116	1	these	these	DET
admet-3007	116	2	enzymes	enzyme	NOUN
admet-3007	116	3	are	be	AUX
admet-3007	116	4	highly	highly	ADV
admet-3007	116	5	expressed	express	VERB
admet-3007	116	6	in	in	ADP
admet-3007	116	7	cscs	cscs	PROPN
admet-3007	116	8	across	across	ADP
admet-3007	116	9	various	various	ADJ
admet-3007	116	10	cancers	cancer	NOUN
admet-3007	116	11	,	,	PUNCT
admet-3007	116	12	with	with	ADP
admet-3007	116	13	elevated	elevated	ADJ
admet-3007	116	14	levels	level	NOUN
admet-3007	116	15	frequently	frequently	ADV
admet-3007	116	16	observed	observe	VERB
admet-3007	116	17	in	in	ADP
admet-3007	116	18	cancer	cancer	NOUN
admet-3007	116	19	patients	patient	NOUN
admet-3007	116	20	.	.	PUNCT
admet-3007	117	1	several	several	ADJ
admet-3007	117	2	aldh	aldh	ADJ
admet-3007	117	3	isoforms	isoform	NOUN
admet-3007	117	4	,	,	PUNCT
admet-3007	117	5	including	include	VERB
admet-3007	117	6	aldh1a2	aldh1a2	PROPN
admet-3007	117	7	,	,	PUNCT
admet-3007	117	8	aldh1a3	aldh1a3	X
admet-3007	117	9	,	,	PUNCT
admet-3007	117	10	aldh1b1	aldh1b1	PROPN
admet-3007	117	11	,	,	PUNCT
admet-3007	117	12	aldh2	aldh2	ADJ
admet-3007	117	13	,	,	PUNCT
admet-3007	117	14	and	and	CCONJ
admet-3007	117	15	aldh3a1	aldh3a1	ADJ
admet-3007	117	16	,	,	PUNCT
admet-3007	117	17	are	be	AUX
admet-3007	117	18	overexpressed	overexpresse	VERB
admet-3007	117	19	in	in	ADP
admet-3007	117	20	cscs	cscs	PROPN
admet-3007	117	21	[	[	X
admet-3007	117	22	49	49	NUM
admet-3007	117	23	]	]	PUNCT
admet-3007	117	24	.	.	PUNCT
admet-3007	118	1	the	the	DET
admet-3007	118	2	expression	expression	NOUN
admet-3007	118	3	and	and	CCONJ
admet-3007	118	4	activity	activity	NOUN
admet-3007	118	5	of	of	ADP
admet-3007	118	6	these	these	DET
admet-3007	118	7	enzymes	enzyme	NOUN
admet-3007	118	8	,	,	PUNCT
admet-3007	118	9	alongside	alongside	ADP
admet-3007	118	10	other	other	ADJ
admet-3007	118	11	biomarkers	biomarker	NOUN
admet-3007	118	12	,	,	PUNCT
admet-3007	118	13	have	have	AUX
admet-3007	118	14	been	be	AUX
admet-3007	118	15	widely	widely	ADV
admet-3007	118	16	used	use	VERB
admet-3007	118	17	to	to	PART
admet-3007	118	18	identify	identify	VERB
admet-3007	118	19	cscs	cscs	PROPN
admet-3007	118	20	in	in	ADP
admet-3007	118	21	different	different	ADJ
admet-3007	118	22	cancer	cancer	NOUN
admet-3007	118	23	types	type	NOUN
admet-3007	118	24	.	.	PUNCT
admet-3007	119	1	in	in	ADP
admet-3007	119	2	essence	essence	NOUN
admet-3007	119	3	,	,	PUNCT
admet-3007	119	4	aldh	aldh	ADJ
admet-3007	119	5	enzymes	enzyme	NOUN
admet-3007	119	6	contribute	contribute	VERB
admet-3007	119	7	to	to	ADP
admet-3007	119	8	cscs	cscs	PROPN
admet-3007	119	9	'	'	PART
admet-3007	119	10	resistance	resistance	NOUN
admet-3007	119	11	to	to	ADP
admet-3007	119	12	chemical	chemical	NOUN
admet-3007	119	13	and	and	CCONJ
admet-3007	119	14	oxidative	oxidative	ADJ
admet-3007	119	15	stress	stress	NOUN
admet-3007	119	16	[	[	X
admet-3007	119	17	50	50	NUM
admet-3007	119	18	]	]	PUNCT
admet-3007	119	19	.	.	PUNCT
admet-3007	120	1	moreover	moreover	ADV
admet-3007	120	2	,	,	PUNCT
admet-3007	120	3	cscs	cscs	PROPN
admet-3007	120	4	counteract	counteract	VERB
admet-3007	120	5	reactive	reactive	ADJ
admet-3007	120	6	oxygen	oxygen	NOUN
admet-3007	120	7	species	specie	NOUN
admet-3007	120	8	(	(	PUNCT
admet-3007	120	9	ros	ros	PROPN
admet-3007	120	10	)	)	PUNCT
admet-3007	120	11	by	by	ADP
admet-3007	120	12	upregulating	upregulating	ADJ
admet-3007	120	13	glutathione	glutathione	NOUN
admet-3007	120	14	synthesis	synthesis	NOUN
admet-3007	120	15	,	,	PUNCT
admet-3007	120	16	a	a	DET
admet-3007	120	17	tripeptide	tripeptide	NOUN
admet-3007	120	18	composed	compose	VERB
admet-3007	120	19	of	of	ADP
admet-3007	120	20	glycine	glycine	NOUN
admet-3007	120	21	,	,	PUNCT
admet-3007	120	22	cysteine	cysteine	NOUN
admet-3007	120	23	,	,	PUNCT
admet-3007	120	24	and	and	CCONJ
admet-3007	120	25	glutamic	glutamic	ADJ
admet-3007	120	26	acid	acid	NOUN
admet-3007	120	27	.	.	PUNCT
admet-3007	121	1	glutathione	glutathione	NOUN
admet-3007	121	2	protects	protect	VERB
admet-3007	121	3	essential	essential	ADJ
admet-3007	121	4	cellular	cellular	ADJ
admet-3007	121	5	components	component	NOUN
admet-3007	121	6	from	from	ADP
admet-3007	121	7	oxidative	oxidative	ADJ
admet-3007	121	8	damage	damage	NOUN
admet-3007	121	9	induced	induce	VERB
admet-3007	121	10	by	by	ADP
admet-3007	121	11	free	free	ADJ
admet-3007	121	12	radicals	radical	NOUN
admet-3007	121	13	,	,	PUNCT
admet-3007	121	14	peroxides	peroxide	NOUN
admet-3007	121	15	,	,	PUNCT
admet-3007	121	16	and	and	CCONJ
admet-3007	121	17	heavy	heavy	ADJ
admet-3007	121	18	metals	metal	NOUN
admet-3007	121	19	[	[	X
admet-3007	121	20	51	51	NUM
admet-3007	121	21	]	]	PUNCT
admet-3007	121	22	.	.	PUNCT
admet-3007	122	1	studies	study	NOUN
admet-3007	122	2	have	have	AUX
admet-3007	122	3	demonstrated	demonstrate	VERB
admet-3007	122	4	that	that	SCONJ
admet-3007	122	5	elevated	elevated	ADJ
admet-3007	122	6	glutathione	glutathione	NOUN
admet-3007	122	7	levels	level	NOUN
admet-3007	122	8	in	in	ADP
admet-3007	122	9	cscs	cscs	PROPN
admet-3007	122	10	enhance	enhance	NOUN
admet-3007	122	11	cell	cell	NOUN
admet-3007	122	12	viability	viability	NOUN
admet-3007	122	13	,	,	PUNCT
admet-3007	122	14	promote	promote	VERB
admet-3007	122	15	cell	cell	NOUN
admet-3007	122	16	cycle	cycle	NOUN
admet-3007	122	17	progression	progression	NOUN
admet-3007	122	18	,	,	PUNCT
admet-3007	122	19	and	and	CCONJ
admet-3007	122	20	increase	increase	VERB
admet-3007	122	21	resistance	resistance	NOUN
admet-3007	122	22	to	to	ADP
admet-3007	122	23	chemotherapy	chemotherapy	NOUN
admet-3007	122	24	.	.	PUNCT
admet-3007	123	1	conversely	conversely	ADV
admet-3007	123	2	,	,	PUNCT
admet-3007	123	3	inhibition	inhibition	NOUN
admet-3007	123	4	of	of	ADP
admet-3007	123	5	glutathione	glutathione	NOUN
admet-3007	123	6	synthesis	synthesis	NOUN
admet-3007	123	7	impairs	impair	VERB
admet-3007	123	8	csc	csc	PROPN
admet-3007	123	9	selfrenewal	selfrenewal	NOUN
admet-3007	123	10	and	and	CCONJ
admet-3007	123	11	sensitizes	sensitize	VERB
admet-3007	123	12	them	they	PRON
admet-3007	123	13	to	to	ADP
admet-3007	123	14	chemotherapeutic	chemotherapeutic	ADJ
admet-3007	123	15	agents	agent	NOUN
admet-3007	123	16	[	[	X
admet-3007	123	17	52	52	NUM
admet-3007	123	18	]	]	PUNCT
admet-3007	123	19	.	.	PUNCT
admet-3007	124	1	escaping	escape	VERB
admet-3007	124	2	apoptosis	apoptosis	NOUN
admet-3007	124	3	apoptosis	apoptosis	NOUN
admet-3007	124	4	,	,	PUNCT
admet-3007	124	5	a	a	DET
admet-3007	124	6	fundamental	fundamental	ADJ
admet-3007	124	7	process	process	NOUN
admet-3007	124	8	for	for	ADP
admet-3007	124	9	maintaining	maintain	VERB
admet-3007	124	10	cellular	cellular	ADJ
admet-3007	124	11	homeostasis	homeostasis	NOUN
admet-3007	124	12	,	,	PUNCT
admet-3007	124	13	is	be	AUX
admet-3007	124	14	tightly	tightly	ADV
admet-3007	124	15	regulated	regulate	VERB
admet-3007	124	16	,	,	PUNCT
admet-3007	124	17	and	and	CCONJ
admet-3007	124	18	its	its	PRON
admet-3007	124	19	disruption	disruption	NOUN
admet-3007	124	20	is	be	AUX
admet-3007	124	21	frequently	frequently	ADV
admet-3007	124	22	associated	associate	VERB
admet-3007	124	23	with	with	ADP
admet-3007	124	24	cancer	cancer	NOUN
admet-3007	124	25	progression	progression	NOUN
admet-3007	124	26	.	.	PUNCT
admet-3007	125	1	cscs	cscs	PROPN
admet-3007	125	2	exhibit	exhibit	VERB
admet-3007	125	3	significant	significant	ADJ
admet-3007	125	4	resistance	resistance	NOUN
admet-3007	125	5	to	to	ADP
admet-3007	125	6	apoptosis	apoptosis	VERB
admet-3007	125	7	,	,	PUNCT
admet-3007	125	8	contributing	contribute	VERB
admet-3007	125	9	to	to	ADP
admet-3007	125	10	treatment	treatment	NOUN
admet-3007	125	11	failure	failure	NOUN
admet-3007	125	12	and	and	CCONJ
admet-3007	125	13	tumour	tumour	NOUN
admet-3007	125	14	recurrence	recurrence	NOUN
admet-3007	125	15	.	.	PUNCT
admet-3007	126	1	for	for	ADP
admet-3007	126	2	instance	instance	NOUN
admet-3007	126	3	,	,	PUNCT
admet-3007	126	4	cscs	cscs	PROPN
admet-3007	126	5	in	in	ADP
admet-3007	126	6	human	human	ADJ
admet-3007	126	7	gliomas	glioma	NOUN
admet-3007	126	8	and	and	CCONJ
admet-3007	126	9	leukaemia	leukaemia	NOUN
admet-3007	126	10	display	display	NOUN
admet-3007	126	11	reduced	reduce	VERB
admet-3007	126	12	expression	expression	NOUN
admet-3007	126	13	of	of	ADP
admet-3007	126	14	fas	fas	PROPN
admet-3007	126	15	and	and	CCONJ
admet-3007	126	16	its	its	PRON
admet-3007	126	17	ligand	ligand	NOUN
admet-3007	126	18	(	(	PUNCT
admet-3007	126	19	fasl	fasl	PROPN
admet-3007	126	20	)	)	PUNCT
admet-3007	126	21	,	,	PUNCT
admet-3007	126	22	crucial	crucial	ADJ
admet-3007	126	23	components	component	NOUN
admet-3007	126	24	of	of	ADP
admet-3007	126	25	the	the	DET
admet-3007	126	26	extrinsic	extrinsic	ADJ
admet-3007	126	27	apoptotic	apoptotic	ADJ
admet-3007	126	28	pathway	pathway	NOUN
admet-3007	126	29	.	.	PUNCT
admet-3007	127	1	fas	fas	NOUN
admet-3007	127	2	,	,	PUNCT
admet-3007	127	3	a	a	DET
admet-3007	127	4	membrane	membrane	NOUN
admet-3007	127	5	-	-	PUNCT
admet-3007	127	6	bound	bind	VERB
admet-3007	127	7	receptor	receptor	NOUN
admet-3007	127	8	from	from	ADP
admet-3007	127	9	the	the	DET
admet-3007	127	10	death	death	NOUN
admet-3007	127	11	receptor	receptor	NOUN
admet-3007	127	12	family	family	NOUN
admet-3007	127	13	,	,	PUNCT
admet-3007	127	14	typically	typically	ADV
admet-3007	127	15	initiates	initiate	VERB
admet-3007	127	16	cell	cell	NOUN
admet-3007	127	17	death	death	NOUN
admet-3007	127	18	upon	upon	SCONJ
admet-3007	127	19	ligand	ligand	ADJ
admet-3007	127	20	binding	binding	NOUN
admet-3007	127	21	.	.	PUNCT
admet-3007	128	1	reduced	reduce	VERB
admet-3007	128	2	expression	expression	NOUN
admet-3007	128	3	of	of	ADP
admet-3007	128	4	fas	fas	PROPN
admet-3007	128	5	and	and	CCONJ
admet-3007	128	6	fasl	fasl	PROPN
admet-3007	128	7	in	in	ADP
admet-3007	128	8	cscs	cscs	PROPN
admet-3007	128	9	leads	lead	VERB
admet-3007	128	10	to	to	ADP
admet-3007	128	11	diminished	diminish	VERB
admet-3007	128	12	sensitivity	sensitivity	NOUN
admet-3007	128	13	to	to	ADP
admet-3007	128	14	apoptotic	apoptotic	ADJ
admet-3007	128	15	signals	signal	NOUN
admet-3007	128	16	through	through	ADP
admet-3007	128	17	the	the	DET
admet-3007	128	18	extrinsic	extrinsic	ADJ
admet-3007	128	19	pathway	pathway	NOUN
admet-3007	128	20	,	,	PUNCT
admet-3007	128	21	thereby	thereby	ADV
admet-3007	128	22	enabling	enable	VERB
admet-3007	128	23	cscs	cscs	PROPN
admet-3007	128	24	to	to	PART
admet-3007	128	25	evade	evade	VERB
admet-3007	128	26	programmed	programmed	ADJ
admet-3007	128	27	cell	cell	NOUN
admet-3007	128	28	death	death	NOUN
admet-3007	128	29	.	.	PUNCT
admet-3007	129	1	moreover	moreover	ADV
admet-3007	129	2	,	,	PUNCT
admet-3007	129	3	cscs	cscs	PROPN
admet-3007	129	4	overexpress	overexpress	NOUN
admet-3007	129	5	inhibitors	inhibitor	NOUN
admet-3007	129	6	of	of	ADP
admet-3007	129	7	apoptosis	apoptosis	NOUN
admet-3007	129	8	proteins	protein	NOUN
admet-3007	129	9	(	(	PUNCT
admet-3007	129	10	iaps	iap	NOUN
admet-3007	129	11	)	)	PUNCT
admet-3007	129	12	,	,	PUNCT
admet-3007	129	13	such	such	ADJ
admet-3007	129	14	as	as	ADP
admet-3007	129	15	xiap	xiap	PROPN
admet-3007	129	16	,	,	PUNCT
admet-3007	129	17	c	c	NOUN
admet-3007	129	18	-	-	PUNCT
admet-3007	129	19	iap1	iap1	NOUN
admet-3007	129	20	,	,	PUNCT
admet-3007	129	21	and	and	CCONJ
admet-3007	129	22	livin	livin	PROPN
admet-3007	129	23	,	,	PUNCT
admet-3007	129	24	which	which	PRON
admet-3007	129	25	act	act	VERB
admet-3007	129	26	as	as	ADP
admet-3007	129	27	potent	potent	ADJ
admet-3007	129	28	suppressors	suppressor	NOUN
admet-3007	129	29	of	of	ADP
admet-3007	129	30	the	the	DET
admet-3007	129	31	intrinsic	intrinsic	ADJ
admet-3007	129	32	apoptotic	apoptotic	ADJ
admet-3007	129	33	pathway	pathway	NOUN
admet-3007	129	34	.	.	PUNCT
admet-3007	130	1	these	these	DET
admet-3007	130	2	proteins	protein	NOUN
admet-3007	130	3	inhibit	inhibit	VERB
admet-3007	130	4	the	the	DET
admet-3007	130	5	activation	activation	NOUN
admet-3007	130	6	of	of	ADP
admet-3007	130	7	caspases	caspase	NOUN
admet-3007	130	8	—	—	PUNCT
admet-3007	130	9	the	the	DET
admet-3007	130	10	central	central	ADJ
admet-3007	130	11	executioners	executioner	NOUN
admet-3007	130	12	of	of	ADP
admet-3007	130	13	apoptosis	apoptosis	NOUN
admet-3007	130	14	-	-	PUNCT
admet-3007	130	15	thus	thus	ADV
admet-3007	130	16	further	far	ADV
admet-3007	130	17	enhancing	enhance	VERB
admet-3007	130	18	the	the	DET
admet-3007	130	19	survival	survival	NOUN
admet-3007	130	20	of	of	ADP
admet-3007	130	21	cscs	cscs	PROPN
admet-3007	130	22	under	under	ADP
admet-3007	130	23	stress	stress	NOUN
admet-3007	130	24	conditions	condition	NOUN
admet-3007	130	25	that	that	PRON
admet-3007	130	26	would	would	AUX
admet-3007	130	27	typically	typically	ADV
admet-3007	130	28	eliminate	eliminate	VERB
admet-3007	130	29	non	non	ADJ
admet-3007	130	30	-	-	ADJ
admet-3007	130	31	stem	stem	ADJ
admet-3007	130	32	cancer	cancer	NOUN
admet-3007	130	33	cells	cell	NOUN
admet-3007	130	34	[	[	X
admet-3007	130	35	53	53	NUM
admet-3007	130	36	]	]	PUNCT
admet-3007	130	37	.	.	PUNCT
admet-3007	131	1	another	another	DET
admet-3007	131	2	crucial	crucial	ADJ
admet-3007	131	3	mechanism	mechanism	NOUN
admet-3007	131	4	contributing	contribute	VERB
admet-3007	131	5	to	to	ADP
admet-3007	131	6	apoptosis	apoptosis	NOUN
admet-3007	131	7	resistance	resistance	NOUN
admet-3007	131	8	in	in	ADP
admet-3007	131	9	cscs	cscs	PROPN
admet-3007	131	10	is	be	AUX
admet-3007	131	11	the	the	DET
admet-3007	131	12	activation	activation	NOUN
admet-3007	131	13	of	of	ADP
admet-3007	131	14	the	the	DET
admet-3007	131	15	g2	g2	PROPN
admet-3007	131	16	/	/	SYM
admet-3007	131	17	m	m	PROPN
admet-3007	131	18	phase	phase	NOUN
admet-3007	131	19	cell	cell	NOUN
admet-3007	131	20	cycle	cycle	NOUN
admet-3007	131	21	checkpoint	checkpoint	NOUN
admet-3007	131	22	.	.	PUNCT
admet-3007	132	1	this	this	DET
admet-3007	132	2	checkpoint	checkpoint	NOUN
admet-3007	132	3	is	be	AUX
admet-3007	132	4	triggered	trigger	VERB
admet-3007	132	5	in	in	ADP
admet-3007	132	6	response	response	NOUN
admet-3007	132	7	to	to	ADP
admet-3007	132	8	dna	dna	PROPN
admet-3007	132	9	damage	damage	NOUN
admet-3007	132	10	or	or	CCONJ
admet-3007	132	11	other	other	ADJ
admet-3007	132	12	cellular	cellular	ADJ
admet-3007	132	13	stressors	stressor	NOUN
admet-3007	132	14	,	,	PUNCT
admet-3007	132	15	halting	halt	VERB
admet-3007	132	16	the	the	DET
admet-3007	132	17	cell	cell	NOUN
admet-3007	132	18	cycle	cycle	NOUN
admet-3007	132	19	before	before	ADP
admet-3007	132	20	mitosis	mitosis	PROPN
admet-3007	132	21	.	.	PUNCT
admet-3007	133	1	in	in	ADP
admet-3007	133	2	cscs	cscs	PROPN
admet-3007	133	3	,	,	PUNCT
admet-3007	133	4	this	this	PRON
admet-3007	133	5	leads	lead	VERB
admet-3007	133	6	to	to	ADP
admet-3007	133	7	a	a	DET
admet-3007	133	8	prolonged	prolonged	ADJ
admet-3007	133	9	g2	g2	PROPN
admet-3007	133	10	/	/	SYM
admet-3007	133	11	m	m	NOUN
admet-3007	133	12	arrest	arrest	NOUN
admet-3007	133	13	,	,	PUNCT
admet-3007	133	14	allowing	allow	VERB
admet-3007	133	15	time	time	NOUN
admet-3007	133	16	for	for	ADP
admet-3007	133	17	dna	dna	PROPN
admet-3007	133	18	repair	repair	NOUN
admet-3007	133	19	and	and	CCONJ
admet-3007	133	20	promoting	promote	VERB
admet-3007	133	21	survival	survival	NOUN
admet-3007	133	22	.	.	PUNCT
admet-3007	134	1	this	this	DET
admet-3007	134	2	selective	selective	ADJ
admet-3007	134	3	advantage	advantage	NOUN
admet-3007	134	4	not	not	PART
admet-3007	134	5	only	only	ADV
admet-3007	134	6	confers	confer	NOUN
admet-3007	134	7	resistance	resistance	NOUN
admet-3007	134	8	to	to	ADP
admet-3007	134	9	chemotherapy	chemotherapy	NOUN
admet-3007	134	10	and	and	CCONJ
admet-3007	134	11	radiation	radiation	NOUN
admet-3007	134	12	,	,	PUNCT
admet-3007	134	13	which	which	PRON
admet-3007	134	14	primarily	primarily	ADV
admet-3007	134	15	target	target	AUX
admet-3007	134	16	rapidly	rapidly	ADV
admet-3007	134	17	dividing	divide	VERB
admet-3007	134	18	cells	cell	NOUN
admet-3007	134	19	,	,	PUNCT
admet-3007	134	20	but	but	CCONJ
admet-3007	134	21	also	also	ADV
admet-3007	134	22	enhances	enhance	VERB
admet-3007	134	23	tumorigenic	tumorigenic	ADJ
admet-3007	134	24	potential	potential	NOUN
admet-3007	134	25	,	,	PUNCT
admet-3007	134	26	as	as	SCONJ
admet-3007	134	27	cells	cell	NOUN
admet-3007	134	28	in	in	ADP
admet-3007	134	29	the	the	DET
admet-3007	134	30	g2	g2	PROPN
admet-3007	134	31	/	/	SYM
admet-3007	134	32	m	m	PROPN
admet-3007	134	33	phase	phase	NOUN
admet-3007	134	34	are	be	AUX
admet-3007	134	35	often	often	ADV
admet-3007	134	36	more	more	ADV
admet-3007	134	37	resistant	resistant	ADJ
admet-3007	134	38	to	to	ADP
admet-3007	134	39	apoptosis	apoptosis	NOUN
admet-3007	134	40	-	-	PUNCT
admet-3007	134	41	inducing	induce	VERB
admet-3007	134	42	agents	agent	NOUN
admet-3007	134	43	[	[	X
admet-3007	134	44	54	54	NUM
admet-3007	134	45	]	]	PUNCT
admet-3007	134	46	.	.	PUNCT
admet-3007	135	1	this	this	DET
admet-3007	135	2	complex	complex	ADJ
admet-3007	135	3	network	network	NOUN
admet-3007	135	4	of	of	ADP
admet-3007	135	5	apoptosis	apoptosis	NOUN
admet-3007	135	6	evasion	evasion	NOUN
admet-3007	135	7	strategies	strategy	NOUN
admet-3007	135	8	highlights	highlight	VERB
admet-3007	135	9	the	the	DET
admet-3007	135	10	major	major	ADJ
admet-3007	135	11	challenge	challenge	NOUN
admet-3007	135	12	in	in	ADP
admet-3007	135	13	targeting	target	VERB
admet-3007	135	14	cscs	cscs	NOUN
admet-3007	135	15	during	during	ADP
admet-3007	135	16	cancer	cancer	NOUN
admet-3007	135	17	treatment	treatment	NOUN
admet-3007	135	18	.	.	PUNCT
admet-3007	136	1	their	their	PRON
admet-3007	136	2	ability	ability	NOUN
admet-3007	136	3	to	to	PART
admet-3007	136	4	resist	resist	VERB
admet-3007	136	5	both	both	CCONJ
admet-3007	136	6	intrinsic	intrinsic	ADJ
admet-3007	136	7	and	and	CCONJ
admet-3007	136	8	extrinsic	extrinsic	ADJ
admet-3007	136	9	apoptotic	apoptotic	ADJ
admet-3007	136	10	signals	signal	NOUN
admet-3007	136	11	,	,	PUNCT
admet-3007	136	12	coupled	couple	VERB
admet-3007	136	13	with	with	ADP
admet-3007	136	14	sustained	sustained	ADJ
admet-3007	136	15	g2	g2	PROPN
admet-3007	136	16	/	/	SYM
admet-3007	136	17	m	m	PROPN
admet-3007	136	18	checkpoint	checkpoint	NOUN
admet-3007	136	19	activation	activation	NOUN
admet-3007	136	20	,	,	PUNCT
admet-3007	136	21	enables	enable	VERB
admet-3007	136	22	them	they	PRON
admet-3007	136	23	to	to	PART
admet-3007	136	24	survive	survive	VERB
admet-3007	136	25	under	under	ADP
admet-3007	136	26	hostile	hostile	ADJ
admet-3007	136	27	therapeutic	therapeutic	ADJ
admet-3007	136	28	conditions	condition	NOUN
admet-3007	136	29	,	,	PUNCT
admet-3007	136	30	contributing	contribute	VERB
admet-3007	136	31	to	to	ADP
admet-3007	136	32	tumour	tumour	NOUN
admet-3007	136	33	persistence	persistence	NOUN
admet-3007	136	34	and	and	CCONJ
admet-3007	136	35	recurrence	recurrence	NOUN
admet-3007	136	36	.	.	PUNCT
admet-3007	137	1	a	a	DET
admet-3007	137	2	deeper	deep	ADJ
admet-3007	137	3	understanding	understanding	NOUN
admet-3007	137	4	of	of	ADP
admet-3007	137	5	these	these	DET
admet-3007	137	6	mechanisms	mechanism	NOUN
admet-3007	137	7	could	could	AUX
admet-3007	137	8	facilitate	facilitate	VERB
admet-3007	137	9	the	the	DET
admet-3007	137	10	development	development	NOUN
admet-3007	137	11	of	of	ADP
admet-3007	137	12	more	more	ADV
admet-3007	137	13	effective	effective	ADJ
admet-3007	137	14	therapies	therapy	NOUN
admet-3007	137	15	specifically	specifically	ADV
admet-3007	137	16	designed	design	VERB
admet-3007	137	17	to	to	PART
admet-3007	137	18	target	target	VERB
admet-3007	137	19	cscs	cscs	NOUN
admet-3007	137	20	and	and	CCONJ
admet-3007	137	21	overcome	overcome	VERB
admet-3007	137	22	their	their	PRON
admet-3007	137	23	apoptotic	apoptotic	ADJ
admet-3007	137	24	resistance	resistance	NOUN
admet-3007	138	1	[	[	X
admet-3007	138	2	55	55	NUM
admet-3007	138	3	]	]	PUNCT
admet-3007	138	4	.	.	PUNCT
admet-3007	139	1	dna	dna	PROPN
admet-3007	139	2	damage	damage	NOUN
admet-3007	139	3	response	response	NOUN
admet-3007	139	4	a	a	DET
admet-3007	139	5	key	key	ADJ
admet-3007	139	6	factor	factor	NOUN
admet-3007	139	7	contributing	contribute	VERB
admet-3007	139	8	to	to	ADP
admet-3007	139	9	the	the	DET
admet-3007	139	10	survival	survival	NOUN
admet-3007	139	11	of	of	ADP
admet-3007	139	12	cscs	cscs	PROPN
admet-3007	139	13	under	under	ADP
admet-3007	139	14	stressful	stressful	ADJ
admet-3007	139	15	conditions	condition	NOUN
admet-3007	139	16	,	,	PUNCT
admet-3007	139	17	such	such	ADJ
admet-3007	139	18	as	as	ADP
admet-3007	139	19	chemotherapy	chemotherapy	NOUN
admet-3007	139	20	and	and	CCONJ
admet-3007	139	21	radiation	radiation	NOUN
admet-3007	139	22	,	,	PUNCT
admet-3007	139	23	is	be	AUX
admet-3007	139	24	their	their	PRON
admet-3007	139	25	enhanced	enhance	VERB
admet-3007	139	26	capacity	capacity	NOUN
admet-3007	139	27	for	for	ADP
admet-3007	139	28	dna	dna	PROPN
admet-3007	139	29	repair	repair	NOUN
admet-3007	139	30	[	[	X
admet-3007	139	31	56	56	NUM
admet-3007	139	32	]	]	PUNCT
admet-3007	139	33	.	.	PUNCT
admet-3007	140	1	this	this	DET
admet-3007	140	2	dna	dna	PROPN
admet-3007	140	3	damage	damage	NOUN
admet-3007	140	4	response	response	NOUN
admet-3007	140	5	(	(	PUNCT
admet-3007	140	6	ddr	ddr	NOUN
admet-3007	140	7	)	)	PUNCT
admet-3007	140	8	is	be	AUX
admet-3007	140	9	crucial	crucial	ADJ
admet-3007	140	10	for	for	ADP
admet-3007	140	11	cscs	cscs	PROPN
admet-3007	140	12	admet	admet	PROPN
admet-3007	140	13	&	&	CCONJ
admet-3007	140	14	dmpk	dmpk	PROPN
admet-3007	140	15	13(5	13(5	NUM
admet-3007	140	16	)	)	PUNCT
admet-3007	140	17	(	(	PUNCT
admet-3007	140	18	2025	2025	NUM
admet-3007	140	19	)	)	PUNCT
admet-3007	140	20	3007	3007	NUM
admet-3007	140	21	nano	nano	NOUN
admet-3007	140	22	-	-	PUNCT
admet-3007	140	23	biomaterials	biomaterial	NOUN
admet-3007	140	24	in	in	ADP
admet-3007	140	25	cancer	cancer	NOUN
admet-3007	140	26	therapy	therapy	NOUN
admet-3007	140	27	doi	doi	PROPN
admet-3007	140	28	:	:	PUNCT
admet-3007	140	29	https://doi.org/10.5599/admet.3007	https://doi.org/10.5599/admet.3007	NOUN
admet-3007	140	30	7	7	NUM
admet-3007	140	31	to	to	PART
admet-3007	140	32	maintain	maintain	VERB
admet-3007	140	33	genomic	genomic	ADJ
admet-3007	140	34	integrity	integrity	NOUN
admet-3007	140	35	,	,	PUNCT
admet-3007	140	36	as	as	SCONJ
admet-3007	140	37	it	it	PRON
admet-3007	140	38	enables	enable	VERB
admet-3007	140	39	them	they	PRON
admet-3007	140	40	to	to	PART
admet-3007	140	41	survive	survive	VERB
admet-3007	140	42	therapies	therapy	NOUN
admet-3007	140	43	that	that	PRON
admet-3007	140	44	induce	induce	VERB
admet-3007	140	45	dna	dna	NOUN
admet-3007	140	46	damage	damage	NOUN
admet-3007	140	47	,	,	PUNCT
admet-3007	140	48	a	a	DET
admet-3007	140	49	common	common	ADJ
admet-3007	140	50	means	mean	NOUN
admet-3007	140	51	of	of	ADP
admet-3007	140	52	killing	kill	VERB
admet-3007	140	53	cancer	cancer	NOUN
admet-3007	140	54	cells	cell	NOUN
admet-3007	140	55	.	.	PUNCT
admet-3007	141	1	the	the	DET
admet-3007	141	2	ability	ability	NOUN
admet-3007	141	3	to	to	PART
admet-3007	141	4	repair	repair	VERB
admet-3007	141	5	dna	dna	NOUN
admet-3007	141	6	following	follow	VERB
admet-3007	141	7	such	such	ADJ
admet-3007	141	8	treatments	treatment	NOUN
admet-3007	141	9	not	not	PART
admet-3007	141	10	only	only	ADV
admet-3007	141	11	protects	protect	VERB
admet-3007	141	12	cscs	cscs	PROPN
admet-3007	141	13	from	from	ADP
admet-3007	141	14	apoptosis	apoptosis	NOUN
admet-3007	141	15	but	but	CCONJ
admet-3007	141	16	also	also	ADV
admet-3007	141	17	preserves	preserve	VERB
admet-3007	141	18	their	their	PRON
admet-3007	141	19	tumorigenic	tumorigenic	ADJ
admet-3007	141	20	potential	potential	NOUN
admet-3007	141	21	[	[	X
admet-3007	141	22	55	55	NUM
admet-3007	141	23	]	]	PUNCT
admet-3007	141	24	.	.	PUNCT
admet-3007	142	1	one	one	NUM
admet-3007	142	2	of	of	ADP
admet-3007	142	3	the	the	DET
admet-3007	142	4	primary	primary	ADJ
admet-3007	142	5	protective	protective	ADJ
admet-3007	142	6	mechanisms	mechanism	NOUN
admet-3007	142	7	in	in	ADP
admet-3007	142	8	cscs	cscs	PROPN
admet-3007	142	9	is	be	AUX
admet-3007	142	10	their	their	PRON
admet-3007	142	11	ability	ability	NOUN
admet-3007	142	12	to	to	PART
admet-3007	142	13	alleviate	alleviate	VERB
admet-3007	142	14	oxidative	oxidative	ADJ
admet-3007	142	15	stress	stress	NOUN
admet-3007	142	16	by	by	ADP
admet-3007	142	17	scavenging	scavenge	VERB
admet-3007	142	18	ros	ros	PROPN
admet-3007	142	19	,	,	PUNCT
admet-3007	142	20	which	which	PRON
admet-3007	142	21	are	be	AUX
admet-3007	142	22	major	major	ADJ
admet-3007	142	23	contributors	contributor	NOUN
admet-3007	142	24	to	to	ADP
admet-3007	142	25	dna	dna	PROPN
admet-3007	142	26	damage	damage	NOUN
admet-3007	142	27	.	.	PUNCT
admet-3007	143	1	cscs	cscs	PROPN
admet-3007	143	2	,	,	PUNCT
admet-3007	143	3	particularly	particularly	ADV
admet-3007	143	4	those	those	PRON
admet-3007	143	5	found	find	VERB
admet-3007	143	6	in	in	ADP
admet-3007	143	7	breast	breast	NOUN
admet-3007	143	8	cancer	cancer	NOUN
admet-3007	143	9	,	,	PUNCT
admet-3007	143	10	have	have	AUX
admet-3007	143	11	been	be	AUX
admet-3007	143	12	shown	show	VERB
admet-3007	143	13	to	to	PART
admet-3007	143	14	maintain	maintain	VERB
admet-3007	143	15	lower	low	ADJ
admet-3007	143	16	intracellular	intracellular	ADJ
admet-3007	143	17	ros	ros	NOUN
admet-3007	143	18	levels	level	NOUN
admet-3007	143	19	,	,	PUNCT
admet-3007	143	20	thereby	thereby	ADV
admet-3007	143	21	minimizing	minimize	VERB
admet-3007	143	22	oxidative	oxidative	ADJ
admet-3007	143	23	dna	dna	PROPN
admet-3007	143	24	injury	injury	NOUN
admet-3007	143	25	.	.	PUNCT
admet-3007	144	1	in	in	ADP
admet-3007	144	2	addition	addition	NOUN
admet-3007	144	3	,	,	PUNCT
admet-3007	144	4	cscs	cscs	PROPN
admet-3007	144	5	enhance	enhance	VERB
admet-3007	144	6	their	their	PRON
admet-3007	144	7	dna	dna	PROPN
admet-3007	144	8	repair	repair	NOUN
admet-3007	144	9	capabilities	capability	NOUN
admet-3007	144	10	by	by	ADP
admet-3007	144	11	activating	activate	VERB
admet-3007	144	12	critical	critical	ADJ
admet-3007	144	13	components	component	NOUN
admet-3007	144	14	of	of	ADP
admet-3007	144	15	the	the	DET
admet-3007	144	16	ddr	ddr	PROPN
admet-3007	144	17	.	.	PUNCT
admet-3007	145	1	for	for	ADP
admet-3007	145	2	instance	instance	NOUN
admet-3007	145	3	,	,	PUNCT
admet-3007	145	4	the	the	DET
admet-3007	145	5	phosphorylation	phosphorylation	NOUN
admet-3007	145	6	of	of	ADP
admet-3007	145	7	ataxia	ataxia	NOUN
admet-3007	145	8	-	-	PUNCT
admet-3007	145	9	telangiectasia	telangiectasia	NOUN
admet-3007	145	10	mutated	mutate	VERB
admet-3007	145	11	(	(	PUNCT
admet-3007	145	12	atm	atm	NOUN
admet-3007	145	13	)	)	PUNCT
admet-3007	145	14	and	and	CCONJ
admet-3007	145	15	checkpoint	checkpoint	NOUN
admet-3007	145	16	kinases	kinase	NOUN
admet-3007	145	17	(	(	PUNCT
admet-3007	145	18	chk1	chk1	NOUN
admet-3007	145	19	/	/	SYM
admet-3007	145	20	chk2	chk2	NOUN
admet-3007	145	21	)	)	PUNCT
admet-3007	145	22	is	be	AUX
admet-3007	145	23	pivotal	pivotal	ADJ
admet-3007	145	24	in	in	ADP
admet-3007	145	25	promoting	promote	VERB
admet-3007	145	26	efficient	efficient	ADJ
admet-3007	145	27	dna	dna	PROPN
admet-3007	145	28	repair	repair	NOUN
admet-3007	145	29	and	and	CCONJ
admet-3007	145	30	cell	cell	NOUN
admet-3007	145	31	cycle	cycle	NOUN
admet-3007	145	32	regulation	regulation	NOUN
admet-3007	145	33	.	.	PUNCT
admet-3007	146	1	these	these	DET
admet-3007	146	2	proteins	protein	NOUN
admet-3007	146	3	are	be	AUX
admet-3007	146	4	central	central	ADJ
admet-3007	146	5	to	to	ADP
admet-3007	146	6	recognizing	recognize	VERB
admet-3007	146	7	dna	dna	PROPN
admet-3007	146	8	damage	damage	NOUN
admet-3007	146	9	and	and	CCONJ
admet-3007	146	10	halting	halt	VERB
admet-3007	146	11	the	the	DET
admet-3007	146	12	cell	cell	NOUN
admet-3007	146	13	cycle	cycle	NOUN
admet-3007	146	14	,	,	PUNCT
admet-3007	146	15	allowing	allow	VERB
admet-3007	146	16	time	time	NOUN
admet-3007	146	17	for	for	ADP
admet-3007	146	18	repair	repair	NOUN
admet-3007	146	19	,	,	PUNCT
admet-3007	146	20	which	which	PRON
admet-3007	146	21	ultimately	ultimately	ADV
admet-3007	146	22	prevents	prevent	VERB
admet-3007	146	23	apoptosis	apoptosis	NOUN
admet-3007	146	24	[	[	X
admet-3007	146	25	57	57	NUM
admet-3007	146	26	]	]	PUNCT
admet-3007	146	27	.	.	PUNCT
admet-3007	147	1	moreover	moreover	ADV
admet-3007	147	2	,	,	PUNCT
admet-3007	147	3	cscs	cscs	PROPN
admet-3007	147	4	are	be	AUX
admet-3007	147	5	adept	adept	ADJ
admet-3007	147	6	at	at	ADP
admet-3007	147	7	activating	activate	VERB
admet-3007	147	8	anti	anti	ADJ
admet-3007	147	9	-	-	ADJ
admet-3007	147	10	apoptotic	apoptotic	ADJ
admet-3007	147	11	signalling	signal	VERB
admet-3007	147	12	pathways	pathway	NOUN
admet-3007	147	13	,	,	PUNCT
admet-3007	147	14	such	such	ADJ
admet-3007	147	15	as	as	ADP
admet-3007	147	16	notch	notch	NOUN
admet-3007	147	17	,	,	PUNCT
admet-3007	147	18	pi3k	pi3k	PROPN
admet-3007	147	19	/	/	SYM
admet-3007	147	20	akt	akt	PROPN
admet-3007	147	21	,	,	PUNCT
admet-3007	147	22	and	and	CCONJ
admet-3007	147	23	wnt	wnt	PROPN
admet-3007	147	24	/	/	SYM
admet-3007	147	25	β	β	NOUN
admet-3007	147	26	-	-	NOUN
admet-3007	147	27	catenin	catenin	NOUN
admet-3007	147	28	,	,	PUNCT
admet-3007	147	29	which	which	PRON
admet-3007	147	30	not	not	PART
admet-3007	147	31	only	only	ADV
admet-3007	147	32	enhance	enhance	VERB
admet-3007	147	33	their	their	PRON
admet-3007	147	34	survival	survival	NOUN
admet-3007	147	35	but	but	CCONJ
admet-3007	147	36	also	also	ADV
admet-3007	147	37	bolster	bolster	VERB
admet-3007	147	38	their	their	PRON
admet-3007	147	39	ability	ability	NOUN
admet-3007	147	40	to	to	PART
admet-3007	147	41	repair	repair	VERB
admet-3007	147	42	single	single	ADJ
admet-3007	147	43	-	-	PUNCT
admet-3007	147	44	strand	strand	NOUN
admet-3007	147	45	breaks	break	NOUN
admet-3007	147	46	in	in	ADP
admet-3007	147	47	dna	dna	PROPN
admet-3007	147	48	.	.	PUNCT
admet-3007	148	1	research	research	NOUN
admet-3007	148	2	has	have	AUX
admet-3007	148	3	shown	show	VERB
admet-3007	148	4	explicitly	explicitly	ADV
admet-3007	148	5	that	that	SCONJ
admet-3007	148	6	breast	breast	NOUN
admet-3007	148	7	cscs	cscs	PROPN
admet-3007	148	8	have	have	VERB
admet-3007	148	9	a	a	DET
admet-3007	148	10	more	more	ADV
admet-3007	148	11	active	active	ADJ
admet-3007	148	12	single	single	ADJ
admet-3007	148	13	-	-	PUNCT
admet-3007	148	14	strand	strand	NOUN
admet-3007	148	15	break	break	NOUN
admet-3007	148	16	repair	repair	NOUN
admet-3007	148	17	pathway	pathway	NOUN
admet-3007	148	18	,	,	PUNCT
admet-3007	148	19	contributing	contribute	VERB
admet-3007	148	20	to	to	ADP
admet-3007	148	21	their	their	PRON
admet-3007	148	22	resilience	resilience	NOUN
admet-3007	148	23	against	against	ADP
admet-3007	148	24	therapeutic	therapeutic	ADJ
admet-3007	148	25	interventions	intervention	NOUN
admet-3007	148	26	.	.	PUNCT
admet-3007	149	1	this	this	DET
admet-3007	149	2	robust	robust	ADJ
admet-3007	149	3	repair	repair	NOUN
admet-3007	149	4	mechanism	mechanism	NOUN
admet-3007	149	5	further	far	ADV
admet-3007	149	6	reinforces	reinforce	VERB
admet-3007	149	7	the	the	DET
admet-3007	149	8	survival	survival	NOUN
admet-3007	149	9	of	of	ADP
admet-3007	149	10	cscs	cscs	PROPN
admet-3007	149	11	by	by	ADP
admet-3007	149	12	reducing	reduce	VERB
admet-3007	149	13	the	the	DET
admet-3007	149	14	likelihood	likelihood	NOUN
admet-3007	149	15	of	of	ADP
admet-3007	149	16	treatment	treatment	NOUN
admet-3007	149	17	-	-	PUNCT
admet-3007	149	18	induced	induce	VERB
admet-3007	149	19	cell	cell	NOUN
admet-3007	149	20	death	death	NOUN
admet-3007	149	21	,	,	PUNCT
admet-3007	149	22	thereby	thereby	ADV
admet-3007	149	23	contributing	contribute	VERB
admet-3007	149	24	to	to	ADP
admet-3007	149	25	resistance	resistance	NOUN
admet-3007	149	26	against	against	ADP
admet-3007	149	27	chemotherapy	chemotherapy	NOUN
admet-3007	149	28	and	and	CCONJ
admet-3007	149	29	radiation	radiation	NOUN
admet-3007	149	30	[	[	X
admet-3007	149	31	58	58	NUM
admet-3007	149	32	]	]	PUNCT
admet-3007	149	33	.	.	PUNCT
admet-3007	150	1	in	in	ADP
admet-3007	150	2	gliomas	glioma	NOUN
admet-3007	150	3	,	,	PUNCT
admet-3007	150	4	cd133⁺	cd133⁺	PROPN
admet-3007	150	5	cscs	cscs	NOUN
admet-3007	150	6	have	have	AUX
admet-3007	150	7	been	be	AUX
admet-3007	150	8	identified	identify	VERB
admet-3007	150	9	as	as	ADP
admet-3007	150	10	key	key	ADJ
admet-3007	150	11	contributors	contributor	NOUN
admet-3007	150	12	to	to	PART
admet-3007	150	13	radioresistance	radioresistance	VERB
admet-3007	150	14	and	and	CCONJ
admet-3007	150	15	tumour	tumour	NOUN
admet-3007	150	16	regeneration	regeneration	NOUN
admet-3007	150	17	.	.	PUNCT
admet-3007	151	1	these	these	DET
admet-3007	151	2	glioma	glioma	NOUN
admet-3007	151	3	stem	stem	NOUN
admet-3007	151	4	cells	cell	NOUN
admet-3007	151	5	display	display	VERB
admet-3007	151	6	enhanced	enhanced	ADJ
admet-3007	151	7	checkpoint	checkpoint	NOUN
admet-3007	151	8	activation	activation	NOUN
admet-3007	151	9	and	and	CCONJ
admet-3007	151	10	more	more	ADV
admet-3007	151	11	efficient	efficient	ADJ
admet-3007	151	12	dna	dna	PROPN
admet-3007	151	13	repair	repair	NOUN
admet-3007	151	14	,	,	PUNCT
admet-3007	151	15	allowing	allow	VERB
admet-3007	151	16	them	they	PRON
admet-3007	151	17	to	to	PART
admet-3007	151	18	withstand	withstand	VERB
admet-3007	151	19	radiation	radiation	NOUN
admet-3007	151	20	-	-	PUNCT
admet-3007	151	21	induced	induce	VERB
admet-3007	151	22	damage	damage	NOUN
admet-3007	151	23	and	and	CCONJ
admet-3007	151	24	recover	recover	VERB
admet-3007	151	25	more	more	ADV
admet-3007	151	26	effectively	effectively	ADV
admet-3007	151	27	than	than	ADP
admet-3007	151	28	non	non	ADJ
admet-3007	151	29	-	-	ADJ
admet-3007	151	30	stem	stem	ADJ
admet-3007	151	31	tumour	tumour	ADJ
admet-3007	151	32	cells	cell	NOUN
admet-3007	151	33	.	.	PUNCT
admet-3007	152	1	by	by	ADP
admet-3007	152	2	rapidly	rapidly	ADV
admet-3007	152	3	repairing	repair	VERB
admet-3007	152	4	dna	dna	NOUN
admet-3007	152	5	lesions	lesion	NOUN
admet-3007	152	6	,	,	PUNCT
admet-3007	152	7	these	these	DET
admet-3007	152	8	cscs	csc	NOUN
admet-3007	152	9	not	not	PART
admet-3007	152	10	only	only	ADV
admet-3007	152	11	evade	evade	VERB
admet-3007	152	12	apoptosis	apoptosis	NOUN
admet-3007	152	13	but	but	CCONJ
admet-3007	152	14	also	also	ADV
admet-3007	152	15	drive	drive	VERB
admet-3007	152	16	tumour	tumour	NOUN
admet-3007	152	17	recurrence	recurrence	NOUN
admet-3007	152	18	,	,	PUNCT
admet-3007	152	19	making	make	VERB
admet-3007	152	20	them	they	PRON
admet-3007	152	21	critical	critical	ADJ
admet-3007	152	22	targets	target	NOUN
admet-3007	152	23	for	for	ADP
admet-3007	152	24	therapeutic	therapeutic	ADJ
admet-3007	152	25	interventions	intervention	NOUN
admet-3007	152	26	aimed	aim	VERB
admet-3007	152	27	at	at	ADP
admet-3007	152	28	minimizing	minimize	VERB
admet-3007	152	29	relapse	relapse	NOUN
admet-3007	152	30	[	[	X
admet-3007	152	31	59	59	NUM
admet-3007	152	32	]	]	PUNCT
admet-3007	152	33	.	.	PUNCT
admet-3007	153	1	indeed	indeed	ADV
admet-3007	153	2	,	,	PUNCT
admet-3007	153	3	the	the	DET
admet-3007	153	4	superior	superior	ADJ
admet-3007	153	5	dna	dna	PROPN
admet-3007	153	6	repair	repair	NOUN
admet-3007	153	7	mechanisms	mechanism	NOUN
admet-3007	153	8	observed	observe	VERB
admet-3007	153	9	in	in	ADP
admet-3007	153	10	cscs	cscs	PROPN
admet-3007	153	11	provide	provide	VERB
admet-3007	153	12	a	a	DET
admet-3007	153	13	substantial	substantial	ADJ
admet-3007	153	14	survival	survival	NOUN
admet-3007	153	15	advantage	advantage	NOUN
admet-3007	153	16	,	,	PUNCT
admet-3007	153	17	enabling	enable	VERB
admet-3007	153	18	them	they	PRON
admet-3007	153	19	to	to	PART
admet-3007	153	20	resist	resist	VERB
admet-3007	153	21	conventional	conventional	ADJ
admet-3007	153	22	treatments	treatment	NOUN
admet-3007	153	23	such	such	ADJ
admet-3007	153	24	as	as	ADP
admet-3007	153	25	chemotherapy	chemotherapy	NOUN
admet-3007	153	26	and	and	CCONJ
admet-3007	153	27	radiation	radiation	NOUN
admet-3007	153	28	.	.	PUNCT
admet-3007	154	1	this	this	DET
admet-3007	154	2	ability	ability	NOUN
admet-3007	154	3	,	,	PUNCT
admet-3007	154	4	combined	combine	VERB
admet-3007	154	5	with	with	ADP
admet-3007	154	6	efficient	efficient	ADJ
admet-3007	154	7	ros	ros	PROPN
admet-3007	154	8	detoxification	detoxification	NOUN
admet-3007	154	9	and	and	CCONJ
admet-3007	154	10	activation	activation	NOUN
admet-3007	154	11	of	of	ADP
admet-3007	154	12	survival	survival	NOUN
admet-3007	154	13	signalling	signal	VERB
admet-3007	154	14	,	,	PUNCT
admet-3007	154	15	highlights	highlight	VERB
admet-3007	154	16	the	the	DET
admet-3007	154	17	resilience	resilience	NOUN
admet-3007	154	18	of	of	ADP
admet-3007	154	19	cscs	cscs	PROPN
admet-3007	154	20	and	and	CCONJ
admet-3007	154	21	emphasizes	emphasize	VERB
admet-3007	154	22	the	the	DET
admet-3007	154	23	urgent	urgent	ADJ
admet-3007	154	24	need	need	NOUN
admet-3007	154	25	for	for	ADP
admet-3007	154	26	novel	novel	ADJ
admet-3007	154	27	therapeutic	therapeutic	ADJ
admet-3007	154	28	strategies	strategy	NOUN
admet-3007	154	29	that	that	PRON
admet-3007	154	30	specifically	specifically	ADV
admet-3007	154	31	target	target	VERB
admet-3007	154	32	their	their	PRON
admet-3007	154	33	dna	dna	PROPN
admet-3007	154	34	repair	repair	NOUN
admet-3007	154	35	machinery	machinery	NOUN
admet-3007	154	36	[	[	X
admet-3007	154	37	60	60	NUM
admet-3007	154	38	]	]	PUNCT
admet-3007	154	39	.	.	PUNCT
admet-3007	155	1	autophagy	autophagy	ADJ
admet-3007	155	2	autophagy	autophagy	NOUN
admet-3007	155	3	plays	play	VERB
admet-3007	155	4	a	a	DET
admet-3007	155	5	critical	critical	ADJ
admet-3007	155	6	role	role	NOUN
admet-3007	155	7	in	in	ADP
admet-3007	155	8	promoting	promote	VERB
admet-3007	155	9	the	the	DET
admet-3007	155	10	resistance	resistance	NOUN
admet-3007	155	11	of	of	ADP
admet-3007	155	12	cscs	cscs	PROPN
admet-3007	155	13	to	to	PART
admet-3007	155	14	chemotherapy	chemotherapy	NOUN
admet-3007	155	15	and	and	CCONJ
admet-3007	155	16	radiation	radiation	NOUN
admet-3007	155	17	therapy	therapy	NOUN
admet-3007	155	18	.	.	PUNCT
admet-3007	156	1	this	this	DET
admet-3007	156	2	cellular	cellular	ADJ
admet-3007	156	3	process	process	NOUN
admet-3007	156	4	functions	function	NOUN
admet-3007	156	5	as	as	ADP
admet-3007	156	6	a	a	DET
admet-3007	156	7	survival	survival	NOUN
admet-3007	156	8	mechanism	mechanism	NOUN
admet-3007	156	9	,	,	PUNCT
admet-3007	156	10	enabling	enable	VERB
admet-3007	156	11	cells	cell	NOUN
admet-3007	156	12	to	to	PART
admet-3007	156	13	adapt	adapt	VERB
admet-3007	156	14	to	to	ADP
admet-3007	156	15	various	various	ADJ
admet-3007	156	16	stressors	stressor	NOUN
admet-3007	156	17	,	,	PUNCT
admet-3007	156	18	including	include	VERB
admet-3007	156	19	nutrient	nutrient	NOUN
admet-3007	156	20	deprivation	deprivation	NOUN
admet-3007	156	21	,	,	PUNCT
admet-3007	156	22	hypoxia	hypoxia	NOUN
admet-3007	156	23	,	,	PUNCT
admet-3007	156	24	and	and	CCONJ
admet-3007	156	25	therapeutic	therapeutic	ADJ
admet-3007	156	26	interventions	intervention	NOUN
admet-3007	156	27	.	.	PUNCT
admet-3007	157	1	during	during	ADP
admet-3007	157	2	autophagy	autophagy	NOUN
admet-3007	157	3	,	,	PUNCT
admet-3007	157	4	damaged	damage	VERB
admet-3007	157	5	or	or	CCONJ
admet-3007	157	6	redundant	redundant	ADJ
admet-3007	157	7	cellular	cellular	ADJ
admet-3007	157	8	components	component	NOUN
admet-3007	157	9	are	be	AUX
admet-3007	157	10	degraded	degrade	VERB
admet-3007	157	11	and	and	CCONJ
admet-3007	157	12	recycled	recycle	VERB
admet-3007	157	13	into	into	ADP
admet-3007	157	14	essential	essential	ADJ
admet-3007	157	15	metabolites	metabolite	NOUN
admet-3007	157	16	,	,	PUNCT
admet-3007	157	17	which	which	PRON
admet-3007	157	18	are	be	AUX
admet-3007	157	19	then	then	ADV
admet-3007	157	20	utilized	utilize	VERB
admet-3007	157	21	to	to	PART
admet-3007	157	22	support	support	VERB
admet-3007	157	23	cell	cell	NOUN
admet-3007	157	24	survival	survival	NOUN
admet-3007	157	25	under	under	ADP
admet-3007	157	26	adverse	adverse	ADJ
admet-3007	157	27	conditions	condition	NOUN
admet-3007	157	28	[	[	X
admet-3007	157	29	61	61	NUM
admet-3007	157	30	]	]	PUNCT
admet-3007	157	31	.	.	PUNCT
admet-3007	158	1	in	in	ADP
admet-3007	158	2	cscs	cscs	PROPN
admet-3007	158	3	,	,	PUNCT
admet-3007	158	4	autophagy	autophagy	VERB
admet-3007	158	5	not	not	PART
admet-3007	158	6	only	only	ADV
admet-3007	158	7	enables	enable	VERB
admet-3007	158	8	adaptation	adaptation	NOUN
admet-3007	158	9	to	to	ADP
admet-3007	158	10	the	the	DET
admet-3007	158	11	harsh	harsh	ADJ
admet-3007	158	12	tme	tme	NOUN
admet-3007	158	13	but	but	CCONJ
admet-3007	158	14	also	also	ADV
admet-3007	158	15	contributes	contribute	VERB
admet-3007	158	16	directly	directly	ADV
admet-3007	158	17	to	to	ADP
admet-3007	158	18	therapeutic	therapeutic	ADJ
admet-3007	158	19	resistance	resistance	NOUN
admet-3007	158	20	.	.	PUNCT
admet-3007	159	1	by	by	ADP
admet-3007	159	2	recycling	recycle	VERB
admet-3007	159	3	intracellular	intracellular	ADJ
admet-3007	159	4	components	component	NOUN
admet-3007	159	5	,	,	PUNCT
admet-3007	159	6	autophagy	autophagy	NOUN
admet-3007	159	7	provides	provide	VERB
admet-3007	159	8	energy	energy	NOUN
admet-3007	159	9	and	and	CCONJ
admet-3007	159	10	biosynthetic	biosynthetic	ADJ
admet-3007	159	11	precursors	precursor	NOUN
admet-3007	159	12	necessary	necessary	ADJ
admet-3007	159	13	for	for	ADP
admet-3007	159	14	cellular	cellular	ADJ
admet-3007	159	15	repair	repair	NOUN
admet-3007	159	16	and	and	CCONJ
admet-3007	159	17	survival	survival	NOUN
admet-3007	159	18	,	,	PUNCT
admet-3007	159	19	especially	especially	ADV
admet-3007	159	20	when	when	SCONJ
admet-3007	159	21	external	external	ADJ
admet-3007	159	22	resources	resource	NOUN
admet-3007	159	23	are	be	AUX
admet-3007	159	24	scarce	scarce	ADJ
admet-3007	159	25	.	.	PUNCT
admet-3007	160	1	moreover	moreover	ADV
admet-3007	160	2	,	,	PUNCT
admet-3007	160	3	studies	study	NOUN
admet-3007	160	4	suggest	suggest	VERB
admet-3007	160	5	that	that	SCONJ
admet-3007	160	6	inhibiting	inhibit	VERB
admet-3007	160	7	autophagy	autophagy	NOUN
admet-3007	160	8	can	can	AUX
admet-3007	160	9	induce	induce	VERB
admet-3007	160	10	apoptosis	apoptosis	NOUN
admet-3007	160	11	in	in	ADP
admet-3007	160	12	cancer	cancer	NOUN
admet-3007	160	13	cells	cell	NOUN
admet-3007	160	14	,	,	PUNCT
admet-3007	160	15	indicating	indicate	VERB
admet-3007	160	16	that	that	SCONJ
admet-3007	160	17	autophagy	autophagy	NOUN
admet-3007	160	18	serves	serve	VERB
admet-3007	160	19	as	as	ADP
admet-3007	160	20	a	a	DET
admet-3007	160	21	protective	protective	ADJ
admet-3007	160	22	shield	shield	NOUN
admet-3007	160	23	against	against	ADP
admet-3007	160	24	cell	cell	NOUN
admet-3007	160	25	death	death	NOUN
admet-3007	160	26	pathways	pathway	NOUN
admet-3007	161	1	[	[	X
admet-3007	161	2	61	61	NUM
admet-3007	161	3	]	]	PUNCT
admet-3007	161	4	.	.	PUNCT
admet-3007	162	1	numerous	numerous	ADJ
admet-3007	162	2	studies	study	NOUN
admet-3007	162	3	have	have	AUX
admet-3007	162	4	documented	document	VERB
admet-3007	162	5	the	the	DET
admet-3007	162	6	significant	significant	ADJ
admet-3007	162	7	role	role	NOUN
admet-3007	162	8	of	of	ADP
admet-3007	162	9	autophagy	autophagy	NOUN
admet-3007	162	10	in	in	ADP
admet-3007	162	11	various	various	ADJ
admet-3007	162	12	types	type	NOUN
admet-3007	162	13	of	of	ADP
admet-3007	162	14	cancers	cancer	NOUN
admet-3007	162	15	,	,	PUNCT
admet-3007	162	16	including	include	VERB
admet-3007	162	17	pancreatic	pancreatic	ADJ
admet-3007	162	18	cancer	cancer	NOUN
admet-3007	162	19	,	,	PUNCT
admet-3007	162	20	bladder	bladder	NOUN
admet-3007	162	21	cancer	cancer	NOUN
admet-3007	162	22	,	,	PUNCT
admet-3007	162	23	colorectal	colorectal	ADJ
admet-3007	162	24	cancer	cancer	NOUN
admet-3007	162	25	,	,	PUNCT
admet-3007	162	26	chronic	chronic	ADJ
admet-3007	162	27	myeloid	myeloid	NOUN
admet-3007	162	28	leukaemia	leukaemia	NOUN
admet-3007	162	29	,	,	PUNCT
admet-3007	162	30	and	and	CCONJ
admet-3007	162	31	glioblastoma	glioblastoma	NOUN
admet-3007	162	32	[	[	X
admet-3007	162	33	62	62	NUM
admet-3007	162	34	]	]	PUNCT
admet-3007	162	35	.	.	PUNCT
admet-3007	163	1	in	in	ADP
admet-3007	163	2	these	these	DET
admet-3007	163	3	cancers	cancer	NOUN
admet-3007	163	4	,	,	PUNCT
admet-3007	163	5	autophagy	autophagy	NOUN
admet-3007	163	6	contributes	contribute	VERB
admet-3007	163	7	to	to	ADP
admet-3007	163	8	tumour	tumour	NOUN
admet-3007	163	9	cell	cell	NOUN
admet-3007	163	10	survival	survival	NOUN
admet-3007	163	11	,	,	PUNCT
admet-3007	163	12	therapy	therapy	NOUN
admet-3007	163	13	resistance	resistance	NOUN
admet-3007	163	14	,	,	PUNCT
admet-3007	163	15	and	and	CCONJ
admet-3007	163	16	disease	disease	NOUN
admet-3007	163	17	progression	progression	NOUN
admet-3007	163	18	.	.	PUNCT
admet-3007	164	1	in	in	ADP
admet-3007	164	2	cscs	cscs	PROPN
admet-3007	164	3	,	,	PUNCT
admet-3007	164	4	in	in	ADP
admet-3007	164	5	particular	particular	ADJ
admet-3007	164	6	,	,	PUNCT
admet-3007	164	7	autophagic	autophagic	ADJ
admet-3007	164	8	activity	activity	NOUN
admet-3007	164	9	is	be	AUX
admet-3007	164	10	often	often	ADV
admet-3007	164	11	elevated	elevate	VERB
admet-3007	164	12	,	,	PUNCT
admet-3007	164	13	as	as	SCONJ
admet-3007	164	14	evidenced	evidence	VERB
admet-3007	164	15	by	by	ADP
admet-3007	164	16	the	the	DET
admet-3007	164	17	overexpression	overexpression	NOUN
admet-3007	164	18	of	of	ADP
admet-3007	164	19	key	key	ADJ
admet-3007	164	20	autophagic	autophagic	ADJ
admet-3007	164	21	markers	marker	NOUN
admet-3007	164	22	such	such	ADJ
admet-3007	164	23	as	as	ADP
admet-3007	164	24	atg5	atg5	NOUN
admet-3007	164	25	and	and	CCONJ
admet-3007	164	26	beclin1	beclin1	NOUN
admet-3007	164	27	,	,	PUNCT
admet-3007	164	28	which	which	PRON
admet-3007	164	29	reflect	reflect	VERB
admet-3007	164	30	increased	increase	VERB
admet-3007	164	31	autophagic	autophagic	ADJ
admet-3007	164	32	flux	flux	NOUN
admet-3007	165	1	[	[	X
admet-3007	165	2	61	61	NUM
admet-3007	165	3	]	]	PUNCT
admet-3007	165	4	.	.	PUNCT
admet-3007	166	1	this	this	DET
admet-3007	166	2	heightened	heighten	VERB
admet-3007	166	3	autophagy	autophagy	ADJ
admet-3007	166	4	https://doi.org/10.5599/admet.3007	https://doi.org/10.5599/admet.3007	NOUN
admet-3007	166	5	m.	m.	NOUN
admet-3007	166	6	dehghani	dehghani	PROPN
admet-3007	166	7	et	et	PROPN
admet-3007	166	8	al	al	PROPN
admet-3007	166	9	.	.	PROPN
admet-3007	166	10	admet	admet	PROPN
admet-3007	166	11	&	&	CCONJ
admet-3007	166	12	dmpk	dmpk	PROPN
admet-3007	166	13	13(5	13(5	NUM
admet-3007	166	14	)	)	PUNCT
admet-3007	166	15	(	(	PUNCT
admet-3007	166	16	2025	2025	NUM
admet-3007	166	17	)	)	PUNCT
admet-3007	166	18	3007	3007	NUM
admet-3007	166	19	8	8	NUM
admet-3007	166	20	enables	enable	VERB
admet-3007	166	21	cscs	cscs	NOUN
admet-3007	166	22	to	to	PART
admet-3007	166	23	maintain	maintain	VERB
admet-3007	166	24	their	their	PRON
admet-3007	166	25	metabolic	metabolic	NOUN
admet-3007	166	26	needs	need	NOUN
admet-3007	166	27	and	and	CCONJ
admet-3007	166	28	protect	protect	VERB
admet-3007	166	29	themselves	themselves	PRON
admet-3007	166	30	from	from	ADP
admet-3007	166	31	the	the	DET
admet-3007	166	32	cytotoxic	cytotoxic	ADJ
admet-3007	166	33	effects	effect	NOUN
admet-3007	166	34	of	of	ADP
admet-3007	166	35	treatments	treatment	NOUN
admet-3007	166	36	aimed	aim	VERB
admet-3007	166	37	at	at	ADP
admet-3007	166	38	inducing	induce	VERB
admet-3007	166	39	oxidative	oxidative	ADJ
admet-3007	166	40	stress	stress	NOUN
admet-3007	166	41	and	and	CCONJ
admet-3007	166	42	dna	dna	NOUN
admet-3007	166	43	damage	damage	NOUN
admet-3007	166	44	[	[	X
admet-3007	166	45	63	63	NUM
admet-3007	166	46	]	]	PUNCT
admet-3007	166	47	.	.	PUNCT
admet-3007	167	1	furthermore	furthermore	ADV
admet-3007	167	2	,	,	PUNCT
admet-3007	167	3	autophagy	autophagy	ADV
admet-3007	167	4	in	in	ADP
admet-3007	167	5	cscs	cscs	PROPN
admet-3007	167	6	plays	play	VERB
admet-3007	167	7	an	an	DET
admet-3007	167	8	essential	essential	ADJ
admet-3007	167	9	role	role	NOUN
admet-3007	167	10	in	in	ADP
admet-3007	167	11	regulating	regulate	VERB
admet-3007	167	12	intracellular	intracellular	ADJ
admet-3007	167	13	ros	ros	PROPN
admet-3007	167	14	levels	level	NOUN
admet-3007	167	15	,	,	PUNCT
admet-3007	167	16	which	which	PRON
admet-3007	167	17	typically	typically	ADV
admet-3007	167	18	increase	increase	VERB
admet-3007	167	19	during	during	ADP
admet-3007	167	20	cancer	cancer	NOUN
admet-3007	167	21	treatments	treatment	NOUN
admet-3007	167	22	.	.	PUNCT
admet-3007	168	1	through	through	ADP
admet-3007	168	2	protective	protective	ADJ
admet-3007	168	3	autophagic	autophagic	ADJ
admet-3007	168	4	pathways	pathway	NOUN
admet-3007	168	5	,	,	PUNCT
admet-3007	168	6	cscs	cscs	PROPN
admet-3007	168	7	maintain	maintain	VERB
admet-3007	168	8	low	low	ADJ
admet-3007	168	9	ros	ros	PROPN
admet-3007	168	10	levels	level	NOUN
admet-3007	168	11	,	,	PUNCT
admet-3007	168	12	thereby	thereby	ADV
admet-3007	168	13	preventing	prevent	VERB
admet-3007	168	14	oxidative	oxidative	ADJ
admet-3007	168	15	damage	damage	NOUN
admet-3007	168	16	that	that	PRON
admet-3007	168	17	could	could	AUX
admet-3007	168	18	otherwise	otherwise	ADV
admet-3007	168	19	trigger	trigger	VERB
admet-3007	168	20	cell	cell	NOUN
admet-3007	168	21	death	death	NOUN
admet-3007	168	22	.	.	PUNCT
admet-3007	169	1	this	this	DET
admet-3007	169	2	capacity	capacity	NOUN
admet-3007	169	3	to	to	PART
admet-3007	169	4	modulate	modulate	VERB
admet-3007	169	5	oxidative	oxidative	ADJ
admet-3007	169	6	stress	stress	NOUN
admet-3007	169	7	is	be	AUX
admet-3007	169	8	a	a	DET
admet-3007	169	9	key	key	ADJ
admet-3007	169	10	contributor	contributor	NOUN
admet-3007	169	11	to	to	ADP
admet-3007	169	12	their	their	PRON
admet-3007	169	13	resistance	resistance	NOUN
admet-3007	169	14	to	to	ADP
admet-3007	169	15	therapies	therapy	NOUN
admet-3007	169	16	relying	rely	VERB
admet-3007	169	17	on	on	ADP
admet-3007	169	18	ros	ros	PROPN
admet-3007	169	19	-	-	PUNCT
admet-3007	169	20	mediated	mediate	VERB
admet-3007	169	21	cytotoxicity	cytotoxicity	NOUN
admet-3007	169	22	.	.	PUNCT
admet-3007	170	1	overall	overall	ADJ
admet-3007	170	2	,	,	PUNCT
admet-3007	170	3	autophagy	autophagy	NOUN
admet-3007	170	4	represents	represent	VERB
admet-3007	170	5	a	a	DET
admet-3007	170	6	double	double	ADJ
admet-3007	170	7	-	-	PUNCT
admet-3007	170	8	edged	edge	VERB
admet-3007	170	9	sword	sword	NOUN
admet-3007	170	10	in	in	ADP
admet-3007	170	11	csc	csc	PROPN
admet-3007	170	12	biology	biology	NOUN
admet-3007	170	13	.	.	PUNCT
admet-3007	171	1	while	while	SCONJ
admet-3007	171	2	it	it	PRON
admet-3007	171	3	enhances	enhance	VERB
admet-3007	171	4	survival	survival	NOUN
admet-3007	171	5	and	and	CCONJ
admet-3007	171	6	resistance	resistance	NOUN
admet-3007	171	7	to	to	ADP
admet-3007	171	8	standard	standard	ADJ
admet-3007	171	9	therapies	therapy	NOUN
admet-3007	171	10	,	,	PUNCT
admet-3007	171	11	it	it	PRON
admet-3007	171	12	also	also	ADV
admet-3007	171	13	offers	offer	VERB
admet-3007	171	14	a	a	DET
admet-3007	171	15	promising	promising	ADJ
admet-3007	171	16	therapeutic	therapeutic	ADJ
admet-3007	171	17	target	target	NOUN
admet-3007	171	18	.	.	PUNCT
admet-3007	172	1	inhibiting	inhibit	VERB
admet-3007	172	2	autophagy	autophagy	NOUN
admet-3007	172	3	in	in	ADP
admet-3007	172	4	cscs	cscs	PROPN
admet-3007	172	5	may	may	AUX
admet-3007	172	6	sensitize	sensitize	VERB
admet-3007	172	7	them	they	PRON
admet-3007	172	8	to	to	PART
admet-3007	172	9	oxidative	oxidative	VERB
admet-3007	172	10	stress	stress	NOUN
admet-3007	172	11	and	and	CCONJ
admet-3007	172	12	apoptosis	apoptosis	NOUN
admet-3007	172	13	,	,	PUNCT
admet-3007	172	14	potentially	potentially	ADV
admet-3007	172	15	improving	improve	VERB
admet-3007	172	16	the	the	DET
admet-3007	172	17	effectiveness	effectiveness	NOUN
admet-3007	172	18	of	of	ADP
admet-3007	172	19	treatments	treatment	NOUN
admet-3007	172	20	such	such	ADJ
admet-3007	172	21	as	as	ADP
admet-3007	172	22	chemotherapy	chemotherapy	NOUN
admet-3007	172	23	and	and	CCONJ
admet-3007	172	24	radiation	radiation	NOUN
admet-3007	172	25	.	.	PUNCT
admet-3007	173	1	a	a	DET
admet-3007	173	2	deeper	deep	ADJ
admet-3007	173	3	understanding	understanding	NOUN
admet-3007	173	4	of	of	ADP
admet-3007	173	5	autophagic	autophagic	ADJ
admet-3007	173	6	processes	process	NOUN
admet-3007	173	7	in	in	ADP
admet-3007	173	8	cscs	cscs	PROPN
admet-3007	173	9	could	could	AUX
admet-3007	173	10	pave	pave	VERB
admet-3007	173	11	the	the	DET
admet-3007	173	12	way	way	NOUN
admet-3007	173	13	for	for	ADP
admet-3007	173	14	more	more	ADV
admet-3007	173	15	effective	effective	ADJ
admet-3007	173	16	strategies	strategy	NOUN
admet-3007	173	17	to	to	PART
admet-3007	173	18	overcome	overcome	VERB
admet-3007	173	19	resistance	resistance	NOUN
admet-3007	173	20	and	and	CCONJ
admet-3007	173	21	prevent	prevent	VERB
admet-3007	173	22	tumour	tumour	NOUN
admet-3007	173	23	recurrence	recurrence	NOUN
admet-3007	173	24	[	[	X
admet-3007	173	25	63	63	NUM
admet-3007	173	26	]	]	PUNCT
admet-3007	173	27	.	.	PUNCT
admet-3007	174	1	overexpression	overexpression	NOUN
admet-3007	174	2	of	of	ADP
admet-3007	174	3	cytokines	cytokine	NOUN
admet-3007	174	4	there	there	PRON
admet-3007	174	5	is	be	VERB
admet-3007	174	6	substantial	substantial	ADJ
admet-3007	174	7	clinical	clinical	ADJ
admet-3007	174	8	and	and	CCONJ
admet-3007	174	9	experimental	experimental	ADJ
admet-3007	174	10	evidence	evidence	NOUN
admet-3007	174	11	linking	link	VERB
admet-3007	174	12	chronic	chronic	ADJ
admet-3007	174	13	inflammation	inflammation	NOUN
admet-3007	174	14	to	to	ADP
admet-3007	174	15	cancer	cancer	NOUN
admet-3007	174	16	development	development	NOUN
admet-3007	174	17	,	,	PUNCT
admet-3007	174	18	with	with	ADP
admet-3007	174	19	growing	grow	VERB
admet-3007	174	20	research	research	NOUN
admet-3007	174	21	emphasizing	emphasize	VERB
admet-3007	174	22	the	the	DET
admet-3007	174	23	role	role	NOUN
admet-3007	174	24	of	of	ADP
admet-3007	174	25	cscs	cscs	PROPN
admet-3007	174	26	in	in	ADP
admet-3007	174	27	this	this	DET
admet-3007	174	28	process	process	NOUN
admet-3007	174	29	.	.	PUNCT
admet-3007	175	1	cscs	cscs	PROPN
admet-3007	175	2	can	can	AUX
admet-3007	175	3	secrete	secrete	VERB
admet-3007	175	4	specific	specific	ADJ
admet-3007	175	5	cytokines	cytokine	NOUN
admet-3007	175	6	that	that	SCONJ
admet-3007	175	7	not	not	PART
admet-3007	175	8	only	only	ADV
admet-3007	175	9	modulate	modulate	VERB
admet-3007	175	10	the	the	DET
admet-3007	175	11	tme	tme	NOUN
admet-3007	175	12	but	but	CCONJ
admet-3007	175	13	also	also	ADV
admet-3007	175	14	enhance	enhance	VERB
admet-3007	175	15	their	their	PRON
admet-3007	175	16	resistance	resistance	NOUN
admet-3007	175	17	to	to	ADP
admet-3007	175	18	chemotherapeutic	chemotherapeutic	ADJ
admet-3007	175	19	agents	agent	NOUN
admet-3007	175	20	.	.	PUNCT
admet-3007	176	1	for	for	ADP
admet-3007	176	2	example	example	NOUN
admet-3007	176	3	,	,	PUNCT
admet-3007	176	4	in	in	ADP
admet-3007	176	5	breast	breast	NOUN
admet-3007	176	6	cancer	cancer	NOUN
admet-3007	176	7	,	,	PUNCT
admet-3007	176	8	cytokines	cytokine	NOUN
admet-3007	176	9	present	present	ADJ
admet-3007	176	10	in	in	ADP
admet-3007	176	11	the	the	DET
admet-3007	176	12	tme	tme	NOUN
admet-3007	176	13	have	have	AUX
admet-3007	176	14	been	be	AUX
admet-3007	176	15	shown	show	VERB
admet-3007	176	16	to	to	PART
admet-3007	176	17	regulate	regulate	VERB
admet-3007	176	18	csc	csc	PROPN
admet-3007	176	19	self	self	NOUN
admet-3007	176	20	-	-	PUNCT
admet-3007	176	21	renewal	renewal	NOUN
admet-3007	176	22	,	,	PUNCT
admet-3007	176	23	survival	survival	NOUN
admet-3007	176	24	,	,	PUNCT
admet-3007	176	25	and	and	CCONJ
admet-3007	176	26	contribute	contribute	VERB
admet-3007	176	27	to	to	ADP
admet-3007	176	28	therapy	therapy	NOUN
admet-3007	176	29	resistance	resistance	NOUN
admet-3007	176	30	through	through	ADP
admet-3007	176	31	multiple	multiple	ADJ
admet-3007	176	32	mechanisms	mechanism	NOUN
admet-3007	176	33	[	[	X
admet-3007	176	34	64	64	NUM
admet-3007	176	35	]	]	PUNCT
admet-3007	176	36	.	.	PUNCT
admet-3007	177	1	inflammatory	inflammatory	ADJ
admet-3007	177	2	cytokines	cytokine	NOUN
admet-3007	177	3	,	,	PUNCT
admet-3007	177	4	such	such	ADJ
admet-3007	177	5	as	as	ADP
admet-3007	177	6	interleukin-1	interleukin-1	NUM
admet-3007	177	7	(	(	PUNCT
admet-3007	177	8	il-1	il-1	NUM
admet-3007	177	9	)	)	PUNCT
admet-3007	177	10	,	,	PUNCT
admet-3007	177	11	interleukin-6	interleukin-6	PROPN
admet-3007	177	12	(	(	PUNCT
admet-3007	177	13	il-6	il-6	NUM
admet-3007	177	14	)	)	PUNCT
admet-3007	177	15	,	,	PUNCT
admet-3007	177	16	and	and	CCONJ
admet-3007	177	17	interleukin-8	interleukin-8	NUM
admet-3007	177	18	(	(	PUNCT
admet-3007	177	19	il-8	il-8	NUM
admet-3007	177	20	)	)	PUNCT
admet-3007	177	21	,	,	PUNCT
admet-3007	177	22	have	have	AUX
admet-3007	177	23	been	be	AUX
admet-3007	177	24	implicated	implicate	VERB
admet-3007	177	25	in	in	ADP
admet-3007	177	26	tumour	tumour	NOUN
admet-3007	177	27	progression	progression	NOUN
admet-3007	177	28	by	by	ADP
admet-3007	177	29	influencing	influence	VERB
admet-3007	177	30	the	the	DET
admet-3007	177	31	csc	csc	PROPN
admet-3007	177	32	population	population	NOUN
admet-3007	177	33	.	.	PUNCT
admet-3007	178	1	il-1	il-1	PUNCT
admet-3007	179	1	levels	level	NOUN
admet-3007	179	2	are	be	AUX
admet-3007	179	3	often	often	ADV
admet-3007	179	4	elevated	elevate	VERB
admet-3007	179	5	in	in	ADP
admet-3007	179	6	patients	patient	NOUN
admet-3007	179	7	with	with	ADP
admet-3007	179	8	metastatic	metastatic	ADJ
admet-3007	179	9	cancer	cancer	NOUN
admet-3007	179	10	,	,	PUNCT
admet-3007	179	11	suggesting	suggest	VERB
admet-3007	179	12	a	a	DET
admet-3007	179	13	pro	pro	ADJ
admet-3007	179	14	-	-	ADJ
admet-3007	179	15	tumorigenic	tumorigenic	ADJ
admet-3007	179	16	role	role	NOUN
admet-3007	179	17	in	in	ADP
admet-3007	179	18	promoting	promote	VERB
admet-3007	179	19	aggressive	aggressive	ADJ
admet-3007	179	20	cancer	cancer	NOUN
admet-3007	179	21	phenotypes	phenotype	NOUN
admet-3007	179	22	.	.	PUNCT
admet-3007	180	1	similarly	similarly	ADV
admet-3007	180	2	,	,	PUNCT
admet-3007	180	3	il-8	il-8	NOUN
admet-3007	180	4	plays	play	VERB
admet-3007	180	5	a	a	DET
admet-3007	180	6	pivotal	pivotal	ADJ
admet-3007	180	7	role	role	NOUN
admet-3007	180	8	in	in	ADP
admet-3007	180	9	breast	breast	NOUN
admet-3007	180	10	cancer	cancer	NOUN
admet-3007	180	11	,	,	PUNCT
admet-3007	180	12	where	where	SCONJ
admet-3007	180	13	increased	increase	VERB
admet-3007	180	14	expression	expression	NOUN
admet-3007	180	15	of	of	ADP
admet-3007	180	16	il-8	il-8	NOUN
admet-3007	180	17	by	by	ADP
admet-3007	180	18	cscs	cscs	PROPN
admet-3007	180	19	enhances	enhance	VERB
admet-3007	180	20	their	their	PRON
admet-3007	180	21	self	self	NOUN
admet-3007	180	22	-	-	PUNCT
admet-3007	180	23	renewal	renewal	NOUN
admet-3007	180	24	capacity	capacity	NOUN
admet-3007	180	25	and	and	CCONJ
admet-3007	180	26	accelerates	accelerate	VERB
admet-3007	180	27	tumour	tumour	NOUN
admet-3007	180	28	growth	growth	NOUN
admet-3007	180	29	.	.	PUNCT
admet-3007	181	1	the	the	DET
admet-3007	181	2	ability	ability	NOUN
admet-3007	181	3	of	of	ADP
admet-3007	181	4	these	these	DET
admet-3007	181	5	inflammatory	inflammatory	ADJ
admet-3007	181	6	cytokines	cytokine	NOUN
admet-3007	181	7	to	to	PART
admet-3007	181	8	sustain	sustain	VERB
admet-3007	181	9	csc	csc	PROPN
admet-3007	181	10	survival	survival	NOUN
admet-3007	181	11	and	and	CCONJ
admet-3007	181	12	proliferation	proliferation	NOUN
admet-3007	181	13	underscores	underscore	VERB
admet-3007	181	14	the	the	DET
admet-3007	181	15	complex	complex	ADJ
admet-3007	181	16	interplay	interplay	NOUN
admet-3007	181	17	between	between	ADP
admet-3007	181	18	inflammation	inflammation	NOUN
admet-3007	181	19	and	and	CCONJ
admet-3007	181	20	cancer	cancer	NOUN
admet-3007	181	21	.	.	PUNCT
admet-3007	182	1	in	in	ADP
admet-3007	182	2	this	this	DET
admet-3007	182	3	context	context	NOUN
admet-3007	182	4	,	,	PUNCT
admet-3007	182	5	the	the	DET
admet-3007	182	6	inflammatory	inflammatory	ADJ
admet-3007	182	7	microenvironment	microenvironment	NOUN
admet-3007	182	8	not	not	PART
admet-3007	182	9	only	only	ADV
admet-3007	182	10	promotes	promote	VERB
admet-3007	182	11	tumour	tumour	NOUN
admet-3007	182	12	progression	progression	NOUN
admet-3007	182	13	but	but	CCONJ
admet-3007	182	14	also	also	ADV
admet-3007	182	15	reinforces	reinforce	VERB
admet-3007	182	16	csc	csc	ADJ
admet-3007	182	17	-	-	PUNCT
admet-3007	182	18	mediated	mediate	VERB
admet-3007	182	19	resistance	resistance	NOUN
admet-3007	182	20	to	to	ADP
admet-3007	182	21	conventional	conventional	ADJ
admet-3007	182	22	therapies	therapy	NOUN
admet-3007	182	23	[	[	X
admet-3007	182	24	65	65	NUM
admet-3007	182	25	]	]	PUNCT
admet-3007	182	26	.	.	PUNCT
admet-3007	183	1	targeting	target	VERB
admet-3007	183	2	cytokine	cytokine	NOUN
admet-3007	183	3	-	-	PUNCT
admet-3007	183	4	driven	drive	VERB
admet-3007	183	5	signalling	signal	VERB
admet-3007	183	6	pathways	pathway	NOUN
admet-3007	183	7	thus	thus	ADV
admet-3007	183	8	represents	represent	VERB
admet-3007	183	9	a	a	DET
admet-3007	183	10	promising	promising	ADJ
admet-3007	183	11	therapeutic	therapeutic	ADJ
admet-3007	183	12	approach	approach	NOUN
admet-3007	183	13	to	to	PART
admet-3007	183	14	reduce	reduce	VERB
admet-3007	183	15	csc	csc	PROPN
admet-3007	183	16	-	-	PUNCT
admet-3007	183	17	associated	associate	VERB
admet-3007	183	18	chemoresistance	chemoresistance	NOUN
admet-3007	183	19	and	and	CCONJ
admet-3007	183	20	tumour	tumour	NOUN
admet-3007	183	21	recurrence	recurrence	NOUN
admet-3007	183	22	.	.	PUNCT
admet-3007	184	1	elucidating	elucidate	VERB
admet-3007	184	2	the	the	DET
admet-3007	184	3	roles	role	NOUN
admet-3007	184	4	of	of	ADP
admet-3007	184	5	key	key	ADJ
admet-3007	184	6	inflammatory	inflammatory	ADJ
admet-3007	184	7	cytokines	cytokine	NOUN
admet-3007	184	8	in	in	ADP
admet-3007	184	9	modulating	modulate	VERB
admet-3007	184	10	csc	csc	PROPN
admet-3007	184	11	dynamics	dynamic	NOUN
admet-3007	184	12	may	may	AUX
admet-3007	184	13	offer	offer	VERB
admet-3007	184	14	new	new	ADJ
admet-3007	184	15	avenues	avenue	NOUN
admet-3007	184	16	for	for	ADP
admet-3007	184	17	the	the	DET
admet-3007	184	18	development	development	NOUN
admet-3007	184	19	of	of	ADP
admet-3007	184	20	more	more	ADV
admet-3007	184	21	effective	effective	ADJ
admet-3007	184	22	treatments	treatment	NOUN
admet-3007	184	23	,	,	PUNCT
admet-3007	184	24	particularly	particularly	ADV
admet-3007	184	25	for	for	ADP
admet-3007	184	26	aggressive	aggressive	ADJ
admet-3007	184	27	and	and	CCONJ
admet-3007	184	28	treatment	treatment	NOUN
admet-3007	184	29	-	-	PUNCT
admet-3007	184	30	resistant	resistant	ADJ
admet-3007	184	31	cancers	cancer	NOUN
admet-3007	184	32	.	.	PUNCT
admet-3007	185	1	angiogenesis	angiogenesis	NOUN
admet-3007	185	2	angiogenesis	angiogenesis	NOUN
admet-3007	185	3	,	,	PUNCT
admet-3007	185	4	the	the	DET
admet-3007	185	5	process	process	NOUN
admet-3007	185	6	of	of	ADP
admet-3007	185	7	forming	form	VERB
admet-3007	185	8	new	new	ADJ
admet-3007	185	9	blood	blood	NOUN
admet-3007	185	10	vessels	vessel	NOUN
admet-3007	185	11	,	,	PUNCT
admet-3007	185	12	is	be	AUX
admet-3007	185	13	essential	essential	ADJ
admet-3007	185	14	for	for	ADP
admet-3007	185	15	tumour	tumour	NOUN
admet-3007	185	16	development	development	NOUN
admet-3007	185	17	,	,	PUNCT
admet-3007	185	18	as	as	SCONJ
admet-3007	185	19	it	it	PRON
admet-3007	185	20	allows	allow	VERB
admet-3007	185	21	tumours	tumour	NOUN
admet-3007	185	22	to	to	PART
admet-3007	185	23	establish	establish	VERB
admet-3007	185	24	a	a	DET
admet-3007	185	25	vascular	vascular	ADJ
admet-3007	185	26	network	network	NOUN
admet-3007	185	27	that	that	PRON
admet-3007	185	28	supplies	supply	VERB
admet-3007	185	29	oxygen	oxygen	NOUN
admet-3007	185	30	and	and	CCONJ
admet-3007	185	31	nutrients	nutrient	NOUN
admet-3007	185	32	while	while	SCONJ
admet-3007	185	33	facilitating	facilitate	VERB
admet-3007	185	34	the	the	DET
admet-3007	185	35	removal	removal	NOUN
admet-3007	185	36	of	of	ADP
admet-3007	185	37	waste	waste	NOUN
admet-3007	185	38	products	product	NOUN
admet-3007	185	39	.	.	PUNCT
admet-3007	186	1	this	this	DET
admet-3007	186	2	vascularization	vascularization	NOUN
admet-3007	186	3	is	be	AUX
admet-3007	186	4	critical	critical	ADJ
admet-3007	186	5	for	for	ADP
admet-3007	186	6	tumour	tumour	NOUN
admet-3007	186	7	growth	growth	NOUN
admet-3007	186	8	and	and	CCONJ
admet-3007	186	9	survival	survival	NOUN
admet-3007	186	10	.	.	PUNCT
admet-3007	187	1	although	although	SCONJ
admet-3007	187	2	angiogenesis	angiogenesis	NOUN
admet-3007	187	3	plays	play	VERB
admet-3007	187	4	a	a	DET
admet-3007	187	5	vital	vital	ADJ
admet-3007	187	6	role	role	NOUN
admet-3007	187	7	in	in	ADP
admet-3007	187	8	normal	normal	ADJ
admet-3007	187	9	physiological	physiological	ADJ
admet-3007	187	10	processes	process	NOUN
admet-3007	187	11	,	,	PUNCT
admet-3007	187	12	it	it	PRON
admet-3007	187	13	is	be	AUX
admet-3007	187	14	also	also	ADV
admet-3007	187	15	a	a	DET
admet-3007	187	16	hallmark	hallmark	NOUN
admet-3007	187	17	of	of	ADP
admet-3007	187	18	various	various	ADJ
admet-3007	187	19	pathological	pathological	ADJ
admet-3007	187	20	conditions	condition	NOUN
admet-3007	187	21	,	,	PUNCT
admet-3007	187	22	including	include	VERB
admet-3007	187	23	cancer	cancer	NOUN
admet-3007	187	24	.	.	PUNCT
admet-3007	188	1	in	in	ADP
admet-3007	188	2	tumours	tumours	PROPN
admet-3007	188	3	,	,	PUNCT
admet-3007	188	4	the	the	DET
admet-3007	188	5	self	self	NOUN
admet-3007	188	6	-	-	PUNCT
admet-3007	188	7	renewal	renewal	NOUN
admet-3007	188	8	capacity	capacity	NOUN
admet-3007	188	9	of	of	ADP
admet-3007	188	10	cscs	cscs	PROPN
admet-3007	188	11	and	and	CCONJ
admet-3007	188	12	the	the	DET
admet-3007	188	13	initiation	initiation	NOUN
admet-3007	188	14	of	of	ADP
admet-3007	188	15	tumorigenesis	tumorigenesis	NOUN
admet-3007	188	16	are	be	AUX
admet-3007	188	17	closely	closely	ADV
admet-3007	188	18	associated	associate	VERB
admet-3007	188	19	with	with	ADP
admet-3007	188	20	the	the	DET
admet-3007	188	21	overexpression	overexpression	NOUN
admet-3007	188	22	of	of	ADP
admet-3007	188	23	key	key	ADJ
admet-3007	188	24	angiogenic	angiogenic	ADJ
admet-3007	188	25	markers	marker	NOUN
admet-3007	188	26	,	,	PUNCT
admet-3007	188	27	such	such	ADJ
admet-3007	188	28	as	as	ADP
admet-3007	188	29	vascular	vascular	ADJ
admet-3007	188	30	endothelial	endothelial	ADJ
admet-3007	188	31	growth	growth	NOUN
admet-3007	188	32	factor	factor	NOUN
admet-3007	188	33	(	(	PUNCT
admet-3007	188	34	vegf	vegf	PROPN
admet-3007	188	35	)	)	PUNCT
admet-3007	188	36	,	,	PUNCT
admet-3007	188	37	vegf	vegf	NOUN
admet-3007	188	38	receptors	receptor	NOUN
admet-3007	188	39	(	(	PUNCT
admet-3007	188	40	vegfr1	vegfr1	NOUN
admet-3007	188	41	and	and	CCONJ
admet-3007	188	42	vegfr2	vegfr2	NOUN
admet-3007	188	43	)	)	PUNCT
admet-3007	188	44	,	,	PUNCT
admet-3007	188	45	and	and	CCONJ
admet-3007	188	46	hypoxia	hypoxia	NOUN
admet-3007	188	47	-	-	PUNCT
admet-3007	188	48	inducible	inducible	ADJ
admet-3007	188	49	factors	factor	NOUN
admet-3007	188	50	(	(	PUNCT
admet-3007	188	51	hif-1α	hif-1α	NOUN
admet-3007	188	52	and	and	CCONJ
admet-3007	188	53	hif-2α	hif-2α	NOUN
admet-3007	188	54	)	)	PUNCT
admet-3007	188	55	.	.	PUNCT
admet-3007	189	1	these	these	DET
admet-3007	189	2	molecules	molecule	NOUN
admet-3007	189	3	drive	drive	VERB
admet-3007	189	4	the	the	DET
admet-3007	189	5	angiogenic	angiogenic	ADJ
admet-3007	189	6	cascade	cascade	NOUN
admet-3007	189	7	,	,	PUNCT
admet-3007	189	8	which	which	PRON
admet-3007	189	9	in	in	ADP
admet-3007	189	10	turn	turn	NOUN
admet-3007	189	11	supports	support	VERB
admet-3007	189	12	the	the	DET
admet-3007	189	13	expansion	expansion	NOUN
admet-3007	189	14	and	and	CCONJ
admet-3007	189	15	maintenance	maintenance	NOUN
admet-3007	189	16	of	of	ADP
admet-3007	189	17	the	the	DET
admet-3007	189	18	csc	csc	PROPN
admet-3007	189	19	population	population	NOUN
admet-3007	190	1	[	[	X
admet-3007	190	2	66	66	NUM
admet-3007	190	3	]	]	PUNCT
admet-3007	190	4	.	.	PUNCT
admet-3007	191	1	the	the	DET
admet-3007	191	2	role	role	NOUN
admet-3007	191	3	of	of	ADP
admet-3007	191	4	angiogenesis	angiogenesis	NOUN
admet-3007	191	5	in	in	ADP
admet-3007	191	6	supporting	support	VERB
admet-3007	191	7	cscs	cscs	NOUN
admet-3007	191	8	is	be	AUX
admet-3007	191	9	particularly	particularly	ADV
admet-3007	191	10	significant	significant	ADJ
admet-3007	191	11	,	,	PUNCT
admet-3007	191	12	as	as	SCONJ
admet-3007	191	13	the	the	DET
admet-3007	191	14	enhanced	enhanced	ADJ
admet-3007	191	15	blood	blood	NOUN
admet-3007	191	16	supply	supply	NOUN
admet-3007	191	17	ensures	ensure	VERB
admet-3007	191	18	csc	csc	PROPN
admet-3007	191	19	viability	viability	NOUN
admet-3007	191	20	and	and	CCONJ
admet-3007	191	21	facilitates	facilitate	VERB
admet-3007	191	22	their	their	PRON
admet-3007	191	23	proliferation	proliferation	NOUN
admet-3007	191	24	.	.	PUNCT
admet-3007	192	1	by	by	ADP
admet-3007	192	2	improving	improve	VERB
admet-3007	192	3	nutrient	nutrient	NOUN
admet-3007	192	4	and	and	CCONJ
admet-3007	192	5	oxygen	oxygen	NOUN
admet-3007	192	6	delivery	delivery	NOUN
admet-3007	192	7	,	,	PUNCT
admet-3007	192	8	angiogenesis	angiogenesis	NOUN
admet-3007	192	9	creates	create	VERB
admet-3007	192	10	a	a	DET
admet-3007	192	11	microenvironment	microenvironment	NOUN
admet-3007	192	12	conducive	conducive	ADJ
admet-3007	192	13	to	to	ADP
admet-3007	192	14	csc	csc	PROPN
admet-3007	192	15	maintenance	maintenance	NOUN
admet-3007	192	16	and	and	CCONJ
admet-3007	192	17	tumour	tumour	NOUN
admet-3007	192	18	progression	progression	NOUN
admet-3007	192	19	.	.	PUNCT
admet-3007	193	1	moreover	moreover	ADV
admet-3007	193	2	,	,	PUNCT
admet-3007	193	3	admet	admet	PROPN
admet-3007	193	4	&	&	CCONJ
admet-3007	193	5	dmpk	dmpk	PROPN
admet-3007	193	6	13(5	13(5	NUM
admet-3007	193	7	)	)	PUNCT
admet-3007	193	8	(	(	PUNCT
admet-3007	193	9	2025	2025	NUM
admet-3007	193	10	)	)	PUNCT
admet-3007	193	11	3007	3007	NUM
admet-3007	193	12	nano	nano	NOUN
admet-3007	193	13	-	-	PUNCT
admet-3007	193	14	biomaterials	biomaterial	NOUN
admet-3007	193	15	in	in	ADP
admet-3007	193	16	cancer	cancer	NOUN
admet-3007	193	17	therapy	therapy	NOUN
admet-3007	193	18	doi	doi	PROPN
admet-3007	193	19	:	:	PUNCT
admet-3007	193	20	https://doi.org/10.5599/admet.3007	https://doi.org/10.5599/admet.3007	NOUN
admet-3007	193	21	9	9	NUM
admet-3007	193	22	studies	study	NOUN
admet-3007	193	23	have	have	AUX
admet-3007	193	24	shown	show	VERB
admet-3007	193	25	that	that	SCONJ
admet-3007	193	26	in	in	ADP
admet-3007	193	27	gliomas	glioma	NOUN
admet-3007	193	28	,	,	PUNCT
admet-3007	193	29	cscs	cscs	PROPN
admet-3007	193	30	actively	actively	ADV
admet-3007	193	31	participate	participate	VERB
admet-3007	193	32	in	in	ADP
admet-3007	193	33	angiogenesis	angiogenesis	NOUN
admet-3007	193	34	by	by	ADP
admet-3007	193	35	secreting	secrete	VERB
admet-3007	193	36	pro	pro	ADJ
admet-3007	193	37	-	-	ADJ
admet-3007	193	38	angiogenic	angiogenic	ADJ
admet-3007	193	39	factors	factor	NOUN
admet-3007	193	40	,	,	PUNCT
admet-3007	193	41	such	such	ADJ
admet-3007	193	42	as	as	ADP
admet-3007	193	43	stromal	stromal	ADJ
admet-3007	193	44	-	-	PUNCT
admet-3007	193	45	derived	derive	VERB
admet-3007	193	46	factor	factor	NOUN
admet-3007	193	47	1	1	NUM
admet-3007	193	48	(	(	PUNCT
admet-3007	193	49	sdf-1	sdf-1	NUM
admet-3007	193	50	)	)	PUNCT
admet-3007	193	51	and	and	CCONJ
admet-3007	193	52	vegf	vegf	PROPN
admet-3007	193	53	,	,	PUNCT
admet-3007	193	54	thereby	thereby	ADV
admet-3007	193	55	promoting	promote	VERB
admet-3007	193	56	the	the	DET
admet-3007	193	57	formation	formation	NOUN
admet-3007	193	58	of	of	ADP
admet-3007	193	59	new	new	ADJ
admet-3007	193	60	tumour	tumour	ADJ
admet-3007	193	61	blood	blood	NOUN
admet-3007	193	62	vessels	vessel	NOUN
admet-3007	193	63	[	[	X
admet-3007	193	64	67	67	NUM
admet-3007	193	65	]	]	PUNCT
admet-3007	193	66	.	.	PUNCT
admet-3007	194	1	this	this	PRON
admet-3007	194	2	not	not	PART
admet-3007	194	3	only	only	ADV
admet-3007	194	4	sustains	sustain	VERB
admet-3007	194	5	tumour	tumour	NOUN
admet-3007	194	6	growth	growth	NOUN
admet-3007	194	7	but	but	CCONJ
admet-3007	194	8	also	also	ADV
admet-3007	194	9	protects	protect	VERB
admet-3007	194	10	cscs	cscs	PROPN
admet-3007	194	11	from	from	ADP
admet-3007	194	12	therapeutic	therapeutic	ADJ
admet-3007	194	13	stress	stress	NOUN
admet-3007	194	14	,	,	PUNCT
admet-3007	194	15	reinforcing	reinforce	VERB
admet-3007	194	16	their	their	PRON
admet-3007	194	17	resistance	resistance	NOUN
admet-3007	194	18	through	through	ADP
admet-3007	194	19	the	the	DET
admet-3007	194	20	formation	formation	NOUN
admet-3007	194	21	of	of	ADP
admet-3007	194	22	a	a	DET
admet-3007	194	23	supportive	supportive	ADJ
admet-3007	194	24	vascular	vascular	ADJ
admet-3007	194	25	niche	niche	NOUN
admet-3007	194	26	.	.	PUNCT
admet-3007	195	1	indeed	indeed	ADV
admet-3007	195	2	,	,	PUNCT
admet-3007	195	3	the	the	DET
admet-3007	195	4	interplay	interplay	NOUN
admet-3007	195	5	between	between	ADP
admet-3007	195	6	cscs	cscs	PROPN
admet-3007	195	7	and	and	CCONJ
admet-3007	195	8	angiogenesis	angiogenesis	NOUN
admet-3007	195	9	represents	represent	VERB
admet-3007	195	10	a	a	DET
admet-3007	195	11	critical	critical	ADJ
admet-3007	195	12	therapeutic	therapeutic	ADJ
admet-3007	195	13	target	target	NOUN
admet-3007	195	14	.	.	PUNCT
admet-3007	196	1	disrupting	disrupt	VERB
admet-3007	196	2	angiogenic	angiogenic	ADJ
admet-3007	196	3	signalling	signal	VERB
admet-3007	196	4	pathways	pathway	NOUN
admet-3007	196	5	,	,	PUNCT
admet-3007	196	6	particularly	particularly	ADV
admet-3007	196	7	those	those	PRON
admet-3007	196	8	mediated	mediate	VERB
admet-3007	196	9	by	by	ADP
admet-3007	196	10	vegf	vegf	PROPN
admet-3007	196	11	and	and	CCONJ
admet-3007	196	12	related	related	ADJ
admet-3007	196	13	factors	factor	NOUN
admet-3007	196	14	,	,	PUNCT
admet-3007	196	15	may	may	AUX
admet-3007	196	16	compromise	compromise	VERB
admet-3007	196	17	csc	csc	PROPN
admet-3007	196	18	survival	survival	NOUN
admet-3007	196	19	and	and	CCONJ
admet-3007	196	20	reduce	reduce	VERB
admet-3007	196	21	tumour	tumour	NOUN
admet-3007	196	22	vascularization	vascularization	NOUN
admet-3007	196	23	.	.	PUNCT
admet-3007	197	1	understanding	understand	VERB
admet-3007	197	2	the	the	DET
admet-3007	197	3	reciprocal	reciprocal	ADJ
admet-3007	197	4	relationship	relationship	NOUN
admet-3007	197	5	between	between	ADP
admet-3007	197	6	cscs	cscs	PROPN
admet-3007	197	7	and	and	CCONJ
admet-3007	197	8	angiogenesis	angiogenesis	NOUN
admet-3007	197	9	provides	provide	VERB
admet-3007	197	10	valuable	valuable	ADJ
admet-3007	197	11	insights	insight	NOUN
admet-3007	197	12	for	for	ADP
admet-3007	197	13	developing	develop	VERB
admet-3007	197	14	novel	novel	ADJ
admet-3007	197	15	therapeutic	therapeutic	ADJ
admet-3007	197	16	strategies	strategy	NOUN
admet-3007	197	17	aimed	aim	VERB
admet-3007	197	18	at	at	ADP
admet-3007	197	19	limiting	limit	VERB
admet-3007	197	20	tumour	tumour	NOUN
admet-3007	197	21	progression	progression	NOUN
admet-3007	197	22	and	and	CCONJ
admet-3007	197	23	overcoming	overcome	VERB
admet-3007	197	24	treatment	treatment	NOUN
admet-3007	197	25	resistance	resistance	NOUN
admet-3007	197	26	.	.	PUNCT
admet-3007	198	1	active	active	ADJ
admet-3007	198	2	telomerase	telomerase	NOUN
admet-3007	198	3	telomerase	telomerase	NOUN
admet-3007	198	4	is	be	AUX
admet-3007	198	5	an	an	DET
admet-3007	198	6	rna	rna	NOUN
admet-3007	198	7	-	-	PUNCT
admet-3007	198	8	dependent	dependent	ADJ
admet-3007	198	9	dna	dna	NOUN
admet-3007	198	10	polymerase	polymerase	NOUN
admet-3007	198	11	enzyme	enzyme	NOUN
admet-3007	198	12	that	that	PRON
admet-3007	198	13	plays	play	VERB
admet-3007	198	14	a	a	DET
admet-3007	198	15	critical	critical	ADJ
admet-3007	198	16	role	role	NOUN
admet-3007	198	17	in	in	ADP
admet-3007	198	18	maintaining	maintain	VERB
admet-3007	198	19	telomere	telomere	NOUN
admet-3007	198	20	length	length	NOUN
admet-3007	198	21	,	,	PUNCT
admet-3007	198	22	which	which	PRON
admet-3007	198	23	is	be	AUX
admet-3007	198	24	essential	essential	ADJ
admet-3007	198	25	for	for	ADP
admet-3007	198	26	chromosomal	chromosomal	ADJ
admet-3007	198	27	stability	stability	NOUN
admet-3007	198	28	[	[	X
admet-3007	198	29	68	68	NUM
admet-3007	198	30	]	]	PUNCT
admet-3007	198	31	.	.	PUNCT
admet-3007	199	1	while	while	SCONJ
admet-3007	199	2	telomerase	telomerase	NOUN
admet-3007	199	3	remains	remain	VERB
admet-3007	199	4	inactive	inactive	ADJ
admet-3007	199	5	in	in	ADP
admet-3007	199	6	most	most	ADV
admet-3007	199	7	normal	normal	ADJ
admet-3007	199	8	somatic	somatic	ADJ
admet-3007	199	9	cells	cell	NOUN
admet-3007	199	10	,	,	PUNCT
admet-3007	199	11	its	its	PRON
admet-3007	199	12	reactivation	reactivation	NOUN
admet-3007	199	13	is	be	AUX
admet-3007	199	14	observed	observe	VERB
admet-3007	199	15	in	in	ADP
admet-3007	199	16	nearly	nearly	ADV
admet-3007	199	17	90	90	NUM
admet-3007	199	18	%	%	NOUN
admet-3007	199	19	of	of	ADP
admet-3007	199	20	human	human	ADJ
admet-3007	199	21	cancers	cancer	NOUN
admet-3007	199	22	.	.	PUNCT
admet-3007	200	1	in	in	ADP
admet-3007	200	2	cscs	cscs	PROPN
admet-3007	200	3	,	,	PUNCT
admet-3007	200	4	telomerase	telomerase	NOUN
admet-3007	200	5	activity	activity	NOUN
admet-3007	200	6	is	be	AUX
admet-3007	200	7	markedly	markedly	ADV
admet-3007	200	8	elevated	elevated	ADJ
admet-3007	200	9	and	and	CCONJ
admet-3007	200	10	is	be	AUX
admet-3007	200	11	crucial	crucial	ADJ
admet-3007	200	12	for	for	ADP
admet-3007	200	13	maintaining	maintain	VERB
admet-3007	200	14	their	their	PRON
admet-3007	200	15	self	self	NOUN
admet-3007	200	16	-	-	PUNCT
admet-3007	200	17	renewal	renewal	NOUN
admet-3007	200	18	capacity	capacity	NOUN
admet-3007	200	19	,	,	PUNCT
admet-3007	200	20	survival	survival	NOUN
admet-3007	200	21	,	,	PUNCT
admet-3007	200	22	and	and	CCONJ
admet-3007	200	23	immortality	immortality	NOUN
admet-3007	200	24	.	.	PUNCT
admet-3007	201	1	this	this	DET
admet-3007	201	2	upregulated	upregulated	ADJ
admet-3007	201	3	activity	activity	NOUN
admet-3007	201	4	allows	allow	VERB
admet-3007	201	5	cscs	cscs	PROPN
admet-3007	201	6	to	to	PART
admet-3007	201	7	bypass	bypass	VERB
admet-3007	201	8	replicative	replicative	ADJ
admet-3007	201	9	senescence	senescence	NOUN
admet-3007	201	10	,	,	PUNCT
admet-3007	201	11	thereby	thereby	ADV
admet-3007	201	12	supporting	support	VERB
admet-3007	201	13	the	the	DET
admet-3007	201	14	uncontrolled	uncontrolled	ADJ
admet-3007	201	15	proliferation	proliferation	NOUN
admet-3007	201	16	and	and	CCONJ
admet-3007	201	17	persistence	persistence	NOUN
admet-3007	201	18	of	of	ADP
admet-3007	201	19	tumours	tumour	NOUN
admet-3007	201	20	[	[	X
admet-3007	201	21	69	69	NUM
admet-3007	201	22	]	]	PUNCT
admet-3007	201	23	.	.	PUNCT
admet-3007	202	1	a	a	DET
admet-3007	202	2	key	key	ADJ
admet-3007	202	3	component	component	NOUN
admet-3007	202	4	of	of	ADP
admet-3007	202	5	telomerase	telomerase	NOUN
admet-3007	202	6	is	be	AUX
admet-3007	202	7	the	the	DET
admet-3007	202	8	human	human	ADJ
admet-3007	202	9	telomerase	telomerase	NOUN
admet-3007	202	10	reverse	reverse	VERB
admet-3007	202	11	transcriptase	transcriptase	NOUN
admet-3007	202	12	(	(	PUNCT
admet-3007	202	13	htert	htert	NOUN
admet-3007	202	14	)	)	PUNCT
admet-3007	202	15	,	,	PUNCT
admet-3007	202	16	the	the	DET
admet-3007	202	17	catalytic	catalytic	ADJ
admet-3007	202	18	subunit	subunit	NOUN
admet-3007	202	19	responsible	responsible	ADJ
admet-3007	202	20	for	for	ADP
admet-3007	202	21	adding	add	VERB
admet-3007	202	22	telomeric	telomeric	ADJ
admet-3007	202	23	repeats	repeat	NOUN
admet-3007	202	24	to	to	ADP
admet-3007	202	25	chromosome	chromosome	NOUN
admet-3007	202	26	ends	end	NOUN
admet-3007	202	27	.	.	PUNCT
admet-3007	203	1	studies	study	NOUN
admet-3007	203	2	have	have	AUX
admet-3007	203	3	demonstrated	demonstrate	VERB
admet-3007	203	4	that	that	SCONJ
admet-3007	203	5	htert	htert	NOUN
admet-3007	203	6	overexpression	overexpression	NOUN
admet-3007	203	7	in	in	ADP
admet-3007	203	8	cscs	cscs	PROPN
admet-3007	203	9	significantly	significantly	ADV
admet-3007	203	10	increases	increase	VERB
admet-3007	203	11	their	their	PRON
admet-3007	203	12	population	population	NOUN
admet-3007	203	13	,	,	PUNCT
admet-3007	203	14	as	as	SCONJ
admet-3007	203	15	seen	see	VERB
admet-3007	203	16	in	in	ADP
admet-3007	203	17	gastric	gastric	ADJ
admet-3007	203	18	cancer	cancer	NOUN
admet-3007	203	19	.	.	PUNCT
admet-3007	204	1	this	this	PRON
admet-3007	204	2	indicates	indicate	VERB
admet-3007	204	3	that	that	SCONJ
admet-3007	204	4	telomerase	telomerase	NOUN
admet-3007	204	5	is	be	AUX
admet-3007	204	6	not	not	PART
admet-3007	204	7	only	only	ADV
admet-3007	204	8	essential	essential	ADJ
admet-3007	204	9	for	for	ADP
admet-3007	204	10	telomere	telomere	NOUN
admet-3007	204	11	maintenance	maintenance	NOUN
admet-3007	204	12	but	but	CCONJ
admet-3007	204	13	also	also	ADV
admet-3007	204	14	directly	directly	ADV
admet-3007	204	15	contributes	contribute	VERB
admet-3007	204	16	to	to	ADP
admet-3007	204	17	csc	csc	ADJ
admet-3007	204	18	proliferation	proliferation	NOUN
admet-3007	204	19	and	and	CCONJ
admet-3007	204	20	tumorigenesis	tumorigenesis	NOUN
admet-3007	204	21	[	[	X
admet-3007	204	22	70	70	NUM
admet-3007	204	23	]	]	PUNCT
admet-3007	204	24	.	.	PUNCT
admet-3007	205	1	moreover	moreover	ADV
admet-3007	205	2	,	,	PUNCT
admet-3007	205	3	impaired	impaired	ADJ
admet-3007	205	4	telomere	telomere	NOUN
admet-3007	205	5	maintenance	maintenance	NOUN
admet-3007	205	6	can	can	AUX
admet-3007	205	7	severely	severely	ADV
admet-3007	205	8	compromise	compromise	VERB
admet-3007	205	9	csc	csc	PROPN
admet-3007	205	10	self	self	NOUN
admet-3007	205	11	-	-	PUNCT
admet-3007	205	12	renewal	renewal	NOUN
admet-3007	205	13	.	.	PUNCT
admet-3007	206	1	in	in	ADP
admet-3007	206	2	the	the	DET
admet-3007	206	3	absence	absence	NOUN
admet-3007	206	4	of	of	ADP
admet-3007	206	5	adequate	adequate	ADJ
admet-3007	206	6	telomerase	telomerase	NOUN
admet-3007	206	7	activity	activity	NOUN
admet-3007	206	8	,	,	PUNCT
admet-3007	206	9	telomere	telomere	NOUN
admet-3007	206	10	shortening	shortening	NOUN
admet-3007	206	11	may	may	AUX
admet-3007	206	12	trigger	trigger	VERB
admet-3007	206	13	cellular	cellular	ADJ
admet-3007	206	14	senescence	senescence	NOUN
admet-3007	206	15	or	or	CCONJ
admet-3007	206	16	apoptosis	apoptosis	NOUN
admet-3007	206	17	,	,	PUNCT
admet-3007	206	18	limiting	limit	VERB
admet-3007	206	19	the	the	DET
admet-3007	206	20	tumorigenic	tumorigenic	ADJ
admet-3007	206	21	potential	potential	NOUN
admet-3007	206	22	of	of	ADP
admet-3007	206	23	cscs	cscs	PROPN
admet-3007	206	24	.	.	PUNCT
admet-3007	207	1	thus	thus	ADV
admet-3007	207	2	,	,	PUNCT
admet-3007	207	3	telomerase	telomerase	NOUN
admet-3007	207	4	plays	play	VERB
admet-3007	207	5	a	a	DET
admet-3007	207	6	pivotal	pivotal	ADJ
admet-3007	207	7	role	role	NOUN
admet-3007	207	8	in	in	ADP
admet-3007	207	9	ensuring	ensure	VERB
admet-3007	207	10	the	the	DET
admet-3007	207	11	longevity	longevity	NOUN
admet-3007	207	12	and	and	CCONJ
admet-3007	207	13	sustainability	sustainability	NOUN
admet-3007	207	14	of	of	ADP
admet-3007	207	15	csc	csc	PROPN
admet-3007	207	16	populations	population	NOUN
admet-3007	207	17	within	within	ADP
admet-3007	207	18	tumours	tumour	NOUN
admet-3007	207	19	[	[	X
admet-3007	207	20	71	71	NUM
admet-3007	207	21	]	]	PUNCT
admet-3007	207	22	.	.	PUNCT
admet-3007	208	1	given	give	VERB
admet-3007	208	2	its	its	PRON
admet-3007	208	3	fundamental	fundamental	ADJ
admet-3007	208	4	role	role	NOUN
admet-3007	208	5	in	in	ADP
admet-3007	208	6	csc	csc	PROPN
admet-3007	208	7	biology	biology	NOUN
admet-3007	208	8	,	,	PUNCT
admet-3007	208	9	telomerase	telomerase	NOUN
admet-3007	208	10	is	be	AUX
admet-3007	208	11	considered	consider	VERB
admet-3007	208	12	a	a	DET
admet-3007	208	13	promising	promising	ADJ
admet-3007	208	14	therapeutic	therapeutic	ADJ
admet-3007	208	15	target	target	NOUN
admet-3007	208	16	.	.	PUNCT
admet-3007	209	1	inhibiting	inhibit	VERB
admet-3007	209	2	telomerase	telomerase	NOUN
admet-3007	209	3	activity	activity	NOUN
admet-3007	209	4	in	in	ADP
admet-3007	209	5	cscs	cscs	PROPN
admet-3007	209	6	could	could	AUX
admet-3007	209	7	potentially	potentially	ADV
admet-3007	209	8	abrogate	abrogate	VERB
admet-3007	209	9	their	their	PRON
admet-3007	209	10	immortality	immortality	NOUN
admet-3007	209	11	,	,	PUNCT
admet-3007	209	12	thereby	thereby	ADV
admet-3007	209	13	reducing	reduce	VERB
admet-3007	209	14	tumour	tumour	ADJ
admet-3007	209	15	growth	growth	NOUN
admet-3007	209	16	and	and	CCONJ
admet-3007	209	17	recurrence	recurrence	NOUN
admet-3007	209	18	.	.	PUNCT
admet-3007	210	1	targeting	target	VERB
admet-3007	210	2	telomerase	telomerase	NOUN
admet-3007	210	3	may	may	AUX
admet-3007	210	4	offer	offer	VERB
admet-3007	210	5	a	a	DET
admet-3007	210	6	powerful	powerful	ADJ
admet-3007	210	7	strategy	strategy	NOUN
admet-3007	210	8	for	for	ADP
admet-3007	210	9	eliminating	eliminate	VERB
admet-3007	210	10	treatmentresistant	treatmentresistant	ADJ
admet-3007	210	11	cancer	cancer	NOUN
admet-3007	210	12	cells	cell	NOUN
admet-3007	210	13	.	.	PUNCT
admet-3007	211	1	understanding	understand	VERB
admet-3007	211	2	the	the	DET
admet-3007	211	3	regulatory	regulatory	ADJ
admet-3007	211	4	mechanisms	mechanism	NOUN
admet-3007	211	5	of	of	ADP
admet-3007	211	6	telomerase	telomerase	NOUN
admet-3007	211	7	expression	expression	NOUN
admet-3007	211	8	and	and	CCONJ
admet-3007	211	9	activity	activity	NOUN
admet-3007	211	10	in	in	ADP
admet-3007	211	11	cscs	cscs	PROPN
admet-3007	211	12	is	be	AUX
admet-3007	211	13	essential	essential	ADJ
admet-3007	211	14	for	for	ADP
admet-3007	211	15	the	the	DET
admet-3007	211	16	development	development	NOUN
admet-3007	211	17	of	of	ADP
admet-3007	211	18	effective	effective	ADJ
admet-3007	211	19	and	and	CCONJ
admet-3007	211	20	durable	durable	ADJ
admet-3007	211	21	anti	anti	ADJ
admet-3007	211	22	-	-	ADJ
admet-3007	211	23	cancer	cancer	ADJ
admet-3007	211	24	therapies	therapy	NOUN
admet-3007	211	25	.	.	PUNCT
admet-3007	212	1	dormancy	dormancy	NOUN
admet-3007	212	2	the	the	DET
admet-3007	212	3	concept	concept	NOUN
admet-3007	212	4	of	of	ADP
admet-3007	212	5	cancer	cancer	NOUN
admet-3007	212	6	cell	cell	NOUN
admet-3007	212	7	dormancy	dormancy	NOUN
admet-3007	212	8	was	be	AUX
admet-3007	212	9	first	first	ADV
admet-3007	212	10	introduced	introduce	VERB
admet-3007	212	11	by	by	ADP
admet-3007	212	12	rupert	rupert	PROPN
admet-3007	212	13	willis	willis	PROPN
admet-3007	212	14	in	in	ADP
admet-3007	212	15	1934	1934	NUM
admet-3007	212	16	[	[	X
admet-3007	212	17	72	72	NUM
admet-3007	212	18	]	]	X
admet-3007	212	19	,	,	PUNCT
admet-3007	212	20	when	when	SCONJ
admet-3007	212	21	he	he	PRON
admet-3007	212	22	observed	observe	VERB
admet-3007	212	23	cases	case	NOUN
admet-3007	212	24	of	of	ADP
admet-3007	212	25	late	late	ADJ
admet-3007	212	26	metastasis	metastasis	NOUN
admet-3007	212	27	in	in	ADP
admet-3007	212	28	patients	patient	NOUN
admet-3007	212	29	without	without	ADP
admet-3007	212	30	any	any	DET
admet-3007	212	31	evidence	evidence	NOUN
admet-3007	212	32	of	of	ADP
admet-3007	212	33	local	local	ADJ
admet-3007	212	34	recurrence	recurrence	NOUN
admet-3007	212	35	.	.	PUNCT
admet-3007	213	1	he	he	PRON
admet-3007	213	2	hypothesized	hypothesize	VERB
admet-3007	213	3	that	that	SCONJ
admet-3007	213	4	cancer	cancer	NOUN
admet-3007	213	5	cells	cell	NOUN
admet-3007	213	6	had	have	AUX
admet-3007	213	7	migrated	migrate	VERB
admet-3007	213	8	to	to	ADP
admet-3007	213	9	secondary	secondary	ADJ
admet-3007	213	10	tissues	tissue	NOUN
admet-3007	213	11	and	and	CCONJ
admet-3007	213	12	"	"	PUNCT
admet-3007	213	13	must	must	AUX
admet-3007	213	14	have	have	VERB
admet-3007	213	15	lain	lie	VERB
admet-3007	213	16	dormant	dormant	VERB
admet-3007	213	17	"	"	PUNCT
admet-3007	213	18	for	for	ADP
admet-3007	213	19	extended	extended	ADJ
admet-3007	213	20	periods	period	NOUN
admet-3007	213	21	.	.	PUNCT
admet-3007	214	1	dormancy	dormancy	NOUN
admet-3007	214	2	is	be	AUX
admet-3007	214	3	now	now	ADV
admet-3007	214	4	recognized	recognize	VERB
admet-3007	214	5	as	as	ADP
admet-3007	214	6	an	an	DET
admet-3007	214	7	adaptive	adaptive	ADJ
admet-3007	214	8	survival	survival	NOUN
admet-3007	214	9	mechanism	mechanism	NOUN
admet-3007	214	10	employed	employ	VERB
admet-3007	214	11	by	by	ADP
admet-3007	214	12	cancer	cancer	NOUN
admet-3007	214	13	stem	stem	NOUN
admet-3007	214	14	cells	cell	NOUN
admet-3007	214	15	to	to	PART
admet-3007	214	16	evade	evade	VERB
admet-3007	214	17	unfavourable	unfavourable	ADJ
admet-3007	214	18	microenvironmental	microenvironmental	ADJ
admet-3007	214	19	conditions	condition	NOUN
admet-3007	214	20	,	,	PUNCT
admet-3007	214	21	including	include	VERB
admet-3007	214	22	chemotherapy	chemotherapy	NOUN
admet-3007	214	23	,	,	PUNCT
admet-3007	214	24	radiation	radiation	NOUN
admet-3007	214	25	,	,	PUNCT
admet-3007	214	26	nutrient	nutrient	NOUN
admet-3007	214	27	deprivation	deprivation	NOUN
admet-3007	214	28	,	,	PUNCT
admet-3007	214	29	and	and	CCONJ
admet-3007	214	30	other	other	ADJ
admet-3007	214	31	stressors	stressor	NOUN
admet-3007	214	32	.	.	PUNCT
admet-3007	215	1	in	in	ADP
admet-3007	215	2	their	their	PRON
admet-3007	215	3	dormant	dormant	ADJ
admet-3007	215	4	state	state	NOUN
admet-3007	215	5	,	,	PUNCT
admet-3007	215	6	cscs	cscs	PROPN
admet-3007	215	7	remain	remain	VERB
admet-3007	215	8	viable	viable	ADJ
admet-3007	215	9	but	but	CCONJ
admet-3007	215	10	temporarily	temporarily	ADV
admet-3007	215	11	suspend	suspend	VERB
admet-3007	215	12	proliferation	proliferation	NOUN
admet-3007	215	13	,	,	PUNCT
admet-3007	215	14	enabling	enable	VERB
admet-3007	215	15	them	they	PRON
admet-3007	215	16	to	to	PART
admet-3007	215	17	survive	survive	VERB
admet-3007	215	18	under	under	ADP
admet-3007	215	19	harsh	harsh	ADJ
admet-3007	215	20	conditions	condition	NOUN
admet-3007	215	21	and	and	CCONJ
admet-3007	215	22	escape	escape	VERB
admet-3007	215	23	detection	detection	NOUN
admet-3007	215	24	by	by	ADP
admet-3007	215	25	conventional	conventional	ADJ
admet-3007	215	26	therapies	therapy	NOUN
admet-3007	215	27	[	[	X
admet-3007	215	28	73	73	NUM
admet-3007	215	29	]	]	PUNCT
admet-3007	215	30	.	.	PUNCT
admet-3007	216	1	there	there	PRON
admet-3007	216	2	are	be	VERB
admet-3007	216	3	several	several	ADJ
admet-3007	216	4	types	type	NOUN
admet-3007	216	5	of	of	ADP
admet-3007	216	6	cscs	cscs	PROPN
admet-3007	216	7	dormancy	dormancy	NOUN
admet-3007	216	8	,	,	PUNCT
admet-3007	216	9	each	each	PRON
admet-3007	216	10	contributing	contribute	VERB
admet-3007	216	11	to	to	ADP
admet-3007	216	12	the	the	DET
admet-3007	216	13	complexity	complexity	NOUN
admet-3007	216	14	of	of	ADP
admet-3007	216	15	cancer	cancer	NOUN
admet-3007	216	16	progression	progression	NOUN
admet-3007	216	17	and	and	CCONJ
admet-3007	216	18	recurrence	recurrence	NOUN
admet-3007	216	19	:	:	PUNCT
admet-3007	216	20	1	1	X
admet-3007	216	21	.	.	PUNCT
admet-3007	216	22	primary	primary	ADJ
admet-3007	216	23	cancer	cancer	NOUN
admet-3007	216	24	dormancy	dormancy	NOUN
admet-3007	216	25	:	:	PUNCT
admet-3007	216	26	cancer	cancer	NOUN
admet-3007	216	27	cells	cell	NOUN
admet-3007	216	28	within	within	ADP
admet-3007	216	29	the	the	DET
admet-3007	216	30	primary	primary	ADJ
admet-3007	216	31	tumour	tumour	NOUN
admet-3007	216	32	temporarily	temporarily	ADV
admet-3007	216	33	cease	cease	VERB
admet-3007	216	34	proliferation	proliferation	NOUN
admet-3007	216	35	but	but	CCONJ
admet-3007	216	36	remain	remain	VERB
admet-3007	216	37	viable	viable	ADJ
admet-3007	216	38	,	,	PUNCT
admet-3007	216	39	ready	ready	ADJ
admet-3007	216	40	to	to	PART
admet-3007	216	41	resume	resume	VERB
admet-3007	216	42	growth	growth	NOUN
admet-3007	216	43	when	when	SCONJ
admet-3007	216	44	environmental	environmental	ADJ
admet-3007	216	45	conditions	condition	NOUN
admet-3007	216	46	become	become	VERB
admet-3007	216	47	favourable	favourable	ADJ
admet-3007	216	48	,	,	PUNCT
admet-3007	216	49	2	2	X
admet-3007	216	50	.	.	PUNCT
admet-3007	216	51	metastatic	metastatic	ADJ
admet-3007	216	52	https://doi.org/10.5599/admet.3007	https://doi.org/10.5599/admet.3007	NOUN
admet-3007	216	53	m.	m.	NOUN
admet-3007	216	54	dehghani	dehghani	PROPN
admet-3007	216	55	et	et	PROPN
admet-3007	216	56	al	al	PROPN
admet-3007	216	57	.	.	PROPN
admet-3007	216	58	admet	admet	PROPN
admet-3007	216	59	&	&	CCONJ
admet-3007	216	60	dmpk	dmpk	PROPN
admet-3007	216	61	13(5	13(5	NUM
admet-3007	216	62	)	)	PUNCT
admet-3007	216	63	(	(	PUNCT
admet-3007	216	64	2025	2025	NUM
admet-3007	216	65	)	)	PUNCT
admet-3007	216	66	3007	3007	NUM
admet-3007	216	67	10	10	NUM
admet-3007	216	68	dormancy	dormancy	NOUN
admet-3007	216	69	:	:	PUNCT
admet-3007	216	70	disseminated	disseminate	VERB
admet-3007	216	71	tumour	tumour	NOUN
admet-3007	216	72	cells	cell	NOUN
admet-3007	216	73	(	(	PUNCT
admet-3007	216	74	dtcs	dtcs	NOUN
admet-3007	216	75	)	)	PUNCT
admet-3007	216	76	that	that	PRON
admet-3007	216	77	have	have	AUX
admet-3007	216	78	spread	spread	VERB
admet-3007	216	79	to	to	ADP
admet-3007	216	80	distant	distant	ADJ
admet-3007	216	81	organs	organ	NOUN
admet-3007	216	82	enter	enter	VERB
admet-3007	216	83	a	a	DET
admet-3007	216	84	dormant	dormant	ADJ
admet-3007	216	85	state	state	NOUN
admet-3007	216	86	,	,	PUNCT
admet-3007	216	87	sometimes	sometimes	ADV
admet-3007	216	88	for	for	ADP
admet-3007	216	89	years	year	NOUN
admet-3007	216	90	or	or	CCONJ
admet-3007	216	91	even	even	ADV
admet-3007	216	92	decades	decade	NOUN
admet-3007	216	93	,	,	PUNCT
admet-3007	216	94	before	before	ADP
admet-3007	216	95	reactivating	reactivate	VERB
admet-3007	216	96	to	to	PART
admet-3007	216	97	initiate	initiate	VERB
admet-3007	216	98	metastatic	metastatic	ADJ
admet-3007	216	99	growth	growth	NOUN
admet-3007	216	100	,	,	PUNCT
admet-3007	216	101	3	3	X
admet-3007	216	102	.	.	X
admet-3007	216	103	therapy	therapy	NOUN
admet-3007	216	104	-	-	PUNCT
admet-3007	216	105	induced	induce	VERB
admet-3007	216	106	dormancy	dormancy	NOUN
admet-3007	216	107	:	:	PUNCT
admet-3007	216	108	exposure	exposure	NOUN
admet-3007	216	109	to	to	ADP
admet-3007	216	110	chemotherapy	chemotherapy	NOUN
admet-3007	216	111	or	or	CCONJ
admet-3007	216	112	radiation	radiation	NOUN
admet-3007	216	113	may	may	AUX
admet-3007	216	114	drive	drive	VERB
admet-3007	216	115	cscs	cscs	PROPN
admet-3007	216	116	into	into	ADP
admet-3007	216	117	a	a	DET
admet-3007	216	118	quiescent	quiescent	ADJ
admet-3007	216	119	state	state	NOUN
admet-3007	216	120	,	,	PUNCT
admet-3007	216	121	allowing	allow	VERB
admet-3007	216	122	them	they	PRON
admet-3007	216	123	to	to	PART
admet-3007	216	124	survive	survive	VERB
admet-3007	216	125	treatment	treatment	NOUN
admet-3007	216	126	and	and	CCONJ
admet-3007	216	127	later	later	ADV
admet-3007	216	128	re	re	VERB
admet-3007	216	129	-	-	VERB
admet-3007	216	130	emerge	emerge	VERB
admet-3007	216	131	,	,	PUNCT
admet-3007	216	132	potentially	potentially	ADV
admet-3007	216	133	leading	lead	VERB
admet-3007	216	134	to	to	ADP
admet-3007	216	135	tumour	tumour	NOUN
admet-3007	216	136	recurrence	recurrence	NOUN
admet-3007	216	137	,	,	PUNCT
admet-3007	216	138	4	4	X
admet-3007	216	139	.	.	NOUN
admet-3007	217	1	immunologic	immunologic	ADJ
admet-3007	217	2	dormancy	dormancy	NOUN
admet-3007	217	3	:	:	PUNCT
admet-3007	217	4	cscs	cscs	PROPN
admet-3007	217	5	remain	remain	VERB
admet-3007	217	6	non	non	ADJ
admet-3007	217	7	-	-	ADJ
admet-3007	217	8	proliferative	proliferative	ADJ
admet-3007	217	9	due	due	ADJ
admet-3007	217	10	to	to	ADP
admet-3007	217	11	constant	constant	ADJ
admet-3007	217	12	immune	immune	ADJ
admet-3007	217	13	surveillance	surveillance	NOUN
admet-3007	217	14	,	,	PUNCT
admet-3007	217	15	which	which	PRON
admet-3007	217	16	prevents	prevent	VERB
admet-3007	217	17	their	their	PRON
admet-3007	217	18	expansion	expansion	NOUN
admet-3007	217	19	without	without	ADP
admet-3007	217	20	fully	fully	ADV
admet-3007	217	21	eliminating	eliminate	VERB
admet-3007	217	22	them	they	PRON
admet-3007	217	23	[	[	X
admet-3007	217	24	74	74	NUM
admet-3007	217	25	]	]	PUNCT
admet-3007	217	26	.	.	PUNCT
admet-3007	218	1	the	the	DET
admet-3007	218	2	types	type	NOUN
admet-3007	218	3	of	of	ADP
admet-3007	218	4	cancer	cancer	NOUN
admet-3007	218	5	dormancy	dormancy	NOUN
admet-3007	218	6	are	be	AUX
admet-3007	218	7	shown	show	VERB
admet-3007	218	8	in	in	ADP
admet-3007	218	9	figure	figure	NOUN
admet-3007	218	10	3	3	NUM
admet-3007	218	11	.	.	PUNCT
admet-3007	218	12	figure	figure	NOUN
admet-3007	218	13	3	3	NUM
admet-3007	218	14	.	.	PUNCT
admet-3007	219	1	different	different	ADJ
admet-3007	219	2	types	type	NOUN
admet-3007	219	3	of	of	ADP
admet-3007	219	4	cancer	cancer	NOUN
admet-3007	219	5	stem	stem	NOUN
admet-3007	219	6	cell	cell	NOUN
admet-3007	219	7	dormancy	dormancy	NOUN
admet-3007	219	8	.	.	PUNCT
admet-3007	220	1	therapy	therapy	NOUN
admet-3007	220	2	-	-	PUNCT
admet-3007	220	3	induced	induce	VERB
admet-3007	220	4	dormancy	dormancy	NOUN
admet-3007	220	5	occurs	occur	VERB
admet-3007	220	6	as	as	ADP
admet-3007	220	7	a	a	DET
admet-3007	220	8	survival	survival	NOUN
admet-3007	220	9	strategy	strategy	NOUN
admet-3007	220	10	following	follow	VERB
admet-3007	220	11	chemotherapy	chemotherapy	NOUN
admet-3007	220	12	or	or	CCONJ
admet-3007	220	13	radiotherapy	radiotherapy	NOUN
admet-3007	220	14	.	.	PUNCT
admet-3007	221	1	metastatic	metastatic	ADJ
admet-3007	221	2	dormancy	dormancy	NOUN
admet-3007	221	3	refers	refer	VERB
admet-3007	221	4	to	to	ADP
admet-3007	221	5	the	the	DET
admet-3007	221	6	quiescent	quiescent	ADJ
admet-3007	221	7	state	state	NOUN
admet-3007	221	8	of	of	ADP
admet-3007	221	9	disseminated	disseminate	VERB
admet-3007	221	10	cancer	cancer	NOUN
admet-3007	221	11	stem	stem	NOUN
admet-3007	221	12	cells	cell	NOUN
admet-3007	221	13	at	at	ADP
admet-3007	221	14	secondary	secondary	ADJ
admet-3007	221	15	sites	site	NOUN
admet-3007	221	16	.	.	PUNCT
admet-3007	222	1	primary	primary	ADJ
admet-3007	222	2	dormancy	dormancy	NOUN
admet-3007	222	3	represents	represent	VERB
admet-3007	222	4	the	the	DET
admet-3007	222	5	intrinsic	intrinsic	ADJ
admet-3007	222	6	quiescence	quiescence	NOUN
admet-3007	222	7	of	of	ADP
admet-3007	222	8	cancer	cancer	NOUN
admet-3007	222	9	stem	stem	NOUN
admet-3007	222	10	cells	cell	NOUN
admet-3007	222	11	within	within	ADP
admet-3007	222	12	the	the	DET
admet-3007	222	13	primary	primary	ADJ
admet-3007	222	14	tumour	tumour	NOUN
admet-3007	222	15	niche	niche	NOUN
admet-3007	222	16	.	.	PUNCT
admet-3007	223	1	immunological	immunological	ADJ
admet-3007	223	2	dormancy	dormancy	NOUN
admet-3007	223	3	is	be	AUX
admet-3007	223	4	maintained	maintain	VERB
admet-3007	223	5	through	through	ADP
admet-3007	223	6	immune	immune	ADJ
admet-3007	223	7	surveillance	surveillance	NOUN
admet-3007	223	8	and	and	CCONJ
admet-3007	223	9	tumour	tumour	ADJ
admet-3007	223	10	-	-	PUNCT
admet-3007	223	11	immune	immune	ADJ
admet-3007	223	12	system	system	NOUN
admet-3007	223	13	interactions	interaction	NOUN
admet-3007	223	14	understanding	understand	VERB
admet-3007	223	15	the	the	DET
admet-3007	223	16	mechanisms	mechanism	NOUN
admet-3007	223	17	of	of	ADP
admet-3007	223	18	dormancy	dormancy	NOUN
admet-3007	223	19	is	be	AUX
admet-3007	223	20	crucial	crucial	ADJ
admet-3007	223	21	for	for	ADP
admet-3007	223	22	developing	develop	VERB
admet-3007	223	23	effective	effective	ADJ
admet-3007	223	24	long	long	ADJ
admet-3007	223	25	-	-	PUNCT
admet-3007	223	26	term	term	NOUN
admet-3007	223	27	cancer	cancer	NOUN
admet-3007	223	28	therapies	therapy	NOUN
admet-3007	223	29	,	,	PUNCT
admet-3007	223	30	as	as	SCONJ
admet-3007	223	31	dormant	dormant	PROPN
admet-3007	223	32	cscs	cscs	PROPN
admet-3007	223	33	are	be	AUX
admet-3007	223	34	believed	believe	VERB
admet-3007	223	35	to	to	PART
admet-3007	223	36	be	be	AUX
admet-3007	223	37	a	a	DET
admet-3007	223	38	key	key	ADJ
admet-3007	223	39	source	source	NOUN
admet-3007	223	40	of	of	ADP
admet-3007	223	41	resistance	resistance	NOUN
admet-3007	223	42	,	,	PUNCT
admet-3007	223	43	relapse	relapse	NOUN
admet-3007	223	44	,	,	PUNCT
admet-3007	223	45	and	and	CCONJ
admet-3007	223	46	metastasis	metastasis	NOUN
admet-3007	223	47	.	.	PUNCT
admet-3007	224	1	the	the	DET
admet-3007	224	2	dormancy	dormancy	NOUN
admet-3007	224	3	phenomenon	phenomenon	NOUN
admet-3007	224	4	poses	pose	VERB
admet-3007	224	5	a	a	DET
admet-3007	224	6	significant	significant	ADJ
admet-3007	224	7	challenge	challenge	NOUN
admet-3007	224	8	to	to	ADP
admet-3007	224	9	cancer	cancer	NOUN
admet-3007	224	10	treatment	treatment	NOUN
admet-3007	224	11	.	.	PUNCT
admet-3007	225	1	dormant	dormant	PROPN
admet-3007	225	2	cscs	cscs	PROPN
admet-3007	225	3	are	be	AUX
admet-3007	225	4	particularly	particularly	ADV
admet-3007	225	5	problematic	problematic	ADJ
admet-3007	225	6	because	because	SCONJ
admet-3007	225	7	they	they	PRON
admet-3007	225	8	can	can	AUX
admet-3007	225	9	evade	evade	VERB
admet-3007	225	10	therapies	therapy	NOUN
admet-3007	225	11	targeting	target	VERB
admet-3007	225	12	rapidly	rapidly	ADV
admet-3007	225	13	dividing	divide	VERB
admet-3007	225	14	cells	cell	NOUN
admet-3007	225	15	.	.	PUNCT
admet-3007	226	1	furthermore	furthermore	ADV
admet-3007	226	2	,	,	PUNCT
admet-3007	226	3	different	different	ADJ
admet-3007	226	4	treatments	treatment	NOUN
admet-3007	226	5	can	can	AUX
admet-3007	226	6	have	have	VERB
admet-3007	226	7	varying	vary	VERB
admet-3007	226	8	effects	effect	NOUN
admet-3007	226	9	on	on	ADP
admet-3007	226	10	dormant	dormant	ADJ
admet-3007	226	11	cells	cell	NOUN
admet-3007	226	12	.	.	PUNCT
admet-3007	227	1	some	some	DET
admet-3007	227	2	therapies	therapy	NOUN
admet-3007	227	3	may	may	AUX
admet-3007	227	4	induce	induce	VERB
admet-3007	227	5	dormancy	dormancy	NOUN
admet-3007	227	6	,	,	PUNCT
admet-3007	227	7	thereby	thereby	ADV
admet-3007	227	8	inhibit	inhibit	VERB
admet-3007	227	9	metastasis	metastasis	NOUN
admet-3007	227	10	and	and	CCONJ
admet-3007	227	11	slow	slow	ADJ
admet-3007	227	12	disease	disease	NOUN
admet-3007	227	13	progression	progression	NOUN
admet-3007	227	14	.	.	PUNCT
admet-3007	228	1	others	other	NOUN
admet-3007	228	2	,	,	PUNCT
admet-3007	228	3	however	however	ADV
admet-3007	228	4	,	,	PUNCT
admet-3007	228	5	can	can	AUX
admet-3007	228	6	inadvertently	inadvertently	ADV
admet-3007	228	7	activate	activate	VERB
admet-3007	228	8	dormant	dormant	ADJ
admet-3007	228	9	cscs	cscs	PROPN
admet-3007	228	10	,	,	PUNCT
admet-3007	228	11	leading	lead	VERB
admet-3007	228	12	to	to	ADP
admet-3007	228	13	tumour	tumour	NOUN
admet-3007	228	14	recurrence	recurrence	NOUN
admet-3007	228	15	and	and	CCONJ
admet-3007	228	16	the	the	DET
admet-3007	228	17	development	development	NOUN
admet-3007	228	18	of	of	ADP
admet-3007	228	19	more	more	ADV
admet-3007	228	20	aggressive	aggressive	ADJ
admet-3007	228	21	forms	form	NOUN
admet-3007	228	22	of	of	ADP
admet-3007	228	23	cancer	cancer	NOUN
admet-3007	228	24	[	[	X
admet-3007	228	25	75	75	NUM
admet-3007	228	26	]	]	PUNCT
admet-3007	228	27	.	.	PUNCT
admet-3007	229	1	this	this	DET
admet-3007	229	2	duality	duality	NOUN
admet-3007	229	3	has	have	AUX
admet-3007	229	4	sparked	spark	VERB
admet-3007	229	5	debate	debate	NOUN
admet-3007	229	6	among	among	ADP
admet-3007	229	7	researchers	researcher	NOUN
admet-3007	229	8	about	about	ADP
admet-3007	229	9	the	the	DET
admet-3007	229	10	best	good	ADJ
admet-3007	229	11	therapeutic	therapeutic	ADJ
admet-3007	229	12	approach	approach	NOUN
admet-3007	229	13	.	.	PUNCT
admet-3007	230	1	some	some	DET
admet-3007	230	2	advocate	advocate	NOUN
admet-3007	230	3	for	for	ADP
admet-3007	230	4	dormancy	dormancy	NOUN
admet-3007	230	5	induction	induction	NOUN
admet-3007	230	6	as	as	ADP
admet-3007	230	7	a	a	DET
admet-3007	230	8	useful	useful	ADJ
admet-3007	230	9	strategy	strategy	NOUN
admet-3007	230	10	,	,	PUNCT
admet-3007	230	11	believing	believe	VERB
admet-3007	230	12	it	it	PRON
admet-3007	230	13	can	can	AUX
admet-3007	230	14	prevent	prevent	VERB
admet-3007	230	15	metastasis	metastasis	PRON
admet-3007	230	16	and	and	CCONJ
admet-3007	230	17	maintain	maintain	VERB
admet-3007	230	18	the	the	DET
admet-3007	230	19	cancer	cancer	NOUN
admet-3007	230	20	in	in	ADP
admet-3007	230	21	a	a	DET
admet-3007	230	22	controlled	control	VERB
admet-3007	230	23	,	,	PUNCT
admet-3007	230	24	non	non	ADJ
admet-3007	230	25	-	-	ADJ
admet-3007	230	26	progressive	progressive	ADJ
admet-3007	230	27	state	state	NOUN
admet-3007	230	28	.	.	PUNCT
admet-3007	231	1	on	on	ADP
admet-3007	231	2	the	the	DET
admet-3007	231	3	other	other	ADJ
admet-3007	231	4	hand	hand	NOUN
admet-3007	231	5	,	,	PUNCT
admet-3007	231	6	others	other	NOUN
admet-3007	231	7	argue	argue	VERB
admet-3007	231	8	that	that	SCONJ
admet-3007	231	9	activating	activate	VERB
admet-3007	231	10	dormant	dormant	ADJ
admet-3007	231	11	cscs	cscs	NOUN
admet-3007	231	12	followed	follow	VERB
admet-3007	231	13	by	by	ADP
admet-3007	231	14	their	their	PRON
admet-3007	231	15	targeted	target	VERB
admet-3007	231	16	elimination	elimination	NOUN
admet-3007	231	17	may	may	AUX
admet-3007	231	18	be	be	AUX
admet-3007	231	19	more	more	ADV
admet-3007	231	20	effective	effective	ADJ
admet-3007	231	21	,	,	PUNCT
admet-3007	231	22	as	as	SCONJ
admet-3007	231	23	it	it	PRON
admet-3007	231	24	could	could	AUX
admet-3007	231	25	eradicate	eradicate	VERB
admet-3007	231	26	the	the	DET
admet-3007	231	27	hidden	hide	VERB
admet-3007	231	28	reservoir	reservoir	NOUN
admet-3007	231	29	of	of	ADP
admet-3007	231	30	cancer	cancer	NOUN
admet-3007	231	31	cells	cell	NOUN
admet-3007	231	32	that	that	PRON
admet-3007	231	33	fuel	fuel	NOUN
admet-3007	231	34	recurrence	recurrence	NOUN
admet-3007	231	35	.	.	PUNCT
admet-3007	232	1	understanding	understand	VERB
admet-3007	232	2	the	the	DET
admet-3007	232	3	mechanisms	mechanism	NOUN
admet-3007	232	4	governing	govern	VERB
admet-3007	232	5	dormancy	dormancy	NOUN
admet-3007	232	6	in	in	ADP
admet-3007	232	7	cscs	cscs	PROPN
admet-3007	232	8	is	be	AUX
admet-3007	232	9	essential	essential	ADJ
admet-3007	232	10	for	for	ADP
admet-3007	232	11	developing	develop	VERB
admet-3007	232	12	more	more	ADV
admet-3007	232	13	effective	effective	ADJ
admet-3007	232	14	treatment	treatment	NOUN
admet-3007	232	15	strategies	strategy	NOUN
admet-3007	232	16	.	.	PUNCT
admet-3007	233	1	whether	whether	SCONJ
admet-3007	233	2	inducing	induce	VERB
admet-3007	233	3	or	or	CCONJ
admet-3007	233	4	disrupting	disrupt	VERB
admet-3007	233	5	dormancy	dormancy	NOUN
admet-3007	233	6	proves	prove	VERB
admet-3007	233	7	to	to	PART
admet-3007	233	8	be	be	AUX
admet-3007	233	9	the	the	DET
admet-3007	233	10	better	well	ADJ
admet-3007	233	11	approach	approach	NOUN
admet-3007	233	12	will	will	AUX
admet-3007	233	13	depend	depend	VERB
admet-3007	233	14	on	on	ADP
admet-3007	233	15	deeper	deep	ADJ
admet-3007	233	16	insights	insight	NOUN
admet-3007	233	17	into	into	ADP
admet-3007	233	18	how	how	SCONJ
admet-3007	233	19	these	these	DET
admet-3007	233	20	cells	cell	NOUN
admet-3007	233	21	respond	respond	VERB
admet-3007	233	22	to	to	ADP
admet-3007	233	23	different	different	ADJ
admet-3007	233	24	therapies	therapy	NOUN
admet-3007	233	25	and	and	CCONJ
admet-3007	233	26	how	how	SCONJ
admet-3007	233	27	dormancy	dormancy	NOUN
admet-3007	233	28	contributes	contribute	VERB
admet-3007	233	29	to	to	ADP
admet-3007	233	30	long	long	ADJ
admet-3007	233	31	-	-	PUNCT
admet-3007	233	32	term	term	NOUN
admet-3007	233	33	cancer	cancer	NOUN
admet-3007	233	34	survival	survival	NOUN
admet-3007	233	35	and	and	CCONJ
admet-3007	233	36	relapse	relapse	NOUN
admet-3007	233	37	.	.	PUNCT
admet-3007	234	1	hypoxia	hypoxia	NOUN
admet-3007	234	2	low	low	ADJ
admet-3007	234	3	oxygen	oxygen	NOUN
admet-3007	234	4	levels	level	NOUN
admet-3007	234	5	,	,	PUNCT
admet-3007	234	6	or	or	CCONJ
admet-3007	234	7	hypoxia	hypoxia	NOUN
admet-3007	234	8	,	,	PUNCT
admet-3007	234	9	play	play	VERB
admet-3007	234	10	a	a	DET
admet-3007	234	11	critical	critical	ADJ
admet-3007	234	12	role	role	NOUN
admet-3007	234	13	in	in	ADP
admet-3007	234	14	maintaining	maintain	VERB
admet-3007	234	15	cscs	cscs	NOUN
admet-3007	234	16	and	and	CCONJ
admet-3007	234	17	promoting	promote	VERB
admet-3007	234	18	their	their	PRON
admet-3007	234	19	malignancy	malignancy	NOUN
admet-3007	234	20	,	,	PUNCT
admet-3007	234	21	thereby	thereby	ADV
admet-3007	234	22	contributing	contribute	VERB
admet-3007	234	23	to	to	ADP
admet-3007	234	24	tumour	tumour	NOUN
admet-3007	234	25	survival	survival	NOUN
admet-3007	234	26	,	,	PUNCT
admet-3007	234	27	progression	progression	NOUN
admet-3007	234	28	,	,	PUNCT
admet-3007	234	29	and	and	CCONJ
admet-3007	234	30	metastasis	metastasis	NOUN
admet-3007	234	31	.	.	PUNCT
admet-3007	235	1	under	under	ADP
admet-3007	235	2	hypoxic	hypoxic	ADJ
admet-3007	235	3	conditions	condition	NOUN
admet-3007	235	4	,	,	PUNCT
admet-3007	235	5	the	the	DET
admet-3007	235	6	expression	expression	NOUN
admet-3007	235	7	of	of	ADP
admet-3007	235	8	hypoxia	hypoxia	NOUN
admet-3007	235	9	-	-	PUNCT
admet-3007	235	10	inducible	inducible	ADJ
admet-3007	235	11	factors	factor	NOUN
admet-3007	235	12	(	(	PUNCT
admet-3007	235	13	hifs	hif	NOUN
admet-3007	235	14	)	)	PUNCT
admet-3007	235	15	,	,	PUNCT
admet-3007	235	16	particularly	particularly	ADV
admet-3007	235	17	hif-1α	hif-1α	NOUN
admet-3007	235	18	and	and	CCONJ
admet-3007	235	19	hif-2α	hif-2α	NOUN
admet-3007	235	20	,	,	PUNCT
admet-3007	235	21	is	be	AUX
admet-3007	235	22	significantly	significantly	ADV
admet-3007	235	23	upregulated	upregulate	VERB
admet-3007	235	24	.	.	PUNCT
admet-3007	236	1	these	these	DET
admet-3007	236	2	transcription	transcription	NOUN
admet-3007	236	3	factors	factor	NOUN
admet-3007	236	4	are	be	AUX
admet-3007	236	5	essential	essential	ADJ
admet-3007	236	6	regulators	regulator	NOUN
admet-3007	236	7	of	of	ADP
admet-3007	236	8	cellular	cellular	ADJ
admet-3007	236	9	adaptation	adaptation	NOUN
admet-3007	236	10	to	to	PART
admet-3007	236	11	low	low	ADJ
admet-3007	236	12	oxygen	oxygen	NOUN
admet-3007	236	13	levels	level	NOUN
admet-3007	236	14	and	and	CCONJ
admet-3007	236	15	are	be	AUX
admet-3007	236	16	admet	admet	PROPN
admet-3007	236	17	&	&	CCONJ
admet-3007	236	18	dmpk	dmpk	PROPN
admet-3007	236	19	13(5	13(5	NOUN
admet-3007	236	20	)	)	PUNCT
admet-3007	236	21	(	(	PUNCT
admet-3007	236	22	2025	2025	NUM
admet-3007	236	23	)	)	PUNCT
admet-3007	236	24	3007	3007	NUM
admet-3007	236	25	nano	nano	NOUN
admet-3007	236	26	-	-	PUNCT
admet-3007	236	27	biomaterials	biomaterial	NOUN
admet-3007	236	28	in	in	ADP
admet-3007	236	29	cancer	cancer	NOUN
admet-3007	236	30	therapy	therapy	NOUN
admet-3007	236	31	doi	doi	PROPN
admet-3007	236	32	:	:	PUNCT
admet-3007	236	33	https://doi.org/10.5599/admet.3007	https://doi.org/10.5599/admet.3007	NOUN
admet-3007	236	34	11	11	NUM
admet-3007	236	35	strongly	strongly	ADV
admet-3007	236	36	associated	associate	VERB
admet-3007	236	37	with	with	ADP
admet-3007	236	38	tumour	tumour	NOUN
admet-3007	236	39	aggressiveness	aggressiveness	NOUN
admet-3007	236	40	,	,	PUNCT
admet-3007	236	41	metastasis	metastasis	NOUN
admet-3007	236	42	,	,	PUNCT
admet-3007	236	43	and	and	CCONJ
admet-3007	236	44	angiogenesis	angiogenesis	NOUN
admet-3007	236	45	induction	induction	NOUN
admet-3007	236	46	.	.	PUNCT
admet-3007	237	1	elevated	elevate	VERB
admet-3007	237	2	hif	hif	PROPN
admet-3007	237	3	expression	expression	NOUN
admet-3007	237	4	correlates	correlate	VERB
admet-3007	237	5	with	with	ADP
admet-3007	237	6	increased	increase	VERB
admet-3007	237	7	malignancy	malignancy	NOUN
admet-3007	237	8	and	and	CCONJ
admet-3007	237	9	resistance	resistance	NOUN
admet-3007	237	10	to	to	ADP
admet-3007	237	11	conventional	conventional	ADJ
admet-3007	237	12	therapies	therapy	NOUN
admet-3007	237	13	such	such	ADJ
admet-3007	237	14	as	as	ADP
admet-3007	237	15	chemotherapy	chemotherapy	NOUN
admet-3007	237	16	and	and	CCONJ
admet-3007	237	17	radiotherapy	radiotherapy	NOUN
admet-3007	237	18	[	[	X
admet-3007	237	19	76	76	NUM
admet-3007	237	20	]	]	PUNCT
admet-3007	237	21	.	.	PUNCT
admet-3007	238	1	for	for	ADP
admet-3007	238	2	example	example	NOUN
admet-3007	238	3	,	,	PUNCT
admet-3007	238	4	glioblastoma	glioblastoma	NOUN
admet-3007	238	5	multiforme	multiforme	NOUN
admet-3007	238	6	(	(	PUNCT
admet-3007	238	7	gbm	gbm	PROPN
admet-3007	238	8	)	)	PUNCT
admet-3007	238	9	,	,	PUNCT
admet-3007	238	10	the	the	DET
admet-3007	238	11	most	most	ADV
admet-3007	238	12	aggressive	aggressive	ADJ
admet-3007	238	13	form	form	NOUN
admet-3007	238	14	of	of	ADP
admet-3007	238	15	brain	brain	NOUN
admet-3007	238	16	cancer	cancer	NOUN
admet-3007	238	17	,	,	PUNCT
admet-3007	238	18	is	be	AUX
admet-3007	238	19	characterized	characterize	VERB
admet-3007	238	20	by	by	ADP
admet-3007	238	21	extensive	extensive	ADJ
admet-3007	238	22	hypoxic	hypoxic	ADJ
admet-3007	238	23	regions	region	NOUN
admet-3007	238	24	.	.	PUNCT
admet-3007	239	1	glioblastoma	glioblastoma	NOUN
admet-3007	239	2	stem	stem	NOUN
admet-3007	239	3	cells	cell	NOUN
admet-3007	239	4	(	(	PUNCT
admet-3007	239	5	gscs	gsc	NOUN
admet-3007	239	6	)	)	PUNCT
admet-3007	239	7	preferentially	preferentially	ADV
admet-3007	239	8	inhabit	inhabit	VERB
admet-3007	239	9	these	these	DET
admet-3007	239	10	hypoxic	hypoxic	ADJ
admet-3007	239	11	niches	niche	NOUN
admet-3007	239	12	,	,	PUNCT
admet-3007	239	13	exhibiting	exhibit	VERB
admet-3007	239	14	enhanced	enhanced	ADJ
admet-3007	239	15	self	self	NOUN
admet-3007	239	16	-	-	PUNCT
admet-3007	239	17	renewal	renewal	NOUN
admet-3007	239	18	,	,	PUNCT
admet-3007	239	19	proliferation	proliferation	NOUN
admet-3007	239	20	,	,	PUNCT
admet-3007	239	21	and	and	CCONJ
admet-3007	239	22	invasive	invasive	ADJ
admet-3007	239	23	potential	potential	NOUN
admet-3007	239	24	.	.	PUNCT
admet-3007	240	1	evidence	evidence	NOUN
admet-3007	240	2	suggests	suggest	VERB
admet-3007	240	3	that	that	SCONJ
admet-3007	240	4	hypoxia	hypoxia	NOUN
admet-3007	240	5	is	be	AUX
admet-3007	240	6	a	a	DET
admet-3007	240	7	major	major	ADJ
admet-3007	240	8	driver	driver	NOUN
admet-3007	240	9	of	of	ADP
admet-3007	240	10	gsc	gsc	PROPN
admet-3007	240	11	malignancy	malignancy	NOUN
admet-3007	240	12	and	and	CCONJ
admet-3007	240	13	their	their	PRON
admet-3007	240	14	resistance	resistance	NOUN
admet-3007	240	15	to	to	ADP
admet-3007	240	16	chemoand	chemoand	PROPN
admet-3007	240	17	radiotherapy	radiotherapy	NOUN
admet-3007	240	18	.	.	PUNCT
admet-3007	241	1	this	this	DET
admet-3007	241	2	hypoxia	hypoxia	NOUN
admet-3007	241	3	-	-	PUNCT
admet-3007	241	4	mediated	mediate	VERB
admet-3007	241	5	resistance	resistance	NOUN
admet-3007	241	6	poses	pose	VERB
admet-3007	241	7	a	a	DET
admet-3007	241	8	significant	significant	ADJ
admet-3007	241	9	challenge	challenge	NOUN
admet-3007	241	10	in	in	ADP
admet-3007	241	11	gbm	gbm	PROPN
admet-3007	241	12	treatment	treatment	NOUN
admet-3007	241	13	,	,	PUNCT
admet-3007	241	14	as	as	SCONJ
admet-3007	241	15	gscs	gsc	NOUN
admet-3007	241	16	can	can	AUX
admet-3007	241	17	survive	survive	VERB
admet-3007	241	18	and	and	CCONJ
admet-3007	241	19	adapt	adapt	VERB
admet-3007	241	20	under	under	ADP
admet-3007	241	21	conditions	condition	NOUN
admet-3007	241	22	that	that	PRON
admet-3007	241	23	are	be	AUX
admet-3007	241	24	lethal	lethal	ADJ
admet-3007	241	25	to	to	ADP
admet-3007	241	26	non	non	ADJ
admet-3007	241	27	-	-	ADJ
admet-3007	241	28	stem	stem	ADJ
admet-3007	241	29	cancer	cancer	NOUN
admet-3007	241	30	cells	cell	NOUN
admet-3007	241	31	[	[	X
admet-3007	241	32	77	77	NUM
admet-3007	241	33	]	]	PUNCT
admet-3007	241	34	.	.	PUNCT
admet-3007	242	1	moreover	moreover	ADV
admet-3007	242	2	,	,	PUNCT
admet-3007	242	3	hypoxia	hypoxia	NOUN
admet-3007	242	4	has	have	AUX
admet-3007	242	5	been	be	AUX
admet-3007	242	6	shown	show	VERB
admet-3007	242	7	to	to	PART
admet-3007	242	8	contribute	contribute	VERB
admet-3007	242	9	to	to	ADP
admet-3007	242	10	drug	drug	NOUN
admet-3007	242	11	resistance	resistance	NOUN
admet-3007	242	12	in	in	ADP
admet-3007	242	13	tumours	tumour	NOUN
admet-3007	242	14	,	,	PUNCT
admet-3007	242	15	primarily	primarily	ADV
admet-3007	242	16	through	through	ADP
admet-3007	242	17	the	the	DET
admet-3007	242	18	regulation	regulation	NOUN
admet-3007	242	19	of	of	ADP
admet-3007	242	20	drug	drug	NOUN
admet-3007	242	21	transporters	transporter	NOUN
admet-3007	242	22	.	.	PUNCT
admet-3007	243	1	a	a	DET
admet-3007	243	2	strong	strong	ADJ
admet-3007	243	3	correlation	correlation	NOUN
admet-3007	243	4	between	between	ADP
admet-3007	243	5	hif-1α	hif-1α	NOUN
admet-3007	243	6	and	and	CCONJ
admet-3007	243	7	the	the	DET
admet-3007	243	8	expression	expression	NOUN
admet-3007	243	9	of	of	ADP
admet-3007	243	10	drug	drug	NOUN
admet-3007	243	11	transporters	transporter	NOUN
admet-3007	243	12	,	,	PUNCT
admet-3007	243	13	such	such	ADJ
admet-3007	243	14	as	as	ADP
admet-3007	243	15	abcb1	abcb1	NOUN
admet-3007	243	16	(	(	PUNCT
admet-3007	243	17	also	also	ADV
admet-3007	243	18	known	know	VERB
admet-3007	243	19	as	as	ADP
admet-3007	243	20	mdr1	mdr1	PROPN
admet-3007	243	21	)	)	PUNCT
admet-3007	243	22	,	,	PUNCT
admet-3007	243	23	has	have	AUX
admet-3007	243	24	been	be	AUX
admet-3007	243	25	observed	observe	VERB
admet-3007	243	26	.	.	PUNCT
admet-3007	244	1	abcb1	abcb1	NOUN
admet-3007	244	2	is	be	AUX
admet-3007	244	3	involved	involve	VERB
admet-3007	244	4	in	in	ADP
admet-3007	244	5	the	the	DET
admet-3007	244	6	efflux	efflux	NOUN
admet-3007	244	7	of	of	ADP
admet-3007	244	8	chemotherapeutic	chemotherapeutic	ADJ
admet-3007	244	9	agents	agent	NOUN
admet-3007	244	10	from	from	ADP
admet-3007	244	11	cancer	cancer	NOUN
admet-3007	244	12	cells	cell	NOUN
admet-3007	244	13	,	,	PUNCT
admet-3007	244	14	contributing	contribute	VERB
admet-3007	244	15	to	to	PART
admet-3007	244	16	multidrug	multidrug	VERB
admet-3007	244	17	resistance	resistance	NOUN
admet-3007	245	1	[	[	X
admet-3007	245	2	78	78	NUM
admet-3007	245	3	]	]	PUNCT
admet-3007	245	4	.	.	PUNCT
admet-3007	246	1	the	the	DET
admet-3007	246	2	hif-1α	hif-1α	NOUN
admet-3007	246	3	binding	bind	VERB
admet-3007	246	4	site	site	NOUN
admet-3007	246	5	in	in	ADP
admet-3007	246	6	the	the	DET
admet-3007	246	7	promoter	promoter	NOUN
admet-3007	246	8	region	region	NOUN
admet-3007	246	9	of	of	ADP
admet-3007	246	10	the	the	DET
admet-3007	246	11	mdr1	mdr1	PROPN
admet-3007	246	12	gene	gene	NOUN
admet-3007	246	13	has	have	AUX
admet-3007	246	14	been	be	AUX
admet-3007	246	15	identified	identify	VERB
admet-3007	246	16	,	,	PUNCT
admet-3007	246	17	demonstrating	demonstrate	VERB
admet-3007	246	18	that	that	SCONJ
admet-3007	246	19	hif-1α	hif-1α	NOUN
admet-3007	246	20	can	can	AUX
admet-3007	246	21	directly	directly	ADV
admet-3007	246	22	upregulate	upregulate	VERB
admet-3007	246	23	the	the	DET
admet-3007	246	24	expression	expression	NOUN
admet-3007	246	25	of	of	ADP
admet-3007	246	26	this	this	DET
admet-3007	246	27	transporter	transporter	NOUN
admet-3007	246	28	.	.	PUNCT
admet-3007	247	1	this	this	DET
admet-3007	247	2	interaction	interaction	NOUN
admet-3007	247	3	underscores	underscore	VERB
admet-3007	247	4	the	the	DET
admet-3007	247	5	role	role	NOUN
admet-3007	247	6	of	of	ADP
admet-3007	247	7	hypoxia	hypoxia	NOUN
admet-3007	247	8	in	in	ADP
admet-3007	247	9	driving	drive	VERB
admet-3007	247	10	not	not	PART
admet-3007	247	11	only	only	ADV
admet-3007	247	12	cscs	cscs	PROPN
admet-3007	247	13	'	'	PART
admet-3007	247	14	survival	survival	NOUN
admet-3007	247	15	and	and	CCONJ
admet-3007	247	16	malignancy	malignancy	NOUN
admet-3007	247	17	but	but	CCONJ
admet-3007	247	18	also	also	ADV
admet-3007	247	19	their	their	PRON
admet-3007	247	20	ability	ability	NOUN
admet-3007	247	21	to	to	PART
admet-3007	247	22	resist	resist	VERB
admet-3007	247	23	multiple	multiple	ADJ
admet-3007	247	24	drugs	drug	NOUN
admet-3007	247	25	,	,	PUNCT
admet-3007	247	26	making	make	VERB
admet-3007	247	27	treatment	treatment	NOUN
admet-3007	247	28	more	more	ADV
admet-3007	247	29	challenging	challenging	ADJ
admet-3007	247	30	.	.	PUNCT
admet-3007	248	1	in	in	ADP
admet-3007	248	2	summary	summary	NOUN
admet-3007	248	3	,	,	PUNCT
admet-3007	248	4	understanding	understand	VERB
admet-3007	248	5	the	the	DET
admet-3007	248	6	impact	impact	NOUN
admet-3007	248	7	of	of	ADP
admet-3007	248	8	hypoxia	hypoxia	NOUN
admet-3007	248	9	on	on	ADP
admet-3007	248	10	cscs	cscs	PROPN
admet-3007	248	11	and	and	CCONJ
admet-3007	248	12	tumour	tumour	NOUN
admet-3007	248	13	biology	biology	NOUN
admet-3007	248	14	underscores	underscore	VERB
admet-3007	248	15	the	the	DET
admet-3007	248	16	necessity	necessity	NOUN
admet-3007	248	17	of	of	ADP
admet-3007	248	18	developing	develop	VERB
admet-3007	248	19	therapeutic	therapeutic	ADJ
admet-3007	248	20	approaches	approach	NOUN
admet-3007	248	21	targeting	target	VERB
admet-3007	248	22	hif	hif	PROPN
admet-3007	248	23	signalling	signal	VERB
admet-3007	248	24	pathways	pathway	NOUN
admet-3007	248	25	and	and	CCONJ
admet-3007	248	26	the	the	DET
admet-3007	248	27	hypoxic	hypoxic	ADJ
admet-3007	248	28	tme	tme	NOUN
admet-3007	248	29	.	.	PUNCT
admet-3007	249	1	strategies	strategy	NOUN
admet-3007	249	2	that	that	PRON
admet-3007	249	3	inhibit	inhibit	VERB
admet-3007	249	4	hif	hif	PROPN
admet-3007	249	5	activity	activity	NOUN
admet-3007	249	6	or	or	CCONJ
admet-3007	249	7	improve	improve	VERB
admet-3007	249	8	tumour	tumour	NOUN
admet-3007	249	9	oxygenation	oxygenation	NOUN
admet-3007	249	10	may	may	AUX
admet-3007	249	11	reduce	reduce	VERB
admet-3007	249	12	csc	csc	PROPN
admet-3007	249	13	-	-	PUNCT
admet-3007	249	14	mediated	mediate	VERB
admet-3007	249	15	drug	drug	NOUN
admet-3007	249	16	resistance	resistance	NOUN
admet-3007	249	17	and	and	CCONJ
admet-3007	249	18	improve	improve	VERB
admet-3007	249	19	the	the	DET
admet-3007	249	20	effectiveness	effectiveness	NOUN
admet-3007	249	21	of	of	ADP
admet-3007	249	22	existing	exist	VERB
admet-3007	249	23	cancer	cancer	NOUN
admet-3007	249	24	treatments	treatment	NOUN
admet-3007	249	25	.	.	PUNCT
admet-3007	250	1	metastasis	metastasis	NOUN
admet-3007	250	2	metastasis	metastasis	NOUN
admet-3007	250	3	is	be	AUX
admet-3007	250	4	a	a	DET
admet-3007	250	5	defining	define	VERB
admet-3007	250	6	hallmark	hallmark	NOUN
admet-3007	250	7	of	of	ADP
admet-3007	250	8	malignant	malignant	ADJ
admet-3007	250	9	tumours	tumour	NOUN
admet-3007	250	10	and	and	CCONJ
admet-3007	250	11	a	a	DET
admet-3007	250	12	major	major	ADJ
admet-3007	250	13	determinant	determinant	NOUN
admet-3007	250	14	of	of	ADP
admet-3007	250	15	cancer	cancer	NOUN
admet-3007	250	16	patient	patient	NOUN
admet-3007	250	17	prognosis	prognosis	NOUN
admet-3007	250	18	and	and	CCONJ
admet-3007	250	19	survival	survival	NOUN
admet-3007	250	20	.	.	PUNCT
admet-3007	251	1	it	it	PRON
admet-3007	251	2	is	be	AUX
admet-3007	251	3	a	a	DET
admet-3007	251	4	complex	complex	ADJ
admet-3007	251	5	,	,	PUNCT
admet-3007	251	6	multistep	multistep	ADJ
admet-3007	251	7	cascade	cascade	NOUN
admet-3007	251	8	through	through	ADP
admet-3007	251	9	which	which	PRON
admet-3007	251	10	cancer	cancer	NOUN
admet-3007	251	11	cells	cell	NOUN
admet-3007	251	12	disseminate	disseminate	VERB
admet-3007	251	13	from	from	ADP
admet-3007	251	14	the	the	DET
admet-3007	251	15	primary	primary	ADJ
admet-3007	251	16	tumour	tumour	NOUN
admet-3007	251	17	and	and	CCONJ
admet-3007	251	18	establish	establish	VERB
admet-3007	251	19	secondary	secondary	ADJ
admet-3007	251	20	tumours	tumour	NOUN
admet-3007	251	21	at	at	ADP
admet-3007	251	22	distant	distant	ADJ
admet-3007	251	23	sites	site	NOUN
admet-3007	251	24	.	.	PUNCT
admet-3007	252	1	a	a	DET
admet-3007	252	2	pivotal	pivotal	ADJ
admet-3007	252	3	event	event	NOUN
admet-3007	252	4	in	in	ADP
admet-3007	252	5	this	this	DET
admet-3007	252	6	cascade	cascade	NOUN
admet-3007	252	7	is	be	AUX
admet-3007	252	8	the	the	DET
admet-3007	252	9	epithelial	epithelial	NOUN
admet-3007	252	10	-	-	PUNCT
admet-3007	252	11	to	to	ADP
admet-3007	252	12	-	-	PUNCT
admet-3007	252	13	mesenchymal	mesenchymal	NOUN
admet-3007	252	14	transition	transition	NOUN
admet-3007	252	15	(	(	PUNCT
admet-3007	252	16	emt	emt	PROPN
admet-3007	252	17	)	)	PUNCT
admet-3007	252	18	,	,	PUNCT
admet-3007	252	19	a	a	DET
admet-3007	252	20	phenotypic	phenotypic	ADJ
admet-3007	252	21	shift	shift	NOUN
admet-3007	252	22	whereby	whereby	SCONJ
admet-3007	252	23	epithelial	epithelial	ADJ
admet-3007	252	24	tumour	tumour	NOUN
admet-3007	252	25	cells	cell	NOUN
admet-3007	252	26	lose	lose	VERB
admet-3007	252	27	their	their	PRON
admet-3007	252	28	polarity	polarity	NOUN
admet-3007	252	29	and	and	CCONJ
admet-3007	252	30	cell	cell	NOUN
admet-3007	252	31	-	-	PUNCT
admet-3007	252	32	cell	cell	NOUN
admet-3007	252	33	adhesion	adhesion	NOUN
admet-3007	252	34	properties	property	NOUN
admet-3007	252	35	and	and	CCONJ
admet-3007	252	36	acquire	acquire	VERB
admet-3007	252	37	a	a	DET
admet-3007	252	38	more	more	ADV
admet-3007	252	39	motile	motile	ADJ
admet-3007	252	40	and	and	CCONJ
admet-3007	252	41	invasive	invasive	ADJ
admet-3007	252	42	mesenchymal	mesenchymal	ADJ
admet-3007	252	43	phenotype	phenotype	NOUN
admet-3007	252	44	.	.	PUNCT
admet-3007	253	1	this	this	DET
admet-3007	253	2	transition	transition	NOUN
admet-3007	253	3	enhances	enhance	VERB
admet-3007	253	4	cellular	cellular	ADJ
admet-3007	253	5	plasticity	plasticity	NOUN
admet-3007	253	6	,	,	PUNCT
admet-3007	253	7	increases	increase	VERB
admet-3007	253	8	metabolic	metabolic	NOUN
admet-3007	253	9	activity	activity	NOUN
admet-3007	253	10	,	,	PUNCT
admet-3007	253	11	and	and	CCONJ
admet-3007	253	12	facilitates	facilitate	VERB
admet-3007	253	13	migration	migration	NOUN
admet-3007	253	14	and	and	CCONJ
admet-3007	253	15	invasion	invasion	NOUN
admet-3007	253	16	,	,	PUNCT
admet-3007	253	17	all	all	PRON
admet-3007	253	18	of	of	ADP
admet-3007	253	19	which	which	PRON
admet-3007	253	20	are	be	AUX
admet-3007	253	21	crucial	crucial	ADJ
admet-3007	253	22	for	for	ADP
admet-3007	253	23	tumour	tumour	NOUN
admet-3007	253	24	spread	spread	NOUN
admet-3007	253	25	[	[	X
admet-3007	253	26	79	79	NUM
admet-3007	253	27	]	]	PUNCT
admet-3007	253	28	.	.	PUNCT
admet-3007	254	1	in	in	ADP
admet-3007	254	2	normal	normal	ADJ
admet-3007	254	3	epithelial	epithelial	ADJ
admet-3007	254	4	tissues	tissue	NOUN
admet-3007	254	5	,	,	PUNCT
admet-3007	254	6	strong	strong	ADJ
admet-3007	254	7	intercellular	intercellular	ADJ
admet-3007	254	8	adhesion	adhesion	NOUN
admet-3007	254	9	,	,	PUNCT
admet-3007	254	10	maintained	maintain	VERB
admet-3007	254	11	by	by	ADP
admet-3007	254	12	tight	tight	ADJ
admet-3007	254	13	and	and	CCONJ
admet-3007	254	14	adhesive	adhesive	ADJ
admet-3007	254	15	junctions	junction	NOUN
admet-3007	254	16	,	,	PUNCT
admet-3007	254	17	preserves	preserve	VERB
admet-3007	254	18	structural	structural	ADJ
admet-3007	254	19	integrity	integrity	NOUN
admet-3007	254	20	and	and	CCONJ
admet-3007	254	21	limits	limit	VERB
admet-3007	254	22	cell	cell	NOUN
admet-3007	254	23	motility	motility	NOUN
admet-3007	254	24	.	.	PUNCT
admet-3007	255	1	however	however	ADV
admet-3007	255	2	,	,	PUNCT
admet-3007	255	3	during	during	ADP
admet-3007	255	4	emt	emt	PROPN
admet-3007	255	5	,	,	PUNCT
admet-3007	255	6	the	the	DET
admet-3007	255	7	disruption	disruption	NOUN
admet-3007	255	8	of	of	ADP
admet-3007	255	9	these	these	DET
admet-3007	255	10	junctions	junction	NOUN
admet-3007	255	11	enables	enable	VERB
admet-3007	255	12	tumour	tumour	PRON
admet-3007	255	13	cells	cell	NOUN
admet-3007	255	14	to	to	PART
admet-3007	255	15	detach	detach	VERB
admet-3007	255	16	from	from	ADP
admet-3007	255	17	the	the	DET
admet-3007	255	18	primary	primary	ADJ
admet-3007	255	19	site	site	NOUN
admet-3007	255	20	.	.	PUNCT
admet-3007	256	1	as	as	SCONJ
admet-3007	256	2	epithelial	epithelial	ADJ
admet-3007	256	3	traits	trait	NOUN
admet-3007	256	4	are	be	AUX
admet-3007	256	5	lost	lose	VERB
admet-3007	256	6	,	,	PUNCT
admet-3007	256	7	cells	cell	NOUN
admet-3007	256	8	adopt	adopt	VERB
admet-3007	256	9	a	a	DET
admet-3007	256	10	spindle	spindle	NOUN
admet-3007	256	11	-	-	PUNCT
admet-3007	256	12	like	like	ADJ
admet-3007	256	13	morphology	morphology	NOUN
admet-3007	256	14	and	and	CCONJ
admet-3007	256	15	acquire	acquire	VERB
admet-3007	256	16	mesenchymal	mesenchymal	NOUN
admet-3007	256	17	features	feature	NOUN
admet-3007	256	18	,	,	PUNCT
admet-3007	256	19	allowing	allow	VERB
admet-3007	256	20	them	they	PRON
admet-3007	256	21	to	to	PART
admet-3007	256	22	infiltrate	infiltrate	VERB
admet-3007	256	23	surrounding	surround	VERB
admet-3007	256	24	tissues	tissue	NOUN
admet-3007	256	25	and	and	CCONJ
admet-3007	256	26	gain	gain	VERB
admet-3007	256	27	access	access	NOUN
admet-3007	256	28	to	to	ADP
admet-3007	256	29	the	the	DET
admet-3007	256	30	circulatory	circulatory	ADJ
admet-3007	256	31	or	or	CCONJ
admet-3007	256	32	lymphatic	lymphatic	ADJ
admet-3007	256	33	systems	system	NOUN
admet-3007	256	34	,	,	PUNCT
admet-3007	256	35	thereby	thereby	ADV
admet-3007	256	36	initiating	initiate	VERB
admet-3007	256	37	metastasis	metastasis	PRON
admet-3007	256	38	[	[	X
admet-3007	256	39	80	80	NUM
admet-3007	256	40	]	]	PUNCT
admet-3007	256	41	.	.	PUNCT
admet-3007	257	1	cscs	cscs	PROPN
admet-3007	257	2	play	play	VERB
admet-3007	257	3	a	a	DET
admet-3007	257	4	crucial	crucial	ADJ
admet-3007	257	5	role	role	NOUN
admet-3007	257	6	in	in	ADP
admet-3007	257	7	the	the	DET
admet-3007	257	8	initiation	initiation	NOUN
admet-3007	257	9	and	and	CCONJ
admet-3007	257	10	progression	progression	NOUN
admet-3007	257	11	of	of	ADP
admet-3007	257	12	metastasis	metastasis	NOUN
admet-3007	257	13	.	.	PUNCT
admet-3007	258	1	studies	study	NOUN
admet-3007	258	2	have	have	AUX
admet-3007	258	3	shown	show	VERB
admet-3007	258	4	that	that	SCONJ
admet-3007	258	5	cscs	cscs	PROPN
admet-3007	258	6	express	express	VERB
admet-3007	258	7	tenascin	tenascin	PRON
admet-3007	258	8	c	c	PROPN
admet-3007	258	9	(	(	PUNCT
admet-3007	258	10	tnc	tnc	PROPN
admet-3007	258	11	)	)	PUNCT
admet-3007	258	12	,	,	PUNCT
admet-3007	258	13	an	an	DET
admet-3007	258	14	extracellular	extracellular	ADJ
admet-3007	258	15	matrix	matrix	NOUN
admet-3007	258	16	glycoprotein	glycoprotein	NOUN
admet-3007	258	17	involved	involve	VERB
admet-3007	258	18	in	in	ADP
admet-3007	258	19	tissue	tissue	NOUN
admet-3007	258	20	remodelling	remodelling	NOUN
admet-3007	258	21	and	and	CCONJ
admet-3007	258	22	metastasis	metastasis	NOUN
admet-3007	258	23	.	.	PUNCT
admet-3007	259	1	the	the	DET
admet-3007	259	2	ability	ability	NOUN
admet-3007	259	3	of	of	ADP
admet-3007	259	4	cscs	cscs	PROPN
admet-3007	259	5	to	to	PART
admet-3007	259	6	produce	produce	VERB
admet-3007	259	7	tnc	tnc	PROPN
admet-3007	259	8	has	have	AUX
admet-3007	259	9	been	be	AUX
admet-3007	259	10	strongly	strongly	ADV
admet-3007	259	11	linked	link	VERB
admet-3007	259	12	to	to	ADP
admet-3007	259	13	metastasis	metastasis	NOUN
admet-3007	259	14	,	,	PUNCT
admet-3007	259	15	particularly	particularly	ADV
admet-3007	259	16	in	in	ADP
admet-3007	259	17	lung	lung	NOUN
admet-3007	259	18	cancer	cancer	NOUN
admet-3007	259	19	models	model	NOUN
admet-3007	259	20	.	.	PUNCT
admet-3007	260	1	experimental	experimental	ADJ
admet-3007	260	2	evidence	evidence	NOUN
admet-3007	260	3	suggests	suggest	VERB
admet-3007	260	4	that	that	SCONJ
admet-3007	260	5	tnc	tnc	NOUN
admet-3007	260	6	expression	expression	NOUN
admet-3007	260	7	by	by	ADP
admet-3007	260	8	cscs	cscs	PROPN
admet-3007	260	9	significantly	significantly	ADV
admet-3007	260	10	contributes	contribute	VERB
admet-3007	260	11	to	to	ADP
admet-3007	260	12	the	the	DET
admet-3007	260	13	metastatic	metastatic	ADJ
admet-3007	260	14	process	process	NOUN
admet-3007	260	15	,	,	PUNCT
admet-3007	260	16	as	as	SCONJ
admet-3007	260	17	reducing	reduce	VERB
admet-3007	260	18	tnc	tnc	NOUN
admet-3007	260	19	levels	level	NOUN
admet-3007	260	20	in	in	ADP
admet-3007	260	21	breast	breast	NOUN
admet-3007	260	22	cancer	cancer	NOUN
admet-3007	260	23	cells	cell	NOUN
admet-3007	260	24	decreases	decrease	VERB
admet-3007	260	25	their	their	PRON
admet-3007	260	26	migratory	migratory	NOUN
admet-3007	260	27	capacity	capacity	NOUN
admet-3007	260	28	,	,	PUNCT
admet-3007	260	29	highlighting	highlight	VERB
admet-3007	260	30	its	its	PRON
admet-3007	260	31	role	role	NOUN
admet-3007	260	32	in	in	ADP
admet-3007	260	33	cell	cell	NOUN
admet-3007	260	34	migration	migration	NOUN
admet-3007	260	35	and	and	CCONJ
admet-3007	260	36	tumour	tumour	NOUN
admet-3007	260	37	dissemination	dissemination	NOUN
admet-3007	261	1	[	[	X
admet-3007	261	2	81	81	NUM
admet-3007	261	3	]	]	PUNCT
admet-3007	261	4	.	.	PUNCT
admet-3007	262	1	cscs	cscs	PROPN
admet-3007	262	2	have	have	AUX
admet-3007	262	3	been	be	AUX
admet-3007	262	4	recognized	recognize	VERB
admet-3007	262	5	as	as	ADP
admet-3007	262	6	key	key	ADJ
admet-3007	262	7	mediators	mediator	NOUN
admet-3007	262	8	of	of	ADP
admet-3007	262	9	metastasis	metastasis	NOUN
admet-3007	262	10	across	across	ADP
admet-3007	262	11	multiple	multiple	ADJ
admet-3007	262	12	tumour	tumour	ADJ
admet-3007	262	13	types	type	NOUN
admet-3007	262	14	,	,	PUNCT
admet-3007	262	15	including	include	VERB
admet-3007	262	16	brain	brain	NOUN
admet-3007	262	17	,	,	PUNCT
admet-3007	262	18	breast	breast	NOUN
admet-3007	262	19	,	,	PUNCT
admet-3007	262	20	uterine	uterine	ADJ
admet-3007	262	21	,	,	PUNCT
admet-3007	262	22	ovarian	ovarian	ADJ
admet-3007	262	23	,	,	PUNCT
admet-3007	262	24	and	and	CCONJ
admet-3007	262	25	pulmonary	pulmonary	ADJ
admet-3007	262	26	cancers	cancer	NOUN
admet-3007	262	27	.	.	PUNCT
admet-3007	263	1	these	these	DET
admet-3007	263	2	cells	cell	NOUN
admet-3007	263	3	often	often	ADV
admet-3007	263	4	exhibit	exhibit	VERB
admet-3007	263	5	remarkable	remarkable	ADJ
admet-3007	263	6	plasticity	plasticity	NOUN
admet-3007	263	7	and	and	CCONJ
admet-3007	263	8	adaptability	adaptability	NOUN
admet-3007	263	9	,	,	PUNCT
admet-3007	263	10	which	which	PRON
admet-3007	263	11	enable	enable	VERB
admet-3007	263	12	them	they	PRON
admet-3007	263	13	to	to	PART
admet-3007	263	14	endure	endure	VERB
admet-3007	263	15	the	the	DET
admet-3007	263	16	hostile	hostile	ADJ
admet-3007	263	17	microenvironments	microenvironment	NOUN
admet-3007	263	18	of	of	ADP
admet-3007	263	19	distant	distant	ADJ
admet-3007	263	20	organs	organ	NOUN
admet-3007	263	21	and	and	CCONJ
admet-3007	263	22	https://doi.org/10.5599/admet.3007	https://doi.org/10.5599/admet.3007	ADJ
admet-3007	263	23	m.	m.	NOUN
admet-3007	263	24	dehghani	dehghani	PROPN
admet-3007	263	25	et	et	PROPN
admet-3007	263	26	al	al	PROPN
admet-3007	263	27	.	.	PROPN
admet-3007	263	28	admet	admet	PROPN
admet-3007	263	29	&	&	CCONJ
admet-3007	263	30	dmpk	dmpk	PROPN
admet-3007	263	31	13(5	13(5	NUM
admet-3007	263	32	)	)	PUNCT
admet-3007	263	33	(	(	PUNCT
admet-3007	263	34	2025	2025	NUM
admet-3007	263	35	)	)	PUNCT
admet-3007	263	36	3007	3007	NUM
admet-3007	263	37	12	12	NUM
admet-3007	263	38	initiate	initiate	VERB
admet-3007	263	39	secondary	secondary	ADJ
admet-3007	263	40	tumour	tumour	NOUN
admet-3007	263	41	formation	formation	NOUN
admet-3007	263	42	.	.	PUNCT
admet-3007	264	1	the	the	DET
admet-3007	264	2	strong	strong	ADJ
admet-3007	264	3	association	association	NOUN
admet-3007	264	4	between	between	ADP
admet-3007	264	5	cscs	cscs	PROPN
admet-3007	264	6	and	and	CCONJ
admet-3007	264	7	metastasis	metastasis	NOUN
admet-3007	264	8	highlights	highlight	VERB
admet-3007	264	9	the	the	DET
admet-3007	264	10	urgent	urgent	ADJ
admet-3007	264	11	need	need	NOUN
admet-3007	264	12	for	for	ADP
admet-3007	264	13	therapies	therapy	NOUN
admet-3007	264	14	specifically	specifically	ADV
admet-3007	264	15	targeting	target	VERB
admet-3007	264	16	the	the	DET
admet-3007	264	17	metastatic	metastatic	ADJ
admet-3007	264	18	capabilities	capability	NOUN
admet-3007	264	19	of	of	ADP
admet-3007	264	20	these	these	DET
admet-3007	264	21	cells	cell	NOUN
admet-3007	264	22	[	[	X
admet-3007	264	23	82	82	NUM
admet-3007	264	24	]	]	PUNCT
admet-3007	264	25	.	.	PUNCT
admet-3007	265	1	targeting	target	VERB
admet-3007	265	2	csc	csc	PROPN
admet-3007	265	3	-	-	PUNCT
admet-3007	265	4	mediated	mediate	VERB
admet-3007	265	5	metastasis	metastasis	NOUN
admet-3007	265	6	offers	offer	VERB
admet-3007	265	7	promising	promise	VERB
admet-3007	265	8	therapeutic	therapeutic	ADJ
admet-3007	265	9	opportunities	opportunity	NOUN
admet-3007	265	10	.	.	PUNCT
admet-3007	266	1	potential	potential	ADJ
admet-3007	266	2	strategies	strategy	NOUN
admet-3007	266	3	include	include	VERB
admet-3007	266	4	inhibiting	inhibit	VERB
admet-3007	266	5	emt	emt	PROPN
admet-3007	266	6	,	,	PUNCT
admet-3007	266	7	downregulating	downregulating	NOUN
admet-3007	266	8	tnc	tnc	PROPN
admet-3007	266	9	expression	expression	NOUN
admet-3007	266	10	,	,	PUNCT
admet-3007	266	11	or	or	CCONJ
admet-3007	266	12	disrupting	disrupt	VERB
admet-3007	266	13	the	the	DET
admet-3007	266	14	metastatic	metastatic	ADJ
admet-3007	266	15	niche	niche	NOUN
admet-3007	266	16	.	.	PUNCT
admet-3007	267	1	by	by	ADP
admet-3007	267	2	effectively	effectively	ADV
admet-3007	267	3	suppressing	suppress	VERB
admet-3007	267	4	the	the	DET
admet-3007	267	5	metastatic	metastatic	ADJ
admet-3007	267	6	mechanisms	mechanism	NOUN
admet-3007	267	7	driven	drive	VERB
admet-3007	267	8	by	by	ADP
admet-3007	267	9	cscs	csc	NOUN
admet-3007	267	10	,	,	PUNCT
admet-3007	267	11	such	such	ADJ
admet-3007	267	12	approaches	approach	NOUN
admet-3007	267	13	could	could	AUX
admet-3007	267	14	improve	improve	VERB
admet-3007	267	15	treatment	treatment	NOUN
admet-3007	267	16	outcomes	outcome	NOUN
admet-3007	267	17	and	and	CCONJ
admet-3007	267	18	reduce	reduce	VERB
admet-3007	267	19	cancer	cancer	NOUN
admet-3007	267	20	recurrence	recurrence	NOUN
admet-3007	267	21	.	.	PUNCT
admet-3007	268	1	cancer	cancer	NOUN
admet-3007	268	2	treatment	treatment	NOUN
admet-3007	268	3	methods	method	NOUN
admet-3007	268	4	and	and	CCONJ
admet-3007	268	5	their	their	PRON
admet-3007	268	6	limitations	limitation	NOUN
admet-3007	268	7	chemotherapy	chemotherapy	NOUN
admet-3007	268	8	and	and	CCONJ
admet-3007	268	9	radiotherapy	radiotherapy	NOUN
admet-3007	268	10	remain	remain	VERB
admet-3007	268	11	two	two	NUM
admet-3007	268	12	of	of	ADP
admet-3007	268	13	the	the	DET
admet-3007	268	14	most	most	ADV
admet-3007	268	15	widely	widely	ADV
admet-3007	268	16	utilized	utilize	VERB
admet-3007	268	17	treatments	treatment	NOUN
admet-3007	268	18	for	for	ADP
admet-3007	268	19	cancer	cancer	NOUN
admet-3007	268	20	.	.	PUNCT
admet-3007	269	1	however	however	ADV
admet-3007	269	2	,	,	PUNCT
admet-3007	269	3	these	these	DET
admet-3007	269	4	conventional	conventional	ADJ
admet-3007	269	5	approaches	approach	NOUN
admet-3007	269	6	often	often	ADV
admet-3007	269	7	demonstrate	demonstrate	VERB
admet-3007	269	8	limited	limited	ADJ
admet-3007	269	9	efficacy	efficacy	NOUN
admet-3007	269	10	and	and	CCONJ
admet-3007	269	11	are	be	AUX
admet-3007	269	12	accompanied	accompany	VERB
admet-3007	269	13	by	by	ADP
admet-3007	269	14	substantial	substantial	ADJ
admet-3007	269	15	side	side	NOUN
admet-3007	269	16	effects	effect	NOUN
admet-3007	269	17	.	.	PUNCT
admet-3007	270	1	while	while	SCONJ
admet-3007	270	2	they	they	PRON
admet-3007	270	3	may	may	AUX
admet-3007	270	4	effectively	effectively	ADV
admet-3007	270	5	destroy	destroy	VERB
admet-3007	270	6	bulk	bulk	ADJ
admet-3007	270	7	tumour	tumour	NOUN
admet-3007	270	8	cells	cell	NOUN
admet-3007	270	9	,	,	PUNCT
admet-3007	270	10	they	they	PRON
admet-3007	270	11	typically	typically	ADV
admet-3007	270	12	fail	fail	VERB
admet-3007	270	13	to	to	PART
admet-3007	270	14	eradicate	eradicate	VERB
admet-3007	270	15	cscs	csc	NOUN
admet-3007	270	16	,	,	PUNCT
admet-3007	270	17	which	which	PRON
admet-3007	270	18	are	be	AUX
admet-3007	270	19	inherently	inherently	ADV
admet-3007	270	20	more	more	ADV
admet-3007	270	21	resistant	resistant	ADJ
admet-3007	270	22	to	to	ADP
admet-3007	270	23	such	such	ADJ
admet-3007	270	24	treatments	treatment	NOUN
admet-3007	270	25	.	.	PUNCT
admet-3007	271	1	csc	csc	PROPN
admet-3007	271	2	resistance	resistance	NOUN
admet-3007	271	3	is	be	AUX
admet-3007	271	4	attributed	attribute	VERB
admet-3007	271	5	to	to	ADP
admet-3007	271	6	mechanisms	mechanism	NOUN
admet-3007	271	7	such	such	ADJ
admet-3007	271	8	as	as	ADP
admet-3007	271	9	enhanced	enhanced	ADJ
admet-3007	271	10	dna	dna	PROPN
admet-3007	271	11	repair	repair	NOUN
admet-3007	271	12	capacity	capacity	NOUN
admet-3007	271	13	,	,	PUNCT
admet-3007	271	14	increased	increase	VERB
admet-3007	271	15	drug	drug	NOUN
admet-3007	271	16	efflux	efflux	NOUN
admet-3007	271	17	activity	activity	NOUN
admet-3007	271	18	,	,	PUNCT
admet-3007	271	19	and	and	CCONJ
admet-3007	271	20	activation	activation	NOUN
admet-3007	271	21	of	of	ADP
admet-3007	271	22	anti	anti	ADJ
admet-3007	271	23	-	-	ADJ
admet-3007	271	24	apoptotic	apoptotic	ADJ
admet-3007	271	25	pathways	pathway	NOUN
admet-3007	271	26	.	.	PUNCT
admet-3007	272	1	this	this	DET
admet-3007	272	2	therapeutic	therapeutic	ADJ
admet-3007	272	3	shortcoming	shortcoming	NOUN
admet-3007	272	4	significantly	significantly	ADV
admet-3007	272	5	compromises	compromise	VERB
admet-3007	272	6	the	the	DET
admet-3007	272	7	overall	overall	ADJ
admet-3007	272	8	success	success	NOUN
admet-3007	272	9	of	of	ADP
admet-3007	272	10	chemotherapy	chemotherapy	NOUN
admet-3007	272	11	and	and	CCONJ
admet-3007	272	12	radiotherapy	radiotherapy	NOUN
admet-3007	272	13	.	.	PUNCT
admet-3007	273	1	surgical	surgical	ADJ
admet-3007	273	2	intervention	intervention	NOUN
admet-3007	273	3	is	be	AUX
admet-3007	273	4	another	another	DET
admet-3007	273	5	standard	standard	ADJ
admet-3007	273	6	treatment	treatment	NOUN
admet-3007	273	7	modality	modality	NOUN
admet-3007	273	8	,	,	PUNCT
admet-3007	273	9	yet	yet	CCONJ
admet-3007	273	10	it	it	PRON
admet-3007	273	11	is	be	AUX
admet-3007	273	12	not	not	PART
admet-3007	273	13	devoid	devoid	ADJ
admet-3007	273	14	of	of	ADP
admet-3007	273	15	complications	complication	NOUN
admet-3007	273	16	.	.	PUNCT
admet-3007	274	1	postoperative	postoperative	ADJ
admet-3007	274	2	issues	issue	NOUN
admet-3007	274	3	,	,	PUNCT
admet-3007	274	4	including	include	VERB
admet-3007	274	5	infections	infection	NOUN
admet-3007	274	6	,	,	PUNCT
admet-3007	274	7	can	can	AUX
admet-3007	274	8	trigger	trigger	VERB
admet-3007	274	9	inflammatory	inflammatory	ADJ
admet-3007	274	10	responses	response	NOUN
admet-3007	274	11	that	that	PRON
admet-3007	274	12	may	may	AUX
admet-3007	274	13	inadvertently	inadvertently	ADV
admet-3007	274	14	promote	promote	VERB
admet-3007	274	15	tumour	tumour	NOUN
admet-3007	274	16	recurrence	recurrence	NOUN
admet-3007	274	17	.	.	PUNCT
admet-3007	275	1	this	this	PRON
admet-3007	275	2	is	be	AUX
admet-3007	275	3	largely	largely	ADV
admet-3007	275	4	mediated	mediate	VERB
admet-3007	275	5	by	by	ADP
admet-3007	275	6	the	the	DET
admet-3007	275	7	release	release	NOUN
admet-3007	275	8	of	of	ADP
admet-3007	275	9	pro	pro	ADJ
admet-3007	275	10	-	-	ADJ
admet-3007	275	11	inflammatory	inflammatory	ADJ
admet-3007	275	12	cytokines	cytokine	NOUN
admet-3007	275	13	and	and	CCONJ
admet-3007	275	14	growth	growth	NOUN
admet-3007	275	15	factors	factor	NOUN
admet-3007	275	16	that	that	PRON
admet-3007	275	17	enhance	enhance	VERB
admet-3007	275	18	cancer	cancer	NOUN
admet-3007	275	19	cell	cell	NOUN
admet-3007	275	20	survival	survival	NOUN
admet-3007	275	21	and	and	CCONJ
admet-3007	275	22	proliferation	proliferation	NOUN
admet-3007	275	23	[	[	X
admet-3007	275	24	83	83	NUM
admet-3007	275	25	]	]	PUNCT
admet-3007	275	26	.	.	PUNCT
admet-3007	276	1	the	the	DET
admet-3007	276	2	advent	advent	NOUN
admet-3007	276	3	of	of	ADP
admet-3007	276	4	cancer	cancer	NOUN
admet-3007	276	5	immunotherapy	immunotherapy	NOUN
admet-3007	276	6	in	in	ADP
admet-3007	276	7	2013	2013	NUM
admet-3007	276	8	marked	mark	VERB
admet-3007	276	9	a	a	DET
admet-3007	276	10	transformative	transformative	ADJ
admet-3007	276	11	milestone	milestone	NOUN
admet-3007	276	12	in	in	ADP
admet-3007	276	13	oncology	oncology	NOUN
admet-3007	276	14	.	.	PUNCT
admet-3007	277	1	this	this	DET
admet-3007	277	2	approach	approach	NOUN
admet-3007	277	3	leverages	leverage	VERB
admet-3007	277	4	the	the	DET
admet-3007	277	5	patient	patient	NOUN
admet-3007	277	6	’s	’s	PART
admet-3007	277	7	immune	immune	ADJ
admet-3007	277	8	system	system	NOUN
admet-3007	277	9	to	to	PART
admet-3007	277	10	recognize	recognize	VERB
admet-3007	277	11	and	and	CCONJ
admet-3007	277	12	eliminate	eliminate	VERB
admet-3007	277	13	cancer	cancer	NOUN
admet-3007	277	14	cells	cell	NOUN
admet-3007	277	15	,	,	PUNCT
admet-3007	277	16	offering	offer	VERB
admet-3007	277	17	new	new	ADJ
admet-3007	277	18	perspectives	perspective	NOUN
admet-3007	277	19	in	in	ADP
admet-3007	277	20	tumour	tumour	ADJ
admet-3007	277	21	immunology	immunology	NOUN
admet-3007	277	22	,	,	PUNCT
admet-3007	277	23	particularly	particularly	ADV
admet-3007	277	24	in	in	ADP
admet-3007	277	25	the	the	DET
admet-3007	277	26	identification	identification	NOUN
admet-3007	277	27	of	of	ADP
admet-3007	277	28	tumour	tumour	NOUN
admet-3007	277	29	-	-	PUNCT
admet-3007	277	30	specific	specific	ADJ
admet-3007	277	31	antigens	antigen	NOUN
admet-3007	277	32	and	and	CCONJ
admet-3007	277	33	the	the	DET
admet-3007	277	34	development	development	NOUN
admet-3007	277	35	of	of	ADP
admet-3007	277	36	targeted	target	VERB
admet-3007	277	37	immunotherapeutic	immunotherapeutic	ADJ
admet-3007	277	38	agents	agent	NOUN
admet-3007	277	39	[	[	X
admet-3007	277	40	84	84	NUM
admet-3007	277	41	]	]	PUNCT
admet-3007	277	42	.	.	PUNCT
admet-3007	278	1	despite	despite	SCONJ
admet-3007	278	2	its	its	PRON
admet-3007	278	3	revolutionary	revolutionary	ADJ
admet-3007	278	4	potential	potential	NOUN
admet-3007	278	5	,	,	PUNCT
admet-3007	278	6	immunotherapy	immunotherapy	NOUN
admet-3007	278	7	presents	present	NOUN
admet-3007	278	8	notable	notable	ADJ
admet-3007	278	9	challenges	challenge	NOUN
admet-3007	278	10	,	,	PUNCT
admet-3007	278	11	including	include	VERB
admet-3007	278	12	autoimmune	autoimmune	ADJ
admet-3007	278	13	reactions	reaction	NOUN
admet-3007	278	14	,	,	PUNCT
admet-3007	278	15	variable	variable	ADJ
admet-3007	278	16	clinical	clinical	ADJ
admet-3007	278	17	responses	response	NOUN
admet-3007	278	18	,	,	PUNCT
admet-3007	278	19	and	and	CCONJ
admet-3007	278	20	severe	severe	ADJ
admet-3007	278	21	adverse	adverse	ADJ
admet-3007	278	22	events	event	NOUN
admet-3007	278	23	such	such	ADJ
admet-3007	278	24	as	as	ADP
admet-3007	278	25	cytokine	cytokine	ADJ
admet-3007	278	26	storms	storm	NOUN
admet-3007	278	27	,	,	PUNCT
admet-3007	278	28	all	all	PRON
admet-3007	278	29	of	of	ADP
admet-3007	278	30	which	which	PRON
admet-3007	278	31	necessitate	necessitate	ADJ
admet-3007	278	32	further	further	ADJ
admet-3007	278	33	refinement	refinement	NOUN
admet-3007	278	34	and	and	CCONJ
admet-3007	278	35	personalized	personalized	ADJ
admet-3007	278	36	application	application	NOUN
admet-3007	278	37	[	[	X
admet-3007	278	38	85	85	NUM
admet-3007	278	39	]	]	PUNCT
admet-3007	278	40	.	.	PUNCT
admet-3007	279	1	hormone	hormone	NOUN
admet-3007	279	2	therapy	therapy	NOUN
admet-3007	279	3	represents	represent	VERB
admet-3007	279	4	an	an	DET
admet-3007	279	5	additional	additional	ADJ
admet-3007	279	6	strategy	strategy	NOUN
admet-3007	279	7	,	,	PUNCT
admet-3007	279	8	particularly	particularly	ADV
admet-3007	279	9	effective	effective	ADJ
admet-3007	279	10	for	for	ADP
admet-3007	279	11	hormone	hormone	NOUN
admet-3007	279	12	-	-	PUNCT
admet-3007	279	13	dependent	dependent	ADJ
admet-3007	279	14	malignancies	malignancy	NOUN
admet-3007	279	15	such	such	ADJ
admet-3007	279	16	as	as	ADP
admet-3007	279	17	breast	breast	NOUN
admet-3007	279	18	and	and	CCONJ
admet-3007	279	19	prostate	prostate	NOUN
admet-3007	279	20	cancers	cancer	NOUN
admet-3007	279	21	.	.	PUNCT
admet-3007	280	1	it	it	PRON
admet-3007	280	2	can	can	AUX
admet-3007	280	3	be	be	AUX
admet-3007	280	4	administered	administer	VERB
admet-3007	280	5	preoperatively	preoperatively	ADV
admet-3007	280	6	to	to	PART
admet-3007	280	7	reduce	reduce	VERB
admet-3007	280	8	tumour	tumour	NOUN
admet-3007	280	9	size	size	NOUN
admet-3007	280	10	or	or	CCONJ
admet-3007	280	11	as	as	ADP
admet-3007	280	12	an	an	DET
admet-3007	280	13	adjunct	adjunct	ADJ
admet-3007	280	14	to	to	PART
admet-3007	280	15	radiotherapy	radiotherapy	VERB
admet-3007	280	16	[	[	X
admet-3007	280	17	86	86	NUM
admet-3007	280	18	]	]	PUNCT
admet-3007	280	19	.	.	PUNCT
admet-3007	281	1	however	however	ADV
admet-3007	281	2	,	,	PUNCT
admet-3007	281	3	in	in	ADP
admet-3007	281	4	breast	breast	NOUN
admet-3007	281	5	cancer	cancer	NOUN
admet-3007	281	6	patients	patient	NOUN
admet-3007	281	7	,	,	PUNCT
admet-3007	281	8	hormone	hormone	NOUN
admet-3007	281	9	therapy	therapy	NOUN
admet-3007	281	10	frequently	frequently	ADV
admet-3007	281	11	induces	induce	VERB
admet-3007	281	12	a	a	DET
admet-3007	281	13	spectrum	spectrum	NOUN
admet-3007	281	14	of	of	ADP
admet-3007	281	15	undesirable	undesirable	ADJ
admet-3007	281	16	side	side	NOUN
admet-3007	281	17	effects	effect	NOUN
admet-3007	281	18	,	,	PUNCT
admet-3007	281	19	including	include	VERB
admet-3007	281	20	cognitive	cognitive	ADJ
admet-3007	281	21	dysfunction	dysfunction	NOUN
admet-3007	281	22	,	,	PUNCT
admet-3007	281	23	fatigue	fatigue	NOUN
admet-3007	281	24	,	,	PUNCT
admet-3007	281	25	hot	hot	ADJ
admet-3007	281	26	flashes	flash	NOUN
admet-3007	281	27	,	,	PUNCT
admet-3007	281	28	anxiety	anxiety	NOUN
admet-3007	281	29	,	,	PUNCT
admet-3007	281	30	insomnia	insomnia	NOUN
admet-3007	281	31	,	,	PUNCT
admet-3007	281	32	pain	pain	NOUN
admet-3007	281	33	,	,	PUNCT
admet-3007	281	34	and	and	CCONJ
admet-3007	281	35	weight	weight	NOUN
admet-3007	281	36	gain	gain	NOUN
admet-3007	281	37	[	[	X
admet-3007	281	38	87	87	NUM
admet-3007	281	39	]	]	PUNCT
admet-3007	281	40	.	.	PUNCT
admet-3007	282	1	photodynamic	photodynamic	ADJ
admet-3007	282	2	therapy	therapy	NOUN
admet-3007	282	3	(	(	PUNCT
admet-3007	282	4	pdt	pdt	PROPN
admet-3007	282	5	)	)	PUNCT
admet-3007	282	6	is	be	AUX
admet-3007	282	7	a	a	DET
admet-3007	282	8	non	non	ADJ
admet-3007	282	9	-	-	ADJ
admet-3007	282	10	invasive	invasive	ADJ
admet-3007	282	11	treatment	treatment	NOUN
admet-3007	282	12	that	that	PRON
admet-3007	282	13	has	have	AUX
admet-3007	282	14	shown	show	VERB
admet-3007	282	15	particular	particular	ADJ
admet-3007	282	16	efficacy	efficacy	NOUN
admet-3007	282	17	in	in	ADP
admet-3007	282	18	cutaneous	cutaneous	ADJ
admet-3007	282	19	malignancies	malignancy	NOUN
admet-3007	282	20	and	and	CCONJ
admet-3007	282	21	superficial	superficial	ADJ
admet-3007	282	22	epithelial	epithelial	ADJ
admet-3007	282	23	tumours	tumour	NOUN
admet-3007	282	24	.	.	PUNCT
admet-3007	283	1	pdt	pdt	PROPN
admet-3007	283	2	may	may	AUX
admet-3007	283	3	also	also	ADV
admet-3007	283	4	be	be	AUX
admet-3007	283	5	used	use	VERB
admet-3007	283	6	synergistically	synergistically	ADV
admet-3007	283	7	with	with	ADP
admet-3007	283	8	chemotherapy	chemotherapy	NOUN
admet-3007	283	9	,	,	PUNCT
admet-3007	283	10	radiotherapy	radiotherapy	NOUN
admet-3007	283	11	,	,	PUNCT
admet-3007	283	12	or	or	CCONJ
admet-3007	283	13	immunotherapy	immunotherapy	NOUN
admet-3007	283	14	to	to	PART
admet-3007	283	15	improve	improve	VERB
admet-3007	283	16	therapeutic	therapeutic	ADJ
admet-3007	283	17	outcomes	outcome	NOUN
admet-3007	284	1	[	[	X
admet-3007	284	2	88	88	NUM
admet-3007	284	3	]	]	PUNCT
admet-3007	284	4	.	.	PUNCT
admet-3007	285	1	gene	gene	NOUN
admet-3007	285	2	therapy	therapy	NOUN
admet-3007	285	3	offers	offer	VERB
admet-3007	285	4	another	another	DET
admet-3007	285	5	promising	promising	ADJ
admet-3007	285	6	frontier	frontier	NOUN
admet-3007	285	7	in	in	ADP
admet-3007	285	8	cancer	cancer	NOUN
admet-3007	285	9	treatment	treatment	NOUN
admet-3007	285	10	.	.	PUNCT
admet-3007	286	1	this	this	DET
admet-3007	286	2	technique	technique	NOUN
admet-3007	286	3	involves	involve	VERB
admet-3007	286	4	the	the	DET
admet-3007	286	5	delivery	delivery	NOUN
admet-3007	286	6	of	of	ADP
admet-3007	286	7	genetic	genetic	ADJ
admet-3007	286	8	material	material	NOUN
admet-3007	286	9	,	,	PUNCT
admet-3007	286	10	dna	dna	NOUN
admet-3007	286	11	or	or	CCONJ
admet-3007	286	12	rna	rna	PROPN
admet-3007	286	13	,	,	PUNCT
admet-3007	286	14	into	into	ADP
admet-3007	286	15	host	host	NOUN
admet-3007	286	16	cells	cell	NOUN
admet-3007	286	17	via	via	ADP
admet-3007	286	18	vectors	vector	NOUN
admet-3007	286	19	,	,	PUNCT
admet-3007	286	20	with	with	ADP
admet-3007	286	21	the	the	DET
admet-3007	286	22	aim	aim	NOUN
admet-3007	286	23	of	of	ADP
admet-3007	286	24	either	either	CCONJ
admet-3007	286	25	correcting	correct	VERB
admet-3007	286	26	genetic	genetic	ADJ
admet-3007	286	27	defects	defect	NOUN
admet-3007	286	28	or	or	CCONJ
admet-3007	286	29	silencing	silence	VERB
admet-3007	286	30	oncogenic	oncogenic	ADJ
admet-3007	286	31	pathways	pathway	NOUN
admet-3007	286	32	.	.	PUNCT
admet-3007	287	1	by	by	ADP
admet-3007	287	2	restoring	restore	VERB
admet-3007	287	3	the	the	DET
admet-3007	287	4	expression	expression	NOUN
admet-3007	287	5	of	of	ADP
admet-3007	287	6	therapeutic	therapeutic	ADJ
admet-3007	287	7	genes	gene	NOUN
admet-3007	287	8	or	or	CCONJ
admet-3007	287	9	inhibiting	inhibit	VERB
admet-3007	287	10	tumourpromoting	tumourpromoting	NOUN
admet-3007	287	11	genes	gene	NOUN
admet-3007	287	12	,	,	PUNCT
admet-3007	287	13	gene	gene	NOUN
admet-3007	287	14	therapy	therapy	NOUN
admet-3007	287	15	holds	hold	VERB
admet-3007	287	16	the	the	DET
admet-3007	287	17	potential	potential	NOUN
admet-3007	287	18	to	to	PART
admet-3007	287	19	significantly	significantly	ADV
admet-3007	287	20	enhance	enhance	VERB
admet-3007	287	21	clinical	clinical	ADJ
admet-3007	287	22	outcomes	outcome	NOUN
admet-3007	287	23	[	[	X
admet-3007	287	24	89	89	NUM
admet-3007	287	25	]	]	PUNCT
admet-3007	287	26	.	.	PUNCT
admet-3007	288	1	despite	despite	SCONJ
admet-3007	288	2	these	these	DET
admet-3007	288	3	advances	advance	NOUN
admet-3007	288	4	,	,	PUNCT
admet-3007	288	5	most	most	ADJ
admet-3007	288	6	of	of	ADP
admet-3007	288	7	these	these	DET
admet-3007	288	8	treatment	treatment	NOUN
admet-3007	288	9	modalities	modality	NOUN
admet-3007	288	10	are	be	AUX
admet-3007	288	11	largely	largely	ADV
admet-3007	288	12	ineffective	ineffective	ADJ
admet-3007	288	13	against	against	ADP
admet-3007	288	14	cscs	csc	NOUN
admet-3007	288	15	,	,	PUNCT
admet-3007	288	16	which	which	PRON
admet-3007	288	17	are	be	AUX
admet-3007	288	18	often	often	ADV
admet-3007	288	19	implicated	implicate	VERB
admet-3007	288	20	in	in	ADP
admet-3007	288	21	tumour	tumour	ADJ
admet-3007	288	22	relapse	relapse	NOUN
admet-3007	288	23	,	,	PUNCT
admet-3007	288	24	metastasis	metastasis	NOUN
admet-3007	288	25	,	,	PUNCT
admet-3007	288	26	and	and	CCONJ
admet-3007	288	27	resistance	resistance	NOUN
admet-3007	288	28	to	to	ADP
admet-3007	288	29	therapy	therapy	NOUN
admet-3007	288	30	.	.	PUNCT
admet-3007	289	1	in	in	ADP
admet-3007	289	2	this	this	DET
admet-3007	289	3	context	context	NOUN
admet-3007	289	4	,	,	PUNCT
admet-3007	289	5	nanotechnology	nanotechnology	NOUN
admet-3007	289	6	emerges	emerge	VERB
admet-3007	289	7	as	as	ADP
admet-3007	289	8	a	a	DET
admet-3007	289	9	powerful	powerful	ADJ
admet-3007	289	10	and	and	CCONJ
admet-3007	289	11	versatile	versatile	ADJ
admet-3007	289	12	platform	platform	NOUN
admet-3007	289	13	that	that	PRON
admet-3007	289	14	enables	enable	VERB
admet-3007	289	15	the	the	DET
admet-3007	289	16	development	development	NOUN
admet-3007	289	17	of	of	ADP
admet-3007	289	18	innovative	innovative	ADJ
admet-3007	289	19	strategies	strategy	NOUN
admet-3007	289	20	to	to	PART
admet-3007	289	21	specifically	specifically	ADV
admet-3007	289	22	target	target	VERB
admet-3007	289	23	and	and	CCONJ
admet-3007	289	24	eliminate	eliminate	VERB
admet-3007	289	25	cscs	cscs	NOUN
admet-3007	289	26	.	.	PUNCT
admet-3007	290	1	this	this	DET
admet-3007	290	2	technology	technology	NOUN
admet-3007	290	3	holds	hold	VERB
admet-3007	290	4	great	great	ADJ
admet-3007	290	5	promise	promise	NOUN
admet-3007	290	6	in	in	ADP
admet-3007	290	7	overcoming	overcome	VERB
admet-3007	290	8	the	the	DET
admet-3007	290	9	limitations	limitation	NOUN
admet-3007	290	10	of	of	ADP
admet-3007	290	11	conventional	conventional	ADJ
admet-3007	290	12	therapies	therapy	NOUN
admet-3007	290	13	and	and	CCONJ
admet-3007	290	14	advancing	advance	VERB
admet-3007	290	15	the	the	DET
admet-3007	290	16	efficacy	efficacy	NOUN
admet-3007	290	17	of	of	ADP
admet-3007	290	18	cancer	cancer	NOUN
admet-3007	290	19	treatment	treatment	NOUN
admet-3007	290	20	.	.	PUNCT
admet-3007	291	1	admet	admet	PROPN
admet-3007	291	2	&	&	CCONJ
admet-3007	291	3	dmpk	dmpk	PROPN
admet-3007	291	4	13(5	13(5	NUM
admet-3007	291	5	)	)	PUNCT
admet-3007	291	6	(	(	PUNCT
admet-3007	291	7	2025	2025	NUM
admet-3007	291	8	)	)	PUNCT
admet-3007	291	9	3007	3007	NUM
admet-3007	291	10	nano	nano	NOUN
admet-3007	291	11	-	-	PUNCT
admet-3007	291	12	biomaterials	biomaterial	NOUN
admet-3007	291	13	in	in	ADP
admet-3007	291	14	cancer	cancer	NOUN
admet-3007	291	15	therapy	therapy	NOUN
admet-3007	291	16	doi	doi	PROPN
admet-3007	291	17	:	:	PUNCT
admet-3007	291	18	https://doi.org/10.5599/admet.3007	https://doi.org/10.5599/admet.3007	NOUN
admet-3007	291	19	13	13	NUM
admet-3007	291	20	application	application	NOUN
admet-3007	291	21	of	of	ADP
admet-3007	291	22	nano	nano	NOUN
admet-3007	291	23	-	-	PUNCT
admet-3007	291	24	biomaterials	biomaterial	NOUN
admet-3007	291	25	in	in	ADP
admet-3007	291	26	targeting	target	VERB
admet-3007	291	27	cancer	cancer	NOUN
admet-3007	291	28	stem	stem	NOUN
admet-3007	291	29	cells	cell	NOUN
admet-3007	291	30	cancer	cancer	NOUN
admet-3007	291	31	stem	stem	NOUN
admet-3007	291	32	cells	cell	NOUN
admet-3007	291	33	(	(	PUNCT
admet-3007	291	34	cscs	cscs	PROPN
admet-3007	291	35	)	)	PUNCT
admet-3007	291	36	constitute	constitute	VERB
admet-3007	291	37	a	a	DET
admet-3007	291	38	small	small	ADJ
admet-3007	291	39	,	,	PUNCT
admet-3007	291	40	yet	yet	CCONJ
admet-3007	291	41	critical	critical	ADJ
admet-3007	291	42	subpopulation	subpopulation	NOUN
admet-3007	291	43	of	of	ADP
admet-3007	291	44	tumour	tumour	NOUN
admet-3007	291	45	cells	cell	NOUN
admet-3007	291	46	present	present	ADJ
admet-3007	291	47	in	in	ADP
admet-3007	291	48	both	both	CCONJ
admet-3007	291	49	solid	solid	ADJ
admet-3007	291	50	and	and	CCONJ
admet-3007	291	51	haematological	haematological	ADJ
admet-3007	291	52	malignancies	malignancy	NOUN
admet-3007	291	53	.	.	PUNCT
admet-3007	292	1	these	these	DET
admet-3007	292	2	cells	cell	NOUN
admet-3007	292	3	play	play	VERB
admet-3007	292	4	a	a	DET
admet-3007	292	5	pivotal	pivotal	ADJ
admet-3007	292	6	role	role	NOUN
admet-3007	292	7	in	in	ADP
admet-3007	292	8	therapy	therapy	NOUN
admet-3007	292	9	resistance	resistance	NOUN
admet-3007	292	10	,	,	PUNCT
admet-3007	292	11	metastasis	metastasis	NOUN
admet-3007	292	12	,	,	PUNCT
admet-3007	292	13	and	and	CCONJ
admet-3007	292	14	disease	disease	NOUN
admet-3007	292	15	relapse	relapse	NOUN
admet-3007	292	16	.	.	PUNCT
admet-3007	293	1	due	due	ADP
admet-3007	293	2	to	to	ADP
admet-3007	293	3	their	their	PRON
admet-3007	293	4	unique	unique	ADJ
admet-3007	293	5	properties	property	NOUN
admet-3007	293	6	,	,	PUNCT
admet-3007	293	7	including	include	VERB
admet-3007	293	8	self	self	NOUN
admet-3007	293	9	-	-	PUNCT
admet-3007	293	10	renewal	renewal	NOUN
admet-3007	293	11	and	and	CCONJ
admet-3007	293	12	differentiation	differentiation	NOUN
admet-3007	293	13	into	into	ADP
admet-3007	293	14	diverse	diverse	ADJ
admet-3007	293	15	tumour	tumour	NOUN
admet-3007	293	16	cell	cell	NOUN
admet-3007	293	17	types	type	NOUN
admet-3007	293	18	,	,	PUNCT
admet-3007	293	19	cscs	cscs	PROPN
admet-3007	293	20	often	often	ADV
admet-3007	293	21	exhibit	exhibit	VERB
admet-3007	293	22	resistance	resistance	NOUN
admet-3007	293	23	to	to	ADP
admet-3007	293	24	conventional	conventional	ADJ
admet-3007	293	25	cancer	cancer	NOUN
admet-3007	293	26	treatments	treatment	NOUN
admet-3007	293	27	,	,	PUNCT
admet-3007	293	28	making	make	VERB
admet-3007	293	29	them	they	PRON
admet-3007	293	30	an	an	DET
admet-3007	293	31	essential	essential	ADJ
admet-3007	293	32	target	target	NOUN
admet-3007	293	33	for	for	ADP
admet-3007	293	34	innovative	innovative	ADJ
admet-3007	293	35	therapeutic	therapeutic	ADJ
admet-3007	293	36	strategies	strategy	NOUN
admet-3007	293	37	[	[	X
admet-3007	293	38	90	90	NUM
admet-3007	293	39	]	]	PUNCT
admet-3007	293	40	.	.	PUNCT
admet-3007	294	1	therefore	therefore	ADV
admet-3007	294	2	,	,	PUNCT
admet-3007	294	3	there	there	PRON
admet-3007	294	4	is	be	VERB
admet-3007	294	5	an	an	DET
admet-3007	294	6	urgent	urgent	ADJ
admet-3007	294	7	need	need	NOUN
admet-3007	294	8	for	for	ADP
admet-3007	294	9	effective	effective	ADJ
admet-3007	294	10	therapeutic	therapeutic	ADJ
admet-3007	294	11	strategies	strategy	NOUN
admet-3007	294	12	that	that	PRON
admet-3007	294	13	can	can	AUX
admet-3007	294	14	selectively	selectively	ADV
admet-3007	294	15	target	target	VERB
admet-3007	294	16	cscs	csc	NOUN
admet-3007	294	17	,	,	PUNCT
admet-3007	294	18	which	which	PRON
admet-3007	294	19	highlights	highlight	VERB
admet-3007	294	20	the	the	DET
admet-3007	294	21	difference	difference	NOUN
admet-3007	294	22	between	between	ADP
admet-3007	294	23	conventional	conventional	ADJ
admet-3007	294	24	therapies	therapy	NOUN
admet-3007	294	25	and	and	CCONJ
admet-3007	294	26	approaches	approach	NOUN
admet-3007	294	27	specifically	specifically	ADV
admet-3007	294	28	designed	design	VERB
admet-3007	294	29	to	to	PART
admet-3007	294	30	eradicate	eradicate	VERB
admet-3007	294	31	these	these	DET
admet-3007	294	32	cells	cell	NOUN
admet-3007	294	33	.	.	PUNCT
admet-3007	295	1	in	in	ADP
admet-3007	295	2	recent	recent	ADJ
admet-3007	295	3	years	year	NOUN
admet-3007	295	4	,	,	PUNCT
admet-3007	295	5	nanotechnology	nanotechnology	NOUN
admet-3007	295	6	has	have	AUX
admet-3007	295	7	emerged	emerge	VERB
admet-3007	295	8	as	as	ADP
admet-3007	295	9	a	a	DET
admet-3007	295	10	promising	promising	ADJ
admet-3007	295	11	platform	platform	NOUN
admet-3007	295	12	for	for	ADP
admet-3007	295	13	targeting	target	VERB
admet-3007	295	14	cscs	cscs	NOUN
admet-3007	295	15	,	,	PUNCT
admet-3007	295	16	providing	provide	VERB
admet-3007	295	17	novel	novel	ADJ
admet-3007	295	18	diagnostic	diagnostic	ADJ
admet-3007	295	19	and	and	CCONJ
admet-3007	295	20	therapeutic	therapeutic	ADJ
admet-3007	295	21	opportunities	opportunity	NOUN
admet-3007	295	22	.	.	PUNCT
admet-3007	296	1	various	various	ADJ
admet-3007	296	2	nanomaterials	nanomaterial	NOUN
admet-3007	296	3	,	,	PUNCT
admet-3007	296	4	including	include	VERB
admet-3007	296	5	metallic	metallic	ADJ
admet-3007	296	6	and	and	CCONJ
admet-3007	296	7	metal	metal	NOUN
admet-3007	296	8	-	-	PUNCT
admet-3007	296	9	oxide	oxide	NOUN
admet-3007	296	10	based	base	VERB
admet-3007	296	11	nanoparticles	nanoparticle	NOUN
admet-3007	296	12	,	,	PUNCT
admet-3007	296	13	carbon	carbon	NOUN
admet-3007	296	14	-	-	PUNCT
admet-3007	296	15	based	base	VERB
admet-3007	296	16	nanomaterials	nanomaterial	NOUN
admet-3007	296	17	,	,	PUNCT
admet-3007	296	18	and	and	CCONJ
admet-3007	296	19	organic	organic	ADJ
admet-3007	296	20	nanoparticles	nanoparticle	NOUN
admet-3007	296	21	have	have	AUX
admet-3007	296	22	demonstrated	demonstrate	VERB
admet-3007	296	23	potential	potential	NOUN
admet-3007	296	24	in	in	ADP
admet-3007	296	25	overcoming	overcome	VERB
admet-3007	296	26	csc	csc	ADJ
admet-3007	296	27	-	-	PUNCT
admet-3007	296	28	associated	associate	VERB
admet-3007	296	29	challenges	challenge	NOUN
admet-3007	296	30	[	[	X
admet-3007	296	31	91	91	NUM
admet-3007	296	32	]	]	PUNCT
admet-3007	296	33	.	.	PUNCT
admet-3007	297	1	the	the	DET
admet-3007	297	2	unique	unique	ADJ
admet-3007	297	3	physicochemical	physicochemical	ADJ
admet-3007	297	4	properties	property	NOUN
admet-3007	297	5	of	of	ADP
admet-3007	297	6	these	these	DET
admet-3007	297	7	nanomaterials	nanomaterial	NOUN
admet-3007	297	8	allow	allow	VERB
admet-3007	297	9	them	they	PRON
admet-3007	297	10	to	to	PART
admet-3007	297	11	circumvent	circumvent	VERB
admet-3007	297	12	limitations	limitation	NOUN
admet-3007	297	13	of	of	ADP
admet-3007	297	14	traditional	traditional	ADJ
admet-3007	297	15	therapies	therapy	NOUN
admet-3007	297	16	,	,	PUNCT
admet-3007	297	17	such	such	ADJ
admet-3007	297	18	as	as	ADP
admet-3007	297	19	poor	poor	ADJ
admet-3007	297	20	drug	drug	NOUN
admet-3007	297	21	solubility	solubility	NOUN
admet-3007	297	22	,	,	PUNCT
admet-3007	297	23	non	non	ADJ
admet-3007	297	24	-	-	ADJ
admet-3007	297	25	specific	specific	ADJ
admet-3007	297	26	biodistribution	biodistribution	NOUN
admet-3007	297	27	,	,	PUNCT
admet-3007	297	28	and	and	CCONJ
admet-3007	297	29	limited	limited	ADJ
admet-3007	297	30	bioavailability	bioavailability	NOUN
admet-3007	297	31	.	.	PUNCT
admet-3007	298	1	furthermore	furthermore	ADV
admet-3007	298	2	,	,	PUNCT
admet-3007	298	3	by	by	ADP
admet-3007	298	4	specifically	specifically	ADV
admet-3007	298	5	targeting	target	VERB
admet-3007	298	6	cscs	csc	NOUN
admet-3007	298	7	,	,	PUNCT
admet-3007	298	8	nanomaterials	nanomaterial	NOUN
admet-3007	298	9	hold	hold	VERB
admet-3007	298	10	promise	promise	NOUN
admet-3007	298	11	to	to	PART
admet-3007	298	12	reduce	reduce	VERB
admet-3007	298	13	metastasis	metastasis	NOUN
admet-3007	298	14	and	and	CCONJ
admet-3007	298	15	cancer	cancer	NOUN
admet-3007	298	16	recurrence	recurrence	NOUN
admet-3007	298	17	,	,	PUNCT
admet-3007	298	18	thereby	thereby	ADV
admet-3007	298	19	improving	improve	VERB
admet-3007	298	20	patient	patient	ADJ
admet-3007	298	21	outcomes	outcome	NOUN
admet-3007	298	22	.	.	PUNCT
admet-3007	299	1	several	several	ADJ
admet-3007	299	2	nanomaterials	nanomaterial	NOUN
admet-3007	299	3	have	have	AUX
admet-3007	299	4	exhibited	exhibit	VERB
admet-3007	299	5	efficacy	efficacy	NOUN
admet-3007	299	6	in	in	ADP
admet-3007	299	7	preclinical	preclinical	ADJ
admet-3007	299	8	models	model	NOUN
admet-3007	299	9	for	for	ADP
admet-3007	299	10	csc	csc	PROPN
admet-3007	299	11	targeting	target	VERB
admet-3007	299	12	[	[	X
admet-3007	299	13	92	92	NUM
admet-3007	299	14	]	]	PUNCT
admet-3007	299	15	.	.	PUNCT
admet-3007	300	1	these	these	DET
admet-3007	300	2	materials	material	NOUN
admet-3007	300	3	,	,	PUNCT
admet-3007	300	4	along	along	ADP
admet-3007	300	5	with	with	ADP
admet-3007	300	6	their	their	PRON
admet-3007	300	7	applications	application	NOUN
admet-3007	300	8	in	in	ADP
admet-3007	300	9	both	both	DET
admet-3007	300	10	diagnostics	diagnostic	NOUN
admet-3007	300	11	and	and	CCONJ
admet-3007	300	12	therapeutics	therapeutic	NOUN
admet-3007	300	13	,	,	PUNCT
admet-3007	300	14	are	be	AUX
admet-3007	300	15	summarized	summarize	VERB
admet-3007	300	16	in	in	ADP
admet-3007	300	17	table	table	NOUN
admet-3007	300	18	2	2	NUM
admet-3007	300	19	.	.	PUNCT
admet-3007	301	1	also	also	ADV
admet-3007	301	2	,	,	PUNCT
admet-3007	301	3	the	the	DET
admet-3007	301	4	biological	biological	ADJ
admet-3007	301	5	effects	effect	NOUN
admet-3007	301	6	of	of	ADP
admet-3007	301	7	nanostructures	nanostructure	NOUN
admet-3007	301	8	on	on	ADP
admet-3007	301	9	cell	cell	NOUN
admet-3007	301	10	physiology	physiology	NOUN
admet-3007	301	11	are	be	AUX
admet-3007	301	12	shown	show	VERB
admet-3007	301	13	in	in	ADP
admet-3007	301	14	figure	figure	NOUN
admet-3007	301	15	4	4	NUM
admet-3007	301	16	.	.	PUNCT
admet-3007	301	17	table	table	NOUN
admet-3007	301	18	2	2	NUM
admet-3007	301	19	.	.	NUM
admet-3007	301	20	types	type	NOUN
admet-3007	301	21	of	of	ADP
admet-3007	301	22	nanostructures	nanostructure	NOUN
admet-3007	301	23	in	in	ADP
admet-3007	301	24	targeting	target	VERB
admet-3007	301	25	cancer	cancer	NOUN
admet-3007	301	26	stem	stem	NOUN
admet-3007	301	27	cells	cell	NOUN
admet-3007	301	28	.	.	PUNCT
admet-3007	302	1	types	type	NOUN
admet-3007	302	2	of	of	ADP
admet-3007	302	3	cscs	cscs	PROPN
admet-3007	302	4	origin	origin	NOUN
admet-3007	302	5	type	type	NOUN
admet-3007	302	6	of	of	ADP
admet-3007	302	7	nanostructure	nanostructure	NOUN
admet-3007	302	8	the	the	DET
admet-3007	302	9	biological	biological	ADJ
admet-3007	302	10	effect	effect	NOUN
admet-3007	302	11	of	of	ADP
admet-3007	302	12	nanostructure	nanostructure	PROPN
admet-3007	302	13	ref	ref	NOUN
admet-3007	302	14	.	.	PUNCT
admet-3007	303	1	breast	breast	NOUN
admet-3007	303	2	cancer	cancer	NOUN
admet-3007	303	3	au	au	VERB
admet-3007	303	4	nanoparticles	nanoparticle	NOUN
admet-3007	303	5	coated	coat	VERB
admet-3007	303	6	with	with	ADP
admet-3007	303	7	poly	poly	ADJ
admet-3007	303	8	(	(	PUNCT
admet-3007	303	9	ethylene	ethylene	NOUN
admet-3007	303	10	glycol	glycol	NOUN
admet-3007	303	11	)	)	PUNCT
admet-3007	303	12	,	,	PUNCT
admet-3007	303	13	loaded	load	VERB
admet-3007	303	14	with	with	ADP
admet-3007	303	15	salinomycin	salinomycin	NOUN
admet-3007	303	16	induce	induce	VERB
admet-3007	303	17	ferroptosis	ferroptosis	NOUN
admet-3007	303	18	and	and	CCONJ
admet-3007	303	19	oxidative	oxidative	ADJ
admet-3007	303	20	stress	stress	NOUN
admet-3007	303	21	[	[	X
admet-3007	303	22	93	93	NUM
admet-3007	303	23	]	]	PUNCT
admet-3007	303	24	head	head	NOUN
admet-3007	303	25	and	and	CCONJ
admet-3007	303	26	neck	neck	NOUN
admet-3007	303	27	cancer	cancer	NOUN
admet-3007	303	28	ag	ag	PROPN
admet-3007	303	29	nanoparticles	nanoparticle	NOUN
admet-3007	303	30	induce	induce	VERB
admet-3007	303	31	apoptosis	apoptosis	NOUN
admet-3007	303	32	by	by	ADP
admet-3007	303	33	stopping	stop	VERB
admet-3007	303	34	the	the	DET
admet-3007	303	35	cell	cell	NOUN
admet-3007	303	36	cycle	cycle	NOUN
admet-3007	303	37	[	[	X
admet-3007	303	38	94	94	NUM
admet-3007	303	39	]	]	SYM
admet-3007	303	40	pancreatic	pancreatic	ADJ
admet-3007	303	41	cancer	cancer	NOUN
admet-3007	303	42	cuo	cuo	PROPN
admet-3007	303	43	nanoparticles	nanoparticle	NOUN
admet-3007	303	44	induced	induce	VERB
admet-3007	303	45	apoptosis	apoptosis	NOUN
admet-3007	303	46	by	by	ADP
admet-3007	303	47	producing	produce	VERB
admet-3007	303	48	ros	ros	PROPN
admet-3007	303	49	[	[	X
admet-3007	303	50	95	95	NUM
admet-3007	303	51	]	]	PUNCT
admet-3007	303	52	breast	breast	NOUN
admet-3007	303	53	cancer	cancer	NOUN
admet-3007	303	54	zno	zno	NOUN
admet-3007	303	55	nanoparticles	nanoparticle	NOUN
admet-3007	303	56	induce	induce	VERB
admet-3007	303	57	apoptosis	apoptosis	NOUN
admet-3007	303	58	[	[	X
admet-3007	303	59	96	96	NUM
admet-3007	303	60	]	]	X
admet-3007	303	61	quiescent	quiescent	ADJ
admet-3007	303	62	colorectal	colorectal	ADJ
admet-3007	303	63	cscs	cscs	NOUN
admet-3007	303	64	iron	iron	NOUN
admet-3007	303	65	oxide	oxide	NOUN
admet-3007	303	66	nanoparticles	nanoparticle	NOUN
admet-3007	303	67	coated	coat	VERB
admet-3007	303	68	with	with	ADP
admet-3007	303	69	heatsensitive	heatsensitive	ADJ
admet-3007	303	70	polymer	polymer	NOUN
admet-3007	303	71	(	(	PUNCT
admet-3007	303	72	poly(degma	poly(degma	NOUN
admet-3007	303	73	-	-	PUNCT
admet-3007	303	74	copegma	copegma	NOUN
admet-3007	303	75	)	)	PUNCT
admet-3007	303	76	)	)	PUNCT
admet-3007	303	77	,	,	PUNCT
admet-3007	303	78	loaded	load	VERB
admet-3007	303	79	with	with	ADP
admet-3007	303	80	doxorubicin	doxorubicin	PROPN
admet-3007	303	81	magnetic	magnetic	PROPN
admet-3007	303	82	hyperthermia	hyperthermia	NOUN
admet-3007	303	83	in	in	ADP
admet-3007	303	84	combination	combination	NOUN
admet-3007	303	85	with	with	ADP
admet-3007	303	86	local	local	ADJ
admet-3007	303	87	chemotherapy	chemotherapy	NOUN
admet-3007	303	88	as	as	ADP
admet-3007	303	89	a	a	DET
admet-3007	303	90	dual	dual	ADJ
admet-3007	303	91	treatment	treatment	NOUN
admet-3007	303	92	inhibits	inhibit	VERB
admet-3007	303	93	dormant	dormant	ADJ
admet-3007	303	94	cscs	cscs	PROPN
admet-3007	303	95	[	[	X
admet-3007	303	96	97	97	NUM
admet-3007	303	97	]	]	X
admet-3007	303	98	ovarian	ovarian	ADJ
admet-3007	303	99	cancer	cancer	NOUN
admet-3007	303	100	spions	spion	NOUN
admet-3007	303	101	induce	induce	VERB
admet-3007	303	102	oxidative	oxidative	ADJ
admet-3007	303	103	stress	stress	NOUN
admet-3007	303	104	,	,	PUNCT
admet-3007	303	105	decrease	decrease	VERB
admet-3007	303	106	autophagy	autophagy	ADJ
admet-3007	303	107	activity	activity	NOUN
admet-3007	303	108	,	,	PUNCT
admet-3007	303	109	activate	activate	VERB
admet-3007	303	110	ferroptosis	ferroptosis	NOUN
admet-3007	303	111	,	,	PUNCT
admet-3007	303	112	inhibit	inhibit	VERB
admet-3007	303	113	proliferation	proliferation	NOUN
admet-3007	303	114	and	and	CCONJ
admet-3007	303	115	invasion	invasion	NOUN
admet-3007	303	116	,	,	PUNCT
admet-3007	303	117	decrease	decrease	VERB
admet-3007	303	118	drug	drug	NOUN
admet-3007	303	119	resistance	resistance	NOUN
admet-3007	303	120	and	and	CCONJ
admet-3007	303	121	tumorigenic	tumorigenic	ADJ
admet-3007	303	122	ability	ability	NOUN
admet-3007	303	123	by	by	ADP
admet-3007	303	124	producing	produce	VERB
admet-3007	303	125	ros	ros	PROPN
admet-3007	303	126	8	8	NUM
admet-3007	303	127	hominid	hominid	X
admet-3007	303	128	testicular	testicular	ADJ
admet-3007	303	129	embryonic	embryonic	ADJ
admet-3007	303	130	ag	ag	PROPN
admet-3007	303	131	nanoparticles	nanoparticle	NOUN
admet-3007	303	132	synthesized	synthesize	VERB
admet-3007	303	133	using	use	VERB
admet-3007	303	134	green	green	ADJ
admet-3007	303	135	tea	tea	NOUN
admet-3007	303	136	(	(	PUNCT
admet-3007	303	137	camellia	camellia	NOUN
admet-3007	303	138	sinensis	sinensis	NOUN
admet-3007	303	139	)	)	PUNCT
admet-3007	303	140	ag	ag	PROPN
admet-3007	303	141	nanoparticles	nanoparticle	NOUN
admet-3007	303	142	increase	increase	VERB
admet-3007	303	143	the	the	DET
admet-3007	303	144	expression	expression	NOUN
admet-3007	303	145	of	of	ADP
admet-3007	303	146	bcl2	bcl2	PROPN
admet-3007	303	147	,	,	PUNCT
admet-3007	303	148	bax	bax	PROPN
admet-3007	303	149	,	,	PUNCT
admet-3007	303	150	caspase	caspase	NOUN
admet-3007	303	151	3	3	NUM
admet-3007	303	152	and	and	CCONJ
admet-3007	303	153	9	9	NUM
admet-3007	303	154	,	,	PUNCT
admet-3007	303	155	p53	p53	NOUN
admet-3007	303	156	and	and	CCONJ
admet-3007	303	157	hspa2	hspa2	NOUN
admet-3007	303	158	genes	gene	NOUN
admet-3007	303	159	and	and	CCONJ
admet-3007	303	160	are	be	AUX
admet-3007	303	161	considered	consider	VERB
admet-3007	303	162	as	as	SCONJ
admet-3007	303	163	an	an	DET
admet-3007	303	164	apoptosis	apoptosis	NOUN
admet-3007	303	165	-	-	PUNCT
admet-3007	303	166	inducing	induce	VERB
admet-3007	303	167	complex	complex	NOUN
admet-3007	303	168	[	[	X
admet-3007	303	169	99	99	NUM
admet-3007	303	170	]	]	PUNCT
admet-3007	303	171	breast	breast	NOUN
admet-3007	303	172	cancer	cancer	NOUN
admet-3007	303	173	carbon	carbon	NOUN
admet-3007	303	174	nanotubes	nanotube	NOUN
admet-3007	303	175	hyperthermia	hyperthermia	NOUN
admet-3007	303	176	with	with	ADP
admet-3007	303	177	carbon	carbon	NOUN
admet-3007	303	178	nanotubes	nanotube	NOUN
admet-3007	303	179	causes	cause	VERB
admet-3007	303	180	more	more	ADJ
admet-3007	303	181	membrane	membrane	NOUN
admet-3007	303	182	permeability	permeability	NOUN
admet-3007	303	183	and	and	CCONJ
admet-3007	303	184	breast	breast	NOUN
admet-3007	303	185	cscs	cscs	PROPN
admet-3007	303	186	necrosis	necrosis	NOUN
admet-3007	303	187	[	[	X
admet-3007	303	188	100	100	NUM
admet-3007	303	189	]	]	PUNCT
admet-3007	303	190	ovarian	ovarian	ADJ
admet-3007	303	191	cancer	cancer	NOUN
admet-3007	303	192	go	go	VERB
admet-3007	303	193	-	-	PUNCT
admet-3007	303	194	ag	ag	NOUN
admet-3007	303	195	nanocomposite	nanocomposite	NOUN
admet-3007	303	196	generation	generation	NOUN
admet-3007	303	197	of	of	ADP
admet-3007	303	198	ros	ros	PROPN
admet-3007	303	199	,	,	PUNCT
admet-3007	303	200	leakage	leakage	NOUN
admet-3007	303	201	of	of	ADP
admet-3007	303	202	lactate	lactate	NOUN
admet-3007	303	203	dehydrogenase	dehydrogenase	NOUN
admet-3007	303	204	,	,	PUNCT
admet-3007	303	205	reduction	reduction	NOUN
admet-3007	303	206	of	of	ADP
admet-3007	303	207	mitochondrial	mitochondrial	ADJ
admet-3007	303	208	membrane	membrane	NOUN
admet-3007	303	209	potential	potential	NOUN
admet-3007	303	210	,	,	PUNCT
admet-3007	303	211	and	and	CCONJ
admet-3007	303	212	enhanced	enhance	VERB
admet-3007	303	213	expression	expression	NOUN
admet-3007	303	214	of	of	ADP
admet-3007	303	215	apoptotic	apoptotic	ADJ
admet-3007	303	216	genes	gene	NOUN
admet-3007	303	217	[	[	X
admet-3007	303	218	101	101	NUM
admet-3007	303	219	]	]	PUNCT
admet-3007	303	220	breast	breast	NOUN
admet-3007	303	221	cancer	cancer	NOUN
admet-3007	303	222	multi	multi	ADJ
admet-3007	303	223	-	-	ADJ
admet-3007	303	224	walled	walled	ADJ
admet-3007	303	225	carbon	carbon	NOUN
admet-3007	303	226	nanotubes	nanotube	NOUN
admet-3007	303	227	(	(	PUNCT
admet-3007	303	228	mwcnts	mwcnt	NOUN
admet-3007	303	229	)	)	PUNCT
admet-3007	303	230	with	with	ADP
admet-3007	303	231	fe3o4	fe3o4	NOUN
admet-3007	303	232	nanoparticles	nanoparticle	NOUN
admet-3007	303	233	on	on	ADP
admet-3007	303	234	the	the	DET
admet-3007	303	235	inner	inner	ADJ
admet-3007	303	236	and	and	CCONJ
admet-3007	303	237	au	au	ADJ
admet-3007	303	238	nanoparticles	nanoparticle	NOUN
admet-3007	303	239	on	on	ADP
admet-3007	303	240	the	the	DET
admet-3007	303	241	outer	outer	ADJ
admet-3007	303	242	surface	surface	NOUN
admet-3007	303	243	,	,	PUNCT
admet-3007	303	244	combined	combine	VERB
admet-3007	303	245	with	with	ADP
admet-3007	303	246	paclitaxel	paclitaxel	PROPN
admet-3007	303	247	induced	induce	VERB
admet-3007	303	248	apoptosis	apoptosis	NOUN
admet-3007	303	249	[	[	X
admet-3007	303	250	102	102	NUM
admet-3007	303	251	]	]	X
admet-3007	303	252	breast	breast	NOUN
admet-3007	303	253	cancer	cancer	NOUN
admet-3007	303	254	ph	ph	ADJ
admet-3007	303	255	-	-	ADJ
admet-3007	303	256	sensitive	sensitive	ADJ
admet-3007	303	257	liposomes	liposome	NOUN
admet-3007	303	258	loaded	load	VERB
admet-3007	303	259	with	with	ADP
admet-3007	303	260	bufalin	bufalin	PROPN
admet-3007	303	261	and	and	CCONJ
admet-3007	303	262	doxorubicin	doxorubicin	PROPN
admet-3007	303	263	inhibited	inhibit	VERB
admet-3007	303	264	tumorigenesis	tumorigenesis	NOUN
admet-3007	303	265	and	and	CCONJ
admet-3007	303	266	self	self	NOUN
admet-3007	303	267	-	-	PUNCT
admet-3007	303	268	renewal	renewal	NOUN
admet-3007	303	269	[	[	X
admet-3007	303	270	103	103	NUM
admet-3007	303	271	]	]	PUNCT
admet-3007	303	272	breast	breast	NOUN
admet-3007	303	273	cancer	cancer	NOUN
admet-3007	303	274	lipid	lipid	NOUN
admet-3007	303	275	nano	nano	NOUN
admet-3007	303	276	capsule	capsule	NOUN
admet-3007	303	277	containing	contain	VERB
admet-3007	303	278	the	the	DET
admet-3007	303	279	drugs	drug	NOUN
admet-3007	303	280	salinomycin	salinomycin	NOUN
admet-3007	303	281	and	and	CCONJ
admet-3007	303	282	paclitaxel	paclitaxel	PROPN
admet-3007	303	283	reduced	reduce	VERB
admet-3007	303	284	tumour	tumour	NOUN
admet-3007	303	285	growth	growth	NOUN
admet-3007	303	286	and	and	CCONJ
admet-3007	303	287	induced	induce	VERB
admet-3007	303	288	apoptosis	apoptosis	NOUN
admet-3007	303	289	[	[	X
admet-3007	303	290	104	104	NUM
admet-3007	303	291	]	]	SYM
admet-3007	303	292	pancreatic	pancreatic	ADJ
admet-3007	303	293	cancer	cancer	NOUN
admet-3007	303	294	nano	nano	NOUN
admet-3007	303	295	capsules	capsule	NOUN
admet-3007	303	296	loaded	load	VERB
admet-3007	303	297	with	with	ADP
admet-3007	303	298	paclitaxel	paclitaxel	ADJ
admet-3007	303	299	anti	anti	ADJ
admet-3007	303	300	-	-	ADJ
admet-3007	303	301	tumour	tumour	ADJ
admet-3007	303	302	effectiveness	effectiveness	NOUN
admet-3007	303	303	of	of	ADP
admet-3007	303	304	the	the	DET
admet-3007	303	305	drug	drug	NOUN
admet-3007	303	306	encapsulated	encapsulate	VERB
admet-3007	303	307	in	in	ADP
admet-3007	303	308	the	the	DET
admet-3007	303	309	nano	nano	NOUN
admet-3007	303	310	capsule	capsule	NOUN
admet-3007	303	311	was	be	AUX
admet-3007	303	312	four	four	NUM
admet-3007	303	313	times	time	NOUN
admet-3007	303	314	higher	high	ADJ
admet-3007	303	315	than	than	ADP
admet-3007	303	316	that	that	PRON
admet-3007	303	317	of	of	ADP
admet-3007	303	318	the	the	DET
admet-3007	303	319	free	free	ADJ
admet-3007	303	320	drug	drug	NOUN
admet-3007	304	1	[	[	X
admet-3007	304	2	105	105	NUM
admet-3007	304	3	]	]	PUNCT
admet-3007	304	4	cancer	cancer	NOUN
admet-3007	304	5	stem	stem	NOUN
admet-3007	304	6	-	-	PUNCT
admet-3007	304	7	like	like	ADJ
admet-3007	304	8	cells	cell	NOUN
admet-3007	304	9	chitosan	chitosan	NOUN
admet-3007	304	10	-	-	PUNCT
admet-3007	304	11	decorated	decorate	VERB
admet-3007	304	12	doxorubicinencapsulated	doxorubicinencapsulate	VERB
admet-3007	304	13	increases	increase	VERB
admet-3007	304	14	the	the	DET
admet-3007	304	15	cytotoxicity	cytotoxicity	NOUN
admet-3007	304	16	by	by	ADP
admet-3007	304	17	six	six	NUM
admet-3007	304	18	times	time	NOUN
admet-3007	304	19	[	[	X
admet-3007	304	20	106	106	NUM
admet-3007	304	21	]	]	X
admet-3007	304	22	pancreatic	pancreatic	ADJ
admet-3007	304	23	cancer	cancer	NOUN
admet-3007	304	24	plga	plga	NOUN
admet-3007	304	25	loaded	load	VERB
admet-3007	304	26	with	with	ADP
admet-3007	304	27	anthothecol	anthothecol	PROPN
admet-3007	304	28	prevented	prevent	VERB
admet-3007	304	29	cell	cell	NOUN
admet-3007	304	30	proliferation	proliferation	NOUN
admet-3007	304	31	and	and	CCONJ
admet-3007	304	32	colony	colony	NOUN
admet-3007	304	33	formation	formation	NOUN
admet-3007	304	34	and	and	CCONJ
admet-3007	304	35	induced	induce	VERB
admet-3007	304	36	apoptosis	apoptosis	NOUN
admet-3007	304	37	[	[	X
admet-3007	304	38	107	107	NUM
admet-3007	304	39	]	]	PUNCT
admet-3007	304	40	https://doi.org/10.5599/admet.3007	https://doi.org/10.5599/admet.3007	NOUN
admet-3007	304	41	m.	m.	NOUN
admet-3007	304	42	dehghani	dehghani	PROPN
admet-3007	304	43	et	et	PROPN
admet-3007	304	44	al	al	PROPN
admet-3007	304	45	.	.	PROPN
admet-3007	304	46	admet	admet	PROPN
admet-3007	304	47	&	&	CCONJ
admet-3007	304	48	dmpk	dmpk	PROPN
admet-3007	304	49	13(5	13(5	NUM
admet-3007	304	50	)	)	PUNCT
admet-3007	304	51	(	(	PUNCT
admet-3007	304	52	2025	2025	NUM
admet-3007	304	53	)	)	PUNCT
admet-3007	304	54	3007	3007	NUM
admet-3007	304	55	14	14	NUM
admet-3007	304	56	figure	figure	NOUN
admet-3007	304	57	4	4	NUM
admet-3007	304	58	.	.	PUNCT
admet-3007	304	59	biological	biological	ADJ
admet-3007	304	60	effects	effect	NOUN
admet-3007	304	61	of	of	ADP
admet-3007	304	62	nanostructures	nanostructure	NOUN
admet-3007	304	63	on	on	ADP
admet-3007	304	64	cancer	cancer	NOUN
admet-3007	304	65	stem	stem	NOUN
admet-3007	304	66	cell	cell	NOUN
admet-3007	304	67	physiology	physiology	NOUN
admet-3007	304	68	.	.	PUNCT
admet-3007	305	1	metal	metal	NOUN
admet-3007	305	2	-	-	PUNCT
admet-3007	305	3	based	base	VERB
admet-3007	305	4	nanomaterials	nanomaterial	NOUN
admet-3007	305	5	metal	metal	NOUN
admet-3007	305	6	-	-	PUNCT
admet-3007	305	7	based	base	VERB
admet-3007	305	8	nanoparticles	nanoparticle	NOUN
admet-3007	305	9	,	,	PUNCT
admet-3007	305	10	such	such	ADJ
admet-3007	305	11	as	as	ADP
admet-3007	305	12	copper	copper	NOUN
admet-3007	305	13	(	(	PUNCT
admet-3007	305	14	cu	cu	PROPN
admet-3007	305	15	)	)	PUNCT
admet-3007	305	16	,	,	PUNCT
admet-3007	305	17	gold	gold	NOUN
admet-3007	305	18	(	(	PUNCT
admet-3007	305	19	au	au	PROPN
admet-3007	305	20	)	)	PUNCT
admet-3007	305	21	,	,	PUNCT
admet-3007	305	22	silver	silver	NOUN
admet-3007	305	23	(	(	PUNCT
admet-3007	305	24	ag	ag	PROPN
admet-3007	305	25	)	)	PUNCT
admet-3007	305	26	,	,	PUNCT
admet-3007	305	27	titanium	titanium	NOUN
admet-3007	305	28	dioxide	dioxide	NOUN
admet-3007	305	29	(	(	PUNCT
admet-3007	305	30	tio₂	tio₂	PROPN
admet-3007	305	31	)	)	PUNCT
admet-3007	305	32	,	,	PUNCT
admet-3007	305	33	iron	iron	NOUN
admet-3007	305	34	oxide	oxide	NOUN
admet-3007	305	35	(	(	PUNCT
admet-3007	305	36	fe₃o₄	fe₃o₄	PROPN
admet-3007	305	37	)	)	PUNCT
admet-3007	305	38	,	,	PUNCT
admet-3007	305	39	manganese	manganese	ADJ
admet-3007	305	40	oxide	oxide	NOUN
admet-3007	305	41	(	(	PUNCT
admet-3007	305	42	mn₃o₄	mn₃o₄	NOUN
admet-3007	305	43	)	)	PUNCT
admet-3007	305	44	,	,	PUNCT
admet-3007	305	45	zinc	zinc	NOUN
admet-3007	305	46	oxide	oxide	NOUN
admet-3007	305	47	(	(	PUNCT
admet-3007	305	48	zno	zno	NOUN
admet-3007	305	49	)	)	PUNCT
admet-3007	305	50	,	,	PUNCT
admet-3007	305	51	and	and	CCONJ
admet-3007	305	52	magnesium	magnesium	NOUN
admet-3007	305	53	oxide	oxide	NOUN
admet-3007	305	54	(	(	PUNCT
admet-3007	305	55	mgo	mgo	PROPN
admet-3007	305	56	)	)	PUNCT
admet-3007	305	57	,	,	PUNCT
admet-3007	305	58	have	have	AUX
admet-3007	305	59	gained	gain	VERB
admet-3007	305	60	widespread	widespread	ADJ
admet-3007	305	61	application	application	NOUN
admet-3007	305	62	across	across	ADP
admet-3007	305	63	diverse	diverse	ADJ
admet-3007	305	64	fields	field	NOUN
admet-3007	305	65	including	include	VERB
admet-3007	305	66	industry	industry	NOUN
admet-3007	305	67	,	,	PUNCT
admet-3007	305	68	biomedicine	biomedicine	NOUN
admet-3007	305	69	,	,	PUNCT
admet-3007	305	70	wastewater	wastewater	NOUN
admet-3007	305	71	treatment	treatment	NOUN
admet-3007	305	72	,	,	PUNCT
admet-3007	305	73	pharmaceuticals	pharmaceutical	NOUN
admet-3007	305	74	,	,	PUNCT
admet-3007	305	75	cosmetics	cosmetic	NOUN
admet-3007	305	76	,	,	PUNCT
admet-3007	305	77	catalysis	catalysis	NOUN
admet-3007	305	78	,	,	PUNCT
admet-3007	305	79	and	and	CCONJ
admet-3007	305	80	energy	energy	NOUN
admet-3007	305	81	storage	storage	NOUN
admet-3007	305	82	[	[	X
admet-3007	305	83	108	108	NUM
admet-3007	305	84	-	-	SYM
admet-3007	305	85	111	111	NUM
admet-3007	305	86	]	]	PUNCT
admet-3007	305	87	.	.	PUNCT
admet-3007	306	1	in	in	ADP
admet-3007	306	2	biomedicine	biomedicine	NOUN
admet-3007	306	3	,	,	PUNCT
admet-3007	306	4	they	they	PRON
admet-3007	306	5	play	play	VERB
admet-3007	306	6	a	a	DET
admet-3007	306	7	prominent	prominent	ADJ
admet-3007	306	8	role	role	NOUN
admet-3007	306	9	in	in	ADP
admet-3007	306	10	disease	disease	NOUN
admet-3007	306	11	diagnosis	diagnosis	NOUN
admet-3007	306	12	(	(	PUNCT
admet-3007	306	13	e.g.	e.g.	ADV
admet-3007	306	14	imaging	imaging	NOUN
admet-3007	306	15	techniques	technique	NOUN
admet-3007	306	16	)	)	PUNCT
admet-3007	306	17	and	and	CCONJ
admet-3007	306	18	therapy	therapy	NOUN
admet-3007	306	19	(	(	PUNCT
admet-3007	306	20	e.g.	e.g.	ADV
admet-3007	306	21	,	,	PUNCT
admet-3007	306	22	targeted	target	VERB
admet-3007	306	23	drug	drug	NOUN
admet-3007	306	24	delivery	delivery	NOUN
admet-3007	306	25	,	,	PUNCT
admet-3007	306	26	photothermal	photothermal	ADJ
admet-3007	306	27	therapy	therapy	NOUN
admet-3007	306	28	,	,	PUNCT
admet-3007	306	29	and	and	CCONJ
admet-3007	306	30	hyperthermia	hyperthermia	NOUN
admet-3007	306	31	)	)	PUNCT
admet-3007	307	1	[	[	X
admet-3007	307	2	112	112	NUM
admet-3007	307	3	-	-	SYM
admet-3007	307	4	114	114	NUM
admet-3007	307	5	]	]	PUNCT
admet-3007	307	6	.	.	PUNCT
admet-3007	308	1	this	this	DET
admet-3007	308	2	section	section	NOUN
admet-3007	308	3	highlights	highlight	VERB
admet-3007	308	4	the	the	DET
admet-3007	308	5	application	application	NOUN
admet-3007	308	6	of	of	ADP
admet-3007	308	7	metal	metal	NOUN
admet-3007	308	8	-	-	PUNCT
admet-3007	308	9	based	base	VERB
admet-3007	308	10	nanoparticles	nanoparticle	NOUN
admet-3007	308	11	in	in	ADP
admet-3007	308	12	detecting	detect	VERB
admet-3007	308	13	and	and	CCONJ
admet-3007	308	14	eliminating	eliminate	VERB
admet-3007	308	15	cscs	cscs	PROPN
admet-3007	308	16	.	.	PUNCT
admet-3007	309	1	functionalized	functionalize	VERB
admet-3007	309	2	metallic	metallic	ADJ
admet-3007	309	3	nanoparticles	nanoparticle	NOUN
admet-3007	309	4	,	,	PUNCT
admet-3007	309	5	particularly	particularly	ADV
admet-3007	309	6	magnetic	magnetic	ADJ
admet-3007	309	7	and	and	CCONJ
admet-3007	309	8	gold	gold	NOUN
admet-3007	309	9	-	-	PUNCT
admet-3007	309	10	based	base	VERB
admet-3007	309	11	,	,	PUNCT
admet-3007	309	12	can	can	AUX
admet-3007	309	13	be	be	AUX
admet-3007	309	14	conjugated	conjugate	VERB
admet-3007	309	15	with	with	ADP
admet-3007	309	16	specific	specific	ADJ
admet-3007	309	17	antibodies	antibody	NOUN
admet-3007	309	18	or	or	CCONJ
admet-3007	309	19	ligands	ligand	NOUN
admet-3007	309	20	that	that	PRON
admet-3007	309	21	target	target	VERB
admet-3007	309	22	csc	csc	PROPN
admet-3007	309	23	surface	surface	NOUN
admet-3007	309	24	markers	marker	NOUN
admet-3007	309	25	such	such	ADJ
admet-3007	309	26	as	as	ADP
admet-3007	309	27	cd44	cd44	PROPN
admet-3007	309	28	,	,	PUNCT
admet-3007	309	29	cd133	cd133	PROPN
admet-3007	309	30	,	,	PUNCT
admet-3007	309	31	or	or	CCONJ
admet-3007	309	32	cd24	cd24	PROPN
admet-3007	309	33	.	.	PUNCT
admet-3007	310	1	these	these	DET
admet-3007	310	2	engineered	engineer	VERB
admet-3007	310	3	nanostructures	nanostructure	NOUN
admet-3007	310	4	enhance	enhance	VERB
admet-3007	310	5	csc	csc	PROPN
admet-3007	310	6	detection	detection	NOUN
admet-3007	310	7	through	through	ADP
admet-3007	310	8	improved	improve	VERB
admet-3007	310	9	imaging	imaging	NOUN
admet-3007	310	10	contrast	contrast	NOUN
admet-3007	310	11	(	(	PUNCT
admet-3007	310	12	e.g.	e.g.	ADV
admet-3007	310	13	mri	mri	NOUN
admet-3007	310	14	,	,	PUNCT
admet-3007	310	15	photoacoustic	photoacoustic	ADJ
admet-3007	310	16	,	,	PUNCT
admet-3007	310	17	or	or	CCONJ
admet-3007	310	18	fluorescence	fluorescence	NOUN
admet-3007	310	19	imaging	imaging	NOUN
admet-3007	310	20	)	)	PUNCT
admet-3007	310	21	or	or	CCONJ
admet-3007	310	22	via	via	ADP
admet-3007	310	23	magnetic	magnetic	ADJ
admet-3007	310	24	separation	separation	NOUN
admet-3007	310	25	techniques	technique	NOUN
admet-3007	310	26	.	.	PUNCT
admet-3007	311	1	for	for	ADP
admet-3007	311	2	instance	instance	NOUN
admet-3007	311	3	,	,	PUNCT
admet-3007	311	4	magnetic	magnetic	ADJ
admet-3007	311	5	nanoparticles	nanoparticle	NOUN
admet-3007	311	6	functionalized	functionalize	VERB
admet-3007	311	7	with	with	ADP
admet-3007	311	8	anti	anti	ADJ
admet-3007	311	9	-	-	ADJ
admet-3007	311	10	cd44	cd44	ADJ
admet-3007	311	11	antibodies	antibody	NOUN
admet-3007	311	12	have	have	AUX
admet-3007	311	13	been	be	AUX
admet-3007	311	14	successfully	successfully	ADV
admet-3007	311	15	used	use	VERB
admet-3007	311	16	to	to	PART
admet-3007	311	17	isolate	isolate	VERB
admet-3007	311	18	and	and	CCONJ
admet-3007	311	19	enrich	enrich	VERB
admet-3007	311	20	cscs	cscs	PROPN
admet-3007	311	21	from	from	ADP
admet-3007	311	22	head	head	NOUN
admet-3007	311	23	and	and	CCONJ
admet-3007	311	24	neck	neck	VERB
admet-3007	311	25	squamous	squamous	ADJ
admet-3007	311	26	cell	cell	NOUN
admet-3007	311	27	carcinoma	carcinoma	NOUN
admet-3007	311	28	(	(	PUNCT
admet-3007	311	29	hnscc	hnscc	NOUN
admet-3007	311	30	)	)	PUNCT
admet-3007	311	31	samples	sample	NOUN
admet-3007	311	32	.	.	PUNCT
admet-3007	312	1	in	in	ADP
admet-3007	312	2	this	this	DET
admet-3007	312	3	study	study	NOUN
admet-3007	312	4	,	,	PUNCT
admet-3007	312	5	a	a	DET
admet-3007	312	6	cd24	cd24	PROPN
admet-3007	312	7	-	-	PUNCT
admet-3007	312	8	gold	gold	NOUN
admet-3007	312	9	nanocomposite	nanocomposite	NOUN
admet-3007	312	10	demonstrated	demonstrate	VERB
admet-3007	312	11	enhanced	enhanced	ADJ
admet-3007	312	12	diagnostic	diagnostic	ADJ
admet-3007	312	13	and	and	CCONJ
admet-3007	312	14	prognostic	prognostic	ADJ
admet-3007	312	15	capabilities	capability	NOUN
admet-3007	312	16	in	in	ADP
admet-3007	312	17	detecting	detect	VERB
admet-3007	312	18	cscs	csc	NOUN
admet-3007	312	19	in	in	ADP
admet-3007	312	20	salivary	salivary	ADJ
admet-3007	312	21	gland	gland	NOUN
admet-3007	312	22	tumours	tumours	PROPN
admet-3007	312	23	,	,	PUNCT
admet-3007	312	24	outperforming	outperform	VERB
admet-3007	312	25	conventional	conventional	ADJ
admet-3007	312	26	diagnostic	diagnostic	ADJ
admet-3007	312	27	methods	method	NOUN
admet-3007	312	28	[	[	X
admet-3007	312	29	115	115	NUM
admet-3007	312	30	]	]	PUNCT
admet-3007	312	31	.	.	PUNCT
admet-3007	313	1	gold	gold	NOUN
admet-3007	313	2	nanoparticles	nanoparticle	NOUN
admet-3007	313	3	have	have	AUX
admet-3007	313	4	also	also	ADV
admet-3007	313	5	been	be	AUX
admet-3007	313	6	employed	employ	VERB
admet-3007	313	7	for	for	ADP
admet-3007	313	8	therapeutic	therapeutic	ADJ
admet-3007	313	9	purposes	purpose	NOUN
admet-3007	313	10	.	.	PUNCT
admet-3007	314	1	zhao	zhao	PROPN
admet-3007	314	2	et	et	PROPN
admet-3007	314	3	al	al	PROPN
admet-3007	314	4	.	.	PUNCT
admet-3007	315	1	[	[	X
admet-3007	315	2	93	93	NUM
admet-3007	315	3	]	]	PUNCT
admet-3007	315	4	conjugated	conjugate	VERB
admet-3007	315	5	salinomycin	salinomycin	PROPN
admet-3007	315	6	,	,	PUNCT
admet-3007	315	7	an	an	DET
admet-3007	315	8	antibiotic	antibiotic	NOUN
admet-3007	315	9	with	with	ADP
admet-3007	315	10	anti	anti	ADJ
admet-3007	315	11	-	-	ADJ
admet-3007	315	12	csc	csc	ADJ
admet-3007	315	13	activity	activity	NOUN
admet-3007	315	14	,	,	PUNCT
admet-3007	315	15	with	with	ADP
admet-3007	315	16	pegylated	pegylated	ADJ
admet-3007	315	17	gold	gold	NOUN
admet-3007	315	18	nanoparticles	nanoparticle	NOUN
admet-3007	315	19	.	.	PUNCT
admet-3007	316	1	the	the	DET
admet-3007	316	2	resulting	result	VERB
admet-3007	316	3	nanocomplex	nanocomplex	NOUN
admet-3007	316	4	selectively	selectively	ADV
admet-3007	316	5	targeted	target	VERB
admet-3007	316	6	breast	breast	NOUN
admet-3007	316	7	cscs	cscs	NOUN
admet-3007	316	8	,	,	PUNCT
admet-3007	316	9	inducing	induce	VERB
admet-3007	316	10	ferroptosis	ferroptosis	NOUN
admet-3007	316	11	and	and	CCONJ
admet-3007	316	12	oxidative	oxidative	ADJ
admet-3007	316	13	stress	stress	NOUN
admet-3007	316	14	.	.	PUNCT
admet-3007	317	1	kaur	kaur	PROPN
admet-3007	317	2	et	et	PROPN
admet-3007	317	3	al	al	PROPN
admet-3007	317	4	.	.	PUNCT
admet-3007	318	1	[	[	X
admet-3007	318	2	94	94	NUM
admet-3007	318	3	]	]	PUNCT
admet-3007	318	4	reported	report	VERB
admet-3007	318	5	that	that	SCONJ
admet-3007	318	6	silver	silver	ADJ
admet-3007	318	7	nanoparticles	nanoparticle	NOUN
admet-3007	318	8	could	could	AUX
admet-3007	318	9	trigger	trigger	VERB
admet-3007	318	10	apoptosis	apoptosis	NOUN
admet-3007	318	11	in	in	ADP
admet-3007	318	12	cscs	cscs	NOUN
admet-3007	318	13	derived	derive	VERB
admet-3007	318	14	from	from	ADP
admet-3007	318	15	head	head	NOUN
admet-3007	318	16	and	and	CCONJ
admet-3007	318	17	neck	neck	NOUN
admet-3007	318	18	cancers	cancer	NOUN
admet-3007	318	19	by	by	ADP
admet-3007	318	20	inducing	induce	VERB
admet-3007	318	21	cell	cell	NOUN
admet-3007	318	22	cycle	cycle	NOUN
admet-3007	318	23	arrest	arrest	NOUN
admet-3007	318	24	.	.	PUNCT
admet-3007	319	1	the	the	DET
admet-3007	319	2	study	study	NOUN
admet-3007	319	3	,	,	PUNCT
admet-3007	319	4	using	use	VERB
admet-3007	319	5	cscs	cscs	PROPN
admet-3007	319	6	from	from	ADP
admet-3007	319	7	the	the	DET
admet-3007	319	8	cal33	cal33	ADJ
admet-3007	319	9	cell	cell	NOUN
admet-3007	319	10	line	line	NOUN
admet-3007	319	11	,	,	PUNCT
admet-3007	319	12	found	find	VERB
admet-3007	319	13	that	that	SCONJ
admet-3007	319	14	relatively	relatively	ADV
admet-3007	319	15	high	high	ADJ
admet-3007	319	16	ic50	ic50	PROPN
admet-3007	319	17	values	value	NOUN
admet-3007	319	18	were	be	AUX
admet-3007	319	19	required	require	VERB
admet-3007	319	20	,	,	PUNCT
admet-3007	319	21	indicating	indicate	VERB
admet-3007	319	22	selective	selective	ADJ
admet-3007	319	23	cytotoxicity	cytotoxicity	NOUN
admet-3007	319	24	.	.	PUNCT
admet-3007	320	1	copper	copper	NOUN
admet-3007	320	2	oxide	oxide	NOUN
admet-3007	320	3	(	(	PUNCT
admet-3007	320	4	cuo	cuo	PROPN
admet-3007	320	5	)	)	PUNCT
admet-3007	320	6	nanoparticles	nanoparticle	NOUN
admet-3007	320	7	have	have	AUX
admet-3007	320	8	also	also	ADV
admet-3007	320	9	shown	show	VERB
admet-3007	320	10	promise	promise	NOUN
admet-3007	320	11	in	in	ADP
admet-3007	320	12	csc	csc	PROPN
admet-3007	320	13	inhibition	inhibition	NOUN
admet-3007	320	14	.	.	PUNCT
admet-3007	321	1	it	it	PRON
admet-3007	321	2	was	be	AUX
admet-3007	321	3	found	find	VERB
admet-3007	321	4	that	that	SCONJ
admet-3007	321	5	they	they	PRON
admet-3007	321	6	induce	induce	VERB
admet-3007	321	7	apoptosis	apoptosis	NOUN
admet-3007	321	8	in	in	ADP
admet-3007	321	9	pancreatic	pancreatic	ADJ
admet-3007	321	10	cscs	cscs	NOUN
admet-3007	321	11	through	through	ADP
admet-3007	321	12	the	the	DET
admet-3007	321	13	generation	generation	NOUN
admet-3007	321	14	of	of	ADP
admet-3007	321	15	ros	ros	PROPN
admet-3007	322	1	[	[	X
admet-3007	322	2	95	95	NUM
admet-3007	322	3	]	]	PUNCT
admet-3007	322	4	.	.	PUNCT
admet-3007	323	1	similarly	similarly	ADV
admet-3007	323	2	,	,	PUNCT
admet-3007	323	3	fakhroueian	fakhroueian	PROPN
admet-3007	323	4	et	et	PROPN
admet-3007	323	5	al	al	PROPN
admet-3007	323	6	.	.	PUNCT
admet-3007	324	1	[	[	X
admet-3007	324	2	96	96	NUM
admet-3007	324	3	]	]	PUNCT
admet-3007	324	4	demonstrated	demonstrate	VERB
admet-3007	324	5	that	that	SCONJ
admet-3007	324	6	zno	zno	NOUN
admet-3007	324	7	nanoparticles	nanoparticle	NOUN
admet-3007	324	8	effectively	effectively	ADV
admet-3007	324	9	induced	induce	VERB
admet-3007	324	10	apoptosis	apoptosis	NOUN
admet-3007	324	11	in	in	ADP
admet-3007	324	12	breast	breast	NOUN
admet-3007	324	13	cscs	cscs	PROPN
admet-3007	324	14	.	.	PUNCT
admet-3007	325	1	admet	admet	PROPN
admet-3007	325	2	&	&	CCONJ
admet-3007	325	3	dmpk	dmpk	PROPN
admet-3007	325	4	13(5	13(5	NUM
admet-3007	325	5	)	)	PUNCT
admet-3007	325	6	(	(	PUNCT
admet-3007	325	7	2025	2025	NUM
admet-3007	325	8	)	)	PUNCT
admet-3007	325	9	3007	3007	NUM
admet-3007	325	10	nano	nano	NOUN
admet-3007	325	11	-	-	PUNCT
admet-3007	325	12	biomaterials	biomaterial	NOUN
admet-3007	325	13	in	in	ADP
admet-3007	325	14	cancer	cancer	NOUN
admet-3007	325	15	therapy	therapy	NOUN
admet-3007	325	16	doi	doi	PROPN
admet-3007	325	17	:	:	PUNCT
admet-3007	325	18	https://doi.org/10.5599/admet.3007	https://doi.org/10.5599/admet.3007	NOUN
admet-3007	325	19	15	15	NUM
admet-3007	325	20	magnetic	magnetic	ADJ
admet-3007	325	21	nanoparticles	nanoparticle	NOUN
admet-3007	325	22	provide	provide	VERB
admet-3007	325	23	a	a	DET
admet-3007	325	24	novel	novel	ADJ
admet-3007	325	25	approach	approach	NOUN
admet-3007	325	26	to	to	ADP
admet-3007	325	27	csc	csc	PROPN
admet-3007	325	28	inhibition	inhibition	NOUN
admet-3007	325	29	via	via	ADP
admet-3007	325	30	magnetic	magnetic	ADJ
admet-3007	325	31	hyperthermia	hyperthermia	NOUN
admet-3007	325	32	.	.	PUNCT
admet-3007	326	1	superparamagnetic	superparamagnetic	ADJ
admet-3007	326	2	iron	iron	NOUN
admet-3007	326	3	oxide	oxide	NOUN
admet-3007	326	4	nanoparticles	nanoparticle	NOUN
admet-3007	326	5	(	(	PUNCT
admet-3007	326	6	spions	spion	NOUN
admet-3007	326	7	)	)	PUNCT
admet-3007	326	8	,	,	PUNCT
admet-3007	326	9	when	when	SCONJ
admet-3007	326	10	exposed	expose	VERB
admet-3007	326	11	to	to	ADP
admet-3007	326	12	alternating	alternate	VERB
admet-3007	326	13	magnetic	magnetic	ADJ
admet-3007	326	14	fields	field	NOUN
admet-3007	326	15	(	(	PUNCT
admet-3007	326	16	amfs	amfs	PROPN
admet-3007	326	17	)	)	PUNCT
admet-3007	326	18	,	,	PUNCT
admet-3007	326	19	produce	produce	VERB
admet-3007	326	20	localized	localized	ADJ
admet-3007	326	21	heating	heating	NOUN
admet-3007	326	22	in	in	ADP
admet-3007	326	23	tumour	tumour	ADJ
admet-3007	326	24	tissues	tissue	NOUN
admet-3007	326	25	[	[	X
admet-3007	326	26	116	116	X
admet-3007	326	27	]	]	PUNCT
admet-3007	326	28	.	.	PUNCT
admet-3007	327	1	the	the	DET
admet-3007	327	2	main	main	ADJ
admet-3007	327	3	advantage	advantage	NOUN
admet-3007	327	4	of	of	ADP
admet-3007	327	5	magnetic	magnetic	ADJ
admet-3007	327	6	hyperthermia	hyperthermia	NOUN
admet-3007	327	7	is	be	AUX
admet-3007	327	8	its	its	PRON
admet-3007	327	9	controllability	controllability	NOUN
admet-3007	327	10	,	,	PUNCT
admet-3007	327	11	as	as	SCONJ
admet-3007	327	12	the	the	DET
admet-3007	327	13	heating	heating	NOUN
admet-3007	327	14	rate	rate	NOUN
admet-3007	327	15	can	can	AUX
admet-3007	327	16	be	be	AUX
admet-3007	327	17	fine	fine	ADV
admet-3007	327	18	-	-	PUNCT
admet-3007	327	19	tuned	tune	VERB
admet-3007	327	20	by	by	ADP
admet-3007	327	21	adjusting	adjust	VERB
admet-3007	327	22	nanoparticle	nanoparticle	NOUN
admet-3007	327	23	size	size	NOUN
admet-3007	327	24	,	,	PUNCT
admet-3007	327	25	shape	shape	NOUN
admet-3007	327	26	and	and	CCONJ
admet-3007	327	27	amf	amf	PROPN
admet-3007	327	28	properties	property	NOUN
admet-3007	327	29	.	.	PUNCT
admet-3007	328	1	several	several	ADJ
admet-3007	328	2	preclinical	preclinical	ADJ
admet-3007	328	3	studies	study	NOUN
admet-3007	328	4	have	have	AUX
admet-3007	328	5	confirmed	confirm	VERB
admet-3007	328	6	the	the	DET
admet-3007	328	7	potential	potential	NOUN
admet-3007	328	8	of	of	ADP
admet-3007	328	9	magnetic	magnetic	ADJ
admet-3007	328	10	hyperthermia	hyperthermia	NOUN
admet-3007	328	11	in	in	ADP
admet-3007	328	12	cancer	cancer	NOUN
admet-3007	328	13	treatment	treatment	NOUN
admet-3007	328	14	[	[	X
admet-3007	328	15	117	117	NUM
admet-3007	328	16	]	]	PUNCT
admet-3007	328	17	.	.	PUNCT
admet-3007	329	1	for	for	ADP
admet-3007	329	2	example	example	NOUN
admet-3007	329	3	,	,	PUNCT
admet-3007	329	4	sadhukha	sadhukha	NOUN
admet-3007	329	5	et	et	PROPN
admet-3007	329	6	al	al	PROPN
admet-3007	329	7	.	.	PUNCT
admet-3007	330	1	[	[	X
admet-3007	330	2	118	118	NUM
admet-3007	330	3	]	]	PUNCT
admet-3007	330	4	demonstrated	demonstrate	VERB
admet-3007	330	5	that	that	SCONJ
admet-3007	330	6	magnetic	magnetic	ADJ
admet-3007	330	7	hyperthermia	hyperthermia	NOUN
admet-3007	330	8	using	use	VERB
admet-3007	330	9	spions	spion	NOUN
admet-3007	330	10	more	more	ADV
admet-3007	330	11	effectively	effectively	ADV
admet-3007	330	12	eradicated	eradicate	VERB
admet-3007	330	13	cscs	cscs	NOUN
admet-3007	330	14	in	in	ADP
admet-3007	330	15	breast	breast	NOUN
admet-3007	330	16	and	and	CCONJ
admet-3007	330	17	lung	lung	NOUN
admet-3007	330	18	cancer	cancer	NOUN
admet-3007	330	19	models	model	NOUN
admet-3007	330	20	compared	compare	VERB
admet-3007	330	21	to	to	ADP
admet-3007	330	22	conventional	conventional	ADJ
admet-3007	330	23	water	water	NOUN
admet-3007	330	24	-	-	PUNCT
admet-3007	330	25	bath	bath	NOUN
admet-3007	330	26	hyperthermia	hyperthermia	NOUN
admet-3007	330	27	,	,	PUNCT
admet-3007	330	28	resulting	result	VERB
admet-3007	330	29	in	in	ADP
admet-3007	330	30	both	both	CCONJ
admet-3007	330	31	necrosis	necrosis	NOUN
admet-3007	330	32	and	and	CCONJ
admet-3007	330	33	apoptosis	apoptosis	NOUN
admet-3007	330	34	.	.	PUNCT
admet-3007	331	1	further	further	ADJ
admet-3007	331	2	research	research	NOUN
admet-3007	331	3	by	by	ADP
admet-3007	331	4	fernandes	fernande	NOUN
admet-3007	331	5	et	et	PROPN
admet-3007	331	6	al	al	PROPN
admet-3007	331	7	.	.	PUNCT
admet-3007	332	1	[	[	X
admet-3007	332	2	97	97	NUM
admet-3007	332	3	]	]	PUNCT
admet-3007	332	4	explored	explore	VERB
admet-3007	332	5	combining	combine	VERB
admet-3007	332	6	magnetic	magnetic	ADJ
admet-3007	332	7	hyperthermia	hyperthermia	NOUN
admet-3007	332	8	with	with	SCONJ
admet-3007	332	9	local	local	ADJ
admet-3007	332	10	chemotherapy	chemotherapy	NOUN
admet-3007	332	11	to	to	PART
admet-3007	332	12	target	target	VERB
admet-3007	332	13	dormant	dormant	ADJ
admet-3007	332	14	colorectal	colorectal	ADJ
admet-3007	332	15	cscs	cscs	NOUN
admet-3007	332	16	.	.	PUNCT
admet-3007	333	1	in	in	ADP
admet-3007	333	2	this	this	DET
admet-3007	333	3	study	study	NOUN
admet-3007	333	4	,	,	PUNCT
admet-3007	333	5	cubic	cubic	ADJ
admet-3007	333	6	iron	iron	NOUN
admet-3007	333	7	oxide	oxide	NOUN
admet-3007	333	8	nanoparticles	nanoparticle	NOUN
admet-3007	333	9	were	be	AUX
admet-3007	333	10	coated	coat	VERB
admet-3007	333	11	with	with	ADP
admet-3007	333	12	a	a	DET
admet-3007	333	13	heat	heat	NOUN
admet-3007	333	14	-	-	PUNCT
admet-3007	333	15	sensitive	sensitive	ADJ
admet-3007	333	16	polymer	polymer	NOUN
admet-3007	333	17	(	(	PUNCT
admet-3007	333	18	poly(degma	poly(degma	PROPN
admet-3007	333	19	-	-	PUNCT
admet-3007	333	20	co	co	NOUN
admet-3007	333	21	-	-	NOUN
admet-3007	333	22	pegma	pegma	NOUN
admet-3007	333	23	)	)	PUNCT
admet-3007	333	24	)	)	PUNCT
admet-3007	333	25	and	and	CCONJ
admet-3007	333	26	loaded	load	VERB
admet-3007	333	27	with	with	ADP
admet-3007	333	28	dox	dox	NOUN
admet-3007	333	29	.	.	PUNCT
admet-3007	334	1	the	the	DET
admet-3007	334	2	polymer	polymer	NOUN
admet-3007	334	3	released	release	VERB
admet-3007	334	4	dox	dox	NOUN
admet-3007	334	5	at	at	ADP
admet-3007	334	6	temperatures	temperature	NOUN
admet-3007	334	7	above	above	ADP
admet-3007	334	8	44	44	NUM
admet-3007	334	9	°	°	NOUN
admet-3007	334	10	c	c	NOUN
admet-3007	334	11	,	,	PUNCT
admet-3007	334	12	causing	cause	VERB
admet-3007	334	13	dormant	dormant	ADJ
admet-3007	334	14	cscs	cscs	PROPN
admet-3007	334	15	to	to	PART
admet-3007	334	16	become	become	VERB
admet-3007	334	17	active	active	ADJ
admet-3007	334	18	.	.	PUNCT
admet-3007	335	1	once	once	ADV
admet-3007	335	2	activated	activate	VERB
admet-3007	335	3	,	,	PUNCT
admet-3007	335	4	the	the	DET
admet-3007	335	5	cscs	cscs	PROPN
admet-3007	335	6	absorbed	absorb	VERB
admet-3007	335	7	the	the	DET
admet-3007	335	8	released	release	VERB
admet-3007	335	9	dox	dox	NOUN
admet-3007	335	10	,	,	PUNCT
admet-3007	335	11	which	which	PRON
admet-3007	335	12	enhanced	enhance	VERB
admet-3007	335	13	the	the	DET
admet-3007	335	14	cytotoxic	cytotoxic	ADJ
admet-3007	335	15	effect	effect	NOUN
admet-3007	335	16	on	on	ADP
admet-3007	335	17	tumour	tumour	ADJ
admet-3007	335	18	cells	cell	NOUN
admet-3007	335	19	.	.	PUNCT
admet-3007	336	1	in	in	ADP
admet-3007	336	2	addition	addition	NOUN
admet-3007	336	3	to	to	ADP
admet-3007	336	4	magnetic	magnetic	ADJ
admet-3007	336	5	systems	system	NOUN
admet-3007	336	6	,	,	PUNCT
admet-3007	336	7	gold	gold	NOUN
admet-3007	336	8	nanoparticles	nanoparticle	NOUN
admet-3007	336	9	have	have	AUX
admet-3007	336	10	been	be	AUX
admet-3007	336	11	utilized	utilize	VERB
admet-3007	336	12	for	for	ADP
admet-3007	336	13	photothermal	photothermal	ADJ
admet-3007	336	14	hyperthermia	hyperthermia	NOUN
admet-3007	336	15	.	.	PUNCT
admet-3007	337	1	a	a	DET
admet-3007	337	2	study	study	NOUN
admet-3007	337	3	by	by	ADP
admet-3007	337	4	xu	xu	PROPN
admet-3007	337	5	et	et	PROPN
admet-3007	337	6	al	al	PROPN
admet-3007	337	7	.	.	PUNCT
admet-3007	338	1	[	[	X
admet-3007	338	2	119	119	NUM
admet-3007	338	3	]	]	PUNCT
admet-3007	338	4	showed	show	VERB
admet-3007	338	5	that	that	SCONJ
admet-3007	338	6	au	au	ADP
admet-3007	338	7	nanorods	nanorod	NOUN
admet-3007	338	8	,	,	PUNCT
admet-3007	338	9	upon	upon	SCONJ
admet-3007	338	10	exposure	exposure	NOUN
admet-3007	338	11	to	to	ADP
admet-3007	338	12	near	near	ADV
admet-3007	338	13	-	-	PUNCT
admet-3007	338	14	infrared	infrared	ADJ
admet-3007	338	15	(	(	PUNCT
admet-3007	338	16	nir	nir	ADJ
admet-3007	338	17	)	)	PUNCT
admet-3007	338	18	light	light	NOUN
admet-3007	338	19	,	,	PUNCT
admet-3007	338	20	generated	generate	VERB
admet-3007	338	21	localized	localized	ADJ
admet-3007	338	22	heat	heat	NOUN
admet-3007	338	23	sufficient	sufficient	ADJ
admet-3007	338	24	to	to	PART
admet-3007	338	25	eliminate	eliminate	VERB
admet-3007	338	26	breast	breast	NOUN
admet-3007	338	27	cscs	cscs	PROPN
admet-3007	338	28	.	.	PUNCT
admet-3007	339	1	the	the	DET
admet-3007	339	2	treatment	treatment	NOUN
admet-3007	339	3	led	lead	VERB
admet-3007	339	4	to	to	ADP
admet-3007	339	5	reduced	reduced	ADJ
admet-3007	339	6	expression	expression	NOUN
admet-3007	339	7	of	of	ADP
admet-3007	339	8	stemnessrelated	stemnessrelate	VERB
admet-3007	339	9	genes	gene	NOUN
admet-3007	339	10	such	such	ADJ
admet-3007	339	11	as	as	ADP
admet-3007	339	12	aldh1	aldh1	PROPN
admet-3007	339	13	and	and	CCONJ
admet-3007	339	14	klf4	klf4	PROPN
admet-3007	339	15	,	,	PUNCT
admet-3007	339	16	suggesting	suggest	VERB
admet-3007	339	17	effective	effective	ADJ
admet-3007	339	18	stem	stem	NOUN
admet-3007	339	19	cell	cell	NOUN
admet-3007	339	20	ablation	ablation	NOUN
admet-3007	339	21	.	.	PUNCT
admet-3007	340	1	carbon	carbon	NOUN
admet-3007	340	2	-	-	PUNCT
admet-3007	340	3	based	base	VERB
admet-3007	340	4	nanomaterials	nanomaterial	NOUN
admet-3007	340	5	carbon	carbon	NOUN
admet-3007	340	6	-	-	PUNCT
admet-3007	340	7	based	base	VERB
admet-3007	340	8	nanomaterials	nanomaterial	NOUN
admet-3007	340	9	(	(	PUNCT
admet-3007	340	10	cbns	cbns	NOUN
admet-3007	340	11	,	,	PUNCT
admet-3007	340	12	including	include	VERB
admet-3007	340	13	fullerenes	fullerene	NOUN
admet-3007	340	14	,	,	PUNCT
admet-3007	340	15	carbon	carbon	NOUN
admet-3007	340	16	nanotubes	nanotube	NOUN
admet-3007	340	17	(	(	PUNCT
admet-3007	340	18	cnts	cnts	PROPN
admet-3007	340	19	)	)	PUNCT
admet-3007	340	20	,	,	PUNCT
admet-3007	340	21	carbon	carbon	NOUN
admet-3007	340	22	nanofibers	nanofiber	NOUN
admet-3007	340	23	,	,	PUNCT
admet-3007	340	24	graphene	graphene	VERB
admet-3007	340	25	quantum	quantum	NOUN
admet-3007	340	26	dots	dot	NOUN
admet-3007	340	27	(	(	PUNCT
admet-3007	340	28	gqds	gqds	NOUN
admet-3007	340	29	)	)	PUNCT
admet-3007	340	30	,	,	PUNCT
admet-3007	340	31	graphene	graphene	ADJ
admet-3007	340	32	oxide	oxide	NOUN
admet-3007	340	33	(	(	PUNCT
admet-3007	340	34	go	go	VERB
admet-3007	340	35	)	)	PUNCT
admet-3007	340	36	,	,	PUNCT
admet-3007	340	37	and	and	CCONJ
admet-3007	340	38	nanodiamonds	nanodiamond	NOUN
admet-3007	340	39	)	)	PUNCT
admet-3007	340	40	possess	possess	VERB
admet-3007	340	41	unique	unique	ADJ
admet-3007	340	42	physical	physical	ADJ
admet-3007	340	43	and	and	CCONJ
admet-3007	340	44	chemical	chemical	NOUN
admet-3007	340	45	properties	property	NOUN
admet-3007	340	46	that	that	PRON
admet-3007	340	47	make	make	VERB
admet-3007	340	48	them	they	PRON
admet-3007	340	49	highly	highly	ADV
admet-3007	340	50	valuable	valuable	ADJ
admet-3007	340	51	in	in	ADP
admet-3007	340	52	biomedical	biomedical	ADJ
admet-3007	340	53	applications	application	NOUN
admet-3007	340	54	.	.	PUNCT
admet-3007	341	1	these	these	DET
admet-3007	341	2	materials	material	NOUN
admet-3007	341	3	are	be	AUX
admet-3007	341	4	widely	widely	ADV
admet-3007	341	5	used	use	VERB
admet-3007	341	6	in	in	ADP
admet-3007	341	7	fields	field	NOUN
admet-3007	341	8	such	such	ADJ
admet-3007	341	9	as	as	ADP
admet-3007	341	10	targeted	target	VERB
admet-3007	341	11	drug	drug	NOUN
admet-3007	341	12	delivery	delivery	NOUN
admet-3007	341	13	,	,	PUNCT
admet-3007	341	14	biomedical	biomedical	ADJ
admet-3007	341	15	imaging	imaging	NOUN
admet-3007	341	16	,	,	PUNCT
admet-3007	341	17	biosensors	biosensor	NOUN
admet-3007	341	18	,	,	PUNCT
admet-3007	341	19	tissue	tissue	NOUN
admet-3007	341	20	engineering	engineering	NOUN
admet-3007	341	21	,	,	PUNCT
admet-3007	341	22	and	and	CCONJ
admet-3007	341	23	cancer	cancer	NOUN
admet-3007	341	24	therapy	therapy	NOUN
admet-3007	341	25	,	,	PUNCT
admet-3007	341	26	including	include	VERB
admet-3007	341	27	the	the	DET
admet-3007	341	28	inhibition	inhibition	NOUN
admet-3007	341	29	of	of	ADP
admet-3007	341	30	cscs	cscs	NOUN
admet-3007	341	31	[	[	X
admet-3007	341	32	120,121	120,121	NUM
admet-3007	341	33	]	]	PUNCT
admet-3007	341	34	.	.	PUNCT
admet-3007	342	1	carbon	carbon	NOUN
admet-3007	342	2	-	-	PUNCT
admet-3007	342	3	based	base	VERB
admet-3007	342	4	nanomaterials	nanomaterial	NOUN
admet-3007	342	5	have	have	AUX
admet-3007	342	6	been	be	AUX
admet-3007	342	7	extensively	extensively	ADV
admet-3007	342	8	explored	explore	VERB
admet-3007	342	9	for	for	ADP
admet-3007	342	10	both	both	CCONJ
admet-3007	342	11	the	the	DET
admet-3007	342	12	detection	detection	NOUN
admet-3007	342	13	and	and	CCONJ
admet-3007	342	14	inhibition	inhibition	NOUN
admet-3007	342	15	of	of	ADP
admet-3007	342	16	cscs	cscs	NOUN
admet-3007	342	17	,	,	PUNCT
admet-3007	342	18	owing	owe	VERB
admet-3007	342	19	to	to	ADP
admet-3007	342	20	their	their	PRON
admet-3007	342	21	unique	unique	ADJ
admet-3007	342	22	physicochemical	physicochemical	ADJ
admet-3007	342	23	properties	property	NOUN
admet-3007	342	24	and	and	CCONJ
admet-3007	342	25	ability	ability	NOUN
admet-3007	342	26	to	to	PART
admet-3007	342	27	be	be	AUX
admet-3007	342	28	functionalized	functionalize	VERB
admet-3007	342	29	with	with	ADP
admet-3007	342	30	targeting	target	VERB
admet-3007	342	31	ligands	ligand	NOUN
admet-3007	342	32	such	such	ADJ
admet-3007	342	33	as	as	ADP
admet-3007	342	34	cd44	cd44	PROPN
admet-3007	342	35	antibodies	antibodie	VERB
admet-3007	342	36	.	.	PUNCT
admet-3007	343	1	for	for	ADP
admet-3007	343	2	example	example	NOUN
admet-3007	343	3	,	,	PUNCT
admet-3007	343	4	in	in	ADP
admet-3007	343	5	the	the	DET
admet-3007	343	6	study	study	NOUN
admet-3007	343	7	by	by	ADP
admet-3007	343	8	al	al	PROPN
admet-3007	343	9	faraj	faraj	PROPN
admet-3007	343	10	et	et	PROPN
admet-3007	343	11	al	al	PROPN
admet-3007	343	12	.	.	PUNCT
admet-3007	344	1	[	[	X
admet-3007	344	2	122	122	NUM
admet-3007	344	3	]	]	PUNCT
admet-3007	344	4	,	,	PUNCT
admet-3007	344	5	pegylated	pegylate	VERB
admet-3007	344	6	single	single	ADJ
admet-3007	344	7	-	-	PUNCT
admet-3007	344	8	walled	wall	VERB
admet-3007	344	9	carbon	carbon	NOUN
admet-3007	344	10	nanotubes	nanotube	NOUN
admet-3007	344	11	(	(	PUNCT
admet-3007	344	12	swcnts	swcnt	NOUN
admet-3007	344	13	)	)	PUNCT
admet-3007	344	14	were	be	AUX
admet-3007	344	15	conjugated	conjugate	VERB
admet-3007	344	16	with	with	ADP
admet-3007	344	17	superparamagnetic	superparamagnetic	ADJ
admet-3007	344	18	iron	iron	NOUN
admet-3007	344	19	oxide	oxide	NOUN
admet-3007	344	20	nanoparticles	nanoparticle	NOUN
admet-3007	344	21	(	(	PUNCT
admet-3007	344	22	spions	spion	NOUN
admet-3007	344	23	)	)	PUNCT
admet-3007	344	24	and	and	CCONJ
admet-3007	344	25	further	far	ADV
admet-3007	344	26	functionalized	functionalize	VERB
admet-3007	344	27	with	with	ADP
admet-3007	344	28	anti	anti	ADJ
admet-3007	344	29	-	-	ADJ
admet-3007	344	30	cd44	cd44	ADJ
admet-3007	344	31	antibodies	antibody	NOUN
admet-3007	344	32	to	to	PART
admet-3007	344	33	specifically	specifically	ADV
admet-3007	344	34	target	target	VERB
admet-3007	344	35	breast	breast	NOUN
admet-3007	344	36	cscs	cscs	NOUN
admet-3007	344	37	.	.	PUNCT
admet-3007	345	1	this	this	DET
admet-3007	345	2	multifunctional	multifunctional	ADJ
admet-3007	345	3	nanoplatform	nanoplatform	NOUN
admet-3007	345	4	enabled	enable	VERB
admet-3007	345	5	the	the	DET
admet-3007	345	6	dual	dual	ADJ
admet-3007	345	7	-	-	PUNCT
admet-3007	345	8	modal	modal	NOUN
admet-3007	345	9	imaging	imaging	NOUN
admet-3007	345	10	of	of	ADP
admet-3007	345	11	cscs	cscs	PROPN
admet-3007	345	12	using	use	VERB
admet-3007	345	13	both	both	CCONJ
admet-3007	345	14	near	near	ADV
admet-3007	345	15	-	-	PUNCT
admet-3007	345	16	infrared	infrared	ADJ
admet-3007	345	17	fluorescence	fluorescence	NOUN
admet-3007	345	18	imaging	imaging	NOUN
admet-3007	345	19	and	and	CCONJ
admet-3007	345	20	mri	mri	NOUN
admet-3007	345	21	.	.	PUNCT
admet-3007	346	1	the	the	DET
admet-3007	346	2	system	system	NOUN
admet-3007	346	3	demonstrated	demonstrate	VERB
admet-3007	346	4	high	high	ADJ
admet-3007	346	5	specificity	specificity	NOUN
admet-3007	346	6	and	and	CCONJ
admet-3007	346	7	accumulation	accumulation	NOUN
admet-3007	346	8	at	at	ADP
admet-3007	346	9	tumour	tumour	NOUN
admet-3007	346	10	sites	site	NOUN
admet-3007	346	11	overexpressing	overexpresse	VERB
admet-3007	346	12	cd44	cd44	PROPN
admet-3007	346	13	,	,	PUNCT
admet-3007	346	14	thereby	thereby	ADV
admet-3007	346	15	providing	provide	VERB
admet-3007	346	16	a	a	DET
admet-3007	346	17	promising	promising	ADJ
admet-3007	346	18	approach	approach	NOUN
admet-3007	346	19	for	for	ADP
admet-3007	346	20	the	the	DET
admet-3007	346	21	non	non	ADJ
admet-3007	346	22	-	-	ADJ
admet-3007	346	23	invasive	invasive	ADJ
admet-3007	346	24	detection	detection	NOUN
admet-3007	346	25	and	and	CCONJ
admet-3007	346	26	monitoring	monitoring	NOUN
admet-3007	346	27	of	of	ADP
admet-3007	346	28	cscs	cscs	PROPN
admet-3007	346	29	in	in	ADP
admet-3007	346	30	breast	breast	NOUN
admet-3007	346	31	cancer	cancer	NOUN
admet-3007	346	32	.	.	PUNCT
admet-3007	347	1	also	also	ADV
admet-3007	347	2	,	,	PUNCT
admet-3007	347	3	carbon	carbon	NOUN
admet-3007	347	4	-	-	PUNCT
admet-3007	347	5	based	base	VERB
admet-3007	347	6	nanomaterials	nanomaterial	NOUN
admet-3007	347	7	have	have	AUX
admet-3007	347	8	emerged	emerge	VERB
admet-3007	347	9	as	as	ADP
admet-3007	347	10	promising	promise	VERB
admet-3007	347	11	platforms	platform	NOUN
admet-3007	347	12	for	for	ADP
admet-3007	347	13	the	the	DET
admet-3007	347	14	suppression	suppression	NOUN
admet-3007	347	15	of	of	ADP
admet-3007	347	16	cscs	cscs	PROPN
admet-3007	347	17	.	.	PUNCT
admet-3007	348	1	burke	burke	PROPN
admet-3007	348	2	et	et	PROPN
admet-3007	348	3	al	al	PROPN
admet-3007	348	4	.	.	PUNCT
admet-3007	349	1	[	[	X
admet-3007	349	2	100	100	NUM
admet-3007	349	3	]	]	PUNCT
admet-3007	349	4	utilized	utilize	VERB
admet-3007	349	5	carbon	carbon	NOUN
admet-3007	349	6	nanotube	nanotube	NOUN
admet-3007	349	7	-	-	PUNCT
admet-3007	349	8	mediated	mediate	VERB
admet-3007	349	9	hyperthermia	hyperthermia	NOUN
admet-3007	349	10	to	to	PART
admet-3007	349	11	target	target	VERB
admet-3007	349	12	breast	breast	NOUN
admet-3007	349	13	cscs	cscs	NOUN
admet-3007	349	14	.	.	PUNCT
admet-3007	350	1	their	their	PRON
admet-3007	350	2	results	result	NOUN
admet-3007	350	3	demonstrated	demonstrate	VERB
admet-3007	350	4	that	that	SCONJ
admet-3007	350	5	thermal	thermal	ADJ
admet-3007	350	6	treatment	treatment	NOUN
admet-3007	350	7	enhanced	enhance	VERB
admet-3007	350	8	membrane	membrane	NOUN
admet-3007	350	9	permeability	permeability	NOUN
admet-3007	350	10	and	and	CCONJ
admet-3007	350	11	induced	induce	VERB
admet-3007	350	12	necrosis	necrosis	NOUN
admet-3007	350	13	in	in	ADP
admet-3007	350	14	these	these	DET
admet-3007	350	15	cells	cell	NOUN
admet-3007	350	16	.	.	PUNCT
admet-3007	351	1	in	in	ADP
admet-3007	351	2	another	another	DET
admet-3007	351	3	study	study	NOUN
admet-3007	351	4	,	,	PUNCT
admet-3007	351	5	choi	choi	PROPN
admet-3007	351	6	et	et	PROPN
admet-3007	351	7	al	al	PROPN
admet-3007	351	8	.	.	PUNCT
admet-3007	352	1	[	[	X
admet-3007	352	2	101	101	NUM
admet-3007	352	3	]	]	PUNCT
admet-3007	352	4	developed	develop	VERB
admet-3007	352	5	a	a	DET
admet-3007	352	6	graphene	graphene	ADJ
admet-3007	352	7	oxide	oxide	NOUN
admet-3007	352	8	-	-	PUNCT
admet-3007	352	9	silver	silver	NOUN
admet-3007	352	10	(	(	PUNCT
admet-3007	352	11	go	go	VERB
admet-3007	352	12	-	-	PUNCT
admet-3007	352	13	ag	ag	NOUN
admet-3007	352	14	)	)	PUNCT
admet-3007	352	15	nanocomposite	nanocomposite	NOUN
admet-3007	352	16	that	that	PRON
admet-3007	352	17	exhibited	exhibit	VERB
admet-3007	352	18	significant	significant	ADJ
admet-3007	352	19	cytotoxicity	cytotoxicity	NOUN
admet-3007	352	20	against	against	ADP
admet-3007	352	21	ovarian	ovarian	ADJ
admet-3007	352	22	cscs	cscs	NOUN
admet-3007	352	23	by	by	ADP
admet-3007	352	24	increasing	increase	VERB
admet-3007	352	25	ros	ros	PROPN
admet-3007	352	26	generation	generation	NOUN
admet-3007	352	27	,	,	PUNCT
admet-3007	352	28	inducing	induce	VERB
admet-3007	352	29	lactate	lactate	NOUN
admet-3007	352	30	dehydrogenase	dehydrogenase	NOUN
admet-3007	352	31	(	(	PUNCT
admet-3007	352	32	ldh	ldh	NOUN
admet-3007	352	33	)	)	PUNCT
admet-3007	352	34	leakage	leakage	NOUN
admet-3007	352	35	,	,	PUNCT
admet-3007	352	36	disrupting	disrupt	VERB
admet-3007	352	37	mitochondrial	mitochondrial	ADJ
admet-3007	352	38	membrane	membrane	NOUN
admet-3007	352	39	potential	potential	NOUN
admet-3007	352	40	,	,	PUNCT
admet-3007	352	41	and	and	CCONJ
admet-3007	352	42	upregulating	upregulating	ADJ
admet-3007	352	43	apoptotic	apoptotic	ADJ
admet-3007	352	44	gene	gene	NOUN
admet-3007	352	45	expression	expression	NOUN
admet-3007	352	46	.	.	PUNCT
admet-3007	353	1	notably	notably	ADV
admet-3007	353	2	,	,	PUNCT
admet-3007	353	3	its	its	PRON
admet-3007	353	4	combination	combination	NOUN
admet-3007	353	5	with	with	ADP
admet-3007	353	6	salinomycin	salinomycin	NOUN
admet-3007	353	7	enhanced	enhance	VERB
admet-3007	353	8	the	the	DET
admet-3007	353	9	apoptotic	apoptotic	ADJ
admet-3007	353	10	response	response	NOUN
admet-3007	353	11	by	by	ADP
admet-3007	353	12	fivefold	fivefold	ADV
admet-3007	353	13	compared	compare	VERB
admet-3007	353	14	to	to	ADP
admet-3007	353	15	individual	individual	ADJ
admet-3007	353	16	treatments	treatment	NOUN
admet-3007	353	17	.	.	PUNCT
admet-3007	354	1	ghoderao	ghoderao	NOUN
admet-3007	354	2	et	et	PROPN
admet-3007	354	3	al	al	PROPN
admet-3007	354	4	.	.	PUNCT
admet-3007	355	1	[	[	X
admet-3007	355	2	102	102	NUM
admet-3007	355	3	]	]	PUNCT
admet-3007	355	4	reported	report	VERB
admet-3007	355	5	the	the	DET
admet-3007	355	6	synthesis	synthesis	NOUN
admet-3007	355	7	of	of	ADP
admet-3007	355	8	magnetic	magnetic	ADJ
admet-3007	355	9	multi	multi	ADJ
admet-3007	355	10	-	-	ADJ
admet-3007	355	11	walled	walled	ADJ
admet-3007	355	12	carbon	carbon	NOUN
admet-3007	355	13	nanotubes	nanotube	NOUN
admet-3007	355	14	(	(	PUNCT
admet-3007	355	15	mwcnts	mwcnt	NOUN
admet-3007	355	16	)	)	PUNCT
admet-3007	355	17	,	,	PUNCT
admet-3007	355	18	functionalized	functionalize	VERB
admet-3007	355	19	with	with	ADP
admet-3007	355	20	iron	iron	NOUN
admet-3007	355	21	oxide	oxide	NOUN
admet-3007	355	22	(	(	PUNCT
admet-3007	355	23	fe₃o₄	fe₃o₄	NOUN
admet-3007	355	24	)	)	PUNCT
admet-3007	355	25	nanoparticles	nanoparticle	NOUN
admet-3007	355	26	on	on	ADP
admet-3007	355	27	the	the	DET
admet-3007	355	28	inner	inner	ADJ
admet-3007	355	29	surface	surface	NOUN
admet-3007	355	30	and	and	CCONJ
admet-3007	355	31	gold	gold	NOUN
admet-3007	355	32	nanoparticles	nanoparticle	NOUN
admet-3007	355	33	on	on	ADP
admet-3007	355	34	the	the	DET
admet-3007	355	35	outer	outer	ADJ
admet-3007	355	36	surface	surface	NOUN
admet-3007	355	37	,	,	PUNCT
admet-3007	355	38	and	and	CCONJ
admet-3007	355	39	loaded	load	VERB
admet-3007	355	40	with	with	ADP
admet-3007	355	41	paclitaxel	paclitaxel	PROPN
admet-3007	355	42	(	(	PUNCT
admet-3007	355	43	ptx	ptx	NOUN
admet-3007	355	44	)	)	PUNCT
admet-3007	355	45	.	.	PUNCT
admet-3007	356	1	this	this	DET
admet-3007	356	2	multifunctional	multifunctional	ADJ
admet-3007	356	3	system	system	NOUN
admet-3007	356	4	effectively	effectively	ADV
admet-3007	356	5	suppressed	suppress	VERB
admet-3007	356	6	breast	breast	NOUN
admet-3007	356	7	cscs	cscs	NOUN
admet-3007	356	8	and	and	CCONJ
admet-3007	356	9	triggered	trigger	VERB
admet-3007	356	10	apoptosis	apoptosis	NOUN
admet-3007	356	11	.	.	PUNCT
admet-3007	356	12	https://doi.org/10.5599/admet.3007	https://doi.org/10.5599/admet.3007	PROPN
admet-3007	356	13	m.	m.	PROPN
admet-3007	356	14	dehghani	dehghani	PROPN
admet-3007	356	15	et	et	PROPN
admet-3007	356	16	al	al	PROPN
admet-3007	356	17	.	.	PROPN
admet-3007	356	18	admet	admet	PROPN
admet-3007	356	19	&	&	CCONJ
admet-3007	356	20	dmpk	dmpk	PROPN
admet-3007	356	21	13(5	13(5	NUM
admet-3007	356	22	)	)	PUNCT
admet-3007	356	23	(	(	PUNCT
admet-3007	356	24	2025	2025	NUM
admet-3007	356	25	)	)	PUNCT
admet-3007	356	26	3007	3007	NUM
admet-3007	356	27	16	16	NUM
admet-3007	356	28	likewise	likewise	ADV
admet-3007	356	29	,	,	PUNCT
admet-3007	356	30	miao	miao	PROPN
admet-3007	356	31	et	et	PROPN
admet-3007	356	32	al	al	PROPN
admet-3007	356	33	.	.	PUNCT
admet-3007	357	1	[	[	X
admet-3007	357	2	123	123	NUM
admet-3007	357	3	]	]	PUNCT
admet-3007	357	4	synthesized	synthesize	VERB
admet-3007	357	5	both	both	CCONJ
admet-3007	357	6	unmodified	unmodified	ADJ
admet-3007	357	7	(	(	PUNCT
admet-3007	357	8	swcnt	swcnt	ADJ
admet-3007	357	9	-	-	PUNCT
admet-3007	357	10	raw	raw	ADJ
admet-3007	357	11	)	)	PUNCT
admet-3007	357	12	and	and	CCONJ
admet-3007	357	13	modified	modify	VERB
admet-3007	357	14	(	(	PUNCT
admet-3007	357	15	swcnt	swcnt	PROPN
admet-3007	357	16	-	-	PUNCT
admet-3007	357	17	cooh	cooh	NOUN
admet-3007	357	18	)	)	PUNCT
admet-3007	357	19	single	single	ADJ
admet-3007	357	20	-	-	PUNCT
admet-3007	357	21	walled	wall	VERB
admet-3007	357	22	carbon	carbon	NOUN
admet-3007	357	23	nanotubes	nanotube	NOUN
admet-3007	357	24	.	.	PUNCT
admet-3007	358	1	these	these	DET
admet-3007	358	2	nanotubes	nanotube	NOUN
admet-3007	358	3	were	be	AUX
admet-3007	358	4	found	find	VERB
admet-3007	358	5	to	to	PART
admet-3007	358	6	inhibit	inhibit	VERB
admet-3007	358	7	the	the	DET
admet-3007	358	8	dedifferentiation	dedifferentiation	NOUN
admet-3007	358	9	of	of	ADP
admet-3007	358	10	osteosarcoma	osteosarcoma	ADJ
admet-3007	358	11	stem	stem	NOUN
admet-3007	358	12	cells	cell	NOUN
admet-3007	358	13	,	,	PUNCT
admet-3007	358	14	reduce	reduce	VERB
admet-3007	358	15	tumour	tumour	NOUN
admet-3007	358	16	growth	growth	NOUN
admet-3007	358	17	and	and	CCONJ
admet-3007	358	18	micro	micro	ADJ
admet-3007	358	19	vessel	vessel	NOUN
admet-3007	358	20	density	density	NOUN
admet-3007	358	21	,	,	PUNCT
admet-3007	358	22	limit	limit	VERB
admet-3007	358	23	the	the	DET
admet-3007	358	24	acquisition	acquisition	NOUN
admet-3007	358	25	of	of	ADP
admet-3007	358	26	stem	stem	NOUN
admet-3007	358	27	cell	cell	NOUN
admet-3007	358	28	phenotypes	phenotype	NOUN
admet-3007	358	29	,	,	PUNCT
admet-3007	358	30	and	and	CCONJ
admet-3007	358	31	enhance	enhance	VERB
admet-3007	358	32	apoptosis	apoptosis	NOUN
admet-3007	358	33	in	in	ADP
admet-3007	358	34	the	the	DET
admet-3007	358	35	osteosarcoma	osteosarcoma	ADJ
admet-3007	358	36	microenvironment	microenvironment	NOUN
admet-3007	358	37	.	.	PUNCT
admet-3007	359	1	organic	organic	ADJ
admet-3007	359	2	nanostructures	nanostructure	NOUN
admet-3007	359	3	organic	organic	ADJ
admet-3007	359	4	nanostructures	nanostructure	NOUN
admet-3007	359	5	,	,	PUNCT
admet-3007	359	6	including	include	VERB
admet-3007	359	7	micelles	micelle	NOUN
admet-3007	359	8	,	,	PUNCT
admet-3007	359	9	dendrimers	dendrimer	NOUN
admet-3007	359	10	,	,	PUNCT
admet-3007	359	11	liposomes	liposome	NOUN
admet-3007	359	12	,	,	PUNCT
admet-3007	359	13	nanogels	nanogel	NOUN
admet-3007	359	14	,	,	PUNCT
admet-3007	359	15	polymeric	polymeric	ADJ
admet-3007	359	16	nanoparticles	nanoparticle	NOUN
admet-3007	359	17	(	(	PUNCT
admet-3007	359	18	such	such	ADJ
admet-3007	359	19	as	as	ADP
admet-3007	359	20	nanospheres	nanosphere	NOUN
admet-3007	359	21	,	,	PUNCT
admet-3007	359	22	nano	nano	NOUN
admet-3007	359	23	capsules	capsule	NOUN
admet-3007	359	24	,	,	PUNCT
admet-3007	359	25	and	and	CCONJ
admet-3007	359	26	protein	protein	NOUN
admet-3007	359	27	-	-	PUNCT
admet-3007	359	28	based	base	VERB
admet-3007	359	29	nanocarriers	nanocarrier	NOUN
admet-3007	359	30	)	)	PUNCT
admet-3007	359	31	,	,	PUNCT
admet-3007	359	32	and	and	CCONJ
admet-3007	359	33	layered	layered	ADJ
admet-3007	359	34	biopolymers	biopolymer	NOUN
admet-3007	359	35	,	,	PUNCT
admet-3007	359	36	are	be	AUX
admet-3007	359	37	widely	widely	ADV
admet-3007	359	38	recognized	recognize	VERB
admet-3007	359	39	for	for	ADP
admet-3007	359	40	their	their	PRON
admet-3007	359	41	excellent	excellent	ADJ
admet-3007	359	42	biocompatibility	biocompatibility	NOUN
admet-3007	359	43	and	and	CCONJ
admet-3007	359	44	biodegradability	biodegradability	NOUN
admet-3007	359	45	[	[	X
admet-3007	359	46	124	124	NUM
admet-3007	359	47	]	]	PUNCT
admet-3007	359	48	.	.	PUNCT
admet-3007	360	1	in	in	ADP
admet-3007	360	2	recent	recent	ADJ
admet-3007	360	3	years	year	NOUN
admet-3007	360	4	,	,	PUNCT
admet-3007	360	5	these	these	DET
admet-3007	360	6	nanostructures	nanostructure	NOUN
admet-3007	360	7	have	have	AUX
admet-3007	360	8	shown	show	VERB
admet-3007	360	9	significant	significant	ADJ
admet-3007	360	10	promise	promise	NOUN
admet-3007	360	11	in	in	ADP
admet-3007	360	12	the	the	DET
admet-3007	360	13	detection	detection	NOUN
admet-3007	360	14	and	and	CCONJ
admet-3007	360	15	targeted	target	VERB
admet-3007	360	16	elimination	elimination	NOUN
admet-3007	360	17	of	of	ADP
admet-3007	360	18	cscs	cscs	PROPN
admet-3007	360	19	.	.	PUNCT
admet-3007	361	1	gao	gao	PROPN
admet-3007	361	2	et	et	PROPN
admet-3007	361	3	al	al	PROPN
admet-3007	361	4	.	.	PUNCT
admet-3007	362	1	[	[	X
admet-3007	362	2	125	125	NUM
admet-3007	362	3	]	]	PUNCT
admet-3007	362	4	developed	develop	VERB
admet-3007	362	5	ph	ph	ADJ
admet-3007	362	6	-	-	ADJ
admet-3007	362	7	sensitive	sensitive	ADJ
admet-3007	362	8	liposomes	liposome	NOUN
admet-3007	362	9	to	to	PART
admet-3007	362	10	target	target	VERB
admet-3007	362	11	breast	breast	NOUN
admet-3007	362	12	cscs	cscs	NOUN
admet-3007	362	13	using	use	VERB
admet-3007	362	14	trastuzumab	trastuzumab	NOUN
admet-3007	362	15	-	-	PUNCT
admet-3007	362	16	sensitive	sensitive	ADJ
admet-3007	362	17	and	and	CCONJ
admet-3007	362	18	resistant	resistant	ADJ
admet-3007	362	19	her2	her2	PROPN
admet-3007	362	20	+	+	CCONJ
admet-3007	362	21	breast	breast	NOUN
admet-3007	362	22	cancer	cancer	NOUN
admet-3007	362	23	models	model	NOUN
admet-3007	362	24	.	.	PUNCT
admet-3007	363	1	their	their	PRON
admet-3007	363	2	study	study	NOUN
admet-3007	363	3	showed	show	VERB
admet-3007	363	4	that	that	SCONJ
admet-3007	363	5	combining	combine	VERB
admet-3007	363	6	bufalin	bufalin	NOUN
admet-3007	363	7	and	and	CCONJ
admet-3007	363	8	dox	dox	NOUN
admet-3007	363	9	in	in	ADP
admet-3007	363	10	liposomes	liposome	NOUN
admet-3007	363	11	reduced	reduce	VERB
admet-3007	363	12	the	the	DET
admet-3007	363	13	breast	breast	NOUN
admet-3007	363	14	cscs	cscs	NOUN
admet-3007	363	15	population	population	NOUN
admet-3007	363	16	by	by	ADP
admet-3007	363	17	85	85	NUM
admet-3007	363	18	%	%	NOUN
admet-3007	363	19	and	and	CCONJ
admet-3007	363	20	inhibited	inhibit	VERB
admet-3007	363	21	both	both	DET
admet-3007	363	22	tumorigenesis	tumorigenesis	NOUN
admet-3007	363	23	and	and	CCONJ
admet-3007	363	24	self	self	NOUN
admet-3007	363	25	-	-	PUNCT
admet-3007	363	26	renewal	renewal	NOUN
admet-3007	363	27	,	,	PUNCT
admet-3007	363	28	though	though	SCONJ
admet-3007	363	29	it	it	PRON
admet-3007	363	30	had	have	VERB
admet-3007	363	31	little	little	ADJ
admet-3007	363	32	effect	effect	NOUN
admet-3007	363	33	on	on	ADP
admet-3007	363	34	cell	cell	NOUN
admet-3007	363	35	migration	migration	NOUN
admet-3007	363	36	and	and	CCONJ
admet-3007	363	37	invasiveness	invasiveness	NOUN
admet-3007	363	38	.	.	PUNCT
admet-3007	364	1	basu	basu	PROPN
admet-3007	364	2	et	et	PROPN
admet-3007	364	3	al	al	PROPN
admet-3007	364	4	.	.	PUNCT
admet-3007	365	1	[	[	X
admet-3007	365	2	104	104	NUM
admet-3007	365	3	]	]	PUNCT
admet-3007	365	4	used	use	VERB
admet-3007	365	5	lipid	lipid	NOUN
admet-3007	365	6	nano	nano	NOUN
admet-3007	365	7	capsules	capsule	NOUN
admet-3007	365	8	co	co	VERB
admet-3007	365	9	-	-	VERB
admet-3007	365	10	loaded	load	VERB
admet-3007	365	11	with	with	ADP
admet-3007	365	12	salinomycin	salinomycin	NOUN
admet-3007	365	13	and	and	CCONJ
admet-3007	365	14	paclitaxel	paclitaxel	PROPN
admet-3007	365	15	(	(	PUNCT
admet-3007	365	16	ptx	ptx	PROPN
admet-3007	365	17	)	)	PUNCT
admet-3007	365	18	to	to	PART
admet-3007	365	19	target	target	VERB
admet-3007	365	20	breast	breast	NOUN
admet-3007	365	21	cscs	cscs	NOUN
admet-3007	365	22	.	.	PUNCT
admet-3007	366	1	the	the	DET
admet-3007	366	2	simultaneous	simultaneous	ADJ
admet-3007	366	3	delivery	delivery	NOUN
admet-3007	366	4	of	of	ADP
admet-3007	366	5	these	these	DET
admet-3007	366	6	drugs	drug	NOUN
admet-3007	366	7	significantly	significantly	ADV
admet-3007	366	8	inhibited	inhibit	VERB
admet-3007	366	9	tumour	tumour	ADJ
admet-3007	366	10	growth	growth	NOUN
admet-3007	366	11	and	and	CCONJ
admet-3007	366	12	induced	induced	ADJ
admet-3007	366	13	apoptosis	apoptosis	NOUN
admet-3007	366	14	.	.	PUNCT
admet-3007	367	1	in	in	ADP
admet-3007	367	2	addition	addition	NOUN
admet-3007	367	3	,	,	PUNCT
admet-3007	367	4	navarro	navarro	PROPN
admet-3007	367	5	-	-	PUNCT
admet-3007	367	6	marchal	marchal	NOUN
admet-3007	367	7	et	et	PROPN
admet-3007	367	8	al	al	PROPN
admet-3007	367	9	.	.	PUNCT
admet-3007	368	1	[	[	X
admet-3007	368	2	105	105	NUM
admet-3007	368	3	]	]	PUNCT
admet-3007	368	4	developed	develop	VERB
admet-3007	368	5	anti	anti	ADJ
admet-3007	368	6	-	-	ADJ
admet-3007	368	7	cd44	cd44	ADJ
admet-3007	368	8	-	-	PUNCT
admet-3007	368	9	conjugated	conjugate	VERB
admet-3007	368	10	olive	olive	ADJ
admet-3007	368	11	oil	oil	NOUN
admet-3007	368	12	liquid	liquid	NOUN
admet-3007	368	13	nano	nano	NOUN
admet-3007	368	14	capsules	capsule	NOUN
admet-3007	368	15	to	to	PART
admet-3007	368	16	target	target	VERB
admet-3007	368	17	pancreatic	pancreatic	ADJ
admet-3007	368	18	cscs	csc	NOUN
admet-3007	368	19	.	.	PUNCT
admet-3007	369	1	encapsulation	encapsulation	NOUN
admet-3007	369	2	of	of	ADP
admet-3007	369	3	ptx	ptx	NOUN
admet-3007	369	4	in	in	ADP
admet-3007	369	5	these	these	DET
admet-3007	369	6	nanocarriers	nanocarrier	NOUN
admet-3007	369	7	resulted	result	VERB
admet-3007	369	8	in	in	ADP
admet-3007	369	9	a	a	DET
admet-3007	369	10	fourfold	fourfold	ADJ
admet-3007	369	11	increase	increase	NOUN
admet-3007	369	12	in	in	ADP
admet-3007	369	13	antitumor	antitumor	PROPN
admet-3007	369	14	efficacy	efficacy	NOUN
admet-3007	369	15	compared	compare	VERB
admet-3007	369	16	to	to	ADP
admet-3007	369	17	the	the	DET
admet-3007	369	18	free	free	ADJ
admet-3007	369	19	drug	drug	NOUN
admet-3007	369	20	.	.	PUNCT
admet-3007	370	1	rao	rao	NOUN
admet-3007	370	2	et	et	PROPN
admet-3007	370	3	al	al	PROPN
admet-3007	370	4	.	.	PUNCT
admet-3007	371	1	[	[	X
admet-3007	371	2	106	106	NUM
admet-3007	371	3	]	]	PUNCT
admet-3007	371	4	created	create	VERB
admet-3007	371	5	chitosan	chitosan	NOUN
admet-3007	371	6	-	-	PUNCT
admet-3007	371	7	decorated	decorate	VERB
admet-3007	371	8	dox	dox	NOUN
admet-3007	371	9	-	-	PUNCT
admet-3007	371	10	encapsulated	encapsulate	VERB
admet-3007	371	11	nanoparticles	nanoparticle	NOUN
admet-3007	371	12	to	to	PART
admet-3007	371	13	target	target	VERB
admet-3007	371	14	and	and	CCONJ
admet-3007	371	15	eliminate	eliminate	VERB
admet-3007	371	16	cancer	cancer	NOUN
admet-3007	371	17	stem	stem	NOUN
admet-3007	371	18	-	-	PUNCT
admet-3007	371	19	like	like	ADJ
admet-3007	371	20	cells	cell	NOUN
admet-3007	371	21	.	.	PUNCT
admet-3007	372	1	these	these	DET
admet-3007	372	2	nanoparticles	nanoparticle	NOUN
admet-3007	372	3	specifically	specifically	ADV
admet-3007	372	4	targeted	target	VERB
admet-3007	372	5	the	the	DET
admet-3007	372	6	cd44	cd44	PROPN
admet-3007	372	7	receptor	receptor	NOUN
admet-3007	372	8	,	,	PUNCT
admet-3007	372	9	enhancing	enhance	VERB
admet-3007	372	10	cytotoxicity	cytotoxicity	NOUN
admet-3007	372	11	sixfold	sixfold	ADV
admet-3007	372	12	by	by	ADP
admet-3007	372	13	efficiently	efficiently	ADV
admet-3007	372	14	releasing	release	VERB
admet-3007	372	15	the	the	DET
admet-3007	372	16	drug	drug	NOUN
admet-3007	372	17	.	.	PUNCT
admet-3007	373	1	verma	verma	PROPN
admet-3007	373	2	et	et	PROPN
admet-3007	373	3	al	al	PROPN
admet-3007	373	4	.	.	PUNCT
admet-3007	374	1	[	[	X
admet-3007	374	2	107	107	NUM
admet-3007	374	3	]	]	X
admet-3007	374	4	utilized	utilize	VERB
admet-3007	374	5	plga	plga	NOUN
admet-3007	374	6	nanoparticles	nanoparticle	NOUN
admet-3007	374	7	encapsulating	encapsulate	VERB
admet-3007	374	8	anthothecol	anthothecol	NOUN
admet-3007	374	9	,	,	PUNCT
admet-3007	374	10	an	an	DET
admet-3007	374	11	antimalarial	antimalarial	ADJ
admet-3007	374	12	agent	agent	NOUN
admet-3007	374	13	,	,	PUNCT
admet-3007	374	14	to	to	PART
admet-3007	374	15	target	target	VERB
admet-3007	374	16	pancreatic	pancreatic	ADJ
admet-3007	374	17	cscs	csc	NOUN
admet-3007	374	18	.	.	PUNCT
admet-3007	375	1	this	this	DET
admet-3007	375	2	formulation	formulation	NOUN
admet-3007	375	3	inhibited	inhibit	VERB
admet-3007	375	4	cell	cell	NOUN
admet-3007	375	5	proliferation	proliferation	NOUN
admet-3007	375	6	and	and	CCONJ
admet-3007	375	7	colony	colony	NOUN
admet-3007	375	8	formation	formation	NOUN
admet-3007	375	9	,	,	PUNCT
admet-3007	375	10	while	while	SCONJ
admet-3007	375	11	inducing	induce	VERB
admet-3007	375	12	apoptosis	apoptosis	NOUN
admet-3007	375	13	in	in	ADP
admet-3007	375	14	both	both	DET
admet-3007	375	15	pancreatic	pancreatic	ADJ
admet-3007	375	16	cscs	cscs	NOUN
admet-3007	375	17	and	and	CCONJ
admet-3007	375	18	cancer	cancer	NOUN
admet-3007	375	19	cell	cell	NOUN
admet-3007	375	20	lines	line	NOUN
admet-3007	375	21	,	,	PUNCT
admet-3007	375	22	without	without	ADP
admet-3007	375	23	affecting	affect	VERB
admet-3007	375	24	normal	normal	ADJ
admet-3007	375	25	pancreatic	pancreatic	ADJ
admet-3007	375	26	ductal	ductal	ADJ
admet-3007	375	27	epithelial	epithelial	ADJ
admet-3007	375	28	cells	cell	NOUN
admet-3007	375	29	.	.	PUNCT
admet-3007	376	1	conclusions	conclusion	NOUN
admet-3007	376	2	cancer	cancer	NOUN
admet-3007	376	3	stem	stem	NOUN
admet-3007	376	4	cells	cell	NOUN
admet-3007	376	5	(	(	PUNCT
admet-3007	376	6	cscs	cscs	PROPN
admet-3007	376	7	)	)	PUNCT
admet-3007	376	8	have	have	AUX
admet-3007	376	9	emerged	emerge	VERB
admet-3007	376	10	as	as	ADP
admet-3007	376	11	critical	critical	ADJ
admet-3007	376	12	players	player	NOUN
admet-3007	376	13	in	in	ADP
admet-3007	376	14	the	the	DET
admet-3007	376	15	pathogenesis	pathogenesis	NOUN
admet-3007	376	16	,	,	PUNCT
admet-3007	376	17	progression	progression	NOUN
admet-3007	376	18	,	,	PUNCT
admet-3007	376	19	and	and	CCONJ
admet-3007	376	20	recurrence	recurrence	NOUN
admet-3007	376	21	of	of	ADP
admet-3007	376	22	cancer	cancer	NOUN
admet-3007	376	23	,	,	PUNCT
admet-3007	376	24	posing	pose	VERB
admet-3007	376	25	formidable	formidable	ADJ
admet-3007	376	26	challenges	challenge	NOUN
admet-3007	376	27	to	to	ADP
admet-3007	376	28	conventional	conventional	ADJ
admet-3007	376	29	treatment	treatment	NOUN
admet-3007	376	30	strategies	strategy	NOUN
admet-3007	376	31	.	.	PUNCT
admet-3007	377	1	their	their	PRON
admet-3007	377	2	intrinsic	intrinsic	ADJ
admet-3007	377	3	capabilities	capability	NOUN
admet-3007	377	4	for	for	ADP
admet-3007	377	5	self	self	NOUN
admet-3007	377	6	-	-	PUNCT
admet-3007	377	7	renewal	renewal	NOUN
admet-3007	377	8	,	,	PUNCT
admet-3007	377	9	differentiation	differentiation	NOUN
admet-3007	377	10	,	,	PUNCT
admet-3007	377	11	and	and	CCONJ
admet-3007	377	12	therapy	therapy	NOUN
admet-3007	377	13	resistance	resistance	NOUN
admet-3007	377	14	make	make	VERB
admet-3007	377	15	them	they	PRON
admet-3007	377	16	key	key	ADJ
admet-3007	377	17	drivers	driver	NOUN
admet-3007	377	18	of	of	ADP
admet-3007	377	19	metastasis	metastasis	NOUN
admet-3007	377	20	and	and	CCONJ
admet-3007	377	21	treatment	treatment	NOUN
admet-3007	377	22	failure	failure	NOUN
admet-3007	377	23	.	.	PUNCT
admet-3007	378	1	the	the	DET
admet-3007	378	2	resistance	resistance	NOUN
admet-3007	378	3	mechanisms	mechanism	NOUN
admet-3007	378	4	employed	employ	VERB
admet-3007	378	5	by	by	ADP
admet-3007	378	6	cscs	csc	NOUN
admet-3007	378	7	,	,	PUNCT
admet-3007	378	8	including	include	VERB
admet-3007	378	9	slow	slow	ADJ
admet-3007	378	10	proliferation	proliferation	NOUN
admet-3007	378	11	rates	rate	NOUN
admet-3007	378	12	,	,	PUNCT
admet-3007	378	13	enhanced	enhance	VERB
admet-3007	378	14	dna	dna	PROPN
admet-3007	378	15	repair	repair	NOUN
admet-3007	378	16	,	,	PUNCT
admet-3007	378	17	evasion	evasion	NOUN
admet-3007	378	18	of	of	ADP
admet-3007	378	19	apoptosis	apoptosis	NOUN
admet-3007	378	20	,	,	PUNCT
admet-3007	378	21	autophagy	autophagy	NOUN
admet-3007	378	22	,	,	PUNCT
admet-3007	378	23	and	and	CCONJ
admet-3007	378	24	survival	survival	NOUN
admet-3007	378	25	under	under	ADP
admet-3007	378	26	hypoxic	hypoxic	ADJ
admet-3007	378	27	conditions	condition	NOUN
admet-3007	378	28	,	,	PUNCT
admet-3007	378	29	highlight	highlight	VERB
admet-3007	378	30	the	the	DET
admet-3007	378	31	complexity	complexity	NOUN
admet-3007	378	32	of	of	ADP
admet-3007	378	33	effectively	effectively	ADV
admet-3007	378	34	targeting	target	VERB
admet-3007	378	35	these	these	DET
admet-3007	378	36	cells	cell	NOUN
admet-3007	378	37	.	.	PUNCT
admet-3007	379	1	moreover	moreover	ADV
admet-3007	379	2	,	,	PUNCT
admet-3007	379	3	the	the	DET
admet-3007	379	4	interaction	interaction	NOUN
admet-3007	379	5	of	of	ADP
admet-3007	379	6	cscs	cscs	PROPN
admet-3007	379	7	with	with	ADP
admet-3007	379	8	the	the	DET
admet-3007	379	9	tme	tme	PROPN
admet-3007	379	10	,	,	PUNCT
admet-3007	379	11	facilitated	facilitate	VERB
admet-3007	379	12	by	by	ADP
admet-3007	379	13	angiogenesis	angiogenesis	NOUN
admet-3007	379	14	,	,	PUNCT
admet-3007	379	15	inflammatory	inflammatory	ADJ
admet-3007	379	16	cytokines	cytokine	NOUN
admet-3007	379	17	,	,	PUNCT
admet-3007	379	18	and	and	CCONJ
admet-3007	379	19	their	their	PRON
admet-3007	379	20	role	role	NOUN
admet-3007	379	21	in	in	ADP
admet-3007	379	22	metastasis	metastasis	NOUN
admet-3007	379	23	,	,	PUNCT
admet-3007	379	24	underscores	underscore	VERB
admet-3007	379	25	their	their	PRON
admet-3007	379	26	adaptability	adaptability	NOUN
admet-3007	379	27	and	and	CCONJ
admet-3007	379	28	resilience	resilience	NOUN
admet-3007	379	29	.	.	PUNCT
admet-3007	380	1	nanotechnology	nanotechnology	PROPN
admet-3007	380	2	has	have	AUX
admet-3007	380	3	opened	open	VERB
admet-3007	380	4	transformative	transformative	ADJ
admet-3007	380	5	avenues	avenue	NOUN
admet-3007	380	6	in	in	ADP
admet-3007	380	7	combating	combat	VERB
admet-3007	380	8	cscs	cscs	PROPN
admet-3007	380	9	.	.	PUNCT
admet-3007	381	1	metal	metal	NOUN
admet-3007	381	2	-	-	PUNCT
admet-3007	381	3	based	base	VERB
admet-3007	381	4	nanoparticles	nanoparticle	NOUN
admet-3007	381	5	,	,	PUNCT
admet-3007	381	6	carbonbased	carbonbase	VERB
admet-3007	381	7	nanomaterials	nanomaterial	NOUN
admet-3007	381	8	,	,	PUNCT
admet-3007	381	9	and	and	CCONJ
admet-3007	381	10	organic	organic	ADJ
admet-3007	381	11	nanostructures	nanostructure	NOUN
admet-3007	381	12	provide	provide	VERB
admet-3007	381	13	novel	novel	ADJ
admet-3007	381	14	strategies	strategy	NOUN
admet-3007	381	15	to	to	PART
admet-3007	381	16	overcome	overcome	VERB
admet-3007	381	17	the	the	DET
admet-3007	381	18	limitations	limitation	NOUN
admet-3007	381	19	of	of	ADP
admet-3007	381	20	traditional	traditional	ADJ
admet-3007	381	21	cancer	cancer	NOUN
admet-3007	381	22	therapies	therapy	NOUN
admet-3007	381	23	.	.	PUNCT
admet-3007	382	1	these	these	DET
admet-3007	382	2	nanomaterials	nanomaterial	NOUN
admet-3007	382	3	enhance	enhance	VERB
admet-3007	382	4	therapeutic	therapeutic	ADJ
admet-3007	382	5	efficacy	efficacy	NOUN
admet-3007	382	6	by	by	ADP
admet-3007	382	7	enabling	enable	VERB
admet-3007	382	8	precise	precise	ADJ
admet-3007	382	9	targeting	targeting	NOUN
admet-3007	382	10	,	,	PUNCT
admet-3007	382	11	improving	improve	VERB
admet-3007	382	12	drug	drug	NOUN
admet-3007	382	13	delivery	delivery	NOUN
admet-3007	382	14	,	,	PUNCT
admet-3007	382	15	and	and	CCONJ
admet-3007	382	16	disrupting	disrupt	VERB
admet-3007	382	17	the	the	DET
admet-3007	382	18	protective	protective	ADJ
admet-3007	382	19	mechanisms	mechanism	NOUN
admet-3007	382	20	of	of	ADP
admet-3007	382	21	cscs	cscs	PROPN
admet-3007	382	22	.	.	PUNCT
admet-3007	383	1	additionally	additionally	ADV
admet-3007	383	2	,	,	PUNCT
admet-3007	383	3	advances	advance	NOUN
admet-3007	383	4	in	in	ADP
admet-3007	383	5	nanoparticle	nanoparticle	NOUN
admet-3007	383	6	-	-	PUNCT
admet-3007	383	7	mediated	mediate	VERB
admet-3007	383	8	hyperthermia	hyperthermia	NOUN
admet-3007	383	9	and	and	CCONJ
admet-3007	383	10	induction	induction	NOUN
admet-3007	383	11	of	of	ADP
admet-3007	383	12	oxidative	oxidative	ADJ
admet-3007	383	13	stress	stress	NOUN
admet-3007	383	14	have	have	AUX
admet-3007	383	15	demonstrated	demonstrate	VERB
admet-3007	383	16	promising	promise	VERB
admet-3007	383	17	preclinical	preclinical	ADJ
admet-3007	383	18	results	result	NOUN
admet-3007	383	19	,	,	PUNCT
admet-3007	383	20	highlighting	highlight	VERB
admet-3007	383	21	their	their	PRON
admet-3007	383	22	potential	potential	NOUN
admet-3007	383	23	to	to	PART
admet-3007	383	24	selectively	selectively	ADV
admet-3007	383	25	eliminate	eliminate	VERB
admet-3007	383	26	cscs	cscs	NOUN
admet-3007	383	27	while	while	SCONJ
admet-3007	383	28	minimizing	minimize	VERB
admet-3007	383	29	damage	damage	NOUN
admet-3007	383	30	to	to	ADP
admet-3007	383	31	normal	normal	ADJ
admet-3007	383	32	cells	cell	NOUN
admet-3007	383	33	.	.	PUNCT
admet-3007	384	1	despite	despite	SCONJ
admet-3007	384	2	significant	significant	ADJ
admet-3007	384	3	progress	progress	NOUN
admet-3007	384	4	,	,	PUNCT
admet-3007	384	5	challenges	challenge	NOUN
admet-3007	384	6	remain	remain	VERB
admet-3007	384	7	in	in	ADP
admet-3007	384	8	translating	translate	VERB
admet-3007	384	9	these	these	DET
admet-3007	384	10	technologies	technology	NOUN
admet-3007	384	11	into	into	ADP
admet-3007	384	12	clinical	clinical	ADJ
admet-3007	384	13	practice	practice	NOUN
admet-3007	384	14	.	.	PUNCT
admet-3007	385	1	issues	issue	NOUN
admet-3007	385	2	such	such	ADJ
admet-3007	385	3	as	as	ADP
admet-3007	385	4	biocompatibility	biocompatibility	NOUN
admet-3007	385	5	,	,	PUNCT
admet-3007	385	6	scalability	scalability	NOUN
admet-3007	385	7	,	,	PUNCT
admet-3007	385	8	and	and	CCONJ
admet-3007	385	9	long	long	ADJ
admet-3007	385	10	-	-	PUNCT
admet-3007	385	11	term	term	NOUN
admet-3007	385	12	safety	safety	NOUN
admet-3007	385	13	require	require	VERB
admet-3007	385	14	thorough	thorough	ADJ
admet-3007	385	15	investigation	investigation	NOUN
admet-3007	385	16	through	through	ADP
admet-3007	385	17	rigorous	rigorous	ADJ
admet-3007	385	18	research	research	NOUN
admet-3007	385	19	and	and	CCONJ
admet-3007	385	20	clinical	clinical	ADJ
admet-3007	385	21	trials	trial	NOUN
admet-3007	385	22	.	.	PUNCT
admet-3007	386	1	admet	admet	PROPN
admet-3007	386	2	&	&	CCONJ
admet-3007	386	3	dmpk	dmpk	PROPN
admet-3007	386	4	13(5	13(5	NUM
admet-3007	386	5	)	)	PUNCT
admet-3007	386	6	(	(	PUNCT
admet-3007	386	7	2025	2025	NUM
admet-3007	386	8	)	)	PUNCT
admet-3007	386	9	3007	3007	NUM
admet-3007	386	10	nano	nano	NOUN
admet-3007	386	11	-	-	PUNCT
admet-3007	386	12	biomaterials	biomaterial	NOUN
admet-3007	386	13	in	in	ADP
admet-3007	386	14	cancer	cancer	NOUN
admet-3007	386	15	therapy	therapy	NOUN
admet-3007	386	16	doi	doi	PROPN
admet-3007	386	17	:	:	PUNCT
admet-3007	386	18	https://doi.org/10.5599/admet.3007	https://doi.org/10.5599/admet.3007	NOUN
admet-3007	386	19	17	17	NUM
admet-3007	386	20	furthermore	furthermore	ADV
admet-3007	386	21	,	,	PUNCT
admet-3007	386	22	a	a	DET
admet-3007	386	23	deeper	deep	ADJ
admet-3007	386	24	understanding	understanding	NOUN
admet-3007	386	25	of	of	ADP
admet-3007	386	26	csc	csc	PROPN
admet-3007	386	27	biology	biology	NOUN
admet-3007	386	28	and	and	CCONJ
admet-3007	386	29	the	the	DET
admet-3007	386	30	development	development	NOUN
admet-3007	386	31	of	of	ADP
admet-3007	386	32	multimodal	multimodal	NOUN
admet-3007	386	33	approaches	approach	NOUN
admet-3007	386	34	that	that	PRON
admet-3007	386	35	combine	combine	VERB
admet-3007	386	36	nanotechnology	nanotechnology	NOUN
admet-3007	386	37	with	with	ADP
admet-3007	386	38	other	other	ADJ
admet-3007	386	39	therapeutic	therapeutic	ADJ
admet-3007	386	40	modalities	modality	NOUN
admet-3007	386	41	could	could	AUX
admet-3007	386	42	further	far	ADV
admet-3007	386	43	improve	improve	VERB
admet-3007	386	44	outcomes	outcome	NOUN
admet-3007	386	45	.	.	PUNCT
admet-3007	387	1	in	in	ADP
admet-3007	387	2	conclusion	conclusion	NOUN
admet-3007	387	3	,	,	PUNCT
admet-3007	387	4	targeting	target	VERB
admet-3007	387	5	cscs	cscs	NOUN
admet-3007	387	6	with	with	ADP
admet-3007	387	7	innovative	innovative	ADJ
admet-3007	387	8	nano	nano	NOUN
admet-3007	387	9	-	-	PUNCT
admet-3007	387	10	biomaterials	biomaterial	NOUN
admet-3007	387	11	represents	represent	VERB
admet-3007	387	12	a	a	DET
admet-3007	387	13	promising	promising	ADJ
admet-3007	387	14	frontier	frontier	NOUN
admet-3007	387	15	in	in	ADP
admet-3007	387	16	cancer	cancer	NOUN
admet-3007	387	17	treatment	treatment	NOUN
admet-3007	387	18	.	.	PUNCT
admet-3007	388	1	by	by	ADP
admet-3007	388	2	addressing	address	VERB
admet-3007	388	3	the	the	DET
admet-3007	388	4	root	root	NOUN
admet-3007	388	5	causes	cause	NOUN
admet-3007	388	6	of	of	ADP
admet-3007	388	7	therapy	therapy	NOUN
admet-3007	388	8	resistance	resistance	NOUN
admet-3007	388	9	and	and	CCONJ
admet-3007	388	10	recurrence	recurrence	NOUN
admet-3007	388	11	,	,	PUNCT
admet-3007	388	12	these	these	DET
admet-3007	388	13	strategies	strategy	NOUN
admet-3007	388	14	hold	hold	VERB
admet-3007	388	15	the	the	DET
admet-3007	388	16	potential	potential	NOUN
admet-3007	388	17	to	to	PART
admet-3007	388	18	revolutionize	revolutionize	VERB
admet-3007	388	19	cancer	cancer	NOUN
admet-3007	388	20	care	care	NOUN
admet-3007	388	21	,	,	PUNCT
admet-3007	388	22	enhance	enhance	VERB
admet-3007	388	23	survival	survival	NOUN
admet-3007	388	24	rates	rate	NOUN
admet-3007	388	25	,	,	PUNCT
admet-3007	388	26	and	and	CCONJ
admet-3007	388	27	reduce	reduce	VERB
admet-3007	388	28	the	the	DET
admet-3007	388	29	burden	burden	NOUN
admet-3007	388	30	of	of	ADP
admet-3007	388	31	metastatic	metastatic	ADJ
admet-3007	388	32	disease	disease	NOUN
admet-3007	388	33	.	.	PUNCT
admet-3007	389	1	continued	continue	VERB
admet-3007	389	2	interdisciplinary	interdisciplinary	ADJ
admet-3007	389	3	collaboration	collaboration	NOUN
admet-3007	389	4	and	and	CCONJ
admet-3007	389	5	sustained	sustained	ADJ
admet-3007	389	6	investment	investment	NOUN
admet-3007	389	7	in	in	ADP
admet-3007	389	8	this	this	DET
admet-3007	389	9	field	field	NOUN
admet-3007	389	10	will	will	AUX
admet-3007	389	11	be	be	AUX
admet-3007	389	12	pivotal	pivotal	ADJ
admet-3007	389	13	in	in	ADP
admet-3007	389	14	advancing	advance	VERB
admet-3007	389	15	the	the	DET
admet-3007	389	16	clinical	clinical	ADJ
admet-3007	389	17	application	application	NOUN
admet-3007	389	18	of	of	ADP
admet-3007	389	19	these	these	DET
admet-3007	389	20	cutting	cut	VERB
admet-3007	389	21	-	-	PUNCT
admet-3007	389	22	edge	edge	NOUN
admet-3007	389	23	technologies	technology	NOUN
admet-3007	389	24	.	.	PUNCT
admet-3007	390	1	abbreviations	abbreviation	NOUN
admet-3007	390	2	abc	abc	PROPN
admet-3007	390	3	atp	atp	PROPN
admet-3007	390	4	-	-	PUNCT
admet-3007	390	5	binding	bind	VERB
admet-3007	390	6	cassette	cassette	NOUN
admet-3007	390	7	abcb1	abcb1	NOUN
admet-3007	390	8	atp	atp	PROPN
admet-3007	390	9	-	-	PUNCT
admet-3007	390	10	binding	bind	VERB
admet-3007	390	11	cassette	cassette	NOUN
admet-3007	390	12	subfamily	subfamily	ADV
admet-3007	390	13	b	b	NOUN
admet-3007	390	14	member	member	NOUN
admet-3007	390	15	1	1	NUM
admet-3007	390	16	abcb5	abcb5	NOUN
admet-3007	390	17	atp	atp	NOUN
admet-3007	390	18	-	-	PUNCT
admet-3007	390	19	binding	bind	VERB
admet-3007	390	20	cassette	cassette	NOUN
admet-3007	390	21	subfamily	subfamily	ADV
admet-3007	390	22	b	b	PROPN
admet-3007	390	23	member	member	NOUN
admet-3007	390	24	5	5	NUM
admet-3007	390	25	abcg2	abcg2	NOUN
admet-3007	390	26	atp	atp	NOUN
admet-3007	390	27	-	-	PUNCT
admet-3007	390	28	binding	bind	VERB
admet-3007	390	29	cassette	cassette	NOUN
admet-3007	390	30	subfamily	subfamily	ADV
admet-3007	390	31	g	g	PROPN
admet-3007	390	32	member	member	NOUN
admet-3007	390	33	2	2	NUM
admet-3007	390	34	aldh	aldh	NOUN
admet-3007	390	35	aldehyde	aldehyde	NOUN
admet-3007	390	36	dehydrogenase	dehydrogenase	NOUN
admet-3007	390	37	aldh1	aldh1	NOUN
admet-3007	390	38	aldehyde	aldehyde	NOUN
admet-3007	390	39	dehydrogenase	dehydrogenase	NOUN
admet-3007	390	40	1	1	NUM
admet-3007	390	41	aldh1a1	aldh1a1	NOUN
admet-3007	390	42	aldehyde	aldehyde	NOUN
admet-3007	390	43	dehydrogenase	dehydrogenase	NOUN
admet-3007	390	44	1	1	NUM
admet-3007	390	45	family	family	NOUN
admet-3007	390	46	member	member	NOUN
admet-3007	390	47	a1	a1	NOUN
admet-3007	390	48	aldh1a3	aldh1a3	NOUN
admet-3007	390	49	aldehyde	aldehyde	NOUN
admet-3007	390	50	dehydrogenase	dehydrogenase	NOUN
admet-3007	390	51	1	1	NUM
admet-3007	390	52	family	family	NOUN
admet-3007	390	53	member	member	NOUN
admet-3007	390	54	a3	a3	NOUN
admet-3007	390	55	amf	amf	PROPN
admet-3007	390	56	alternating	alternate	VERB
admet-3007	390	57	magnetic	magnetic	ADJ
admet-3007	390	58	field	field	NOUN
admet-3007	390	59	au	au	ADP
admet-3007	390	60	gold	gold	PROPN
admet-3007	390	61	ag	ag	PROPN
admet-3007	390	62	silver	silver	PROPN
admet-3007	390	63	bcl2	bcl2	PROPN
admet-3007	390	64	b	b	PROPN
admet-3007	390	65	-	-	PUNCT
admet-3007	390	66	cell	cell	NOUN
admet-3007	390	67	lymphoma	lymphoma	NOUN
admet-3007	390	68	2	2	NUM
admet-3007	390	69	bax	bax	PROPN
admet-3007	390	70	bcl-2	bcl-2	VERB
admet-3007	390	71	-	-	ADJ
admet-3007	390	72	associated	associated	ADJ
admet-3007	390	73	x	x	SYM
admet-3007	390	74	protein	protein	NOUN
admet-3007	390	75	cd	cd	NOUN
admet-3007	390	76	cluster	cluster	NOUN
admet-3007	390	77	of	of	ADP
admet-3007	390	78	differentiation	differentiation	NOUN
admet-3007	390	79	cd13	cd13	PROPN
admet-3007	390	80	aminopeptidase	aminopeptidase	NOUN
admet-3007	390	81	n	n	PROPN
admet-3007	390	82	cd24	cd24	PROPN
admet-3007	390	83	cluster	cluster	NOUN
admet-3007	390	84	of	of	ADP
admet-3007	390	85	differentiation	differentiation	NOUN
admet-3007	390	86	24	24	NUM
admet-3007	390	87	cd44	cd44	PROPN
admet-3007	390	88	cluster	cluster	NOUN
admet-3007	390	89	of	of	ADP
admet-3007	390	90	differentiation	differentiation	NOUN
admet-3007	390	91	44	44	NUM
admet-3007	390	92	cd49f	cd49f	NOUN
admet-3007	390	93	integrin	integrin	NOUN
admet-3007	390	94	alpha-6	alpha-6	CCONJ
admet-3007	390	95	cd90	cd90	PROPN
admet-3007	390	96	thy-1	thy-1	NUM
admet-3007	390	97	cell	cell	NOUN
admet-3007	390	98	surface	surface	NOUN
admet-3007	390	99	antigen	antigen	ADJ
admet-3007	390	100	cd105	cd105	ADJ
admet-3007	390	101	endoglin	endoglin	NOUN
admet-3007	390	102	cd117	cd117	PROPN
admet-3007	391	1	c	c	X
admet-3007	391	2	-	-	PUNCT
admet-3007	391	3	kit	kit	NOUN
admet-3007	391	4	receptor	receptor	NOUN
admet-3007	391	5	tyrosine	tyrosine	NOUN
admet-3007	391	6	kinase	kinase	PROPN
admet-3007	391	7	cd133	cd133	PROPN
admet-3007	391	8	prominin-1	prominin-1	PUNCT
admet-3007	392	1	ck19	ck19	PROPN
admet-3007	392	2	cytokeratin	cytokeratin	NOUN
admet-3007	392	3	19	19	NUM
admet-3007	392	4	csc	csc	PROPN
admet-3007	392	5	cancer	cancer	NOUN
admet-3007	392	6	stem	stem	NOUN
admet-3007	392	7	cell	cell	NOUN
admet-3007	392	8	cscs	cscs	NOUN
admet-3007	392	9	cancer	cancer	NOUN
admet-3007	392	10	stem	stem	NOUN
admet-3007	392	11	cells	cell	NOUN
admet-3007	392	12	cu	cu	PROPN
admet-3007	392	13	copper	copper	PROPN
admet-3007	392	14	cuo	cuo	PROPN
admet-3007	392	15	copper	copper	NOUN
admet-3007	392	16	oxide	oxide	NOUN
admet-3007	392	17	cxcr4	cxcr4	NOUN
admet-3007	392	18	c	c	X
admet-3007	392	19	-	-	PUNCT
admet-3007	392	20	x	x	NOUN
admet-3007	392	21	-	-	ADJ
admet-3007	392	22	c	c	ADJ
admet-3007	392	23	chemokine	chemokine	ADJ
admet-3007	392	24	receptor	receptor	NOUN
admet-3007	392	25	type	type	NOUN
admet-3007	392	26	4	4	NUM
admet-3007	392	27	dclk1	dclk1	NOUN
admet-3007	392	28	doublecortin	doublecortin	NOUN
admet-3007	392	29	-	-	PUNCT
admet-3007	392	30	like	like	ADJ
admet-3007	392	31	kinase	kinase	PROPN
admet-3007	392	32	1	1	NUM
admet-3007	392	33	dlk1	dlk1	PROPN
admet-3007	392	34	delta	delta	NOUN
admet-3007	392	35	-	-	PUNCT
admet-3007	392	36	like	like	ADJ
admet-3007	392	37	non	non	ADJ
admet-3007	392	38	-	-	ADJ
admet-3007	392	39	canonical	canonical	ADJ
admet-3007	392	40	notch	notch	ADJ
admet-3007	392	41	ligand	ligand	NOUN
admet-3007	392	42	1	1	NUM
admet-3007	392	43	dna	dna	PROPN
admet-3007	392	44	deoxyribonucleic	deoxyribonucleic	VERB
admet-3007	392	45	acid	acid	NOUN
admet-3007	392	46	dox	dox	NOUN
admet-3007	392	47	doxorubicin	doxorubicin	PROPN
admet-3007	392	48	emt	emt	PROPN
admet-3007	392	49	epithelial	epithelial	NOUN
admet-3007	392	50	-	-	PUNCT
admet-3007	392	51	to	to	ADP
admet-3007	392	52	-	-	PUNCT
admet-3007	392	53	mesenchymal	mesenchymal	NOUN
admet-3007	392	54	transition	transition	NOUN
admet-3007	392	55	epcam	epcam	VERB
admet-3007	392	56	epithelial	epithelial	ADJ
admet-3007	392	57	cell	cell	NOUN
admet-3007	392	58	adhesion	adhesion	NOUN
admet-3007	392	59	molecule	molecule	NOUN
admet-3007	392	60	esa	esa	NOUN
admet-3007	392	61	epithelial	epithelial	ADJ
admet-3007	392	62	-	-	PUNCT
admet-3007	392	63	specific	specific	ADJ
admet-3007	392	64	antigen	antigen	NOUN
admet-3007	392	65	ef	ef	X
admet-3007	392	66	environmental	environmental	ADJ
admet-3007	392	67	factors	factor	NOUN
admet-3007	392	68	fe3o4	fe3o4	VERB
admet-3007	392	69	iron	iron	NOUN
admet-3007	392	70	oxide	oxide	NOUN
admet-3007	392	71	go	go	VERB
admet-3007	392	72	graphene	graphene	ADJ
admet-3007	392	73	oxide	oxide	NOUN
admet-3007	392	74	hnscc	hnscc	NOUN
admet-3007	392	75	head	head	NOUN
admet-3007	392	76	and	and	CCONJ
admet-3007	392	77	neck	neck	VERB
admet-3007	392	78	squamous	squamous	ADJ
admet-3007	392	79	cell	cell	NOUN
admet-3007	392	80	carcinoma	carcinoma	NOUN
admet-3007	392	81	her2	her2	VERB
admet-3007	392	82	human	human	ADJ
admet-3007	392	83	epidermal	epidermal	ADJ
admet-3007	392	84	growth	growth	NOUN
admet-3007	392	85	factor	factor	NOUN
admet-3007	392	86	receptor	receptor	NOUN
admet-3007	392	87	2	2	NUM
admet-3007	392	88	hspa2	hspa2	NOUN
admet-3007	392	89	heat	heat	NOUN
admet-3007	392	90	shock	shock	NOUN
admet-3007	392	91	-	-	PUNCT
admet-3007	392	92	related	relate	VERB
admet-3007	392	93	70	70	NUM
admet-3007	392	94	kda	kda	NOUN
admet-3007	392	95	protein	protein	NOUN
admet-3007	392	96	2	2	NUM
admet-3007	392	97	ic50	ic50	PROPN
admet-3007	392	98	half	half	PRON
admet-3007	392	99	maximal	maximal	ADJ
admet-3007	392	100	inhibitory	inhibitory	ADJ
admet-3007	392	101	concentration	concentration	NOUN
admet-3007	392	102	il1rap	il1rap	NOUN
admet-3007	392	103	interleukin	interleukin	NOUN
admet-3007	392	104	1	1	NUM
admet-3007	392	105	receptor	receptor	NOUN
admet-3007	392	106	accessory	accessory	NOUN
admet-3007	392	107	protein	protein	NOUN
admet-3007	392	108	insf	insf	ADJ
admet-3007	392	109	iran	iran	PROPN
admet-3007	392	110	national	national	PROPN
admet-3007	392	111	science	science	PROPN
admet-3007	392	112	foundation	foundation	PROPN
admet-3007	392	113	klf4	klf4	PROPN
admet-3007	392	114	krüppel	krüppel	PROPN
admet-3007	392	115	-	-	PUNCT
admet-3007	392	116	like	like	ADJ
admet-3007	392	117	factor	factor	NOUN
admet-3007	392	118	4	4	NUM
admet-3007	392	119	lgr5	lgr5	PROPN
admet-3007	392	120	leucine	leucine	NOUN
admet-3007	392	121	-	-	PUNCT
admet-3007	392	122	rich	rich	ADJ
admet-3007	392	123	repeat	repeat	NOUN
admet-3007	392	124	-	-	PUNCT
admet-3007	392	125	containing	contain	VERB
admet-3007	392	126	g	g	NOUN
admet-3007	392	127	-	-	PUNCT
admet-3007	392	128	protein	protein	NOUN
admet-3007	392	129	coupled	couple	VERB
admet-3007	392	130	receptor	receptor	NOUN
admet-3007	392	131	5	5	NUM
admet-3007	392	132	lnc	lnc	PROPN
admet-3007	392	133	lipid	lipid	PROPN
admet-3007	392	134	nanocapsule	nanocapsule	PROPN
admet-3007	392	135	mgo	mgo	PROPN
admet-3007	392	136	magnesium	magnesium	NOUN
admet-3007	392	137	oxide	oxide	NOUN
admet-3007	392	138	https://doi.org/10.5599/admet.3007	https://doi.org/10.5599/admet.3007	NOUN
admet-3007	392	139	m.	m.	NOUN
admet-3007	392	140	dehghani	dehghani	PROPN
admet-3007	392	141	et	et	PROPN
admet-3007	392	142	al	al	PROPN
admet-3007	392	143	.	.	PROPN
admet-3007	392	144	admet	admet	PROPN
admet-3007	392	145	&	&	CCONJ
admet-3007	392	146	dmpk	dmpk	PROPN
admet-3007	392	147	13(5	13(5	NUM
admet-3007	392	148	)	)	PUNCT
admet-3007	392	149	(	(	PUNCT
admet-3007	392	150	2025	2025	NUM
admet-3007	392	151	)	)	PUNCT
admet-3007	392	152	3007	3007	NUM
admet-3007	392	153	18	18	NUM
admet-3007	392	154	mn3o4	mn3o4	PROPN
admet-3007	392	155	manganese	manganese	ADJ
admet-3007	392	156	oxide	oxide	NOUN
admet-3007	392	157	mri	mri	NOUN
admet-3007	392	158	magnetic	magnetic	ADJ
admet-3007	392	159	resonance	resonance	NOUN
admet-3007	392	160	imaging	image	VERB
admet-3007	392	161	mwcnt	mwcnt	ADJ
admet-3007	392	162	multi	multi	ADJ
admet-3007	392	163	-	-	ADJ
admet-3007	392	164	walled	walled	ADJ
admet-3007	392	165	carbon	carbon	NOUN
admet-3007	392	166	nanotube	nanotube	NOUN
admet-3007	392	167	nir	nir	NOUN
admet-3007	392	168	near	near	ADV
admet-3007	392	169	-	-	PUNCT
admet-3007	392	170	infrared	infrare	VERB
admet-3007	392	171	oct4	oct4	PROPN
admet-3007	392	172	octamer	octamer	ADV
admet-3007	392	173	-	-	PUNCT
admet-3007	392	174	binding	bind	VERB
admet-3007	392	175	transcription	transcription	NOUN
admet-3007	392	176	factor	factor	NOUN
admet-3007	392	177	4	4	NUM
admet-3007	392	178	pcor	pcor	NOUN
admet-3007	392	179	protocadherin	protocadherin	NOUN
admet-3007	392	180	-	-	PUNCT
admet-3007	392	181	related	relate	VERB
admet-3007	392	182	receptor	receptor	NOUN
admet-3007	392	183	pdt	pdt	PROPN
admet-3007	392	184	photodynamic	photodynamic	ADJ
admet-3007	392	185	therapy	therapy	NOUN
admet-3007	392	186	peg	peg	NOUN
admet-3007	392	187	polyethylene	polyethylene	NOUN
admet-3007	392	188	glycol	glycol	NOUN
admet-3007	392	189	pegma	pegma	VERB
admet-3007	392	190	poly(ethylene	poly(ethylene	ADJ
admet-3007	392	191	glycol	glycol	NOUN
admet-3007	392	192	)	)	PUNCT
admet-3007	392	193	methacrylate	methacrylate	NOUN
admet-3007	392	194	plga	plga	NOUN
admet-3007	392	195	poly(lactic	poly(lactic	NOUN
admet-3007	392	196	-	-	PUNCT
admet-3007	392	197	co	co	NOUN
admet-3007	392	198	-	-	ADJ
admet-3007	392	199	glycolic	glycolic	ADJ
admet-3007	392	200	acid	acid	NOUN
admet-3007	392	201	)	)	PUNCT
admet-3007	392	202	poly(degma	poly(degma	PROPN
admet-3007	392	203	-	-	PUNCT
admet-3007	392	204	co	co	NOUN
admet-3007	392	205	-	-	NOUN
admet-3007	392	206	pegma	pegma	ADJ
admet-3007	392	207	)	)	PUNCT
admet-3007	392	208	poly(diethylene	poly(diethylene	ADJ
admet-3007	392	209	glycol	glycol	NOUN
admet-3007	392	210	methacrylate	methacrylate	NOUN
admet-3007	392	211	-	-	PUNCT
admet-3007	392	212	co	co	NOUN
admet-3007	392	213	-	-	ADJ
admet-3007	392	214	polyethylene	polyethylene	ADJ
admet-3007	392	215	glycol	glycol	NOUN
admet-3007	392	216	methacrylate	methacrylate	NOUN
admet-3007	392	217	)	)	PUNCT
admet-3007	392	218	ptx	ptx	NOUN
admet-3007	392	219	paclitaxel	paclitaxel	PROPN
admet-3007	392	220	rna	rna	PROPN
admet-3007	392	221	ribonucleic	ribonucleic	ADJ
admet-3007	392	222	acid	acid	PROPN
admet-3007	392	223	ros	ros	PROPN
admet-3007	392	224	reactive	reactive	ADJ
admet-3007	392	225	oxygen	oxygen	NOUN
admet-3007	392	226	species	specie	NOUN
admet-3007	392	227	sca-1	sca-1	PART
admet-3007	392	228	stem	stem	NOUN
admet-3007	392	229	cell	cell	NOUN
admet-3007	392	230	antigen-1	antigen-1	NUM
admet-3007	392	231	sox2	sox2	PROPN
admet-3007	392	232	sry	sry	PROPN
admet-3007	392	233	-	-	PUNCT
admet-3007	392	234	box	box	NOUN
admet-3007	392	235	transcription	transcription	NOUN
admet-3007	392	236	factor	factor	NOUN
admet-3007	392	237	2	2	NUM
admet-3007	392	238	sox9	sox9	PROPN
admet-3007	392	239	sry	sry	PROPN
admet-3007	392	240	-	-	PUNCT
admet-3007	392	241	box	box	NOUN
admet-3007	392	242	transcription	transcription	NOUN
admet-3007	392	243	factor	factor	NOUN
admet-3007	392	244	9	9	NUM
admet-3007	392	245	spion	spion	NOUN
admet-3007	392	246	superparamagnetic	superparamagnetic	ADJ
admet-3007	392	247	iron	iron	NOUN
admet-3007	392	248	oxide	oxide	NOUN
admet-3007	392	249	nanoparticle	nanoparticle	NOUN
admet-3007	392	250	tme	tme	PROPN
admet-3007	392	251	tumor	tumor	PROPN
admet-3007	392	252	microenvironment	microenvironment	NOUN
admet-3007	392	253	tio2	tio2	NOUN
admet-3007	392	254	titanium	titanium	NOUN
admet-3007	392	255	dioxide	dioxide	NOUN
admet-3007	392	256	zno	zno	PROPN
admet-3007	392	257	zinc	zinc	PROPN
admet-3007	392	258	oxide	oxide	NOUN
admet-3007	392	259	funding	funding	NOUN
admet-3007	392	260	:	:	PUNCT
admet-3007	392	261	this	this	DET
admet-3007	392	262	work	work	NOUN
admet-3007	392	263	is	be	AUX
admet-3007	392	264	based	base	VERB
admet-3007	392	265	upon	upon	SCONJ
admet-3007	392	266	research	research	NOUN
admet-3007	392	267	funded	fund	VERB
admet-3007	392	268	by	by	ADP
admet-3007	392	269	the	the	DET
admet-3007	392	270	iran	iran	PROPN
admet-3007	392	271	national	national	PROPN
admet-3007	392	272	science	science	PROPN
admet-3007	392	273	foundation	foundation	PROPN
admet-3007	392	274	(	(	PUNCT
admet-3007	392	275	insf	insf	ADJ
admet-3007	392	276	)	)	PUNCT
admet-3007	392	277	under	under	ADP
admet-3007	392	278	project	project	NOUN
admet-3007	392	279	no	no	NOUN
admet-3007	392	280	.	.	NOUN
admet-3007	392	281	4031227	4031227	NUM
admet-3007	392	282	.	.	PUNCT
admet-3007	393	1	acknowledgements	acknowledgement	NOUN
admet-3007	393	2	:	:	PUNCT
admet-3007	393	3	the	the	DET
admet-3007	393	4	authors	author	NOUN
admet-3007	393	5	would	would	AUX
admet-3007	393	6	like	like	VERB
admet-3007	393	7	to	to	PART
admet-3007	393	8	thank	thank	VERB
admet-3007	393	9	the	the	DET
admet-3007	393	10	research	research	NOUN
admet-3007	393	11	council	council	PROPN
admet-3007	393	12	of	of	ADP
admet-3007	393	13	tarbiat	tarbiat	PROPN
admet-3007	393	14	modares	modares	PROPN
admet-3007	393	15	university	university	NOUN
admet-3007	393	16	conflict	conflict	NOUN
admet-3007	393	17	of	of	ADP
admet-3007	393	18	interest	interest	NOUN
admet-3007	393	19	:	:	PUNCT
admet-3007	393	20	the	the	DET
admet-3007	393	21	authors	author	NOUN
admet-3007	393	22	certify	certify	VERB
admet-3007	393	23	that	that	SCONJ
admet-3007	393	24	they	they	PRON
admet-3007	393	25	have	have	VERB
admet-3007	393	26	no	no	DET
admet-3007	393	27	financial	financial	ADJ
admet-3007	393	28	or	or	CCONJ
admet-3007	393	29	other	other	ADJ
admet-3007	393	30	conflict	conflict	NOUN
admet-3007	393	31	of	of	ADP
admet-3007	393	32	interest	interest	NOUN
admet-3007	393	33	.	.	PUNCT
admet-3007	394	1	references	reference	NOUN
admet-3007	394	2	[	[	X
admet-3007	394	3	1	1	NUM
admet-3007	394	4	]	]	X
admet-3007	394	5	r.l	r.l	PROPN
admet-3007	394	6	.	.	PROPN
admet-3007	394	7	siegel	siegel	PROPN
admet-3007	394	8	,	,	PUNCT
admet-3007	394	9	k.d	k.d	PROPN
admet-3007	394	10	.	.	PROPN
admet-3007	394	11	miller	miller	PROPN
admet-3007	394	12	,	,	PUNCT
admet-3007	394	13	a.	a.	PROPN
admet-3007	394	14	jemal	jemal	PROPN
admet-3007	394	15	.	.	PUNCT
admet-3007	395	1	cancer	cancer	NOUN
admet-3007	395	2	statistics	statistic	NOUN
admet-3007	395	3	,	,	PUNCT
admet-3007	395	4	2019	2019	NUM
admet-3007	395	5	.	.	PUNCT
admet-3007	396	1	ca	ca	NOUN
admet-3007	396	2	:	:	PUNCT
admet-3007	396	3	a	a	DET
admet-3007	396	4	cancer	cancer	NOUN
admet-3007	396	5	journal	journal	NOUN
admet-3007	396	6	for	for	ADP
admet-3007	396	7	clinicians	clinician	NOUN
admet-3007	396	8	69	69	NUM
admet-3007	396	9	(	(	PUNCT
admet-3007	396	10	2019	2019	NUM
admet-3007	396	11	)	)	PUNCT
admet-3007	396	12	7	7	NUM
admet-3007	396	13	-	-	SYM
admet-3007	396	14	34	34	NUM
admet-3007	396	15	.	.	PUNCT
admet-3007	397	1	https://doi.org/10.3322/caac.21551	https://doi.org/10.3322/caac.21551	X
admet-3007	398	1	[	[	X
admet-3007	398	2	2	2	NUM
admet-3007	398	3	]	]	X
admet-3007	398	4	r.l	r.l	PROPN
admet-3007	398	5	.	.	PROPN
admet-3007	398	6	siegel	siegel	PROPN
admet-3007	398	7	,	,	PUNCT
admet-3007	398	8	a.n	a.n	PROPN
admet-3007	398	9	.	.	PROPN
admet-3007	398	10	giaquinto	giaquinto	PROPN
admet-3007	398	11	,	,	PUNCT
admet-3007	398	12	a.	a.	NOUN
admet-3007	398	13	jemal	jemal	PROPN
admet-3007	398	14	.	.	PUNCT
admet-3007	399	1	cancer	cancer	NOUN
admet-3007	399	2	statistics	statistic	NOUN
admet-3007	399	3	,	,	PUNCT
admet-3007	399	4	2024	2024	NUM
admet-3007	399	5	.	.	PUNCT
admet-3007	400	1	ca	ca	NOUN
admet-3007	400	2	:	:	PUNCT
admet-3007	400	3	a	a	DET
admet-3007	400	4	cancer	cancer	NOUN
admet-3007	400	5	journal	journal	NOUN
admet-3007	400	6	for	for	ADP
admet-3007	400	7	clinicians	clinician	NOUN
admet-3007	400	8	74	74	NUM
admet-3007	400	9	(	(	PUNCT
admet-3007	400	10	2024	2024	NUM
admet-3007	400	11	)	)	PUNCT
admet-3007	400	12	12	12	NUM
admet-3007	400	13	-	-	SYM
admet-3007	400	14	49	49	NUM
admet-3007	400	15	.	.	PUNCT
admet-3007	401	1	https://doi.org/10.3322/caac.21820	https://doi.org/10.3322/caac.21820	NOUN
admet-3007	402	1	[	[	X
admet-3007	402	2	3	3	X
admet-3007	402	3	]	]	X
admet-3007	402	4	r.	r.	NOUN
admet-3007	402	5	mirzayans	mirzayans	PROPN
admet-3007	402	6	,	,	PUNCT
admet-3007	402	7	d.	d.	PROPN
admet-3007	402	8	murray	murray	PROPN
admet-3007	402	9	.	.	PUNCT
admet-3007	403	1	what	what	PRON
admet-3007	403	2	are	be	AUX
admet-3007	403	3	the	the	DET
admet-3007	403	4	reasons	reason	NOUN
admet-3007	403	5	for	for	ADP
admet-3007	403	6	continuing	continue	VERB
admet-3007	403	7	failures	failure	NOUN
admet-3007	403	8	in	in	ADP
admet-3007	403	9	cancer	cancer	NOUN
admet-3007	403	10	therapy	therapy	NOUN
admet-3007	403	11	?	?	PUNCT
admet-3007	404	1	are	be	AUX
admet-3007	404	2	misleading	mislead	VERB
admet-3007	404	3	/	/	SYM
admet-3007	404	4	inappropriate	inappropriate	ADJ
admet-3007	404	5	preclinical	preclinical	ADJ
admet-3007	404	6	assays	assay	NOUN
admet-3007	404	7	to	to	PART
admet-3007	404	8	be	be	AUX
admet-3007	404	9	blamed	blame	VERB
admet-3007	404	10	?	?	PUNCT
admet-3007	405	1	might	might	AUX
admet-3007	405	2	some	some	DET
admet-3007	405	3	modern	modern	ADJ
admet-3007	405	4	therapies	therapy	NOUN
admet-3007	405	5	cause	cause	VERB
admet-3007	405	6	more	more	ADJ
admet-3007	405	7	harm	harm	NOUN
admet-3007	405	8	than	than	ADP
admet-3007	405	9	benefit	benefit	NOUN
admet-3007	405	10	?	?	PUNCT
admet-3007	406	1	international	international	ADJ
admet-3007	406	2	journal	journal	NOUN
admet-3007	406	3	of	of	ADP
admet-3007	406	4	molecular	molecular	ADJ
admet-3007	406	5	sciences	science	NOUN
admet-3007	406	6	23	23	NUM
admet-3007	406	7	(	(	PUNCT
admet-3007	406	8	2022	2022	NUM
admet-3007	406	9	)	)	PUNCT
admet-3007	406	10	13217	13217	NUM
admet-3007	406	11	.	.	PUNCT
admet-3007	407	1	https://doi.org/10.3390/ijms232113217	https://doi.org/10.3390/ijms232113217	NOUN
admet-3007	407	2	[	[	X
admet-3007	407	3	4	4	NUM
admet-3007	407	4	]	]	PUNCT
admet-3007	407	5	f.	f.	PROPN
admet-3007	407	6	molaabasi	molaabasi	PROPN
admet-3007	407	7	,	,	PUNCT
admet-3007	407	8	a.	a.	PROPN
admet-3007	407	9	kefayat	kefayat	PROPN
admet-3007	407	10	,	,	PUNCT
admet-3007	407	11	m.	m.	PROPN
admet-3007	407	12	sarparast	sarparast	PROPN
admet-3007	407	13	,	,	PUNCT
admet-3007	407	14	b.	b.	PROPN
admet-3007	407	15	hajipour	hajipour	NOUN
admet-3007	407	16	-	-	PUNCT
admet-3007	407	17	verdom	verdom	NOUN
admet-3007	407	18	,	,	PUNCT
admet-3007	407	19	m.	m.	NOUN
admet-3007	407	20	shamsipur	shamsipur	NOUN
admet-3007	407	21	,	,	PUNCT
admet-3007	407	22	a.	a.	PROPN
admet-3007	407	23	seyfoori	seyfoori	PROPN
admet-3007	407	24	,	,	PUNCT
admet-3007	407	25	a.a	a.a	PROPN
admet-3007	407	26	.	.	PROPN
admet-3007	407	27	moosavimovahedi	moosavimovahedi	PROPN
admet-3007	407	28	,	,	PUNCT
admet-3007	407	29	m.	m.	NOUN
admet-3007	407	30	bahrami	bahrami	NOUN
admet-3007	407	31	,	,	PUNCT
admet-3007	407	32	m.	m.	NOUN
admet-3007	407	33	karami	karami	PROPN
admet-3007	407	34	,	,	PUNCT
admet-3007	407	35	m.	m.	NOUN
admet-3007	407	36	dehshiri	dehshiri	NOUN
admet-3007	407	37	.	.	PUNCT
admet-3007	408	1	bioelectrocatalytic	bioelectrocatalytic	ADJ
admet-3007	408	2	activity	activity	NOUN
admet-3007	408	3	of	of	ADP
admet-3007	408	4	one	one	NUM
admet-3007	408	5	-	-	PUNCT
admet-3007	408	6	dimensional	dimensional	ADJ
admet-3007	408	7	porous	porous	ADJ
admet-3007	408	8	pt	pt	NOUN
admet-3007	408	9	nanoribbons	nanoribbon	NOUN
admet-3007	408	10	for	for	ADP
admet-3007	408	11	efficient	efficient	ADJ
admet-3007	408	12	inhibition	inhibition	NOUN
admet-3007	408	13	of	of	ADP
admet-3007	408	14	tumor	tumor	NOUN
admet-3007	408	15	growth	growth	NOUN
admet-3007	408	16	and	and	CCONJ
admet-3007	408	17	metastasis	metastasis	NOUN
admet-3007	408	18	.	.	PUNCT
admet-3007	409	1	acs	acs	PROPN
admet-3007	409	2	applied	apply	VERB
admet-3007	409	3	materials	material	NOUN
admet-3007	409	4	&	&	CCONJ
admet-3007	409	5	interfaces	interface	NOUN
admet-3007	409	6	16	16	NUM
admet-3007	409	7	(	(	PUNCT
admet-3007	409	8	2024	2024	NUM
admet-3007	409	9	)	)	PUNCT
admet-3007	409	10	29581	29581	NUM
admet-3007	409	11	-	-	SYM
admet-3007	409	12	29599	29599	NUM
admet-3007	409	13	.	.	PUNCT
admet-3007	410	1	https://doi.org/10.1021/acsami.4c00757	https://doi.org/10.1021/acsami.4c00757	NOUN
admet-3007	410	2	[	[	X
admet-3007	410	3	5	5	NUM
admet-3007	410	4	]	]	PUNCT
admet-3007	410	5	d.	d.	PROPN
admet-3007	410	6	bonnet	bonnet	PROPN
admet-3007	410	7	,	,	PUNCT
admet-3007	410	8	j.e	j.e	PROPN
admet-3007	410	9	.	.	PROPN
admet-3007	410	10	dick	dick	PROPN
admet-3007	410	11	.	.	PUNCT
admet-3007	411	1	human	human	PROPN
admet-3007	411	2	acute	acute	PROPN
admet-3007	411	3	myeloid	myeloid	PROPN
admet-3007	411	4	leukemia	leukemia	NOUN
admet-3007	411	5	is	be	AUX
admet-3007	411	6	organized	organize	VERB
admet-3007	411	7	as	as	ADP
admet-3007	411	8	a	a	DET
admet-3007	411	9	hierarchy	hierarchy	NOUN
admet-3007	411	10	that	that	PRON
admet-3007	411	11	originates	originate	VERB
admet-3007	411	12	from	from	ADP
admet-3007	411	13	a	a	DET
admet-3007	411	14	primitive	primitive	ADJ
admet-3007	411	15	hematopoietic	hematopoietic	ADJ
admet-3007	411	16	cell	cell	NOUN
admet-3007	411	17	.	.	PUNCT
admet-3007	412	1	nature	nature	NOUN
admet-3007	412	2	medicine	medicine	PROPN
admet-3007	412	3	3	3	NUM
admet-3007	412	4	(	(	PUNCT
admet-3007	412	5	1997	1997	NUM
admet-3007	412	6	)	)	PUNCT
admet-3007	412	7	730	730	NUM
admet-3007	412	8	-	-	SYM
admet-3007	412	9	737	737	NUM
admet-3007	412	10	.	.	PUNCT
admet-3007	413	1	https://doi.org/10.1038/nm0797-730	https://doi.org/10.1038/nm0797-730	X
admet-3007	414	1	[	[	X
admet-3007	414	2	6	6	NUM
admet-3007	414	3	]	]	X
admet-3007	414	4	r.	r.	PROPN
admet-3007	414	5	bjerkvig	bjerkvig	PROPN
admet-3007	414	6	,	,	PUNCT
admet-3007	414	7	b.b	b.b	PROPN
admet-3007	414	8	.	.	PROPN
admet-3007	414	9	tysnes	tysnes	PROPN
admet-3007	414	10	,	,	PUNCT
admet-3007	414	11	k.s	k.s	PROPN
admet-3007	414	12	.	.	PROPN
admet-3007	414	13	aboody	aboody	PROPN
admet-3007	414	14	,	,	PUNCT
admet-3007	414	15	j.	j.	PROPN
admet-3007	414	16	najbauer	najbauer	PROPN
admet-3007	414	17	,	,	PUNCT
admet-3007	414	18	a.	a.	NOUN
admet-3007	414	19	terzis	terzi	NOUN
admet-3007	414	20	.	.	PUNCT
admet-3007	415	1	the	the	DET
admet-3007	415	2	origin	origin	NOUN
admet-3007	415	3	of	of	ADP
admet-3007	415	4	the	the	DET
admet-3007	415	5	cancer	cancer	NOUN
admet-3007	415	6	stem	stem	NOUN
admet-3007	415	7	cell	cell	NOUN
admet-3007	415	8	:	:	PUNCT
admet-3007	415	9	current	current	ADJ
admet-3007	415	10	controversies	controversy	NOUN
admet-3007	415	11	and	and	CCONJ
admet-3007	415	12	new	new	ADJ
admet-3007	415	13	insights	insight	NOUN
admet-3007	415	14	.	.	PUNCT
admet-3007	416	1	nature	nature	NOUN
admet-3007	416	2	reviews	review	VERB
admet-3007	416	3	cancer	cancer	NOUN
admet-3007	416	4	5	5	NUM
admet-3007	416	5	(	(	PUNCT
admet-3007	416	6	2005	2005	NUM
admet-3007	416	7	)	)	PUNCT
admet-3007	416	8	899	899	NUM
admet-3007	416	9	-	-	SYM
admet-3007	416	10	904	904	NUM
admet-3007	416	11	.	.	PUNCT
admet-3007	417	1	https://doi.org/10.1038/nrc1740	https://doi.org/10.1038/nrc1740	NOUN
admet-3007	417	2	[	[	X
admet-3007	417	3	7	7	NUM
admet-3007	417	4	]	]	PUNCT
admet-3007	417	5	z.	z.	PROPN
admet-3007	417	6	yu	yu	PROPN
admet-3007	417	7	,	,	PUNCT
admet-3007	417	8	t.g	t.g	PROPN
admet-3007	417	9	.	.	PROPN
admet-3007	417	10	pestell	pestell	PROPN
admet-3007	417	11	,	,	PUNCT
admet-3007	417	12	m.p	m.p	PROPN
admet-3007	417	13	.	.	PROPN
admet-3007	417	14	lisanti	lisanti	PROPN
admet-3007	417	15	,	,	PUNCT
admet-3007	417	16	r.g	r.g	PROPN
admet-3007	417	17	.	.	PROPN
admet-3007	417	18	pestell	pestell	PROPN
admet-3007	417	19	.	.	PUNCT
admet-3007	418	1	cancer	cancer	NOUN
admet-3007	418	2	stem	stem	NOUN
admet-3007	418	3	cells	cell	NOUN
admet-3007	418	4	.	.	PUNCT
admet-3007	419	1	the	the	DET
admet-3007	419	2	international	international	ADJ
admet-3007	419	3	journal	journal	NOUN
admet-3007	419	4	of	of	ADP
admet-3007	419	5	biochemistry	biochemistry	PROPN
admet-3007	419	6	&	&	CCONJ
admet-3007	419	7	cell	cell	NOUN
admet-3007	419	8	biology	biology	NOUN
admet-3007	419	9	44	44	NUM
admet-3007	419	10	(	(	PUNCT
admet-3007	419	11	2012	2012	NUM
admet-3007	419	12	)	)	PUNCT
admet-3007	419	13	2144	2144	NUM
admet-3007	419	14	-	-	SYM
admet-3007	419	15	2151	2151	NUM
admet-3007	419	16	.	.	PUNCT
admet-3007	420	1	https://doi.org/10.1016/j.biocel.2012.08.022	https://doi.org/10.1016/j.biocel.2012.08.022	NOUN
admet-3007	420	2	[	[	X
admet-3007	420	3	8	8	NUM
admet-3007	420	4	]	]	X
admet-3007	420	5	l.t.h	l.t.h	NOUN
admet-3007	420	6	.	.	PUNCT
admet-3007	421	1	phi	phi	PROPN
admet-3007	421	2	,	,	PUNCT
admet-3007	421	3	i.n	i.n	PROPN
admet-3007	421	4	.	.	PROPN
admet-3007	421	5	sari	sari	PROPN
admet-3007	421	6	,	,	PUNCT
admet-3007	421	7	y.-g	y.-g	PROPN
admet-3007	421	8	.	.	PUNCT
admet-3007	422	1	yang	yang	PROPN
admet-3007	422	2	,	,	PUNCT
admet-3007	422	3	s.-h	s.-h	PROPN
admet-3007	422	4	.	.	PUNCT
admet-3007	423	1	lee	lee	PROPN
admet-3007	423	2	,	,	PUNCT
admet-3007	423	3	n.	n.	PROPN
admet-3007	423	4	jun	jun	PROPN
admet-3007	423	5	,	,	PUNCT
admet-3007	423	6	k.s	k.s	PROPN
admet-3007	423	7	.	.	PROPN
admet-3007	423	8	kim	kim	PROPN
admet-3007	423	9	,	,	PUNCT
admet-3007	423	10	y.k	y.k	PROPN
admet-3007	423	11	.	.	PROPN
admet-3007	423	12	lee	lee	PROPN
admet-3007	423	13	,	,	PUNCT
admet-3007	423	14	h.y	h.y	PROPN
admet-3007	423	15	.	.	PROPN
admet-3007	423	16	kwon	kwon	PROPN
admet-3007	423	17	.	.	PUNCT
admet-3007	424	1	cancer	cancer	NOUN
admet-3007	424	2	stem	stem	NOUN
admet-3007	424	3	cells	cell	NOUN
admet-3007	424	4	(	(	PUNCT
admet-3007	424	5	cscs	cscs	PROPN
admet-3007	424	6	)	)	PUNCT
admet-3007	424	7	in	in	ADP
admet-3007	424	8	drug	drug	NOUN
admet-3007	424	9	resistance	resistance	NOUN
admet-3007	424	10	and	and	CCONJ
admet-3007	424	11	their	their	PRON
admet-3007	424	12	therapeutic	therapeutic	ADJ
admet-3007	424	13	implications	implication	NOUN
admet-3007	424	14	in	in	ADP
admet-3007	424	15	cancer	cancer	NOUN
admet-3007	424	16	treatment	treatment	NOUN
admet-3007	424	17	.	.	PUNCT
admet-3007	425	1	stem	stem	NOUN
admet-3007	425	2	cells	cell	NOUN
admet-3007	425	3	international	international	ADJ
admet-3007	425	4	2018	2018	NUM
admet-3007	425	5	(	(	PUNCT
admet-3007	425	6	2018	2018	NUM
admet-3007	425	7	)	)	PUNCT
admet-3007	425	8	5416923	5416923	NUM
admet-3007	425	9	.	.	PUNCT
admet-3007	426	1	https://doi.org/10.1155/2018/5416923	https://doi.org/10.1155/2018/5416923	PROPN
admet-3007	426	2	[	[	X
admet-3007	426	3	9	9	NUM
admet-3007	426	4	]	]	PUNCT
admet-3007	426	5	e.	e.	PROPN
admet-3007	426	6	batlle	batlle	PROPN
admet-3007	426	7	,	,	PUNCT
admet-3007	426	8	h.	h.	PROPN
admet-3007	426	9	clevers	clevers	PROPN
admet-3007	426	10	.	.	PUNCT
admet-3007	427	1	cancer	cancer	NOUN
admet-3007	427	2	stem	stem	NOUN
admet-3007	427	3	cells	cell	NOUN
admet-3007	427	4	revisited	revisit	VERB
admet-3007	427	5	.	.	PUNCT
admet-3007	428	1	nature	nature	NOUN
admet-3007	428	2	medicine	medicine	NOUN
admet-3007	428	3	23	23	NUM
admet-3007	428	4	(	(	PUNCT
admet-3007	428	5	2017	2017	NUM
admet-3007	428	6	)	)	PUNCT
admet-3007	428	7	1124	1124	NUM
admet-3007	428	8	-	-	SYM
admet-3007	428	9	1134	1134	NUM
admet-3007	428	10	.	.	PUNCT
admet-3007	429	1	https://doi.org/10.1038/nm.4409	https://doi.org/10.1038/nm.4409	PUNCT
admet-3007	430	1	[	[	X
admet-3007	430	2	10	10	NUM
admet-3007	430	3	]	]	PUNCT
admet-3007	430	4	p.	p.	NOUN
admet-3007	430	5	grodzinski	grodzinski	PROPN
admet-3007	430	6	,	,	PUNCT
admet-3007	430	7	m.	m.	NOUN
admet-3007	430	8	kircher	kircher	PROPN
admet-3007	430	9	,	,	PUNCT
admet-3007	430	10	m.	m.	PROPN
admet-3007	430	11	goldberg	goldberg	PROPN
admet-3007	430	12	,	,	PUNCT
admet-3007	430	13	a.	a.	NOUN
admet-3007	430	14	gabizon	gabizon	PROPN
admet-3007	430	15	.	.	PUNCT
admet-3007	431	1	integrating	integrate	VERB
admet-3007	431	2	nanotechnology	nanotechnology	NOUN
admet-3007	431	3	into	into	ADP
admet-3007	431	4	cancer	cancer	NOUN
admet-3007	431	5	care	care	NOUN
admet-3007	431	6	.	.	PUNCT
admet-3007	432	1	acs	acs	PROPN
admet-3007	432	2	nano	nano	VERB
admet-3007	432	3	13	13	NUM
admet-3007	432	4	(	(	PUNCT
admet-3007	432	5	2019	2019	NUM
admet-3007	432	6	)	)	PUNCT
admet-3007	432	7	7370	7370	NUM
admet-3007	432	8	-	-	SYM
admet-3007	432	9	7376	7376	NUM
admet-3007	432	10	.	.	PUNCT
admet-3007	433	1	https://doi.org/10.1021/acsnano.9b04266	https://doi.org/10.1021/acsnano.9b04266	NOUN
admet-3007	433	2	https://doi.org/10.3322/caac.21551	https://doi.org/10.3322/caac.21551	VERB
admet-3007	433	3	https://doi.org/10.3322/caac.21820	https://doi.org/10.3322/caac.21820	NOUN
admet-3007	433	4	https://doi.org/10.3390/ijms232113217	https://doi.org/10.3390/ijms232113217	NOUN
admet-3007	433	5	https://doi.org/10.1021/acsami.4c00757	https://doi.org/10.1021/acsami.4c00757	VERB
admet-3007	433	6	https://doi.org/10.1038/nm0797-730	https://doi.org/10.1038/nm0797-730	PUNCT
admet-3007	433	7	https://doi.org/10.1038/nrc1740	https://doi.org/10.1038/nrc1740	NOUN
admet-3007	433	8	https://doi.org/10.1016/j.biocel.2012.08.022	https://doi.org/10.1016/j.biocel.2012.08.022	VERB
admet-3007	433	9	https://doi.org/10.1155/2018/5416923	https://doi.org/10.1155/2018/5416923	PRON
admet-3007	433	10	https://doi.org/10.1038/nm.4409	https://doi.org/10.1038/nm.4409	SYM
admet-3007	433	11	https://doi.org/10.1021/acsnano.9b04266	https://doi.org/10.1021/acsnano.9b04266	NOUN
admet-3007	433	12	admet	admet	PROPN
admet-3007	433	13	&	&	CCONJ
admet-3007	433	14	dmpk	dmpk	PROPN
admet-3007	433	15	13(5	13(5	NUM
admet-3007	433	16	)	)	PUNCT
admet-3007	433	17	(	(	PUNCT
admet-3007	433	18	2025	2025	NUM
admet-3007	433	19	)	)	PUNCT
admet-3007	433	20	3007	3007	NUM
admet-3007	433	21	nano	nano	NOUN
admet-3007	433	22	-	-	PUNCT
admet-3007	433	23	biomaterials	biomaterial	NOUN
admet-3007	433	24	in	in	ADP
admet-3007	433	25	cancer	cancer	NOUN
admet-3007	433	26	therapy	therapy	NOUN
admet-3007	433	27	doi	doi	PROPN
admet-3007	433	28	:	:	PUNCT
admet-3007	433	29	https://doi.org/10.5599/admet.3007	https://doi.org/10.5599/admet.3007	NOUN
admet-3007	433	30	19	19	NUM
admet-3007	434	1	[	[	SYM
admet-3007	434	2	11	11	NUM
admet-3007	434	3	]	]	X
admet-3007	434	4	g.m	g.m	PROPN
admet-3007	434	5	.	.	PROPN
admet-3007	434	6	whitesides	whiteside	NOUN
admet-3007	434	7	,	,	PUNCT
admet-3007	434	8	j.p	j.p	PROPN
admet-3007	434	9	.	.	PROPN
admet-3007	434	10	mathias	mathias	PROPN
admet-3007	434	11	,	,	PUNCT
admet-3007	434	12	c.t	c.t	PROPN
admet-3007	434	13	.	.	PROPN
admet-3007	434	14	seto	seto	NOUN
admet-3007	434	15	.	.	PUNCT
admet-3007	435	1	molecular	molecular	ADJ
admet-3007	435	2	self	self	NOUN
admet-3007	435	3	-	-	PUNCT
admet-3007	435	4	assembly	assembly	NOUN
admet-3007	435	5	and	and	CCONJ
admet-3007	435	6	nanochemistry	nanochemistry	NOUN
admet-3007	435	7	:	:	PUNCT
admet-3007	435	8	a	a	DET
admet-3007	435	9	chemical	chemical	NOUN
admet-3007	435	10	strategy	strategy	NOUN
admet-3007	435	11	for	for	ADP
admet-3007	435	12	the	the	DET
admet-3007	435	13	synthesis	synthesis	NOUN
admet-3007	435	14	of	of	ADP
admet-3007	435	15	nanostructures	nanostructure	NOUN
admet-3007	435	16	.	.	PUNCT
admet-3007	436	1	science	science	NOUN
admet-3007	436	2	254	254	NUM
admet-3007	436	3	(	(	PUNCT
admet-3007	436	4	1991	1991	NUM
admet-3007	436	5	)	)	PUNCT
admet-3007	436	6	1312	1312	NUM
admet-3007	436	7	-	-	SYM
admet-3007	436	8	1319	1319	NUM
admet-3007	436	9	.	.	PUNCT
admet-3007	437	1	https://doi.org/10.1126/science.1962191	https://doi.org/10.1126/science.1962191	X
admet-3007	438	1	[	[	X
admet-3007	438	2	12	12	NUM
admet-3007	438	3	]	]	X
admet-3007	438	4	n.i.m	n.i.m	NOUN
admet-3007	438	5	.	.	PUNCT
admet-3007	439	1	fadilah	fadilah	PROPN
admet-3007	439	2	,	,	PUNCT
admet-3007	439	3	i.l.m	i.l.m	ADJ
admet-3007	439	4	.	.	PUNCT
admet-3007	439	5	isa	isa	PROPN
admet-3007	439	6	,	,	PUNCT
admet-3007	439	7	w.s.w.k	w.s.w.k	PROPN
admet-3007	439	8	.	.	PUNCT
admet-3007	439	9	zaman	zaman	PROPN
admet-3007	439	10	,	,	PUNCT
admet-3007	439	11	y.	y.	PROPN
admet-3007	439	12	tabata	tabata	PROPN
admet-3007	439	13	,	,	PUNCT
admet-3007	439	14	m.b	m.b	PROPN
admet-3007	439	15	.	.	PROPN
admet-3007	439	16	fauzi	fauzi	PROPN
admet-3007	439	17	.	.	PUNCT
admet-3007	440	1	the	the	DET
admet-3007	440	2	effect	effect	NOUN
admet-3007	440	3	of	of	ADP
admet-3007	440	4	nanoparticleincorporated	nanoparticleincorporate	VERB
admet-3007	440	5	natural	natural	ADJ
admet-3007	440	6	-	-	PUNCT
admet-3007	440	7	based	base	VERB
admet-3007	440	8	biomaterials	biomaterial	NOUN
admet-3007	440	9	towards	towards	ADP
admet-3007	440	10	cells	cell	NOUN
admet-3007	440	11	on	on	ADP
admet-3007	440	12	activated	activated	ADJ
admet-3007	440	13	pathways	pathway	NOUN
admet-3007	440	14	:	:	PUNCT
admet-3007	440	15	a	a	DET
admet-3007	440	16	systematic	systematic	ADJ
admet-3007	440	17	review	review	NOUN
admet-3007	440	18	.	.	PUNCT
admet-3007	441	1	polymers	polymer	NOUN
admet-3007	441	2	14	14	NUM
admet-3007	441	3	(	(	PUNCT
admet-3007	441	4	2022	2022	NUM
admet-3007	441	5	)	)	PUNCT
admet-3007	441	6	476	476	NUM
admet-3007	441	7	.	.	PUNCT
admet-3007	442	1	https://doi.org/10.3390/polym14030476	https://doi.org/10.3390/polym14030476	PROPN
admet-3007	442	2	[	[	X
admet-3007	442	3	13	13	NUM
admet-3007	442	4	]	]	X
admet-3007	442	5	l.c	l.c	PROPN
admet-3007	442	6	.	.	PROPN
admet-3007	442	7	massimino	massimino	PROPN
admet-3007	442	8	,	,	PUNCT
admet-3007	442	9	h.a	h.a	PROPN
admet-3007	442	10	.	.	PROPN
admet-3007	442	11	faria	faria	PROPN
admet-3007	442	12	,	,	PUNCT
admet-3007	442	13	s.a	s.a	PROPN
admet-3007	442	14	.	.	PROPN
admet-3007	442	15	yoshioka	yoshioka	PROPN
admet-3007	442	16	.	.	PUNCT
admet-3007	443	1	curcumin	curcumin	PROPN
admet-3007	443	2	bioactive	bioactive	PROPN
admet-3007	443	3	nanosizing	nanosizing	PROPN
admet-3007	443	4	:	:	PUNCT
admet-3007	443	5	increase	increase	NOUN
admet-3007	443	6	of	of	ADP
admet-3007	443	7	bioavailability	bioavailability	NOUN
admet-3007	443	8	.	.	PUNCT
admet-3007	444	1	industrial	industrial	ADJ
admet-3007	444	2	crops	crop	NOUN
admet-3007	444	3	and	and	CCONJ
admet-3007	444	4	products	product	NOUN
admet-3007	444	5	109	109	NUM
admet-3007	444	6	(	(	PUNCT
admet-3007	444	7	2017	2017	NUM
admet-3007	444	8	)	)	PUNCT
admet-3007	444	9	493	493	NUM
admet-3007	444	10	-	-	SYM
admet-3007	444	11	497	497	NUM
admet-3007	444	12	.	.	PUNCT
admet-3007	445	1	https://doi.org/10.1016/j.indcrop.2017.09.001	https://doi.org/10.1016/j.indcrop.2017.09.001	PROPN
admet-3007	446	1	[	[	X
admet-3007	446	2	14	14	NUM
admet-3007	446	3	]	]	PUNCT
admet-3007	446	4	z.	z.	PROPN
admet-3007	446	5	zhang	zhang	PROPN
admet-3007	446	6	,	,	PUNCT
admet-3007	446	7	m.	m.	PROPN
admet-3007	446	8	sant’ana	sant’ana	PROPN
admet-3007	446	9	filho	filho	PROPN
admet-3007	446	10	,	,	PUNCT
admet-3007	446	11	j.e	j.e	PROPN
admet-3007	446	12	.	.	PROPN
admet-3007	446	13	noer	noer	NOUN
admet-3007	446	14	.	.	PUNCT
admet-3007	447	1	the	the	DET
admet-3007	447	2	biology	biology	NOUN
admet-3007	447	3	of	of	ADP
admet-3007	447	4	head	head	NOUN
admet-3007	447	5	and	and	CCONJ
admet-3007	447	6	neck	neck	NOUN
admet-3007	447	7	cancer	cancer	NOUN
admet-3007	447	8	stem	stem	NOUN
admet-3007	447	9	cells	cell	NOUN
admet-3007	447	10	.	.	PUNCT
admet-3007	448	1	oral	oral	ADJ
admet-3007	448	2	oncology	oncology	NOUN
admet-3007	448	3	48	48	NUM
admet-3007	448	4	(	(	PUNCT
admet-3007	448	5	2012	2012	NUM
admet-3007	448	6	)	)	PUNCT
admet-3007	448	7	1	1	NUM
admet-3007	448	8	-	-	SYM
admet-3007	448	9	9	9	NUM
admet-3007	448	10	.	.	PUNCT
admet-3007	448	11	https://doi.org/10.1016/j.oraloncology.2011.10.004	https://doi.org/10.1016/j.oraloncology.2011.10.004	PROPN
admet-3007	448	12	[	[	X
admet-3007	448	13	15	15	NUM
admet-3007	448	14	]	]	X
admet-3007	448	15	c.a	c.a	PROPN
admet-3007	448	16	.	.	PROPN
admet-3007	448	17	goldthwaite	goldthwaite	PROPN
admet-3007	448	18	.	.	PUNCT
admet-3007	448	19	are	be	AUX
admet-3007	448	20	stem	stem	NOUN
admet-3007	448	21	cells	cell	NOUN
admet-3007	448	22	involved	involve	VERB
admet-3007	448	23	in	in	ADP
admet-3007	448	24	cancer	cancer	NOUN
admet-3007	448	25	.	.	PUNCT
admet-3007	449	1	regenerative	regenerative	ADJ
admet-3007	449	2	medicine	medicine	NOUN
admet-3007	449	3	9	9	NUM
admet-3007	449	4	(	(	PUNCT
admet-3007	449	5	2006	2006	NUM
admet-3007	449	6	)	)	PUNCT
admet-3007	449	7	89	89	NUM
admet-3007	449	8	-	-	SYM
admet-3007	449	9	96	96	NUM
admet-3007	449	10	.	.	PUNCT
admet-3007	450	1	https://scholar.google.com/scholar	https://scholar.google.com/scholar	PROPN
admet-3007	451	1	[	[	X
admet-3007	451	2	16	16	NUM
admet-3007	451	3	]	]	X
admet-3007	451	4	f.	f.	PROPN
admet-3007	451	5	li	li	PROPN
admet-3007	451	6	,	,	PUNCT
admet-3007	451	7	b.	b.	PROPN
admet-3007	451	8	tiede	tiede	PROPN
admet-3007	451	9	,	,	PUNCT
admet-3007	451	10	j.	j.	PROPN
admet-3007	451	11	massagué	massagué	PROPN
admet-3007	451	12	,	,	PUNCT
admet-3007	451	13	y.	y.	PROPN
admet-3007	451	14	kang	kang	PROPN
admet-3007	451	15	.	.	PUNCT
admet-3007	452	1	beyond	beyond	ADP
admet-3007	452	2	tumorigenesis	tumorigenesis	NOUN
admet-3007	452	3	:	:	PUNCT
admet-3007	452	4	cancer	cancer	NOUN
admet-3007	452	5	stem	stem	NOUN
admet-3007	452	6	cells	cell	NOUN
admet-3007	452	7	in	in	ADP
admet-3007	452	8	metastasis	metastasis	NOUN
admet-3007	452	9	.	.	PUNCT
admet-3007	453	1	cell	cell	NOUN
admet-3007	453	2	research	research	NOUN
admet-3007	453	3	17	17	NUM
admet-3007	453	4	(	(	PUNCT
admet-3007	453	5	2007	2007	NUM
admet-3007	453	6	)	)	PUNCT
admet-3007	453	7	3	3	NUM
admet-3007	453	8	-	-	SYM
admet-3007	453	9	14	14	NUM
admet-3007	453	10	.	.	PUNCT
admet-3007	454	1	https://doi.org/10.1038/sj.cr.7310118	https://doi.org/10.1038/sj.cr.7310118	PROPN
admet-3007	455	1	[	[	X
admet-3007	455	2	17	17	NUM
admet-3007	455	3	]	]	PUNCT
admet-3007	455	4	a.	a.	NOUN
admet-3007	455	5	biddle	biddle	PROPN
admet-3007	455	6	,	,	PUNCT
admet-3007	455	7	i.c	i.c	PROPN
admet-3007	455	8	.	.	PROPN
admet-3007	455	9	mackenzie	mackenzie	PROPN
admet-3007	455	10	.	.	PUNCT
admet-3007	456	1	cancer	cancer	NOUN
admet-3007	456	2	stem	stem	NOUN
admet-3007	456	3	cells	cell	NOUN
admet-3007	456	4	and	and	CCONJ
admet-3007	456	5	emt	emt	NOUN
admet-3007	456	6	in	in	ADP
admet-3007	456	7	carcinoma	carcinoma	NOUN
admet-3007	456	8	.	.	PUNCT
admet-3007	457	1	cancer	cancer	NOUN
admet-3007	457	2	and	and	CCONJ
admet-3007	457	3	metastasis	metastasis	NOUN
admet-3007	457	4	reviews	review	VERB
admet-3007	457	5	31	31	NUM
admet-3007	457	6	(	(	PUNCT
admet-3007	457	7	2012	2012	NUM
admet-3007	457	8	)	)	PUNCT
admet-3007	457	9	285	285	NUM
admet-3007	457	10	-	-	SYM
admet-3007	457	11	293	293	NUM
admet-3007	457	12	.	.	PUNCT
admet-3007	457	13	https://doi.org/10.1007/s10555-012-9345-0	https://doi.org/10.1007/s10555-012-9345-0	NUM
admet-3007	458	1	[	[	X
admet-3007	458	2	18	18	NUM
admet-3007	458	3	]	]	X
admet-3007	458	4	g.	g.	PROPN
admet-3007	458	5	basati	basati	PROPN
admet-3007	458	6	,	,	PUNCT
admet-3007	458	7	m.	m.	PROPN
admet-3007	458	8	khaksarian	khaksarian	PROPN
admet-3007	458	9	,	,	PUNCT
admet-3007	458	10	s.	s.	PROPN
admet-3007	458	11	abbaszadeh	abbaszadeh	PROPN
admet-3007	458	12	,	,	PUNCT
admet-3007	458	13	h.e	h.e	PROPN
admet-3007	458	14	.	.	PROPN
admet-3007	458	15	lashgarian	lashgarian	PROPN
admet-3007	458	16	,	,	PUNCT
admet-3007	458	17	a.	a.	PROPN
admet-3007	458	18	marzban	marzban	PROPN
admet-3007	458	19	.	.	PUNCT
admet-3007	459	1	cancer	cancer	NOUN
admet-3007	459	2	stem	stem	NOUN
admet-3007	459	3	cells	cell	NOUN
admet-3007	459	4	and	and	CCONJ
admet-3007	459	5	nanotechnological	nanotechnological	ADJ
admet-3007	459	6	approaches	approach	NOUN
admet-3007	459	7	for	for	ADP
admet-3007	459	8	eradication	eradication	NOUN
admet-3007	459	9	.	.	PUNCT
admet-3007	460	1	stem	stem	NOUN
admet-3007	460	2	cell	cell	NOUN
admet-3007	460	3	investigation	investigation	NOUN
admet-3007	460	4	6	6	NUM
admet-3007	460	5	(	(	PUNCT
admet-3007	460	6	2019	2019	NUM
admet-3007	460	7	)	)	PUNCT
admet-3007	460	8	38	38	NUM
admet-3007	460	9	.	.	PUNCT
admet-3007	461	1	https://doi.org/10.21037/sci.2019.10.07	https://doi.org/10.21037/sci.2019.10.07	X
admet-3007	462	1	[	[	X
admet-3007	462	2	19	19	NUM
admet-3007	462	3	]	]	X
admet-3007	462	4	i.	i.	PROPN
admet-3007	462	5	conde	conde	PROPN
admet-3007	462	6	,	,	PUNCT
admet-3007	462	7	a.s	a.s	PROPN
admet-3007	462	8	.	.	PROPN
admet-3007	462	9	ribeiro	ribeiro	PROPN
admet-3007	462	10	,	,	PUNCT
admet-3007	462	11	j.	j.	PROPN
admet-3007	462	12	paredes	paredes	PROPN
admet-3007	462	13	.	.	PUNCT
admet-3007	462	14	breast	breast	NOUN
admet-3007	462	15	cancer	cancer	NOUN
admet-3007	462	16	stem	stem	NOUN
admet-3007	462	17	cell	cell	NOUN
admet-3007	462	18	membrane	membrane	NOUN
admet-3007	462	19	biomarkers	biomarker	NOUN
admet-3007	462	20	:	:	PUNCT
admet-3007	462	21	therapy	therapy	NOUN
admet-3007	462	22	targeting	target	VERB
admet-3007	462	23	and	and	CCONJ
admet-3007	462	24	clinical	clinical	ADJ
admet-3007	462	25	implications	implication	NOUN
admet-3007	462	26	.	.	PUNCT
admet-3007	463	1	cells	cell	NOUN
admet-3007	463	2	11	11	NUM
admet-3007	463	3	(	(	PUNCT
admet-3007	463	4	2022	2022	NUM
admet-3007	463	5	)	)	PUNCT
admet-3007	463	6	934	934	NUM
admet-3007	463	7	.	.	PUNCT
admet-3007	464	1	https://doi.org/10.3390/cells11060934	https://doi.org/10.3390/cells11060934	NOUN
admet-3007	465	1	[	[	X
admet-3007	465	2	20	20	NUM
admet-3007	465	3	]	]	PUNCT
admet-3007	465	4	k.	k.	PROPN
admet-3007	465	5	frąszczak	frąszczak	PROPN
admet-3007	465	6	,	,	PUNCT
admet-3007	465	7	b.	b.	PROPN
admet-3007	465	8	barczyński	barczyński	PROPN
admet-3007	465	9	.	.	PUNCT
admet-3007	466	1	the	the	DET
admet-3007	466	2	role	role	NOUN
admet-3007	466	3	of	of	ADP
admet-3007	466	4	cancer	cancer	NOUN
admet-3007	466	5	stem	stem	NOUN
admet-3007	466	6	cell	cell	NOUN
admet-3007	466	7	markers	marker	NOUN
admet-3007	466	8	in	in	ADP
admet-3007	466	9	ovarian	ovarian	ADJ
admet-3007	466	10	cancer	cancer	NOUN
admet-3007	466	11	.	.	PUNCT
admet-3007	467	1	cancers	cancer	NOUN
admet-3007	467	2	16	16	NUM
admet-3007	467	3	(	(	PUNCT
admet-3007	467	4	2023	2023	NUM
admet-3007	467	5	)	)	PUNCT
admet-3007	467	6	40	40	NUM
admet-3007	467	7	.	.	PUNCT
admet-3007	468	1	https://doi.org/10.3390/cancers16010040	https://doi.org/10.3390/cancers16010040	PROPN
admet-3007	468	2	[	[	X
admet-3007	468	3	21	21	NUM
admet-3007	468	4	]	]	X
admet-3007	468	5	y.	y.	PROPN
admet-3007	468	6	zheng	zheng	PROPN
admet-3007	468	7	,	,	PUNCT
admet-3007	468	8	l.	l.	PROPN
admet-3007	468	9	wang	wang	PROPN
admet-3007	468	10	,	,	PUNCT
admet-3007	468	11	l.	l.	PROPN
admet-3007	468	12	yin	yin	PROPN
admet-3007	468	13	,	,	PUNCT
admet-3007	468	14	z.	z.	PROPN
admet-3007	468	15	yao	yao	PROPN
admet-3007	468	16	,	,	PUNCT
admet-3007	468	17	r.	r.	PROPN
admet-3007	468	18	tong	tong	PROPN
admet-3007	468	19	,	,	PUNCT
admet-3007	468	20	j.	j.	PROPN
admet-3007	468	21	xue	xue	PROPN
admet-3007	468	22	,	,	PUNCT
admet-3007	468	23	y.	y.	PROPN
admet-3007	468	24	lu	lu	PROPN
admet-3007	468	25	.	.	PUNCT
admet-3007	469	1	lung	lung	NOUN
admet-3007	469	2	cancer	cancer	NOUN
admet-3007	469	3	stem	stem	NOUN
admet-3007	469	4	cell	cell	NOUN
admet-3007	469	5	markers	marker	NOUN
admet-3007	469	6	as	as	ADP
admet-3007	469	7	therapeutic	therapeutic	ADJ
admet-3007	469	8	targets	target	NOUN
admet-3007	469	9	:	:	PUNCT
admet-3007	469	10	an	an	DET
admet-3007	469	11	update	update	NOUN
admet-3007	469	12	on	on	ADP
admet-3007	469	13	signaling	signal	VERB
admet-3007	469	14	pathways	pathway	NOUN
admet-3007	469	15	and	and	CCONJ
admet-3007	469	16	therapies	therapy	NOUN
admet-3007	469	17	.	.	PUNCT
admet-3007	470	1	frontiers	frontier	NOUN
admet-3007	470	2	in	in	ADP
admet-3007	470	3	oncology	oncology	NOUN
admet-3007	470	4	12	12	NUM
admet-3007	470	5	(	(	PUNCT
admet-3007	470	6	2022	2022	NUM
admet-3007	470	7	)	)	PUNCT
admet-3007	470	8	873994	873994	NUM
admet-3007	470	9	.	.	PUNCT
admet-3007	471	1	https://doi.org/10.3389/fonc.2022.873994	https://doi.org/10.3389/fonc.2022.873994	PROPN
admet-3007	472	1	[	[	X
admet-3007	472	2	22	22	NUM
admet-3007	472	3	]	]	PUNCT
admet-3007	472	4	v.	v.	ADP
admet-3007	472	5	sumbly	sumbly	PROPN
admet-3007	472	6	,	,	PUNCT
admet-3007	472	7	i.	i.	PROPN
admet-3007	472	8	landry	landry	PROPN
admet-3007	472	9	.	.	PUNCT
admet-3007	473	1	understanding	understand	VERB
admet-3007	473	2	pancreatic	pancreatic	ADJ
admet-3007	473	3	cancer	cancer	NOUN
admet-3007	473	4	stem	stem	NOUN
admet-3007	473	5	cells	cell	NOUN
admet-3007	473	6	and	and	CCONJ
admet-3007	473	7	their	their	PRON
admet-3007	473	8	role	role	NOUN
admet-3007	473	9	in	in	ADP
admet-3007	473	10	carcinogenesis	carcinogenesis	NOUN
admet-3007	473	11	:	:	PUNCT
admet-3007	473	12	a	a	DET
admet-3007	473	13	narrative	narrative	NOUN
admet-3007	473	14	review	review	NOUN
admet-3007	473	15	.	.	PUNCT
admet-3007	474	1	stem	stem	NOUN
admet-3007	474	2	cell	cell	NOUN
admet-3007	474	3	investigation	investigation	NOUN
admet-3007	474	4	9	9	NUM
admet-3007	474	5	(	(	PUNCT
admet-3007	474	6	2022	2022	NUM
admet-3007	474	7	)	)	PUNCT
admet-3007	474	8	1	1	NUM
admet-3007	474	9	.	.	PUNCT
admet-3007	475	1	https://doi.org/10.21037/sci-2021-067	https://doi.org/10.21037/sci-2021-067	NOUN
admet-3007	475	2	[	[	X
admet-3007	475	3	23	23	NUM
admet-3007	475	4	]	]	PUNCT
admet-3007	475	5	m.	m.	NOUN
admet-3007	475	6	fedyanin	fedyanin	NOUN
admet-3007	475	7	,	,	PUNCT
admet-3007	475	8	p.	p.	NOUN
admet-3007	475	9	anna	anna	PROPN
admet-3007	475	10	,	,	PUNCT
admet-3007	475	11	p.	p.	PROPN
admet-3007	475	12	elizaveta	elizaveta	PROPN
admet-3007	475	13	,	,	PUNCT
admet-3007	475	14	t.	t.	PROPN
admet-3007	475	15	sergei	sergei	PROPN
admet-3007	475	16	.	.	PUNCT
admet-3007	476	1	role	role	NOUN
admet-3007	476	2	of	of	ADP
admet-3007	476	3	stem	stem	NOUN
admet-3007	476	4	cells	cell	NOUN
admet-3007	476	5	in	in	ADP
admet-3007	476	6	colorectal	colorectal	ADJ
admet-3007	476	7	cancer	cancer	NOUN
admet-3007	476	8	progression	progression	NOUN
admet-3007	476	9	and	and	CCONJ
admet-3007	476	10	prognostic	prognostic	ADJ
admet-3007	476	11	and	and	CCONJ
admet-3007	476	12	predictive	predictive	ADJ
admet-3007	476	13	characteristics	characteristic	NOUN
admet-3007	476	14	of	of	ADP
admet-3007	476	15	stem	stem	NOUN
admet-3007	476	16	cell	cell	NOUN
admet-3007	476	17	markers	marker	NOUN
admet-3007	476	18	in	in	ADP
admet-3007	476	19	colorectal	colorectal	ADJ
admet-3007	476	20	cancer	cancer	NOUN
admet-3007	476	21	.	.	PUNCT
admet-3007	477	1	current	current	ADJ
admet-3007	477	2	stem	stem	NOUN
admet-3007	477	3	cell	cell	NOUN
admet-3007	477	4	research	research	NOUN
admet-3007	477	5	&	&	CCONJ
admet-3007	477	6	therapy	therapy	PROPN
admet-3007	477	7	12	12	NUM
admet-3007	477	8	(	(	PUNCT
admet-3007	477	9	2017	2017	NUM
admet-3007	477	10	)	)	PUNCT
admet-3007	477	11	19	19	NUM
admet-3007	477	12	-	-	SYM
admet-3007	477	13	30	30	NUM
admet-3007	477	14	.	.	PUNCT
admet-3007	478	1	https://doi.org/10.2174/1574888x11666160905092938	https://doi.org/10.2174/1574888x11666160905092938	PROPN
admet-3007	479	1	[	[	X
admet-3007	479	2	24	24	NUM
admet-3007	479	3	]	]	X
admet-3007	479	4	i.m	i.m	PROPN
admet-3007	479	5	.	.	PUNCT
admet-3007	479	6	koukourakis	koukourakis	PROPN
admet-3007	479	7	,	,	PUNCT
admet-3007	479	8	k.	k.	PROPN
admet-3007	479	9	platoni	platoni	PROPN
admet-3007	479	10	,	,	PUNCT
admet-3007	479	11	v.	v.	PROPN
admet-3007	479	12	kouloulias	kouloulias	PROPN
admet-3007	479	13	,	,	PUNCT
admet-3007	479	14	s.	s.	PROPN
admet-3007	479	15	arelaki	arelaki	PROPN
admet-3007	479	16	,	,	PUNCT
admet-3007	479	17	a.	a.	PROPN
admet-3007	479	18	zygogianni	zygogianni	PROPN
admet-3007	479	19	.	.	PUNCT
admet-3007	480	1	prostate	prostate	NOUN
admet-3007	480	2	cancer	cancer	NOUN
admet-3007	480	3	stem	stem	NOUN
admet-3007	480	4	cells	cell	NOUN
admet-3007	480	5	:	:	PUNCT
admet-3007	480	6	biology	biology	NOUN
admet-3007	480	7	and	and	CCONJ
admet-3007	480	8	treatment	treatment	NOUN
admet-3007	480	9	implications	implication	NOUN
admet-3007	480	10	.	.	PUNCT
admet-3007	481	1	international	international	ADJ
admet-3007	481	2	journal	journal	NOUN
admet-3007	481	3	of	of	ADP
admet-3007	481	4	molecular	molecular	ADJ
admet-3007	481	5	sciences	science	NOUN
admet-3007	481	6	24	24	NUM
admet-3007	481	7	(	(	PUNCT
admet-3007	481	8	2023	2023	NUM
admet-3007	481	9	)	)	PUNCT
admet-3007	481	10	14890	14890	NUM
admet-3007	481	11	.	.	PUNCT
admet-3007	482	1	https://doi.org/10.3390/ijms241914890	https://doi.org/10.3390/ijms241914890	VERB
admet-3007	482	2	[	[	X
admet-3007	482	3	25	25	NUM
admet-3007	482	4	]	]	PUNCT
admet-3007	482	5	s.	s.	PROPN
admet-3007	482	6	lin	lin	PROPN
admet-3007	482	7	,	,	PUNCT
admet-3007	482	8	k.	k.	PROPN
admet-3007	482	9	li	li	PROPN
admet-3007	482	10	,	,	PUNCT
admet-3007	482	11	l.	l.	PROPN
admet-3007	482	12	qi	qi	PROPN
admet-3007	482	13	.	.	PUNCT
admet-3007	483	1	cancer	cancer	NOUN
admet-3007	483	2	stem	stem	NOUN
admet-3007	483	3	cells	cell	NOUN
admet-3007	483	4	in	in	ADP
admet-3007	483	5	brain	brain	NOUN
admet-3007	483	6	tumors	tumor	NOUN
admet-3007	483	7	:	:	PUNCT
admet-3007	483	8	from	from	ADP
admet-3007	483	9	origin	origin	NOUN
admet-3007	483	10	to	to	ADP
admet-3007	483	11	clinical	clinical	ADJ
admet-3007	483	12	implications	implication	NOUN
admet-3007	483	13	.	.	PUNCT
admet-3007	484	1	medcomm	medcomm	NOUN
admet-3007	484	2	4	4	NUM
admet-3007	484	3	(	(	PUNCT
admet-3007	484	4	2023	2023	NUM
admet-3007	484	5	)	)	PUNCT
admet-3007	484	6	e341	e341	PROPN
admet-3007	484	7	.	.	PUNCT
admet-3007	485	1	https://doi.org/10.1002/mco2.341	https://doi.org/10.1002/mco2.341	PROPN
admet-3007	486	1	[	[	X
admet-3007	486	2	26	26	NUM
admet-3007	486	3	]	]	X
admet-3007	486	4	r.	r.	PROPN
admet-3007	486	5	kinstrie	kinstrie	PROPN
admet-3007	486	6	,	,	PUNCT
admet-3007	486	7	g.a	g.a	PROPN
admet-3007	486	8	.	.	PROPN
admet-3007	486	9	horne	horne	PROPN
admet-3007	486	10	,	,	PUNCT
admet-3007	486	11	h.	h.	PROPN
admet-3007	486	12	morrison	morrison	PROPN
admet-3007	486	13	,	,	PUNCT
admet-3007	486	14	h.a	h.a	PROPN
admet-3007	486	15	.	.	PROPN
admet-3007	486	16	moka	moka	PROPN
admet-3007	486	17	,	,	PUNCT
admet-3007	486	18	j.	j.	PROPN
admet-3007	486	19	cassels	cassels	PROPN
admet-3007	486	20	,	,	PUNCT
admet-3007	486	21	k.	k.	PROPN
admet-3007	486	22	dunn	dunn	PROPN
admet-3007	486	23	,	,	PUNCT
admet-3007	486	24	p.	p.	PROPN
admet-3007	486	25	herzyk	herzyk	NOUN
admet-3007	486	26	,	,	PUNCT
admet-3007	486	27	d.a	d.a	PROPN
admet-3007	486	28	.	.	PROPN
admet-3007	486	29	irvine	irvine	PROPN
admet-3007	486	30	,	,	PUNCT
admet-3007	486	31	m.	m.	NOUN
admet-3007	486	32	copland	copland	PROPN
admet-3007	486	33	.	.	PUNCT
admet-3007	487	1	cd93	cd93	PROPN
admet-3007	487	2	is	be	AUX
admet-3007	487	3	a	a	DET
admet-3007	487	4	novel	novel	ADJ
admet-3007	487	5	biomarker	biomarker	NOUN
admet-3007	487	6	of	of	ADP
admet-3007	487	7	leukemia	leukemia	NOUN
admet-3007	487	8	stem	stem	NOUN
admet-3007	487	9	cells	cell	NOUN
admet-3007	487	10	in	in	ADP
admet-3007	487	11	chronic	chronic	ADJ
admet-3007	487	12	myeloid	myeloid	NOUN
admet-3007	487	13	leukemia	leukemia	NOUN
admet-3007	487	14	.	.	PUNCT
admet-3007	488	1	blood	blood	NOUN
admet-3007	488	2	126	126	NUM
admet-3007	488	3	(	(	PUNCT
admet-3007	488	4	2015	2015	NUM
admet-3007	488	5	)	)	PUNCT
admet-3007	488	6	49	49	NUM
admet-3007	488	7	.	.	PUNCT
admet-3007	489	1	https://doi.org/10.1182/blood.v126.23.49.49	https://doi.org/10.1182/blood.v126.23.49.49	PROPN
admet-3007	490	1	[	[	X
admet-3007	490	2	27	27	NUM
admet-3007	490	3	]	]	X
admet-3007	490	4	g.	g.	PROPN
admet-3007	490	5	civenni	civenni	PROPN
admet-3007	490	6	,	,	PUNCT
admet-3007	490	7	a.	a.	PROPN
admet-3007	490	8	walter	walter	PROPN
admet-3007	490	9	,	,	PUNCT
admet-3007	490	10	n.	n.	PROPN
admet-3007	490	11	kobert	kobert	PROPN
admet-3007	490	12	,	,	PUNCT
admet-3007	490	13	d.	d.	PROPN
admet-3007	490	14	mihic	mihic	ADV
admet-3007	490	15	-	-	PUNCT
admet-3007	490	16	probst	probst	NOUN
admet-3007	490	17	,	,	PUNCT
admet-3007	490	18	m.	m.	NOUN
admet-3007	490	19	zipser	zipser	NOUN
admet-3007	490	20	,	,	PUNCT
admet-3007	490	21	b.	b.	PROPN
admet-3007	490	22	belloni	belloni	PROPN
admet-3007	490	23	,	,	PUNCT
admet-3007	490	24	b.	b.	PROPN
admet-3007	490	25	seifert	seifert	PROPN
admet-3007	490	26	,	,	PUNCT
admet-3007	490	27	h.	h.	PROPN
admet-3007	490	28	moch	moch	PROPN
admet-3007	490	29	,	,	PUNCT
admet-3007	490	30	r.	r.	PROPN
admet-3007	490	31	dummer	dummer	PROPN
admet-3007	490	32	,	,	PUNCT
admet-3007	490	33	m.	m.	NOUN
admet-3007	490	34	van	van	PROPN
admet-3007	490	35	den	den	PROPN
admet-3007	490	36	broek	broek	PROPN
admet-3007	490	37	.	.	PUNCT
admet-3007	491	1	human	human	ADJ
admet-3007	491	2	cd271	cd271	PROPN
admet-3007	491	3	-	-	PUNCT
admet-3007	491	4	positive	positive	ADJ
admet-3007	491	5	melanoma	melanoma	NOUN
admet-3007	491	6	stem	stem	NOUN
admet-3007	491	7	cells	cell	NOUN
admet-3007	491	8	associated	associate	VERB
admet-3007	491	9	with	with	ADP
admet-3007	491	10	metastasis	metastasis	NOUN
admet-3007	491	11	establish	establish	VERB
admet-3007	491	12	tumor	tumor	NOUN
admet-3007	491	13	heterogeneity	heterogeneity	NOUN
admet-3007	491	14	and	and	CCONJ
admet-3007	491	15	long	long	ADJ
admet-3007	491	16	-	-	PUNCT
admet-3007	491	17	term	term	NOUN
admet-3007	491	18	growth	growth	NOUN
admet-3007	491	19	.	.	PUNCT
admet-3007	492	1	cancer	cancer	NOUN
admet-3007	492	2	research	research	NOUN
admet-3007	492	3	71	71	NUM
admet-3007	492	4	(	(	PUNCT
admet-3007	492	5	2011	2011	NUM
admet-3007	492	6	)	)	PUNCT
admet-3007	492	7	3098	3098	NUM
admet-3007	492	8	-	-	SYM
admet-3007	492	9	3109	3109	NUM
admet-3007	492	10	.	.	PUNCT
admet-3007	493	1	https://doi.org/10.1158/0008-5472.can-10-3997	https://doi.org/10.1158/0008-5472.can-10-3997	PUNCT
admet-3007	494	1	[	[	X
admet-3007	494	2	28	28	NUM
admet-3007	494	3	]	]	X
admet-3007	494	4	l.-a	l.-a	PROPN
admet-3007	494	5	.	.	PUNCT
admet-3007	495	1	schulte	schulte	PROPN
admet-3007	495	2	,	,	PUNCT
admet-3007	495	3	j.c	j.c	PROPN
admet-3007	495	4	.	.	PROPN
admet-3007	495	5	lópez	lópez	PROPN
admet-3007	495	6	-	-	PUNCT
admet-3007	495	7	gil	gil	PROPN
admet-3007	495	8	,	,	PUNCT
admet-3007	495	9	b.	b.	PROPN
admet-3007	495	10	sainz	sainz	PROPN
admet-3007	495	11	jr	jr	PROPN
admet-3007	495	12	,	,	PUNCT
admet-3007	495	13	p.c	p.c	PROPN
admet-3007	495	14	.	.	PROPN
admet-3007	495	15	hermann	hermann	PROPN
admet-3007	495	16	.	.	PUNCT
admet-3007	496	1	the	the	DET
admet-3007	496	2	cancer	cancer	NOUN
admet-3007	496	3	stem	stem	NOUN
admet-3007	496	4	cell	cell	NOUN
admet-3007	496	5	in	in	ADP
admet-3007	496	6	hepatocellular	hepatocellular	ADJ
admet-3007	496	7	carcinoma	carcinoma	NOUN
admet-3007	496	8	.	.	PUNCT
admet-3007	497	1	cancers	cancer	NOUN
admet-3007	497	2	12	12	NUM
admet-3007	497	3	(	(	PUNCT
admet-3007	497	4	2020	2020	NUM
admet-3007	497	5	)	)	PUNCT
admet-3007	497	6	684	684	NUM
admet-3007	497	7	.	.	PUNCT
admet-3007	498	1	https://doi.org/10.3390/cancers12030684	https://doi.org/10.3390/cancers12030684	X
admet-3007	499	1	[	[	X
admet-3007	499	2	29	29	NUM
admet-3007	499	3	]	]	PUNCT
admet-3007	499	4	n.-s	n.-	NOUN
admet-3007	499	5	.	.	PUNCT
admet-3007	500	1	wang	wang	PROPN
admet-3007	500	2	,	,	PUNCT
admet-3007	500	3	m.	m.	PROPN
admet-3007	500	4	wei	wei	PROPN
admet-3007	500	5	,	,	PUNCT
admet-3007	500	6	w.-l	w.-l	PROPN
admet-3007	500	7	.	.	PUNCT
admet-3007	501	1	ma	ma	PROPN
admet-3007	501	2	,	,	PUNCT
admet-3007	501	3	w.	w.	PROPN
admet-3007	501	4	meng	meng	PROPN
admet-3007	501	5	,	,	PUNCT
admet-3007	501	6	w.-l	w.-l	PROPN
admet-3007	501	7	.	.	PUNCT
admet-3007	502	1	zheng	zheng	PROPN
admet-3007	502	2	.	.	PUNCT
admet-3007	503	1	knockdown	knockdown	NOUN
admet-3007	503	2	of	of	ADP
admet-3007	503	3	cd44	cd44	PROPN
admet-3007	503	4	enhances	enhance	VERB
admet-3007	503	5	chemosensitivity	chemosensitivity	NOUN
admet-3007	503	6	of	of	ADP
admet-3007	503	7	acute	acute	ADJ
admet-3007	503	8	myeloid	myeloid	NOUN
admet-3007	503	9	leukemia	leukemia	NOUN
admet-3007	503	10	cells	cell	NOUN
admet-3007	503	11	to	to	ADP
admet-3007	503	12	adm	adm	PROPN
admet-3007	503	13	and	and	CCONJ
admet-3007	503	14	ara	ara	PROPN
admet-3007	503	15	-	-	PUNCT
admet-3007	503	16	c.	c.	PROPN
admet-3007	503	17	tumor	tumor	NOUN
admet-3007	503	18	biology	biology	NOUN
admet-3007	503	19	35	35	NUM
admet-3007	503	20	(	(	PUNCT
admet-3007	503	21	2014	2014	NUM
admet-3007	503	22	)	)	PUNCT
admet-3007	503	23	3933	3933	NUM
admet-3007	503	24	-	-	SYM
admet-3007	503	25	3940	3940	NUM
admet-3007	503	26	.	.	PUNCT
admet-3007	504	1	https://doi.org/10.1007/s13277-013-1523-3	https://doi.org/10.1007/s13277-013-1523-3	NUM
admet-3007	504	2	https://doi.org/10.5599/admet.3007	https://doi.org/10.5599/admet.3007	NOUN
admet-3007	504	3	https://doi.org/10.1126/science.1962191	https://doi.org/10.1126/science.1962191	X
admet-3007	504	4	https://www.mdpi.com/2073-4360/14/3/476	https://www.mdpi.com/2073-4360/14/3/476	NOUN
admet-3007	504	5	https://doi.org/10.1016/j.indcrop.2017.09.001	https://doi.org/10.1016/j.indcrop.2017.09.001	PROPN
admet-3007	504	6	https://doi.org/10.1016/j.oraloncology.2011.10.004	https://doi.org/10.1016/j.oraloncology.2011.10.004	PROPN
admet-3007	504	7	https://scholar.google.com/scholar_lookup?journal=regenerative%20med&title=are%20stem%20cells%20involved%20in%20cancer&author=ca%20goldthwaite&volume=9&publication_year=2006&pages=89-96	https://scholar.google.com/scholar_lookup?journal=regenerative%20med&title=are%20stem%20cells%20involved%20in%20cancer&author=ca%20goldthwaite&volume=9&publication_year=2006&pages=89-96	NOUN
admet-3007	504	8	&	&	CCONJ
admet-3007	504	9	https://doi.org/10.1038/sj.cr.7310118	https://doi.org/10.1038/sj.cr.7310118	PROPN
admet-3007	504	10	https://doi.org/10.1007/s10555-012-9345-0	https://doi.org/10.1007/s10555-012-9345-0	NUM
admet-3007	504	11	https://doi.org/10.21037/sci.2019.10.07	https://doi.org/10.21037/sci.2019.10.07	PROPN
admet-3007	504	12	https://doi.org/10.3390/cells11060934	https://doi.org/10.3390/cells11060934	NOUN
admet-3007	504	13	https://doi.org/10.3390/cancers16010040	https://doi.org/10.3390/cancers16010040	VERB
admet-3007	504	14	https://doi.org/10.3389/fonc.2022.873994	https://doi.org/10.3389/fonc.2022.873994	PROPN
admet-3007	504	15	https://doi.org/10.21037/sci-2021-067	https://doi.org/10.21037/sci-2021-067	VERB
admet-3007	504	16	https://doi.org/10.2174/1574888x11666160905092938	https://doi.org/10.2174/1574888x11666160905092938	PRON
admet-3007	504	17	https://doi.org/10.3390/ijms241914890	https://doi.org/10.3390/ijms241914890	NOUN
admet-3007	504	18	https://doi.org/10.1002/mco2.341	https://doi.org/10.1002/mco2.341	PROPN
admet-3007	504	19	https://doi.org/10.1182/blood.v126.23.49.49	https://doi.org/10.1182/blood.v126.23.49.49	PROPN
admet-3007	504	20	https://doi.org/10.1158/0008-5472.can-10-3997	https://doi.org/10.1158/0008-5472.can-10-3997	X
admet-3007	505	1	https://doi.org/10.3390/cancers12030684	https://doi.org/10.3390/cancers12030684	PROPN
admet-3007	505	2	https://doi.org/10.1007/s13277-013-1523-3	https://doi.org/10.1007/s13277-013-1523-3	PROPN
admet-3007	505	3	m.	m.	NOUN
admet-3007	505	4	dehghani	dehghani	PROPN
admet-3007	505	5	et	et	PROPN
admet-3007	505	6	al	al	PROPN
admet-3007	505	7	.	.	PROPN
admet-3007	505	8	admet	admet	PROPN
admet-3007	505	9	&	&	CCONJ
admet-3007	505	10	dmpk	dmpk	PROPN
admet-3007	505	11	13(5	13(5	NUM
admet-3007	505	12	)	)	PUNCT
admet-3007	505	13	(	(	PUNCT
admet-3007	505	14	2025	2025	NUM
admet-3007	505	15	)	)	PUNCT
admet-3007	505	16	3007	3007	NUM
admet-3007	505	17	20	20	NUM
admet-3007	505	18	[	[	SYM
admet-3007	505	19	30	30	NUM
admet-3007	505	20	]	]	PUNCT
admet-3007	505	21	z.	z.	PROPN
admet-3007	505	22	li	li	PROPN
admet-3007	505	23	.	.	PUNCT
admet-3007	506	1	cd133	cd133	NOUN
admet-3007	506	2	:	:	PUNCT
admet-3007	506	3	a	a	DET
admet-3007	506	4	stem	stem	NOUN
admet-3007	506	5	cell	cell	NOUN
admet-3007	506	6	biomarker	biomarker	NOUN
admet-3007	506	7	and	and	CCONJ
admet-3007	506	8	beyond	beyond	ADP
admet-3007	506	9	.	.	PUNCT
admet-3007	507	1	experimental	experimental	ADJ
admet-3007	507	2	hematology	hematology	PROPN
admet-3007	507	3	&	&	CCONJ
admet-3007	507	4	oncology	oncology	NOUN
admet-3007	507	5	2	2	NUM
admet-3007	507	6	(	(	PUNCT
admet-3007	507	7	2013	2013	NUM
admet-3007	507	8	)	)	PUNCT
admet-3007	507	9	17	17	NUM
admet-3007	507	10	.	.	PUNCT
admet-3007	507	11	https://doi.org/10.1186/2162-3619-2-17	https://doi.org/10.1186/2162-3619-2-17	PUNCT
admet-3007	508	1	[	[	X
admet-3007	508	2	31	31	NUM
admet-3007	508	3	]	]	PUNCT
admet-3007	508	4	a.	a.	NOUN
admet-3007	508	5	koren	koren	PROPN
admet-3007	508	6	,	,	PUNCT
admet-3007	508	7	m.	m.	NOUN
admet-3007	508	8	rijavec	rijavec	PROPN
admet-3007	508	9	,	,	PUNCT
admet-3007	508	10	i.	i.	PROPN
admet-3007	508	11	kern	kern	PROPN
admet-3007	508	12	,	,	PUNCT
admet-3007	508	13	e.	e.	PROPN
admet-3007	508	14	sodja	sodja	PROPN
admet-3007	508	15	,	,	PUNCT
admet-3007	508	16	p.	p.	PROPN
admet-3007	508	17	korosec	korosec	PROPN
admet-3007	508	18	,	,	PUNCT
admet-3007	508	19	t.	t.	NOUN
admet-3007	508	20	cufer	cufer	NOUN
admet-3007	508	21	.	.	PUNCT
admet-3007	509	1	bmi1	bmi1	PROPN
admet-3007	509	2	,	,	PUNCT
admet-3007	509	3	aldh1a1	aldh1a1	ADV
admet-3007	509	4	,	,	PUNCT
admet-3007	509	5	and	and	CCONJ
admet-3007	509	6	cd133	cd133	ADJ
admet-3007	509	7	transcripts	transcript	NOUN
admet-3007	509	8	connect	connect	VERB
admet-3007	509	9	epithelial	epithelial	ADJ
admet-3007	509	10	-	-	PUNCT
admet-3007	509	11	mesenchymal	mesenchymal	ADJ
admet-3007	509	12	transition	transition	NOUN
admet-3007	509	13	to	to	ADP
admet-3007	509	14	cancer	cancer	NOUN
admet-3007	509	15	stem	stem	NOUN
admet-3007	509	16	cells	cell	NOUN
admet-3007	509	17	in	in	ADP
admet-3007	509	18	lung	lung	NOUN
admet-3007	509	19	carcinoma	carcinoma	NOUN
admet-3007	509	20	.	.	PUNCT
admet-3007	510	1	stem	stem	NOUN
admet-3007	510	2	cells	cell	NOUN
admet-3007	510	3	international	international	ADJ
admet-3007	510	4	2016	2016	NUM
admet-3007	510	5	(	(	PUNCT
admet-3007	510	6	2016	2016	NUM
admet-3007	510	7	)	)	PUNCT
admet-3007	510	8	9714315	9714315	NUM
admet-3007	510	9	.	.	PUNCT
admet-3007	511	1	https://doi.org/10.1155/2016/9714315	https://doi.org/10.1155/2016/9714315	PROPN
admet-3007	512	1	[	[	X
admet-3007	512	2	32	32	NUM
admet-3007	512	3	]	]	PUNCT
admet-3007	512	4	z.	z.	PROPN
admet-3007	512	5	pei	pei	PROPN
admet-3007	512	6	,	,	PUNCT
admet-3007	512	7	g.	g.	PROPN
admet-3007	512	8	zhu	zhu	PROPN
admet-3007	512	9	,	,	PUNCT
admet-3007	512	10	x.	x.	PROPN
admet-3007	512	11	huo	huo	PROPN
admet-3007	512	12	,	,	PUNCT
admet-3007	512	13	l.	l.	PROPN
admet-3007	512	14	gao	gao	PROPN
admet-3007	512	15	,	,	PUNCT
admet-3007	512	16	s.	s.	PROPN
admet-3007	512	17	liao	liao	PROPN
admet-3007	512	18	,	,	PUNCT
admet-3007	512	19	j.	j.	PROPN
admet-3007	512	20	he	he	PROPN
admet-3007	512	21	,	,	PUNCT
admet-3007	512	22	y.	y.	PROPN
admet-3007	512	23	long	long	PROPN
admet-3007	512	24	,	,	PUNCT
admet-3007	512	25	h.	h.	PROPN
admet-3007	512	26	yi	yi	PROPN
admet-3007	512	27	,	,	PUNCT
admet-3007	512	28	s.	s.	PROPN
admet-3007	512	29	xiao	xiao	PROPN
admet-3007	512	30	,	,	PUNCT
admet-3007	512	31	w.	w.	PROPN
admet-3007	512	32	yi	yi	PROPN
admet-3007	512	33	.	.	PUNCT
admet-3007	513	1	cd24	cd24	PROPN
admet-3007	513	2	promotes	promote	VERB
admet-3007	513	3	the	the	DET
admet-3007	513	4	proliferation	proliferation	NOUN
admet-3007	513	5	and	and	CCONJ
admet-3007	513	6	inhibits	inhibit	VERB
admet-3007	513	7	the	the	DET
admet-3007	513	8	apoptosis	apoptosis	NOUN
admet-3007	513	9	of	of	ADP
admet-3007	513	10	cervical	cervical	ADJ
admet-3007	513	11	cancer	cancer	NOUN
admet-3007	513	12	cells	cell	NOUN
admet-3007	513	13	in	in	ADP
admet-3007	513	14	vitro	vitro	X
admet-3007	513	15	.	.	PUNCT
admet-3007	514	1	oncology	oncology	NOUN
admet-3007	514	2	reports	report	VERB
admet-3007	514	3	35	35	NUM
admet-3007	514	4	(	(	PUNCT
admet-3007	514	5	2016	2016	NUM
admet-3007	514	6	)	)	PUNCT
admet-3007	514	7	1593	1593	NUM
admet-3007	514	8	-	-	SYM
admet-3007	514	9	1601	1601	NUM
admet-3007	514	10	.	.	PUNCT
admet-3007	515	1	https://doi.org/10.3892/or.2015.4521	https://doi.org/10.3892/or.2015.4521	NOUN
admet-3007	515	2	[	[	X
admet-3007	515	3	33	33	NUM
admet-3007	515	4	]	]	X
admet-3007	515	5	y.	y.	PROPN
admet-3007	515	6	zhou	zhou	PROPN
admet-3007	515	7	,	,	PUNCT
admet-3007	515	8	l.	l.	PROPN
admet-3007	515	9	xia	xia	PROPN
admet-3007	515	10	,	,	PUNCT
admet-3007	515	11	h.	h.	PROPN
admet-3007	515	12	wang	wang	PROPN
admet-3007	515	13	,	,	PUNCT
admet-3007	515	14	l.	l.	PROPN
admet-3007	515	15	oyang	oyang	PROPN
admet-3007	515	16	,	,	PUNCT
admet-3007	515	17	m.	m.	PROPN
admet-3007	515	18	su	su	PROPN
admet-3007	515	19	,	,	PUNCT
admet-3007	515	20	q.	q.	PROPN
admet-3007	515	21	liu	liu	PROPN
admet-3007	515	22	,	,	PUNCT
admet-3007	515	23	j.	j.	PROPN
admet-3007	515	24	lin	lin	PROPN
admet-3007	515	25	,	,	PUNCT
admet-3007	515	26	s.	s.	PROPN
admet-3007	515	27	tan	tan	PROPN
admet-3007	515	28	,	,	PUNCT
admet-3007	515	29	y.	y.	PROPN
admet-3007	515	30	tian	tian	PROPN
admet-3007	515	31	,	,	PUNCT
admet-3007	515	32	q.	q.	PROPN
admet-3007	515	33	liao	liao	PROPN
admet-3007	515	34	.	.	PUNCT
admet-3007	516	1	cancer	cancer	NOUN
admet-3007	516	2	stem	stem	NOUN
admet-3007	516	3	cells	cell	NOUN
admet-3007	516	4	in	in	ADP
admet-3007	516	5	progression	progression	NOUN
admet-3007	516	6	of	of	ADP
admet-3007	516	7	colorectal	colorectal	ADJ
admet-3007	516	8	cancer	cancer	NOUN
admet-3007	516	9	.	.	PUNCT
admet-3007	517	1	oncotarget	oncotarget	NOUN
admet-3007	517	2	9	9	NUM
admet-3007	517	3	(	(	PUNCT
admet-3007	517	4	2018	2018	NUM
admet-3007	517	5	)	)	PUNCT
admet-3007	517	6	33403	33403	NUM
admet-3007	517	7	.	.	PUNCT
admet-3007	518	1	https://doi.org/10.18632/oncotarget.23607	https://doi.org/10.18632/oncotarget.23607	VERB
admet-3007	518	2	[	[	X
admet-3007	518	3	34	34	NUM
admet-3007	518	4	]	]	X
admet-3007	518	5	r.	r.	PROPN
admet-3007	518	6	januchowski	januchowski	PROPN
admet-3007	518	7	,	,	PUNCT
admet-3007	518	8	k.	k.	PROPN
admet-3007	518	9	wojtowicz	wojtowicz	PROPN
admet-3007	518	10	,	,	PUNCT
admet-3007	518	11	m.	m.	NOUN
admet-3007	518	12	zabel	zabel	PROPN
admet-3007	518	13	.	.	PUNCT
admet-3007	519	1	the	the	DET
admet-3007	519	2	role	role	NOUN
admet-3007	519	3	of	of	ADP
admet-3007	519	4	aldehyde	aldehyde	NOUN
admet-3007	519	5	dehydrogenase	dehydrogenase	NOUN
admet-3007	519	6	(	(	PUNCT
admet-3007	519	7	aldh	aldh	NOUN
admet-3007	519	8	)	)	PUNCT
admet-3007	519	9	in	in	ADP
admet-3007	519	10	cancer	cancer	NOUN
admet-3007	519	11	drug	drug	NOUN
admet-3007	519	12	resistance	resistance	NOUN
admet-3007	519	13	.	.	PUNCT
admet-3007	520	1	biomedicine	biomedicine	NOUN
admet-3007	520	2	&	&	CCONJ
admet-3007	520	3	pharmacotherapy	pharmacotherapy	NOUN
admet-3007	520	4	67	67	NUM
admet-3007	520	5	(	(	PUNCT
admet-3007	520	6	2013	2013	NUM
admet-3007	520	7	)	)	PUNCT
admet-3007	520	8	669	669	NUM
admet-3007	520	9	-	-	SYM
admet-3007	520	10	680	680	NUM
admet-3007	520	11	.	.	PUNCT
admet-3007	521	1	https://doi.org/10.1016/j.biopha.2013.04.005	https://doi.org/10.1016/j.biopha.2013.04.005	PROPN
admet-3007	522	1	[	[	X
admet-3007	522	2	35	35	NUM
admet-3007	522	3	]	]	PUNCT
admet-3007	522	4	p.	p.	PROPN
admet-3007	522	5	marcato	marcato	PROPN
admet-3007	522	6	,	,	PUNCT
admet-3007	522	7	c.a	c.a	PROPN
admet-3007	522	8	.	.	PROPN
admet-3007	522	9	dean	dean	PROPN
admet-3007	522	10	,	,	PUNCT
admet-3007	522	11	d.	d.	PROPN
admet-3007	522	12	pan	pan	PROPN
admet-3007	522	13	,	,	PUNCT
admet-3007	522	14	r.	r.	PROPN
admet-3007	522	15	araslanova	araslanova	PROPN
admet-3007	522	16	,	,	PUNCT
admet-3007	522	17	m.	m.	PROPN
admet-3007	522	18	gillis	gillis	PROPN
admet-3007	522	19	,	,	PUNCT
admet-3007	522	20	m.	m.	PROPN
admet-3007	522	21	joshi	joshi	PROPN
admet-3007	522	22	,	,	PUNCT
admet-3007	522	23	l.	l.	PROPN
admet-3007	522	24	helyer	helyer	PROPN
admet-3007	522	25	,	,	PUNCT
admet-3007	522	26	l.	l.	PROPN
admet-3007	522	27	pan	pan	PROPN
admet-3007	522	28	,	,	PUNCT
admet-3007	522	29	a.	a.	NOUN
admet-3007	522	30	leidal	leidal	PROPN
admet-3007	522	31	,	,	PUNCT
admet-3007	522	32	s.	s.	PROPN
admet-3007	522	33	gujar	gujar	PROPN
admet-3007	522	34	.	.	PUNCT
admet-3007	523	1	aldehyde	aldehyde	NOUN
admet-3007	523	2	dehydrogenase	dehydrogenase	NOUN
admet-3007	523	3	activity	activity	NOUN
admet-3007	523	4	of	of	ADP
admet-3007	523	5	breast	breast	NOUN
admet-3007	523	6	cancer	cancer	NOUN
admet-3007	523	7	stem	stem	NOUN
admet-3007	523	8	cells	cell	NOUN
admet-3007	523	9	is	be	AUX
admet-3007	523	10	primarily	primarily	ADV
admet-3007	523	11	due	due	ADJ
admet-3007	523	12	to	to	ADP
admet-3007	523	13	isoform	isoform	VERB
admet-3007	523	14	aldh1a3	aldh1a3	NOUN
admet-3007	523	15	and	and	CCONJ
admet-3007	523	16	its	its	PRON
admet-3007	523	17	expression	expression	NOUN
admet-3007	523	18	is	be	AUX
admet-3007	523	19	predictive	predictive	ADJ
admet-3007	523	20	of	of	ADP
admet-3007	523	21	metastasis	metastasis	NOUN
admet-3007	523	22	.	.	PUNCT
admet-3007	524	1	stem	stem	NOUN
admet-3007	524	2	cells	cell	NOUN
admet-3007	524	3	29	29	NUM
admet-3007	524	4	(	(	PUNCT
admet-3007	524	5	2011	2011	NUM
admet-3007	524	6	)	)	PUNCT
admet-3007	524	7	32	32	NUM
admet-3007	524	8	-	-	SYM
admet-3007	524	9	45	45	NUM
admet-3007	524	10	.	.	PUNCT
admet-3007	525	1	https://doi.org/10.1002/stem.563	https://doi.org/10.1002/stem.563	NOUN
admet-3007	526	1	[	[	X
admet-3007	526	2	36	36	NUM
admet-3007	526	3	]	]	X
admet-3007	526	4	w.	w.	PROPN
admet-3007	526	5	mo	mo	PROPN
admet-3007	526	6	,	,	PUNCT
admet-3007	526	7	j.-y	j.-y	PROPN
admet-3007	526	8	.	.	PUNCT
admet-3007	527	1	liu	liu	PROPN
admet-3007	527	2	,	,	PUNCT
admet-3007	527	3	j.-t	j.-t	PROPN
admet-3007	527	4	.	.	PUNCT
admet-3007	528	1	zhang	zhang	PROPN
admet-3007	528	2	.	.	PUNCT
admet-3007	529	1	biochemistry	biochemistry	PROPN
admet-3007	529	2	and	and	CCONJ
admet-3007	529	3	pharmacology	pharmacology	NOUN
admet-3007	529	4	of	of	ADP
admet-3007	529	5	human	human	PROPN
admet-3007	529	6	abcc1	abcc1	PROPN
admet-3007	529	7	/	/	SYM
admet-3007	529	8	mrp1	mrp1	PROPN
admet-3007	529	9	and	and	CCONJ
admet-3007	529	10	its	its	PRON
admet-3007	529	11	role	role	NOUN
admet-3007	529	12	in	in	ADP
admet-3007	529	13	detoxification	detoxification	NOUN
admet-3007	529	14	and	and	CCONJ
admet-3007	529	15	in	in	ADP
admet-3007	529	16	multidrug	multidrug	NOUN
admet-3007	529	17	resistance	resistance	NOUN
admet-3007	529	18	of	of	ADP
admet-3007	529	19	cancer	cancer	NOUN
admet-3007	529	20	chemotherapy	chemotherapy	NOUN
admet-3007	529	21	.	.	PUNCT
admet-3007	530	1	recent	recent	ADJ
admet-3007	530	2	advances	advance	NOUN
admet-3007	530	3	in	in	ADP
admet-3007	530	4	cancer	cancer	NOUN
admet-3007	530	5	research	research	NOUN
admet-3007	530	6	and	and	CCONJ
admet-3007	530	7	therapy	therapy	NOUN
admet-3007	530	8	(	(	PUNCT
admet-3007	530	9	2012	2012	NUM
admet-3007	530	10	)	)	PUNCT
admet-3007	530	11	371	371	NUM
admet-3007	530	12	-	-	SYM
admet-3007	530	13	404	404	NUM
admet-3007	530	14	.	.	PUNCT
admet-3007	531	1	https://doi.org/10.1016/b978-0-12-397833-2.00014-5	https://doi.org/10.1016/b978-0-12-397833-2.00014-5	NOUN
admet-3007	531	2	[	[	X
admet-3007	532	1	37	37	NUM
admet-3007	532	2	]	]	X
admet-3007	532	3	r.w	r.w	PROPN
admet-3007	532	4	.	.	PROPN
admet-3007	532	5	robey	robey	PROPN
admet-3007	532	6	,	,	PUNCT
admet-3007	532	7	o.	o.	PROPN
admet-3007	532	8	polgar	polgar	NOUN
admet-3007	532	9	,	,	PUNCT
admet-3007	532	10	j.	j.	PROPN
admet-3007	532	11	deeken	deeken	PROPN
admet-3007	532	12	,	,	PUNCT
admet-3007	532	13	k.w	k.w	PROPN
admet-3007	532	14	.	.	PROPN
admet-3007	533	1	to	to	ADP
admet-3007	533	2	,	,	PUNCT
admet-3007	533	3	s.e	s.e	PROPN
admet-3007	533	4	.	.	PROPN
admet-3007	533	5	bates	bates	PROPN
admet-3007	533	6	.	.	PUNCT
admet-3007	534	1	abcg2	abcg2	NOUN
admet-3007	534	2	:	:	PUNCT
admet-3007	534	3	determining	determine	VERB
admet-3007	534	4	its	its	PRON
admet-3007	534	5	relevance	relevance	NOUN
admet-3007	534	6	in	in	ADP
admet-3007	534	7	clinical	clinical	ADJ
admet-3007	534	8	drug	drug	NOUN
admet-3007	534	9	resistance	resistance	NOUN
admet-3007	534	10	.	.	PUNCT
admet-3007	535	1	cancer	cancer	NOUN
admet-3007	535	2	and	and	CCONJ
admet-3007	535	3	metastasis	metastasis	NOUN
admet-3007	535	4	reviews	review	VERB
admet-3007	535	5	26	26	NUM
admet-3007	535	6	(	(	PUNCT
admet-3007	535	7	2007	2007	NUM
admet-3007	535	8	)	)	PUNCT
admet-3007	535	9	39	39	NUM
admet-3007	535	10	-	-	SYM
admet-3007	535	11	57	57	NUM
admet-3007	535	12	.	.	PUNCT
admet-3007	536	1	https://doi.org/10.1007/s10555-007-9042-6	https://doi.org/10.1007/s10555-007-9042-6	NUM
admet-3007	537	1	[	[	X
admet-3007	537	2	38	38	NUM
admet-3007	537	3	]	]	X
admet-3007	537	4	d.d	d.d	PROPN
admet-3007	537	5	.	.	PROPN
admet-3007	537	6	ross	ross	PROPN
admet-3007	537	7	,	,	PUNCT
admet-3007	537	8	t.	t.	PROPN
admet-3007	537	9	nakanishi	nakanishi	PROPN
admet-3007	537	10	.	.	PUNCT
admet-3007	538	1	impact	impact	NOUN
admet-3007	538	2	of	of	ADP
admet-3007	538	3	breast	breast	NOUN
admet-3007	538	4	cancer	cancer	NOUN
admet-3007	538	5	resistance	resistance	NOUN
admet-3007	538	6	protein	protein	NOUN
admet-3007	538	7	on	on	ADP
admet-3007	538	8	cancer	cancer	NOUN
admet-3007	538	9	treatment	treatment	NOUN
admet-3007	538	10	outcomes	outcome	NOUN
admet-3007	538	11	.	.	PUNCT
admet-3007	539	1	multi	multi	ADJ
admet-3007	539	2	-	-	ADJ
admet-3007	539	3	drug	drug	ADJ
admet-3007	539	4	resistance	resistance	NOUN
admet-3007	539	5	in	in	ADP
admet-3007	539	6	cancer	cancer	NOUN
admet-3007	539	7	(	(	PUNCT
admet-3007	539	8	2010	2010	NUM
admet-3007	539	9	)	)	PUNCT
admet-3007	539	10	251	251	NUM
admet-3007	539	11	-	-	SYM
admet-3007	539	12	290	290	NUM
admet-3007	539	13	.	.	PUNCT
admet-3007	540	1	https://doi.org/10.1007/978-1-60761-416-6_12	https://doi.org/10.1007/978-1-60761-416-6_12	PROPN
admet-3007	541	1	[	[	X
admet-3007	541	2	39	39	NUM
admet-3007	541	3	]	]	X
admet-3007	541	4	p.r	p.r	PROPN
admet-3007	541	5	.	.	PROPN
admet-3007	541	6	prasetyanti	prasetyanti	PROPN
admet-3007	541	7	,	,	PUNCT
admet-3007	541	8	j.p	j.p	PROPN
admet-3007	541	9	.	.	PROPN
admet-3007	541	10	medema	medema	PROPN
admet-3007	541	11	.	.	PUNCT
admet-3007	542	1	intra	intra	ADJ
admet-3007	542	2	-	-	ADJ
admet-3007	542	3	tumor	tumor	ADJ
admet-3007	542	4	heterogeneity	heterogeneity	NOUN
admet-3007	542	5	from	from	ADP
admet-3007	542	6	a	a	DET
admet-3007	542	7	cancer	cancer	NOUN
admet-3007	542	8	stem	stem	NOUN
admet-3007	542	9	cell	cell	NOUN
admet-3007	542	10	perspective	perspective	NOUN
admet-3007	542	11	.	.	PUNCT
admet-3007	543	1	molecular	molecular	ADJ
admet-3007	543	2	cancer	cancer	NOUN
admet-3007	543	3	16	16	NUM
admet-3007	543	4	(	(	PUNCT
admet-3007	543	5	2017	2017	NUM
admet-3007	543	6	)	)	PUNCT
admet-3007	543	7	41	41	NUM
admet-3007	543	8	.	.	PUNCT
admet-3007	544	1	https://doi.org/10.1186/s12943-017-0600-4	https://doi.org/10.1186/s12943-017-0600-4	NUM
admet-3007	544	2	[	[	X
admet-3007	544	3	40	40	NUM
admet-3007	544	4	]	]	PUNCT
admet-3007	544	5	c.	c.	NOUN
admet-3007	544	6	saygin	saygin	NOUN
admet-3007	544	7	,	,	PUNCT
admet-3007	544	8	d.	d.	PROPN
admet-3007	544	9	matei	matei	PROPN
admet-3007	544	10	,	,	PUNCT
admet-3007	544	11	r.	r.	PROPN
admet-3007	544	12	majeti	majeti	PROPN
admet-3007	544	13	,	,	PUNCT
admet-3007	544	14	o.	o.	PROPN
admet-3007	544	15	reizes	reizes	PROPN
admet-3007	544	16	,	,	PUNCT
admet-3007	544	17	j.d	j.d	PROPN
admet-3007	544	18	.	.	PROPN
admet-3007	544	19	lathia	lathia	PROPN
admet-3007	544	20	.	.	PUNCT
admet-3007	545	1	targeting	target	VERB
admet-3007	545	2	cancer	cancer	NOUN
admet-3007	545	3	stemness	stemness	NOUN
admet-3007	545	4	in	in	ADP
admet-3007	545	5	the	the	DET
admet-3007	545	6	clinic	clinic	NOUN
admet-3007	545	7	:	:	PUNCT
admet-3007	545	8	from	from	ADP
admet-3007	545	9	hype	hype	NOUN
admet-3007	545	10	to	to	ADP
admet-3007	545	11	hope	hope	NOUN
admet-3007	545	12	.	.	PUNCT
admet-3007	546	1	cell	cell	NOUN
admet-3007	546	2	stem	stem	NOUN
admet-3007	546	3	cell	cell	NOUN
admet-3007	546	4	24	24	NUM
admet-3007	546	5	(	(	PUNCT
admet-3007	546	6	2019	2019	NUM
admet-3007	546	7	)	)	PUNCT
admet-3007	546	8	25	25	NUM
admet-3007	546	9	-	-	SYM
admet-3007	546	10	40	40	NUM
admet-3007	546	11	.	.	PUNCT
admet-3007	547	1	https://doi.org/10.1016/j.stem.2018.11.017	https://doi.org/10.1016/j.stem.2018.11.017	NUM
admet-3007	548	1	[	[	X
admet-3007	548	2	41	41	NUM
admet-3007	548	3	]	]	X
admet-3007	548	4	p.c	p.c	PROPN
admet-3007	548	5	.	.	PROPN
admet-3007	548	6	hermann	hermann	PROPN
admet-3007	548	7	,	,	PUNCT
admet-3007	548	8	s.l	s.l	PROPN
admet-3007	548	9	.	.	PROPN
admet-3007	548	10	huber	huber	PROPN
admet-3007	548	11	,	,	PUNCT
admet-3007	548	12	t.	t.	NOUN
admet-3007	548	13	herrler	herrler	NOUN
admet-3007	548	14	,	,	PUNCT
admet-3007	548	15	a.	a.	PROPN
admet-3007	548	16	aicher	aicher	PROPN
admet-3007	548	17	,	,	PUNCT
admet-3007	548	18	j.w	j.w	PROPN
admet-3007	548	19	.	.	PROPN
admet-3007	548	20	ellwart	ellwart	PROPN
admet-3007	548	21	,	,	PUNCT
admet-3007	548	22	m.	m.	NOUN
admet-3007	548	23	guba	guba	NOUN
admet-3007	548	24	,	,	PUNCT
admet-3007	548	25	c.j	c.j	PROPN
admet-3007	548	26	.	.	PROPN
admet-3007	548	27	bruns	bruns	PROPN
admet-3007	548	28	,	,	PUNCT
admet-3007	548	29	c.	c.	PROPN
admet-3007	548	30	heeschen	heeschen	PROPN
admet-3007	548	31	.	.	PUNCT
admet-3007	549	1	distinct	distinct	ADJ
admet-3007	549	2	populations	population	NOUN
admet-3007	549	3	of	of	ADP
admet-3007	549	4	cancer	cancer	NOUN
admet-3007	549	5	stem	stem	NOUN
admet-3007	549	6	cells	cell	NOUN
admet-3007	549	7	determine	determine	VERB
admet-3007	549	8	tumor	tumor	NOUN
admet-3007	549	9	growth	growth	NOUN
admet-3007	549	10	and	and	CCONJ
admet-3007	549	11	metastatic	metastatic	ADJ
admet-3007	549	12	activity	activity	NOUN
admet-3007	549	13	in	in	ADP
admet-3007	549	14	human	human	ADJ
admet-3007	549	15	pancreatic	pancreatic	ADJ
admet-3007	549	16	cancer	cancer	NOUN
admet-3007	549	17	.	.	PUNCT
admet-3007	550	1	cell	cell	NOUN
admet-3007	550	2	stem	stem	NOUN
admet-3007	550	3	cell	cell	NOUN
admet-3007	550	4	1	1	NUM
admet-3007	550	5	(	(	PUNCT
admet-3007	550	6	2007	2007	NUM
admet-3007	550	7	)	)	PUNCT
admet-3007	550	8	313	313	NUM
admet-3007	550	9	-	-	SYM
admet-3007	550	10	323	323	NUM
admet-3007	550	11	.	.	PUNCT
admet-3007	551	1	https://doi.org/10.1016/j.stem.2007.06.002	https://doi.org/10.1016/j.stem.2007.06.002	PROPN
admet-3007	551	2	[	[	X
admet-3007	551	3	42	42	NUM
admet-3007	551	4	]	]	PUNCT
admet-3007	551	5	s.	s.	PROPN
admet-3007	551	6	selleri	selleri	PROPN
admet-3007	551	7	,	,	PUNCT
admet-3007	551	8	f.	f.	PROPN
admet-3007	551	9	arnaboldi	arnaboldi	PROPN
admet-3007	551	10	,	,	PUNCT
admet-3007	551	11	m.	m.	NOUN
admet-3007	551	12	palazzo	palazzo	PROPN
admet-3007	551	13	,	,	PUNCT
admet-3007	551	14	u.	u.	PROPN
admet-3007	551	15	hussein	hussein	PROPN
admet-3007	551	16	,	,	PUNCT
admet-3007	551	17	a.	a.	NOUN
admet-3007	551	18	balsari	balsari	PROPN
admet-3007	551	19	,	,	PUNCT
admet-3007	551	20	c.	c.	PROPN
admet-3007	551	21	rumio	rumio	PROPN
admet-3007	551	22	.	.	PUNCT
admet-3007	552	1	caveolin‐1	caveolin‐1	VERB
admet-3007	552	2	is	be	AUX
admet-3007	552	3	expressed	express	VERB
admet-3007	552	4	on	on	ADP
admet-3007	552	5	multipotent	multipotent	NOUN
admet-3007	552	6	cells	cell	NOUN
admet-3007	552	7	of	of	ADP
admet-3007	552	8	hair	hair	NOUN
admet-3007	552	9	follicles	follicle	NOUN
admet-3007	552	10	and	and	CCONJ
admet-3007	552	11	might	might	AUX
admet-3007	552	12	be	be	AUX
admet-3007	552	13	involved	involve	VERB
admet-3007	552	14	in	in	ADP
admet-3007	552	15	their	their	PRON
admet-3007	552	16	resistance	resistance	NOUN
admet-3007	552	17	to	to	ADP
admet-3007	552	18	chemotherapy	chemotherapy	NOUN
admet-3007	552	19	.	.	PUNCT
admet-3007	553	1	british	british	ADJ
admet-3007	553	2	journal	journal	PROPN
admet-3007	553	3	of	of	ADP
admet-3007	553	4	dermatology	dermatology	NOUN
admet-3007	553	5	153	153	NUM
admet-3007	553	6	(	(	PUNCT
admet-3007	553	7	2005	2005	NUM
admet-3007	553	8	)	)	PUNCT
admet-3007	553	9	506	506	NUM
admet-3007	553	10	-	-	SYM
admet-3007	553	11	513	513	NUM
admet-3007	553	12	.	.	PUNCT
admet-3007	554	1	https://doi.org/10.1111/j.1365-2133.2005.06746.x	https://doi.org/10.1111/j.1365-2133.2005.06746.x	PRON
admet-3007	555	1	[	[	X
admet-3007	555	2	43	43	NUM
admet-3007	555	3	]	]	PUNCT
admet-3007	555	4	j.	j.	PROPN
admet-3007	555	5	wang	wang	PROPN
admet-3007	555	6	,	,	PUNCT
admet-3007	555	7	x.	x.	PROPN
admet-3007	555	8	liu	liu	PROPN
admet-3007	555	9	,	,	PUNCT
admet-3007	555	10	z.	z.	PROPN
admet-3007	555	11	jiang	jiang	PROPN
admet-3007	555	12	,	,	PUNCT
admet-3007	555	13	l.	l.	PROPN
admet-3007	555	14	li	li	PROPN
admet-3007	555	15	,	,	PUNCT
admet-3007	555	16	z.	z.	PROPN
admet-3007	555	17	cui	cui	PROPN
admet-3007	555	18	,	,	PUNCT
admet-3007	555	19	y.	y.	PROPN
admet-3007	555	20	gao	gao	PROPN
admet-3007	555	21	,	,	PUNCT
admet-3007	555	22	d.	d.	PROPN
admet-3007	555	23	kong	kong	PROPN
admet-3007	555	24	,	,	PUNCT
admet-3007	555	25	x.	x.	PROPN
admet-3007	555	26	liu	liu	PROPN
admet-3007	555	27	.	.	PUNCT
admet-3007	556	1	a	a	DET
admet-3007	556	2	novel	novel	ADJ
admet-3007	556	3	method	method	NOUN
admet-3007	556	4	to	to	PART
admet-3007	556	5	limit	limit	VERB
admet-3007	556	6	breast	breast	NOUN
admet-3007	556	7	cancer	cancer	NOUN
admet-3007	556	8	stem	stem	NOUN
admet-3007	556	9	cells	cell	NOUN
admet-3007	556	10	in	in	ADP
admet-3007	556	11	states	state	NOUN
admet-3007	556	12	of	of	ADP
admet-3007	556	13	quiescence	quiescence	NOUN
admet-3007	556	14	,	,	PUNCT
admet-3007	556	15	proliferation	proliferation	NOUN
admet-3007	556	16	or	or	CCONJ
admet-3007	556	17	differentiation	differentiation	NOUN
admet-3007	556	18	:	:	PUNCT
admet-3007	556	19	use	use	NOUN
admet-3007	556	20	of	of	ADP
admet-3007	556	21	gel	gel	NOUN
admet-3007	556	22	stress	stress	NOUN
admet-3007	556	23	in	in	ADP
admet-3007	556	24	combination	combination	NOUN
admet-3007	556	25	with	with	ADP
admet-3007	556	26	stem	stem	NOUN
admet-3007	556	27	cell	cell	NOUN
admet-3007	556	28	growth	growth	NOUN
admet-3007	556	29	factors	factor	NOUN
admet-3007	556	30	.	.	PUNCT
admet-3007	557	1	oncology	oncology	NOUN
admet-3007	557	2	letters	letter	NOUN
admet-3007	557	3	12	12	NUM
admet-3007	557	4	(	(	PUNCT
admet-3007	557	5	2016	2016	NUM
admet-3007	557	6	)	)	PUNCT
admet-3007	557	7	1355	1355	NUM
admet-3007	557	8	-	-	SYM
admet-3007	557	9	1360	1360	NUM
admet-3007	557	10	.	.	PUNCT
admet-3007	558	1	https://doi.org/10.3892/ol.2016.4757	https://doi.org/10.3892/ol.2016.4757	VERB
admet-3007	558	2	[	[	X
admet-3007	558	3	44	44	NUM
admet-3007	558	4	]	]	PUNCT
admet-3007	558	5	h.	h.	PROPN
admet-3007	558	6	glavinas	glavinas	PROPN
admet-3007	558	7	,	,	PUNCT
admet-3007	558	8	p.	p.	PROPN
admet-3007	558	9	krajcsi	krajcsi	PROPN
admet-3007	558	10	,	,	PUNCT
admet-3007	558	11	j.	j.	PROPN
admet-3007	558	12	cserepes	cserepes	PROPN
admet-3007	558	13	,	,	PUNCT
admet-3007	558	14	b.	b.	PROPN
admet-3007	558	15	sarkadi	sarkadi	PROPN
admet-3007	558	16	.	.	PUNCT
admet-3007	559	1	the	the	DET
admet-3007	559	2	role	role	NOUN
admet-3007	559	3	of	of	ADP
admet-3007	559	4	abc	abc	PROPN
admet-3007	559	5	transporters	transporter	NOUN
admet-3007	559	6	in	in	ADP
admet-3007	559	7	drug	drug	NOUN
admet-3007	559	8	resistance	resistance	NOUN
admet-3007	559	9	,	,	PUNCT
admet-3007	559	10	metabolism	metabolism	NOUN
admet-3007	559	11	and	and	CCONJ
admet-3007	559	12	toxicity	toxicity	NOUN
admet-3007	559	13	.	.	PUNCT
admet-3007	560	1	current	current	ADJ
admet-3007	560	2	drug	drug	NOUN
admet-3007	560	3	delivery	delivery	NOUN
admet-3007	560	4	1	1	NUM
admet-3007	560	5	(	(	PUNCT
admet-3007	560	6	2004	2004	NUM
admet-3007	560	7	)	)	PUNCT
admet-3007	560	8	27	27	NUM
admet-3007	560	9	-	-	SYM
admet-3007	560	10	42	42	NUM
admet-3007	560	11	.	.	PUNCT
admet-3007	560	12	https://doi.org/10.2174/1567201043480036	https://doi.org/10.2174/1567201043480036	X
admet-3007	561	1	[	[	X
admet-3007	561	2	45	45	NUM
admet-3007	561	3	]	]	PUNCT
admet-3007	561	4	s.	s.	PROPN
admet-3007	561	5	nobili	nobili	PROPN
admet-3007	561	6	,	,	PUNCT
admet-3007	561	7	a.	a.	NOUN
admet-3007	561	8	lapucci	lapucci	PROPN
admet-3007	561	9	,	,	PUNCT
admet-3007	561	10	i.	i.	PROPN
admet-3007	561	11	landini	landini	PROPN
admet-3007	561	12	,	,	PUNCT
admet-3007	561	13	m.	m.	NOUN
admet-3007	561	14	coronnello	coronnello	PROPN
admet-3007	561	15	,	,	PUNCT
admet-3007	561	16	g.	g.	PROPN
admet-3007	561	17	roviello	roviello	PROPN
admet-3007	561	18	,	,	PUNCT
admet-3007	561	19	e.	e.	PROPN
admet-3007	561	20	mini	mini	PROPN
admet-3007	561	21	.	.	PUNCT
admet-3007	562	1	role	role	NOUN
admet-3007	562	2	of	of	ADP
admet-3007	562	3	atp	atp	NOUN
admet-3007	562	4	-	-	PUNCT
admet-3007	562	5	binding	bind	VERB
admet-3007	562	6	cassette	cassette	NOUN
admet-3007	562	7	transporters	transporter	NOUN
admet-3007	562	8	in	in	ADP
admet-3007	562	9	cancer	cancer	NOUN
admet-3007	562	10	initiation	initiation	NOUN
admet-3007	562	11	and	and	CCONJ
admet-3007	562	12	progression	progression	NOUN
admet-3007	562	13	,	,	PUNCT
admet-3007	562	14	seminars	seminar	NOUN
admet-3007	562	15	in	in	ADP
admet-3007	562	16	cancer	cancer	NOUN
admet-3007	562	17	biology	biology	NOUN
admet-3007	562	18	60	60	NUM
admet-3007	562	19	(	(	PUNCT
admet-3007	562	20	2020	2020	NUM
admet-3007	562	21	)	)	PUNCT
admet-3007	562	22	,	,	PUNCT
admet-3007	562	23	72	72	NUM
admet-3007	562	24	-	-	SYM
admet-3007	562	25	95	95	NUM
admet-3007	562	26	.	.	PUNCT
admet-3007	563	1	https://doi.org/10.1016/j.semcancer.2019.08.006	https://doi.org/10.1016/j.semcancer.2019.08.006	NOUN
admet-3007	563	2	[	[	NOUN
admet-3007	563	3	46	46	NUM
admet-3007	563	4	]	]	X
admet-3007	563	5	c.	c.	PROPN
admet-3007	563	6	hirschmann	hirschmann	PROPN
admet-3007	563	7	-	-	PUNCT
admet-3007	563	8	jax	jax	PROPN
admet-3007	563	9	,	,	PUNCT
admet-3007	563	10	a.e	a.e	PROPN
admet-3007	563	11	.	.	PROPN
admet-3007	563	12	foster	foster	PROPN
admet-3007	563	13	,	,	PUNCT
admet-3007	563	14	g.g	g.g	PROPN
admet-3007	563	15	.	.	PROPN
admet-3007	563	16	wulf	wulf	PROPN
admet-3007	563	17	,	,	PUNCT
admet-3007	563	18	j.g	j.g	PROPN
admet-3007	563	19	.	.	PROPN
admet-3007	563	20	nuchtern	nuchtern	PROPN
admet-3007	563	21	,	,	PUNCT
admet-3007	563	22	t.w	t.w	PROPN
admet-3007	563	23	.	.	PROPN
admet-3007	563	24	jax	jax	PROPN
admet-3007	563	25	,	,	PUNCT
admet-3007	563	26	u.	u.	PROPN
admet-3007	563	27	gobel	gobel	PROPN
admet-3007	563	28	,	,	PUNCT
admet-3007	563	29	m.a	m.a	PROPN
admet-3007	563	30	.	.	PROPN
admet-3007	563	31	goodell	goodell	PROPN
admet-3007	563	32	,	,	PUNCT
admet-3007	563	33	m.k	m.k	PROPN
admet-3007	563	34	.	.	PUNCT
admet-3007	563	35	brenner	brenner	PROPN
admet-3007	563	36	.	.	PUNCT
admet-3007	564	1	a	a	DET
admet-3007	564	2	distinct	distinct	ADJ
admet-3007	564	3	“	"	PUNCT
admet-3007	564	4	side	side	ADJ
admet-3007	564	5	population	population	NOUN
admet-3007	564	6	”	"	PUNCT
admet-3007	564	7	of	of	ADP
admet-3007	564	8	cells	cell	NOUN
admet-3007	564	9	with	with	ADP
admet-3007	564	10	high	high	ADJ
admet-3007	564	11	drug	drug	NOUN
admet-3007	564	12	efflux	efflux	NOUN
admet-3007	564	13	capacity	capacity	NOUN
admet-3007	564	14	in	in	ADP
admet-3007	564	15	human	human	ADJ
admet-3007	564	16	tumor	tumor	NOUN
admet-3007	564	17	cells	cell	NOUN
admet-3007	564	18	.	.	PUNCT
admet-3007	565	1	proceedings	proceeding	NOUN
admet-3007	565	2	of	of	ADP
admet-3007	565	3	the	the	DET
admet-3007	565	4	national	national	PROPN
admet-3007	565	5	academy	academy	PROPN
admet-3007	565	6	of	of	ADP
admet-3007	565	7	sciences	sciences	PROPN
admet-3007	565	8	101	101	NUM
admet-3007	565	9	(	(	PUNCT
admet-3007	565	10	2004	2004	NUM
admet-3007	565	11	)	)	PUNCT
admet-3007	565	12	14228	14228	NUM
admet-3007	565	13	-	-	SYM
admet-3007	565	14	14233	14233	NUM
admet-3007	565	15	.	.	PUNCT
admet-3007	566	1	https://doi.org/10.1073/pnas.0400067101	https://doi.org/10.1073/pnas.0400067101	PROPN
admet-3007	566	2	[	[	X
admet-3007	566	3	47	47	NUM
admet-3007	566	4	]	]	PUNCT
admet-3007	566	5	k.	k.	PROPN
admet-3007	566	6	moitra	moitra	PROPN
admet-3007	566	7	.	.	PUNCT
admet-3007	567	1	overcoming	overcome	VERB
admet-3007	567	2	multidrug	multidrug	NOUN
admet-3007	567	3	resistance	resistance	NOUN
admet-3007	567	4	in	in	ADP
admet-3007	567	5	cancer	cancer	NOUN
admet-3007	567	6	stem	stem	NOUN
admet-3007	567	7	cells	cell	NOUN
admet-3007	567	8	.	.	PUNCT
admet-3007	568	1	biomed	biome	VERB
admet-3007	568	2	research	research	NOUN
admet-3007	568	3	international	international	ADJ
admet-3007	568	4	2015	2015	NUM
admet-3007	568	5	(	(	PUNCT
admet-3007	568	6	2015	2015	NUM
admet-3007	568	7	)	)	PUNCT
admet-3007	568	8	635745	635745	NUM
admet-3007	568	9	.	.	PUNCT
admet-3007	569	1	https://doi.org/10.1155/2015/635745	https://doi.org/10.1155/2015/635745	PROPN
admet-3007	569	2	https://doi.org/10.1186/2162-3619-2-17	https://doi.org/10.1186/2162-3619-2-17	PROPN
admet-3007	569	3	https://doi.org/10.1155/2016/9714315	https://doi.org/10.1155/2016/9714315	PROPN
admet-3007	569	4	https://doi.org/10.3892/or.2015.4521	https://doi.org/10.3892/or.2015.4521	NOUN
admet-3007	569	5	https://doi.org/10.18632/oncotarget.23607	https://doi.org/10.18632/oncotarget.23607	VERB
admet-3007	569	6	https://doi.org/10.1016/j.biopha.2013.04.005	https://doi.org/10.1016/j.biopha.2013.04.005	NUM
admet-3007	569	7	https://doi.org/10.1002/stem.563	https://doi.org/10.1002/stem.563	NOUN
admet-3007	569	8	https://doi.org/10.1016/b978-0-12-397833-2.00014-5	https://doi.org/10.1016/b978-0-12-397833-2.00014-5	NOUN
admet-3007	569	9	https://doi.org/10.1007/s10555-007-9042-6	https://doi.org/10.1007/s10555-007-9042-6	PROPN
admet-3007	569	10	https://doi.org/10.1007/978-1-60761-416-6_12	https://doi.org/10.1007/978-1-60761-416-6_12	PROPN
admet-3007	569	11	https://doi.org/10.1186/s12943-017-0600-4	https://doi.org/10.1186/s12943-017-0600-4	NUM
admet-3007	569	12	https://doi.org/10.1016/j.stem.2018.11.017	https://doi.org/10.1016/j.stem.2018.11.017	NUM
admet-3007	569	13	https://doi.org/10.1016/j.stem.2007.06.002	https://doi.org/10.1016/j.stem.2007.06.002	PRON
admet-3007	569	14	https://doi.org/10.1111/j.1365-2133.2005.06746.x	https://doi.org/10.1111/j.1365-2133.2005.06746.x	PRON
admet-3007	569	15	https://doi.org/10.3892/ol.2016.4757	https://doi.org/10.3892/ol.2016.4757	VERB
admet-3007	569	16	https://doi.org/10.2174/1567201043480036	https://doi.org/10.2174/1567201043480036	NOUN
admet-3007	569	17	https://doi.org/10.1016/j.semcancer.2019.08.006	https://doi.org/10.1016/j.semcancer.2019.08.006	NOUN
admet-3007	569	18	https://doi.org/10.1073/pnas.0400067101	https://doi.org/10.1073/pnas.0400067101	ADJ
admet-3007	569	19	https://doi.org/10.1155/2015/635745	https://doi.org/10.1155/2015/635745	PROPN
admet-3007	569	20	admet	admet	PROPN
admet-3007	569	21	&	&	CCONJ
admet-3007	569	22	dmpk	dmpk	PROPN
admet-3007	569	23	13(5	13(5	NOUN
admet-3007	569	24	)	)	PUNCT
admet-3007	569	25	(	(	PUNCT
admet-3007	569	26	2025	2025	NUM
admet-3007	569	27	)	)	PUNCT
admet-3007	569	28	3007	3007	NUM
admet-3007	569	29	nano	nano	NOUN
admet-3007	569	30	-	-	PUNCT
admet-3007	569	31	biomaterials	biomaterial	NOUN
admet-3007	569	32	in	in	ADP
admet-3007	569	33	cancer	cancer	NOUN
admet-3007	569	34	therapy	therapy	NOUN
admet-3007	569	35	doi	doi	PROPN
admet-3007	569	36	:	:	PUNCT
admet-3007	569	37	https://doi.org/10.5599/admet.3007	https://doi.org/10.5599/admet.3007	NOUN
admet-3007	569	38	21	21	NUM
admet-3007	570	1	[	[	SYM
admet-3007	570	2	48	48	NUM
admet-3007	570	3	]	]	PUNCT
admet-3007	570	4	b.	b.	PROPN
admet-3007	570	5	huang	huang	PROPN
admet-3007	570	6	,	,	PUNCT
admet-3007	570	7	s.j	s.j	PROPN
admet-3007	570	8	.	.	PROPN
admet-3007	570	9	fu	fu	PROPN
admet-3007	570	10	,	,	PUNCT
admet-3007	570	11	w.z	w.z	PROPN
admet-3007	570	12	.	.	PROPN
admet-3007	570	13	fan	fan	PROPN
admet-3007	570	14	,	,	PUNCT
admet-3007	570	15	z.h	z.h	PROPN
admet-3007	570	16	.	.	PROPN
admet-3007	570	17	wang	wang	PROPN
admet-3007	570	18	,	,	PUNCT
admet-3007	570	19	z.b	z.b	PROPN
admet-3007	570	20	.	.	PROPN
admet-3007	570	21	chen	chen	PROPN
admet-3007	570	22	,	,	PUNCT
admet-3007	570	23	s.j	s.j	PROPN
admet-3007	570	24	.	.	PROPN
admet-3007	570	25	guo	guo	PROPN
admet-3007	570	26	,	,	PUNCT
admet-3007	570	27	j.x	j.x	PROPN
admet-3007	570	28	.	.	PROPN
admet-3007	570	29	chen	chen	PROPN
admet-3007	570	30	,	,	PUNCT
admet-3007	570	31	s.p	s.p	PROPN
admet-3007	570	32	.	.	PUNCT
admet-3007	570	33	qiu	qiu	PROPN
admet-3007	570	34	.	.	PUNCT
admet-3007	571	1	pkcε	pkcε	PROPN
admet-3007	571	2	inhibits	inhibit	VERB
admet-3007	571	3	isolation	isolation	NOUN
admet-3007	571	4	and	and	CCONJ
admet-3007	571	5	stemness	stemness	NOUN
admet-3007	571	6	of	of	ADP
admet-3007	571	7	side	side	ADJ
admet-3007	571	8	population	population	NOUN
admet-3007	571	9	cells	cell	NOUN
admet-3007	571	10	via	via	ADP
admet-3007	571	11	the	the	DET
admet-3007	571	12	suppression	suppression	NOUN
admet-3007	571	13	of	of	ADP
admet-3007	571	14	abcb1	abcb1	NOUN
admet-3007	571	15	transporter	transporter	NOUN
admet-3007	571	16	and	and	CCONJ
admet-3007	571	17	pi3k	pi3k	PROPN
admet-3007	571	18	/	/	SYM
admet-3007	571	19	akt	akt	PROPN
admet-3007	571	20	,	,	PUNCT
admet-3007	571	21	mapk	mapk	PROPN
admet-3007	571	22	/	/	SYM
admet-3007	571	23	erk	erk	PROPN
admet-3007	571	24	signaling	signal	VERB
admet-3007	571	25	in	in	ADP
admet-3007	571	26	renal	renal	ADJ
admet-3007	571	27	cell	cell	NOUN
admet-3007	571	28	carcinoma	carcinoma	NOUN
admet-3007	571	29	cell	cell	NOUN
admet-3007	571	30	line	line	NOUN
admet-3007	571	31	769p	769p	PROPN
admet-3007	571	32	.	.	PUNCT
admet-3007	572	1	cancer	cancer	NOUN
admet-3007	572	2	letters	letter	NOUN
admet-3007	572	3	376	376	NUM
admet-3007	572	4	(	(	PUNCT
admet-3007	572	5	2016	2016	NUM
admet-3007	572	6	)	)	PUNCT
admet-3007	572	7	148	148	NUM
admet-3007	572	8	-	-	SYM
admet-3007	572	9	154	154	NUM
admet-3007	572	10	.	.	PUNCT
admet-3007	573	1	https://doi.org/10.1016/j.canlet.2016.03.041	https://doi.org/10.1016/j.canlet.2016.03.041	PRON
admet-3007	573	2	[	[	X
admet-3007	573	3	49	49	NUM
admet-3007	573	4	]	]	PUNCT
admet-3007	573	5	i.	i.	NOUN
admet-3007	573	6	tsochantaridis	tsochantaridis	PROPN
admet-3007	573	7	,	,	PUNCT
admet-3007	573	8	a.	a.	NOUN
admet-3007	573	9	roupas	roupas	PROPN
admet-3007	573	10	,	,	PUNCT
admet-3007	573	11	s.	s.	PROPN
admet-3007	573	12	mohlin	mohlin	PROPN
admet-3007	573	13	,	,	PUNCT
admet-3007	573	14	a.	a.	PROPN
admet-3007	573	15	pappa	pappa	PROPN
admet-3007	573	16	,	,	PUNCT
admet-3007	573	17	g.-p	g.-p	NOUN
admet-3007	573	18	.	.	PUNCT
admet-3007	574	1	voulgaridou	voulgaridou	ADJ
admet-3007	574	2	.	.	PUNCT
admet-3007	575	1	the	the	DET
admet-3007	575	2	concept	concept	NOUN
admet-3007	575	3	of	of	ADP
admet-3007	575	4	cancer	cancer	NOUN
admet-3007	575	5	stem	stem	NOUN
admet-3007	575	6	cells	cell	NOUN
admet-3007	575	7	:	:	PUNCT
admet-3007	575	8	elaborating	elaborate	VERB
admet-3007	575	9	on	on	ADP
admet-3007	575	10	aldh1b1	aldh1b1	NOUN
admet-3007	575	11	as	as	ADP
admet-3007	575	12	an	an	DET
admet-3007	575	13	emerging	emerge	VERB
admet-3007	575	14	marker	marker	NOUN
admet-3007	575	15	of	of	ADP
admet-3007	575	16	cancer	cancer	NOUN
admet-3007	575	17	progression	progression	NOUN
admet-3007	575	18	.	.	PUNCT
admet-3007	576	1	life	life	NOUN
admet-3007	576	2	13	13	NUM
admet-3007	576	3	(	(	PUNCT
admet-3007	576	4	2023	2023	NUM
admet-3007	576	5	)	)	PUNCT
admet-3007	576	6	197	197	NUM
admet-3007	576	7	.	.	PUNCT
admet-3007	577	1	https://doi.org/10.3390/life13010197	https://doi.org/10.3390/life13010197	NOUN
admet-3007	578	1	[	[	X
admet-3007	578	2	50	50	NUM
admet-3007	578	3	]	]	X
admet-3007	578	4	c.j	c.j	PROPN
admet-3007	578	5	.	.	PROPN
admet-3007	578	6	hessman	hessman	PROPN
admet-3007	578	7	,	,	PUNCT
admet-3007	578	8	e.j	e.j	PROPN
admet-3007	578	9	.	.	PROPN
admet-3007	578	10	bubbers	bubbers	PROPN
admet-3007	578	11	,	,	PUNCT
admet-3007	578	12	k.g	k.g	PROPN
admet-3007	578	13	.	.	PROPN
admet-3007	578	14	billingsley	billingsley	PROPN
admet-3007	578	15	,	,	PUNCT
admet-3007	578	16	d.o	d.o	PROPN
admet-3007	578	17	.	.	PROPN
admet-3007	578	18	herzig	herzig	PROPN
admet-3007	578	19	,	,	PUNCT
admet-3007	578	20	m.h	m.h	PROPN
admet-3007	578	21	.	.	PROPN
admet-3007	578	22	wong	wong	PROPN
admet-3007	578	23	.	.	PUNCT
admet-3007	579	1	loss	loss	NOUN
admet-3007	579	2	of	of	ADP
admet-3007	579	3	expression	expression	NOUN
admet-3007	579	4	of	of	ADP
admet-3007	579	5	the	the	DET
admet-3007	579	6	cancer	cancer	NOUN
admet-3007	579	7	stem	stem	NOUN
admet-3007	579	8	cell	cell	NOUN
admet-3007	579	9	marker	marker	NOUN
admet-3007	579	10	aldehyde	aldehyde	NOUN
admet-3007	579	11	dehydrogenase	dehydrogenase	NOUN
admet-3007	579	12	1	1	NUM
admet-3007	579	13	correlates	correlate	VERB
admet-3007	579	14	with	with	ADP
admet-3007	579	15	advanced	advanced	ADJ
admet-3007	579	16	-	-	PUNCT
admet-3007	579	17	stage	stage	NOUN
admet-3007	579	18	colorectal	colorectal	ADJ
admet-3007	579	19	cancer	cancer	NOUN
admet-3007	579	20	.	.	PUNCT
admet-3007	580	1	the	the	DET
admet-3007	580	2	american	american	PROPN
admet-3007	580	3	journal	journal	PROPN
admet-3007	580	4	of	of	ADP
admet-3007	580	5	surgery	surgery	NOUN
admet-3007	580	6	203	203	NUM
admet-3007	580	7	(	(	PUNCT
admet-3007	580	8	2012	2012	NUM
admet-3007	580	9	)	)	PUNCT
admet-3007	580	10	649	649	NUM
admet-3007	580	11	-	-	SYM
admet-3007	580	12	653	653	NUM
admet-3007	580	13	.	.	PUNCT
admet-3007	581	1	https://doi.org/10.3390/life13010197	https://doi.org/10.3390/life13010197	NOUN
admet-3007	582	1	[	[	X
admet-3007	582	2	51	51	NUM
admet-3007	582	3	]	]	X
admet-3007	582	4	d.a	d.a	PROPN
admet-3007	582	5	.	.	PROPN
admet-3007	582	6	averill	averill	PROPN
admet-3007	582	7	-	-	PUNCT
admet-3007	582	8	bates	bates	PROPN
admet-3007	582	9	.	.	PUNCT
admet-3007	583	1	the	the	DET
admet-3007	583	2	antioxidant	antioxidant	ADJ
admet-3007	583	3	glutathione	glutathione	NOUN
admet-3007	583	4	.	.	PUNCT
admet-3007	584	1	vitamins	vitamin	NOUN
admet-3007	584	2	and	and	CCONJ
admet-3007	584	3	hormones	hormone	NOUN
admet-3007	584	4	121	121	NUM
admet-3007	584	5	(	(	PUNCT
admet-3007	584	6	2023)109	2023)109	PROPN
admet-3007	584	7	-	-	PUNCT
admet-3007	584	8	141	141	NUM
admet-3007	584	9	.	.	PUNCT
admet-3007	585	1	https://doi.org/10.1016/bs.vh.2022.09.002	https://doi.org/10.1016/bs.vh.2022.09.002	ADJ
admet-3007	585	2	[	[	X
admet-3007	585	3	52	52	NUM
admet-3007	585	4	]	]	PUNCT
admet-3007	585	5	q.	q.	PROPN
admet-3007	585	6	wei	wei	PROPN
admet-3007	585	7	,	,	PUNCT
admet-3007	585	8	j.	j.	PROPN
admet-3007	585	9	lin	lin	PROPN
admet-3007	585	10	,	,	PUNCT
admet-3007	585	11	z.	z.	PROPN
admet-3007	585	12	lin	lin	PROPN
admet-3007	585	13	,	,	PUNCT
admet-3007	585	14	n.	n.	PROPN
admet-3007	585	15	yu	yu	PROPN
admet-3007	585	16	,	,	PUNCT
admet-3007	585	17	y.	y.	PROPN
admet-3007	585	18	wu	wu	PROPN
admet-3007	585	19	,	,	PUNCT
admet-3007	585	20	x.	x.	PROPN
admet-3007	585	21	tan	tan	PROPN
admet-3007	585	22	,	,	PUNCT
admet-3007	585	23	d.	d.	PROPN
admet-3007	585	24	xue	xue	PROPN
admet-3007	585	25	.	.	PUNCT
admet-3007	586	1	golph3	golph3	NOUN
admet-3007	586	2	inhibition	inhibition	NOUN
admet-3007	586	3	overcomes	overcome	VERB
admet-3007	586	4	cisplatin	cisplatin	NOUN
admet-3007	586	5	resistance	resistance	NOUN
admet-3007	586	6	by	by	ADP
admet-3007	586	7	restoring	restore	VERB
admet-3007	586	8	the	the	DET
admet-3007	586	9	glutathione	glutathione	NOUN
admet-3007	586	10	/	/	SYM
admet-3007	586	11	reactive	reactive	ADJ
admet-3007	586	12	oxygen	oxygen	NOUN
admet-3007	586	13	species	specie	NOUN
admet-3007	586	14	balance	balance	NOUN
admet-3007	586	15	in	in	ADP
admet-3007	586	16	the	the	DET
admet-3007	586	17	a549	a549	PROPN
admet-3007	586	18	non‑small	non‑small	DET
admet-3007	586	19	cell	cell	NOUN
admet-3007	586	20	lung	lung	NOUN
admet-3007	586	21	cancer	cancer	NOUN
admet-3007	586	22	cell	cell	NOUN
admet-3007	586	23	line	line	NOUN
admet-3007	586	24	.	.	PUNCT
admet-3007	587	1	oncology	oncology	NOUN
admet-3007	587	2	reports	report	VERB
admet-3007	587	3	52	52	NUM
admet-3007	587	4	(	(	PUNCT
admet-3007	587	5	2024	2024	NUM
admet-3007	587	6	)	)	PUNCT
admet-3007	587	7	170	170	NUM
admet-3007	587	8	.	.	PUNCT
admet-3007	587	9	https://doi.org/10.3892/or.2024.8829	https://doi.org/10.3892/or.2024.8829	PROPN
admet-3007	588	1	[	[	X
admet-3007	588	2	53	53	NUM
admet-3007	588	3	]	]	PUNCT
admet-3007	588	4	f.	f.	PROPN
admet-3007	588	5	jin	jin	PROPN
admet-3007	588	6	,	,	PUNCT
admet-3007	588	7	l.	l.	PROPN
admet-3007	588	8	zhao	zhao	PROPN
admet-3007	588	9	,	,	PUNCT
admet-3007	588	10	h.-y	h.-y	NOUN
admet-3007	588	11	.	.	PUNCT
admet-3007	589	1	zhao	zhao	NOUN
admet-3007	589	2	,	,	PUNCT
admet-3007	589	3	s.-g	s.-g	PROPN
admet-3007	589	4	.	.	PUNCT
admet-3007	590	1	guo	guo	PROPN
admet-3007	590	2	,	,	PUNCT
admet-3007	590	3	j.	j.	PROPN
admet-3007	590	4	feng	feng	PROPN
admet-3007	590	5	,	,	PUNCT
admet-3007	590	6	x.-b	x.-b	PROPN
admet-3007	590	7	.	.	PUNCT
admet-3007	591	1	jiang	jiang	PROPN
admet-3007	591	2	,	,	PUNCT
admet-3007	591	3	s.-l	s.-l	PROPN
admet-3007	591	4	.	.	PUNCT
admet-3007	592	1	zhang	zhang	PROPN
admet-3007	592	2	,	,	PUNCT
admet-3007	592	3	y.-j	y.-j	PROPN
admet-3007	592	4	.	.	PUNCT
admet-3007	593	1	wei	wei	PROPN
admet-3007	593	2	,	,	PUNCT
admet-3007	593	3	r.	r.	PROPN
admet-3007	593	4	fu	fu	PROPN
admet-3007	593	5	,	,	PUNCT
admet-3007	593	6	j.-s	j.-s	PROPN
admet-3007	593	7	.	.	PUNCT
admet-3007	594	1	zhao	zhao	NOUN
admet-3007	594	2	.	.	PUNCT
admet-3007	595	1	comparison	comparison	NOUN
admet-3007	595	2	between	between	ADP
admet-3007	595	3	cells	cell	NOUN
admet-3007	595	4	and	and	CCONJ
admet-3007	595	5	cancer	cancer	NOUN
admet-3007	595	6	stem	stem	NOUN
admet-3007	595	7	-	-	PUNCT
admet-3007	595	8	like	like	ADJ
admet-3007	595	9	cells	cell	NOUN
admet-3007	595	10	isolated	isolate	VERB
admet-3007	595	11	from	from	ADP
admet-3007	595	12	glioblastoma	glioblastoma	NOUN
admet-3007	595	13	and	and	CCONJ
admet-3007	595	14	astrocytoma	astrocytoma	NOUN
admet-3007	595	15	on	on	ADP
admet-3007	595	16	expression	expression	NOUN
admet-3007	595	17	of	of	ADP
admet-3007	595	18	anti	anti	ADJ
admet-3007	595	19	-	-	ADJ
admet-3007	595	20	apoptotic	apoptotic	ADJ
admet-3007	595	21	and	and	CCONJ
admet-3007	595	22	multidrug	multidrug	VERB
admet-3007	595	23	resistance	resistance	NOUN
admet-3007	595	24	-	-	PUNCT
admet-3007	595	25	associated	associate	VERB
admet-3007	595	26	protein	protein	NOUN
admet-3007	595	27	genes	gene	NOUN
admet-3007	595	28	.	.	PUNCT
admet-3007	596	1	neuroscience	neuroscience	NOUN
admet-3007	596	2	154	154	NUM
admet-3007	596	3	(	(	PUNCT
admet-3007	596	4	2008	2008	NUM
admet-3007	596	5	)	)	PUNCT
admet-3007	596	6	541	541	NUM
admet-3007	596	7	-	-	SYM
admet-3007	596	8	550	550	NUM
admet-3007	596	9	.	.	PUNCT
admet-3007	597	1	https://doi.org/10.1016/j.neuroscience.2008.03.054	https://doi.org/10.1016/j.neuroscience.2008.03.054	VERB
admet-3007	598	1	[	[	X
admet-3007	598	2	54	54	NUM
admet-3007	598	3	]	]	PUNCT
admet-3007	598	4	j.	j.	PROPN
admet-3007	598	5	chappell	chappell	PROPN
admet-3007	598	6	,	,	PUNCT
admet-3007	598	7	s.	s.	PROPN
admet-3007	598	8	dalton	dalton	PROPN
admet-3007	598	9	.	.	PUNCT
admet-3007	599	1	altered	alter	VERB
admet-3007	599	2	cell	cell	NOUN
admet-3007	599	3	cycle	cycle	NOUN
admet-3007	599	4	regulation	regulation	NOUN
admet-3007	599	5	helps	help	VERB
admet-3007	599	6	stem	stem	VERB
admet-3007	599	7	-	-	PUNCT
admet-3007	599	8	like	like	ADJ
admet-3007	599	9	carcinoma	carcinoma	NOUN
admet-3007	599	10	cells	cell	NOUN
admet-3007	599	11	resist	resist	VERB
admet-3007	599	12	apoptosis	apoptosis	NOUN
admet-3007	599	13	.	.	PUNCT
admet-3007	600	1	bmc	bmc	ADJ
admet-3007	600	2	biology	biology	NOUN
admet-3007	600	3	8	8	NUM
admet-3007	600	4	(	(	PUNCT
admet-3007	600	5	2010	2010	NUM
admet-3007	600	6	)	)	PUNCT
admet-3007	600	7	1	1	NUM
admet-3007	600	8	-	-	SYM
admet-3007	600	9	3	3	NUM
admet-3007	600	10	.	.	PUNCT
admet-3007	600	11	https://doi.org/10.1186/1741-7007-8-63	https://doi.org/10.1186/1741-7007-8-63	NOUN
admet-3007	601	1	[	[	X
admet-3007	601	2	55	55	NUM
admet-3007	601	3	]	]	PUNCT
admet-3007	601	4	x.	x.	PROPN
admet-3007	601	5	chu	chu	PROPN
admet-3007	601	6	,	,	PUNCT
admet-3007	601	7	w.	w.	PROPN
admet-3007	601	8	tian	tian	PROPN
admet-3007	601	9	,	,	PUNCT
admet-3007	601	10	j.	j.	PROPN
admet-3007	601	11	ning	ning	PROPN
admet-3007	601	12	,	,	PUNCT
admet-3007	601	13	g.	g.	PROPN
admet-3007	601	14	xiao	xiao	PROPN
admet-3007	601	15	,	,	PUNCT
admet-3007	601	16	y.	y.	PROPN
admet-3007	601	17	zhou	zhou	PROPN
admet-3007	601	18	,	,	PUNCT
admet-3007	601	19	z.	z.	PROPN
admet-3007	601	20	wang	wang	PROPN
admet-3007	601	21	,	,	PUNCT
admet-3007	601	22	z.	z.	PROPN
admet-3007	601	23	zhai	zhai	PROPN
admet-3007	601	24	,	,	PUNCT
admet-3007	601	25	g.	g.	PROPN
admet-3007	601	26	tanzhu	tanzhu	PROPN
admet-3007	601	27	,	,	PUNCT
admet-3007	601	28	j.	j.	PROPN
admet-3007	601	29	yang	yang	PROPN
admet-3007	601	30	,	,	PUNCT
admet-3007	601	31	r.	r.	PROPN
admet-3007	601	32	zhou	zhou	PROPN
admet-3007	601	33	.	.	PUNCT
admet-3007	602	1	cancer	cancer	NOUN
admet-3007	602	2	stem	stem	NOUN
admet-3007	602	3	cells	cell	NOUN
admet-3007	602	4	:	:	PUNCT
admet-3007	602	5	advances	advance	NOUN
admet-3007	602	6	in	in	ADP
admet-3007	602	7	knowledge	knowledge	NOUN
admet-3007	602	8	and	and	CCONJ
admet-3007	602	9	implications	implication	NOUN
admet-3007	602	10	for	for	ADP
admet-3007	602	11	cancer	cancer	NOUN
admet-3007	602	12	therapy	therapy	NOUN
admet-3007	602	13	.	.	PUNCT
admet-3007	603	1	signal	signal	ADJ
admet-3007	603	2	transduction	transduction	NOUN
admet-3007	603	3	and	and	CCONJ
admet-3007	603	4	targeted	target	VERB
admet-3007	603	5	therapy	therapy	NOUN
admet-3007	603	6	9	9	NUM
admet-3007	603	7	(	(	PUNCT
admet-3007	603	8	2024	2024	NUM
admet-3007	603	9	)	)	PUNCT
admet-3007	603	10	170	170	NUM
admet-3007	603	11	.	.	PUNCT
admet-3007	604	1	https://doi.org/10.1038/s41392-024-01851-y	https://doi.org/10.1038/s41392-024-01851-y	VERB
admet-3007	605	1	[	[	X
admet-3007	605	2	56	56	NUM
admet-3007	605	3	]	]	X
admet-3007	605	4	e.	e.	PROPN
admet-3007	605	5	abad	abad	PROPN
admet-3007	605	6	,	,	PUNCT
admet-3007	605	7	d.	d.	PROPN
admet-3007	605	8	graifer	graifer	PROPN
admet-3007	605	9	,	,	PUNCT
admet-3007	605	10	a.	a.	NOUN
admet-3007	605	11	lyakhovich	lyakhovich	NOUN
admet-3007	605	12	.	.	PUNCT
admet-3007	606	1	dna	dna	PROPN
admet-3007	606	2	damage	damage	NOUN
admet-3007	606	3	response	response	NOUN
admet-3007	606	4	and	and	CCONJ
admet-3007	606	5	resistance	resistance	NOUN
admet-3007	606	6	of	of	ADP
admet-3007	606	7	cancer	cancer	NOUN
admet-3007	606	8	stem	stem	NOUN
admet-3007	606	9	cells	cell	NOUN
admet-3007	606	10	.	.	PUNCT
admet-3007	607	1	cancer	cancer	NOUN
admet-3007	607	2	letters	letter	NOUN
admet-3007	607	3	474	474	NUM
admet-3007	607	4	(	(	PUNCT
admet-3007	607	5	2020	2020	NUM
admet-3007	607	6	)	)	PUNCT
admet-3007	607	7	106	106	NUM
admet-3007	607	8	-	-	SYM
admet-3007	607	9	117	117	NUM
admet-3007	607	10	.	.	PUNCT
admet-3007	608	1	https://doi.org/10.1016/j.canlet.2020.01.008	https://doi.org/10.1016/j.canlet.2020.01.008	NOUN
admet-3007	609	1	[	[	X
admet-3007	609	2	57	57	NUM
admet-3007	609	3	]	]	PUNCT
admet-3007	609	4	p.	p.	NOUN
admet-3007	609	5	vishnupriya	vishnupriya	PROPN
admet-3007	609	6	,	,	PUNCT
admet-3007	609	7	a.	a.	PROPN
admet-3007	609	8	aparna	aparna	PROPN
admet-3007	609	9	,	,	PUNCT
admet-3007	609	10	v.	v.	PROPN
admet-3007	609	11	vijaya	vijaya	PROPN
admet-3007	609	12	padma	padma	PROPN
admet-3007	609	13	.	.	PUNCT
admet-3007	610	1	functional	functional	ADJ
admet-3007	610	2	correlation	correlation	NOUN
admet-3007	610	3	between	between	ADP
admet-3007	610	4	ros	ros	PROPN
admet-3007	610	5	and	and	CCONJ
admet-3007	610	6	cancer	cancer	NOUN
admet-3007	610	7	stem	stem	NOUN
admet-3007	610	8	cells	cell	NOUN
admet-3007	610	9	in	in	ADP
admet-3007	610	10	cancer	cancer	NOUN
admet-3007	610	11	progression	progression	NOUN
admet-3007	610	12	.	.	PUNCT
admet-3007	611	1	handbook	handbook	NOUN
admet-3007	611	2	of	of	ADP
admet-3007	611	3	oxidative	oxidative	ADJ
admet-3007	611	4	stress	stress	NOUN
admet-3007	611	5	in	in	ADP
admet-3007	611	6	cancer	cancer	NOUN
admet-3007	611	7	:	:	PUNCT
admet-3007	611	8	therapeutic	therapeutic	ADJ
admet-3007	611	9	aspects	aspect	NOUN
admet-3007	611	10	(	(	PUNCT
admet-3007	611	11	2022	2022	NUM
admet-3007	611	12	)	)	PUNCT
admet-3007	611	13	1905	1905	NUM
admet-3007	611	14	-	-	SYM
admet-3007	611	15	1929	1929	NUM
admet-3007	611	16	.	.	PUNCT
admet-3007	612	1	https://doi.org/10.1007/978-981-16-5422-0_89	https://doi.org/10.1007/978-981-16-5422-0_89	NUM
admet-3007	613	1	[	[	X
admet-3007	613	2	58	58	NUM
admet-3007	613	3	]	]	X
admet-3007	613	4	y.	y.	PROPN
admet-3007	613	5	zhang	zhang	PROPN
admet-3007	613	6	,	,	PUNCT
admet-3007	613	7	x.	x.	PROPN
admet-3007	613	8	wang	wang	PROPN
admet-3007	613	9	.	.	PUNCT
admet-3007	614	1	targeting	target	VERB
admet-3007	614	2	the	the	DET
admet-3007	614	3	wnt	wnt	NOUN
admet-3007	614	4	/	/	SYM
admet-3007	614	5	β	β	NOUN
admet-3007	614	6	-	-	ADJ
admet-3007	614	7	catenin	catenin	ADJ
admet-3007	614	8	signaling	signal	VERB
admet-3007	614	9	pathway	pathway	NOUN
admet-3007	614	10	in	in	ADP
admet-3007	614	11	cancer	cancer	NOUN
admet-3007	614	12	.	.	PUNCT
admet-3007	615	1	journal	journal	PROPN
admet-3007	615	2	of	of	ADP
admet-3007	615	3	hematology	hematology	PROPN
admet-3007	615	4	&	&	CCONJ
admet-3007	615	5	oncology	oncology	NOUN
admet-3007	615	6	13	13	NUM
admet-3007	615	7	(	(	PUNCT
admet-3007	615	8	2020	2020	NUM
admet-3007	615	9	)	)	PUNCT
admet-3007	615	10	165	165	NUM
admet-3007	615	11	.	.	PUNCT
admet-3007	615	12	https://doi.org/10.1186/s13045-020-00990-3	https://doi.org/10.1186/s13045-020-00990-3	NOUN
admet-3007	616	1	[	[	X
admet-3007	616	2	59	59	NUM
admet-3007	616	3	]	]	PUNCT
admet-3007	616	4	s.	s.	PROPN
admet-3007	616	5	bao	bao	PROPN
admet-3007	616	6	,	,	PUNCT
admet-3007	616	7	q.	q.	PROPN
admet-3007	616	8	wu	wu	PROPN
admet-3007	616	9	,	,	PUNCT
admet-3007	616	10	r.e	r.e	PROPN
admet-3007	616	11	.	.	PROPN
admet-3007	616	12	mclendon	mclendon	PROPN
admet-3007	616	13	,	,	PUNCT
admet-3007	616	14	y.	y.	PROPN
admet-3007	616	15	hao	hao	PROPN
admet-3007	616	16	,	,	PUNCT
admet-3007	616	17	q.	q.	PROPN
admet-3007	616	18	shi	shi	PROPN
admet-3007	616	19	,	,	PUNCT
admet-3007	616	20	a.b	a.b	PROPN
admet-3007	616	21	.	.	PROPN
admet-3007	616	22	hjelmeland	hjelmeland	PROPN
admet-3007	616	23	,	,	PUNCT
admet-3007	616	24	m.w	m.w	PROPN
admet-3007	616	25	.	.	PROPN
admet-3007	616	26	dewhirst	dewhirst	PROPN
admet-3007	616	27	,	,	PUNCT
admet-3007	616	28	d.d	d.d	PROPN
admet-3007	616	29	.	.	PROPN
admet-3007	616	30	bigner	bigner	PROPN
admet-3007	616	31	,	,	PUNCT
admet-3007	616	32	j.n	j.n	PROPN
admet-3007	616	33	.	.	PROPN
admet-3007	616	34	rich	rich	ADJ
admet-3007	616	35	.	.	PUNCT
admet-3007	617	1	glioma	glioma	NOUN
admet-3007	617	2	stem	stem	NOUN
admet-3007	617	3	cells	cell	NOUN
admet-3007	617	4	promote	promote	VERB
admet-3007	617	5	radioresistance	radioresistance	NOUN
admet-3007	617	6	by	by	ADP
admet-3007	617	7	preferential	preferential	ADJ
admet-3007	617	8	activation	activation	NOUN
admet-3007	617	9	of	of	ADP
admet-3007	617	10	the	the	DET
admet-3007	617	11	dna	dna	PROPN
admet-3007	617	12	damage	damage	NOUN
admet-3007	617	13	response	response	NOUN
admet-3007	617	14	.	.	PUNCT
admet-3007	618	1	nature	nature	NOUN
admet-3007	618	2	444	444	NUM
admet-3007	618	3	(	(	PUNCT
admet-3007	618	4	2006	2006	NUM
admet-3007	618	5	)	)	PUNCT
admet-3007	618	6	756	756	NUM
admet-3007	618	7	-	-	SYM
admet-3007	618	8	760	760	NUM
admet-3007	618	9	.	.	PUNCT
admet-3007	619	1	https://doi.org/10.1038/nature05236	https://doi.org/10.1038/nature05236	PROPN
admet-3007	619	2	[	[	X
admet-3007	619	3	60	60	NUM
admet-3007	619	4	]	]	PUNCT
admet-3007	619	5	m.	m.	NOUN
admet-3007	619	6	louka	louka	PROPN
admet-3007	619	7	,	,	PUNCT
admet-3007	619	8	e.	e.	PROPN
admet-3007	619	9	boutou	boutou	PROPN
admet-3007	619	10	,	,	PUNCT
admet-3007	619	11	v.	v.	CCONJ
admet-3007	619	12	bakou	bakou	PROPN
admet-3007	619	13	,	,	PUNCT
admet-3007	619	14	v.	v.	ADP
admet-3007	619	15	pappa	pappa	NOUN
admet-3007	619	16	,	,	PUNCT
admet-3007	619	17	a.	a.	NOUN
admet-3007	619	18	georgoulis	georgoulis	NOUN
admet-3007	619	19	,	,	PUNCT
admet-3007	619	20	h.-w	h.-w	PROPN
admet-3007	619	21	.	.	PUNCT
admet-3007	620	1	stürzbecher	stürzbecher	PROPN
admet-3007	620	2	,	,	PUNCT
admet-3007	620	3	c.e	c.e	PROPN
admet-3007	620	4	.	.	PROPN
admet-3007	620	5	vorgias	vorgias	PROPN
admet-3007	620	6	,	,	PUNCT
admet-3007	620	7	d.	d.	PROPN
admet-3007	620	8	vlachodimitropoulos	vlachodimitropoulos	PROPN
admet-3007	620	9	.	.	PUNCT
admet-3007	621	1	dna	dna	PROPN
admet-3007	621	2	damage	damage	NOUN
admet-3007	621	3	response	response	NOUN
admet-3007	621	4	/	/	SYM
admet-3007	621	5	repair	repair	NOUN
admet-3007	621	6	in	in	ADP
admet-3007	621	7	cancer	cancer	NOUN
admet-3007	621	8	stem	stem	NOUN
admet-3007	621	9	cells	cell	NOUN
admet-3007	621	10	—	—	PUNCT
admet-3007	621	11	potential	potential	ADJ
admet-3007	621	12	vs.	vs.	ADP
admet-3007	621	13	controversies	controversy	NOUN
admet-3007	621	14	.	.	PUNCT
admet-3007	622	1	advances	advance	NOUN
admet-3007	622	2	in	in	ADP
admet-3007	622	3	dna	dna	PROPN
admet-3007	622	4	repair	repair	NOUN
admet-3007	622	5	10	10	NUM
admet-3007	622	6	(	(	PUNCT
admet-3007	622	7	2015	2015	NUM
admet-3007	622	8	)	)	PUNCT
admet-3007	622	9	61355	61355	NUM
admet-3007	622	10	.	.	PUNCT
admet-3007	623	1	https://doi.org/10.5772/61355	https://doi.org/10.5772/61355	NUM
admet-3007	624	1	[	[	X
admet-3007	624	2	61	61	NUM
admet-3007	624	3	]	]	X
admet-3007	624	4	d.	d.	PROPN
admet-3007	624	5	li	li	PROPN
admet-3007	624	6	,	,	PUNCT
admet-3007	624	7	x.	x.	PROPN
admet-3007	624	8	peng	peng	PROPN
admet-3007	624	9	,	,	PUNCT
admet-3007	624	10	g.	g.	PROPN
admet-3007	624	11	he	he	PRON
admet-3007	624	12	,	,	PUNCT
admet-3007	624	13	j.	j.	PROPN
admet-3007	624	14	liu	liu	PROPN
admet-3007	624	15	,	,	PUNCT
admet-3007	624	16	x.	x.	PROPN
admet-3007	624	17	li	li	PROPN
admet-3007	624	18	,	,	PUNCT
admet-3007	624	19	w.	w.	PROPN
admet-3007	624	20	lin	lin	PROPN
admet-3007	624	21	,	,	PUNCT
admet-3007	624	22	j.	j.	PROPN
admet-3007	624	23	fang	fang	PROPN
admet-3007	624	24	,	,	PUNCT
admet-3007	624	25	x.	x.	PROPN
admet-3007	624	26	li	li	PROPN
admet-3007	624	27	,	,	PUNCT
admet-3007	624	28	s.	s.	PROPN
admet-3007	624	29	yang	yang	PROPN
admet-3007	624	30	,	,	PUNCT
admet-3007	624	31	l.	l.	PROPN
admet-3007	624	32	yang	yang	PROPN
admet-3007	624	33	.	.	PROPN
admet-3007	624	34	crosstalk	crosstalk	VERB
admet-3007	624	35	between	between	ADP
admet-3007	624	36	autophagy	autophagy	NOUN
admet-3007	624	37	and	and	CCONJ
admet-3007	624	38	cscs	csc	NOUN
admet-3007	624	39	:	:	PUNCT
admet-3007	624	40	molecular	molecular	ADJ
admet-3007	624	41	mechanisms	mechanism	NOUN
admet-3007	624	42	and	and	CCONJ
admet-3007	624	43	translational	translational	ADJ
admet-3007	624	44	implications	implication	NOUN
admet-3007	624	45	.	.	PUNCT
admet-3007	625	1	cell	cell	NOUN
admet-3007	625	2	death	death	NOUN
admet-3007	625	3	&	&	CCONJ
admet-3007	625	4	disease	disease	PROPN
admet-3007	625	5	14	14	NUM
admet-3007	625	6	(	(	PUNCT
admet-3007	625	7	2023	2023	NUM
admet-3007	625	8	)	)	PUNCT
admet-3007	625	9	409	409	NUM
admet-3007	625	10	.	.	PUNCT
admet-3007	626	1	https://doi.org/10.1038/s41419-023-05929-3	https://doi.org/10.1038/s41419-023-05929-3	PROPN
admet-3007	627	1	[	[	X
admet-3007	627	2	62	62	NUM
admet-3007	627	3	]	]	PUNCT
admet-3007	627	4	m.	m.	NOUN
admet-3007	627	5	najafi	najafi	PROPN
admet-3007	627	6	,	,	PUNCT
admet-3007	627	7	k.	k.	PROPN
admet-3007	627	8	mortezaee	mortezaee	PROPN
admet-3007	627	9	,	,	PUNCT
admet-3007	627	10	j.	j.	PROPN
admet-3007	627	11	majidpoor	majidpoor	PROPN
admet-3007	627	12	.	.	PUNCT
admet-3007	628	1	cancer	cancer	NOUN
admet-3007	628	2	stem	stem	NOUN
admet-3007	628	3	cell	cell	NOUN
admet-3007	628	4	(	(	PUNCT
admet-3007	628	5	csc	csc	PROPN
admet-3007	628	6	)	)	PUNCT
admet-3007	628	7	resistance	resistance	NOUN
admet-3007	628	8	drivers	driver	NOUN
admet-3007	628	9	.	.	PUNCT
admet-3007	629	1	life	life	NOUN
admet-3007	629	2	sciences	science	NOUN
admet-3007	629	3	234	234	NUM
admet-3007	629	4	(	(	PUNCT
admet-3007	629	5	2019	2019	NUM
admet-3007	629	6	)	)	PUNCT
admet-3007	629	7	116781	116781	NUM
admet-3007	629	8	.	.	PUNCT
admet-3007	630	1	https://doi.org/10.1016/j.lfs.2019.116781	https://doi.org/10.1016/j.lfs.2019.116781	PUNCT
admet-3007	631	1	[	[	X
admet-3007	631	2	63	63	NUM
admet-3007	631	3	]	]	PUNCT
admet-3007	631	4	d.	d.	PROPN
admet-3007	631	5	liu	liu	PROPN
admet-3007	631	6	,	,	PUNCT
admet-3007	631	7	x.	x.	PROPN
admet-3007	631	8	li	li	PROPN
admet-3007	631	9	,	,	PUNCT
admet-3007	631	10	b.	b.	PROPN
admet-3007	631	11	zeng	zeng	PROPN
admet-3007	631	12	,	,	PUNCT
admet-3007	631	13	q.	q.	PROPN
admet-3007	631	14	zhao	zhao	PROPN
admet-3007	631	15	,	,	PUNCT
admet-3007	631	16	h.	h.	PROPN
admet-3007	631	17	chen	chen	PROPN
admet-3007	631	18	,	,	PUNCT
admet-3007	631	19	y.	y.	PROPN
admet-3007	631	20	zhang	zhang	PROPN
admet-3007	631	21	,	,	PUNCT
admet-3007	631	22	y.	y.	PROPN
admet-3007	631	23	chen	chen	PROPN
admet-3007	631	24	,	,	PUNCT
admet-3007	631	25	j.	j.	PROPN
admet-3007	631	26	wang	wang	PROPN
admet-3007	631	27	,	,	PUNCT
admet-3007	631	28	h.r	h.r	PROPN
admet-3007	631	29	.	.	PROPN
admet-3007	631	30	xing	xing	PROPN
admet-3007	631	31	.	.	PUNCT
admet-3007	632	1	exosomal	exosomal	ADJ
admet-3007	632	2	microrna-4535	microrna-4535	NOUN
admet-3007	632	3	of	of	ADP
admet-3007	632	4	melanoma	melanoma	NOUN
admet-3007	632	5	stem	stem	NOUN
admet-3007	632	6	cells	cell	NOUN
admet-3007	632	7	promotes	promote	VERB
admet-3007	632	8	metastasis	metastasis	NOUN
admet-3007	632	9	by	by	ADP
admet-3007	632	10	inhibiting	inhibit	VERB
admet-3007	632	11	autophagy	autophagy	ADJ
admet-3007	632	12	pathway	pathway	NOUN
admet-3007	632	13	.	.	PUNCT
admet-3007	633	1	stem	stem	NOUN
admet-3007	633	2	cell	cell	NOUN
admet-3007	633	3	reviews	review	NOUN
admet-3007	633	4	and	and	CCONJ
admet-3007	633	5	reports	report	NOUN
admet-3007	633	6	19	19	NUM
admet-3007	633	7	(	(	PUNCT
admet-3007	633	8	2023	2023	NUM
admet-3007	633	9	)	)	PUNCT
admet-3007	633	10	155	155	NUM
admet-3007	633	11	-	-	SYM
admet-3007	633	12	169	169	NUM
admet-3007	633	13	.	.	PUNCT
admet-3007	634	1	https://doi.org/10.1007/s12015-022-10358-4	https://doi.org/10.1007/s12015-022-10358-4	NUM
admet-3007	635	1	[	[	X
admet-3007	635	2	64	64	NUM
admet-3007	635	3	]	]	PUNCT
admet-3007	635	4	w.	w.	PROPN
admet-3007	635	5	chen	chen	PROPN
admet-3007	635	6	,	,	PUNCT
admet-3007	635	7	y.	y.	PROPN
admet-3007	635	8	qin	qin	PROPN
admet-3007	635	9	,	,	PUNCT
admet-3007	635	10	s.	s.	PROPN
admet-3007	635	11	liu	liu	PROPN
admet-3007	635	12	.	.	PUNCT
admet-3007	636	1	cytokines	cytokine	NOUN
admet-3007	636	2	,	,	PUNCT
admet-3007	636	3	breast	breast	NOUN
admet-3007	636	4	cancer	cancer	NOUN
admet-3007	636	5	stem	stem	NOUN
admet-3007	636	6	cells	cell	NOUN
admet-3007	636	7	(	(	PUNCT
admet-3007	636	8	bcscs	bcsc	NOUN
admet-3007	636	9	)	)	PUNCT
admet-3007	636	10	and	and	CCONJ
admet-3007	636	11	chemoresistance	chemoresistance	NOUN
admet-3007	636	12	.	.	PUNCT
admet-3007	637	1	clinical	clinical	ADJ
admet-3007	637	2	and	and	CCONJ
admet-3007	637	3	translational	translational	ADJ
admet-3007	637	4	medicine	medicine	NOUN
admet-3007	637	5	7	7	NUM
admet-3007	637	6	(	(	PUNCT
admet-3007	637	7	2018	2018	NUM
admet-3007	637	8	)	)	PUNCT
admet-3007	637	9	e27	e27	NOUN
admet-3007	637	10	.	.	PUNCT
admet-3007	637	11	https://doi.org/10.1186/s40169-018-0205-6	https://doi.org/10.1186/s40169-018-0205-6	PART
admet-3007	638	1	[	[	X
admet-3007	638	2	65	65	NUM
admet-3007	638	3	]	]	X
admet-3007	638	4	h.	h.	PROPN
admet-3007	638	5	korkaya	korkaya	PROPN
admet-3007	638	6	,	,	PUNCT
admet-3007	638	7	s.	s.	PROPN
admet-3007	638	8	liu	liu	PROPN
admet-3007	638	9	,	,	PUNCT
admet-3007	638	10	m.s	m.s	PROPN
admet-3007	638	11	.	.	PROPN
admet-3007	638	12	wicha	wicha	PROPN
admet-3007	638	13	.	.	PUNCT
admet-3007	639	1	regulation	regulation	NOUN
admet-3007	639	2	of	of	ADP
admet-3007	639	3	cancer	cancer	NOUN
admet-3007	639	4	stem	stem	NOUN
admet-3007	639	5	cells	cell	NOUN
admet-3007	639	6	by	by	ADP
admet-3007	639	7	cytokine	cytokine	ADJ
admet-3007	639	8	networks	network	NOUN
admet-3007	639	9	:	:	PUNCT
admet-3007	639	10	attacking	attack	VERB
admet-3007	639	11	cancer	cancer	NOUN
admet-3007	639	12	's	's	PART
admet-3007	639	13	inflammatory	inflammatory	ADJ
admet-3007	639	14	roots	root	NOUN
admet-3007	639	15	.	.	PUNCT
admet-3007	640	1	clinical	clinical	ADJ
admet-3007	640	2	cancer	cancer	NOUN
admet-3007	640	3	research	research	NOUN
admet-3007	640	4	17	17	NUM
admet-3007	640	5	(	(	PUNCT
admet-3007	640	6	2011	2011	NUM
admet-3007	640	7	)	)	PUNCT
admet-3007	640	8	6125	6125	NUM
admet-3007	640	9	-	-	SYM
admet-3007	640	10	6129	6129	NUM
admet-3007	640	11	.	.	PUNCT
admet-3007	641	1	https://doi.org/10.1158/10780432.ccr-10-2743	https://doi.org/10.1158/10780432.ccr-10-2743	PROPN
admet-3007	641	2	https://doi.org/10.5599/admet.3007	https://doi.org/10.5599/admet.3007	NOUN
admet-3007	641	3	https://doi.org/10.1016/j.canlet.2016.03.041	https://doi.org/10.1016/j.canlet.2016.03.041	PROPN
admet-3007	641	4	https://doi.org/10.3390/life13010197	https://doi.org/10.3390/life13010197	NOUN
admet-3007	641	5	https://doi.org/10.3390/life13010197	https://doi.org/10.3390/life13010197	PROPN
admet-3007	641	6	https://doi.org/10.1016/bs.vh.2022.09.002	https://doi.org/10.1016/bs.vh.2022.09.002	NOUN
admet-3007	641	7	https://doi.org/10.3892/or.2024.8829	https://doi.org/10.3892/or.2024.8829	PROPN
admet-3007	641	8	https://doi.org/10.1016/j.neuroscience.2008.03.054	https://doi.org/10.1016/j.neuroscience.2008.03.054	NOUN
admet-3007	641	9	https://doi.org/10.1186/1741-7007-8-63	https://doi.org/10.1186/1741-7007-8-63	PRON
admet-3007	641	10	https://doi.org/10.1038/s41392-024-01851-y	https://doi.org/10.1038/s41392-024-01851-y	VERB
admet-3007	641	11	https://doi.org/10.1016/j.canlet.2020.01.008	https://doi.org/10.1016/j.canlet.2020.01.008	NOUN
admet-3007	641	12	https://doi.org/10.1007/978-981-16-5422-0_89	https://doi.org/10.1007/978-981-16-5422-0_89	NUM
admet-3007	641	13	https://doi.org/10.1186/s13045-020-00990-3	https://doi.org/10.1186/s13045-020-00990-3	NOUN
admet-3007	641	14	https://doi.org/10.1038/nature05236	https://doi.org/10.1038/nature05236	ADJ
admet-3007	641	15	https://doi.org/10.5772/61355	https://doi.org/10.5772/61355	NUM
admet-3007	641	16	https://doi.org/10.1038/s41419-023-05929-3	https://doi.org/10.1038/s41419-023-05929-3	NUM
admet-3007	642	1	https://doi.org/10.1016/j.lfs.2019.116781	https://doi.org/10.1016/j.lfs.2019.116781	X
admet-3007	642	2	https://doi.org/10.1007/s12015-022-10358-4	https://doi.org/10.1007/s12015-022-10358-4	NUM
admet-3007	642	3	https://doi.org/10.1186/s40169-018-0205-6	https://doi.org/10.1186/s40169-018-0205-6	NUM
admet-3007	643	1	https://doi.org/10.1158/1078-0432.ccr-10-2743	https://doi.org/10.1158/1078-0432.ccr-10-2743	PRON
admet-3007	643	2	https://doi.org/10.1158/1078-0432.ccr-10-2743	https://doi.org/10.1158/1078-0432.ccr-10-2743	PROPN
admet-3007	643	3	m.	m.	NOUN
admet-3007	643	4	dehghani	dehghani	PROPN
admet-3007	643	5	et	et	PROPN
admet-3007	643	6	al	al	PROPN
admet-3007	643	7	.	.	PROPN
admet-3007	643	8	admet	admet	PROPN
admet-3007	643	9	&	&	CCONJ
admet-3007	643	10	dmpk	dmpk	PROPN
admet-3007	643	11	13(5	13(5	NUM
admet-3007	643	12	)	)	PUNCT
admet-3007	643	13	(	(	PUNCT
admet-3007	643	14	2025	2025	NUM
admet-3007	643	15	)	)	PUNCT
admet-3007	643	16	3007	3007	NUM
admet-3007	643	17	22	22	NUM
admet-3007	644	1	[	[	X
admet-3007	644	2	66	66	NUM
admet-3007	644	3	]	]	PUNCT
admet-3007	644	4	j.	j.	PROPN
admet-3007	644	5	chen	chen	PROPN
admet-3007	644	6	,	,	PUNCT
admet-3007	644	7	s.	s.	PROPN
admet-3007	644	8	chen	chen	PROPN
admet-3007	644	9	,	,	PUNCT
admet-3007	644	10	l.	l.	PROPN
admet-3007	644	11	zhuo	zhuo	PROPN
admet-3007	644	12	,	,	PUNCT
admet-3007	644	13	y.	y.	PROPN
admet-3007	644	14	zhu	zhu	PROPN
admet-3007	644	15	,	,	PUNCT
admet-3007	644	16	h.	h.	PROPN
admet-3007	644	17	zheng	zheng	PROPN
admet-3007	644	18	.	.	PUNCT
admet-3007	645	1	regulation	regulation	NOUN
admet-3007	645	2	of	of	ADP
admet-3007	645	3	cancer	cancer	NOUN
admet-3007	645	4	stem	stem	NOUN
admet-3007	645	5	cell	cell	NOUN
admet-3007	645	6	properties	property	NOUN
admet-3007	645	7	,	,	PUNCT
admet-3007	645	8	angiogenesis	angiogenesis	NOUN
admet-3007	645	9	,	,	PUNCT
admet-3007	645	10	and	and	CCONJ
admet-3007	645	11	vasculogenic	vasculogenic	ADJ
admet-3007	645	12	mimicry	mimicry	NOUN
admet-3007	645	13	by	by	ADP
admet-3007	645	14	mir-450a-5p	mir-450a-5p	PROPN
admet-3007	645	15	/	/	SYM
admet-3007	645	16	sox2	sox2	NOUN
admet-3007	645	17	axis	axis	NOUN
admet-3007	645	18	in	in	ADP
admet-3007	645	19	colorectal	colorectal	ADJ
admet-3007	645	20	cancer	cancer	NOUN
admet-3007	645	21	.	.	PUNCT
admet-3007	646	1	cell	cell	NOUN
admet-3007	646	2	death	death	NOUN
admet-3007	646	3	&	&	CCONJ
admet-3007	646	4	disease	disease	PROPN
admet-3007	646	5	11	11	NUM
admet-3007	646	6	(	(	PUNCT
admet-3007	646	7	2020	2020	NUM
admet-3007	646	8	)	)	PUNCT
admet-3007	646	9	173	173	NUM
admet-3007	646	10	.	.	PUNCT
admet-3007	647	1	https://doi.org/10.1038/s41419-020-2361-z	https://doi.org/10.1038/s41419-020-2361-z	NOUN
admet-3007	647	2	[	[	X
admet-3007	647	3	67	67	NUM
admet-3007	647	4	]	]	X
admet-3007	647	5	c.	c.	NOUN
admet-3007	647	6	folkins	folkin	NOUN
admet-3007	647	7	,	,	PUNCT
admet-3007	647	8	y.	y.	PROPN
admet-3007	647	9	shaked	shaked	PROPN
admet-3007	647	10	,	,	PUNCT
admet-3007	647	11	s.	s.	PROPN
admet-3007	647	12	man	man	PROPN
admet-3007	647	13	,	,	PUNCT
admet-3007	647	14	t.	t.	PROPN
admet-3007	647	15	tang	tang	PROPN
admet-3007	647	16	,	,	PUNCT
admet-3007	647	17	c.r	c.r	PROPN
admet-3007	647	18	.	.	PROPN
admet-3007	647	19	lee	lee	PROPN
admet-3007	647	20	,	,	PUNCT
admet-3007	647	21	z.	z.	PROPN
admet-3007	647	22	zhu	zhu	PROPN
admet-3007	647	23	,	,	PUNCT
admet-3007	647	24	r.m	r.m	PROPN
admet-3007	647	25	.	.	PROPN
admet-3007	647	26	hoffman	hoffman	PROPN
admet-3007	647	27	,	,	PUNCT
admet-3007	648	1	r.s	r.s	PROPN
admet-3007	648	2	.	.	PROPN
admet-3007	648	3	kerbel	kerbel	PROPN
admet-3007	648	4	.	.	PUNCT
admet-3007	649	1	glioma	glioma	ADJ
admet-3007	649	2	tumor	tumor	NOUN
admet-3007	649	3	stemlike	stemlike	PROPN
admet-3007	649	4	cells	cell	NOUN
admet-3007	649	5	promote	promote	VERB
admet-3007	649	6	tumor	tumor	NOUN
admet-3007	649	7	angiogenesis	angiogenesis	NOUN
admet-3007	649	8	and	and	CCONJ
admet-3007	649	9	vasculogenesis	vasculogenesis	NOUN
admet-3007	649	10	via	via	ADP
admet-3007	649	11	vascular	vascular	ADJ
admet-3007	649	12	endothelial	endothelial	ADJ
admet-3007	649	13	growth	growth	NOUN
admet-3007	649	14	factor	factor	NOUN
admet-3007	649	15	and	and	CCONJ
admet-3007	649	16	stromal	stromal	ADJ
admet-3007	649	17	-	-	PUNCT
admet-3007	649	18	derived	derive	VERB
admet-3007	649	19	factor	factor	NOUN
admet-3007	649	20	1	1	NUM
admet-3007	649	21	.	.	PUNCT
admet-3007	650	1	cancer	cancer	NOUN
admet-3007	650	2	research	research	NOUN
admet-3007	650	3	69	69	NUM
admet-3007	650	4	(	(	PUNCT
admet-3007	650	5	2009	2009	NUM
admet-3007	650	6	)	)	PUNCT
admet-3007	650	7	7243	7243	NUM
admet-3007	650	8	-	-	SYM
admet-3007	650	9	7251	7251	NUM
admet-3007	650	10	.	.	PUNCT
admet-3007	651	1	https://doi.org/10.1158/00085472.can-09-0167	https://doi.org/10.1158/00085472.can-09-0167	ADJ
admet-3007	651	2	[	[	X
admet-3007	651	3	68	68	NUM
admet-3007	651	4	]	]	X
admet-3007	651	5	e.	e.	PROPN
admet-3007	651	6	hiyama	hiyama	PROPN
admet-3007	651	7	,	,	PUNCT
admet-3007	651	8	k.	k.	PROPN
admet-3007	651	9	hiyama	hiyama	PROPN
admet-3007	651	10	.	.	PUNCT
admet-3007	652	1	telomere	telomere	NOUN
admet-3007	652	2	and	and	CCONJ
admet-3007	652	3	telomerase	telomerase	NOUN
admet-3007	652	4	in	in	ADP
admet-3007	652	5	stem	stem	NOUN
admet-3007	652	6	cells	cell	NOUN
admet-3007	652	7	.	.	PUNCT
admet-3007	653	1	british	british	ADJ
admet-3007	653	2	journal	journal	PROPN
admet-3007	653	3	of	of	ADP
admet-3007	653	4	cancer	cancer	NOUN
admet-3007	653	5	96	96	NUM
admet-3007	653	6	(	(	PUNCT
admet-3007	653	7	2007	2007	NUM
admet-3007	653	8	)	)	PUNCT
admet-3007	653	9	10201024	10201024	NUM
admet-3007	653	10	.	.	PUNCT
admet-3007	654	1	https://doi.org/10.1038/sj.bjc.6603671	https://doi.org/10.1038/sj.bjc.6603671	PROPN
admet-3007	655	1	[	[	X
admet-3007	655	2	69	69	NUM
admet-3007	655	3	]	]	PUNCT
admet-3007	655	4	k.	k.	PROPN
admet-3007	655	5	walter	walter	PROPN
admet-3007	655	6	,	,	PUNCT
admet-3007	655	7	e.	e.	PROPN
admet-3007	655	8	rodriguez	rodriguez	PROPN
admet-3007	655	9	-	-	PUNCT
admet-3007	655	10	aznar	aznar	PROPN
admet-3007	655	11	,	,	PUNCT
admet-3007	655	12	m.s.v	m.s.v	PROPN
admet-3007	655	13	.	.	PUNCT
admet-3007	655	14	ferreira	ferreira	PROPN
admet-3007	655	15	,	,	PUNCT
admet-3007	655	16	p.-o	p.-o	NOUN
admet-3007	655	17	.	.	PUNCT
admet-3007	656	1	frappart	frappart	ADJ
admet-3007	656	2	,	,	PUNCT
admet-3007	656	3	t.	t.	NOUN
admet-3007	656	4	dittrich	dittrich	PROPN
admet-3007	656	5	,	,	PUNCT
admet-3007	656	6	k.	k.	PROPN
admet-3007	656	7	tiwary	tiwary	PROPN
admet-3007	656	8	,	,	PUNCT
admet-3007	656	9	s.	s.	PROPN
admet-3007	656	10	meessen	meessen	PROPN
admet-3007	656	11	,	,	PUNCT
admet-3007	656	12	l.	l.	PROPN
admet-3007	656	13	lerma	lerma	PROPN
admet-3007	656	14	,	,	PUNCT
admet-3007	656	15	n.	n.	PROPN
admet-3007	656	16	daiss	daiss	PROPN
admet-3007	656	17	,	,	PUNCT
admet-3007	656	18	l.-a	l.-a	PROPN
admet-3007	656	19	.	.	PUNCT
admet-3007	657	1	schulte	schulte	PROPN
admet-3007	657	2	.	.	PROPN
admet-3007	657	3	telomerase	telomerase	NOUN
admet-3007	657	4	and	and	CCONJ
admet-3007	657	5	pluripotency	pluripotency	ADJ
admet-3007	657	6	factors	factor	NOUN
admet-3007	657	7	jointly	jointly	ADV
admet-3007	657	8	regulate	regulate	VERB
admet-3007	657	9	stemness	stemness	ADV
admet-3007	657	10	in	in	ADP
admet-3007	657	11	pancreatic	pancreatic	ADJ
admet-3007	657	12	cancer	cancer	NOUN
admet-3007	657	13	stem	stem	NOUN
admet-3007	657	14	cells	cell	NOUN
admet-3007	657	15	.	.	PUNCT
admet-3007	658	1	cancers	cancer	NOUN
admet-3007	658	2	13	13	NUM
admet-3007	658	3	(	(	PUNCT
admet-3007	658	4	2021	2021	NUM
admet-3007	658	5	)	)	PUNCT
admet-3007	658	6	3145	3145	NUM
admet-3007	658	7	.	.	PUNCT
admet-3007	659	1	https://doi.org/10.3390/cancers13133145	https://doi.org/10.3390/cancers13133145	PROPN
admet-3007	660	1	[	[	X
admet-3007	660	2	70	70	NUM
admet-3007	660	3	]	]	PUNCT
admet-3007	660	4	z.	z.	PROPN
admet-3007	660	5	liu	liu	PROPN
admet-3007	660	6	,	,	PUNCT
admet-3007	660	7	q.	q.	PROPN
admet-3007	660	8	li	li	PROPN
admet-3007	660	9	,	,	PUNCT
admet-3007	660	10	k.	k.	PROPN
admet-3007	660	11	li	li	PROPN
admet-3007	660	12	,	,	PUNCT
admet-3007	660	13	l.	l.	PROPN
admet-3007	660	14	chen	chen	PROPN
admet-3007	660	15	,	,	PUNCT
admet-3007	660	16	w.	w.	PROPN
admet-3007	660	17	li	li	PROPN
admet-3007	660	18	,	,	PUNCT
admet-3007	660	19	m.	m.	NOUN
admet-3007	660	20	hou	hou	PROPN
admet-3007	660	21	,	,	PUNCT
admet-3007	660	22	t.	t.	PROPN
admet-3007	660	23	liu	liu	PROPN
admet-3007	660	24	,	,	PUNCT
admet-3007	660	25	j.	j.	PROPN
admet-3007	660	26	yang	yang	PROPN
admet-3007	660	27	,	,	PUNCT
admet-3007	660	28	c.	c.	PROPN
admet-3007	660	29	lindvall	lindvall	PROPN
admet-3007	660	30	,	,	PUNCT
admet-3007	660	31	m.	m.	NOUN
admet-3007	660	32	björkholm	björkholm	PROPN
admet-3007	660	33	.	.	PUNCT
admet-3007	661	1	telomerase	telomerase	NOUN
admet-3007	661	2	reverse	reverse	ADJ
admet-3007	661	3	transcriptase	transcriptase	NOUN
admet-3007	661	4	promotes	promote	VERB
admet-3007	661	5	epithelial	epithelial	ADJ
admet-3007	661	6	-	-	PUNCT
admet-3007	661	7	mesenchymal	mesenchymal	NOUN
admet-3007	661	8	transition	transition	NOUN
admet-3007	661	9	and	and	CCONJ
admet-3007	661	10	stem	stem	NOUN
admet-3007	661	11	cell	cell	NOUN
admet-3007	661	12	-	-	PUNCT
admet-3007	661	13	like	like	ADJ
admet-3007	661	14	traits	trait	NOUN
admet-3007	661	15	in	in	ADP
admet-3007	661	16	cancer	cancer	NOUN
admet-3007	661	17	cells	cell	NOUN
admet-3007	661	18	.	.	PUNCT
admet-3007	662	1	oncogene	oncogene	NOUN
admet-3007	662	2	32	32	NUM
admet-3007	662	3	(	(	PUNCT
admet-3007	662	4	2013	2013	NUM
admet-3007	662	5	)	)	PUNCT
admet-3007	662	6	4203	4203	NUM
admet-3007	662	7	-	-	SYM
admet-3007	662	8	4213	4213	NUM
admet-3007	662	9	.	.	PUNCT
admet-3007	663	1	https://doi.org/10.1038/onc.2012.441	https://doi.org/10.1038/onc.2012.441	VERB
admet-3007	664	1	[	[	X
admet-3007	664	2	71	71	NUM
admet-3007	664	3	]	]	X
admet-3007	664	4	f.	f.	PROPN
admet-3007	664	5	dogan	dogan	PROPN
admet-3007	664	6	,	,	PUNCT
admet-3007	664	7	c.b	c.b	PROPN
admet-3007	664	8	.	.	PUNCT
admet-3007	664	9	avci	avci	PROPN
admet-3007	664	10	.	.	PUNCT
admet-3007	665	1	correlation	correlation	NOUN
admet-3007	665	2	between	between	ADP
admet-3007	665	3	telomerase	telomerase	NOUN
admet-3007	665	4	and	and	CCONJ
admet-3007	665	5	mtor	mtor	NOUN
admet-3007	665	6	pathway	pathway	NOUN
admet-3007	665	7	in	in	ADP
admet-3007	665	8	cancer	cancer	NOUN
admet-3007	665	9	stem	stem	NOUN
admet-3007	665	10	cells	cell	NOUN
admet-3007	665	11	.	.	PUNCT
admet-3007	666	1	gene	gene	NOUN
admet-3007	666	2	641	641	NUM
admet-3007	666	3	(	(	PUNCT
admet-3007	666	4	2018	2018	NUM
admet-3007	666	5	)	)	PUNCT
admet-3007	666	6	235	235	NUM
admet-3007	666	7	-	-	SYM
admet-3007	666	8	239	239	NUM
admet-3007	666	9	.	.	PUNCT
admet-3007	667	1	https://doi.org/10.1016/j.gene.2017.09.072	https://doi.org/10.1016/j.gene.2017.09.072	NOUN
admet-3007	667	2	[	[	X
admet-3007	667	3	72	72	NUM
admet-3007	667	4	]	]	X
admet-3007	667	5	r.	r.	PROPN
admet-3007	667	6	a.	a.	PROPN
admet-3007	667	7	willis	willis	PROPN
admet-3007	667	8	,	,	PUNCT
admet-3007	667	9	the	the	DET
admet-3007	667	10	spread	spread	NOUN
admet-3007	667	11	of	of	ADP
admet-3007	667	12	tumours	tumour	NOUN
admet-3007	667	13	in	in	ADP
admet-3007	667	14	the	the	DET
admet-3007	667	15	human	human	ADJ
admet-3007	667	16	body	body	NOUN
admet-3007	667	17	,	,	PUNCT
admet-3007	667	18	butterworth	butterworth	PROPN
admet-3007	667	19	&	&	CCONJ
admet-3007	667	20	co	co	PROPN
admet-3007	667	21	,	,	PUNCT
admet-3007	667	22	london	london	PROPN
admet-3007	667	23	,	,	PUNCT
admet-3007	667	24	uk	uk	PROPN
admet-3007	667	25	,	,	PUNCT
admet-3007	667	26	1973	1973	NUM
admet-3007	667	27	.	.	PUNCT
admet-3007	668	1	isbn	isbn	ADJ
admet-3007	668	2	97804073	97804073	NUM
admet-3007	668	3	-	-	SYM
admet-3007	668	4	990	990	NUM
admet-3007	668	5	-	-	SYM
admet-3007	668	6	13	13	NUM
admet-3007	668	7	[	[	X
admet-3007	668	8	73	73	NUM
admet-3007	668	9	]	]	PUNCT
admet-3007	668	10	b.	b.	PROPN
admet-3007	668	11	quesnel	quesnel	PROPN
admet-3007	668	12	.	.	PUNCT
admet-3007	669	1	tumor	tumor	NOUN
admet-3007	669	2	dormancy	dormancy	NOUN
admet-3007	669	3	:	:	PUNCT
admet-3007	669	4	long	long	ADJ
admet-3007	669	5	-	-	PUNCT
admet-3007	669	6	term	term	NOUN
admet-3007	669	7	survival	survival	NOUN
admet-3007	669	8	in	in	ADP
admet-3007	669	9	a	a	DET
admet-3007	669	10	hostile	hostile	ADJ
admet-3007	669	11	environment	environment	NOUN
admet-3007	669	12	.	.	PUNCT
admet-3007	670	1	systems	system	NOUN
admet-3007	670	2	biology	biology	NOUN
admet-3007	670	3	of	of	ADP
admet-3007	670	4	tumor	tumor	NOUN
admet-3007	670	5	dormancy	dormancy	NOUN
admet-3007	670	6	734	734	NUM
admet-3007	670	7	(	(	PUNCT
admet-3007	670	8	2013	2013	NUM
admet-3007	670	9	)	)	PUNCT
admet-3007	670	10	181	181	NUM
admet-3007	670	11	-	-	SYM
admet-3007	670	12	200	200	NUM
admet-3007	670	13	.	.	PUNCT
admet-3007	671	1	https://doi.org/10.1007/978-1-4614-1445-2_9	https://doi.org/10.1007/978-1-4614-1445-2_9	ADJ
admet-3007	671	2	[	[	X
admet-3007	671	3	74	74	NUM
admet-3007	671	4	]	]	PUNCT
admet-3007	671	5	p.	p.	NOUN
admet-3007	671	6	patel	patel	PROPN
admet-3007	671	7	,	,	PUNCT
admet-3007	671	8	e.i	e.i	PROPN
admet-3007	671	9	.	.	PUNCT
admet-3007	671	10	chen	chen	PROPN
admet-3007	671	11	.	.	PUNCT
admet-3007	672	1	cancer	cancer	NOUN
admet-3007	672	2	stem	stem	NOUN
admet-3007	672	3	cells	cell	NOUN
admet-3007	672	4	,	,	PUNCT
admet-3007	672	5	tumor	tumor	NOUN
admet-3007	672	6	dormancy	dormancy	NOUN
admet-3007	672	7	,	,	PUNCT
admet-3007	672	8	and	and	CCONJ
admet-3007	672	9	metastasis	metastasis	NOUN
admet-3007	672	10	.	.	PUNCT
admet-3007	673	1	frontiers	frontier	NOUN
admet-3007	673	2	in	in	ADP
admet-3007	673	3	endocrinology	endocrinology	NOUN
admet-3007	673	4	3	3	NUM
admet-3007	673	5	(	(	PUNCT
admet-3007	673	6	2012	2012	NUM
admet-3007	673	7	)	)	PUNCT
admet-3007	673	8	125	125	NUM
admet-3007	673	9	.	.	PUNCT
admet-3007	674	1	https://doi.org/10.3389/fendo.2012.00125	https://doi.org/10.3389/fendo.2012.00125	PROPN
admet-3007	675	1	[	[	X
admet-3007	675	2	75	75	NUM
admet-3007	675	3	]	]	PUNCT
admet-3007	675	4	s.	s.	PROPN
admet-3007	675	5	talukdar	talukdar	PROPN
admet-3007	675	6	,	,	PUNCT
admet-3007	675	7	p.	p.	PROPN
admet-3007	675	8	bhoopathi	bhoopathi	PROPN
admet-3007	675	9	,	,	PUNCT
admet-3007	675	10	l.	l.	PROPN
admet-3007	675	11	emdad	emdad	PROPN
admet-3007	675	12	,	,	PUNCT
admet-3007	675	13	s.	s.	PROPN
admet-3007	675	14	das	das	PROPN
admet-3007	675	15	,	,	PUNCT
admet-3007	675	16	d.	d.	PROPN
admet-3007	675	17	sarkar	sarkar	PROPN
admet-3007	675	18	,	,	PUNCT
admet-3007	675	19	p.b	p.b	PROPN
admet-3007	675	20	.	.	PROPN
admet-3007	675	21	fisher	fisher	PROPN
admet-3007	675	22	.	.	PUNCT
admet-3007	676	1	dormancy	dormancy	NOUN
admet-3007	676	2	and	and	CCONJ
admet-3007	676	3	cancer	cancer	NOUN
admet-3007	676	4	stem	stem	NOUN
admet-3007	676	5	cells	cell	NOUN
admet-3007	676	6	:	:	PUNCT
admet-3007	676	7	an	an	DET
admet-3007	676	8	enigma	enigma	NOUN
admet-3007	676	9	for	for	ADP
admet-3007	676	10	cancer	cancer	NOUN
admet-3007	676	11	therapeutic	therapeutic	ADJ
admet-3007	676	12	targeting	targeting	NOUN
admet-3007	676	13	.	.	PUNCT
admet-3007	677	1	advances	advance	NOUN
admet-3007	677	2	in	in	ADP
admet-3007	677	3	cancer	cancer	NOUN
admet-3007	677	4	research	research	NOUN
admet-3007	677	5	141	141	NUM
admet-3007	677	6	(	(	PUNCT
admet-3007	677	7	2019	2019	NUM
admet-3007	677	8	)	)	PUNCT
admet-3007	677	9	43	43	NUM
admet-3007	677	10	-	-	SYM
admet-3007	677	11	84	84	NUM
admet-3007	677	12	.	.	PUNCT
admet-3007	678	1	https://doi.org/10.1016/bs.acr.2018.12.002	https://doi.org/10.1016/bs.acr.2018.12.002	NOUN
admet-3007	679	1	[	[	X
admet-3007	679	2	76	76	NUM
admet-3007	679	3	]	]	X
admet-3007	679	4	j.	j.	PROPN
admet-3007	679	5	heddleston	heddleston	PROPN
admet-3007	679	6	,	,	PUNCT
admet-3007	679	7	z.	z.	PROPN
admet-3007	679	8	li	li	PROPN
admet-3007	679	9	,	,	PUNCT
admet-3007	679	10	j.a	j.a	PROPN
admet-3007	679	11	.	.	PROPN
admet-3007	679	12	lathia	lathia	PROPN
admet-3007	679	13	,	,	PUNCT
admet-3007	679	14	s.	s.	PROPN
admet-3007	679	15	bao	bao	PROPN
admet-3007	679	16	,	,	PUNCT
admet-3007	679	17	a.	a.	NOUN
admet-3007	679	18	hjelmeland	hjelmeland	PROPN
admet-3007	679	19	,	,	PUNCT
admet-3007	679	20	j.	j.	PROPN
admet-3007	679	21	rich	rich	PROPN
admet-3007	679	22	.	.	PUNCT
admet-3007	680	1	hypoxia	hypoxia	VERB
admet-3007	680	2	inducible	inducible	ADJ
admet-3007	680	3	factors	factor	NOUN
admet-3007	680	4	in	in	ADP
admet-3007	680	5	cancer	cancer	NOUN
admet-3007	680	6	stem	stem	NOUN
admet-3007	680	7	cells	cell	NOUN
admet-3007	680	8	.	.	PUNCT
admet-3007	681	1	british	british	ADJ
admet-3007	681	2	journal	journal	PROPN
admet-3007	681	3	of	of	ADP
admet-3007	681	4	cancer	cancer	NOUN
admet-3007	681	5	102	102	NUM
admet-3007	681	6	(	(	PUNCT
admet-3007	681	7	2010	2010	NUM
admet-3007	681	8	)	)	PUNCT
admet-3007	681	9	789	789	NUM
admet-3007	681	10	-	-	SYM
admet-3007	681	11	795	795	NUM
admet-3007	681	12	.	.	PUNCT
admet-3007	682	1	https://doi.org/10.1038/sj.bjc.6605551	https://doi.org/10.1038/sj.bjc.6605551	NUM
admet-3007	683	1	[	[	X
admet-3007	683	2	77	77	X
admet-3007	683	3	]	]	PUNCT
admet-3007	683	4	t.	t.	PROPN
admet-3007	683	5	shi	shi	PROPN
admet-3007	683	6	,	,	PUNCT
admet-3007	683	7	j.	j.	PROPN
admet-3007	683	8	zhu	zhu	PROPN
admet-3007	683	9	,	,	PUNCT
admet-3007	683	10	x.	x.	PROPN
admet-3007	683	11	zhang	zhang	PROPN
admet-3007	683	12	,	,	PUNCT
admet-3007	683	13	x.	x.	PROPN
admet-3007	683	14	mao	mao	PROPN
admet-3007	683	15	.	.	PUNCT
admet-3007	684	1	the	the	DET
admet-3007	684	2	role	role	NOUN
admet-3007	684	3	of	of	ADP
admet-3007	684	4	hypoxia	hypoxia	NOUN
admet-3007	684	5	and	and	CCONJ
admet-3007	684	6	cancer	cancer	NOUN
admet-3007	684	7	stem	stem	NOUN
admet-3007	684	8	cells	cell	NOUN
admet-3007	684	9	in	in	ADP
admet-3007	684	10	development	development	NOUN
admet-3007	684	11	of	of	ADP
admet-3007	684	12	glioblastoma	glioblastoma	NOUN
admet-3007	684	13	.	.	PUNCT
admet-3007	685	1	cancers	cancer	NOUN
admet-3007	685	2	15	15	NUM
admet-3007	685	3	(	(	PUNCT
admet-3007	685	4	2023	2023	NUM
admet-3007	685	5	)	)	PUNCT
admet-3007	685	6	2613	2613	NUM
admet-3007	685	7	.	.	PUNCT
admet-3007	686	1	https://doi.org/10.3390/cancers15092613	https://doi.org/10.3390/cancers15092613	PROPN
admet-3007	686	2	[	[	X
admet-3007	686	3	78	78	NUM
admet-3007	686	4	]	]	PUNCT
admet-3007	686	5	j.	j.	PROPN
admet-3007	686	6	chen	chen	PROPN
admet-3007	686	7	,	,	PUNCT
admet-3007	686	8	z.	z.	PROPN
admet-3007	686	9	ding	ding	PROPN
admet-3007	686	10	,	,	PUNCT
admet-3007	686	11	y.	y.	PROPN
admet-3007	686	12	peng	peng	PROPN
admet-3007	686	13	,	,	PUNCT
admet-3007	686	14	f.	f.	PROPN
admet-3007	686	15	pan	pan	PROPN
admet-3007	686	16	,	,	PUNCT
admet-3007	686	17	j.	j.	PROPN
admet-3007	686	18	li	li	PROPN
admet-3007	686	19	,	,	PUNCT
admet-3007	686	20	l.	l.	PROPN
admet-3007	686	21	zou	zou	PROPN
admet-3007	686	22	,	,	PUNCT
admet-3007	686	23	y.	y.	PROPN
admet-3007	686	24	zhang	zhang	PROPN
admet-3007	686	25	,	,	PUNCT
admet-3007	686	26	h.	h.	PROPN
admet-3007	686	27	liang	liang	PROPN
admet-3007	686	28	.	.	PUNCT
admet-3007	687	1	hif-1α	hif-1α	NOUN
admet-3007	687	2	inhibition	inhibition	NOUN
admet-3007	687	3	reverses	reverse	VERB
admet-3007	687	4	multidrug	multidrug	NOUN
admet-3007	687	5	resistance	resistance	NOUN
admet-3007	687	6	in	in	ADP
admet-3007	687	7	colon	colon	NOUN
admet-3007	687	8	cancer	cancer	NOUN
admet-3007	687	9	cells	cell	NOUN
admet-3007	687	10	via	via	ADP
admet-3007	687	11	downregulation	downregulation	NOUN
admet-3007	687	12	of	of	ADP
admet-3007	687	13	mdr1	mdr1	PROPN
admet-3007	687	14	/	/	SYM
admet-3007	687	15	p	p	NOUN
admet-3007	687	16	-	-	PUNCT
admet-3007	687	17	glycoprotein	glycoprotein	NOUN
admet-3007	687	18	.	.	PUNCT
admet-3007	688	1	plos	plos	PROPN
admet-3007	688	2	one	one	NUM
admet-3007	688	3	9	9	NUM
admet-3007	688	4	(	(	PUNCT
admet-3007	688	5	2014	2014	NUM
admet-3007	688	6	)	)	PUNCT
admet-3007	688	7	e98882	e98882	NOUN
admet-3007	688	8	.	.	PUNCT
admet-3007	688	9	https://doi.org/10.1371/journal.pone.0098882	https://doi.org/10.1371/journal.pone.0098882	PROPN
admet-3007	689	1	[	[	X
admet-3007	689	2	79	79	NUM
admet-3007	689	3	]	]	PUNCT
admet-3007	689	4	p.	p.	NOUN
admet-3007	689	5	nisticò	nisticò	PROPN
admet-3007	689	6	,	,	PUNCT
admet-3007	689	7	m.j	m.j	PROPN
admet-3007	689	8	.	.	PROPN
admet-3007	689	9	bissell	bissell	PROPN
admet-3007	689	10	,	,	PUNCT
admet-3007	689	11	d.c	d.c	PROPN
admet-3007	689	12	.	.	PROPN
admet-3007	689	13	radisky	radisky	PROPN
admet-3007	689	14	.	.	PUNCT
admet-3007	690	1	epithelial	epithelial	ADJ
admet-3007	690	2	-	-	PUNCT
admet-3007	690	3	mesenchymal	mesenchymal	NOUN
admet-3007	690	4	transition	transition	NOUN
admet-3007	690	5	:	:	PUNCT
admet-3007	690	6	general	general	ADJ
admet-3007	690	7	principles	principle	NOUN
admet-3007	690	8	and	and	CCONJ
admet-3007	690	9	pathological	pathological	ADJ
admet-3007	690	10	relevance	relevance	NOUN
admet-3007	690	11	with	with	ADP
admet-3007	690	12	special	special	ADJ
admet-3007	690	13	emphasis	emphasis	NOUN
admet-3007	690	14	on	on	ADP
admet-3007	690	15	the	the	DET
admet-3007	690	16	role	role	NOUN
admet-3007	690	17	of	of	ADP
admet-3007	690	18	matrix	matrix	NOUN
admet-3007	690	19	metalloproteinases	metalloproteinase	NOUN
admet-3007	690	20	.	.	PUNCT
admet-3007	691	1	cold	cold	ADJ
admet-3007	691	2	spring	spring	NOUN
admet-3007	691	3	harbor	harbor	NOUN
admet-3007	691	4	perspectives	perspective	NOUN
admet-3007	691	5	in	in	ADP
admet-3007	691	6	biology	biology	NOUN
admet-3007	691	7	4	4	NUM
admet-3007	691	8	(	(	PUNCT
admet-3007	691	9	2012	2012	NUM
admet-3007	691	10	)	)	PUNCT
admet-3007	691	11	a011908	a011908	NOUN
admet-3007	691	12	.	.	PUNCT
admet-3007	692	1	https://doi.org/10.1101/cshperspect.a011908	https://doi.org/10.1101/cshperspect.a011908	PROPN
admet-3007	693	1	[	[	X
admet-3007	693	2	80	80	NUM
admet-3007	693	3	]	]	PUNCT
admet-3007	693	4	s.	s.	PROPN
admet-3007	693	5	heerboth	heerboth	PROPN
admet-3007	693	6	,	,	PUNCT
admet-3007	693	7	g.	g.	PROPN
admet-3007	693	8	housman	housman	PROPN
admet-3007	693	9	,	,	PUNCT
admet-3007	693	10	m.	m.	PROPN
admet-3007	693	11	leary	leary	PROPN
admet-3007	693	12	,	,	PUNCT
admet-3007	693	13	m.	m.	PROPN
admet-3007	693	14	longacre	longacre	PROPN
admet-3007	693	15	,	,	PUNCT
admet-3007	693	16	s.	s.	PROPN
admet-3007	693	17	byler	byler	PROPN
admet-3007	693	18	,	,	PUNCT
admet-3007	693	19	k.	k.	PROPN
admet-3007	693	20	lapinska	lapinska	PROPN
admet-3007	693	21	,	,	PUNCT
admet-3007	693	22	a.	a.	NOUN
admet-3007	693	23	willbanks	willbanks	PROPN
admet-3007	693	24	,	,	PUNCT
admet-3007	693	25	s.	s.	PROPN
admet-3007	693	26	sarkar	sarkar	PROPN
admet-3007	693	27	.	.	PUNCT
admet-3007	694	1	emt	emt	PROPN
admet-3007	694	2	and	and	CCONJ
admet-3007	694	3	tumor	tumor	NOUN
admet-3007	694	4	metastasis	metastasis	NOUN
admet-3007	694	5	.	.	PUNCT
admet-3007	695	1	clinical	clinical	ADJ
admet-3007	695	2	and	and	CCONJ
admet-3007	695	3	translational	translational	ADJ
admet-3007	695	4	medicine	medicine	NOUN
admet-3007	695	5	4	4	NUM
admet-3007	695	6	(	(	PUNCT
admet-3007	695	7	2015	2015	NUM
admet-3007	695	8	)	)	PUNCT
admet-3007	695	9	6	6	NUM
admet-3007	695	10	.	.	PUNCT
admet-3007	696	1	https://doi.org/10.1186/s40169-0150048-3	https://doi.org/10.1186/s40169-0150048-3	NOUN
admet-3007	696	2	[	[	X
admet-3007	696	3	81	81	NUM
admet-3007	696	4	]	]	X
admet-3007	696	5	y.	y.	PROPN
admet-3007	696	6	shiozawa	shiozawa	PROPN
admet-3007	696	7	,	,	PUNCT
admet-3007	696	8	b.	b.	PROPN
admet-3007	696	9	nie	nie	PROPN
admet-3007	696	10	,	,	PUNCT
admet-3007	696	11	k.j	k.j	PROPN
admet-3007	696	12	.	.	PROPN
admet-3007	696	13	pienta	pienta	PROPN
admet-3007	696	14	,	,	PUNCT
admet-3007	696	15	t.m	t.m	PROPN
admet-3007	696	16	.	.	PROPN
admet-3007	696	17	morgan	morgan	PROPN
admet-3007	696	18	,	,	PUNCT
admet-3007	696	19	r.s	r.s	PROPN
admet-3007	696	20	.	.	PROPN
admet-3007	696	21	taichman	taichman	PROPN
admet-3007	696	22	.	.	PUNCT
admet-3007	697	1	cancer	cancer	NOUN
admet-3007	697	2	stem	stem	NOUN
admet-3007	697	3	cells	cell	NOUN
admet-3007	697	4	and	and	CCONJ
admet-3007	697	5	their	their	PRON
admet-3007	697	6	role	role	NOUN
admet-3007	697	7	in	in	ADP
admet-3007	697	8	metastasis	metastasis	NOUN
admet-3007	697	9	.	.	PUNCT
admet-3007	698	1	pharmacology	pharmacology	NOUN
admet-3007	698	2	&	&	CCONJ
admet-3007	698	3	therapeutics	therapeutic	NOUN
admet-3007	698	4	138	138	NUM
admet-3007	698	5	(	(	PUNCT
admet-3007	698	6	2013	2013	NUM
admet-3007	698	7	)	)	PUNCT
admet-3007	698	8	285	285	NUM
admet-3007	698	9	-	-	SYM
admet-3007	698	10	293	293	NUM
admet-3007	698	11	.	.	PUNCT
admet-3007	698	12	https://doi.org/10.1016/j.pharmthera.2013.01.014	https://doi.org/10.1016/j.pharmthera.2013.01.014	PROPN
admet-3007	699	1	[	[	X
admet-3007	699	2	82	82	NUM
admet-3007	699	3	]	]	X
admet-3007	699	4	e.	e.	PROPN
admet-3007	699	5	aydemir	aydemir	PROPN
admet-3007	699	6	çoban	çoban	PROPN
admet-3007	699	7	,	,	PUNCT
admet-3007	699	8	f.	f.	PROPN
admet-3007	699	9	şahin	şahin	PROPN
admet-3007	699	10	.	.	PUNCT
admet-3007	700	1	cancer	cancer	NOUN
admet-3007	700	2	stem	stem	NOUN
admet-3007	700	3	cells	cell	NOUN
admet-3007	700	4	in	in	ADP
admet-3007	700	5	metastasis	metastasis	NOUN
admet-3007	700	6	therapy	therapy	NOUN
admet-3007	700	7	.	.	PUNCT
admet-3007	701	1	cell	cell	NOUN
admet-3007	701	2	biology	biology	NOUN
admet-3007	701	3	and	and	CCONJ
admet-3007	701	4	translational	translational	ADJ
admet-3007	701	5	medicine	medicine	NOUN
admet-3007	701	6	,	,	PUNCT
admet-3007	701	7	volume	volume	NOUN
admet-3007	701	8	2	2	NUM
admet-3007	701	9	:	:	PUNCT
admet-3007	701	10	approaches	approach	NOUN
admet-3007	701	11	for	for	ADP
admet-3007	701	12	diverse	diverse	ADJ
admet-3007	701	13	diseases	disease	NOUN
admet-3007	701	14	and	and	CCONJ
admet-3007	701	15	conditions	condition	NOUN
admet-3007	701	16	2	2	NUM
admet-3007	701	17	(	(	PUNCT
admet-3007	701	18	2018	2018	NUM
admet-3007	701	19	)	)	PUNCT
admet-3007	701	20	97	97	NUM
admet-3007	701	21	-	-	SYM
admet-3007	701	22	113	113	NUM
admet-3007	701	23	.	.	PUNCT
admet-3007	702	1	https://doi.org/10.1007/5584_2018_279	https://doi.org/10.1007/5584_2018_279	PROPN
admet-3007	703	1	[	[	X
admet-3007	703	2	83	83	NUM
admet-3007	703	3	]	]	SYM
admet-3007	703	4	s.m	s.m	PROPN
admet-3007	703	5	.	.	PROPN
admet-3007	703	6	beecher	beecher	PROPN
admet-3007	703	7	,	,	PUNCT
admet-3007	703	8	d.p	d.p	PROPN
admet-3007	703	9	.	.	PROPN
admet-3007	703	10	oʼleary	oʼleary	PROPN
admet-3007	703	11	,	,	PUNCT
admet-3007	703	12	r.	r.	PROPN
admet-3007	703	13	mclaughlin	mclaughlin	PROPN
admet-3007	703	14	,	,	PUNCT
admet-3007	703	15	m.j	m.j	PROPN
admet-3007	703	16	.	.	PROPN
admet-3007	703	17	kerin	kerin	PROPN
admet-3007	703	18	.	.	PUNCT
admet-3007	704	1	the	the	DET
admet-3007	704	2	impact	impact	NOUN
admet-3007	704	3	of	of	ADP
admet-3007	704	4	surgical	surgical	ADJ
admet-3007	704	5	complications	complication	NOUN
admet-3007	704	6	on	on	ADP
admet-3007	704	7	cancer	cancer	NOUN
admet-3007	704	8	recurrence	recurrence	NOUN
admet-3007	704	9	rates	rate	NOUN
admet-3007	704	10	:	:	PUNCT
admet-3007	704	11	a	a	DET
admet-3007	704	12	literature	literature	NOUN
admet-3007	704	13	review	review	NOUN
admet-3007	704	14	.	.	PUNCT
admet-3007	705	1	oncology	oncology	NOUN
admet-3007	705	2	research	research	NOUN
admet-3007	705	3	and	and	CCONJ
admet-3007	705	4	treatment	treatment	NOUN
admet-3007	705	5	41	41	NUM
admet-3007	705	6	(	(	PUNCT
admet-3007	705	7	2018	2018	NUM
admet-3007	705	8	)	)	PUNCT
admet-3007	705	9	478	478	NUM
admet-3007	705	10	-	-	SYM
admet-3007	705	11	482	482	NUM
admet-3007	705	12	.	.	PUNCT
admet-3007	706	1	https://doi.org/10.1159/000487510	https://doi.org/10.1159/000487510	PUNCT
admet-3007	706	2	[	[	X
admet-3007	706	3	84	84	NUM
admet-3007	706	4	]	]	PUNCT
admet-3007	706	5	c.	c.	PROPN
admet-3007	706	6	liu	liu	PROPN
admet-3007	706	7	,	,	PUNCT
admet-3007	706	8	m.	m.	PROPN
admet-3007	706	9	yang	yang	PROPN
admet-3007	706	10	,	,	PUNCT
admet-3007	706	11	d.	d.	PROPN
admet-3007	706	12	zhang	zhang	PROPN
admet-3007	706	13	,	,	PUNCT
admet-3007	706	14	m.	m.	PROPN
admet-3007	706	15	chen	chen	PROPN
admet-3007	706	16	,	,	PUNCT
admet-3007	706	17	d.	d.	PROPN
admet-3007	706	18	zhu	zhu	PROPN
admet-3007	706	19	.	.	PUNCT
admet-3007	707	1	clinical	clinical	ADJ
admet-3007	707	2	cancer	cancer	NOUN
admet-3007	707	3	immunotherapy	immunotherapy	NOUN
admet-3007	707	4	:	:	PUNCT
admet-3007	707	5	current	current	ADJ
admet-3007	707	6	progress	progress	NOUN
admet-3007	707	7	and	and	CCONJ
admet-3007	707	8	prospects	prospect	NOUN
admet-3007	707	9	.	.	PUNCT
admet-3007	708	1	frontiers	frontier	NOUN
admet-3007	708	2	in	in	ADP
admet-3007	708	3	immunology	immunology	NOUN
admet-3007	708	4	13	13	NUM
admet-3007	708	5	(	(	PUNCT
admet-3007	708	6	2022	2022	NUM
admet-3007	708	7	)	)	PUNCT
admet-3007	708	8	961805	961805	NUM
admet-3007	708	9	.	.	PUNCT
admet-3007	709	1	https://doi.org/10.3389/fimmu.2022.961805	https://doi.org/10.3389/fimmu.2022.961805	PROPN
admet-3007	709	2	https://doi.org/10.1038/s41419-020-2361-z	https://doi.org/10.1038/s41419-020-2361-z	NOUN
admet-3007	709	3	https://doi.org/10.1158/0008-5472.can-09-0167	https://doi.org/10.1158/0008-5472.can-09-0167	PRON
admet-3007	709	4	https://doi.org/10.1158/0008-5472.can-09-0167	https://doi.org/10.1158/0008-5472.can-09-0167	DET
admet-3007	709	5	https://doi.org/10.1038/sj.bjc.6603671	https://doi.org/10.1038/sj.bjc.6603671	PROPN
admet-3007	709	6	https://doi.org/10.3390/cancers13133145	https://doi.org/10.3390/cancers13133145	PROPN
admet-3007	709	7	https://doi.org/10.1038/onc.2012.441	https://doi.org/10.1038/onc.2012.441	PROPN
admet-3007	709	8	https://doi.org/10.1016/j.gene.2017.09.072	https://doi.org/10.1016/j.gene.2017.09.072	PROPN
admet-3007	709	9	https://doi.org/10.1007/978-1-4614-1445-2_9	https://doi.org/10.1007/978-1-4614-1445-2_9	PROPN
admet-3007	709	10	https://doi.org/10.3389/fendo.2012.00125	https://doi.org/10.3389/fendo.2012.00125	PROPN
admet-3007	709	11	https://doi.org/10.1016/bs.acr.2018.12.002	https://doi.org/10.1016/bs.acr.2018.12.002	PROPN
admet-3007	709	12	https://doi.org/10.1038/sj.bjc.6605551	https://doi.org/10.1038/sj.bjc.6605551	NUM
admet-3007	709	13	https://doi.org/10.3390/cancers15092613	https://doi.org/10.3390/cancers15092613	PROPN
admet-3007	709	14	https://doi.org/10.1371/journal.pone.0098882	https://doi.org/10.1371/journal.pone.0098882	PROPN
admet-3007	709	15	https://doi.org/10.1101/cshperspect.a011908	https://doi.org/10.1101/cshperspect.a011908	PROPN
admet-3007	709	16	https://doi.org/10.1186/s40169-015-0048-3	https://doi.org/10.1186/s40169-015-0048-3	PROPN
admet-3007	709	17	https://doi.org/10.1186/s40169-015-0048-3	https://doi.org/10.1186/s40169-015-0048-3	NUM
admet-3007	709	18	https://doi.org/10.1016/j.pharmthera.2013.01.014	https://doi.org/10.1016/j.pharmthera.2013.01.014	PROPN
admet-3007	709	19	https://doi.org/10.1007/5584_2018_279	https://doi.org/10.1007/5584_2018_279	PROPN
admet-3007	709	20	https://doi.org/10.1159/000487510	https://doi.org/10.1159/000487510	PROPN
admet-3007	709	21	https://doi.org/10.3389/fimmu.2022.961805	https://doi.org/10.3389/fimmu.2022.961805	PROPN
admet-3007	709	22	admet	admet	PROPN
admet-3007	709	23	&	&	CCONJ
admet-3007	709	24	dmpk	dmpk	PROPN
admet-3007	709	25	13(5	13(5	NUM
admet-3007	709	26	)	)	PUNCT
admet-3007	709	27	(	(	PUNCT
admet-3007	709	28	2025	2025	NUM
admet-3007	709	29	)	)	PUNCT
admet-3007	709	30	3007	3007	NUM
admet-3007	709	31	nano	nano	NOUN
admet-3007	709	32	-	-	PUNCT
admet-3007	709	33	biomaterials	biomaterial	NOUN
admet-3007	709	34	in	in	ADP
admet-3007	709	35	cancer	cancer	NOUN
admet-3007	709	36	therapy	therapy	NOUN
admet-3007	709	37	doi	doi	PROPN
admet-3007	709	38	:	:	PUNCT
admet-3007	709	39	https://doi.org/10.5599/admet.3007	https://doi.org/10.5599/admet.3007	NOUN
admet-3007	709	40	23	23	NUM
admet-3007	710	1	[	[	SYM
admet-3007	710	2	85	85	NUM
admet-3007	710	3	]	]	X
admet-3007	710	4	s.	s.	PROPN
admet-3007	710	5	tan	tan	PROPN
admet-3007	710	6	,	,	PUNCT
admet-3007	710	7	d.	d.	PROPN
admet-3007	710	8	li	li	PROPN
admet-3007	710	9	,	,	PUNCT
admet-3007	710	10	x.	x.	PROPN
admet-3007	710	11	zhu	zhu	PROPN
admet-3007	710	12	.	.	PUNCT
admet-3007	711	1	cancer	cancer	NOUN
admet-3007	711	2	immunotherapy	immunotherapy	NOUN
admet-3007	711	3	:	:	PUNCT
admet-3007	712	1	pros	pro	NOUN
admet-3007	712	2	,	,	PUNCT
admet-3007	712	3	cons	con	NOUN
admet-3007	712	4	and	and	CCONJ
admet-3007	712	5	beyond	beyond	ADP
admet-3007	712	6	.	.	PUNCT
admet-3007	713	1	biomedicine	biomedicine	NOUN
admet-3007	713	2	&	&	CCONJ
admet-3007	713	3	pharmacotherapy	pharmacotherapy	NOUN
admet-3007	713	4	124	124	NUM
admet-3007	713	5	(	(	PUNCT
admet-3007	713	6	2020	2020	NUM
admet-3007	713	7	)	)	PUNCT
admet-3007	713	8	109821	109821	NUM
admet-3007	713	9	.	.	PUNCT
admet-3007	714	1	https://doi.org/10.1016/j.biopha.2020.109821	https://doi.org/10.1016/j.biopha.2020.109821	PROPN
admet-3007	714	2	[	[	X
admet-3007	714	3	86	86	NUM
admet-3007	714	4	]	]	PUNCT
admet-3007	714	5	j.	j.	PROPN
admet-3007	714	6	abraham	abraham	PROPN
admet-3007	714	7	,	,	PUNCT
admet-3007	714	8	j.	j.	PROPN
admet-3007	714	9	staffurth	staffurth	PROPN
admet-3007	714	10	.	.	PUNCT
admet-3007	715	1	hormonal	hormonal	ADJ
admet-3007	715	2	therapy	therapy	NOUN
admet-3007	715	3	for	for	ADP
admet-3007	715	4	cancer	cancer	NOUN
admet-3007	715	5	.	.	PUNCT
admet-3007	716	1	medicine	medicine	NOUN
admet-3007	716	2	44	44	NUM
admet-3007	716	3	(	(	PUNCT
admet-3007	716	4	2016	2016	NUM
admet-3007	716	5	)	)	PUNCT
admet-3007	716	6	30	30	NUM
admet-3007	716	7	-	-	SYM
admet-3007	716	8	33	33	NUM
admet-3007	716	9	.	.	PUNCT
admet-3007	717	1	https://doi.org/10.1016/j.mpmed.2019.11.007	https://doi.org/10.1016/j.mpmed.2019.11.007	VERB
admet-3007	717	2	[	[	X
admet-3007	717	3	87	87	NUM
admet-3007	717	4	]	]	PUNCT
admet-3007	717	5	l.	l.	PROPN
admet-3007	717	6	fleming	fleming	PROPN
admet-3007	717	7	,	,	PUNCT
admet-3007	717	8	s.	s.	PROPN
admet-3007	717	9	agnew	agnew	PROPN
admet-3007	717	10	,	,	PUNCT
admet-3007	717	11	n.	n.	PROPN
admet-3007	717	12	peddie	peddie	PROPN
admet-3007	717	13	,	,	PUNCT
admet-3007	717	14	m.	m.	PROPN
admet-3007	717	15	crawford	crawford	PROPN
admet-3007	717	16	,	,	PUNCT
admet-3007	717	17	d.	d.	PROPN
admet-3007	717	18	dixon	dixon	PROPN
admet-3007	717	19	,	,	PUNCT
admet-3007	717	20	i.	i.	PROPN
admet-3007	717	21	macpherson	macpherson	PROPN
admet-3007	717	22	.	.	PUNCT
admet-3007	718	1	the	the	DET
admet-3007	718	2	impact	impact	NOUN
admet-3007	718	3	of	of	ADP
admet-3007	718	4	medication	medication	NOUN
admet-3007	718	5	side	side	NOUN
admet-3007	718	6	effects	effect	NOUN
admet-3007	718	7	on	on	ADP
admet-3007	718	8	adherence	adherence	NOUN
admet-3007	718	9	and	and	CCONJ
admet-3007	718	10	persistence	persistence	NOUN
admet-3007	718	11	to	to	ADP
admet-3007	718	12	hormone	hormone	NOUN
admet-3007	718	13	therapy	therapy	NOUN
admet-3007	718	14	in	in	ADP
admet-3007	718	15	breast	breast	NOUN
admet-3007	718	16	cancer	cancer	NOUN
admet-3007	718	17	survivors	survivor	NOUN
admet-3007	718	18	:	:	PUNCT
admet-3007	718	19	a	a	DET
admet-3007	718	20	quantitative	quantitative	ADJ
admet-3007	718	21	systematic	systematic	ADJ
admet-3007	718	22	review	review	NOUN
admet-3007	718	23	.	.	PUNCT
admet-3007	719	1	the	the	DET
admet-3007	719	2	breast	breast	NOUN
admet-3007	719	3	64	64	NUM
admet-3007	719	4	(	(	PUNCT
admet-3007	719	5	2022	2022	NUM
admet-3007	719	6	)	)	PUNCT
admet-3007	719	7	63	63	NUM
admet-3007	719	8	-	-	SYM
admet-3007	719	9	84	84	NUM
admet-3007	719	10	.	.	PUNCT
admet-3007	720	1	https://doi.org/10.1016/j.breast.2022.04.010	https://doi.org/10.1016/j.breast.2022.04.010	NOUN
admet-3007	720	2	[	[	X
admet-3007	720	3	88	88	NUM
admet-3007	720	4	]	]	X
admet-3007	720	5	l.	l.	PROPN
admet-3007	720	6	torezan	torezan	PROPN
admet-3007	720	7	,	,	PUNCT
admet-3007	720	8	b.	b.	PROPN
admet-3007	720	9	grinblat	grinblat	PROPN
admet-3007	720	10	,	,	PUNCT
admet-3007	720	11	m.	m.	NOUN
admet-3007	720	12	hædersdal	hædersdal	NOUN
admet-3007	720	13	,	,	PUNCT
admet-3007	720	14	n.	n.	PROPN
admet-3007	720	15	valente	valente	PROPN
admet-3007	720	16	,	,	PUNCT
admet-3007	720	17	c.	c.	PROPN
admet-3007	720	18	festa‐neto	festa‐neto	PROPN
admet-3007	720	19	,	,	PUNCT
admet-3007	720	20	r.	r.	PROPN
admet-3007	720	21	szeimies	szeimies	PROPN
admet-3007	720	22	.	.	PUNCT
admet-3007	721	1	a	a	DET
admet-3007	721	2	randomized	randomize	VERB
admet-3007	721	3	split‐scalp	split‐scalp	NOUN
admet-3007	721	4	study	study	NOUN
admet-3007	721	5	comparing	compare	VERB
admet-3007	721	6	calcipotriol‐assisted	calcipotriol‐assiste	VERB
admet-3007	721	7	methyl	methyl	NOUN
admet-3007	721	8	aminolaevulinate	aminolaevulinate	NOUN
admet-3007	721	9	photodynamic	photodynamic	ADJ
admet-3007	721	10	therapy	therapy	NOUN
admet-3007	721	11	(	(	PUNCT
admet-3007	721	12	mal‐pdt	mal‐pdt	PROPN
admet-3007	721	13	)	)	PUNCT
admet-3007	721	14	with	with	ADP
admet-3007	721	15	conventional	conventional	ADJ
admet-3007	721	16	mal‐pdt	mal‐pdt	NOUN
admet-3007	721	17	for	for	ADP
admet-3007	721	18	the	the	DET
admet-3007	721	19	treatment	treatment	NOUN
admet-3007	721	20	of	of	ADP
admet-3007	721	21	actinic	actinic	ADJ
admet-3007	721	22	keratosis	keratosis	NOUN
admet-3007	721	23	.	.	PUNCT
admet-3007	722	1	british	british	ADJ
admet-3007	722	2	journal	journal	PROPN
admet-3007	722	3	of	of	ADP
admet-3007	722	4	dermatology	dermatology	NOUN
admet-3007	722	5	179	179	NUM
admet-3007	722	6	(	(	PUNCT
admet-3007	722	7	2018	2018	NUM
admet-3007	722	8	)	)	PUNCT
admet-3007	722	9	829	829	NUM
admet-3007	722	10	-	-	SYM
admet-3007	722	11	835	835	NUM
admet-3007	722	12	.	.	PUNCT
admet-3007	723	1	https://doi.org/10.1111/bjd.16473	https://doi.org/10.1111/bjd.16473	X
admet-3007	724	1	[	[	X
admet-3007	724	2	89	89	NUM
admet-3007	724	3	]	]	X
admet-3007	724	4	b.	b.	PROPN
admet-3007	724	5	cesur‐ergün	cesur‐ergün	PROPN
admet-3007	724	6	,	,	PUNCT
admet-3007	724	7	d.	d.	PROPN
admet-3007	724	8	demir‐dora	demir‐dora	PROPN
admet-3007	724	9	.	.	PUNCT
admet-3007	725	1	gene	gene	NOUN
admet-3007	725	2	therapy	therapy	NOUN
admet-3007	725	3	in	in	ADP
admet-3007	725	4	cancer	cancer	NOUN
admet-3007	725	5	.	.	PUNCT
admet-3007	726	1	the	the	DET
admet-3007	726	2	journal	journal	NOUN
admet-3007	726	3	of	of	ADP
admet-3007	726	4	gene	gene	NOUN
admet-3007	726	5	medicine	medicine	NOUN
admet-3007	726	6	25	25	NUM
admet-3007	726	7	(	(	PUNCT
admet-3007	726	8	2023	2023	NUM
admet-3007	726	9	)	)	PUNCT
admet-3007	726	10	e3550	e3550	NOUN
admet-3007	726	11	.	.	PUNCT
admet-3007	727	1	https://doi.org/10.1002/jgm.3550	https://doi.org/10.1002/jgm.3550	PROPN
admet-3007	728	1	[	[	X
admet-3007	728	2	90	90	NUM
admet-3007	728	3	]	]	PUNCT
admet-3007	728	4	a.	a.	NOUN
admet-3007	728	5	mitra	mitra	PROPN
admet-3007	728	6	,	,	PUNCT
admet-3007	728	7	l.	l.	PROPN
admet-3007	728	8	mishra	mishra	PROPN
admet-3007	728	9	,	,	PUNCT
admet-3007	728	10	s.	s.	PROPN
admet-3007	728	11	li	li	PROPN
admet-3007	728	12	.	.	PROPN
admet-3007	729	1	emt	emt	PROPN
admet-3007	729	2	,	,	PUNCT
admet-3007	729	3	ctcs	ctcs	PROPN
admet-3007	729	4	and	and	CCONJ
admet-3007	729	5	cscs	cscs	PROPN
admet-3007	729	6	in	in	ADP
admet-3007	729	7	tumor	tumor	NOUN
admet-3007	729	8	relapse	relapse	NOUN
admet-3007	729	9	and	and	CCONJ
admet-3007	729	10	drug	drug	NOUN
admet-3007	729	11	-	-	PUNCT
admet-3007	729	12	resistance	resistance	NOUN
admet-3007	729	13	.	.	PUNCT
admet-3007	730	1	oncotarget	oncotarget	NOUN
admet-3007	730	2	6	6	NUM
admet-3007	730	3	(	(	PUNCT
admet-3007	730	4	2015	2015	NUM
admet-3007	730	5	)	)	PUNCT
admet-3007	730	6	10697	10697	NUM
admet-3007	730	7	.	.	PUNCT
admet-3007	730	8	https://doi.org/10.18632/oncotarget.4037	https://doi.org/10.18632/oncotarget.4037	VERB
admet-3007	731	1	[	[	X
admet-3007	731	2	91	91	NUM
admet-3007	731	3	]	]	PUNCT
admet-3007	731	4	a.	a.	NOUN
admet-3007	731	5	orza	orza	NOUN
admet-3007	731	6	,	,	PUNCT
admet-3007	731	7	o.	o.	PROPN
admet-3007	731	8	soriţău	soriţău	PROPN
admet-3007	731	9	,	,	PUNCT
admet-3007	731	10	c.	c.	PROPN
admet-3007	731	11	tomuleasa	tomuleasa	PROPN
admet-3007	731	12	,	,	PUNCT
admet-3007	731	13	l.	l.	PROPN
admet-3007	731	14	olenic	olenic	PROPN
admet-3007	731	15	,	,	PUNCT
admet-3007	731	16	a.	a.	NOUN
admet-3007	731	17	florea	florea	PROPN
admet-3007	731	18	,	,	PUNCT
admet-3007	731	19	o.	o.	PROPN
admet-3007	731	20	pana	pana	PROPN
admet-3007	731	21	,	,	PUNCT
admet-3007	731	22	i.	i.	PROPN
admet-3007	731	23	bratu	bratu	PROPN
admet-3007	731	24	,	,	PUNCT
admet-3007	731	25	e.	e.	PROPN
admet-3007	731	26	pall	pall	PROPN
admet-3007	731	27	,	,	PUNCT
admet-3007	731	28	s.	s.	PROPN
admet-3007	731	29	florian	florian	PROPN
admet-3007	731	30	,	,	PUNCT
admet-3007	731	31	d.	d.	PROPN
admet-3007	731	32	casciano	casciano	PROPN
admet-3007	731	33	.	.	PUNCT
admet-3007	732	1	reversing	reverse	VERB
admet-3007	732	2	chemoresistance	chemoresistance	NOUN
admet-3007	732	3	of	of	ADP
admet-3007	732	4	malignant	malignant	ADJ
admet-3007	732	5	glioma	glioma	NOUN
admet-3007	732	6	stem	stem	NOUN
admet-3007	732	7	cells	cell	NOUN
admet-3007	732	8	using	use	VERB
admet-3007	732	9	gold	gold	ADJ
admet-3007	732	10	nanoparticles	nanoparticle	NOUN
admet-3007	732	11	.	.	PUNCT
admet-3007	733	1	international	international	ADJ
admet-3007	733	2	journal	journal	NOUN
admet-3007	733	3	of	of	ADP
admet-3007	733	4	nanomedicine	nanomedicine	ADJ
admet-3007	733	5	8(1	8(1	NOUN
admet-3007	733	6	)	)	PUNCT
admet-3007	733	7	(	(	PUNCT
admet-3007	733	8	2013	2013	NUM
admet-3007	733	9	)	)	PUNCT
admet-3007	733	10	689	689	NUM
admet-3007	733	11	-	-	SYM
admet-3007	733	12	702	702	NUM
admet-3007	733	13	.	.	PUNCT
admet-3007	734	1	https://doi.org/10.2147/ijn.s37481	https://doi.org/10.2147/ijn.s37481	PRON
admet-3007	735	1	[	[	X
admet-3007	735	2	92	92	NUM
admet-3007	735	3	]	]	X
admet-3007	735	4	y.n	y.n	PROPN
admet-3007	735	5	.	.	PROPN
admet-3007	735	6	ertas	ertas	PROPN
admet-3007	735	7	,	,	PUNCT
admet-3007	735	8	k.	k.	PROPN
admet-3007	735	9	abedi	abedi	PROPN
admet-3007	735	10	dorcheh	dorcheh	PROPN
admet-3007	735	11	,	,	PUNCT
admet-3007	735	12	a.	a.	NOUN
admet-3007	735	13	akbari	akbari	PROPN
admet-3007	735	14	,	,	PUNCT
admet-3007	735	15	e.	e.	PROPN
admet-3007	735	16	jabbari	jabbari	PROPN
admet-3007	735	17	.	.	PUNCT
admet-3007	736	1	nanoparticles	nanoparticle	NOUN
admet-3007	736	2	for	for	ADP
admet-3007	736	3	targeted	target	VERB
admet-3007	736	4	drug	drug	NOUN
admet-3007	736	5	delivery	delivery	NOUN
admet-3007	736	6	to	to	ADP
admet-3007	736	7	cancer	cancer	NOUN
admet-3007	736	8	stem	stem	NOUN
admet-3007	736	9	cells	cell	NOUN
admet-3007	736	10	:	:	PUNCT
admet-3007	736	11	a	a	DET
admet-3007	736	12	review	review	NOUN
admet-3007	736	13	of	of	ADP
admet-3007	736	14	recent	recent	ADJ
admet-3007	736	15	advances	advance	NOUN
admet-3007	736	16	.	.	PUNCT
admet-3007	737	1	nanomaterials	nanomaterial	NOUN
admet-3007	737	2	11	11	NUM
admet-3007	737	3	(	(	PUNCT
admet-3007	737	4	2021	2021	NUM
admet-3007	737	5	)	)	PUNCT
admet-3007	737	6	1755	1755	NUM
admet-3007	737	7	.	.	PUNCT
admet-3007	738	1	https://doi.org/10.3390/nano11071755	https://doi.org/10.3390/nano11071755	PROPN
admet-3007	739	1	[	[	X
admet-3007	739	2	93	93	X
admet-3007	739	3	]	]	PUNCT
admet-3007	739	4	y.	y.	PROPN
admet-3007	739	5	zhao	zhao	PROPN
admet-3007	739	6	,	,	PUNCT
admet-3007	739	7	w.	w.	PROPN
admet-3007	739	8	zhao	zhao	PROPN
admet-3007	739	9	,	,	PUNCT
admet-3007	739	10	y.c	y.c	PROPN
admet-3007	739	11	.	.	PROPN
admet-3007	739	12	lim	lim	PROPN
admet-3007	739	13	,	,	PUNCT
admet-3007	739	14	t.	t.	PROPN
admet-3007	739	15	liu	liu	PROPN
admet-3007	739	16	.	.	PUNCT
admet-3007	740	1	salinomycin	salinomycin	PROPN
admet-3007	740	2	-	-	PUNCT
admet-3007	740	3	loaded	load	VERB
admet-3007	740	4	gold	gold	NOUN
admet-3007	740	5	nanoparticles	nanoparticle	NOUN
admet-3007	740	6	for	for	ADP
admet-3007	740	7	treating	treat	VERB
admet-3007	740	8	cancer	cancer	NOUN
admet-3007	740	9	stem	stem	NOUN
admet-3007	740	10	cells	cell	NOUN
admet-3007	740	11	by	by	ADP
admet-3007	740	12	ferroptosis	ferroptosis	NOUN
admet-3007	740	13	-	-	PUNCT
admet-3007	740	14	induced	induce	VERB
admet-3007	740	15	cell	cell	NOUN
admet-3007	740	16	death	death	NOUN
admet-3007	740	17	.	.	PUNCT
admet-3007	741	1	molecular	molecular	ADJ
admet-3007	741	2	pharmaceutics	pharmaceutic	NOUN
admet-3007	741	3	16	16	NUM
admet-3007	741	4	(	(	PUNCT
admet-3007	741	5	2019	2019	NUM
admet-3007	741	6	)	)	PUNCT
admet-3007	741	7	2532	2532	NUM
admet-3007	741	8	-	-	SYM
admet-3007	741	9	2539	2539	NUM
admet-3007	741	10	.	.	PUNCT
admet-3007	742	1	https://doi.org/10.1021/acs.molpharmaceut.9b00132	https://doi.org/10.1021/acs.molpharmaceut.9b00132	PRON
admet-3007	743	1	[	[	X
admet-3007	743	2	94	94	NUM
admet-3007	743	3	]	]	X
admet-3007	743	4	r.	r.	PROPN
admet-3007	743	5	kaur	kaur	PROPN
admet-3007	743	6	,	,	PUNCT
admet-3007	743	7	k.	k.	PROPN
admet-3007	743	8	singh	singh	PROPN
admet-3007	743	9	,	,	PUNCT
admet-3007	743	10	s.	s.	PROPN
admet-3007	743	11	agarwal	agarwal	PROPN
admet-3007	743	12	,	,	PUNCT
admet-3007	743	13	m.	m.	NOUN
admet-3007	743	14	masih	masih	PROPN
admet-3007	743	15	,	,	PUNCT
admet-3007	743	16	a.	a.	PROPN
admet-3007	743	17	chauhan	chauhan	PROPN
admet-3007	743	18	,	,	PUNCT
admet-3007	743	19	p.k	p.k	PROPN
admet-3007	743	20	.	.	PROPN
admet-3007	743	21	gautam	gautam	PROPN
admet-3007	743	22	.	.	PUNCT
admet-3007	744	1	silver	silver	ADJ
admet-3007	744	2	nanoparticles	nanoparticle	NOUN
admet-3007	744	3	induces	induce	VERB
admet-3007	744	4	apoptosis	apoptosis	NOUN
admet-3007	744	5	of	of	ADP
admet-3007	744	6	cancer	cancer	NOUN
admet-3007	744	7	stem	stem	NOUN
admet-3007	744	8	cells	cell	NOUN
admet-3007	744	9	in	in	ADP
admet-3007	744	10	head	head	NOUN
admet-3007	744	11	and	and	CCONJ
admet-3007	744	12	neck	neck	NOUN
admet-3007	744	13	cancer	cancer	NOUN
admet-3007	744	14	.	.	PUNCT
admet-3007	745	1	toxicology	toxicology	NOUN
admet-3007	745	2	reports	report	VERB
admet-3007	745	3	12	12	NUM
admet-3007	745	4	(	(	PUNCT
admet-3007	745	5	2024	2024	NUM
admet-3007	745	6	)	)	PUNCT
admet-3007	745	7	10	10	NUM
admet-3007	745	8	-	-	SYM
admet-3007	745	9	17	17	NUM
admet-3007	745	10	.	.	PUNCT
admet-3007	746	1	https://doi.org/10.1016/j.toxrep.2023.11.008	https://doi.org/10.1016/j.toxrep.2023.11.008	NOUN
admet-3007	746	2	[	[	X
admet-3007	746	3	95	95	NUM
admet-3007	746	4	]	]	PUNCT
admet-3007	746	5	m.	m.	NOUN
admet-3007	746	6	benguigui	benguigui	PROPN
admet-3007	746	7	,	,	PUNCT
admet-3007	746	8	i.s	i.s	PROPN
admet-3007	746	9	.	.	PROPN
admet-3007	746	10	weitz	weitz	PROPN
admet-3007	746	11	,	,	PUNCT
admet-3007	746	12	m.	m.	NOUN
admet-3007	746	13	timaner	timaner	NOUN
admet-3007	746	14	,	,	PUNCT
admet-3007	746	15	t.	t.	PROPN
admet-3007	746	16	kan	kan	PROPN
admet-3007	746	17	,	,	PUNCT
admet-3007	746	18	d.	d.	PROPN
admet-3007	746	19	shechter	shechter	PROPN
admet-3007	746	20	,	,	PUNCT
admet-3007	746	21	o.	o.	PROPN
admet-3007	746	22	perlman	perlman	NOUN
admet-3007	746	23	,	,	PUNCT
admet-3007	746	24	s.	s.	PROPN
admet-3007	746	25	sivan	sivan	PROPN
admet-3007	746	26	,	,	PUNCT
admet-3007	746	27	z.	z.	PROPN
admet-3007	746	28	raviv	raviv	PROPN
admet-3007	746	29	,	,	PUNCT
admet-3007	746	30	h	h	PROPN
admet-3007	746	31	.	.	PUNCT
admet-3007	747	1	azhari	azhari	PROPN
admet-3007	747	2	,	,	PUNCT
admet-3007	747	3	y.	y.	PROPN
admet-3007	747	4	shaked	shaked	PROPN
admet-3007	747	5	.	.	PUNCT
admet-3007	748	1	copper	copper	NOUN
admet-3007	748	2	oxide	oxide	NOUN
admet-3007	748	3	nanoparticles	nanoparticle	NOUN
admet-3007	748	4	inhibit	inhibit	VERB
admet-3007	748	5	pancreatic	pancreatic	ADJ
admet-3007	748	6	tumor	tumor	NOUN
admet-3007	748	7	growth	growth	NOUN
admet-3007	748	8	primarily	primarily	ADV
admet-3007	748	9	by	by	ADP
admet-3007	748	10	targeting	target	VERB
admet-3007	748	11	tumor	tumor	NOUN
admet-3007	748	12	initiating	initiate	VERB
admet-3007	748	13	cells	cell	NOUN
admet-3007	748	14	.	.	PUNCT
admet-3007	749	1	scientific	scientific	ADJ
admet-3007	749	2	reports	report	NOUN
admet-3007	749	3	9	9	NUM
admet-3007	749	4	(	(	PUNCT
admet-3007	749	5	2019	2019	NUM
admet-3007	749	6	)	)	PUNCT
admet-3007	749	7	12613	12613	NUM
admet-3007	749	8	.	.	PUNCT
admet-3007	750	1	https://doi.org/10.1038/s41598-019-48959-8	https://doi.org/10.1038/s41598-019-48959-8	NOUN
admet-3007	751	1	[	[	X
admet-3007	751	2	96	96	NUM
admet-3007	751	3	]	]	PUNCT
admet-3007	751	4	z.	z.	PROPN
admet-3007	751	5	fakhroueian	fakhroueian	PROPN
admet-3007	751	6	,	,	PUNCT
admet-3007	751	7	s.	s.	PROPN
admet-3007	751	8	rajabi	rajabi	PROPN
admet-3007	751	9	,	,	PUNCT
admet-3007	751	10	n.	n.	PROPN
admet-3007	751	11	salehi	salehi	PROPN
admet-3007	751	12	,	,	PUNCT
admet-3007	751	13	m.r	m.r	PROPN
admet-3007	751	14	.	.	PROPN
admet-3007	751	15	tavirani	tavirani	PROPN
admet-3007	751	16	,	,	PUNCT
admet-3007	751	17	s.	s.	PROPN
admet-3007	751	18	noori	noori	PROPN
admet-3007	751	19	,	,	PUNCT
admet-3007	751	20	m.	m.	NOUN
admet-3007	751	21	nourbakhsh	nourbakhsh	PROPN
admet-3007	751	22	.	.	PUNCT
admet-3007	752	1	anticancer	anticancer	NOUN
admet-3007	752	2	properties	property	NOUN
admet-3007	752	3	of	of	ADP
admet-3007	752	4	novel	novel	ADJ
admet-3007	752	5	zinc	zinc	NOUN
admet-3007	752	6	oxide	oxide	NOUN
admet-3007	752	7	quantum	quantum	NOUN
admet-3007	752	8	dot	dot	NOUN
admet-3007	752	9	nanoparticles	nanoparticle	NOUN
admet-3007	752	10	against	against	ADP
admet-3007	752	11	breast	breast	NOUN
admet-3007	752	12	cancer	cancer	NOUN
admet-3007	752	13	stem	stem	NOUN
admet-3007	752	14	-	-	PUNCT
admet-3007	752	15	like	like	ADJ
admet-3007	752	16	cells	cell	NOUN
admet-3007	752	17	.	.	PUNCT
admet-3007	753	1	anti	anti	ADJ
admet-3007	753	2	-	-	ADJ
admet-3007	753	3	cancer	cancer	ADJ
admet-3007	753	4	drugs	drug	NOUN
admet-3007	753	5	33	33	NUM
admet-3007	753	6	(	(	PUNCT
admet-3007	753	7	2022	2022	NUM
admet-3007	753	8	)	)	PUNCT
admet-3007	753	9	e311	e311	PROPN
admet-3007	753	10	-	-	PUNCT
admet-3007	753	11	e326	e326	PROPN
admet-3007	753	12	.	.	PUNCT
admet-3007	754	1	https://doi.org/10.1097/cad.0000000000001207	https://doi.org/10.1097/cad.0000000000001207	NOUN
admet-3007	754	2	[	[	X
admet-3007	754	3	97	97	NUM
admet-3007	754	4	]	]	PUNCT
admet-3007	754	5	s.	s.	PROPN
admet-3007	754	6	fernandes	fernandes	PROPN
admet-3007	754	7	,	,	PUNCT
admet-3007	754	8	t.	t.	PROPN
admet-3007	754	9	fernandez	fernandez	PROPN
admet-3007	754	10	,	,	PUNCT
admet-3007	754	11	s.	s.	PROPN
admet-3007	754	12	metze	metze	PROPN
admet-3007	754	13	,	,	PUNCT
admet-3007	754	14	p.b	p.b	PROPN
admet-3007	754	15	.	.	PROPN
admet-3007	754	16	balakrishnan	balakrishnan	PROPN
admet-3007	754	17	,	,	PUNCT
admet-3007	754	18	b.t	b.t	PROPN
admet-3007	754	19	.	.	PROPN
admet-3007	754	20	mai	mai	PROPN
admet-3007	754	21	,	,	PUNCT
admet-3007	754	22	j.	j.	PROPN
admet-3007	754	23	conteh	conteh	PROPN
admet-3007	754	24	,	,	PUNCT
admet-3007	754	25	c.	c.	PROPN
admet-3007	754	26	de	de	PROPN
admet-3007	754	27	mei	mei	PROPN
admet-3007	754	28	,	,	PUNCT
admet-3007	754	29	a.	a.	PROPN
admet-3007	754	30	turdo	turdo	PROPN
admet-3007	754	31	,	,	PUNCT
admet-3007	754	32	s.	s.	PROPN
admet-3007	754	33	di	di	PROPN
admet-3007	754	34	franco	franco	PROPN
admet-3007	754	35	,	,	PUNCT
admet-3007	754	36	g.	g.	PROPN
admet-3007	754	37	stassi	stassi	PROPN
admet-3007	754	38	.	.	PUNCT
admet-3007	755	1	magnetic	magnetic	ADJ
admet-3007	755	2	nanoparticle	nanoparticle	NOUN
admet-3007	755	3	-	-	PUNCT
admet-3007	755	4	based	base	VERB
admet-3007	755	5	hyperthermia	hyperthermia	NOUN
admet-3007	755	6	mediates	mediate	NOUN
admet-3007	755	7	drug	drug	NOUN
admet-3007	755	8	delivery	delivery	NOUN
admet-3007	756	1	and	and	CCONJ
admet-3007	757	1	impairs	impair	VERB
admet-3007	757	2	the	the	DET
admet-3007	757	3	tumorigenic	tumorigenic	ADJ
admet-3007	757	4	capacity	capacity	NOUN
admet-3007	757	5	of	of	ADP
admet-3007	757	6	quiescent	quiescent	ADJ
admet-3007	757	7	colorectal	colorectal	ADJ
admet-3007	757	8	cancer	cancer	NOUN
admet-3007	757	9	stem	stem	NOUN
admet-3007	757	10	cells	cell	NOUN
admet-3007	757	11	.	.	PUNCT
admet-3007	758	1	acs	acs	PROPN
admet-3007	758	2	applied	apply	VERB
admet-3007	758	3	materials	material	NOUN
admet-3007	758	4	&	&	CCONJ
admet-3007	758	5	interfaces	interface	NOUN
admet-3007	758	6	13	13	NUM
admet-3007	758	7	(	(	PUNCT
admet-3007	758	8	2021	2021	NUM
admet-3007	758	9	)	)	PUNCT
admet-3007	758	10	15959	15959	NUM
admet-3007	758	11	-	-	SYM
admet-3007	758	12	15972	15972	NUM
admet-3007	758	13	.	.	PUNCT
admet-3007	759	1	https://doi.org/10.1021/acsami.0c21349	https://doi.org/10.1021/acsami.0c21349	X
admet-3007	760	1	[	[	X
admet-3007	760	2	98	98	NUM
admet-3007	760	3	]	]	X
admet-3007	760	4	y.	y.	PROPN
admet-3007	760	5	huang	huang	PROPN
admet-3007	760	6	,	,	PUNCT
admet-3007	760	7	j.	j.	PROPN
admet-3007	760	8	lin	lin	PROPN
admet-3007	760	9	,	,	PUNCT
admet-3007	760	10	y.	y.	PROPN
admet-3007	760	11	xiong	xiong	PROPN
admet-3007	760	12	,	,	PUNCT
admet-3007	760	13	j.	j.	PROPN
admet-3007	760	14	chen	chen	PROPN
admet-3007	760	15	,	,	PUNCT
admet-3007	760	16	x.	x.	PROPN
admet-3007	760	17	du	du	PROPN
admet-3007	760	18	,	,	PUNCT
admet-3007	760	19	q.	q.	PROPN
admet-3007	760	20	liu	liu	PROPN
admet-3007	760	21	,	,	PUNCT
admet-3007	760	22	t.	t.	PROPN
admet-3007	760	23	liu	liu	PROPN
admet-3007	760	24	.	.	PUNCT
admet-3007	761	1	superparamagnetic	superparamagnetic	ADJ
admet-3007	761	2	iron	iron	NOUN
admet-3007	761	3	oxide	oxide	NOUN
admet-3007	761	4	nanoparticles	nanoparticle	NOUN
admet-3007	761	5	induce	induce	VERB
admet-3007	761	6	ferroptosis	ferroptosis	NOUN
admet-3007	761	7	of	of	ADP
admet-3007	761	8	human	human	ADJ
admet-3007	761	9	ovarian	ovarian	ADJ
admet-3007	761	10	cancer	cancer	NOUN
admet-3007	761	11	stem	stem	NOUN
admet-3007	761	12	cells	cell	NOUN
admet-3007	761	13	by	by	ADP
admet-3007	761	14	weakening	weaken	VERB
admet-3007	761	15	cellular	cellular	ADJ
admet-3007	761	16	autophagy	autophagy	NOUN
admet-3007	761	17	.	.	PUNCT
admet-3007	762	1	journal	journal	PROPN
admet-3007	762	2	of	of	ADP
admet-3007	762	3	biomedical	biomedical	ADJ
admet-3007	762	4	nanotechnology	nanotechnology	NOUN
admet-3007	762	5	16	16	NUM
admet-3007	762	6	(	(	PUNCT
admet-3007	762	7	2020	2020	NUM
admet-3007	762	8	)	)	PUNCT
admet-3007	762	9	1612	1612	NUM
admet-3007	762	10	-	-	SYM
admet-3007	762	11	1622	1622	NUM
admet-3007	762	12	.	.	PUNCT
admet-3007	763	1	https://doi.org/10.1166/jbn.2020.2991	https://doi.org/10.1166/jbn.2020.2991	PROPN
admet-3007	764	1	[	[	X
admet-3007	764	2	99	99	NUM
admet-3007	764	3	]	]	X
admet-3007	764	4	f.	f.	PROPN
admet-3007	764	5	mobaraki	mobaraki	PROPN
admet-3007	764	6	,	,	PUNCT
admet-3007	764	7	m.	m.	NOUN
admet-3007	764	8	momeni	momeni	PROPN
admet-3007	764	9	,	,	PUNCT
admet-3007	764	10	m.	m.	NOUN
admet-3007	764	11	jahromi	jahromi	PROPN
admet-3007	764	12	,	,	PUNCT
admet-3007	764	13	f.m	f.m	PROPN
admet-3007	764	14	.	.	PROPN
admet-3007	764	15	kasmaie	kasmaie	PROPN
admet-3007	764	16	,	,	PUNCT
admet-3007	764	17	m.	m.	NOUN
admet-3007	764	18	barghbani	barghbani	NOUN
admet-3007	764	19	,	,	PUNCT
admet-3007	764	20	m.e.t	m.e.t	PROPN
admet-3007	764	21	.	.	PROPN
admet-3007	764	22	yazdi	yazdi	PROPN
admet-3007	764	23	,	,	PUNCT
admet-3007	764	24	z.	z.	PROPN
admet-3007	764	25	meshkat	meshkat	PROPN
admet-3007	764	26	,	,	PUNCT
admet-3007	764	27	f.h	f.h	PROPN
admet-3007	764	28	.	.	PROPN
admet-3007	764	29	shandiz	shandiz	PROPN
admet-3007	764	30	,	,	PUNCT
admet-3007	764	31	s.m	s.m	PROPN
admet-3007	764	32	.	.	PROPN
admet-3007	764	33	hosseini	hosseini	PROPN
admet-3007	764	34	.	.	PUNCT
admet-3007	765	1	apoptotic	apoptotic	ADJ
admet-3007	765	2	,	,	PUNCT
admet-3007	765	3	antioxidant	antioxidant	ADJ
admet-3007	765	4	and	and	CCONJ
admet-3007	765	5	cytotoxic	cytotoxic	ADJ
admet-3007	765	6	properties	property	NOUN
admet-3007	765	7	of	of	ADP
admet-3007	765	8	synthesized	synthesize	VERB
admet-3007	765	9	agnps	agnps	NOUN
admet-3007	765	10	using	use	VERB
admet-3007	765	11	green	green	ADJ
admet-3007	765	12	tea	tea	NOUN
admet-3007	765	13	against	against	ADP
admet-3007	765	14	human	human	ADJ
admet-3007	765	15	testicular	testicular	ADJ
admet-3007	765	16	embryonic	embryonic	ADJ
admet-3007	765	17	cancer	cancer	NOUN
admet-3007	765	18	stem	stem	NOUN
admet-3007	765	19	cells	cell	NOUN
admet-3007	765	20	.	.	PUNCT
admet-3007	766	1	process	process	NOUN
admet-3007	766	2	biochemistry	biochemistry	NOUN
admet-3007	766	3	119	119	NUM
admet-3007	766	4	(	(	PUNCT
admet-3007	766	5	2022	2022	NUM
admet-3007	766	6	)	)	PUNCT
admet-3007	766	7	106118	106118	NUM
admet-3007	766	8	.	.	PUNCT
admet-3007	767	1	https://doi.org/10.1016/j.procbio.2022.05.021	https://doi.org/10.1016/j.procbio.2022.05.021	NUM
admet-3007	767	2	[	[	X
admet-3007	767	3	100	100	NUM
admet-3007	767	4	]	]	X
admet-3007	767	5	a.r	a.r	PROPN
admet-3007	767	6	.	.	PROPN
admet-3007	767	7	burke	burke	PROPN
admet-3007	767	8	,	,	PUNCT
admet-3007	767	9	r.n	r.n	PROPN
admet-3007	767	10	.	.	PROPN
admet-3007	767	11	singh	singh	PROPN
admet-3007	767	12	,	,	PUNCT
admet-3007	767	13	d.l	d.l	PROPN
admet-3007	767	14	.	.	PROPN
admet-3007	767	15	carroll	carroll	PROPN
admet-3007	767	16	,	,	PUNCT
admet-3007	767	17	j.c	j.c	PROPN
admet-3007	767	18	.	.	PROPN
admet-3007	767	19	wood	wood	PROPN
admet-3007	767	20	,	,	PUNCT
admet-3007	767	21	r.b	r.b	NOUN
admet-3007	767	22	.	.	PROPN
admet-3007	767	23	d’agostino	d’agostino	PROPN
admet-3007	767	24	jr	jr	PROPN
admet-3007	767	25	,	,	PUNCT
admet-3007	767	26	p.m.	p.m.	PROPN
admet-3007	767	27	ajayan	ajayan	PROPN
admet-3007	767	28	,	,	PUNCT
admet-3007	767	29	f.m	f.m	PROPN
admet-3007	767	30	.	.	PROPN
admet-3007	767	31	torti	torti	PROPN
admet-3007	767	32	,	,	PUNCT
admet-3007	767	33	s.v	s.v	PROPN
admet-3007	767	34	.	.	PROPN
admet-3007	767	35	torti	torti	PROPN
admet-3007	767	36	.	.	PUNCT
admet-3007	768	1	the	the	DET
admet-3007	768	2	resistance	resistance	NOUN
admet-3007	768	3	of	of	ADP
admet-3007	768	4	breast	breast	NOUN
admet-3007	768	5	cancer	cancer	NOUN
admet-3007	768	6	stem	stem	NOUN
admet-3007	768	7	cells	cell	NOUN
admet-3007	768	8	to	to	ADP
admet-3007	768	9	conventional	conventional	ADJ
admet-3007	768	10	hyperthermia	hyperthermia	NOUN
admet-3007	768	11	and	and	CCONJ
admet-3007	768	12	their	their	PRON
admet-3007	768	13	sensitivity	sensitivity	NOUN
admet-3007	768	14	to	to	ADP
admet-3007	768	15	nanoparticle	nanoparticle	NOUN
admet-3007	768	16	-	-	PUNCT
admet-3007	768	17	mediated	mediate	VERB
admet-3007	768	18	photothermal	photothermal	ADJ
admet-3007	768	19	therapy	therapy	NOUN
admet-3007	768	20	.	.	PUNCT
admet-3007	769	1	biomaterials	biomaterial	NOUN
admet-3007	769	2	33	33	NUM
admet-3007	769	3	(	(	PUNCT
admet-3007	769	4	2012	2012	NUM
admet-3007	769	5	)	)	PUNCT
admet-3007	769	6	2961	2961	NUM
admet-3007	769	7	-	-	SYM
admet-3007	769	8	2970	2970	NUM
admet-3007	769	9	.	.	PUNCT
admet-3007	770	1	https://doi.org/10.1016/j.biomaterials.2011.12.052	https://doi.org/10.1016/j.biomaterials.2011.12.052	PRON
admet-3007	771	1	[	[	X
admet-3007	771	2	101	101	NUM
admet-3007	771	3	]	]	PUNCT
admet-3007	771	4	y.-j	y.-j	PROPN
admet-3007	771	5	.	.	PUNCT
admet-3007	771	6	choi	choi	PROPN
admet-3007	771	7	,	,	PUNCT
admet-3007	771	8	s.	s.	PROPN
admet-3007	771	9	gurunathan	gurunathan	PROPN
admet-3007	771	10	,	,	PUNCT
admet-3007	771	11	j.-h	j.-h	PROPN
admet-3007	771	12	.	.	PUNCT
admet-3007	772	1	kim	kim	PROPN
admet-3007	772	2	.	.	PUNCT
admet-3007	773	1	graphene	graphene	VERB
admet-3007	773	2	oxide	oxide	NOUN
admet-3007	773	3	-	-	PUNCT
admet-3007	773	4	silver	silver	NOUN
admet-3007	773	5	nanocomposite	nanocomposite	NOUN
admet-3007	773	6	enhances	enhance	VERB
admet-3007	773	7	cytotoxic	cytotoxic	ADJ
admet-3007	773	8	and	and	CCONJ
admet-3007	773	9	apoptotic	apoptotic	ADJ
admet-3007	773	10	potential	potential	NOUN
admet-3007	773	11	of	of	ADP
admet-3007	773	12	salinomycin	salinomycin	NOUN
admet-3007	773	13	in	in	ADP
admet-3007	773	14	human	human	ADJ
admet-3007	773	15	ovarian	ovarian	ADJ
admet-3007	773	16	cancer	cancer	NOUN
admet-3007	773	17	stem	stem	NOUN
admet-3007	773	18	cells	cell	NOUN
admet-3007	773	19	(	(	PUNCT
admet-3007	773	20	ovcscs	ovcscs	PROPN
admet-3007	773	21	):	):	PUNCT
admet-3007	773	22	a	a	DET
admet-3007	773	23	novel	novel	ADJ
admet-3007	773	24	approach	approach	NOUN
admet-3007	773	25	for	for	ADP
admet-3007	773	26	https://doi.org/10.5599/admet.3007	https://doi.org/10.5599/admet.3007	ADJ
admet-3007	773	27	https://doi.org/10.1016/j.biopha.2020.109821	https://doi.org/10.1016/j.biopha.2020.109821	PROPN
admet-3007	773	28	https://doi.org/10.1016/j.mpmed.2019.11.007	https://doi.org/10.1016/j.mpmed.2019.11.007	VERB
admet-3007	773	29	https://doi.org/10.1111/bjd.16473	https://doi.org/10.1111/bjd.16473	VERB
admet-3007	773	30	https://doi.org/10.1002/jgm.3550	https://doi.org/10.1002/jgm.3550	PROPN
admet-3007	773	31	https://doi.org/10.18632/oncotarget.4037	https://doi.org/10.18632/oncotarget.4037	VERB
admet-3007	773	32	https://doi.org/10.2147/ijn.s37481	https://doi.org/10.2147/ijn.s37481	AUX
admet-3007	773	33	https://www.mdpi.com/2079-4991/11/7/1755	https://www.mdpi.com/2079-4991/11/7/1755	VERB
admet-3007	773	34	https://doi.org/10.1021/acs.molpharmaceut.9b00132	https://doi.org/10.1021/acs.molpharmaceut.9b00132	PROPN
admet-3007	773	35	https://doi.org/10.1016/j.toxrep.2023.11.008	https://doi.org/10.1016/j.toxrep.2023.11.008	PROPN
admet-3007	773	36	https://doi.org/10.1038/s41598-019-48959-8	https://doi.org/10.1038/s41598-019-48959-8	PROPN
admet-3007	773	37	https://doi.org/10.1097/cad.0000000000001207	https://doi.org/10.1097/cad.0000000000001207	PROPN
admet-3007	773	38	https://doi.org/10.1021/acsami.0c21349	https://doi.org/10.1021/acsami.0c21349	PROPN
admet-3007	773	39	https://doi.org/10.1166/jbn.2020.2991	https://doi.org/10.1166/jbn.2020.2991	PROPN
admet-3007	773	40	https://doi.org/10.1016/j.procbio.2022.05.021	https://doi.org/10.1016/j.procbio.2022.05.021	VERB
admet-3007	774	1	https://doi.org/10.1016/j.biomaterials.2011.12.052	https://doi.org/10.1016/j.biomaterials.2011.12.052	PROPN
admet-3007	774	2	m.	m.	NOUN
admet-3007	774	3	dehghani	dehghani	PROPN
admet-3007	774	4	et	et	PROPN
admet-3007	774	5	al	al	PROPN
admet-3007	774	6	.	.	PROPN
admet-3007	774	7	admet	admet	PROPN
admet-3007	774	8	&	&	CCONJ
admet-3007	774	9	dmpk	dmpk	PROPN
admet-3007	774	10	13(5	13(5	NUM
admet-3007	774	11	)	)	PUNCT
admet-3007	774	12	(	(	PUNCT
admet-3007	774	13	2025	2025	NUM
admet-3007	774	14	)	)	PUNCT
admet-3007	774	15	3007	3007	NUM
admet-3007	774	16	24	24	NUM
admet-3007	774	17	cancer	cancer	NOUN
admet-3007	774	18	therapy	therapy	NOUN
admet-3007	774	19	.	.	PUNCT
admet-3007	775	1	international	international	ADJ
admet-3007	775	2	journal	journal	NOUN
admet-3007	775	3	of	of	ADP
admet-3007	775	4	molecular	molecular	ADJ
admet-3007	775	5	sciences	science	NOUN
admet-3007	775	6	19	19	NUM
admet-3007	775	7	(	(	PUNCT
admet-3007	775	8	2018	2018	NUM
admet-3007	775	9	)	)	PUNCT
admet-3007	775	10	710	710	NUM
admet-3007	775	11	.	.	PUNCT
admet-3007	776	1	https://doi.org/10.3390/ijms19030710	https://doi.org/10.3390/ijms19030710	PROPN
admet-3007	777	1	[	[	X
admet-3007	777	2	102	102	NUM
admet-3007	777	3	]	]	X
admet-3007	777	4	p.	p.	NOUN
admet-3007	777	5	ghoderao	ghoderao	PROPN
admet-3007	777	6	,	,	PUNCT
admet-3007	777	7	s.	s.	PROPN
admet-3007	777	8	sahare	sahare	PROPN
admet-3007	777	9	,	,	PUNCT
admet-3007	777	10	a.a	a.a	PROPN
admet-3007	777	11	.	.	PROPN
admet-3007	777	12	kulkarni	kulkarni	PROPN
admet-3007	777	13	,	,	PUNCT
admet-3007	777	14	t.	t.	PROPN
admet-3007	777	15	bhave	bhave	PROPN
admet-3007	777	16	,	,	PUNCT
admet-3007	777	17	paclitaxel	paclitaxel	PROPN
admet-3007	777	18	conjugated	conjugate	VERB
admet-3007	777	19	magnetic	magnetic	ADJ
admet-3007	777	20	carbon	carbon	NOUN
admet-3007	777	21	nanotubes	nanotube	NOUN
admet-3007	777	22	induce	induce	VERB
admet-3007	777	23	apoptosis	apoptosis	NOUN
admet-3007	777	24	in	in	ADP
admet-3007	777	25	breast	breast	NOUN
admet-3007	777	26	cancer	cancer	NOUN
admet-3007	777	27	cells	cell	NOUN
admet-3007	777	28	and	and	CCONJ
admet-3007	777	29	breast	breast	NOUN
admet-3007	777	30	cancer	cancer	NOUN
admet-3007	777	31	stem	stem	NOUN
admet-3007	777	32	cells	cell	NOUN
admet-3007	777	33	in	in	ADP
admet-3007	777	34	vitro	vitro	VERB
admet-3007	777	35	.	.	PUNCT
admet-3007	778	1	paclitaxel	paclitaxel	PROPN
admet-3007	778	2	(	(	PUNCT
admet-3007	778	3	2022	2022	NUM
admet-3007	778	4	)	)	PUNCT
admet-3007	778	5	309	309	NUM
admet-3007	778	6	-	-	SYM
admet-3007	778	7	331	331	NUM
admet-3007	778	8	.	.	PUNCT
admet-3007	779	1	https://doi.org/10.1016/b978-0-323-90951-8.00001-1	https://doi.org/10.1016/b978-0-323-90951-8.00001-1	PRON
admet-3007	780	1	[	[	X
admet-3007	780	2	103	103	NUM
admet-3007	780	3	]	]	X
admet-3007	780	4	y.	y.	PROPN
admet-3007	780	5	gao	gao	PROPN
admet-3007	780	6	,	,	PUNCT
admet-3007	780	7	a.n	a.n	PROPN
admet-3007	780	8	.	.	PROPN
admet-3007	780	9	shelling	shelling	PROPN
admet-3007	780	10	,	,	PUNCT
admet-3007	780	11	e.	e.	PROPN
admet-3007	780	12	nolan	nolan	PROPN
admet-3007	780	13	,	,	PUNCT
admet-3007	780	14	d.	d.	PROPN
admet-3007	780	15	porter	porter	PROPN
admet-3007	780	16	,	,	PUNCT
admet-3007	780	17	e.	e.	PROPN
admet-3007	780	18	leung	leung	PROPN
admet-3007	780	19	,	,	PUNCT
admet-3007	780	20	z.	z.	PROPN
admet-3007	780	21	wu	wu	PROPN
admet-3007	780	22	.	.	PUNCT
admet-3007	780	23	liposome	liposome	NOUN
admet-3007	780	24	-	-	PUNCT
admet-3007	780	25	enabled	enable	VERB
admet-3007	780	26	bufalin	bufalin	NOUN
admet-3007	780	27	and	and	CCONJ
admet-3007	780	28	doxorubicin	doxorubicin	PROPN
admet-3007	780	29	combination	combination	NOUN
admet-3007	780	30	therapy	therapy	NOUN
admet-3007	780	31	for	for	ADP
admet-3007	780	32	trastuzumab	trastuzumab	NOUN
admet-3007	780	33	-	-	PUNCT
admet-3007	780	34	resistant	resistant	ADJ
admet-3007	780	35	breast	breast	NOUN
admet-3007	780	36	cancer	cancer	NOUN
admet-3007	780	37	with	with	ADP
admet-3007	780	38	a	a	DET
admet-3007	780	39	focus	focus	NOUN
admet-3007	780	40	on	on	ADP
admet-3007	780	41	cancer	cancer	NOUN
admet-3007	780	42	stem	stem	NOUN
admet-3007	780	43	cells	cell	NOUN
admet-3007	780	44	.	.	PUNCT
admet-3007	781	1	journal	journal	NOUN
admet-3007	781	2	of	of	ADP
admet-3007	781	3	liposome	liposome	PROPN
admet-3007	781	4	research	research	NOUN
admet-3007	781	5	34	34	NUM
admet-3007	781	6	(	(	PUNCT
admet-3007	781	7	2024	2024	NUM
admet-3007	781	8	)	)	PUNCT
admet-3007	781	9	489	489	NUM
admet-3007	781	10	-	-	PUNCT
admet-3007	781	11	506	506	NUM
admet-3007	781	12	.	.	PUNCT
admet-3007	782	1	https://doi.org/10.1080/08982104.2024.2305866	https://doi.org/10.1080/08982104.2024.2305866	X
admet-3007	783	1	[	[	X
admet-3007	783	2	104	104	NUM
admet-3007	783	3	]	]	X
admet-3007	783	4	s.m	s.m	PROPN
admet-3007	783	5	.	.	PROPN
admet-3007	783	6	basu	basu	PROPN
admet-3007	783	7	,	,	PUNCT
admet-3007	783	8	s.k	s.k	PROPN
admet-3007	783	9	.	.	PROPN
admet-3007	783	10	yadava	yadava	PROPN
admet-3007	783	11	,	,	PUNCT
admet-3007	783	12	r.	r.	PROPN
admet-3007	783	13	singh	singh	PROPN
admet-3007	783	14	,	,	PUNCT
admet-3007	783	15	j.	j.	PROPN
admet-3007	783	16	giri	giri	PROPN
admet-3007	783	17	.	.	PUNCT
admet-3007	784	1	lipid	lipid	PROPN
admet-3007	784	2	nanocapsules	nanocapsule	NOUN
admet-3007	784	3	co	co	VERB
admet-3007	785	1	-	-	VERB
admet-3007	785	2	encapsulating	encapsulate	VERB
admet-3007	785	3	paclitaxel	paclitaxel	NOUN
admet-3007	785	4	and	and	CCONJ
admet-3007	785	5	salinomycin	salinomycin	NOUN
admet-3007	785	6	for	for	ADP
admet-3007	785	7	eradicating	eradicate	VERB
admet-3007	785	8	breast	breast	NOUN
admet-3007	785	9	cancer	cancer	NOUN
admet-3007	785	10	and	and	CCONJ
admet-3007	785	11	cancer	cancer	NOUN
admet-3007	785	12	stem	stem	NOUN
admet-3007	785	13	cells	cell	NOUN
admet-3007	785	14	.	.	PUNCT
admet-3007	786	1	colloids	colloid	NOUN
admet-3007	786	2	and	and	CCONJ
admet-3007	786	3	surfaces	surface	NOUN
admet-3007	786	4	b	b	NUM
admet-3007	786	5	:	:	PUNCT
admet-3007	786	6	biointerfaces	biointerface	NOUN
admet-3007	786	7	204	204	NUM
admet-3007	786	8	(	(	PUNCT
admet-3007	786	9	2021	2021	NUM
admet-3007	786	10	)	)	PUNCT
admet-3007	786	11	111775	111775	NUM
admet-3007	786	12	.	.	PUNCT
admet-3007	787	1	https://doi.org/10.1016/j.colsurfb.2021.111775	https://doi.org/10.1016/j.colsurfb.2021.111775	NOUN
admet-3007	788	1	[	[	X
admet-3007	788	2	105	105	NUM
admet-3007	788	3	]	]	X
admet-3007	788	4	s.a	s.a	PROPN
admet-3007	788	5	.	.	PROPN
admet-3007	788	6	navarro	navarro	PROPN
admet-3007	788	7	-	-	PUNCT
admet-3007	788	8	marchal	marchal	NOUN
admet-3007	788	9	,	,	PUNCT
admet-3007	788	10	c.	c.	PROPN
admet-3007	788	11	grinan	grinan	PROPN
admet-3007	788	12	-	-	PUNCT
admet-3007	788	13	lison	lison	NOUN
admet-3007	788	14	,	,	PUNCT
admet-3007	788	15	j.-m	j.-m	PROPN
admet-3007	788	16	.	.	PUNCT
admet-3007	789	1	entrena	entrena	PROPN
admet-3007	789	2	,	,	PUNCT
admet-3007	789	3	g.	g.	PROPN
admet-3007	789	4	ruiz	ruiz	NOUN
admet-3007	789	5	-	-	PUNCT
admet-3007	789	6	alcalá	alcalá	NOUN
admet-3007	789	7	,	,	PUNCT
admet-3007	789	8	m.	m.	NOUN
admet-3007	789	9	tristán	tristán	PROPN
admet-3007	789	10	-	-	PUNCT
admet-3007	789	11	manzano	manzano	PROPN
admet-3007	789	12	,	,	PUNCT
admet-3007	789	13	f.	f.	PROPN
admet-3007	789	14	martin	martin	PROPN
admet-3007	789	15	,	,	PUNCT
admet-3007	789	16	i.	i.	PROPN
admet-3007	789	17	pérez	pérez	PROPN
admet-3007	789	18	-	-	PUNCT
admet-3007	789	19	victoria	victoria	PROPN
admet-3007	789	20	,	,	PUNCT
admet-3007	789	21	j.m	j.m	PROPN
admet-3007	789	22	.	.	PROPN
admet-3007	789	23	peula	peula	NOUN
admet-3007	789	24	-	-	PUNCT
admet-3007	789	25	garcía	garcía	ADJ
admet-3007	789	26	,	,	PUNCT
admet-3007	789	27	j.a	j.a	PROPN
admet-3007	789	28	.	.	PROPN
admet-3007	789	29	marchal	marchal	NOUN
admet-3007	789	30	.	.	PUNCT
admet-3007	790	1	anti	anti	ADJ
admet-3007	790	2	-	-	ADJ
admet-3007	790	3	cd44	cd44	ADJ
admet-3007	790	4	-	-	PUNCT
admet-3007	790	5	conjugated	conjugate	VERB
admet-3007	790	6	olive	olive	ADJ
admet-3007	790	7	oil	oil	NOUN
admet-3007	790	8	liquid	liquid	NOUN
admet-3007	790	9	nanocapsules	nanocapsule	NOUN
admet-3007	790	10	for	for	ADP
admet-3007	790	11	targeting	target	VERB
admet-3007	790	12	pancreatic	pancreatic	ADJ
admet-3007	790	13	cancer	cancer	NOUN
admet-3007	790	14	stem	stem	NOUN
admet-3007	790	15	cells	cell	NOUN
admet-3007	790	16	.	.	PUNCT
admet-3007	791	1	biomacromolecules	biomacromolecule	NOUN
admet-3007	791	2	22	22	NUM
admet-3007	791	3	(	(	PUNCT
admet-3007	791	4	2021	2021	NUM
admet-3007	791	5	)	)	PUNCT
admet-3007	791	6	1374	1374	NUM
admet-3007	791	7	-	-	SYM
admet-3007	791	8	1388	1388	NUM
admet-3007	791	9	.	.	PUNCT
admet-3007	792	1	https://doi.org/10.1021/acs.biomac.0c01546	https://doi.org/10.1021/acs.biomac.0c01546	NOUN
admet-3007	792	2	[	[	X
admet-3007	792	3	106	106	NUM
admet-3007	792	4	]	]	X
admet-3007	792	5	w.	w.	PROPN
admet-3007	792	6	rao	rao	PROPN
admet-3007	792	7	,	,	PUNCT
admet-3007	792	8	h.	h.	PROPN
admet-3007	792	9	wang	wang	PROPN
admet-3007	792	10	,	,	PUNCT
admet-3007	792	11	j.	j.	PROPN
admet-3007	792	12	han	han	PROPN
admet-3007	792	13	,	,	PUNCT
admet-3007	792	14	s.	s.	PROPN
admet-3007	792	15	zhao	zhao	PROPN
admet-3007	792	16	,	,	PUNCT
admet-3007	792	17	j.	j.	PROPN
admet-3007	792	18	dumbleton	dumbleton	PROPN
admet-3007	792	19	,	,	PUNCT
admet-3007	792	20	p.	p.	PROPN
admet-3007	792	21	agarwal	agarwal	PROPN
admet-3007	792	22	,	,	PUNCT
admet-3007	792	23	w.	w.	PROPN
admet-3007	792	24	zhang	zhang	PROPN
admet-3007	792	25	,	,	PUNCT
admet-3007	792	26	g.	g.	PROPN
admet-3007	792	27	zhao	zhao	PROPN
admet-3007	792	28	,	,	PUNCT
admet-3007	792	29	j.	j.	PROPN
admet-3007	792	30	yu	yu	PROPN
admet-3007	792	31	,	,	PUNCT
admet-3007	792	32	d.l	d.l	PROPN
admet-3007	792	33	.	.	PROPN
admet-3007	792	34	zynger	zynger	NOUN
admet-3007	792	35	.	.	PUNCT
admet-3007	793	1	chitosan	chitosan	NOUN
admet-3007	793	2	-	-	PUNCT
admet-3007	793	3	decorated	decorate	VERB
admet-3007	793	4	doxorubicin	doxorubicin	PROPN
admet-3007	793	5	-	-	PUNCT
admet-3007	793	6	encapsulated	encapsulate	VERB
admet-3007	793	7	nanoparticle	nanoparticle	NOUN
admet-3007	793	8	targets	target	NOUN
admet-3007	793	9	and	and	CCONJ
admet-3007	793	10	eliminates	eliminate	VERB
admet-3007	793	11	tumor	tumor	NOUN
admet-3007	793	12	reinitiating	reinitiate	VERB
admet-3007	793	13	cancer	cancer	NOUN
admet-3007	793	14	stem	stem	NOUN
admet-3007	793	15	-	-	PUNCT
admet-3007	793	16	like	like	ADJ
admet-3007	793	17	cells	cell	NOUN
admet-3007	793	18	.	.	PUNCT
admet-3007	794	1	acs	acs	PROPN
admet-3007	794	2	nano	nano	VERB
admet-3007	794	3	9	9	NUM
admet-3007	794	4	(	(	PUNCT
admet-3007	794	5	2015	2015	NUM
admet-3007	794	6	)	)	PUNCT
admet-3007	794	7	5725	5725	NUM
admet-3007	794	8	-	-	SYM
admet-3007	794	9	5740	5740	NUM
admet-3007	794	10	.	.	PUNCT
admet-3007	795	1	https://doi.org/10.1021/nn506928p	https://doi.org/10.1021/nn506928p	PROPN
admet-3007	796	1	[	[	X
admet-3007	796	2	107	107	X
admet-3007	796	3	]	]	X
admet-3007	796	4	r.k	r.k	PROPN
admet-3007	796	5	.	.	PROPN
admet-3007	796	6	verma	verma	PROPN
admet-3007	796	7	,	,	PUNCT
admet-3007	796	8	w.	w.	PROPN
admet-3007	796	9	yu	yu	PROPN
admet-3007	796	10	,	,	PUNCT
admet-3007	796	11	s.p	s.p	PROPN
admet-3007	796	12	.	.	PROPN
admet-3007	796	13	singh	singh	PROPN
admet-3007	796	14	,	,	PUNCT
admet-3007	796	15	s.	s.	PROPN
admet-3007	796	16	shankar	shankar	PROPN
admet-3007	796	17	,	,	PUNCT
admet-3007	796	18	r.k	r.k	PROPN
admet-3007	796	19	.	.	PROPN
admet-3007	796	20	srivastava	srivastava	PROPN
admet-3007	796	21	.	.	PUNCT
admet-3007	797	1	anthothecol	anthothecol	PROPN
admet-3007	797	2	-	-	PUNCT
admet-3007	797	3	encapsulated	encapsulate	VERB
admet-3007	797	4	plga	plga	NOUN
admet-3007	797	5	nanoparticles	nanoparticle	NOUN
admet-3007	797	6	inhibit	inhibit	VERB
admet-3007	797	7	pancreatic	pancreatic	ADJ
admet-3007	797	8	cancer	cancer	NOUN
admet-3007	797	9	stem	stem	NOUN
admet-3007	797	10	cell	cell	NOUN
admet-3007	797	11	growth	growth	NOUN
admet-3007	797	12	by	by	ADP
admet-3007	797	13	modulating	modulate	VERB
admet-3007	797	14	sonic	sonic	ADJ
admet-3007	797	15	hedgehog	hedgehog	NOUN
admet-3007	797	16	pathway	pathway	NOUN
admet-3007	797	17	.	.	PUNCT
admet-3007	798	1	nanomedicine	nanomedicine	NOUN
admet-3007	798	2	:	:	PUNCT
admet-3007	798	3	nanotechnology	nanotechnology	NOUN
admet-3007	798	4	,	,	PUNCT
admet-3007	798	5	biology	biology	NOUN
admet-3007	798	6	and	and	CCONJ
admet-3007	798	7	medicine	medicine	NOUN
admet-3007	798	8	11	11	NUM
admet-3007	798	9	(	(	PUNCT
admet-3007	798	10	2015	2015	NUM
admet-3007	798	11	)	)	PUNCT
admet-3007	798	12	2061	2061	NUM
admet-3007	798	13	-	-	SYM
admet-3007	798	14	2070	2070	NUM
admet-3007	798	15	.	.	PUNCT
admet-3007	799	1	https://doi.org/10.1016/j.nano.2015.07.001	https://doi.org/10.1016/j.nano.2015.07.001	NOUN
admet-3007	799	2	[	[	X
admet-3007	799	3	108	108	NUM
admet-3007	799	4	]	]	X
admet-3007	799	5	l.a	l.a	PROPN
admet-3007	799	6	.	.	PROPN
admet-3007	799	7	kolahalam	kolahalam	PROPN
admet-3007	799	8	,	,	PUNCT
admet-3007	799	9	i.k	i.k	PROPN
admet-3007	799	10	.	.	PROPN
admet-3007	799	11	viswanath	viswanath	PROPN
admet-3007	799	12	,	,	PUNCT
admet-3007	799	13	b.s	b.s	PROPN
admet-3007	799	14	.	.	PROPN
admet-3007	799	15	diwakar	diwakar	PROPN
admet-3007	799	16	,	,	PUNCT
admet-3007	799	17	b.	b.	PROPN
admet-3007	799	18	govindh	govindh	PROPN
admet-3007	799	19	,	,	PUNCT
admet-3007	799	20	v.	v.	CCONJ
admet-3007	799	21	reddy	reddy	PROPN
admet-3007	799	22	,	,	PUNCT
admet-3007	799	23	y.	y.	PROPN
admet-3007	799	24	murthy	murthy	PROPN
admet-3007	799	25	.	.	PUNCT
admet-3007	800	1	review	review	NOUN
admet-3007	800	2	on	on	ADP
admet-3007	800	3	nanomaterials	nanomaterial	NOUN
admet-3007	800	4	:	:	PUNCT
admet-3007	800	5	synthesis	synthesis	NOUN
admet-3007	800	6	and	and	CCONJ
admet-3007	800	7	applications	application	NOUN
admet-3007	800	8	.	.	PUNCT
admet-3007	801	1	materials	material	NOUN
admet-3007	801	2	today	today	NOUN
admet-3007	801	3	:	:	PUNCT
admet-3007	801	4	proceedings	proceeding	NOUN
admet-3007	801	5	18	18	NUM
admet-3007	801	6	(	(	PUNCT
admet-3007	801	7	2019	2019	NUM
admet-3007	801	8	)	)	PUNCT
admet-3007	801	9	2182	2182	NUM
admet-3007	801	10	-	-	SYM
admet-3007	801	11	2190	2190	NUM
admet-3007	801	12	.	.	PUNCT
admet-3007	802	1	https://doi.org/10.1016/j.matpr.2019.07.371	https://doi.org/10.1016/j.matpr.2019.07.371	NOUN
admet-3007	802	2	[	[	X
admet-3007	802	3	109	109	NUM
admet-3007	802	4	]	]	PUNCT
admet-3007	802	5	m.	m.	NOUN
admet-3007	802	6	dehghani	dehghani	PROPN
admet-3007	802	7	,	,	PUNCT
admet-3007	802	8	p.	p.	NOUN
admet-3007	802	9	ghadam	ghadam	NOUN
admet-3007	802	10	.	.	PUNCT
admet-3007	803	1	green	green	ADJ
admet-3007	803	2	synthesis	synthesis	NOUN
admet-3007	803	3	of	of	ADP
admet-3007	803	4	zno	zno	PROPN
admet-3007	803	5	-	-	PUNCT
admet-3007	803	6	nps	nps	PROPN
admet-3007	803	7	by	by	ADP
admet-3007	803	8	juglans	juglan	NOUN
admet-3007	803	9	regia	regia	NOUN
admet-3007	803	10	green	green	ADJ
admet-3007	803	11	husk	husk	NOUN
admet-3007	803	12	aqueous	aqueous	ADJ
admet-3007	803	13	extract	extract	NOUN
admet-3007	803	14	.	.	PUNCT
admet-3007	804	1	materials	material	NOUN
admet-3007	804	2	proceedings	proceeding	NOUN
admet-3007	804	3	14	14	NUM
admet-3007	804	4	(	(	PUNCT
admet-3007	804	5	2023	2023	NUM
admet-3007	804	6	)	)	PUNCT
admet-3007	804	7	7	7	NUM
admet-3007	804	8	.	.	PUNCT
admet-3007	804	9	https://doi.org/10.3390/iocn2023-14444	https://doi.org/10.3390/iocn2023-14444	NOUN
admet-3007	805	1	[	[	X
admet-3007	805	2	110	110	NUM
admet-3007	805	3	]	]	PUNCT
admet-3007	805	4	m.	m.	NOUN
admet-3007	805	5	dehghani	dehghani	PROPN
admet-3007	805	6	,	,	PUNCT
admet-3007	805	7	b.	b.	PROPN
admet-3007	805	8	hajipour	hajipour	NOUN
admet-3007	805	9	-	-	PUNCT
admet-3007	805	10	verdom	verdom	NOUN
admet-3007	805	11	,	,	PUNCT
admet-3007	805	12	p.	p.	PROPN
admet-3007	805	13	abdolmaleki	abdolmaleki	PROPN
admet-3007	805	14	.	.	PUNCT
admet-3007	806	1	effect	effect	NOUN
admet-3007	806	2	of	of	ADP
admet-3007	806	3	precipitating	precipitate	VERB
admet-3007	806	4	agent	agent	NOUN
admet-3007	806	5	,	,	PUNCT
admet-3007	806	6	n2	n2	ADJ
admet-3007	806	7	gas	gas	NOUN
admet-3007	806	8	,	,	PUNCT
admet-3007	806	9	extract	extract	VERB
admet-3007	806	10	volume	volume	NOUN
admet-3007	806	11	and	and	CCONJ
admet-3007	806	12	ph	ph	NOUN
admet-3007	806	13	on	on	ADP
admet-3007	806	14	the	the	DET
admet-3007	806	15	magnetic	magnetic	ADJ
admet-3007	806	16	properties	property	NOUN
admet-3007	806	17	of	of	ADP
admet-3007	806	18	magnetite	magnetite	ADJ
admet-3007	806	19	nanoparticles	nanoparticle	NOUN
admet-3007	806	20	by	by	ADP
admet-3007	806	21	green	green	ADJ
admet-3007	806	22	synthesis	synthesis	NOUN
admet-3007	806	23	from	from	ADP
admet-3007	806	24	aqueous	aqueous	ADJ
admet-3007	806	25	pomegranate	pomegranate	NOUN
admet-3007	806	26	peel	peel	NOUN
admet-3007	806	27	extract	extract	NOUN
admet-3007	806	28	.	.	PUNCT
admet-3007	807	1	frontiers	frontier	NOUN
admet-3007	807	2	in	in	ADP
admet-3007	807	3	chemistry	chemistry	NOUN
admet-3007	807	4	12	12	NUM
admet-3007	807	5	(	(	PUNCT
admet-3007	807	6	2024	2024	NUM
admet-3007	807	7	)	)	PUNCT
admet-3007	807	8	1413077	1413077	NUM
admet-3007	807	9	.	.	PUNCT
admet-3007	808	1	https://doi.org/10.3389/fchem.2024.1413077	https://doi.org/10.3389/fchem.2024.1413077	PROPN
admet-3007	808	2	[	[	X
admet-3007	808	3	111	111	NUM
admet-3007	808	4	]	]	PUNCT
admet-3007	808	5	s.	s.	PROPN
admet-3007	808	6	chenarani	chenarani	PROPN
admet-3007	808	7	,	,	PUNCT
admet-3007	808	8	m.	m.	PROPN
admet-3007	808	9	ebrahimi	ebrahimi	PROPN
admet-3007	808	10	,	,	PUNCT
admet-3007	808	11	v.	v.	PROPN
admet-3007	808	12	arabali	arabali	PROPN
admet-3007	808	13	,	,	PUNCT
admet-3007	808	14	s.a	s.a	PROPN
admet-3007	808	15	.	.	PROPN
admet-3007	808	16	beyramabadi	beyramabadi	PROPN
admet-3007	808	17	.	.	PUNCT
admet-3007	809	1	zno/1	zno/1	PROPN
admet-3007	809	2	-	-	PUNCT
admet-3007	809	3	hexyl-3	hexyl-3	NOUN
admet-3007	809	4	-	-	PUNCT
admet-3007	809	5	methylimidazolium	methylimidazolium	NOUN
admet-3007	809	6	chloride	chloride	NOUN
admet-3007	809	7	paste	paste	NOUN
admet-3007	809	8	electrode	electrode	NOUN
admet-3007	809	9	,	,	PUNCT
admet-3007	809	10	highly	highly	ADV
admet-3007	809	11	sensitive	sensitive	ADJ
admet-3007	809	12	lorazepam	lorazepam	NOUN
admet-3007	809	13	sensor	sensor	PROPN
admet-3007	809	14	.	.	PUNCT
admet-3007	810	1	journal	journal	PROPN
admet-3007	810	2	of	of	ADP
admet-3007	810	3	electrochemical	electrochemical	ADJ
admet-3007	810	4	science	science	NOUN
admet-3007	810	5	and	and	CCONJ
admet-3007	810	6	engineering	engineering	NOUN
admet-3007	810	7	14	14	NUM
admet-3007	810	8	(	(	PUNCT
admet-3007	810	9	2024	2024	NUM
admet-3007	810	10	)	)	PUNCT
admet-3007	810	11	83	83	NUM
admet-3007	810	12	-	-	SYM
admet-3007	810	13	92	92	NUM
admet-3007	810	14	.	.	PUNCT
admet-3007	811	1	https://doi.org/10.5599/jese.1577	https://doi.org/10.5599/jese.1577	PRON
admet-3007	812	1	[	[	X
admet-3007	812	2	112	112	NUM
admet-3007	812	3	]	]	X
admet-3007	812	4	l.s	l.s	PROPN
admet-3007	812	5	.	.	PROPN
admet-3007	812	6	arias	arias	PROPN
admet-3007	812	7	,	,	PUNCT
admet-3007	812	8	j.p	j.p	PROPN
admet-3007	812	9	.	.	PROPN
admet-3007	812	10	pessan	pessan	PROPN
admet-3007	812	11	,	,	PUNCT
admet-3007	812	12	a.p.m	a.p.m	INTJ
admet-3007	812	13	.	.	PUNCT
admet-3007	812	14	vieira	vieira	PROPN
admet-3007	812	15	,	,	PUNCT
admet-3007	812	16	t.m.t.d	t.m.t.d	PROPN
admet-3007	812	17	.	.	PUNCT
admet-3007	812	18	lima	lima	PROPN
admet-3007	812	19	,	,	PUNCT
admet-3007	812	20	a.c.b	a.c.b	NOUN
admet-3007	812	21	.	.	PUNCT
admet-3007	813	1	delbem	delbem	PROPN
admet-3007	813	2	,	,	PUNCT
admet-3007	813	3	d.r	d.r	PROPN
admet-3007	813	4	.	.	PROPN
admet-3007	813	5	monteiro	monteiro	PROPN
admet-3007	813	6	.	.	PUNCT
admet-3007	814	1	iron	iron	NOUN
admet-3007	814	2	oxide	oxide	NOUN
admet-3007	814	3	nanoparticles	nanoparticle	NOUN
admet-3007	814	4	for	for	ADP
admet-3007	814	5	biomedical	biomedical	ADJ
admet-3007	814	6	applications	application	NOUN
admet-3007	814	7	:	:	PUNCT
admet-3007	814	8	a	a	DET
admet-3007	814	9	perspective	perspective	NOUN
admet-3007	814	10	on	on	ADP
admet-3007	814	11	synthesis	synthesis	NOUN
admet-3007	814	12	,	,	PUNCT
admet-3007	814	13	drugs	drug	NOUN
admet-3007	814	14	,	,	PUNCT
admet-3007	814	15	antimicrobial	antimicrobial	ADJ
admet-3007	814	16	activity	activity	NOUN
admet-3007	814	17	,	,	PUNCT
admet-3007	814	18	and	and	CCONJ
admet-3007	814	19	toxicity	toxicity	NOUN
admet-3007	814	20	.	.	PUNCT
admet-3007	815	1	antibiotics	antibiotic	NOUN
admet-3007	815	2	7	7	NUM
admet-3007	815	3	(	(	PUNCT
admet-3007	815	4	2018	2018	NUM
admet-3007	815	5	)	)	PUNCT
admet-3007	815	6	46	46	NUM
admet-3007	815	7	.	.	PUNCT
admet-3007	816	1	https://doi.org/10.3390/antibiotics7020046	https://doi.org/10.3390/antibiotics7020046	NOUN
admet-3007	816	2	[	[	X
admet-3007	816	3	113	113	NUM
admet-3007	816	4	]	]	PUNCT
admet-3007	816	5	m.	m.	NOUN
admet-3007	816	6	kazemi‐ashtiyani	kazemi‐ashtiyani	PROPN
admet-3007	816	7	,	,	PUNCT
admet-3007	816	8	b.	b.	PROPN
admet-3007	816	9	hajipour‐verdom	hajipour‐verdom	PROPN
admet-3007	816	10	,	,	PUNCT
admet-3007	816	11	m.	m.	NOUN
admet-3007	816	12	satari	satari	NOUN
admet-3007	816	13	,	,	PUNCT
admet-3007	816	14	p.	p.	PROPN
admet-3007	816	15	abdolmaleki	abdolmaleki	PROPN
admet-3007	816	16	,	,	PUNCT
admet-3007	816	17	s.	s.	PROPN
admet-3007	816	18	hosseinkhani	hosseinkhani	PROPN
admet-3007	816	19	,	,	PUNCT
admet-3007	816	20	h.	h.	PROPN
admet-3007	816	21	shaki	shaki	PROPN
admet-3007	816	22	.	.	PUNCT
admet-3007	817	1	estimating	estimate	VERB
admet-3007	817	2	the	the	DET
admet-3007	817	3	two	two	NUM
admet-3007	817	4	graph	graph	NOUN
admet-3007	817	5	dextran	dextran	NOUN
admet-3007	817	6	-	-	PUNCT
admet-3007	817	7	stearic	stearic	NOUN
admet-3007	817	8	acid	acid	NOUN
admet-3007	817	9	-	-	PUNCT
admet-3007	817	10	spermine	spermine	NOUN
admet-3007	817	11	polymers	polymer	NOUN
admet-3007	817	12	based	base	VERB
admet-3007	817	13	on	on	ADP
admet-3007	817	14	iron	iron	NOUN
admet-3007	817	15	oxide	oxide	NOUN
admet-3007	817	16	nanoparticles	nanoparticle	NOUN
admet-3007	817	17	as	as	ADP
admet-3007	817	18	carrier	carrier	NOUN
admet-3007	817	19	for	for	ADP
admet-3007	817	20	gene	gene	NOUN
admet-3007	817	21	delivery	delivery	NOUN
admet-3007	817	22	.	.	PUNCT
admet-3007	818	1	biopolymers	biopolymer	NOUN
admet-3007	818	2	113	113	NUM
admet-3007	818	3	(	(	PUNCT
admet-3007	818	4	2022	2022	NUM
admet-3007	818	5	)	)	PUNCT
admet-3007	818	6	e23491	e23491	NOUN
admet-3007	818	7	.	.	PUNCT
admet-3007	819	1	https://doi.org/10.1002/bip.23491	https://doi.org/10.1002/bip.23491	PROPN
admet-3007	820	1	[	[	X
admet-3007	820	2	114	114	NUM
admet-3007	820	3	]	]	PUNCT
admet-3007	820	4	f.	f.	PROPN
admet-3007	820	5	ashoori	ashoori	PROPN
admet-3007	820	6	,	,	PUNCT
admet-3007	820	7	b.	b.	PROPN
admet-3007	820	8	hajipour	hajipour	PROPN
admet-3007	820	9	-	-	PUNCT
admet-3007	820	10	verdom	verdom	NOUN
admet-3007	820	11	,	,	PUNCT
admet-3007	820	12	m.	m.	NOUN
admet-3007	820	13	satari	satari	NOUN
admet-3007	820	14	,	,	PUNCT
admet-3007	820	15	p.	p.	PROPN
admet-3007	820	16	abdolmaleki	abdolmaleki	PROPN
admet-3007	820	17	.	.	PUNCT
admet-3007	821	1	polyethylenimine	polyethylenimine	NOUN
admet-3007	821	2	-	-	PUNCT
admet-3007	821	3	based	base	VERB
admet-3007	821	4	iron	iron	NOUN
admet-3007	821	5	oxide	oxide	NOUN
admet-3007	821	6	nanoparticles	nanoparticle	NOUN
admet-3007	821	7	enhance	enhance	VERB
admet-3007	821	8	cisplatin	cisplatin	NOUN
admet-3007	821	9	toxicity	toxicity	NOUN
admet-3007	821	10	in	in	ADP
admet-3007	821	11	ovarian	ovarian	ADJ
admet-3007	821	12	cancer	cancer	NOUN
admet-3007	821	13	cells	cell	NOUN
admet-3007	821	14	in	in	ADP
admet-3007	821	15	the	the	DET
admet-3007	821	16	presence	presence	NOUN
admet-3007	821	17	of	of	ADP
admet-3007	821	18	a	a	DET
admet-3007	821	19	static	static	ADJ
admet-3007	821	20	magnetic	magnetic	ADJ
admet-3007	821	21	field	field	NOUN
admet-3007	821	22	.	.	PUNCT
admet-3007	822	1	frontiers	frontier	NOUN
admet-3007	822	2	in	in	ADP
admet-3007	822	3	oncology	oncology	NOUN
admet-3007	822	4	13	13	NUM
admet-3007	822	5	(	(	PUNCT
admet-3007	822	6	2023	2023	NUM
admet-3007	822	7	)	)	PUNCT
admet-3007	822	8	1217800	1217800	NUM
admet-3007	822	9	.	.	PUNCT
admet-3007	823	1	https://doi.org/10.3389/fonc.2023.1217800	https://doi.org/10.3389/fonc.2023.1217800	PROPN
admet-3007	823	2	[	[	X
admet-3007	823	3	115	115	NUM
admet-3007	823	4	]	]	X
admet-3007	823	5	a.f	a.f	PROPN
admet-3007	823	6	.	.	PROPN
admet-3007	823	7	farag	farag	PROPN
admet-3007	823	8	,	,	PUNCT
admet-3007	823	9	n.f	n.f	PROPN
admet-3007	823	10	.	.	PROPN
admet-3007	823	11	hassabou	hassabou	PROPN
admet-3007	823	12	.	.	PUNCT
admet-3007	824	1	cd24	cd24	PROPN
admet-3007	824	2	-	-	PUNCT
admet-3007	824	3	gold	gold	NOUN
admet-3007	824	4	nanocomposite	nanocomposite	NOUN
admet-3007	824	5	as	as	ADP
admet-3007	824	6	promising	promising	ADJ
admet-3007	824	7	and	and	CCONJ
admet-3007	824	8	sensitive	sensitive	ADJ
admet-3007	824	9	biomarker	biomarker	NOUN
admet-3007	824	10	for	for	ADP
admet-3007	824	11	cancer	cancer	NOUN
admet-3007	824	12	stem	stem	NOUN
admet-3007	824	13	cells	cell	NOUN
admet-3007	824	14	in	in	ADP
admet-3007	824	15	salivary	salivary	ADJ
admet-3007	824	16	gland	gland	NOUN
admet-3007	824	17	tumors	tumor	NOUN
admet-3007	824	18	.	.	PUNCT
admet-3007	825	1	nanomedicine	nanomedicine	NOUN
admet-3007	825	2	:	:	PUNCT
admet-3007	825	3	nanotechnology	nanotechnology	NOUN
admet-3007	825	4	,	,	PUNCT
admet-3007	825	5	biology	biology	NOUN
admet-3007	825	6	and	and	CCONJ
admet-3007	825	7	medicine	medicine	NOUN
admet-3007	825	8	46	46	NUM
admet-3007	825	9	(	(	PUNCT
admet-3007	825	10	2022	2022	NUM
admet-3007	825	11	)	)	PUNCT
admet-3007	825	12	102598	102598	NUM
admet-3007	825	13	.	.	PUNCT
admet-3007	826	1	https://doi.org/10.1016/j.nano.2022.102598	https://doi.org/10.1016/j.nano.2022.102598	ADJ
admet-3007	826	2	[	[	X
admet-3007	826	3	116	116	NUM
admet-3007	826	4	]	]	PUNCT
admet-3007	826	5	m.	m.	NOUN
admet-3007	826	6	satari	satari	PROPN
admet-3007	826	7	,	,	PUNCT
admet-3007	826	8	b.	b.	PROPN
admet-3007	826	9	hajipoor	hajipoor	PROPN
admet-3007	826	10	,	,	PUNCT
admet-3007	826	11	s.	s.	PROPN
admet-3007	826	12	hosseinkhani	hosseinkhani	PROPN
admet-3007	826	13	,	,	PUNCT
admet-3007	826	14	p.	p.	PROPN
admet-3007	826	15	abdolmaleki	abdolmaleki	PROPN
admet-3007	826	16	.	.	PUNCT
admet-3007	827	1	investigating	investigate	VERB
admet-3007	827	2	the	the	DET
admet-3007	827	3	effect	effect	NOUN
admet-3007	827	4	of	of	ADP
admet-3007	827	5	50	50	NUM
admet-3007	827	6	hz	hz	VERB
admet-3007	827	7	alternating	alternate	VERB
admet-3007	827	8	magnetic	magnetic	ADJ
admet-3007	827	9	field	field	NOUN
admet-3007	827	10	on	on	ADP
admet-3007	827	11	nucleic	nucleic	ADJ
admet-3007	827	12	acid	acid	NOUN
admet-3007	827	13	delivery	delivery	NOUN
admet-3007	827	14	by	by	ADP
admet-3007	827	15	magnetofection	magnetofection	NOUN
admet-3007	827	16	method	method	NOUN
admet-3007	827	17	.	.	PUNCT
admet-3007	828	1	modares	modare	NOUN
admet-3007	828	2	journal	journal	PROPN
admet-3007	828	3	of	of	ADP
admet-3007	828	4	biotechnology	biotechnology	NOUN
admet-3007	828	5	15	15	NUM
admet-3007	828	6	(	(	PUNCT
admet-3007	828	7	2024	2024	NUM
admet-3007	828	8	)	)	PUNCT
admet-3007	828	9	22721	22721	NUM
admet-3007	828	10	.	.	PUNCT
admet-3007	829	1	https://biot.modares.ac.ir/article_22721	https://biot.modares.ac.ir/article_22721	PROPN
admet-3007	829	2	https://doi.org/10.3390/ijms19030710	https://doi.org/10.3390/ijms19030710	PROPN
admet-3007	829	3	https://doi.org/10.1016/b978-0-323-90951-8.00001-1	https://doi.org/10.1016/b978-0-323-90951-8.00001-1	PROPN
admet-3007	829	4	https://doi.org/10.1080/08982104.2024.2305866	https://doi.org/10.1080/08982104.2024.2305866	PROPN
admet-3007	830	1	https://doi.org/10.1016/j.colsurfb.2021.111775	https://doi.org/10.1016/j.colsurfb.2021.111775	PROPN
admet-3007	830	2	https://doi.org/10.1021/acs.biomac.0c01546	https://doi.org/10.1021/acs.biomac.0c01546	VERB
admet-3007	830	3	https://doi.org/10.1021/nn506928p	https://doi.org/10.1021/nn506928p	PROPN
admet-3007	830	4	https://doi.org/10.1016/j.nano.2015.07.001	https://doi.org/10.1016/j.nano.2015.07.001	VERB
admet-3007	830	5	https://doi.org/10.1016/j.matpr.2019.07.371	https://doi.org/10.1016/j.matpr.2019.07.371	NOUN
admet-3007	830	6	https://doi.org/10.3390/iocn2023-14444	https://doi.org/10.3390/iocn2023-14444	NOUN
admet-3007	830	7	https://doi.org/10.3389/fchem.2024.1413077	https://doi.org/10.3389/fchem.2024.1413077	PROPN
admet-3007	831	1	https://doi.org/10.5599/jese.1577	https://doi.org/10.5599/jese.1577	PRON
admet-3007	831	2	https://doi.org/10.3390/antibiotics7020046	https://doi.org/10.3390/antibiotics7020046	NOUN
admet-3007	831	3	https://doi.org/10.1002/bip.23491	https://doi.org/10.1002/bip.23491	PROPN
admet-3007	831	4	https://doi.org/10.3389/fonc.2023.1217800	https://doi.org/10.3389/fonc.2023.1217800	PROPN
admet-3007	831	5	https://doi.org/10.1016/j.nano.2022.102598	https://doi.org/10.1016/j.nano.2022.102598	PROPN
admet-3007	831	6	https://biot.modares.ac.ir/article_22721_67ab956e8f485c44a4c5060e33dd6ca0.pdf	https://biot.modares.ac.ir/article_22721_67ab956e8f485c44a4c5060e33dd6ca0.pdf	PROPN
admet-3007	831	7	admet	admet	PROPN
admet-3007	831	8	&	&	CCONJ
admet-3007	831	9	dmpk	dmpk	PROPN
admet-3007	831	10	13(5	13(5	NOUN
admet-3007	831	11	)	)	PUNCT
admet-3007	831	12	(	(	PUNCT
admet-3007	831	13	2025	2025	NUM
admet-3007	831	14	)	)	PUNCT
admet-3007	831	15	3007	3007	NUM
admet-3007	831	16	nano	nano	NOUN
admet-3007	831	17	-	-	PUNCT
admet-3007	831	18	biomaterials	biomaterial	NOUN
admet-3007	831	19	in	in	ADP
admet-3007	831	20	cancer	cancer	NOUN
admet-3007	831	21	therapy	therapy	NOUN
admet-3007	831	22	doi	doi	PROPN
admet-3007	831	23	:	:	PUNCT
admet-3007	831	24	https://doi.org/10.5599/admet.3007	https://doi.org/10.5599/admet.3007	NOUN
admet-3007	831	25	25	25	NUM
admet-3007	832	1	[	[	SYM
admet-3007	832	2	117	117	NUM
admet-3007	832	3	]	]	X
admet-3007	832	4	h.p	h.p	PROPN
admet-3007	832	5	.	.	PROPN
admet-3007	832	6	kok	kok	PROPN
admet-3007	832	7	,	,	PUNCT
admet-3007	832	8	e.n	e.n	PROPN
admet-3007	832	9	.	.	PROPN
admet-3007	832	10	cressman	cressman	PROPN
admet-3007	832	11	,	,	PUNCT
admet-3007	832	12	w.	w.	PROPN
admet-3007	832	13	ceelen	ceelen	PROPN
admet-3007	832	14	,	,	PUNCT
admet-3007	832	15	c.l	c.l	PROPN
admet-3007	832	16	.	.	PROPN
admet-3007	832	17	brace	brace	PROPN
admet-3007	832	18	,	,	PUNCT
admet-3007	832	19	r.	r.	PROPN
admet-3007	832	20	ivkov	ivkov	PROPN
admet-3007	832	21	,	,	PUNCT
admet-3007	832	22	h.	h.	PROPN
admet-3007	832	23	grüll	grüll	PROPN
admet-3007	832	24	,	,	PUNCT
admet-3007	832	25	g.	g.	PROPN
admet-3007	832	26	ter	ter	PROPN
admet-3007	832	27	haar	haar	PROPN
admet-3007	832	28	,	,	PUNCT
admet-3007	832	29	p.	p.	NOUN
admet-3007	832	30	wust	wust	NOUN
admet-3007	832	31	,	,	PUNCT
admet-3007	832	32	j.	j.	PROPN
admet-3007	832	33	crezee	crezee	PROPN
admet-3007	832	34	.	.	PUNCT
admet-3007	833	1	heating	heating	NOUN
admet-3007	833	2	technology	technology	NOUN
admet-3007	833	3	for	for	ADP
admet-3007	833	4	malignant	malignant	ADJ
admet-3007	833	5	tumors	tumor	NOUN
admet-3007	833	6	.	.	PUNCT
admet-3007	834	1	international	international	ADJ
admet-3007	834	2	journal	journal	PROPN
admet-3007	834	3	of	of	ADP
admet-3007	834	4	hyperthermia	hyperthermia	PROPN
admet-3007	834	5	37	37	NUM
admet-3007	834	6	(	(	PUNCT
admet-3007	834	7	2020	2020	NUM
admet-3007	834	8	)	)	PUNCT
admet-3007	834	9	711	711	NUM
admet-3007	834	10	-	-	SYM
admet-3007	834	11	741	741	NUM
admet-3007	834	12	.	.	PUNCT
admet-3007	834	13	https://doi.org/10.1080/02656736.2020.1779357	https://doi.org/10.1080/02656736.2020.1779357	PUNCT
admet-3007	835	1	[	[	X
admet-3007	835	2	118	118	NUM
admet-3007	835	3	]	]	PUNCT
admet-3007	835	4	t.	t.	PROPN
admet-3007	835	5	sadhukha	sadhukha	PROPN
admet-3007	835	6	,	,	PUNCT
admet-3007	835	7	l.	l.	PROPN
admet-3007	835	8	niu	niu	PROPN
admet-3007	835	9	,	,	PUNCT
admet-3007	835	10	t.s	t.s	PROPN
admet-3007	835	11	.	.	PROPN
admet-3007	835	12	wiedmann	wiedmann	PROPN
admet-3007	835	13	,	,	PUNCT
admet-3007	835	14	j.	j.	PROPN
admet-3007	835	15	panyam	panyam	PROPN
admet-3007	835	16	.	.	PUNCT
admet-3007	836	1	effective	effective	ADJ
admet-3007	836	2	elimination	elimination	NOUN
admet-3007	836	3	of	of	ADP
admet-3007	836	4	cancer	cancer	NOUN
admet-3007	836	5	stem	stem	NOUN
admet-3007	836	6	cells	cell	NOUN
admet-3007	836	7	by	by	ADP
admet-3007	836	8	magnetic	magnetic	ADJ
admet-3007	836	9	hyperthermia	hyperthermia	NOUN
admet-3007	836	10	.	.	PUNCT
admet-3007	837	1	molecular	molecular	ADJ
admet-3007	837	2	pharmaceutics	pharmaceutic	NOUN
admet-3007	837	3	10	10	NUM
admet-3007	837	4	(	(	PUNCT
admet-3007	837	5	2013	2013	NUM
admet-3007	837	6	)	)	PUNCT
admet-3007	837	7	1432	1432	NUM
admet-3007	837	8	-	-	SYM
admet-3007	837	9	1441	1441	NUM
admet-3007	837	10	.	.	PUNCT
admet-3007	838	1	https://doi.org/10.1021/mp400015b	https://doi.org/10.1021/mp400015b	NOUN
admet-3007	839	1	[	[	X
admet-3007	839	2	119	119	NUM
admet-3007	839	3	]	]	X
admet-3007	839	4	y.	y.	PROPN
admet-3007	839	5	xu	xu	PROPN
admet-3007	839	6	,	,	PUNCT
admet-3007	839	7	j.	j.	PROPN
admet-3007	839	8	wang	wang	PROPN
admet-3007	839	9	,	,	PUNCT
admet-3007	839	10	x.	x.	PROPN
admet-3007	839	11	li	li	PROPN
admet-3007	839	12	,	,	PUNCT
admet-3007	839	13	y.	y.	PROPN
admet-3007	839	14	liu	liu	PROPN
admet-3007	839	15	,	,	PUNCT
admet-3007	839	16	l.	l.	PROPN
admet-3007	839	17	dai	dai	PROPN
admet-3007	839	18	,	,	PUNCT
admet-3007	839	19	x.	x.	PROPN
admet-3007	839	20	wu	wu	PROPN
admet-3007	839	21	,	,	PUNCT
admet-3007	839	22	c.	c.	PROPN
admet-3007	839	23	chen	chen	PROPN
admet-3007	839	24	.	.	PUNCT
admet-3007	840	1	selective	selective	ADJ
admet-3007	840	2	inhibition	inhibition	NOUN
admet-3007	840	3	of	of	ADP
admet-3007	840	4	breast	breast	NOUN
admet-3007	840	5	cancer	cancer	NOUN
admet-3007	840	6	stem	stem	NOUN
admet-3007	840	7	cells	cell	NOUN
admet-3007	840	8	by	by	ADP
admet-3007	840	9	gold	gold	NOUN
admet-3007	840	10	nanorods	nanorod	NOUN
admet-3007	840	11	mediated	mediate	VERB
admet-3007	840	12	plasmonic	plasmonic	NOUN
admet-3007	840	13	hyperthermia	hyperthermia	NOUN
admet-3007	840	14	.	.	PUNCT
admet-3007	841	1	biomaterials	biomaterial	NOUN
admet-3007	841	2	35	35	NUM
admet-3007	841	3	(	(	PUNCT
admet-3007	841	4	2014	2014	NUM
admet-3007	841	5	)	)	PUNCT
admet-3007	841	6	4667	4667	NUM
admet-3007	841	7	-	-	SYM
admet-3007	841	8	4677	4677	NUM
admet-3007	841	9	.	.	PUNCT
admet-3007	842	1	https://doi.org/10.1016/j.biomaterials.2014.02.035	https://doi.org/10.1016/j.biomaterials.2014.02.035	NOUN
admet-3007	842	2	[	[	PUNCT
admet-3007	842	3	120	120	NUM
admet-3007	842	4	]	]	PUNCT
admet-3007	842	5	k.	k.	PROPN
admet-3007	842	6	bhattacharya	bhattacharya	PROPN
admet-3007	842	7	,	,	PUNCT
admet-3007	842	8	s.p	s.p	PROPN
admet-3007	842	9	.	.	PROPN
admet-3007	842	10	mukherjee	mukherjee	PROPN
admet-3007	842	11	,	,	PUNCT
admet-3007	842	12	a.	a.	PROPN
admet-3007	842	13	gallud	gallud	PROPN
admet-3007	842	14	,	,	PUNCT
admet-3007	842	15	s.c	s.c	PROPN
admet-3007	842	16	.	.	PROPN
admet-3007	842	17	burkert	burkert	PROPN
admet-3007	842	18	,	,	PUNCT
admet-3007	842	19	s.	s.	PROPN
admet-3007	842	20	bistarelli	bistarelli	PROPN
admet-3007	842	21	,	,	PUNCT
admet-3007	842	22	s.	s.	PROPN
admet-3007	842	23	bellucci	bellucci	PROPN
admet-3007	842	24	,	,	PUNCT
admet-3007	842	25	m.	m.	NOUN
admet-3007	842	26	bottini	bottini	PROPN
admet-3007	842	27	,	,	PUNCT
admet-3007	842	28	a.	a.	NOUN
admet-3007	842	29	star	star	PROPN
admet-3007	842	30	,	,	PUNCT
admet-3007	842	31	b.	b.	PROPN
admet-3007	842	32	fadeel	fadeel	PROPN
admet-3007	842	33	.	.	PUNCT
admet-3007	843	1	biological	biological	ADJ
admet-3007	843	2	interactions	interaction	NOUN
admet-3007	843	3	of	of	ADP
admet-3007	843	4	carbon	carbon	NOUN
admet-3007	843	5	-	-	PUNCT
admet-3007	843	6	based	base	VERB
admet-3007	843	7	nanomaterials	nanomaterial	NOUN
admet-3007	843	8	:	:	PUNCT
admet-3007	843	9	from	from	ADP
admet-3007	843	10	coronation	coronation	NOUN
admet-3007	843	11	to	to	ADP
admet-3007	843	12	degradation	degradation	NOUN
admet-3007	843	13	.	.	PUNCT
admet-3007	844	1	nanomedicine	nanomedicine	NOUN
admet-3007	844	2	:	:	PUNCT
admet-3007	844	3	nanotechnology	nanotechnology	NOUN
admet-3007	844	4	,	,	PUNCT
admet-3007	844	5	biology	biology	NOUN
admet-3007	844	6	and	and	CCONJ
admet-3007	844	7	medicine	medicine	NOUN
admet-3007	844	8	12	12	NUM
admet-3007	844	9	(	(	PUNCT
admet-3007	844	10	2016	2016	NUM
admet-3007	844	11	)	)	PUNCT
admet-3007	844	12	333	333	NUM
admet-3007	844	13	-	-	SYM
admet-3007	844	14	351	351	NUM
admet-3007	844	15	.	.	PUNCT
admet-3007	845	1	https://doi.org/10.1016/j.nano.2015.11.011	https://doi.org/10.1016/j.nano.2015.11.011	NUM
admet-3007	846	1	[	[	X
admet-3007	846	2	121	121	NUM
admet-3007	846	3	]	]	PUNCT
admet-3007	846	4	p.	p.	NOUN
admet-3007	846	5	gowtham	gowtham	PROPN
admet-3007	846	6	,	,	PUNCT
admet-3007	846	7	k.	k.	PROPN
admet-3007	846	8	harini	harini	PROPN
admet-3007	846	9	,	,	PUNCT
admet-3007	846	10	a.	a.	NOUN
admet-3007	846	11	thirumalai	thirumalai	PROPN
admet-3007	846	12	,	,	PUNCT
admet-3007	846	13	p.	p.	PROPN
admet-3007	846	14	pallavi	pallavi	PROPN
admet-3007	846	15	,	,	PUNCT
admet-3007	846	16	k.	k.	PROPN
admet-3007	846	17	girigoswami	girigoswami	PROPN
admet-3007	846	18	,	,	PUNCT
admet-3007	846	19	a.	a.	PROPN
admet-3007	846	20	girigoswami	girigoswami	PROPN
admet-3007	846	21	.	.	PUNCT
admet-3007	847	1	synthetic	synthetic	ADJ
admet-3007	847	2	routes	route	NOUN
admet-3007	847	3	to	to	ADP
admet-3007	847	4	theranostic	theranostic	ADJ
admet-3007	847	5	applications	application	NOUN
admet-3007	847	6	of	of	ADP
admet-3007	847	7	carbon	carbon	NOUN
admet-3007	847	8	-	-	PUNCT
admet-3007	847	9	based	base	VERB
admet-3007	847	10	quantum	quantum	NOUN
admet-3007	847	11	dots	dot	NOUN
admet-3007	847	12	.	.	PUNCT
admet-3007	848	1	admet	admet	PROPN
admet-3007	848	2	and	and	CCONJ
admet-3007	848	3	dmpk	dmpk	X
admet-3007	848	4	11	11	NUM
admet-3007	848	5	(	(	PUNCT
admet-3007	848	6	2023	2023	NUM
admet-3007	848	7	)	)	PUNCT
admet-3007	848	8	457	457	NUM
admet-3007	848	9	-	-	SYM
admet-3007	848	10	485	485	NUM
admet-3007	848	11	.	.	PUNCT
admet-3007	848	12	https://doi.org/10.5599/admet.1747	https://doi.org/10.5599/admet.1747	X
admet-3007	849	1	[	[	X
admet-3007	849	2	122	122	NUM
admet-3007	849	3	]	]	PUNCT
admet-3007	849	4	a.	a.	NOUN
admet-3007	849	5	al	al	PROPN
admet-3007	849	6	faraj	faraj	PROPN
admet-3007	849	7	,	,	PUNCT
admet-3007	849	8	a.s	a.s	PROPN
admet-3007	849	9	.	.	PROPN
admet-3007	849	10	shaik	shaik	PROPN
admet-3007	849	11	,	,	PUNCT
admet-3007	849	12	b.	b.	PROPN
admet-3007	849	13	al	al	PROPN
admet-3007	849	14	sayed	sayed	PROPN
admet-3007	849	15	,	,	PUNCT
admet-3007	849	16	r.	r.	PROPN
admet-3007	849	17	halwani	halwani	PROPN
admet-3007	849	18	,	,	PUNCT
admet-3007	849	19	i.	i.	PROPN
admet-3007	849	20	al	al	PROPN
admet-3007	849	21	jammaz	jammaz	PROPN
admet-3007	849	22	.	.	PUNCT
admet-3007	850	1	specific	specific	ADJ
admet-3007	850	2	targeting	targeting	NOUN
admet-3007	850	3	and	and	CCONJ
admet-3007	850	4	noninvasive	noninvasive	ADJ
admet-3007	850	5	imaging	imaging	NOUN
admet-3007	850	6	of	of	ADP
admet-3007	850	7	breast	breast	NOUN
admet-3007	850	8	cancer	cancer	NOUN
admet-3007	850	9	stem	stem	NOUN
admet-3007	850	10	cells	cell	NOUN
admet-3007	850	11	using	use	VERB
admet-3007	850	12	single	single	ADJ
admet-3007	850	13	-	-	PUNCT
admet-3007	850	14	walled	wall	VERB
admet-3007	850	15	carbon	carbon	NOUN
admet-3007	850	16	nanotubes	nanotube	NOUN
admet-3007	850	17	as	as	ADP
admet-3007	850	18	novel	novel	ADJ
admet-3007	850	19	multimodality	multimodality	NOUN
admet-3007	850	20	nanoprobes	nanoprobe	NOUN
admet-3007	850	21	.	.	PUNCT
admet-3007	851	1	nanomedicine	nanomedicine	NOUN
admet-3007	851	2	11	11	NUM
admet-3007	851	3	(	(	PUNCT
admet-3007	851	4	2016	2016	NUM
admet-3007	851	5	)	)	PUNCT
admet-3007	851	6	31	31	NUM
admet-3007	851	7	-	-	SYM
admet-3007	851	8	46	46	NUM
admet-3007	851	9	.	.	PUNCT
admet-3007	852	1	https://doi.org/10.2217/nnm.15.182	https://doi.org/10.2217/nnm.15.182	PROPN
admet-3007	853	1	[	[	X
admet-3007	853	2	123	123	NUM
admet-3007	853	3	]	]	PUNCT
admet-3007	853	4	y.	y.	PROPN
admet-3007	853	5	miao	miao	PROPN
admet-3007	853	6	,	,	PUNCT
admet-3007	853	7	h.	h.	PROPN
admet-3007	853	8	zhang	zhang	PROPN
admet-3007	853	9	,	,	PUNCT
admet-3007	853	10	y.	y.	PROPN
admet-3007	853	11	pan	pan	PROPN
admet-3007	853	12	,	,	PUNCT
admet-3007	853	13	j.	j.	PROPN
admet-3007	853	14	ren	ren	PROPN
admet-3007	853	15	,	,	PUNCT
admet-3007	853	16	m.	m.	NOUN
admet-3007	853	17	ye	ye	PROPN
admet-3007	853	18	,	,	PUNCT
admet-3007	853	19	f.	f.	PROPN
admet-3007	853	20	xia	xia	PROPN
admet-3007	853	21	,	,	PUNCT
admet-3007	853	22	r.	r.	PROPN
admet-3007	853	23	huang	huang	PROPN
admet-3007	853	24	,	,	PUNCT
admet-3007	853	25	z.	z.	PROPN
admet-3007	853	26	lin	lin	PROPN
admet-3007	853	27	,	,	PUNCT
admet-3007	853	28	s.	s.	PROPN
admet-3007	853	29	jiang	jiang	PROPN
admet-3007	853	30	,	,	PUNCT
admet-3007	853	31	y.	y.	PROPN
admet-3007	853	32	zhang	zhang	PROPN
admet-3007	853	33	.	.	PUNCT
admet-3007	854	1	single	single	ADJ
admet-3007	854	2	-	-	PUNCT
admet-3007	854	3	walled	wall	VERB
admet-3007	854	4	carbon	carbon	NOUN
admet-3007	854	5	nanotube	nanotube	NOUN
admet-3007	854	6	:	:	PUNCT
admet-3007	854	7	one	one	NUM
admet-3007	854	8	specific	specific	ADJ
admet-3007	854	9	inhibitor	inhibitor	NOUN
admet-3007	854	10	of	of	ADP
admet-3007	854	11	cancer	cancer	NOUN
admet-3007	854	12	stem	stem	NOUN
admet-3007	854	13	cells	cell	NOUN
admet-3007	854	14	in	in	ADP
admet-3007	854	15	osteosarcoma	osteosarcoma	ADJ
admet-3007	854	16	upon	upon	SCONJ
admet-3007	854	17	downregulation	downregulation	NOUN
admet-3007	854	18	of	of	ADP
admet-3007	854	19	the	the	DET
admet-3007	854	20	tgfβ1	tgfβ1	NOUN
admet-3007	854	21	signaling	signal	VERB
admet-3007	854	22	.	.	PUNCT
admet-3007	855	1	biomaterials	biomaterial	NOUN
admet-3007	855	2	149	149	NUM
admet-3007	855	3	(	(	PUNCT
admet-3007	855	4	2017	2017	NUM
admet-3007	855	5	)	)	PUNCT
admet-3007	855	6	29	29	NUM
admet-3007	855	7	-	-	SYM
admet-3007	855	8	40	40	NUM
admet-3007	855	9	.	.	PUNCT
admet-3007	856	1	https://doi.org/10.1016/j.biomaterials.2017.09.032	https://doi.org/10.1016/j.biomaterials.2017.09.032	PRON
admet-3007	857	1	[	[	X
admet-3007	857	2	124	124	NUM
admet-3007	857	3	]	]	X
admet-3007	857	4	j.p	j.p	PROPN
admet-3007	857	5	.	.	PROPN
admet-3007	857	6	rao	rao	PROPN
admet-3007	857	7	,	,	PUNCT
admet-3007	857	8	k.e	k.e	PROPN
admet-3007	857	9	.	.	PROPN
admet-3007	857	10	geckeler	geckeler	NOUN
admet-3007	857	11	.	.	PUNCT
admet-3007	858	1	polymer	polymer	NOUN
admet-3007	858	2	nanoparticles	nanoparticle	NOUN
admet-3007	858	3	:	:	PUNCT
admet-3007	858	4	preparation	preparation	NOUN
admet-3007	858	5	techniques	technique	NOUN
admet-3007	858	6	and	and	CCONJ
admet-3007	858	7	size	size	NOUN
admet-3007	858	8	-	-	PUNCT
admet-3007	858	9	control	control	NOUN
admet-3007	858	10	parameters	parameter	NOUN
admet-3007	858	11	.	.	PUNCT
admet-3007	859	1	progress	progress	NOUN
admet-3007	859	2	in	in	ADP
admet-3007	859	3	polymer	polymer	NOUN
admet-3007	859	4	science	science	NOUN
admet-3007	859	5	36	36	NUM
admet-3007	859	6	(	(	PUNCT
admet-3007	859	7	2011	2011	NUM
admet-3007	859	8	)	)	PUNCT
admet-3007	859	9	887	887	NUM
admet-3007	859	10	-	-	SYM
admet-3007	859	11	913	913	NUM
admet-3007	859	12	.	.	PUNCT
admet-3007	860	1	https://doi.org/10.1016/j.progpolymsci.2011.01.001	https://doi.org/10.1016/j.progpolymsci.2011.01.001	NOUN
admet-3007	861	1	[	[	X
admet-3007	861	2	125	125	NUM
admet-3007	861	3	]	]	X
admet-3007	861	4	y.	y.	PROPN
admet-3007	861	5	gao	gao	PROPN
admet-3007	861	6	,	,	PUNCT
admet-3007	861	7	a.n	a.n	PROPN
admet-3007	861	8	.	.	PROPN
admet-3007	861	9	shelling	shelling	PROPN
admet-3007	861	10	,	,	PUNCT
admet-3007	861	11	e.	e.	PROPN
admet-3007	861	12	nolan	nolan	PROPN
admet-3007	861	13	,	,	PUNCT
admet-3007	861	14	d.	d.	PROPN
admet-3007	861	15	porter	porter	PROPN
admet-3007	861	16	,	,	PUNCT
admet-3007	861	17	e.	e.	PROPN
admet-3007	861	18	leung	leung	PROPN
admet-3007	861	19	,	,	PUNCT
admet-3007	861	20	z.	z.	PROPN
admet-3007	861	21	wu	wu	PROPN
admet-3007	861	22	.	.	PUNCT
admet-3007	861	23	liposome	liposome	NOUN
admet-3007	861	24	-	-	PUNCT
admet-3007	861	25	enabled	enable	VERB
admet-3007	861	26	bufalin	bufalin	NOUN
admet-3007	861	27	and	and	CCONJ
admet-3007	861	28	doxorubicin	doxorubicin	PROPN
admet-3007	861	29	combination	combination	NOUN
admet-3007	861	30	therapy	therapy	NOUN
admet-3007	861	31	for	for	ADP
admet-3007	861	32	trastuzumab	trastuzumab	NOUN
admet-3007	861	33	-	-	PUNCT
admet-3007	861	34	resistant	resistant	ADJ
admet-3007	861	35	breast	breast	NOUN
admet-3007	861	36	cancer	cancer	NOUN
admet-3007	861	37	with	with	ADP
admet-3007	861	38	a	a	DET
admet-3007	861	39	focus	focus	NOUN
admet-3007	861	40	on	on	ADP
admet-3007	861	41	cancer	cancer	NOUN
admet-3007	861	42	stem	stem	NOUN
admet-3007	861	43	cells	cell	NOUN
admet-3007	861	44	.	.	PUNCT
admet-3007	862	1	journal	journal	NOUN
admet-3007	862	2	of	of	ADP
admet-3007	862	3	liposome	liposome	PROPN
admet-3007	862	4	research	research	NOUN
admet-3007	862	5	34	34	NUM
admet-3007	862	6	(	(	PUNCT
admet-3007	862	7	2024	2024	NUM
admet-3007	862	8	)	)	PUNCT
admet-3007	862	9	489	489	NUM
admet-3007	862	10	-	-	PUNCT
admet-3007	862	11	506	506	NUM
admet-3007	862	12	.	.	PUNCT
admet-3007	863	1	https://doi.org/10.1080/08982104.2024.2305866	https://doi.org/10.1080/08982104.2024.2305866	PROPN
admet-3007	864	1	©	©	PROPN
admet-3007	864	2	2025	2025	NUM
admet-3007	864	3	by	by	ADP
admet-3007	864	4	the	the	DET
admet-3007	864	5	authors	author	NOUN
admet-3007	864	6	;	;	PUNCT
admet-3007	864	7	licensee	licensee	PROPN
admet-3007	864	8	iapc	iapc	PROPN
admet-3007	864	9	,	,	PUNCT
admet-3007	864	10	zagreb	zagreb	PROPN
admet-3007	864	11	,	,	PUNCT
admet-3007	864	12	croatia	croatia	PROPN
admet-3007	864	13	.	.	PUNCT
admet-3007	865	1	this	this	DET
admet-3007	865	2	article	article	NOUN
admet-3007	865	3	is	be	AUX
admet-3007	865	4	an	an	DET
admet-3007	865	5	open	open	ADJ
admet-3007	865	6	-	-	PUNCT
admet-3007	865	7	access	access	NOUN
admet-3007	865	8	article	article	NOUN
admet-3007	865	9	distributed	distribute	VERB
admet-3007	865	10	under	under	ADP
admet-3007	865	11	the	the	DET
admet-3007	865	12	terms	term	NOUN
admet-3007	865	13	and	and	CCONJ
admet-3007	865	14	conditions	condition	NOUN
admet-3007	865	15	of	of	ADP
admet-3007	865	16	the	the	DET
admet-3007	865	17	creative	creative	ADJ
admet-3007	865	18	commons	common	NOUN
admet-3007	865	19	attribution	attribution	NOUN
admet-3007	865	20	license	license	NOUN
admet-3007	865	21	(	(	PUNCT
admet-3007	865	22	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN
admet-3007	865	23	)	)	PUNCT
admet-3007	865	24	https://doi.org/10.5599/admet.3007	https://doi.org/10.5599/admet.3007	NOUN
admet-3007	865	25	https://doi.org/10.1080/02656736.2020.1779357	https://doi.org/10.1080/02656736.2020.1779357	X
admet-3007	865	26	https://doi.org/10.1021/mp400015b	https://doi.org/10.1021/mp400015b	PROPN
admet-3007	865	27	https://doi.org/10.1016/j.biomaterials.2014.02.035	https://doi.org/10.1016/j.biomaterials.2014.02.035	NOUN
admet-3007	865	28	https://doi.org/10.1016/j.nano.2015.11.011	https://doi.org/10.1016/j.nano.2015.11.011	NUM
admet-3007	865	29	https://doi.org/10.5599/admet.1747	https://doi.org/10.5599/admet.1747	NOUN
admet-3007	865	30	https://doi.org/10.2217/nnm.15.182	https://doi.org/10.2217/nnm.15.182	NOUN
admet-3007	865	31	https://doi.org/10.1016/j.progpolymsci.2011.01.001	https://doi.org/10.1016/j.progpolymsci.2011.01.001	NOUN
admet-3007	865	32	https://doi.org/10.1080/08982104.2024.2305866	https://doi.org/10.1080/08982104.2024.2305866	PROPN
admet-3007	865	33	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN